Citrus Sinensis ID: 005054
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 716 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.305 | 0.234 | 0.630 | 9e-81 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.312 | 0.272 | 0.622 | 7e-78 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.297 | 0.165 | 0.479 | 2e-55 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.291 | 0.126 | 0.436 | 5e-54 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.284 | 0.317 | 0.480 | 4e-53 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.298 | 0.285 | 0.455 | 9e-53 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.287 | 0.298 | 0.461 | 2e-51 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.294 | 0.230 | 0.446 | 3e-51 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.294 | 0.129 | 0.427 | 7e-49 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.291 | 0.126 | 0.436 | 2e-48 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 301 bits (772), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 138/219 (63%), Positives = 169/219 (77%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEV 553
D D + EI W DL I E+IG GS G VYHA W+G++VAVK F Q++S + FR EV
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEV 715
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+A
Sbjct: 716 RIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVA 775
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GTP+WMA
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
PEVLRNEPS+EK DVYSFGVILWELAT ++PW +N MQ
Sbjct: 836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQ 874
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 142/228 (62%), Positives = 179/228 (78%), Gaps = 4/228 (1%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVI 546
A ++ LD D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++ E +
Sbjct: 533 ANRELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV 590
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRR 604
+ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD RR
Sbjct: 591 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 650
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
R+ MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K+
Sbjct: 651 RLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 710
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
GTP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN Q
Sbjct: 711 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 758
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 103/215 (47%), Positives = 142/215 (66%), Gaps = 2/215 (0%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ ++ IG +IG+G G V+ W G++VAVK+ + ++I R+EV L+
Sbjct: 842 FEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLC 901
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
+LRHPN++LFMGA T P CIVTE+L RGSL +L + ++DW R+ + D ARG++
Sbjct: 902 KLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMT 961
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
YLH NP IIHRDLK+ NLLVD W VKV DFGL+ +K T+ KT GT W+APEVL
Sbjct: 962 YLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVL 1019
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
E EK+DVYS+ ++LWEL T IP+ N+MQ
Sbjct: 1020 AEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ 1054
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 5e-54, Method: Compositional matrix adjust.
Identities = 92/211 (43%), Positives = 146/211 (69%), Gaps = 2/211 (0%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I ++++ +GEQIG GS G VY W DVA+K F +Q+ + + R+E++ +K+L H
Sbjct: 1394 INYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKKLHH 1453
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ +GA +CIVTE++ +G+L ++ T KL+W ++I + ++IA+G+SYLH
Sbjct: 1454 PNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHS 1513
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+PPIIHRD+K SN+L+D++W VK+ DFG +R+K E + T+ GTP W APE++RN+
Sbjct: 1514 FDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTRC--GTPCWTAPEIIRNDI 1571
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
DEK DV+SFG+++WE+ T K P+ N M+
Sbjct: 1572 YDEKVDVFSFGIVMWEVLTCKEPFIGANFMK 1602
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (533), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 99/206 (48%), Positives = 136/206 (66%), Gaps = 2/206 (0%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ IG +IG+G+ G VY W GS VAVK ++ ++ F +E++LMK LRHPNV+
Sbjct: 374 IKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNVIQ 433
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
F+G+ P +CI TE++PRGSL+ +L +L W I M +D A+GV YLH+ P I
Sbjct: 434 FLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLHNSTPVI 493
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
+HRDLKS NLLVD++W VKV DFGLS ++ + T T GTP W +PEVLR++ EK+
Sbjct: 494 LHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTEKA 551
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQ 712
DVYSFG+ILWE AT + P+ + Q
Sbjct: 552 DVYSFGIILWECATRQDPYFGIPPFQ 577
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 9e-53, Method: Compositional matrix adjust.
Identities = 102/224 (45%), Positives = 143/224 (63%), Gaps = 10/224 (4%)
Query: 499 DYEILWE-------DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE-VIHSFR 550
DY+ L+E ++ + +IG+GSC V+ W G VA+K DE ++
Sbjct: 476 DYKTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELA 535
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
QE ++M +LRHPN+ F+G +P + IV E++P GSL+R+L + LDW R MAL
Sbjct: 536 QEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMAL 595
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RL-KHETYLTTKTGKGT 668
DIA+G++YLH C+P +IHRDLKS NLLVD+H+ VK+ DFGLS R KH T T GT
Sbjct: 596 DIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGT 655
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
P W APEVLRN+P EK+DV+SF ++LWE+ T + P+ + + Q
Sbjct: 656 PCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQ 699
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 96/208 (46%), Positives = 134/208 (64%), Gaps = 2/208 (0%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ + IG +IG+G+ G VY W GS VAVK ++ ++ F +E++LMK LRHPNV
Sbjct: 389 QQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNV 448
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ F+G+ +CI TE++PRGSL+ +L K+ W M +D A+G+ YLH P
Sbjct: 449 IQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLHGSTP 508
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
I+HRDLKS NLLVD++W VKV DFGLS ++ + T T GTP W +PEVLR++ E
Sbjct: 509 VILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTE 566
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQ 712
K+DVYSFG+ILWE AT + P+ + Q
Sbjct: 567 KADVYSFGIILWECATRQDPYFGIPPFQ 594
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 96/215 (44%), Positives = 149/215 (69%), Gaps = 4/215 (1%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVK-VFSRQEYSDEVIHSFRQEVSLMK 557
D EI + +L I ++G+G+ G VY +W GS VA+K + ++ +++V+ FR+E++++
Sbjct: 654 DIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILS 713
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
RLRHPN++L M A T+P LC +TE+LP GSL+ L K++ + +A+ IA+G++
Sbjct: 714 RLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMN 773
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
YLH +IHRD+KS NLL+D+H VK+ DFGLS+LK ++ TK+ G+P WM+PE+L
Sbjct: 774 YLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKS-IGSPIWMSPELL 830
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
E EK DVY+FG+ILWEL T ++P+ L+S+Q
Sbjct: 831 MGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQ 865
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 7e-49, Method: Compositional matrix adjust.
Identities = 91/213 (42%), Positives = 140/213 (65%), Gaps = 2/213 (0%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I +++++IG+QIG GS G V++ W G DVAVK F +Q+ S+ + FR E++ + L+H
Sbjct: 1359 INYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKH 1418
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
N++ F+GA +CIVTE++ G+L +L+ K+ + ++ + A G+ YLH
Sbjct: 1419 SNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHS 1478
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
NP I+HRD+K +N+LVD+H+ VK+ DFG +R+K + TT T GTP W APEV+R E
Sbjct: 1479 SNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPEVIRGEK 1536
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
EK+DV+SFGV++WE+ T K P+ N M+ S
Sbjct: 1537 YCEKADVFSFGVVMWEVLTGKEPFAECNFMKVS 1569
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 93/213 (43%), Positives = 138/213 (64%), Gaps = 4/213 (1%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I ++D+ IG+QIG GS G V W +VAVK F +Q+ ++ + FR E++ + +LRH
Sbjct: 1389 INYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQLRH 1448
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P+++L +GA +CIVTEF+ GSL +++ TTK +W+ +I M A G+ YLH+
Sbjct: 1449 PHIILMIGACLKRPNICIVTEFMGNGSLRNVIK--TTKPEWKLKIKMLYQTALGIGYLHN 1506
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+P IIHRD+K SN+LVD VK+ DFG +R+K E + T+ GTP W APE++R E
Sbjct: 1507 SDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSVMTRC--GTPCWTAPEIIRGEK 1564
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
EK DV+SFG+++WE+ T K P+ N M+ S
Sbjct: 1565 YTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVS 1597
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 716 | ||||||
| 224108736 | 781 | predicted protein [Populus trichocarpa] | 0.974 | 0.893 | 0.743 | 0.0 | |
| 255556394 | 796 | map3k delta-1 protein kinase, putative [ | 0.976 | 0.878 | 0.762 | 0.0 | |
| 224101557 | 759 | predicted protein [Populus trichocarpa] | 0.955 | 0.901 | 0.739 | 0.0 | |
| 225431966 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.966 | 0.897 | 0.725 | 0.0 | |
| 356521762 | 770 | PREDICTED: uncharacterized protein LOC10 | 0.958 | 0.890 | 0.705 | 0.0 | |
| 356564864 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.959 | 0.891 | 0.707 | 0.0 | |
| 296083240 | 732 | unnamed protein product [Vitis vinifera] | 0.914 | 0.894 | 0.695 | 0.0 | |
| 147827145 | 760 | hypothetical protein VITISV_034769 [Viti | 0.937 | 0.882 | 0.689 | 0.0 | |
| 449462150 | 774 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.952 | 0.881 | 0.655 | 0.0 | |
| 449532230 | 748 | PREDICTED: uncharacterized protein LOC10 | 0.913 | 0.874 | 0.686 | 0.0 |
| >gi|224108736|ref|XP_002314950.1| predicted protein [Populus trichocarpa] gi|222863990|gb|EEF01121.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1069 bits (2764), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/722 (74%), Positives = 605/722 (83%), Gaps = 24/722 (3%)
Query: 1 MDANTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVS 60
M++ AEELL+KIQ+LEAG HL+Q++SKLK+S +TTT QQRSHS+S
Sbjct: 1 MESTAPQAEELLKKIQQLEAGHHHLQQQMSKLKLS--------STTTDPKPTQQRSHSIS 52
Query: 61 PRRPRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNS 120
P+R +GP +R GG TG +AWK SASFRHSSPLQRES+ +S + + G+SN
Sbjct: 53 PQR---SGPRNRVAGGPTGSSFEAAWK-KGSASFRHSSPLQRESRSLNSNNA-SDGHSNG 107
Query: 121 G----------PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA 170
G PS+ FTD+QYLNILQS+GQSVHIFD S RIIYWNR+AE LYGYSA EA
Sbjct: 108 GGEGGDGNRGGPSSVKFTDKQYLNILQSVGQSVHIFDHSGRIIYWNRTAENLYGYSAAEA 167
Query: 171 LGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGT 230
LGQDAIELL D RD+ VA IV R+ MGE+WTG+FP K K ER VVATNTP YDDDG
Sbjct: 168 LGQDAIELLIDSRDYAVANGIVQRVSMGEKWTGKFPVKNKMAERFTVVATNTPLYDDDGA 227
Query: 231 LVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKI 290
LVGI+CVS+DSRPFQE AL D++N + +S+ + PRN V +KLGLDSQQPLQA +ASKI
Sbjct: 228 LVGIICVSSDSRPFQEVGVALLDSRNLEAESSNSSPRNIVMSKLGLDSQQPLQAAVASKI 287
Query: 291 SNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRG 350
SNLA+KVSNKVKS+IR G+N MDREGGSGDSH+SDHG+SDAALSDHRED SSGASTPRG
Sbjct: 288 SNLASKVSNKVKSKIRPGENSMDREGGSGDSHYSDHGYSDAALSDHREDANSSGASTPRG 347
Query: 351 DVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNE 410
DV P PFGVFSH+D++SP +S R+SGDESEGKPAIHKI TSKAE W+GKKGLSWPWKGNE
Sbjct: 348 DVHPSPFGVFSHLDDRSPAQSCRESGDESEGKPAIHKIFTSKAEAWIGKKGLSWPWKGNE 407
Query: 411 REGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVN 470
+EGS+A+T RF WPW DQ++E+ Q+SPS G K ESH+ E NR NNEA GSWSSS+N
Sbjct: 408 KEGSEARTTRFGWPWLQNDQESETFHQRSPSSGAKSESHVSESNRPANNEASGSWSSSIN 467
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD 530
VNSTSS SSC ++SS VNKVD D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSD
Sbjct: 468 VNSTSSASSC-GSTSSTVNKVDPDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSD 526
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVKVFS+QEYSD+VI +F+QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF
Sbjct: 527 VAVKVFSKQEYSDDVILAFKQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 586
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
RLLQRNTTKLDWRRR MALDIARG++YLHH NPPIIHRDLKSSNLLVDK+WTVKVGDFG
Sbjct: 587 RLLQRNTTKLDWRRRAHMALDIARGMNYLHHYNPPIIHRDLKSSNLLVDKNWTVKVGDFG 646
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710
LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLNS
Sbjct: 647 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNS 706
Query: 711 MQ 712
MQ
Sbjct: 707 MQ 708
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556394|ref|XP_002519231.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223541546|gb|EEF43095.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1051 bits (2718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/723 (76%), Positives = 604/723 (83%), Gaps = 24/723 (3%)
Query: 8 AEELLRKIQELEAGQEHLKQELSKLKISNDPKSET-----------ITTTTTTTHHQQRS 56
AEELL+KIQELEAGQ HLK+++SK K+++DP S++ QQRS
Sbjct: 7 AEELLKKIQELEAGQAHLKEQMSKFKLTSDPVSDSQLHHHHHHHHHHHRQQQQQQQQQRS 66
Query: 57 HSVSPRRPRLAGPASRRKGGGTGP---DAASAWKATNSASFRHSSPLQRESKGGDSGGSD 113
HS+SP+R +RR GGG G + +AWK S SFRHSSPLQRES+ + +
Sbjct: 67 HSISPQRT-----GTRRSGGGAGAGGFEVVAAWKK-GSTSFRHSSPLQRESRSSSADKIN 120
Query: 114 AA----GNSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEE 169
AA G + GPSA FTD+QYLNILQSMGQSVHIF LS RIIYWNR+AE LYGYS+ E
Sbjct: 121 AAVKEEGGNKCGPSAVKFTDKQYLNILQSMGQSVHIFYLSGRIIYWNRTAENLYGYSSAE 180
Query: 170 ALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDG 229
ALGQDAIELL D RDF VA +IVHR+ MGERWTGQFP K K ER VATNTPFYDDDG
Sbjct: 181 ALGQDAIELLVDPRDFAVANNIVHRVAMGERWTGQFPVKNKMGERFTAVATNTPFYDDDG 240
Query: 230 TLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASK 289
TL+GI+CVS D RPFQETR AL KNS+ DS+ +RPR+TVT KLGLDSQQPLQA IASK
Sbjct: 241 TLIGIICVSGDVRPFQETRVALIGPKNSEADSSFSRPRSTVTTKLGLDSQQPLQAVIASK 300
Query: 290 ISNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPR 349
I+NLA++VSNKVKS+IRTGDN MDREGGSGDSH SDHGFSDAALSDHRED SSGASTPR
Sbjct: 301 ITNLASRVSNKVKSKIRTGDNIMDREGGSGDSHQSDHGFSDAALSDHREDANSSGASTPR 360
Query: 350 GDVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGN 409
GD+ P FG FSHVDEKSP K++RDSG ESEGKP IHKIITSKAE W+GKKGLSWPWKG
Sbjct: 361 GDIHPSQFGTFSHVDEKSPMKAIRDSGYESEGKPGIHKIITSKAEAWIGKKGLSWPWKGI 420
Query: 410 EREGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSV 469
EREG D KT+RF WPW DQ++E + Q+SP G KPES + E NR NNEA GSWSSSV
Sbjct: 421 EREGPDTKTSRFVWPWLQNDQESELLHQRSPPAGAKPESQLNESNRPTNNEASGSWSSSV 480
Query: 470 NVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS 529
NVNSTSS SSCGSTSSSA+NKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS
Sbjct: 481 NVNSTSSASSCGSTSSSAINKVDMDIDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS 540
Query: 530 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
DVAVKVFS+QEYSD+VI +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI+TEFLPRGSL
Sbjct: 541 DVAVKVFSKQEYSDDVILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIITEFLPRGSL 600
Query: 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649
FRLLQRNTTKLDWRRRI MALDI RG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDF
Sbjct: 601 FRLLQRNTTKLDWRRRIHMALDIVRGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDF 660
Query: 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN
Sbjct: 661 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 720
Query: 710 SMQ 712
SMQ
Sbjct: 721 SMQ 723
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101557|ref|XP_002312329.1| predicted protein [Populus trichocarpa] gi|222852149|gb|EEE89696.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1048 bits (2711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/709 (73%), Positives = 589/709 (83%), Gaps = 25/709 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELL+KI+ELEAG HL+QE+SKLK+S +TTT QQRSHS+SP+R
Sbjct: 3 STAPAEELLKKIEELEAGHHHLQQEVSKLKLS--------STTTDPRSTQQRSHSISPQR 54
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
+GP R GG TG +AW SAS RHSSPLQ+E G+ NSGPS
Sbjct: 55 ---SGPRRRVSGGPTGSSFEAAWNK-GSASSRHSSPLQKER-----------GDGNSGPS 99
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A FTD+QYLNILQSMGQSVHIFD+S RIIYWNR+AE LYGYSA EALGQDAI LL D R
Sbjct: 100 AVKFTDKQYLNILQSMGQSVHIFDVSGRIIYWNRTAENLYGYSAAEALGQDAIGLLIDPR 159
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A I+ R+ MGE+WTG+FP K K ER VATNTP YDDDG LVGI+CVS+DSRP
Sbjct: 160 DYALANGIIQRVSMGEKWTGKFPVKNKMAERFTAVATNTPLYDDDGALVGIICVSSDSRP 219
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKS 303
FQE AL D++N +T+S+ RP+NTV KLGLDSQQPLQ +ASKISNLA+KVSNKVKS
Sbjct: 220 FQEMEVALSDSRNLETESSHRRPKNTVMTKLGLDSQQPLQTAVASKISNLASKVSNKVKS 279
Query: 304 RIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSHV 363
+I G++ DRE GSGDSH+SDHG+SDAALSDHRED SSGASTPRGD+ P PFGVFS++
Sbjct: 280 KIHMGESNTDREVGSGDSHYSDHGYSDAALSDHREDANSSGASTPRGDLHPSPFGVFSNL 339
Query: 364 DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAW 423
D+KSP K RDSGDESEGKPAIHKIITSKAE W+GKKGLSWPWKGNE+EGS+A+T RF W
Sbjct: 340 DDKSPVKPSRDSGDESEGKPAIHKIITSKAEAWIGKKGLSWPWKGNEKEGSEARTTRFGW 399
Query: 424 PWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGST 483
PW DQ++E+ Q SPS G K ES + E R NEA GSW SS+NVNSTSS SS +
Sbjct: 400 PWLQNDQESETYHQTSPSSGAKSESQVSESIRPATNEASGSW-SSINVNSTSSASS-CGS 457
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD 543
+SS VNKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKVFS+QEYSD
Sbjct: 458 TSSTVNKVDMDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKVFSKQEYSD 517
Query: 544 EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
++I +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR
Sbjct: 518 DIILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 577
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
RR+ MALDIARG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLKHETYLTTK
Sbjct: 578 RRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLKHETYLTTK 637
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
TGKGTPQWMAPEVLRNEPSDEKSD+YS+GVILWEL+TEKIPWDNLNSMQ
Sbjct: 638 TGKGTPQWMAPEVLRNEPSDEKSDIYSYGVILWELSTEKIPWDNLNSMQ 686
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431966|ref|XP_002278360.1| PREDICTED: uncharacterized protein LOC100256793 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2605), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/714 (72%), Positives = 596/714 (83%), Gaps = 22/714 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPA--SRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSG 121
R + PA S RKG G G D + W+ SASFRHSSPLQRES+ D + G
Sbjct: 52 SRFSSPATSSWRKGSG-GFDGPAGWR-RGSASFRHSSPLQRESRSRDPS---STAGGGGG 106
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
P+A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D
Sbjct: 107 PAAYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSD 166
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
+D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS
Sbjct: 167 VQDYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDS 226
Query: 242 RPFQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNK 300
+PFQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNK
Sbjct: 227 QPFQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNK 286
Query: 301 VKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+ +I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+F
Sbjct: 287 VR-KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIF 345
Query: 361 SHV--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKT 418
S DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT
Sbjct: 346 SQATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKT 405
Query: 419 ARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
RF WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVS
Sbjct: 406 NRFGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVS 464
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSR 538
SCGSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+
Sbjct: 465 SCGSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSK 524
Query: 539 QEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
QEYSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT+
Sbjct: 525 QEYSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTS 584
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
+LDWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHET
Sbjct: 585 RLDWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHET 644
Query: 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLN+MQ
Sbjct: 645 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNTMQ 698
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521762|ref|XP_003529520.1| PREDICTED: uncharacterized protein LOC100800867 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/717 (70%), Positives = 572/717 (79%), Gaps = 31/717 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGD------SGGSDAAGNS 118
RL P +R DA +AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRS------DAPAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGGEEAA--P 103
Query: 119 NSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIEL 178
GPSA NFT+RQYLNILQSMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IEL
Sbjct: 104 RRGPSAVNFTERQYLNILQSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIEL 163
Query: 179 LTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVS 238
L D RD D+A + V+R+ MGE WTGQFP K K E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 164 LVDPRDLDLANNTVNRVMMGESWTGQFPIKNKMGEKFLAVATNTPFYDDDGSLVGLICVS 223
Query: 239 TDSRPFQETRAALWDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 224 IDLRPFLEMKVPMPSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 283
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI TG+N +DRE GSG+SHHS+H S++ + RED SSGASTPRGDVPP
Sbjct: 284 VGNKVKSRIWTGENNLDRESGSGESHHSEHSLSESVFLEQREDANSSGASTPRGDVPPSH 343
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG F HV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 344 FGAFPHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 401
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A PW DQ+NESV QK S K ES E NR N+EA GSWSS NVNSTSS
Sbjct: 402 ANVRVAGPWRQNDQENESVNQKILSSSLKQESQAGESNRPTNHEASGSWSS-FNVNSTSS 460
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKV
Sbjct: 461 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKV 520
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
FS+QEYSD+VI SFRQEVS+MKRLRHPN+LLFMGAVTSPQRLCIVTEFLPRGSL RLL R
Sbjct: 521 FSKQEYSDDVILSFRQEVSVMKRLRHPNILLFMGAVTSPQRLCIVTEFLPRGSLCRLLHR 580
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
NT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLK
Sbjct: 581 NTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLK 640
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
HET+LTTKTG+GTPQWMAPEVLRNEPSDEKSDVY FGVILWE+ TEKIPWDNLNSMQ
Sbjct: 641 HETFLTTKTGRGTPQWMAPEVLRNEPSDEKSDVYGFGVILWEIVTEKIPWDNLNSMQ 697
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564864|ref|XP_003550667.1| PREDICTED: uncharacterized protein LOC100785569 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/717 (70%), Positives = 573/717 (79%), Gaps = 30/717 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGG-----DSGGSDAAGNSN 119
RL P +R A+AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRSDA-----PAAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGEEAA--PR 104
Query: 120 SGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
GPSA NFT+RQYLNIL+SMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IELL
Sbjct: 105 RGPSAVNFTERQYLNILRSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIELL 164
Query: 180 TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVST 239
D RD D+A + V+R+ MGE WTGQFP K KT E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 165 VDPRDLDLANNTVNRVMMGESWTGQFPVKNKTGEKFLAVATNTPFYDDDGSLVGLICVSI 224
Query: 240 DSRPFQETRAAL-WDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 225 DLRPFLEMKVPMPTSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 284
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI G+N +DRE GSG+SHHS+H ++ + RED SSGASTPRGDVPP
Sbjct: 285 VGNKVKSRIWMGENNLDRESGSGESHHSEHSLLESVFLEQREDANSSGASTPRGDVPPSH 344
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG FSHV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 345 FGAFSHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 402
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A W DQ+NESV QK S G K ES E NR NNEA GSWSS NVNSTSS
Sbjct: 403 MNVRVAGSWRQNDQENESVNQKILSSGLKQESQAGESNRPTNNEASGSWSS-FNVNSTSS 461
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKV
Sbjct: 462 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKV 521
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
FS+QEYSD+VI SFRQEVS+MKRLRHPN+LL+MGAVTSPQRLCIVTEFLPRGSL RLL R
Sbjct: 522 FSKQEYSDDVILSFRQEVSVMKRLRHPNILLYMGAVTSPQRLCIVTEFLPRGSLCRLLHR 581
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
NT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLK
Sbjct: 582 NTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLK 641
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
HETYLTTKTG+GTPQWMAPEVLRNEPSDEKSDVYSFGVILWE+ATEKIPWDNLNSMQ
Sbjct: 642 HETYLTTKTGRGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEIATEKIPWDNLNSMQ 698
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083240|emb|CBI22876.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 965 bits (2495), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/712 (69%), Positives = 571/712 (80%), Gaps = 57/712 (8%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
R + PA+ + GP+
Sbjct: 52 SRFSSPAT------------------------------------------STAGGGGGPA 69
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 70 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 129
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 130 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 189
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNKV+
Sbjct: 190 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNKVR 249
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 250 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 308
Query: 363 V--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 309 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 368
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVSSC
Sbjct: 369 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVSSC 427
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+QE
Sbjct: 428 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSKQE 487
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
YSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT++L
Sbjct: 488 YSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTSRL 547
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
DWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHETYL
Sbjct: 548 DWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHETYL 607
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
TTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLN+MQ
Sbjct: 608 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNTMQ 659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827145|emb|CAN70981.1| hypothetical protein VITISV_034769 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/724 (68%), Positives = 574/724 (79%), Gaps = 53/724 (7%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H Q
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQ--------- 42
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
RKG G G D + W+ SASFRHSSPLQRES+ D + GP+
Sbjct: 43 ---------RKGSG-GFDGPAGWR-RGSASFRHSSPLQRESRSRDPS---STAGGGGGPA 88
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 89 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 148
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 149 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 208
Query: 244 FQETRAALWDTKNSDTDSNIN-RPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ N ++ +AKLGLD QQP+QA IASKISNL VSNKV+
Sbjct: 209 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNL---VSNKVR 265
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 266 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 324
Query: 363 --VDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 325 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 384
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSW SS NVNSTSSVSSC
Sbjct: 385 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSW-SSFNVNSTSSVSSC 443
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+QE
Sbjct: 444 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSKQE 503
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL----------- 589
YSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L
Sbjct: 504 YSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRCVLCFPIENFLKQA 563
Query: 590 -FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
F L NT++LDWRRR+LMALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGD
Sbjct: 564 YFMCLALNTSRLDWRRRVLMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGD 623
Query: 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708
FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNL
Sbjct: 624 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNL 683
Query: 709 NSMQ 712
N+MQ
Sbjct: 684 NTMQ 687
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462150|ref|XP_004148804.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101221874 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/718 (65%), Positives = 550/718 (76%), Gaps = 36/718 (5%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T PAEELLRK+QELE GQ HLK+E+SKL +S + + + S+
Sbjct: 3 TPPAEELLRKVQELEEGQAHLKKEMSKLLLSVQ-----LRPPNPPSPPSPSTFSI----- 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESK--------GGDSGGSDAAG 116
GG G AA+AWK S+SFRHSSPLQ+E+ +S D G
Sbjct: 53 -------HTTGGLDG--AAAAWK-RGSSSFRHSSPLQKEALPRFDISPLQRESRTRDPIG 102
Query: 117 NSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAI 176
S GP+A NFT++QYLNILQS+GQ V+IFDL+ IIYWNR+AE++YGYSA EALGQDAI
Sbjct: 103 CS--GPAAVNFTNKQYLNILQSLGQPVYIFDLNYHIIYWNRAAEIVYGYSAAEALGQDAI 160
Query: 177 ELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVC 236
ELL D DF + ++ R+ GE WTG P K K ++ +VVATNTPFYDD G L+GI+C
Sbjct: 161 ELLVDPEDFAITNHVILRVMAGENWTGHLPVKNKMGQKFVVVATNTPFYDD-GALIGIIC 219
Query: 237 VSTDSRPFQETRAAL-WDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLAT 295
+S+DSRPFQ+ + L +K D DS++ R R V+ KLGLD QQPLQ IASK+SNLA+
Sbjct: 220 ISSDSRPFQDLKIPLSIGSKQQDADSSMVRSRVPVSVKLGLDPQQPLQVAIASKLSNLAS 279
Query: 296 KVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPC 355
KVSNKVKS+IRTG+N +DREGGSGD +HSDHG DA L D+R+D SSGASTPRGD
Sbjct: 280 KVSNKVKSKIRTGENSLDREGGSGDGYHSDHGHPDAVLCDNRDDANSSGASTPRGD--ST 337
Query: 356 PFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREG-S 414
G FS V+EK G+ VRDS DE +GKP I KI++SKAE+W+ KKGLSWPWKG E+EG S
Sbjct: 338 AHGAFSQVEEKLSGRLVRDSSDEGKGKPTIQKILSSKAEEWIAKKGLSWPWKGTEQEGGS 397
Query: 415 DAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNST 474
+ + ARF WPW DQ+ E KS S K E +G+R+VNNEA GSWSS +++
Sbjct: 398 ETRAARFVWPWVQIDQEAEPANHKSSSISGKLEMQQNDGHRAVNNEASGSWSSININSTS 457
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVK 534
S S STSSSAVNKV+ D DCLD+EILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVK
Sbjct: 458 SVSSCG-STSSSAVNKVESDMDCLDHEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVK 516
Query: 535 VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 594
VFS+QEYSD+VI SF+QEVSLMK+LRHPN+LLFMG VTSPQRLCIVTEFLPRGSLFRLLQ
Sbjct: 517 VFSKQEYSDDVILSFKQEVSLMKKLRHPNILLFMGVVTSPQRLCIVTEFLPRGSLFRLLQ 576
Query: 595 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
RNT KLDWRRR+ MALDIARG++YLHHCNPPIIHRDLKSSNLL+DK+WTVKVGDFGLSRL
Sbjct: 577 RNTGKLDWRRRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLIDKNWTVKVGDFGLSRL 636
Query: 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD+YSFGVILWELATEKIPW+NLNSMQ
Sbjct: 637 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDIYSFGVILWELATEKIPWENLNSMQ 694
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449532230|ref|XP_004173085.1| PREDICTED: uncharacterized protein LOC101228396, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/666 (68%), Positives = 530/666 (79%), Gaps = 12/666 (1%)
Query: 54 QRSHSVSPRRPRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGD----- 108
QRS S+SP+R R A R G AA+AWK S+SFRHSSPLQRES+ D
Sbjct: 8 QRSQSISPQRSRFAATRRRGGTTGGLDGAAAAWK-RGSSSFRHSSPLQRESRTRDPMNPA 66
Query: 109 SGGSDAAGNSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE 168
+ + G SGP+A NFT++QYLNILQS+GQ V+IFDL+ IIYWNR+AE++YGYSA
Sbjct: 67 AAAAADGGGGCSGPAAVNFTNKQYLNILQSLGQPVYIFDLNYHIIYWNRAAEIVYGYSAA 126
Query: 169 EALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDD 228
EALGQDAIELL D DF + ++ R+ GE WTG P K K ++ +VVATNTPFY DD
Sbjct: 127 EALGQDAIELLVDPEDFAITNHVILRVMAGENWTGHLPVKNKMGQKFVVVATNTPFY-DD 185
Query: 229 GTLVGIVCVSTDSRPFQETRAAL-WDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIA 287
G L+GI+C+S+DSRPFQ+ + L +K D DS++ R R V+ KLGLD QQPLQ IA
Sbjct: 186 GALIGIICISSDSRPFQDLKIPLSIGSKQQDADSSMVRSRVPVSVKLGLDPQQPLQVAIA 245
Query: 288 SKISNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGAST 347
SK+SNLA+KVSNKVKS+IRTG+N +DREGGSGD +HSDHG DA L D+R+D SSGAST
Sbjct: 246 SKLSNLASKVSNKVKSKIRTGENSLDREGGSGDGYHSDHGHPDAGLCDNRDDANSSGAST 305
Query: 348 PRGDVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWK 407
PRGD G FS V+EK G+ VRDS DE +GKP I KI++SKAE+W+ KKGLSWPWK
Sbjct: 306 PRGD--STAHGAFSQVEEKLSGRLVRDSSDEGKGKPTIQKILSSKAEEWIAKKGLSWPWK 363
Query: 408 GNERE-GSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWS 466
G E+E GS+ + ARF WPW DQ+ E KS S K E +G+R+VNNEA GSWS
Sbjct: 364 GTEQEGGSETRAARFVWPWVQIDQEAEPANHKSSSISGKLEMQQNDGHRAVNNEASGSWS 423
Query: 467 SSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVW 526
S +++S S GSTSSSAVNKV+ D DCLD+EILWEDLTIGEQIGQGSCGTVYHA+W
Sbjct: 424 SININSTSSVSSC-GSTSSSAVNKVESDMDCLDHEILWEDLTIGEQIGQGSCGTVYHALW 482
Query: 527 YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586
YGSDVAVKVFS+QEYSD+VI SF+QEVSLMK+LRHPN+LLFMG VTSPQRLCIVTEFLPR
Sbjct: 483 YGSDVAVKVFSKQEYSDDVILSFKQEVSLMKKLRHPNILLFMGVVTSPQRLCIVTEFLPR 542
Query: 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV 646
GSLFRLLQRNT KLDWRRR+ MALDIARG++YLHHCNPPIIHRDLKSSNLL+DK+WTVKV
Sbjct: 543 GSLFRLLQRNTGKLDWRRRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLIDKNWTVKV 602
Query: 647 GDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
GDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD+YSFGVILWELATEKIPW+
Sbjct: 603 GDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDIYSFGVILWELATEKIPWE 662
Query: 707 NLNSMQ 712
NLNSMQ
Sbjct: 663 NLNSMQ 668
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 716 | ||||||
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.951 | 0.880 | 0.577 | 3.2e-216 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.935 | 0.875 | 0.560 | 3.6e-211 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.769 | 0.663 | 0.493 | 2.7e-203 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.814 | 0.868 | 0.581 | 1e-193 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.308 | 0.300 | 0.598 | 2e-96 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.311 | 0.216 | 0.638 | 7.5e-78 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.297 | 0.242 | 0.638 | 6.5e-74 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.305 | 0.234 | 0.630 | 9.6e-73 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.304 | 0.219 | 0.623 | 2e-72 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.308 | 0.269 | 0.626 | 5.3e-72 |
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2089 (740.4 bits), Expect = 3.2e-216, P = 3.2e-216
Identities = 416/720 (57%), Positives = 506/720 (70%)
Query: 7 PAEELLRKIQELEAGQEHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRL 66
PAEELL+KI ELE QEHLKQE+S+LK+S + + QRSHSVSP RP
Sbjct: 5 PAEELLKKILELEESQEHLKQEMSRLKVSTELR--------------QRSHSVSPHRP-- 48
Query: 67 AGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFN 126
+RR G + A +W+ + +ASFR++SPL++ES+ PSA
Sbjct: 49 ----ARRNIG----EGAPSWRKSGAASFRNASPLRKESRIQNSMRLRSEVGGGG-PSAGK 99
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
FTD+QYLNILQSM Q+VH FDL+ RII+WN AE +YGYSA EALG++ I ++ D RD
Sbjct: 100 FTDKQYLNILQSMAQAVHAFDLNMRIIFWNAMAEKVYGYSAAEALGENPINVIADDRDAA 159
Query: 187 VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
A +I R GE WTG+FP K+K+ +R V T +PFYDDDG L+GI+C+++++ P+
Sbjct: 160 FAMNIARRCVRGESWTGEFPVKSKSGDRFSAVTTCSPFYDDDGALMGIICITSNTAPYLN 219
Query: 247 TRAALWDTKNSDTDSNINRP-RNT------------VTAKLGLDSQQPLQATIASKISNL 293
R +L K + + P RN+ V +KLGLDS QP+Q IASKIS+L
Sbjct: 220 PRISLAKLKAQEEGETSSIPARNSFASKLGLDSRGAVISKLGLDSDQPIQVAIASKISDL 279
Query: 294 ATKVSNKVKSRIRTGDNFMD-REXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDV 352
A+KVSNKV+S++R GDN E A L DHR+D SSGASTPRGD
Sbjct: 280 ASKVSNKVRSKMRAGDNSATLSEGGSGDSHQKDHNVFGATLVDHRDDAASSGASTPRGDF 339
Query: 353 PPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNERE 412
PFGVF+ DEK K +DS DES+GKPAIHK++TSKAE+WM KKGLSWPWKGNE+E
Sbjct: 340 IQSPFGVFTCNDEKFVSKPFKDSSDESDGKPAIHKVLTSKAEEWMVKKGLSWPWKGNEQE 399
Query: 413 GSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXX 472
GS + WPW +Q E Q +PS G + ESH +E N+ +NNE
Sbjct: 400 GSKGRPTNSVWPWVQNEQKKERCHQINPSAGVQYESHAFESNKPINNEASSLWSSPINAN 459
Query: 473 XXXXXXXXXXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVA 532
NKVD D++ L+YEILW+DLTIGEQ+GQGSCGTVYH +W+GSDVA
Sbjct: 460 STSSASSCGSTSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVA 519
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
VKVFS+QEYS EVI SF+QEV LMKRLRHPNVLLFMGAVTSPQRLCIV+EFLPRGSLFRL
Sbjct: 520 VKVFSKQEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRL 579
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
LQ++T+KLDWRRRI MALDIARG++YLHHC+PPIIHRDLKSSNLLVDK+WTVKV DFGLS
Sbjct: 580 LQKSTSKLDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLS 639
Query: 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
R+KHETYLT+K+GKGTPQWMAPEVLRNE +DEKSD+YSFGV+LWELATEKIPW+ LNSMQ
Sbjct: 640 RIKHETYLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQ 699
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1945 (689.7 bits), Expect = 3.6e-211, Sum P(2) = 3.6e-211
Identities = 394/703 (56%), Positives = 473/703 (67%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + ++RSHS SP+RP SRR G P
Sbjct: 9 EKLLKKIRELEESQEDLKREMSKLKVSAEIKRRSHSSSPKRP------SRRNSGEGTP-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES PSA FTD+QYLNILQSM Q+
Sbjct: 61 --LWRKTGAASFRHASPLRKESHSKDGVAGGGDG-----PSAGKFTDKQYLNILQSMAQA 113
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D+I +L DG+D VA +I R GE WT
Sbjct: 114 VHVFDLNGQIIFWNSMAEKLYGFSAAEALGKDSINILVDGQDAAVAKNIFQRCSSGESWT 173
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSN 262
G+FP K K ER VV T +PFYDDDG L+GI+C++ DS FQ R + + DS+
Sbjct: 174 GEFPVKNKMGERFSVVTTISPFYDDDGLLIGIICITNDSALFQRPRVPPAKNRWQEGDSS 233
Query: 263 INRPRN------------TVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGDN 310
R N V +KLGLDSQQP+QA IASKIS+LA+KV NKV+S++R GDN
Sbjct: 234 FCRGTNGVASRLGFDSKEAVVSKLGLDSQQPIQAAIASKISDLASKVGNKVRSKMRAGDN 293
Query: 311 FMDR-EXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSPG 369
E AA SD RED ++ ASTPRG++ PFGVF D+KS
Sbjct: 294 NASHPEGGNGGSHQSDQGFFDAAFSDQREDAETNDASTPRGNLIQSPFGVFLCNDDKSSS 353
Query: 370 KSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHGD 429
K+ +S DE++ + K +TSK E+WM KKGLSWPWKGNEREG + + A WPW H +
Sbjct: 354 KASGESNDENDRNSVVPKKLTSKTEEWMVKKGLSWPWKGNEREGLERRNAHSVWPWVHNE 413
Query: 430 QDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXXN 489
Q E + K ES E N+ NNE N
Sbjct: 414 QQKEEAHHSNSYNSVKSESLASESNKPANNENMGSVNVNSASSASSCGSTSSSVM----N 469
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSF 549
KVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GSDVAVKVFS+QEYS+E+I SF
Sbjct: 470 KVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSF 529
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
+QEVSLMKRLRHPNVLLFMGAV SPQRLCIVTEFLPRGSLFRLLQRN +KLD RRRI MA
Sbjct: 530 KQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMA 589
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
DIARG++YLHHC+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KHETYLTT G+GTP
Sbjct: 590 SDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTN-GRGTP 648
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
QWMAPEVLRNE +DEKSDVYSFGV+LWEL TEKIPW+NLN+MQ
Sbjct: 649 QWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQ 691
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 2.7e-203, Sum P(3) = 2.7e-203
Identities = 288/584 (49%), Positives = 359/584 (61%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + +QRSHS SP+RP R GT P
Sbjct: 9 EELLKKIRELEESQEHLKREMSRLKVSAEMKQRSHSASPQRP-----VRRNSNDGT-P-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES SA FTD+QYLNILQSM Q+
Sbjct: 61 --MWRKTGAASFRHASPLRKESHAKVAGGGGEGQ------SAGKFTDKQYLNILQSMAQA 112
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D I++L D +D VA +I R GE WT
Sbjct: 113 VHVFDLNGQIIFWNSMAEKLYGFSASEALGKDPIDILVDVQDASVAQNITRRCSSGESWT 172
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS-DTDS 261
G+FP K K ER VV T +P YDDDG L+GI+C++ DS FQ+ R + T+ + ++
Sbjct: 173 GEFPVKNKAGERFSVVTTMSPSYDDDGCLIGIICITNDSALFQDPRGSPAKTRRGQEGET 232
Query: 262 NINR------------PRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ +R + V +KLGLDSQQP+Q IASKIS+L V NKVKS++R GD
Sbjct: 233 SFSRVTSSVASKLGLDSKEAVVSKLGLDSQQPIQVAIASKISDL---VGNKVKSKMRAGD 289
Query: 310 N-FMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSP 368
N + E AA +D RED +SGA TPRGD PFGVF DEK+
Sbjct: 290 NNAANLEGGSGDSHQSDQGFFDAAFADRREDAATSGADTPRGDFIQSPFGVFLRSDEKAS 349
Query: 369 GKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHG 428
K RDS DES+G + K +TSKAE+WM KKGLSWPWKGNEREG + + + WPW
Sbjct: 350 TKPFRDSSDESDGNSVVPKTLTSKAEEWMVKKGLSWPWKGNEREGLEGRRSHSVWPWVRN 409
Query: 429 DQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXX 488
+Q + Q + ++ K ES E ++ +NE
Sbjct: 410 EQQKQQAYQSNSNHSVKSESQACESIKASSNEPMGYWSSSVNVNSTSSSSSCGSTSSSVM 469
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
NKVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GSDVAVKVFS+QEYS+E+I S
Sbjct: 470 NKVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITS 529
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L L
Sbjct: 530 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRFGLITL 573
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1804 (640.1 bits), Expect = 1.0e-193, Sum P(2) = 1.0e-193
Identities = 344/592 (58%), Positives = 428/592 (72%)
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
PS FTD+QYLNILQS+ QSVH+ DL+ RII+WN +E LYGYSA E +G++ + ++ D
Sbjct: 56 PSPGKFTDKQYLNILQSLAQSVHVLDLNTRIIFWNAMSEKLYGYSAAEVVGRNPVHVIVD 115
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
++ A ++ R GE WTG+FP KTK+ + V T +PFYDD+GT+VGI+ +++D
Sbjct: 116 DQNAAFALNVARRCANGESWTGEFPVKTKSGKIFSAVTTCSPFYDDNGTVVGIISITSDI 175
Query: 242 RPFQETRAALWDTKNSDTDSNINRP-RNTVTAKLGLDSQQPLQATIASKISNLATKVSNK 300
P+ R +L K + + + + V +K GLDS QP+Q +IASKIS+LA+K+SNK
Sbjct: 176 APYLNPRLSLPRLKPQEPERKLGLDSKGAVISKPGLDSDQPIQVSIASKISSLASKLSNK 235
Query: 301 VKSRIRTGDNFMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+S++R GDN LSDHR+D SSGASTPRGD PFGVF
Sbjct: 236 VRSKMRAGDN-----SACGDSHHSDHDVFGDTLSDHRDDAASSGASTPRGDFIQSPFGVF 290
Query: 361 SHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
+ D+K P K +DS D KPAIHK+ TSKAE+WM KKGLS PWKGNE+EGS +
Sbjct: 291 TCYDDKFPSKPSKDSSDR---KPAIHKVPTSKAEEWMVKKGLSRPWKGNEQEGSRVRPTH 347
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXX 480
W W +Q+ + Q PS G K ESH E N+ ++E
Sbjct: 348 SVWSWVENEQEKDKYHQIYPSAGVKSESHGSESNKPTDDEASNMWSSSINANSTNSASSC 407
Query: 481 XXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
+KVD+D+D L++EILW+DLTIGEQIG+GSCGTVYH +W+GSDVAVKVFS+QE
Sbjct: 408 GSTSRSVMDKVDIDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQE 467
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
YS+ VI SF +EVSLMKRLRHPNVLLFMGAVTSPQRLCIV+EF+PRGSLFRLLQR+ +KL
Sbjct: 468 YSESVIKSFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKL 527
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
DWRRRI MALDIARG++YLH C+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KH+TYL
Sbjct: 528 DWRRRINMALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYL 587
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
T+K+GKGTPQWMAPEVLRNE +DEKSD+YSFGV+LWELATEKIPW+NLNSMQ
Sbjct: 588 TSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQ 639
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 2.0e-96, Sum P(2) = 2.0e-96
Identities = 134/224 (59%), Positives = 178/224 (79%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
N++ D+ C EI WEDL +GE++G+GS V+ VW GSDVA+KV+ +Y+ +
Sbjct: 453 NRLVTDSSC---EIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTE 509
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
++E+++MK+LRHPNVLLFMGAV + ++ I+ E++PRGSLF++L LD +RR+ M
Sbjct: 510 CKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRM 569
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
ALD+ARG++YLH NPPI+HRDLKSSNLLVDK+W VKVGDFGLS+ K+ T+L+TK+GKGT
Sbjct: 570 ALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGT 629
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
PQWMAPEVLR+EPS+EK DV+SFGVILWEL T +PWD LNS+Q
Sbjct: 630 PQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQ 673
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 764 (274.0 bits), Expect = 7.5e-78, Sum P(2) = 7.5e-78
Identities = 143/224 (63%), Positives = 175/224 (78%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
+K D D D D EILWE++T+GE+IG GS G VY W+G++VAVK F Q+ + E +
Sbjct: 731 SKSDCD-DVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEE 789
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
FR EV +MK+LRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD RRR+ M
Sbjct: 790 FRSEVRIMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRM 849
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
ALD ARG++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ GT
Sbjct: 850 ALDAARGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGT 909
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+WMAPEVLRNEP+DEK DVYS+GVILWEL T + PW +N MQ
Sbjct: 910 AEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQ 953
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
Identities = 136/213 (63%), Positives = 171/213 (80%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+EI+WEDL IGE+IG GS G VY A W G++VAVK F Q++S + + F+ E+ +M RL
Sbjct: 602 WEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRL 661
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
RHPNV+LFMGAVT P I+TEFLPRGSL+RLL R +LD +RR+ MALD+A+G++YL
Sbjct: 662 RHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKGMNYL 721
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H +P ++HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ GTP+WMAPEVLRN
Sbjct: 722 HTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLRN 781
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
EP++EK DVYSFGVILWELAT ++PW LN MQ
Sbjct: 782 EPANEKCDVYSFGVILWELATSRVPWKGLNPMQ 814
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
Identities = 138/219 (63%), Positives = 169/219 (77%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEV 553
D D + EI W DL I E+IG GS G VYHA W+G++VAVK F Q++S + FR EV
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEV 715
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+A
Sbjct: 716 RIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVA 775
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GTP+WMA
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
PEVLRNEPS+EK DVYSFGVILWELAT ++PW +N MQ
Sbjct: 836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQ 874
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
Identities = 136/218 (62%), Positives = 169/218 (77%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVS 554
+D + EILWE++T+ E+IG GS G VY W+G+ VAVK F Q+ + E + FR EV
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVR 762
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M+RLRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD R+R+ MALD AR
Sbjct: 763 MMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAAR 822
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
G++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+K TYL++K+ GT +WMAP
Sbjct: 823 GMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAP 882
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
EVLRNEP+DEK DVYS+GVILWEL T + PW +N MQ
Sbjct: 883 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQ 920
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 5.3e-72, P = 5.3e-72
Identities = 141/225 (62%), Positives = 178/225 (79%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSF 549
++ LD D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++ E ++ F
Sbjct: 536 ELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEF 593
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRIL 607
+EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD RRR+
Sbjct: 594 LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 653
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K+ G
Sbjct: 654 MAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 713
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
TP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN Q
Sbjct: 714 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 758
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 716 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-66 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-65 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-65 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-65 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-64 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-43 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-41 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-40 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-40 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-39 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-37 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-36 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-35 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-35 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-35 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-34 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-33 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-32 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-32 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-32 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-31 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-31 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-30 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-30 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-29 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-26 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-24 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-24 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-23 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-23 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-23 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-21 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-18 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 8e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 5e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| pfam08448 | 110 | pfam08448, PAS_4, PAS fold | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| COG3829 | 560 | COG3829, RocR, Transcriptional regulator containin | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| pfam13188 | 64 | pfam13188, PAS_8, PAS domain | 3e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 8e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| PRK11360 | 607 | PRK11360, PRK11360, sensory histidine kinase AtoS; | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| PRK11359 | 799 | PRK11359, PRK11359, cyclic-di-GMP phosphodiesteras | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 4e-67
Identities = 83/215 (38%), Positives = 126/215 (58%), Gaps = 12/215 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L +G+++G+G+ G VY G VAVK ++ S+E F +E S+MK+L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPN++ +G T + L IVTE++P G L L+++ KL + + MAL IA+G+ YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQ-WMAPEVLR 678
N +HRDL + N LV ++ VK+ DFGLSR +E Y + G P WMAPE L+
Sbjct: 120 SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 679 NEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
+ KSDV+SFGV+LWE+ T + P+ +++ +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 3e-66
Identities = 78/207 (37%), Positives = 112/207 (54%), Gaps = 6/207 (2%)
Query: 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ ++G GS GTVY A G VAVK+ ++ + + R+E+ +++RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + A L +V E+ G LF L R L +AL I RG+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR-NEPSD 683
IIHRDLK N+L+D++ VK+ DFGL++ ++ + T GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNS 710
K DV+S GVIL+EL T K P+ N
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENI 204
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 1e-65
Identities = 71/208 (34%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G+GS G VY A + VA+KV +++ + +E+ ++K+L+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIV 60
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNP 624
+L +V E+ G LF LL++ D R I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLHSKG- 117
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
I+HRDLK N+L+D+ VK+ DFGL+R T T GTP++MAPEVL + +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPEVLLGKGYGK 175
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQ 712
D++S GVIL+EL T K P+ + +
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLL 203
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 1e-65
Identities = 83/211 (39%), Positives = 123/211 (58%), Gaps = 11/211 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPNV+ +G T + L IV E++ G L L++N KL + AL IARG+ YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
N IHRDL + N LV ++ VK+ DFGLSR L + Y + GK +WMAPE L+
Sbjct: 120 SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 680 EPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709
KSDV+SFGV+LWE+ T + P+ ++
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 1e-65
Identities = 76/190 (40%), Positives = 107/190 (56%), Gaps = 7/190 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G GTVY A + VA+K+ +E S ++ +E+ ++K+L HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK-KEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630
L +V E+ GSL LL+ N KL + + L I G+ YLH IIHRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRD 117
Query: 631 LKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDV 688
LK N+L+D + VK+ DFGLS+L KT GTP +MAPEVL + EKSD+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 689 YSFGVILWEL 698
+S GVIL+EL
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 2e-64
Identities = 83/212 (39%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYL 619
HPN++ +G T + L IV E++P G L L++N +L + AL IARG+ YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLR 678
N IHRDL + N LV ++ VK+ DFGLSR L + Y K GK +WMAPE L+
Sbjct: 120 ESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 679 NEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709
KSDV+SFGV+LWE+ T + P+ ++
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 1e-58
Identities = 76/218 (34%), Positives = 120/218 (55%), Gaps = 19/218 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G+G+ G VY G +VAVK +++ S+E F +E +MK+L HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVS 617
+G T + L +V E++ G L L+++ + L + + A+ IA+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPE 675
YL +HRDL + N LV + VK+ DFGLSR + + Y KTG P +WMAPE
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 676 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
L++ KSDV+SFGV+LWE+ T P+ L++ +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 73/214 (34%), Positives = 115/214 (53%), Gaps = 9/214 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+ T GE +G+GS G+VY A G +AVK S+E + + +E+ ++ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 564 VLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
++ + G+ ++ L I E++ GSL LL++ KL I G++YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS 119
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTPQWMAPEVLRN 679
I+HRD+K +N+LVD VK+ DFG ++ + T + +GTP WMAPEV+R
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
E +D++S G + E+AT K PW L +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 76/218 (34%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY---GSDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 560
I E+IG+G G VY + G +VA+KV +E +++I E+ ++K+ +
Sbjct: 1 LFEILEKIGKGGFGEVY-KARHKRTGKEVAIKVIKLESKEKKEKII----NEIQILKKCK 55
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIAR 614
HPN++ + G+ L IV EF GSL LL+ L + +L L+
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE--- 112
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
YLH IIHRD+K++N+L+ VK+ DFGLS +L T GTP WMA
Sbjct: 113 ---YLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMVGTPYWMA 165
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
PEV+ +P D K+D++S G+ ELA K P+ L M
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM 203
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 26/219 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
YEI+ +QIG+GS G VY G +K S++ EV ++
Sbjct: 1 KYEII-------KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKIL 53
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRIL 607
K+L HPN++ + + +LCIV E+ G L + +++ + LDW ++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+AL YLH I+HRD+K N+ + + VK+GDFG+S++ T KT G
Sbjct: 114 LALK------YLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
TP +++PE+ +N+P + KSD++S G +L+EL T K P++
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 14/205 (6%)
Query: 507 LTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L +Q+G+G G V + G VAVK ++ F +E+ +++ L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLD 64
Query: 561 HPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
H N++ + G P L ++ E+LP GSL LQR+ +++ +R +L + I +G+ Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPE 675
L + IHRDL + N+LV+ VK+ DFGL+++ + Y + G+ W APE
Sbjct: 125 LG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 676 VLRNEPSDEKSDVYSFGVILWELAT 700
LR SDV+SFGV L+EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 66/208 (31%), Positives = 117/208 (56%), Gaps = 5/208 (2%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+ +G+ IG+G+ G VY + G VA+K S ++ +E + S QE+ L+K L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ ++G++ + L I+ E+ GSL +++++ + + +G++YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH--E 117
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
+IHRD+K++N+L K VK+ DFG++ ++ + GTP WMAPEV+ +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNSM 711
SD++S G + EL T P+ +LN M
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 72/195 (36%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++L +G IG+G G V + G VAVK +F E S+M LRHPN+
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNL 62
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +G V L IVTE++ +GSL L+ R + +++ ALD+ G+ YL N
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
+HRDL + N+LV + KV DFGL++ E +GK +W APE LR +
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 684 EKSDVYSFGVILWEL 698
KSDV+SFG++LWE+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 80/219 (36%), Positives = 119/219 (54%), Gaps = 21/219 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + G + VA+K + E I F E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ------RNTTKLD---WR 603
S+MK +V+ +G V++ Q +V E + +G L L+ N L +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ I MA +IA G++YL +HRDL + N +V + TVK+GDFG++R +ET K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
GKG P +WMAPE L++ KSDV+SFGV+LWE+AT
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 76/205 (37%), Positives = 109/205 (53%), Gaps = 9/205 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+E+ D+T+ ++G G G VY VW Y VAVK + F +E ++MK
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGV 616
++HPN++ +G T I+TEF+ G+L L+ N +++ + MA I+ +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 675
YL N IHRDL + N LV ++ VKV DFGLSRL T G P +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 676 VLRNEPSDEKSDVYSFGVILWELAT 700
L KSDV++FGV+LWE+AT
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 70/207 (33%), Positives = 113/207 (54%), Gaps = 20/207 (9%)
Query: 510 GEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
GE +G GS G+VY + G AVK + + E + QE++L+ +L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL 619
+ ++G L I E +P GSL +LL++ + R+IL+ G+ YL
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------GLEYL 118
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H N +HRD+K +N+LVD + VK+ DFG+++ + + K+ KG+P WMAPEV+
Sbjct: 119 HDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 680 E-PSDEKSDVYSFGVILWELATEKIPW 705
+ +D++S G + E+AT K PW
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-39
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 8/210 (3%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+LT +++G G G V+ W G DVA+K+ S++ F +E +M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ G T + + IVTE++ G L L+ KL + M D+ + YL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSD 683
IHRDL + N LV + VKV DFGL+R + T+ G P +W PEV
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 684 EKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV+SFGV++WE+ +E K+P++ ++ +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 63/196 (32%), Positives = 111/196 (56%), Gaps = 17/196 (8%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+G+ G VY A G +VA+K ++ + E+I E+ +MK +HPN++ +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYY 81
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V E++ GSL ++ +N +++ + + ++ +G+ YLH + +IH
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--SQNVIH 139
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-----GTPQWMAPEVLRNEPSD 683
RD+KS N+L+ K +VK+ DFG + LT + K GTP WMAPEV++ +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFA-----AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 684 EKSDVYSFGVILWELA 699
K D++S G++ E+A
Sbjct: 195 PKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 75/217 (34%), Positives = 116/217 (53%), Gaps = 9/217 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++G G G V+ W G+ VAVK S E +F QE +MK+
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
LRH ++ + + + IVTE++ +GSL L+ KL + + MA IA G++
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
YL N IHRDL + N+LV ++ K+ DFGL+RL + T + G P +W APE
Sbjct: 118 YLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV+SFG++L E+ T ++P+ + + +
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 6e-37
Identities = 76/205 (37%), Positives = 108/205 (52%), Gaps = 10/205 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVS 554
YEI ED+T+G IG+G G VY V+ + VAVK + S V F QE
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAY 59
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M++ HP+++ +G V + + IV E P G L LQ N LD IL + ++
Sbjct: 60 IMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMA 673
++YL +HRD+ + N+LV VK+GDFGLSR L+ E+Y GK +WMA
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 674 PEVLRNEPSDEKSDVYSFGVILWEL 698
PE + SDV+ FGV +WE+
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 8/209 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E I E++G+GS G+VY A+ G VA+KV +E + +E+S++K+ P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ + G+ L IV E+ GS+ +++ L + +G+ YLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
IHRD+K+ N+L+++ K+ DFG+S +T T GTP WMAPEV++
Sbjct: 119 K--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSM 711
+ K+D++S G+ E+A K P+ +++ M
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPM 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 78/220 (35%), Positives = 108/220 (49%), Gaps = 30/220 (13%)
Query: 511 EQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G GS G V W S VAVK + SD ++ F +E ++M L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLI 59
Query: 566 LFMGAV-TSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARGVS 617
G V T P L +VTE P GSL L+++ +T D+ A+ IA G+
Sbjct: 60 RLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMR 111
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQWMAP 674
YL IHRDL + N+L+ VK+GDFGL R + Y+ + K W AP
Sbjct: 112 YLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 675 EVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQ 712
E LR SDV+ FGV LWE+ T E+ PW L+ Q
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEE-PWAGLSGSQ 208
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 77/219 (35%), Positives = 115/219 (52%), Gaps = 29/219 (13%)
Query: 510 GEQIGQGSCGTVY--HAVWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMKRLRHPN 563
G+ +GQG+ G VY + V G ++AVK E EV ++ E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV-NALECEIQLLKNLQHER 65
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGS------LFRLLQRNTTKLDWRRRILMALDIARGVS 617
++ + G + + L I E++P GS + L T+ + R+IL GV
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQIL------EGVE 118
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLK----HETYLTTKTGKGTPQWM 672
YLH + I+HRD+K +N+L D VK+GDFG S RL+ T + + TG TP WM
Sbjct: 119 YLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG--TPYWM 174
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
+PEV+ E K+DV+S G + E+ TEK PW +M
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 7/208 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E+ T+ ++G G G V+ +W VA+K+ F++EV +KRLRH +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKH 63
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHC 622
++ + + + I+TE + +GSL L+ + L I MA +A G++YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
N IHRDL + N+LV + KV DFGL+RL E + K +W APE +
Sbjct: 124 N--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 683 DEKSDVYSFGVILWELATE-KIPWDNLN 709
KSDV+SFG++L+E+ T ++P+ +N
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 77/216 (35%), Positives = 111/216 (51%), Gaps = 14/216 (6%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+TI + IG G G V DVA+K + SD+ F E S+M +
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFD 63
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPN++ G VT + + I+TE++ GSL + L+ N K + + M IA G+ YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVL 677
N +HRDL + N+LV+ + KV DFGLSR + TY TTK GK +W APE +
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-TTKGGKIPIRWTAPEAI 180
Query: 678 RNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSM 711
SDV+SFG+++WE+ + E+ WD N
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI + + ++G G G V+ +W + VAVK + F E +MK+
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
LRHP ++ T + + IVTE + GSL LQ L + I MA +A G++
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
YL N IHRDL + N+LV ++ KV DFGL+R+ E + G P +W APE
Sbjct: 118 YLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPW 705
KSDV+SFG++L E+ T ++P+
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 73/206 (35%), Positives = 110/206 (53%), Gaps = 8/206 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+LT+ ++IG G G V+ W VA+K S+E F +E +M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G T +C+V EF+ G L L+ K + M LD+ G++YL N
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPS 682
+IHRDL + N LV ++ VKV DFG++R + T+ TG P +W +PEV
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 683 DEKSDVYSFGVILWELATE-KIPWDN 707
KSDV+SFGV++WE+ +E K P++N
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 20/218 (9%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
D + +++G+GS G+VY V SD A+K S + E+ ++ + HP
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARG 615
N++ + A +LCIV E+ P G L + + + + WR + + + RG
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRG 115
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+ LH I+HRDLKS+N+L+ + VK+GD G+S++ + T+ G TP +MAPE
Sbjct: 116 LQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG--TPHYMAPE 171
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
V + P KSD++S G +L+E+AT P+ SMQD
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L + +G G+ GTVY VW VA+KV R+E S + E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVD 67
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL- 619
HP+V+ +G S Q + ++T+ +P G L ++ + + + + + IA+G+SYL
Sbjct: 68 HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 620 -HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEV 676
++HRDL + N+LV VK+ DFGL++L E + GK +WMA E
Sbjct: 127 EKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 677 LRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709
+ + KSDV+S+GV +WEL T P++ +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 7/206 (3%)
Query: 511 EQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E+IG+G+ G VY V ++VAVK R ++ F QE ++K+ HPN++ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
Q + IV E +P GSL L++ +L ++ + M+LD A G+ YL N IHR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHR 117
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTP-QWMAPEVLRNEPSDEKSD 687
DL + N LV ++ +K+ DFG+SR + T G K P +W APE L +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 688 VYSFGVILWELATE-KIPWDNLNSMQ 712
V+S+G++LWE + P+ +++ Q
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 75/226 (33%), Positives = 114/226 (50%), Gaps = 30/226 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ ++IG G+ G VY A + VA+KV + + +QE+S++
Sbjct: 4 DYELI-------QRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISML 54
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 613
K RHPN++ + G+ +L IV E+ GSL + Q R L L IA
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-------RGPLSELQIAYVC 107
Query: 614 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
+G++YLH IHRD+K +N+L+ + VK+ DFG+S T K+ GTP
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP 165
Query: 670 QWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
WMAPEV R D K D+++ G+ ELA + P +L+ M+
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 71/211 (33%), Positives = 113/211 (53%), Gaps = 8/211 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+DLT +++G G G V + W G DVA+K+ S++ F +E +M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G T + + IVTE++ G L L+ + + + + M D+ G++YL +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--S 118
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPS 682
IHRDL + N LVD VKV DFGLSR + T+ G P +W PEVL
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 683 DEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
KSDV++FGV++WE+ + K+P++ N+ +
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 75/234 (32%), Positives = 114/234 (48%), Gaps = 53/234 (22%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA---------VW----YGSDVAVKVFSRQEYSDEV 545
DYE+L E IG+GS GTV VW YG+ + +E V
Sbjct: 1 DYEVL-------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN------MTEKEKQQLV 47
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMG--AVTSPQRLCIVTEFLPRGSLFRLLQR---NTTKL 600
EV++++ L+HPN++ + S Q L IV E+ G L +L+Q+ +
Sbjct: 48 S-----EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102
Query: 601 D----WRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
+ WR IL L +A L+ C ++HRDLK +N+ +D + VK+GDFG
Sbjct: 103 EEEFIWR--ILTQLLLA-----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP 704
L+++ KT GTP +M+PE L + DEKSD++S G +++EL P
Sbjct: 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVI-HSFRQEVSLMKRLRH 561
DL + +GQGS G VY G A+K DE +E+ ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCES 58
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL--DIARGVSYL 619
P V+ GA + IV E++ GSL LL++ +L + I +G+ YL
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYL 115
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H IIHRD+K SNLL++ VK+ DFG+S++ T T GT +M+PE ++
Sbjct: 116 HTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
E +D++S G+ L E A K P+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 74/209 (35%), Positives = 113/209 (54%), Gaps = 7/209 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E T+ E IG+GS G VY A+ ++ VA+KV +E DE I +QE+ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + G+ +L I+ E+ GS LL+ KLD + ++ G+ YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
IHRD+K++N+L+ + VK+ DFG+S T T GTP WMAPEV++
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSM 711
DEK+D++S G+ ELA + P +L+ M
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 30/220 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA-------VWYGSDVAVKVFSRQEYSDEVIHSFRQ 551
D+EIL +IG+GS G V+ V+ + + +R+E + +
Sbjct: 1 DFEIL-------NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-----D 48
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRI 606
E ++ +L ++ + + +L IV E+ G L +LL + WR I
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
+ L G+++LH + I+HRD+KS NL +D + VK+GD G+++L + T
Sbjct: 109 QILL----GLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV 162
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
GTP +++PE+ ++P +EKSDV++ GV+L+E T K P+D
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 72/210 (34%), Positives = 110/210 (52%), Gaps = 8/210 (3%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+LT +++G G G V+ W VA+K + S+E F +E +M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ G T + L IVTEF+ G L L++ KL + M D+ G+ YL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS- 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSD 683
IHRDL + N LV VKV DFG++R + T+ +G P +W PEV
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 684 EKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV+SFGV++WE+ TE K+P++ ++ +
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 12/210 (5%)
Query: 510 GEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
G +IG G+ G VY AV G +AVK Q+ + I E+ +++ L+HPN++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
G +++ I E+ G+L LL + LD + L + G++YLH I+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGK---GTPQWMAPEVLRNEPSD 683
HRD+K +N+ +D + +K+GDFG + +LK+ T + + GTP +MAPEV+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 684 EK---SDVYSFGVILWELATEKIPWDNLNS 710
+D++S G ++ E+AT K PW L++
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 4e-32
Identities = 79/210 (37%), Positives = 120/210 (57%), Gaps = 10/210 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK+
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH L+ + AV S + + IVTE++ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRHEK-LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 117 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPW 705
KSDV+SFG++L EL T+ ++P+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 79/217 (36%), Positives = 122/217 (56%), Gaps = 10/217 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + +++G G G V+ W G + VAVK S E SF +E +MK+
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH + L+ + AV S + + IVTE++ +GSL L+ + L + MA +A G++
Sbjct: 58 LRH-DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N IHRDL+S+N+LV K+ DFGL+RL + T + G P +W APE
Sbjct: 117 YIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV+SFG++L EL T+ ++P+ +N+ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 17/221 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRLRHP-NVL 565
I ++G+GS G VY A VA+KV +++ S F +E+ ++ L HP N++
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCN 623
L +V E++ GSL LL++ L + + I + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 624 PPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL------KHETYLTTKTGKGTPQWMAPEV 676
IIHRD+K N+L+D+ VK+ DFGL++L T GTP +MAPEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 677 LR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
L + SD++S G+ L+EL T P++ + +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220
|
Length = 384 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 74/228 (32%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ E IG G+ VY A+ VA+K ++ V R+EV M
Sbjct: 2 DYELI-------EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAM 53
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 613
+ HPNV+ + + L +V +L GSL ++ K + R L IA
Sbjct: 54 SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM-----KSSYPRGGLDEAIIATVL 108
Query: 614 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TYLTTKTG 665
+G+ YLH + IHRD+K+ N+L+ + +VK+ DFG+S + T KT
Sbjct: 109 KEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 666 KGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
GTP WMAPEV+ D K+D++SFG+ ELAT P+ M+
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 71/196 (36%), Positives = 108/196 (55%), Gaps = 11/196 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++L + + IG+G G V + G+ VAVK +D +F E S+M +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNL 61
Query: 565 LLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHC 622
+ +G + + L IVTE++ +GSL L+ R + L + +LD+ + YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
N +HRDL + N+LV + KV DFGL++ E T TGK +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKF 176
Query: 683 DEKSDVYSFGVILWEL 698
KSDV+SFG++LWE+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 73/224 (32%), Positives = 119/224 (53%), Gaps = 30/224 (13%)
Query: 510 GEQIGQGSCGTVY---HAVWYGSDVAVKVF-------SRQEYSDEVIHSFRQEVSLMKRL 559
G IG GS G+VY +A G +AVK S ++ ++ + +E++L+K L
Sbjct: 5 GALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIAR 614
+H N++ ++G+ L I E++P GS+ LL T ++ R+IL +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL------K 117
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ---- 670
G++YLH N IIHRD+K +N+LVD +K+ DFG+S+ L+TKT P
Sbjct: 118 GLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 671 --WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
WMAPEV++ K+D++S G ++ E+ T K P+ + +Q
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-31
Identities = 79/210 (37%), Positives = 119/210 (56%), Gaps = 10/210 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K E +F QE +MK+
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH + L+ + AV S + + IVTEF+ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRH-DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPW 705
KSDV+SFG++L EL T+ ++P+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 510 GEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--------VIHSFRQEVSLMKRL 559
GE IG+G+ G VY A V G +AVK ++ + R E+ +K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
H N++ ++G T+ + L I E++P GS+ L R + + + + G++YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVL 677
H + I+HRDLK+ NLLVD K+ DFG+S+ + Y + +G+ WMAPEV+
Sbjct: 125 H--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 678 RNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ K D++S G ++ E+ + PW + ++
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 74/210 (35%), Positives = 120/210 (57%), Gaps = 10/210 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+E+ E L + +++G G G V+ + G + VA+K + S E +F E +LMK+
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+HP L+ + AV + + + I+TE++ GSL L+ KL + I MA IA G++
Sbjct: 58 LQHPR-LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
++ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPW 705
+ KSDV+SFG++L E+ T +IP+
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 66/195 (33%), Positives = 106/195 (54%), Gaps = 11/195 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ LT+GE IG+G G V + G VAVK D +F +E ++M +L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK----CDVTAQAFLEETAVMTKLHHKNL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +G + L IV E + +G+L L+ R + + + +LD+A G+ YL +
Sbjct: 62 VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--S 118
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDL + N+LV + KV DFGL+R+ +K +W APE L+++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEALKHKKFS 175
Query: 684 EKSDVYSFGVILWEL 698
KSDV+S+GV+LWE+
Sbjct: 176 SKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 73/201 (36%), Positives = 112/201 (55%), Gaps = 15/201 (7%)
Query: 511 EQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+Q+G+G+ G+V + G VAVK Q + E + F +E+ ++K L+H N+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 565 LLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + G S R L +V E+LP GSL LQ++ +LD R+ +L A I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLRN 679
+ +HRDL + N+LV+ VK+GDFGL+++ E Y + G+ W APE L
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 680 EPSDEKSDVYSFGVILWELAT 700
SDV+SFGV+L+EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 72/219 (32%), Positives = 114/219 (52%), Gaps = 30/219 (13%)
Query: 510 GEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPN 563
G+Q+G G+ + Y A V G+ +AVK + + +EV+ + R+E+ LM RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSY 618
++ +GA + E++ GS+ LL + +++ ++L RG+SY
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL------RGLSY 118
Query: 619 LHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLS-RLKHETYLTTKTGK------GTPQ 670
LH IIHRD+K +NLL+D +++ DFG + RL T G+ GT
Sbjct: 119 LH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIA 173
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
+MAPEVLR E DV+S G ++ E+AT K PW+
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 74/224 (33%), Positives = 109/224 (48%), Gaps = 31/224 (13%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEV 553
EI + E++G+G+ G VY G + VA+K ++ +V FRQE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEA 59
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------T 598
LM L+HPN++ +G T Q C++ E+L G L L RN+ +
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-- 654
LD + +A+ IA G+ YL HH +HRDL + N LV + TVK+ DFGLSR
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+ Y +WM PE + +SD++SFGV+LWE+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 77/207 (37%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 511 EQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IG+G G VYH SD AVK +R +EV F +E +MK HPNVL
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 566 LFMGAVTSPQRL-CIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+G + +V ++ G L R N T D I L +A+G+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL-- 114
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETY-LTTKTGKGTP-QWMAPEVL 677
+ +HRDL + N ++D+ +TVKV DFGL+R E Y + TG P +WMA E L
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIP 704
+ + KSDV+SFGV+LWEL T P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 77/232 (33%), Positives = 126/232 (54%), Gaps = 22/232 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + G + VA+K + E I F E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---------WR 603
S+MK +V+ +G V+ Q ++ E + RG L L+ +++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +ET K
Sbjct: 120 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
GKG +WM+PE L++ SDV+SFGV+LWE+AT + P+ +++ Q
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 22/211 (10%)
Query: 513 IGQGSCGTVYHAV-------WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN 563
+G+GS G V V Y A+KV +++ EV H+ E +++ R+ HP
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLY----AMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPF 54
Query: 564 V--LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+ L + A + ++L +V E+ P G LF L + + R R A +I + YLH
Sbjct: 55 IVKLHY--AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
II+RDLK N+L+D +K+ DFGL++ T T GTP+++APEVL +
Sbjct: 112 LG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D +S GV+L+E+ T K P+ + +
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 68/214 (31%), Positives = 116/214 (54%), Gaps = 23/214 (10%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH---PNVL 565
E IG+G+ G VY V G VA+K+ + D+V ++EV+L+ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNIT 65
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIARGVSYL 619
+ G+ RL I+ E+ GS+ L++ + + R +L+AL Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVAL------KYI 117
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H +IHRD+K++N+LV VK+ DFG++ L ++ T GTP WMAPEV+
Sbjct: 118 HKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 680 EPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
D K+D++S G+ ++E+AT P+ ++++ +
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 70/224 (31%), Positives = 116/224 (51%), Gaps = 25/224 (11%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHA-VWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMK 557
W T GE +G+G+ GTVY G +AVK S +++ ++EV L+K
Sbjct: 1 EW---TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARG 615
L+H N++ ++G + I EF+P GS+ +L R + + + LD G
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---G 114
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKG 667
V+YLH+ ++HRD+K +N+++ + +K+ DFG +R H L K+ G
Sbjct: 115 VAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHG 170
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
TP WMAPEV+ KSD++S G ++E+AT K P +++ +
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 77/224 (34%), Positives = 121/224 (54%), Gaps = 27/224 (12%)
Query: 505 EDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMKR 558
+ +G+ +G+G+ G VY + G ++AVK QE S EV ++ E+ L+K
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKN 60
Query: 559 LRHPNVLLFMGAVTSPQ--RLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMAL 610
LRH ++ + G + P+ +L I E++P GS+ + L N T+ + R+IL
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQIL--- 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTGKG 667
+GVSYLH + I+HRD+K +N+L D VK+GDFG S+ ++ K+ G
Sbjct: 117 ---QGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
TP WM+PEV+ E K+DV+S + E+ TEK PW +M
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/206 (28%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL 559
+D + +G GS G V V + G A+K+ S+ + +V H E +++ +
Sbjct: 1 DDFEFIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSI 58
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRR----RILMALDIAR 614
RHP ++ G+ L +V E++P G LF L+++ R ++++AL+
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE--- 115
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
YLH + I++RDLK NLL+D +K+ DFG + R+K TY T GTP+++A
Sbjct: 116 ---YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLA 166
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELA 699
PE++ ++ + D ++ G++++E+
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 9/210 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E + + +++G G G V+ + S VAVK S + +F +E +LMK
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+H ++ VT + + I+TE++ +GSL L+ + K+ + I + IA G++
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N IHRDL+++N+LV + K+ DFGL+R+ + T + G P +W APE
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 677 LRNEPSDEKSDVYSFGVILWELAT-EKIPW 705
+ KSDV+SFG++L+E+ T KIP+
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 16/217 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+DL ++G G+ G V G +AVK R E ++ + +E+ ++ + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARGVSYLH 620
++ F GA + + I E++ GSL ++L+ ++ RIL +A+ + +G++YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLH 117
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTGKGTPQWMAPEVL 677
IIHRD+K SN+LV+ +K+ DFG+S L KT GT +MAPE +
Sbjct: 118 E-KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
+ KSD++S G+ L ELAT + P+ N D
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 30/205 (14%)
Query: 511 EQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS--FRQEVSLMKRLRHP 562
E++G+G+ G VY A D VA+K R + +E I S R E+SL+K L+HP
Sbjct: 5 EKLGEGTYGVVYKAR----DKKTGEIVALKKI-RLDNEEEGIPSTALR-EISLLKELKHP 58
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-H 621
N++ + + + ++L +V E+ L + L + L + + RG++Y H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-APEV 676
I+HRDLK N+L+++ +K+ DFGL+R T + W APE+
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEI 169
Query: 677 LRNEPSDEKS-DVYSFGVILWELAT 700
L + D++S G I E+ T
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQ----EVSLMKR 558
+ I ++IG+G VY A+ G VA+K E D RQ E+ L+K+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQ 58
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIARG 615
L HPNV+ ++ + L IV E G L R++ ++ + R + +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-----GTPQ 670
+ ++H + I+HRD+K +N+ + VK+GD GL R + ++KT GTP
Sbjct: 119 LEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPY 171
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+M+PE + + KSD++S G +L+E+A + P+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 73/230 (31%), Positives = 114/230 (49%), Gaps = 36/230 (15%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVF----SRQEYSDEVIHS 548
+E+ + LT+G+ +G+G+ G V A G D VAVK+ + ++ SD V
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV--- 63
Query: 549 FRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN----------- 596
E+ +MK + +H N++ +G T L +V E+ G+L L+
Sbjct: 64 --SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 597 ----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
L + + A +ARG+ +L + IHRDL + N+LV + +K+ DFGL+
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 653 RLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
R H KT G P +WMAPE L + +SDV+SFGV+LWE+ T
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 19/198 (9%)
Query: 511 EQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G G+ G+V V+ G +VAVK QE+ F +E S+M +L HP ++
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+G L +V E P G L + L+ R D +A +A G++YL +
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKH 115
Query: 624 PPIIHRDLKSSN-LLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQWMAPEVLRN 679
+HRDL + N LLV++H K+ DFG+SR + Y T G+ +W APE +
Sbjct: 116 --FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 680 EPSDEKSDVYSFGVILWE 697
KSDV+S+GV LWE
Sbjct: 173 GKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 68/204 (33%), Positives = 115/204 (56%), Gaps = 7/204 (3%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G VY + + VA+K+ +E DE I +QE++++ + P + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ + + IL +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR--EILKGLDYLH--SERKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K++N+L+ + VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 689 YSFGVILWELATEKIPWDNLNSMQ 712
+S G+ ELA + P +L+ M+
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMR 208
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 64/206 (31%), Positives = 115/206 (55%), Gaps = 6/206 (2%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
++IG+GS G +Y A +K + + + ++EV L+ +++HPN++ F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPII 627
+ RL IV E+ G L + + R L +IL + I+ G+ ++H + I+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKIL 123
Query: 628 HRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
HRD+KS N+ + K+ V K+GDFG++R +++ T GTP +++PE+ +N P + K+
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQ 712
D++S G +L+EL T K P++ N Q
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-27
Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 10/208 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E+IG+G+ G V+ + V V S R+ ++ F QE ++K+ HPN++ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--HCNPPII 627
T Q + IV E + G L+ +L + I M + A G+ YL HC I
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----I 116
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-TYLTTKTGKGTP-QWMAPEVLRNEPSDEK 685
HRDL + N LV + +K+ DFG+SR + + Y +T K P +W APE L +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 686 SDVYSFGVILWE-LATEKIPWDNLNSMQ 712
SDV+SFG++LWE + +P+ NL++ Q
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 64/211 (30%), Positives = 113/211 (53%), Gaps = 27/211 (12%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G V+ V +K ++ + + + + E ++K L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCN 623
+ L IV E+ P G+L +Q+ T L + +IL+AL H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH--------HVHT 119
Query: 624 PPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTK----TGKGTPQWMAPEVLR 678
I+HRDLK+ N+L+DKH V K+GDFG+S++ L++K T GTP +++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCE 174
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
+P ++KSD+++ G +L+ELA+ K ++ N
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+G+ G VY A G VA+K + S+ + + +E+ L+K L HPN++ +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
L +V EF+ L++L++ L + +G+++ H I+H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILH 121
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQ----WM-APEVLRNE 680
RDLK NLL++ +K+ DFGL+R Y T W APE+L +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--------THYVVTRWYRAPELLLGD 173
Query: 681 PS-DEKSDVYSFGVILWELATEKIPW 705
D++S G I EL + + +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 69/204 (33%), Positives = 115/204 (56%), Gaps = 7/204 (3%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G V+ + + VA+K+ +E DE I +QE++++ + P V +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ LD + + +I +G+ YLH + IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--SEKKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K++N+L+ +H VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 689 YSFGVILWELATEKIPWDNLNSMQ 712
+S G+ ELA + P L+ M+
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 72/217 (33%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 509 IGEQIGQGSCGTVY-----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
I E IG G G V VA+K + Y+++ F E S+M + HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G VT + + I+TEF+ G+L L++N + + + M IA G+ YL N
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-----TYLTTKTGKGTPQWMAPEVLR 678
+HRDL + N+LV+ + KV DFGLSR + TY ++ GK +W APE +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 679 NEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQD 713
SDV+S+G+++WE+ + E+ WD N QD
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 76/220 (34%), Positives = 116/220 (52%), Gaps = 27/220 (12%)
Query: 509 IGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEV---IHSFRQEVSLMKRLRHPN 563
+G+ +GQG+ G VY + G ++AVK S E +++ E+ L+K L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 564 VLLFMGAVTSPQR--LCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIARG 615
++ + G + P L I E +P GS+ + L N T+ + R+IL G
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQIL------EG 118
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG----KGTPQW 671
VSYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG GTP W
Sbjct: 119 VSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASK-RLQTICLSGTGMKSVTGTPYW 175
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
M+PEV+ E K+D++S G + E+ TEK PW +M
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 37/229 (16%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRL-R 560
+D G+ IG+GS TV A ++ A+K+ +++ E + + E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR----RILMALDIARG 615
HP ++ + L V E+ P G L + +++ + R IL+AL+
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE---- 116
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--------- 666
YLH IIHRDLK N+L+DK +K+ DFG +++
Sbjct: 117 --YLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 667 -----------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP 704
GT ++++PE+L +P+ + SD+++ G I++++ T K P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPNVLLFMG 569
I +G+ G V+ A G A+KV + + + + E ++ + + P V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD--WRR----RILMALDIARGVSYLHHCN 623
+ + L +V E+LP G L LL N LD R I++AL+ YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALE------YLHSNG 113
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLS------RLKHETYLTTKTGK--GTPQWMAPE 675
IIHRDLK N+L+D + +K+ DFGLS R + + + GTP ++APE
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 676 VLRNEPSDEKSDVYSFGVILWELAT 700
V+ + + D +S G IL+E
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 67/204 (32%), Positives = 113/204 (55%), Gaps = 7/204 (3%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G V+ + VA+K+ +E DE I +QE++++ + P V +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ D + M +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLH--SEKKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K++N+L+ + VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 689 YSFGVILWELATEKIPWDNLNSMQ 712
+S G+ ELA + P +++ M+
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMR 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 63/189 (33%), Positives = 104/189 (55%), Gaps = 5/189 (2%)
Query: 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E +G+G+ G V+ + VAVK +++ E+ F E ++K+ HPN++ +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
T Q + IV E +P G L++ +L ++ + ALD A G++YL N IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHR 117
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDV 688
DL + N LV ++ +K+ DFG+SR + + ++ K P +W APE L +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 689 YSFGVILWE 697
+S+G++LWE
Sbjct: 178 WSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 77/232 (33%), Positives = 119/232 (51%), Gaps = 22/232 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + VAVK + E I F E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-------QRNTTKL--DWR 603
S+MK +V+ +G V+ Q +V E + G L L + N + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
I MA +IA G++YL+ +HRDL + N +V +TVK+GDFG++R +ET K
Sbjct: 120 EMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
GKG +WMAPE L++ SD++SFGV+LWE+ + + P+ L++ Q
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 70/217 (32%), Positives = 122/217 (56%), Gaps = 10/217 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + +++G G G V+ A + + VAVK S + +F E ++MK
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+H + L+ + AV + + + I+TEF+ +GSL L+ + +K + I + IA G++
Sbjct: 58 LQH-DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
++ N IHRDL+++N+LV K+ DFGL+R+ + T + G P +W APE
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
+ KSDV+SFG++L E+ T +IP+ +++ +
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 513 IGQGSCG--TVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G T+Y S V K + S++ E+ ++ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 571 VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
L I E+ G+L+ +++++ + + I VSY+H I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVY 689
D+K+ N+ + K +K+GDFG+S++ Y +T GTP +M+PE+ + + KSD++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 690 SFGVILWELATEKIPWDNLN 709
+ G +L+EL T K +D N
Sbjct: 186 ALGCVLYELLTLKRTFDATN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRL- 559
WED+ + IG+G+ G V A+ G + + +E++ E H F E+ ++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRR 604
HPN++ +GA + L I E+ P G+L L+++ + L ++
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
+ A D+A G+ YL IHRDL + N+LV ++ K+ DFGLSR E Y+
Sbjct: 121 LLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTM 177
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
G+ +WMA E L KSDV+SFGV+LWE+ +
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 71/223 (31%), Positives = 112/223 (50%), Gaps = 26/223 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 564
+ E IG+G+ G VY A G VA+K+ + ++ ++E +++++ HPN+
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 565 LLFMGA------VTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIA 613
F GA + +L +V E GS+ L++ K +W IL +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR--ETL 123
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
RG++YLH +IHRD+K N+L+ K+ VK+ DFG+S T T GTP WMA
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 674 PEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSM 711
PEV+ + D +SDV+S G+ ELA K P +++ M
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
L +G+ +G+G G+V D VAVK ++ I F E + MK H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 562 PNVLLFMG------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLDWRRRILMAL 610
PNV+ +G ++ + ++ F+ G L F L R KL + + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGKGT 668
DIA G+ YL + N IHRDL + N ++ + TV V DFGLS+ + Y + K
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+W+A E L + KSDV++FGV +WE+AT
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 30/230 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+ + + ++G+G+ G V+ Y VAVK ++ S++ F +E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLT 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRR 604
+H N++ F G T +V E++ G L + L+ + +L +
Sbjct: 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 605 RILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLT 661
+ +A+ IA G+ YL H +HRDL + N LV VK+GDFG+SR + T Y
Sbjct: 124 LLQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 662 TKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709
P +WM PE + +SDV+SFGV+LWE+ T K PW L+
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 62/184 (33%), Positives = 101/184 (54%), Gaps = 8/184 (4%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VA+K + Y+++ F E S+M + HPN++ G VT + + IVTE++ GSL
Sbjct: 35 VAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+++ + + + M IA G+ YL + +HRDL + N+LV+ + KV DFG
Sbjct: 94 AFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 651 LSRLKH---ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPW 705
LSR+ E TT+ GK +W APE + SDV+S+G+++WE+ + E+ W
Sbjct: 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211
Query: 706 DNLN 709
+ N
Sbjct: 212 EMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/160 (32%), Positives = 92/160 (57%), Gaps = 15/160 (9%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNT-----TKLDW 602
R+EV+++ ++HPN++ + + L IV ++ G L++ + QR LDW
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+I +AL H + I+HRD+KS N+ + K T+K+GDFG++R+ + T
Sbjct: 107 FVQICLALK--------HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK 702
+T GTP +++PE+ N P + KSD+++ G +L+E+ T K
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/178 (35%), Positives = 98/178 (55%), Gaps = 10/178 (5%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTEFLP 585
G VAVK R E + +++E++++K L H N++ + G + + L ++ E++P
Sbjct: 33 GEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
GSL L ++ KL+ + +L A I G++YLH + IHRDL + N+L+D VK
Sbjct: 92 LGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVK 147
Query: 646 VGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+GDFGL++ HE Y + G W A E L+ SDV+SFGV L+EL T
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 15/208 (7%)
Query: 513 IGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
IG G G V+ + VA+K + Y+++ F E S+M + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
G VT + I+TE++ G+L + L+ + + + + M IA G+ YL N +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YV 129
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TYLTTKTGKGTPQWMAPEVLRNEPSD 683
HRDL + N+LV+ + KV DFGLSR+ + TY TT GK +W APE +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY-TTSGGKIPIRWTAPEAIAYRKFT 188
Query: 684 EKSDVYSFGVILWELAT--EKIPWDNLN 709
SDV+SFG+++WE+ + E+ WD N
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 71/234 (30%), Positives = 117/234 (50%), Gaps = 34/234 (14%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDE 544
L + WE L +G+ +G+G G V A YG D VAVK+ + +D+
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDK 59
Query: 545 VIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-------------- 589
+ E+ LMK + +H N++ +G T L ++ E+ +G+L
Sbjct: 60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDY 119
Query: 590 -FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
F + + +L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ D
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIAD 177
Query: 649 FGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
FGL+R H+ Y T G+ +WMAPE L + +SDV+SFG+++WE+ T
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
WE IGE +G G+ G VY A + + A K+ + S+E + F E+ ++ +H
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKH 61
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ A +L I+ EF G+L ++ L + + + +++LH
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH- 120
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL---- 677
+ +IHRDLK+ N+L+ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 121 -SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 678 -RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ P D K+D++S G+ L ELA + P LN M+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 75/222 (33%), Positives = 119/222 (53%), Gaps = 33/222 (14%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQ--------EYSDEVIHSFRQEVSLMKRLRH 561
G+ +GQG+ G VY + Y D ++ ++Q E S EV + E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVY--LCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQH 63
Query: 562 PNVLLFMGAVT--SPQRLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIA 613
++ + G + + + L I E++P GS+ + L + T+ + R+IL
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQIL------ 116
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG----KGTP 669
G+SYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG GTP
Sbjct: 117 EGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICMSGTGIRSVTGTP 173
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
WM+PEV+ E K+DV+S G + E+ TEK PW +M
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 71/190 (37%), Positives = 102/190 (53%), Gaps = 7/190 (3%)
Query: 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A GS AVKV ++ E H + L+K L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + ++L V +++ G LF LQR L+ R R A ++A + YLH N II+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRAR-FYAAEVASAIGYLHSLN--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D V + DFGL + E TT T GTP+++APEVLR EP D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 689 YSFGVILWEL 698
+ G +L+E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 67/190 (35%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A AVKV ++ E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + +L V +++ G LF LQR + + R R A +IA + YLH N II+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR-FYAAEIASALGYLHSLN--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D V + DFGL + E TT T GTP+++APEVLR +P D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 689 YSFGVILWEL 698
+ G +L+E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 78/227 (34%), Positives = 114/227 (50%), Gaps = 32/227 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A V VA+K S + S+E +EV
Sbjct: 12 DPEKLFTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA-- 613
+++LRHPN + + G +V E+ L + L+ ++ L ++IA
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAI 120
Query: 614 -----RGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+G++YLH H IHRD+K+ N+L+ + TVK+ DFG + L + G
Sbjct: 121 CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANSFVG 173
Query: 668 TPQWMAPEVL--RNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSM 711
TP WMAPEV+ +E D K DV+S G+ ELA K P N+N+M
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 78/243 (32%), Positives = 117/243 (48%), Gaps = 45/243 (18%)
Query: 507 LTIGEQIGQGSCGTVYHA----------------VWYGSD--VAVKVFSRQEYSDEVIHS 548
L E++G+G G V+ + VAVKV R + SD
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNARED 65
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----------NTT 598
F +EV ++ RL PN+ +G T LC++ E++ G L + LQ+ N+
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
L + + MA IA G+ YL N +HRDL + N LV K++T+K+ DFG+SR
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR---NL 180
Query: 659 YLTT--KTGKGTP---QWMAPE-VLRNEPSDEKSDVYSFGVILWE---LATEKIPWDNLN 709
Y + + P +WMA E VL + + KSDV++FGV LWE L E+ P+++L
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQ-PYEHLT 238
Query: 710 SMQ 712
Q
Sbjct: 239 DQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 70/216 (32%), Positives = 114/216 (52%), Gaps = 18/216 (8%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG---SD----VAVKVFSRQEYSDEVI 546
L Y++ WE +L+ G+ +G G+ G V A YG SD VAVK+ +S E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER- 82
Query: 547 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR 604
+ E+ +M L H N++ +GA T + ++TE+ G L L+R L
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTK 663
+ + +A+G+++L N IHRDL + N+L+ VK+ DFGL+R + +++ K
Sbjct: 143 LLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200
Query: 664 TGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
P +WMAPE + N +SDV+S+G++LWE+
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 69/209 (33%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 513 IGQGSCGTVYHA-----VWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+G G+ G VY + GS VAVK + E F +E LM HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTK----LDWRRRILMALDIARGVSY 618
+ +G + I+ E + G L L+ R L + + + LD+A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 619 LHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR--LKHETYLTTKTGKGTPQW 671
L + IHRDL + N LV D VK+GDFGL+R K + Y G +W
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELAT 700
MAPE L + +SDV+SFGV++WE+ T
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 63/178 (35%), Positives = 96/178 (53%), Gaps = 8/178 (4%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTEFLP 585
G VAVK + E I ++E+ +++ L H N++ + G T + ++ EFLP
Sbjct: 33 GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
GSL L RN K++ ++++ A+ I +G+ YL +HRDL + N+LV+ VK
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVK 149
Query: 646 VGDFGLSRL--KHETYLTTKTGKGTPQ-WMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+GDFGL++ + Y T K +P W APE L SDV+SFGV L+EL T
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 26/218 (11%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIH-SFRQEVSLMKR 558
W D+ + IG+G+ G V A D A+K +EY+ + H F E+ ++ +
Sbjct: 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCK 63
Query: 559 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL---------------FRLLQRNTTKLDW 602
L HPN++ +GA L + E+ P G+L F + + L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 124 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKK 180
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
G+ +WMA E L SDV+S+GV+LWE+ +
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 64/183 (34%), Positives = 97/183 (53%), Gaps = 16/183 (8%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R + + + F +E+ +M RL++PN++ +G S LC++TE++ G L
Sbjct: 47 VAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 591 RLL-QR----------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
+ L QR N + + MA+ IA G+ YL N +HRDL + N LV
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVG 163
Query: 640 KHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWE 697
H+T+K+ DFG+SR L Y + P +WMA E + SDV++FGV LWE
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 698 LAT 700
+ T
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 513 IGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IGQG+ G V+ A G + VAVK+ ++E S ++ F++E +LM HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDHPNIV 71
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------------------LDWRR 604
+G + +C++ E++ G L L+ + + L
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTK 663
++ +A +A G++YL +HRDL + N LV ++ VK+ DFGLSR + Y
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 664 TGKGTP-QWMAPE-VLRNEPSDEKSDVYSFGVILWEL 698
P +WM PE + N + E SDV+++GV+LWE+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHP 562
+ +++G+GS GTVY + ++ +E +E + + QE L+ +L HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYL 619
++ F + CI+TE+ L L+ L + + + GV Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H I+HRDLK+ N+ + + +K+GDFG+SRL + T GTP +M+PE L++
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 680 EPSDEKSDVYSFGVILWEL 698
+ D KSD++S G IL+E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
T+G +G+G G+V A D VAVK+ +S I F +E + MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 562 PNVLLFMGAV---TSPQRLCI---VTEFLPRGSL--FRLLQR---NTTKLDWRRRILMAL 610
PNV+ +G + RL I + F+ G L F L+ R L + + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGKGT 668
DIA G+ YL N IHRDL + N +++++ TV V DFGLS+ + Y K
Sbjct: 121 DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+W+A E L + SDV++FGV +WE+ T
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 10/211 (4%)
Query: 505 EDLTIGEQIGQGSCGTV--YHAVWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRH 561
L +IG+GS G V G VAVK R++ E++ + EV +M+ +H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQH 75
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ + L +V EFL G+L ++ T+++ + + L + + +S+LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH- 132
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+ P
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D++S G+++ E+ + P+ N +Q
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 35/216 (16%)
Query: 511 EQIGQGSCGTVYHAVWY--GSD----VAVKVF----SRQEYSDEVIHSFRQEVSLMKRLR 560
E++G+ + G +Y Y G D VA+K + Q++ + F+QE SLM L
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-----FQQEASLMAELH 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--------------QRNTTK--LDWRR 604
HPN++ +G VT Q +C++ E+L +G L L + T K LD
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTK 663
+ +A+ IA G+ YL + +H+DL + N+L+ + VK+ D GLSR + Y +
Sbjct: 126 FLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 664 TGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
P +WM PE + SD++SFGV+LWE+
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 22/212 (10%)
Query: 513 IGQGSCGTVYHAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
+G+GS G V V + +D +K + + S + QE L+ +L+HPN++ +
Sbjct: 8 VGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 570 AVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVSYLHH 621
+ L IV F G L+ L+ KL +W +I MAL YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLHE 120
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+ I+HRDLK+ N+ + + +KVGD G++R+ T GTP +M+PE+ N+P
Sbjct: 121 KH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 682 SDEKSDVYSFGVILWELATEKIPWD--NLNSM 711
+ KSDV++ G ++E+AT K ++ ++NS+
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIH--SFRQEVSL 555
YE+L +G+G+ G V G VA+K F ++ DE + + R EV +
Sbjct: 3 YEVL-------GVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALR-EVKV 53
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRILMALDIA 613
+++LRH N++ A RL +V E++ R +L LL+ + L R + L
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--L 110
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-------TYLTTKTGK 666
+ ++Y H N IIHRD+K N+LV + +K+ DFG +R Y+ T+
Sbjct: 111 QAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--- 165
Query: 667 GTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELAT 700
W APE+L + + K DV++ G I+ EL
Sbjct: 166 ----WYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 69/228 (30%), Positives = 117/228 (51%), Gaps = 30/228 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E+ + L +G+ +G+G G V A G D VAVK+ + + +++ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLI 71
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------- 596
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 597 --TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 655 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
H + Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y +L +G+GS G SD A+K R S + R+E L+
Sbjct: 1 QYNVL-------RVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLL 52
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM-ALDIARG 615
+++HPN++ F + + L IV E+ G L + ++ KL IL + + G
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
V ++H ++HRD+KS N+ + ++ VK+GDFG +RL T GTP ++ PE
Sbjct: 113 VQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIP-----WDNL 708
+ N P + KSD++S G IL+EL T K P W NL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLF 567
IG G+ G V AV G VA+K S D++I + R +E+ L++ LRH N++
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 568 MGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + P IVTE + L ++++ D + + I RG+ YLH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYLHSA 122
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--HETYLTTKTGKGTPQWM-APEVLRN 679
N +IHRDLK SN+LV+ + +K+ DFGL+R E T +W APE+L +
Sbjct: 123 N--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 680 EPSDEKS-DVYSFGVILWELATEKI 703
K+ D++S G I EL T K
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 22/216 (10%)
Query: 512 QIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHS-FRQEVSLMKRLRHPN 563
+G+G G V+ A G + V VK Q+ DE + S FR+E+ + ++L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--------RILMALDIARG 615
V+ +G + ++ E+ G L + L+ +K + + ++ + IA G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAP 674
+ +L N +HRDL + N LV VKV LS+ + + Y + +W+AP
Sbjct: 130 MDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 675 EVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709
E ++ + KSDV+SFGV++WE+ T ++P+ L+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 10/205 (4%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A V G +VA+K + +Q+ E+I + E+ +M+ +HPN++ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKHPNIVNY 81
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 137
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 688 VYSFGVILWELATEKIPWDNLNSMQ 712
++S G++ E+ + P+ N N ++
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 7/204 (3%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A + AVKV ++ E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + +L V +++ G LF LQR L+ R R A +IA + YLH N I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR-FYAAEIASALGYLHSLN--IVY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D + + DFGL + E TT T GTP+++APEVL +P D D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNSMQ 712
+ G +L+E+ P+ + N+ +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 77/228 (33%), Positives = 119/228 (52%), Gaps = 26/228 (11%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
LD +WE IGE +G G+ G VY A G+ A KV + S+E + + E+ +
Sbjct: 8 LDPNEVWE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEI 62
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWR---RRILMA 609
+ HP ++ +GA +L I+ EF P G++ + L R T+ + R++L A
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
L YLH + IIHRDLK+ N+L+ +K+ DFG+S +T + GTP
Sbjct: 123 L------QYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 670 QWMAPEV-----LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
WMAPEV +++ P D K+D++S G+ L E+A + P LN M+
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 5e-23
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNV 564
+ +Q+G G+ G+VY A G VA+K ++ YS +E + + R+ SL K HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNEHPNI 60
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVS 617
+ L V E++ G+L++L++ K +IL L
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA------ 113
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL-----SRLKHETYLTTKTGKGTPQWM 672
++H HRDLK NLLV VK+ DFGL SR + Y++T+ W
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WY 164
Query: 673 -APEV-LRNEPSDEKSDVYSFGVILWELAT 700
APE+ LR+ D+++ G I+ EL T
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 7/205 (3%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572
+G+G+ G VY A + V + + E + +E++L L+H N++ ++G+ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR--ILMALDIARGVSYLHHCNPPIIHRD 630
I E +P GSL LL+ L + I I G+ YLH + I+HRD
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRD 133
Query: 631 LKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS--DEKSD 687
+K N+LV+ + VK+ DFG S+ T+T GT Q+MAPEV+ P +D
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193
Query: 688 VYSFGVILWELATEKIPWDNLNSMQ 712
++S G + E+AT K P+ L Q
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 71/227 (31%), Positives = 112/227 (49%), Gaps = 35/227 (15%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+L +G+ +G+G G V A + + VAVK+ S E + E +L+K+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQ 59
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLD-- 601
+ HP+V+ GA + L ++ E+ GSL L+ RN++ LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 602 ------WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
I A I+RG+ YL ++HRDL + N+LV + +K+ DFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 656 HE--TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+E +Y+ G+ +WMA E L + +SDV+SFGV+LWE+ T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 6e-23
Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 8/204 (3%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IGQG+ GTV+ A V G +VA+K + Q+ + + E+ +MK L++PN++ F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFL 82
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V E+L GSL ++ T +D + + + + + +LH +IH
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 689 YSFGVILWELATEKIPWDNLNSMQ 712
+S G++ E+ + P+ N N ++
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-23
Identities = 72/228 (31%), Positives = 118/228 (51%), Gaps = 30/228 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E+ LT+G+ +G+G G V A G D VAVK+ + + +D+ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLV 65
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDW------ 602
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +D+
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 603 --------RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 655 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
H + Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 17/196 (8%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R++ + + F +E+ +M RL+ PN++ + + LC++TE++ G L
Sbjct: 49 VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 591 RLLQR----------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640
+ L R + + + I MA IA G+ YL N +HRDL + N LV K
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGK 165
Query: 641 HWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
++T+K+ DFG+SR L Y + P +WM+ E + SDV++FGV LWE+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 699 AT--EKIPWDNLNSMQ 712
T ++ P+ L+ Q
Sbjct: 226 LTLCKEQPYSQLSDEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 69/228 (30%), Positives = 118/228 (51%), Gaps = 30/228 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E + LT+G+ +G+G G V A G D VAVK+ + + +++ +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV 68
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILM 608
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +++ I
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 609 ALD--------------IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
D +ARG+ YL + IHRDL + N+LV ++ +K+ DFGL+R
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 655 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ + Y T G+ +WMAPE L + +SDV+SFGV++WE+ T
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 9e-23
Identities = 56/165 (33%), Positives = 88/165 (53%), Gaps = 4/165 (2%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH C+ +++RDLK NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
KT GTP+++APEVL + D + GV+++E+ ++P+ N
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-22
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 513 IGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIH-SFRQEVSLMKRL-RHPNVLL 566
IG+G+ G V A D A+K +EY+ + H F E+ ++ +L HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALD 611
+GA L + E+ P G+L L+++ + L ++ + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQW 671
+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+ G+ +W
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRW 177
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELAT 700
MA E L SDV+S+GV+LWE+ +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHP 562
T+ + + +G+ G +++ + G + V V + ++++ E+ + QE L+ L H
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 563 NVLLFMGAVTS-PQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIAR 614
N+L + + ++ ++ G+L LQ+ N L ++ + MA+ IA
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWM 672
G+SYLH +IH+D+ + N ++D+ VK+ D LSR L Y + P +WM
Sbjct: 129 GMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELAT 700
A E L N+ SDV+SFGV+LWEL T
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 71/232 (30%), Positives = 117/232 (50%), Gaps = 28/232 (12%)
Query: 505 EDLTIGEQIGQGSCGTVY----HAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMK 557
D+ + ++G+G+ G V+ H + D VAVK +E S+ F++E L+
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------TTKLDWR 603
L+H +++ F G T + L +V E++ G L R L+ + +L
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ + +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR + T
Sbjct: 123 QMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 664 TGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
G+ P +WM PE + +SD++SFGV+LWE+ T K PW L++ +
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + ++IG G+ G VY A V G A+KV + D + +QE+ +MK +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKDCKHS 66
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + G+ +L I EF GSL + + T L + ++ + +G+ YLH
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLH-- 123
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL---RN 679
+ +HRD+K +N+L+ + VK+ DFG+S T K+ GTP WMAPEV R
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ D+++ G+ ELA + P +L+ M+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 513 IGQGSCGTVYHAVWY---GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+G+ G V V A+K ++Q+ + + E +++ L HP ++
Sbjct: 8 IGKGAFGKVC-IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + +V + L G L L + + + + + +I + YLH IIH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG--IIH 123
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K N+L+D+ V + DF ++ LTT + GTP +MAPEVL + D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STSGTPGYMAPEVLCRQGYSVAVDW 182
Query: 689 YSFGVILWELATEKIPWDN 707
+S GV +E K P+
Sbjct: 183 WSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
++ + ++G+G+ G V+ A Y + V V + ++ SD F +E L+ L+
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------TTKLDWRRRILM 608
H +++ F G L +V E++ G L + L+ + +L + + +
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKG 667
A IA G+ YL + +HRDL + N LV ++ VK+GDFG+SR + T Y
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 668 TP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNS 710
P +WM PE + +SDV+S GV+LWE+ T K PW L++
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 511 EQIGQGSCGTVY----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V H + V VK DE + F QEV + L HPNVL
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRIL--MALDIARGVSYLHHC 622
+G +V EF P G L L+ N ++ +L MA ++A G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTP-QWMAPEVLRNE 680
+ IH DL N + +VK+GD+GL+ ++ E Y TK P +W+APE++
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 681 PSD-------EKSDVYSFGVILWELATEKI-PWDNLNSMQ 712
D +KS+++S GV +WEL T P+ +L+ Q
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 21/216 (9%)
Query: 511 EQIGQGSCGTVYHAVWY----GSDVAVK-VFSR-------QEYSDEVIHSFRQEVSLMK- 557
E +G G+ G VY V + +A+K + + D+ I EV+++K
Sbjct: 6 EHLGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFL---PRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+LRHPN++ + RL IV + + P G F L+ + R + + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTPQWMA 673
+ YLH I+HRDL +N+++ + V + DFGL++ K E+ LT+ G T +
Sbjct: 125 ALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG--TILYSC 181
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
PE+++NEP EK+DV++FG IL+++ T + P+ + N
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 9e-22
Identities = 76/219 (34%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A V VA+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+++LRHPN + + G +V E+ GS LL+ + L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YLH N +IHRD+K+ N+L+ + VK+GDFG + + GTP WMAPE
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPE 181
Query: 676 V---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
V + D K DV+S G+ ELA K P N+N+M
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--VIHSFRQEVSL 555
YE + QIG+G+ G VY A G VA+K R E E I + R E+ L
Sbjct: 1 YEKI-------AQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIR-EIKL 51
Query: 556 MKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKL-DWRRRILMALDI 612
+++LRHPN++ VTS + + +V E++ L LL K + + + M +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM-KQL 109
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ-- 670
G+ YLH I+HRD+K SN+L++ +K+ DFGL+R Y + T +
Sbjct: 110 LEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVI 163
Query: 671 --WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
W PE+L + D++S G IL EL K
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 75/225 (33%), Positives = 113/225 (50%), Gaps = 20/225 (8%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSL 555
L+ E WE IGE +G G+ G VY A + V A KV + S+E + + E+ +
Sbjct: 1 LNPEEFWE--IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWRRRILMALDI 612
+ HPN++ + A L I+ EF G++ + L+R T+ R L+
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE- 114
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
++YLH IIHRDLK+ N+L +K+ DFG+S T + GTP WM
Sbjct: 115 --ALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170
Query: 673 APEVL-----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
APEV+ ++ P D K+DV+S G+ L E+A + P LN M+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH 561
D +GE +G GS G V A G+ A+K ++E +V H QE S++ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSH 77
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGV 616
P ++ M + R+ + EF+ G LF L++ N + +++A +
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----- 132
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 675
YLH + II+RDLK NLL+D VKV DFG + ++ T+ T GTP+++APE
Sbjct: 133 -YLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLAPE 185
Query: 676 VLRNEPSDEKSDVYSFGVILWEL 698
V++++ + D ++ GV+L+E
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH-----SFRQEVSLMKRLRHPNVLLF 567
+G G+ GTVY +W VK+ + +E F E +M + HP+++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G SP + +VT+ +P G L + + + + + + IA+G+ YL ++
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LV 131
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
HRDL + N+LV VK+ DFGL+RL E GK +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 686 SDVYSFGVILWELAT 700
SDV+S+GV +WEL T
Sbjct: 192 SDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 67/197 (34%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 513 IGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G G+ GTVY +W G + VA+KV R+ S + E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 567 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+G +TS +L VT+ +P G L ++ N ++ + + + IA+G+SYL
Sbjct: 74 LLGICLTSTVQL--VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR-- 129
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDL + N+LV VK+ DFGL+RL ET GK +WMA E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 684 EKSDVYSFGVILWELAT 700
+SDV+S+GV +WEL T
Sbjct: 190 HQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 13/193 (6%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
I +G+ G+VY A G A+KV + + ++V + + +M + P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ S L +V E+L G L++ DW ++ ++ GV LH II
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG--II 119
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+K NLL+D+ +K+ DFGLSR L K GTP ++APE + D+ SD
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 688 VYSFGVILWELAT 700
+S G +++E
Sbjct: 176 WWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 7/190 (3%)
Query: 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A G AVKV ++ + E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + ++L V +F+ G LF LQR + + R R A +IA + YLH N I++
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN--IVY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D V + DFGL + TT T GTP+++APEV+R +P D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 689 YSFGVILWEL 698
+ G +L+E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 10/205 (4%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A + G +VA+K + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 81
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH--SNQVI 137
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 688 VYSFGVILWELATEKIPWDNLNSMQ 712
++S G++ E+ + P+ N N ++
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVK----VFSRQEYSDEVIHSF 549
E+ + +T+ +G G+ G VY ++ G D VAVK S Q+ SD F
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-----F 56
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL------QRNTTKLDWR 603
E +M + H N++ +G I+ E + G L L + L +
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYL 660
+ A D+A+G YL + IHRD+ + N L+ K+ DFG++R +
Sbjct: 117 DLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 661 TTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
K G+ P +WM PE + K+DV+SFGV+LWE+
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 72/219 (32%), Positives = 113/219 (51%), Gaps = 24/219 (10%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567
E +G G+ G VY V G A+KV E +E I + E++++K+ H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI---KLEINMLKKYSHHRNIATY 78
Query: 568 MGAVT--SP----QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 618
GA SP +L +V EF GS+ L++ N K DW I +I RG+++
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAH 136
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 137 LHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 679 NEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ + D +SD++S G+ E+A P +++ M+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 5e-21
Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 8/199 (4%)
Query: 513 IGQGSCGTV--YHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G+ G V G A+K+ ++ DEV H+ E ++K RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSLK 61
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + RLC V E++ G LF L R + R R A +I + YLH + I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLH--SGKIVY 118
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK NL++DK +K+ DFGL + T KT GTP+++APEVL + D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 689 YSFGVILWELATEKIPWDN 707
+ GV+++E+ ++P+ N
Sbjct: 179 WGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+D+ E +G G+ GTVY A + +AVKV + + E+ E+ ++ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LMALDIARGV 616
++ F GA R+ I TEF+ GSL D R+I +A+ + +G+
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGL 108
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
+YL I+HRD+K SN+LV+ VK+ DFG+S + KT GT +MAPE
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPER 164
Query: 677 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
+ E SDV+S G+ ELA + P+ + Q S
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G G+ GTVY +W VA+K R+ S + E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 567 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+G +TS +L +T+ +P G L ++ + + + + + IA+G++YL
Sbjct: 74 LLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR-- 129
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDL + N+LV VK+ DFGL++L E + GK +WMA E + +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 684 EKSDVYSFGVILWELAT 700
+SDV+S+GV +WEL T
Sbjct: 190 HQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSF 549
DL N EDL +G G+ G+V + G+ +A KV V
Sbjct: 1 DLRN---------EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVV-HIGAKSSVRKQI 50
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILM 608
+E+ +M R P ++ F GA + +C+ EF+ GSL R+ ++ ++ +I
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI-- 108
Query: 609 ALDIARGVSYL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKT 664
A+ + G++YL H I+HRD+K SN+LV+ +K+ DFG+S L + T
Sbjct: 109 AVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADT 161
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
GT +M+PE ++ KSDV+S G+ + ELA K P+ N D
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 51/208 (24%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSR-QEYSDEVIHSFRQEVSLMKRLRHPNVL----LF 567
I + ++Y ++ +V ++ F + + +I E+ ++R+ N+L
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPI 626
+ V RL ++ E+ RG L +L L ++ ++ MA+D +G+ L+ + N P
Sbjct: 88 IDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRN--EPS 682
+++L S + LV +++ +K+ GL E L++ K + + ++L +
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNFMVYFSYKMLNDIFSEY 199
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNS 710
K D+YS GV+LWE+ T KIP++NL +
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTT 227
|
Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 4/165 (2%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + A + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTV-TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH + +++RD+K NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
KT GTP+++APEVL + D + GV+++E+ ++P+ N
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+ + ++G+G+ G V+ A Y VAVK + F++E L+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTN 63
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLDWR 603
L+H +++ F G L +V E++ G L + L+ + +L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTT 662
+ + +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR + T Y
Sbjct: 124 QMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 663 KTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
P +WM PE + +SDV+SFGVILWE+ T K PW L+
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 64/219 (29%), Positives = 116/219 (52%), Gaps = 17/219 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ +++G G+ G VY A + G AVK+ + D + +QE+ ++
Sbjct: 10 DYELI-------QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMV 60
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
K +H N++ + G+ S ++L I E+ GSL + + T L + + + +G+
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQGL 119
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
+YLH + +HRD+K +N+L+ + VK+ DFG++ T K+ GTP WMAPEV
Sbjct: 120 AYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 677 L---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+N ++ D+++ G+ ELA + P +L+ M+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEV-SLM--KRL-----RHP 562
+G+GS G V A G+D AVKV + D ++ +V M KR+ +HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKK----DVILQ--DDDVECTMTEKRVLALAGKHP 56
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + RL V E++ G L +QR + + D R A +I G+ +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
II+RDLK N+L+D +K+ DFG+ + +TT T GTP ++APE+L +P
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 683 DEKSDVYSFGVILWELATEKIPWD 706
D ++ GV+L+E+ + P++
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
Y DL +IG G+CG VY + G +AVK R +E ++K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 615
P ++ G + + I E L L +LL+R + IL M + I +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKR--IQGPIPEDILGKMTVAIVKA 126
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+ YL +IHRD+K SN+L+D VK+ DFG+S ++ T++ G +MAPE
Sbjct: 127 LHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPE 184
Query: 676 VLRNEPSDEK------SDVYSFGVILWELATEKIPWDNLNS 710
R +P D +DV+S G+ L ELAT + P+ N +
Sbjct: 185 --RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK R++ E++ + EV +M+ H NV+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMY 85
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V EFL G+L ++ T+++ + + L + R +SYLH N +IH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH--NQGVIH 141
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS ++L+ +K+ DFG + K+ GTP WMAPEV+ P + D+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 689 YSFGVILWELATEKIPWDNLNSMQ 712
+S G+++ E+ + P+ N +Q
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQ 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 23/188 (12%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R + + + F +EV ++ RL+ PN++ +G LC++TE++ G L
Sbjct: 49 VAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 591 RLLQRNTTK------------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632
+ L + + + + +AL IA G+ YL N +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLA 165
Query: 633 SSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYS 690
+ N LV ++ T+K+ DFG+SR L Y + P +WMA E + SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 691 FGVILWEL 698
FGV LWE+
Sbjct: 226 FGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 73/219 (33%), Positives = 108/219 (49%), Gaps = 16/219 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY V VA+K S + S+E +EV
Sbjct: 22 DPEKLFTDL---REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
++R++HPN + + G +V E+ GS LL+ + L + +G
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YLH N +IHRD+K+ N+L+ + VK+ DFG + + + GTP WMAPE
Sbjct: 138 LAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANSFVGTPYWMAPE 191
Query: 676 V---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
V + D K DV+S G+ ELA K P N+N+M
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-20
Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 10/205 (4%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A V G +VA++ + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 82
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 138
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 688 VYSFGVILWELATEKIPWDNLNSMQ 712
++S G++ E+ + P+ N N ++
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLR 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 513 IGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLFM 568
+G G G V A+K ++ + H F E +++ HP ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF-SEKEILEECNHPFIVKLY 59
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYLH 620
+ + ++ E+ G L+ +L R R L AR YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL---------RDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
+ II+RDLK NLL+D + VK+ DFG ++ K ++ T T GTP+++APE++ N+
Sbjct: 111 NRG--IIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNK 167
Query: 681 PSDEKSDVYSFGVILWELATEKIP 704
D D +S G++L+EL T + P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 6e-20
Identities = 72/219 (32%), Positives = 112/219 (51%), Gaps = 24/219 (10%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567
E +G G+ G VY V G A+KV +E I +QE++++K+ H N+ +
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHHRNIATY 68
Query: 568 MGAVTSPQ------RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 618
GA +L +V EF GS+ L++ NT K +W I +I RG+S+
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSH 126
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 127 LHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 679 NEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ + D KSD++S G+ E+A P +++ M+
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
G+++G+G+ VY A + VA+K + R+E D + + +E+ L++ L+HP
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVSYL 619
N++ + + +V EF+ L ++++ + L D + +LM L RG+ YL
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYL 118
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-AP 674
H I+HRDLK +NLL+ +K+ DFGL+R ++ + K T Q W AP
Sbjct: 119 HSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNR-KMTHQVVTRWYRAP 171
Query: 675 EVLRNEPSDEKS-DVYSFGVILWEL 698
E+L D++S G I EL
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 3/165 (1%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH +++RDLK NL++DK +K+ DFGL + + T
Sbjct: 96 RARFYGA-EIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
KT GTP+++APEVL + D + GV+++E+ ++P+ N
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 18/229 (7%)
Query: 492 DLDNDCLDYEILWEDLTIG-EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR 550
D + L Y+ E++ +G +IG GS G VY A ++ V V + YS + +
Sbjct: 7 DPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAV-KKMSYSGKQTNEKW 65
Query: 551 Q----EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
Q EV +++L+HPN + + G +V E+ GS LL+ + L
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 124
Query: 607 LMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+ +G++YLH H +IHRD+K+ N+L+ + VK+ DFG + +
Sbjct: 125 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSF 177
Query: 666 KGTPQWMAPEV---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
GTP WMAPEV + D K DV+S G+ ELA K P N+N+M
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 62/197 (31%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRH 561
D I Q+GQG G V+ A + VA+K + +EV H E ++ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKS 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLH 620
++ + A + L + E++P G FR L N L R MA ++ V LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMA-EMFEAVDALH 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
IHRDLK N L+D +K+ DFGLS+ + G+P +MAPEVLR +
Sbjct: 119 ELG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 681 PSDEKSDVYSFGVILWE 697
D D +S G +L+E
Sbjct: 174 GYDFTVDYWSLGCMLYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 72/223 (32%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 504 WEDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR- 560
WE I E IG+G+ G V+ GS AVK+ DE I + E +++K L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA---EYNILKALSD 73
Query: 561 HPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
HPNV+ F G V + +L +V E GS+ L++ + + ++A +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 616 VSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
+ L H IHRD+K +N+L+ VK+ DFG+S T L T GTP WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 675 EVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
EV+ E D + DV+S G+ EL P +L+ M+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A G VA+K R E DE + S +E+SL+K L HPN++
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMAL-DIARGVSYLHHCNPP 625
+ V S +L +V EFL L + + T LD I L + +G++Y H +
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYCH--SHR 119
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAPEVL 677
++HRDLK NLL+D+ +K+ DFGL+R HE T + APE+L
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--------TLWYRAPEIL 171
Query: 678 RNEPSDEKS-DVYSFGVILWELATEK 702
D++S G I E+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 550 RQEV-SLM--KRL-------RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
R EV SLM KR+ RHP ++ + +C V E+ G L + +
Sbjct: 40 RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV-- 97
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
R + A + G+ YLH I++RDLK NLL+D VK+ DFGL +
Sbjct: 98 FSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
T T GTP+++APEVL D + GV+++E+
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD----VAVK-----VFSRQEYSDEVIHSFRQEVSLMK 557
L +G+ +G+G G+V D VAVK + +R E D F E MK
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-----FLSEAVCMK 55
Query: 558 RLRHPNVLLFMG---------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLDWR 603
HPNV+ +G SP ++ F+ G L F L R L +
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLT 661
+ DIA G+ YL + IHRDL + N +++++ V V DFGLS+ + Y
Sbjct: 113 MLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170
Query: 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ K +W+A E L + KSDV+SFGV +WE+AT
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 6/179 (3%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VA+ R SD+ F E + + H N++ G +T + IVTE++ G+L
Sbjct: 36 VAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+++ +L + + M +A G+ YL +H+ L + +LV+ K+ F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 651 -LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWD 706
L K E TT +GK W APE ++ SDV+SFG+++WE+ + E+ WD
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 512 QIGQGSCGTV----YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
++G G+ GTV Y VAVK+ + +E ++M++L +P ++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G + + +V E G L + LQ+N + + + ++ G+ YL N +
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN--FV 117
Query: 628 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKT-GKGTPQWMAPEVLRNEPSD 683
HRDL + N LLV +H+ K+ DFGLS+ E Y KT GK +W APE +
Sbjct: 118 HRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 684 EKSDVYSFGVILWE 697
KSDV+SFGV++WE
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 564
+G+GS G V A G+D A+K+ + D +I E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ RL V E++ G L +Q+ K + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
II+RDLK N+++D +K+ DFG+ + TT+T GTP ++APE++ +P +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 685 KSDVYSFGVILWELATEKIPWD 706
D ++FGV+L+E+ + P+D
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-19
Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 21/237 (8%)
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VA 532
S SS S+SSSA L +L +IG G+ GTVY + + A
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSL------SELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
+KV + D V +E+ +++ + HPNV+ + ++ EF+ GSL
Sbjct: 104 LKVIY-GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--- 159
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
T D + +A I G++YLH + I+HRD+K SNLL++ VK+ DFG+S
Sbjct: 160 --EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK-----SDVYSFGVILWELATEKIP 704
R+ +T + GT +M+PE + + + D++S GV + E + P
Sbjct: 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 52/160 (32%), Positives = 85/160 (53%), Gaps = 11/160 (6%)
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRI 606
+E+ + K + P ++ + GA + I E+ GSL + ++ K R ++
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK-VKKRGGRIGEKV 106
Query: 607 L--MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
L +A + +G+SYLH IIHRD+K SN+L+ + VK+ DFG+S + T T
Sbjct: 107 LGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP 704
GT +MAPE ++ +P SDV+S G+ L E+A + P
Sbjct: 165 --GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 10/212 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHP 562
+ I ++IG+G VY A VA+K E D + +E+ L+K+L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVSYL 619
NV+ ++ + L IV E G L ++++ + +L R + + + V ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H + ++HRD+K +N+ + VK+GD GL R + GTP +M+PE +
Sbjct: 123 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 680 EPSDEKSDVYSFGVILWELATEKIPW--DNLN 709
+ KSD++S G +L+E+A + P+ D +N
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 68/211 (32%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPN 563
+IG+G+ GTVY A + G VA+K + + S +E++L+K+L HPN
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 564 VLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQR--------NTTKLDWRRRILMAL 610
++ + P+ L +V E + + L L + T K D R++L
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL--- 117
Query: 611 DIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGT 668
RGV +LH H I+HRDLK N+LV VK+ DFGL+R+ E LT+
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV---V 168
Query: 669 PQWM-APEVLRNEPSDEKSDVYSFGVILWEL 698
W APEVL D++S G I EL
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +IG+G+ G V+ A + VA+K + + + + +E+ ++ +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 566 LFMGAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E++P + R +R + + + M L GV+Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHANG 119
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----W-MAPEVLR 678
I+HRDLK +NLL+ +K+ DFGL+RL + + + Q W APE+L
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 679 NEPS-DEKSDVYSFGVILWEL 698
D D+++ G I EL
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG+G+ G VY A S VA+K V E I S R E++L+ LRHPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73
Query: 570 AVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPI 626
V + +V E+ + L LL T + + L + RG+ YLH + I
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-APEVLRNEP 681
IHRDLK SNLL+ +K+ DFGL+R TP+ W APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-----KPMTPKVVTLWYRAPELLLGCT 184
Query: 682 SDEKS-DVYSFGVILWELATEK 702
+ + D+++ G IL EL K
Sbjct: 185 TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+L + +G G GTV+ +W VA+K + + + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSL 66
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
H ++ +G L +VT+ P GSL ++++ LD +R + + IA+G+ YL
Sbjct: 67 DHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 620 H-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTPQWMA 673
H ++HR+L + N+L+ V++ DFG++ L K Y KT +WMA
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT---PIKWMA 179
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELAT 700
E + +SDV+S+GV +WE+ +
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 10/212 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHP 562
+ I ++IG+G VY A G VA+K + D + +E+ L+K+L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVSYL 619
NV+ + + L IV E G L R+++ + +L + + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H + ++HRD+K +N+ + VK+GD GL R + GTP +M+PE +
Sbjct: 123 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 680 EPSDEKSDVYSFGVILWELATEKIPW--DNLN 709
+ KSD++S G +L+E+A + P+ D +N
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 506 DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHP 562
D T E+IG+G+ G VY G VA+K R E +E + S +E+SL+K L+HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH- 621
N++ + RL ++ EFL L + L ++ +D SYL+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKG------QYMDAELVKSYLYQI 110
Query: 622 ------CNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGK 666
C+ ++HRDLK NLL+D +K+ DFGL+R HE
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV------- 163
Query: 667 GTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + APEVL P D++S G I E+AT+K
Sbjct: 164 -TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 56/194 (28%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 512 QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
++G G+ G V V+ DVA+KV + E V +E +M +L +P ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G V + L +V E G L + L ++ + + ++ G+ YL N +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FV 117
Query: 628 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-QWMAPEVLRNEPSD 683
HRDL + N LLV++H+ K+ DFGLS+ ++Y ++ P +W APE +
Sbjct: 118 HRDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 684 EKSDVYSFGVILWE 697
+SDV+S+G+ +WE
Sbjct: 177 SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 564
+G+GS G V A G+D A+K+ + D VI E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ RL V E++ G L +Q+ + + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
II+RDLK N+++D +K+ DFG+ + +TTKT GTP ++APE++ +P +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 685 KSDVYSFGVILWELATEKIPWD 706
D ++FGV+L+E+ + P++
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 73/217 (33%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-R 560
WE I E IG+G+ G VY GS AVK+ DE I + E ++++ L
Sbjct: 24 WE---IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---EYNILQSLPN 77
Query: 561 HPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDI 612
HPNV+ F G + L +V E GS+ L++ +LD +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
G+ +LH N IIHRD+K +N+L+ VK+ DFG+S T L T GTP WM
Sbjct: 138 LLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195
Query: 673 APEVLRNEPS-----DEKSDVYSFGVILWELATEKIP 704
APEV+ E D + DV+S G+ EL P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK R++ E++ + EV +M+ +H NV+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMY 83
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V EFL G+L ++ T+++ + + L + + +S LH +IH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLH--AQGVIH 139
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS ++L+ VK+ DFG + K+ GTP WMAPE++ P + D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 689 YSFGVILWELATEKIPWDN 707
+S G+++ E+ + P+ N
Sbjct: 200 WSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 511 EQIGQGSCGTVY----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V ++ + + V VK E + F +E + L+H N+L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRIL--MALDIARGVSYLHHC 622
+G T +V EF P G L L+ R + L MA +IA G+ +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTP-QWMAPEVLRNE 680
N IH DL N L+ TVK+GD+GLS K+ E Y T P +W+APE++
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 681 PSD-------EKSDVYSFGVILWEL 698
+ ++S+V+S GV +WEL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 34/221 (15%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFR--QEV 553
+ +WE +G G+ G V A + VA+K SR S IH+ R +E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYREL 65
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKL-DWRRRI 606
L+K + H NV+ + T L +VT + L +++ KL D +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK--CQKLSDDHIQF 122
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTK 663
L I RG+ Y+H IIHRDLK SN+ V++ +K+ DFGL+R + Y+ T+
Sbjct: 123 L-VYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 664 TGKGTPQW-MAPEVLRNEPSDEKS-DVYSFGVILWELATEK 702
W APE++ N ++ D++S G I+ EL T K
Sbjct: 180 -------WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-17
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY--SDEVIHSFRQEVSLMKR 558
+ED +G GS G V A + D VA+K F + + +V H F E ++
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNY 87
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ HP + G+ L +V EF+ G F L+RN + A I Y
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEY 146
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVL 677
L N I++RDLK NLL+DK +K+ DFG +++ TY T GTP+++APE+L
Sbjct: 147 LQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPEYIAPEIL 200
Query: 678 RNEPSDEKSDVYSFGVILWEL 698
N + +D ++ G+ ++E+
Sbjct: 201 LNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK+ R++ E++ + EV +M+ +H NV+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMY 84
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L ++ EFL G+L ++ + T+L+ + + + + + YLH + +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--SQGVIH 140
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+ P + D+
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 689 YSFGVILWELATEKIPW 705
+S G+++ E+ + P+
Sbjct: 201 WSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-17
Identities = 62/189 (32%), Positives = 89/189 (47%), Gaps = 19/189 (10%)
Query: 528 GSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIVTEFLP 585
G +VA+K+ +E FR+E +L RL HPN V L P L V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 586 RGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 640
+L +L + + R +L LD ++ H N I+HRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAH--NQGIVHRDLKPQNIMVSQTGV 117
Query: 641 HWTVKVGDFGLSRL---KHETYLTTKTGK----GTPQWMAPEVLRNEPSDEKSDVYSFGV 693
KV DFG+ L + + T T GTP + APE LR EP SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 694 ILWELATEK 702
I E T +
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 28/226 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRH- 561
EDL +IG+G+ GTV + S AVK R ++ ++ ++ R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRIL--MALDIARGVS 617
P ++ F GA+ I E L SL + + L IL +A+ + ++
Sbjct: 63 PYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 618 YL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK----GTPQ 670
YL IIHRD+K SN+L+D++ +K+ DFG+S L K G
Sbjct: 122 YLKEELK----IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRP 172
Query: 671 WMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
+MAPE + + D +SDV+S G+ L+E+AT K P+ NS+ D
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD 218
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 56/198 (28%), Positives = 104/198 (52%), Gaps = 7/198 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G+D A+K+ + D+V + ++ L + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +Q+ K + + A +I+ G+ +LH II+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG--IIY 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+++D +K+ DFG+ + +TT+T GTP ++APE++ +P + D
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 689 YSFGVILWELATEKIPWD 706
+++GV+L+E+ + P+D
Sbjct: 185 WAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 7/199 (3%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ +G+GS G V+ A G++ A+K + D+V + ++ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + L V E+L G L +Q + K D R A +I G+ +LH + I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLH--SKGI 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
++RDLK N+L+D +K+ DFG+ + T T GTP ++APE+L + +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 687 DVYSFGVILWELATEKIPW 705
D +SFGV+L+E+ + P+
Sbjct: 178 DWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 59/216 (27%), Positives = 112/216 (51%), Gaps = 33/216 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFS-------RQEYSDEVIHSFRQEVSL 555
+DL + +G G+ G V+ A+KV + +QE + +H+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE---QHVHN---EKRV 54
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMAL 610
+K + HP ++ + L ++ E++P G LF L+ N+T L + I+ AL
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP 669
+ YLH I++RDLK N+L+DK +K+ DFG ++ L+ T+ T GTP
Sbjct: 115 E------YLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTP 162
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+++APEV++++ ++ D ++ G++++E+ P+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 511 EQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E++G+ G VY +G+ VA+K + + + F+ E + RL+HPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRILMALD------- 611
++ +G VT Q L ++ + L L + D + + L+
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 612 ---IARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTG 665
IA G+ +L HH ++H+DL + N+LV VK+ D GL R + Y
Sbjct: 130 VTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 666 KGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
P +WM+PE + SD++S+GV+LWE+
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 6/138 (4%)
Query: 570 AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A + LC+V + G L + + R I A I G+ +LH I++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVY 118
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
RDLK N+L+D H V++ D GL+ LK K GTP +MAPEVL+ E D D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 688 VYSFGVILWELATEKIPW 705
++ G L+E+ + P+
Sbjct: 177 WFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G+D A+KV + D+V + ++ L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR + K D R A ++ + +LH +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG--VIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D K+ DFG+ + +TT T GTP ++APE+L+ D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 689 YSFGVILWELATEKIPW--DNLNSMQDS 714
++ GV+++E+ + P+ DN + + +S
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFES 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLF 567
IG G+ G V Y V G +VA+K SR V H+ R +E+ LMK + H N++
Sbjct: 24 IGSGAQGIVCAAYDTV-TGQNVAIKKLSRP--FQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 568 MGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ T PQ+ + +V E + +L +++Q + LD R + + G+ +LH
Sbjct: 81 LNVFT-PQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH 135
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
+ IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGM 192
Query: 681 PSDEKSDVYSFGVILWELATEKI 703
E D++S G I+ E+ +
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+GS G V G VA+K F E V +E+ ++K+LRH N++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630
+RL +V EF+ ++ L++ LD R I RG+ + H N IIHRD
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRD 125
Query: 631 LKSSNLLVDKHWTVKVGDFGLSRL------KHETYLTTKTGKGTPQWM-APEVLRNEPSD 683
+K N+LV + VK+ DFG +R + Y+ T+ W APE+L +
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-------WYRAPELLVGDTKY 178
Query: 684 EKS-DVYSFGVILWELAT 700
++ D+++ G ++ E+ T
Sbjct: 179 GRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQ-------------EV 553
G +G+G+ G V A G VA+K E S++V RQ E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKD-RQLVGMCGIHFTTLREL 71
Query: 554 SLMKRLRHPNVLLFMGAV---TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+M ++H N+ MG V + +V + + L +++ R + + + ++ L
Sbjct: 72 KIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-L 126
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP 669
I G++ LH +HRDL +N+ ++ K+ DFGL+R + Y T + T
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 670 Q------------WM-APEVLRN-EPSDEKSDVYSFGVILWELATEK 702
Q W APE+L E D++S G I EL T K
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-16
Identities = 29/96 (30%), Positives = 47/96 (48%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204
+ D RI+Y N +A L GY+ EE LG+ +L G D + + ++ G +
Sbjct: 3 VLDPDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGGEVEVE 62
Query: 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ K E V+ + +P D+DG +VGIV + D
Sbjct: 63 LELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRD 98
|
Length = 101 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 54/170 (31%), Positives = 91/170 (53%), Gaps = 6/170 (3%)
Query: 544 EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
EV H+ E +++ ++ P ++ + SP++L +V F+ G LF LQR R
Sbjct: 36 EVTHTL-AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR 94
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
R A ++ + LH N +I+RDLK N+L+D + + DFGL +L + T
Sbjct: 95 ARFYTA-ELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSM 711
T GTP+++APE+L + D ++ GV+L+E+ T P+ +N+N M
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKR------LRHPNV 564
+G+GS G V A G++ A+K + D V+ E ++++R HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK----DVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + L V E+L G L +Q ++ + D R A +I G+ +LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHKKG- 116
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRNEPS 682
II+RDLK N+L+DK +K+ DFG+ K K GTP ++APE+L+ +
Sbjct: 117 -IIYRDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 683 DEKSDVYSFGVILWELATEKIPW 705
+E D +SFGV+L+E+ + P+
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 41/108 (37%), Positives = 63/108 (58%), Gaps = 14/108 (12%)
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+A+ I + + YLH +IHRD+K SN+L++++ VK+ DFG+S YL K
Sbjct: 108 IAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKT 161
Query: 667 ---GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDN 707
G +MAPE + E + D KSDV+S G+ + ELAT + P+D+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 51/233 (21%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY--SDEVIHSFRQEVSLMKRL 559
+D + + IG+G+ G V+ V A+KV + + +++ H R E ++
Sbjct: 1 DDFEVIKVIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADA 58
Query: 560 RHPNVL-LFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRR----RILMALDIA 613
P ++ L+ + + L +V E++P G L LL R + + R +++ALD
Sbjct: 59 DSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-------------RLKHETYL 660
+ + IHRD+K N+L+D +K+ DFGL H
Sbjct: 118 HKLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 661 TTKTGK----------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
GTP ++APEVLR P + D +S GVIL+E
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 48/234 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFR------ 550
DYEIL ++G+G+ G VY A G VA+K ++H+ +
Sbjct: 9 DYEIL-------GKLGEGTFGEVYKARQIKTGRVVALKKI--------LMHNEKDGFPIT 53
Query: 551 --QEVSLMKRLRHPNV--LLFMGAVTSPQ----RLCI--VTEFLPRGSLFRLLQRNTTKL 600
+E+ ++K+L+HPNV L+ M + R + VT ++ L LL+ + KL
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKL 112
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
+ L + G++YLH N I+HRD+K++N+L+D +K+ DFGL+R
Sbjct: 113 TESQIKCYMLQLLEGINYLH-ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 661 TTKTGKG-----------TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEK 702
K G G T + PE+L E + D++ G + E+ T +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 40/212 (18%)
Query: 513 IGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFR--QEVSLMKRLRHPNV 564
IG+G+ G V A VA+K F D I + R +E+ L++ L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAF------DNRIDAKRTLREIKLLRHLDHENV 66
Query: 565 LLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+ + P R + IV E L L ++++ + T D + + + RG+ Y+
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYI 124
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET------YLTTKTGKGTPQWMA 673
H N ++HRDLK SNLL++ + +K+ DFGL+R E Y+ T+ + A
Sbjct: 125 HSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR------WYRA 176
Query: 674 PEVLRNEPSDEKS---DVYSFGVILWELATEK 702
PE+L N E + DV+S G I EL K
Sbjct: 177 PELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRL 559
IG+G+ G V A G VA+K F Q + + R E+ +++R
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC---QRTLR-EIKILRRF 60
Query: 560 RHPNVLLFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+H N++ + + P + IV E + L++L++ T L I R
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILR 117
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTP 669
G+ Y+H N ++HRDLK SNLL++ + +K+ DFGL+R+ H +LT T
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV--ATR 173
Query: 670 QWMAPEVLRNEPSDEKS-DVYSFGVILWEL 698
+ APE++ N K+ D++S G IL E+
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 8e-16
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSR----QEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G+GS G V A S AVKV + Q+ E + ++ +SL + HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+P RL V EF+ G L +Q+ + + D R A +I + +LH + I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLH--DKGI 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
I+RDLK N+L+D K+ DFG+ + TT T GTP ++APE+L+
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 687 DVYSFGVILWELATEKIPWDNLN 709
D ++ GV+L+E+ P++ N
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-16
Identities = 41/99 (41%), Positives = 68/99 (68%), Gaps = 6/99 (6%)
Query: 619 LHHCNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK---GTPQWMAP 674
+HH + +IHRD+KS+N+L+ + VK+GDFG S++ T ++ G+ GTP ++AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYVAP 214
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
E+ R +P +K+D++S GV+L+EL T K P+D N M++
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEE 252
|
Length = 496 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 50/224 (22%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR--QEVSL 555
Y+ + E IG G+ G V A+ G VA+K D + R +E+ +
Sbjct: 7 YKPI-------ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA--FDVPTLAKRTLRELKI 57
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-------LLQRNTTKLDWRRRILM 608
++ +H N++ I P G+ F+ L++ + + + L
Sbjct: 58 LRHFKHDNII------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 609 A-------LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------K 655
+ RG+ Y+H N +IHRDLK SNLLV++ +++GDFG++R +
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 698
H+ ++T T + APE+L + P D++S G I E+
Sbjct: 164 HKYFMTEYV--ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ GTV+ A VA+K R + DE + S +E+ L+K L+H N++
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ S ++L +V E+ + L + +D + +G+++ H N ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VL 121
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAPEVLRN 679
HRDLK NLL++K+ +K+ DFGL+R E T + P+VL
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--------TLWYRPPDVLFG 173
Query: 680 EPSDEKS-DVYSFGVILWELATEKIPWDNLNSMQD 713
S D++S G I ELA P N + D
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 22/195 (11%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLFM 568
+G G+ G V A G +VA+K + +S V+ ++R E+ L+K LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75
Query: 569 GAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
SP + + VTE L L RLL + L+ + I RG+ Y+H ++
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG--VV 130
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLK--HET-YLTTKTGKGTPQWMAPEV-LRNEPSD 683
HRDLK SN+L++++ +K+ DFGL+R++ T Y++T+ + APE+ L + D
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR------YYRAPEIMLTWQKYD 184
Query: 684 EKSDVYSFGVILWEL 698
+ D++S G I E+
Sbjct: 185 VEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 513 IGQGSCGTVYHA-VWYGSDV----AVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRHPNVL 565
+GQGS G V+ G D A+KV + + D V + E ++ + HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV--RTKMERDILAEVNHPFIV 61
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
A + +L ++ +FL G LF L + + + +A ++A + +LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG-- 118
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
II+RDLK N+L+D+ +K+ DFGLS+ + + GT ++MAPEV+ +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 686 SDVYSFGVILWELATEKIPW 705
+D +SFGV+++E+ T +P+
Sbjct: 179 ADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 36/215 (16%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL---- 565
+G GS G V+ AV D VAVK + S V H+ R E+ +++RL H N++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 566 -LF---------MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
L +G++T + IV E++ L +L++ + R L + RG
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHAR--LFMYQLLRG 126
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRL-----KHETYLTTKTGKGTP 669
+ Y+H N ++HRDLK +N+ ++ V K+GDFGL+R+ H+ YL+
Sbjct: 127 LKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL---VT 181
Query: 670 QWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
+W +P +L + + K+ D+++ G I E+ T K
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+ + + VAVK + S E + +QE+ ++L+HPN+L ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL---DIARGVSYLHHCNPP 625
+ L +V+ + GS LL+ + + + +A D+ + Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG-- 121
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDF--GLSRLKH-----ETYLTTKTGKGTPQWMAPEVLR 678
IHR +K+S++L+ V + +S +KH + K+ W++PEVL+
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 679 NEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+EKSD+YS G+ ELA +P+ ++ + Q
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 28/186 (15%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQ------EVSLMKRLRHPNVL-----LFMGAVTSPQR 576
GS+ V V ++ D V+ Q E L++ + HP+V+ L GA+T
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT---- 132
Query: 577 LCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634
C+V LP L+ L + + L + +++ I G+ YLH IIHRD+K+
Sbjct: 133 -CMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTE 186
Query: 635 NLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFG 692
N+ ++ V +GD G ++ + +L GT + APEVL + + K+D++S G
Sbjct: 187 NIFINDVDQVCIGDLGAAQFPVVAPAFLGL---AGTVETNAPEVLARDKYNSKADIWSAG 243
Query: 693 VILWEL 698
++L+E+
Sbjct: 244 IVLFEM 249
|
Length = 357 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+G+ G VY A G VA+K ++ V + +E+SL+K L HPN++ +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 569 GAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + +L +V EFL + + L + L L +G+++ H + +
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH--SHRV 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EPSDE 684
+HRDLK NLL++ +K+ DFGL+R + T T + W APE+L +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 685 KSDVYSFGVILWELATEK 702
D++S G I E+ T +
Sbjct: 181 AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY---SDEVIHSFRQEVSLMKRL 559
ED + + IG+G+ G V S A+K+ S+ E SD F +E +M
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARG 615
P V+ A + L +V E++P G L L+ W + +++ALD
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS 160
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTPQWMAP 674
+ +IHRD+K N+L+DKH +K+ DFG ET + T GTP +++P
Sbjct: 161 MG--------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212
Query: 675 EVLRNEPSD----EKSDVYSFGVILWELATEKIPW 705
EVL+++ D + D +S GV L+E+ P+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFM 568
IG+GS V + A+KV ++ + DE I + E + + HP ++
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V EF+ G L +QR KL + +I+ +++LH II+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 689 YSFGVILWELATEKIPWD 706
++ GV+++E+ + P+D
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 511 EQIGQGSCGTVYH--AVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+GS TVY + G VA+KV QE + R E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E++ L + + ++ L L + RG+SY+H I+H
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ--RYILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYSTC 184
Query: 687 -DVYSFGVILWELATEKIPWDNLNSMQD 713
D++ G I E+ + + +QD
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH--PNVLL 566
IG+G+ G VY + A+KV S++E EV H+ + L++ L P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + L +VT+++ G LF LQ+ + R + +A ++ + +LH + I
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--I 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
++RDLK N+L+D + + DFGLS+ TT T GT +++APEVL +E K
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 687 -DVYSFGVILWEL 698
D +S GV+++E+
Sbjct: 178 VDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG G+ G V Y AV +VA+K SR + +E+ LMK + H N++ +
Sbjct: 25 IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNP 624
T PQ+ + EF + L+ N +LD R + + G+ +LH
Sbjct: 84 VFT-PQK--SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+ E
Sbjct: 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKE 197
Query: 685 KSDVYSFGVILWELATEKI 703
D++S G I+ E+ KI
Sbjct: 198 NVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY---SDEV 545
D N D + ED + + IG+G+ G V V + S A+K+ S+ E SD
Sbjct: 30 DTINKIRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR- 604
F +E +M P V+ A + L +V E++P G L L+ W R
Sbjct: 89 F--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 146
Query: 605 ---RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYL 660
+++ALD + + IHRD+K N+L+DK +K+ DFG ++ E +
Sbjct: 147 YTAEVVLALDAIHSMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 661 TTKTGKGTPQWMAPEVLRNEPSD----EKSDVYSFGVILWELATEKIPW 705
T GTP +++PEVL+++ D + D +S GV L+E+ P+
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+GS TVY + G VA+KV S + + V + +E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L V E++ L + + ++ L L + RG++Y+H + I+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+ +K+ DFGL+R K T + T + P+VL +D S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA-TDYSSAL 185
Query: 687 DVYSFGVILWEL 698
D++ G I E+
Sbjct: 186 DIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 511 EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V + Y + V VK S E + F Q+ + L+HPN+L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR---IL----MALDIARGVSYL 619
+G +V E+ G L L + W RR +L MA +IA GV+++
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE----QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL--SRLKHETYLTTKTGKGTP-QWMAPEV 676
H N +H DL N + TVKVGD+G+ SR K E Y+ T+ K P +W+APE+
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDKCVPLRWLAPEL 172
Query: 677 -------LRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQ 712
L + S+V++ GV LWEL P+ +L+ +
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 511 EQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ TV+ + + VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L L + L + + + RG+SY H I+H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK--RKILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+++ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYSTP 184
Query: 687 -DVYSFGVILWELAT 700
D++ G IL+E+AT
Sbjct: 185 IDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFM 568
IG+GS V ++ A+KV ++ +D E I + E + ++ HP ++
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR KL + +I+ ++YLH II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNS 710
++ GV+++E+ + P+D + S
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGS 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E++G+G+ TVY G VA+K ++E S +E+SLMK L+H N++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRL 63
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRILMALDIARGVSYLHHCNPP 625
+ + +L +V E++ L + + + + LD + +G+++ H
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
++HRDLK NLL++K +K+ DFGL+R T T + AP+VL +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 686 S-DVYSFGVILWELAT 700
S D++S G I+ E+ T
Sbjct: 181 SIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 5/132 (3%)
Query: 577 LCIVTEFLPRGSL-FRL--LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633
LC+V + G L + + + R I G+ +LH II+RDLK
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKP 125
Query: 634 SNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 693
N+L+D V++ D GL+ + TK GTP +MAPE+L+ E D D ++ GV
Sbjct: 126 ENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGV 185
Query: 694 ILWELATEKIPW 705
L+E+ + P+
Sbjct: 186 TLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV---WYGSDVAVKVFSR-QEYSDEVIHSFRQEVSLMKRLR 560
+D + +G+G G V V G A+KV + + E + F +E ++
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD------WRRRILMALDIAR 614
P + A L +V E+ P G L LL R + D + +++A+
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
+ Y +HRD+K N+L+D+ +K+ DFG + RL + +K GTP ++A
Sbjct: 120 QMGY--------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 674 PEVLRNEPSDEKS------DVYSFGVILWELATEKIPWDNLNS 710
PEVL D K D +S GVI +E+ + P+ S
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 32/209 (15%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A +A+K R E DE + S +E+SL+K ++H N++
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--RILMAL--DIARGVSYLHHCN 623
V S +RL +V E+L L + + D+ + R++ I RG++Y H +
Sbjct: 67 QDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--S 120
Query: 624 PPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAP 674
++HRDLK NLL+D+ +K+ DFGL+R HE T + AP
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--------TLWYRAP 172
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
E+L D++S G I E+ +K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 15/151 (9%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIH--SFRQEVSLMKRLRHPNVLL 566
+IG+GS G V+ G VA+K F E D VI + R E+ ++K+L+HPN++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALR-EIRMLKQLKHPNLVN 64
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---WRRRILMALDIARGVSYLHHCN 623
+ ++L +V E+ ++ L++N + ++ I L V++ H N
Sbjct: 65 LIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQ---AVNFCHKHN 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
IHRD+K N+L+ K +K+ DFG +R+
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+Q+G G+ GTV A+ G+ VA+K R S+ +E+ L+K ++H NV+ +
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 569 GAVTSPQRLCIVTEF---LP-RGS-LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
T L +F +P G+ L +L++ KL R + + +G+ Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAG 138
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EP 681
IIHRDLK NL V++ +K+ DFGL+R + TG +W APEV+ N
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVILNWMH 192
Query: 682 SDEKSDVYSFGVILWELATEK 702
+ D++S G I+ E+ T K
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 39/114 (34%), Positives = 66/114 (57%), Gaps = 5/114 (4%)
Query: 606 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 663
I + +ARG+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQDSCR 716
+ +WMAPE + ++ +SDV+SFGV+LWE+ + P+ + ++ CR
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG G+ G V Y A+ +VA+K SR + +E+ LMK + H N++ +
Sbjct: 32 IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 570 AVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
T PQ+ + IV E + +L +++Q +LD R + + G+ +LH
Sbjct: 91 VFT-PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGY 202
Query: 683 DEKSDVYSFGVILWELATEKI 703
E D++S G I+ E+ +
Sbjct: 203 KENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY---SDEVIHSFRQEVSLMKR 558
ED + + IG+G+ G V V + S A+K+ S+ E SD F +E +M
Sbjct: 43 EDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAH 99
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIAR 614
++ A + L +V E++P G L L+ W R +++ALD
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
+ + IHRD+K N+L+DK +K+ DFG ++ + T GTP +++
Sbjct: 160 SMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYIS 211
Query: 674 PEVLRNEPSD----EKSDVYSFGVILWEL 698
PEVL+++ D + D +S GV L+E+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWR 603
+ E ++++ ++HP ++ + A + +L ++ E+L G LF L+R +T +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YL 106
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
I +AL+ +LH II+RDLK N+L+D VK+ DFGL + T
Sbjct: 107 SEISLALE------HLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
T GT ++MAPE+L + D +S G +++++ T P+
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ----EVSLMKRLR 560
+D ++G G+ G V + S + + +R+ E+ + R E+ ++
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGL---IMARKLIHLEIKPAIRNQIIRELKVLHECN 57
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI----LMALDIA--R 614
P ++ F GA S + I E + GSL ++L++ RI L + IA R
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPENILGKISIAVLR 110
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
G++YL I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+P
Sbjct: 111 GLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 167
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIP 704
E L+ +SD++S G+ L E+A + P
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 7/205 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 568
IG+GS V +D A+KV ++ + DE I + E + ++ +P ++
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL +V E++ G L +QR KL A +I +++LH II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNSMQD 713
++ GV+++E+ + P+D + D
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 7/193 (3%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ TVY +D VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L + L + L ++ L + RG++Y H ++H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR--RKVLH 127
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSD 687
RDLK NLL+++ +K+ DFGL+R K T T + P++L + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 688 VYSFGVILWELAT 700
++ G I +E++T
Sbjct: 188 MWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 13/193 (6%)
Query: 513 IGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
IG G+ G V A G +VAVK SR + +E+ L+K + H N++ +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTK-----LDWRRRILMALDIARGVSYLHHCNPP 625
T PQ+ + EF + L+ N + LD R + + G+ +LH
Sbjct: 89 FT-PQK--SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG-- 143
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
IIHRDLK SN++V T+K+ DFGL+R ++ T T + APEV+ E
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY-VVTRYYRAPEVILGMGYKEN 202
Query: 686 SDVYSFGVILWEL 698
D++S G I+ EL
Sbjct: 203 VDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+GS TVY + VA+K + + R E SL+K L+H N++
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L L + + L L + RG++Y H ++H
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG---TPQWMAPEVLRNEPSDEK 685
RDLK NLL+ + +K+ DFGL+R K + +KT T + P+VL S E
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKS---VPSKTYSNEVVTLWYRPPDVLLG--STEY 181
Query: 686 S---DVYSFGVILWELAT 700
S D++ G I +E+AT
Sbjct: 182 STSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+G+ TV+ ++ VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
V + + L +V E+L + L + + + + I RG++Y H ++H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--RRKVLH 127
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+++ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--SSEYSTQ 185
Query: 687 -DVYSFGVILWELAT 700
D++ G I +E+A+
Sbjct: 186 IDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 64/226 (28%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 512 QIGQGSCG--TVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
+IG+G C +VY A G+ V V++ + ++E + + + EV L RHPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWRRRILMALDIARGVSYLHH 621
T+ L +++ F+ GS LL+ + + IL RG++YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI---GNILFG--ALRGLNYLHQ 119
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT------PQ----- 670
IHR++K+S++L+ V + GLS L Y + G+ PQ
Sbjct: 120 NG--YIHRNIKASHILISGDGLVSLS--GLSHL----YSLVRNGQKAKVVYDFPQFSTSV 171
Query: 671 --WMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
W++PE+LR + + KSD+YS G+ ELAT ++P+ ++ Q
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 497 CLD-YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK-VFSRQEYSDEVIHSFRQE 552
C+D ++I+ QIG+G+ G VY A G VA+K V E I + R E
Sbjct: 5 CVDKFDII-------GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-E 56
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL-- 610
+ ++++L H N++ VT Q +F F L+ ++ LM L
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQD---ALDFKKDKGAFYLV------FEYMDHDLMGLLE 107
Query: 611 ----------------DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+ G++Y H N +HRD+K SN+L++ +K+ DFGL+RL
Sbjct: 108 SGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 655 KHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
+ T K W PE+L E + DV+S G IL EL T+K
Sbjct: 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV----IHSFRQE 552
+YE L +I +G+ G VY A + VA+K + + E I S R E
Sbjct: 6 EYEKL-------NRIEEGTYGVVYRARDKKTGEIVALK---KLKMEKEKEGFPITSLR-E 54
Query: 553 VSLMKRLRHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
++++ +L+HPN++ + +G ++ ++ +V E++ L L++ +
Sbjct: 55 INILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL 111
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-----LKHETYLTTK 663
L + GV++LH I+HRDLK+SNLL++ +K+ DFGL+R LK T L
Sbjct: 112 MLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168
Query: 664 TGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + APE+L D++S G I EL T+K
Sbjct: 169 ----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 49/165 (29%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 607
R E +++ +R P ++ A + +L ++ +++ G LF L QR R+
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVY 110
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+A +I + +LH II+RD+K N+L+D V + DFGLS+ +L + +
Sbjct: 111 IA-EIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERA 163
Query: 667 ----GTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPW 705
GT ++MAPEV+R D+ D +S GV+ +EL T P+
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFM 568
+G G+ G+V A G VAVK SR S +IH+ R +E+ L+K ++H NV+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 569 GAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
T + L +VT + G+ + + D + L+ I RG+ Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-E 680
+ IIHRDLK SNL V++ +K+ DFGL+R + TG +W APE++ N
Sbjct: 140 D--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWM 193
Query: 681 PSDEKSDVYSFGVILWELATEKIPW---DNLNSMQ 712
++ D++S G I+ EL T + + D+++ ++
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 36/95 (37%), Positives = 59/95 (62%), Gaps = 4/95 (4%)
Query: 606 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 663
I + +ARG+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 177 ICYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 234
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+ + +WMAPE + ++ +SDV+SFGV+LWE+
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ P ++ A S LC+V + G L + + L+ R I +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTP 669
I G+ +LH + I++RD+K N+L+D ++ D GL+ LK +T + G T
Sbjct: 103 QITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG--TN 158
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
+MAPE+L+ EP D ++ G ++E+ + P+ +
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G AVK + D+V + ++ L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L V EFL G L +Q + + D R A +I G+ +LH + II+
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLH--SKGIIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWMAPEVLRNEPSDEKS 686
RDLK N+++D+ +K+ DFG+ K + + T GTP ++APE+L+
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 687 DVYSFGVILWELATEKIPW--DNLNSMQDSCR 716
D +SFGV+L+E+ + P+ D+ + + +S R
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E++ M +L+HPN++ +G S + ++ E++ +L +L RN L W RR +A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-RN---LSWERRRKIAIG 788
Query: 612 IARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG-TP 669
IA+ + +LH C+P ++ +L +++D D RL L T T +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISS 842
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
++APE + EKSD+Y FG+IL EL T K P D
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLL 566
+IG G+ GTVY A G VA+K Q D + S +EV+L+KRL HPN++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 567 FMGAVTSPQ-----RLCIVTEFLP---RGSLFRL----LQRNTTKLDWRRRILMALDIAR 614
M + + ++ +V E + R L ++ L T K D R+ L R
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK-DLMRQFL------R 119
Query: 615 GVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
G+ +LH +C I+HRDLK N+LV VK+ DFGL+R+ + + T + A
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRA 175
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEK 702
PEVL D++S G I E+ K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 4/155 (2%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+I G+ LH I++RDLK N+L+D H +++ D GL+ E T K GT
Sbjct: 110 EICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVG 166
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+MAPEV++NE D ++ G +L+E+ + P+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR--GSLFRLLQRNTTKLDWRRRI--- 606
E +++ + HP+++ G T + C++ LPR L+ L +R I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA-------KRNIAIC 182
Query: 607 -LMALD--IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
++A++ + R + YLH IIHRD+K+ N+ ++ V +GDFG + +
Sbjct: 183 DILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 664 TG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
G GT APE+L +P D++S G++L+E+AT
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR----QEVSLMKRLR 560
+D ++G G+ G V S + + +R+ E+ + R +E+ ++
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGL---IMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR---RILMALDIA--RG 615
P ++ F GA S + I E + GSL ++L+ + +R IL + IA RG
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------EAKRIPEEILGKVSIAVLRG 115
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YL I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE
Sbjct: 116 LAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPE 172
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIP 704
L+ +SD++S G+ L ELA + P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 38/114 (33%), Positives = 65/114 (57%), Gaps = 5/114 (4%)
Query: 606 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 663
I + +A+G+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 182 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQDSCR 716
+ +WMAPE + + +SDV+SFGV+LWE+ + P+ + ++ CR
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-12
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 513 IGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSD-EVIHS-FRQEVSLMKRLRHPNVLLFM 568
IG+G G VY + VA+K R++ S+ ++ F +E + L HP ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL---------------MALDIA 613
++ S T G + L ++ W++ L + I
Sbjct: 69 -SICSDGDPVYYTMPYIEGYTLKSLLKSV----WQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLT---------- 661
+ Y+H + ++HRDLK N+L+ V + D+G + K E L
Sbjct: 124 ATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 662 ----TKTGK--GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
T GK GTP +MAPE L P+ E +D+Y+ GVIL+++ T P+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 34/168 (20%)
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR------ 614
+P V+ + + + LC+V E++ G LL +N L +D+AR
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGAL--------PVDMARMYFAET 110
Query: 615 --GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--------HETYLTTKT 664
+ YLH N I+HRDLK NLL+ +K+ DFGLS++ +E ++ T
Sbjct: 111 VLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 665 GK-------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+ GTP+++APEV+ + + D ++ G+IL+E +P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 512 QIGQGSCGTVYHAVWY----GSDVAVKVF-SRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
IG+G+ G VY A G + A+K F +E + S +E++L++ L+H NV+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 567 FMGAVTSPQRLCI--VTEFLP----------RGSLFRLLQRNTTK-LDWRRRILMALDIA 613
+ + + ++ R + + + K L W+ I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKG-- 667
GV YLH + ++HRDLK +N+LV + VK+GD GL+RL +
Sbjct: 119 NGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 668 -TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELAT 700
T + APE+L K+ D+++ G I EL T
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ G+VY + + V A+K R E + + E+ ++ + P ++ F
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL----DWRRRILMALDIARGVSYLHHCNP 624
GA + + E++ GSL +L D RRI A + +G+ +L
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE-EH 122
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSD 683
IIHRD+K +N+LV+ + VK+ DFG+S + KT G +MAPE +++ P+
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 684 E-----KSDVYSFGVILWELATEKIPW 705
+SDV+S G+ + E+A + P+
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 511 EQIGQGSCGTVYHAVW----------YGSDVAV--KVFSRQEYSDEVIHSFRQEVSLMKR 558
E +GQG+ +Y V G +V+V KV +F + SLM +
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL---AFFETASLMSQ 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGV 616
L H +++ G V +V E++ G L L R L W+ + L A +
Sbjct: 58 LSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL--ASAL 114
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYLTTKTGKGTP 669
YL + ++H ++ N+LV ++ +K+ D G+ T L+ +
Sbjct: 115 HYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERI 168
Query: 670 QWMAPEVLRNEPS--DEKSDVYSFGVILWEL 698
W+APE +RN + +D +SFG L E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR----QEVSLMKRLR 560
+D ++G G+ G V+ S + + +R+ E+ + R +E+ ++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGL---IMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--RGVSY 618
P ++ F GA S + I E + GSL ++L++ ++ +IL + IA +G++Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIP--EQILGKVSIAVIKGLTY 118
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
L I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L+
Sbjct: 119 LRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQ 175
Query: 679 NEPSDEKSDVYSFGVILWELATEKIP 704
+SD++S G+ L E+A + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-11
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 1/109 (0%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
IL+S+ + + D RI+Y N +AE L G S EE +G+ ++L+ + D +VA
Sbjct: 1 EDLRAILESLPDGIFVVDEDGRILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAE 60
Query: 190 DIVHRIKMGERW-TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
+ + GE + + V +P D G + G + V
Sbjct: 61 LLRQALLQGEESRGFEVSFRVPDGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 41/223 (18%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVK-VFSRQEYSDEVIHSFRQE 552
YEIL +++G+G+ Y VW D VA+K +F + + +FR E
Sbjct: 9 YEIL-------QKLGKGA----YGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-E 56
Query: 553 VSLMKRLR-HPNV--LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
+ ++ L HPN+ LL + + + + +V E++ L +++ N + +R I+
Sbjct: 57 IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMYQ 115
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
L + + Y+H N +IHRDLK SN+L++ VK+ DFGL+R + + P
Sbjct: 116 L--LKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENP 167
Query: 670 --------QWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
+W APE+L K D++S G IL E+ K
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 12/193 (6%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G V + VA+K F E ++EV + +E+ +++ L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNP-PII 627
+L +V E++ + ++ LL+ N + R + L + +H C+ I+
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQL-----IKAIHWCHKNDIV 122
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS 686
HRD+K NLL+ + +K+ DFG +R E T +W +PE+L P +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 687 DVYSFGVILWELA 699
D++S G IL EL+
Sbjct: 183 DMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 40/139 (28%), Positives = 72/139 (51%), Gaps = 4/139 (2%)
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V + +R ++ + +L+ + LD + + +A+G+S+L
Sbjct: 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS 232
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRN 679
N IHRDL + N+L+ K+ DFGL+R +++++ K P +WMAPE + N
Sbjct: 233 KN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 680 EPSDEKSDVYSFGVILWEL 698
+SDV+S+G++LWE+
Sbjct: 291 CVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 47/227 (20%)
Query: 511 EQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLF 567
+ +G+G G V+ G+ A+KV ++E + E ++ L HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRR----RILMALDIARGVSYLH 620
+ + LC+V ++ P G LFRLLQR K + R +L+AL+ YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE------YLH 120
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGK------------- 666
I++RDLK N+L+ + + + DF LS + E +K +
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 667 ---------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
GT +++APEV+ + D ++ G++L+E+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 45/217 (20%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IG G+ G V+ G VA+K VF V FR E+ ++ +H NVL
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV---FR-ELKMLCFFKHDNVL 62
Query: 566 LFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA-------LDIA 613
+ + P + + +VTE L+Q + K+ + L + I
Sbjct: 63 SALDILQPPHIDPFEEIYVVTE---------LMQSDLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------KHETYLTTKTGKG 667
RG+ YLH I+HRD+K NLLV+ + +K+ DFGL+R+ KH T
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV----- 166
Query: 668 TPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKI 703
T + APE+L D++S G I EL +I
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
LMK +PN + +VT+ + ++ +++ G LF LL++ KL + +
Sbjct: 63 QLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLV 119
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
++ LH N IIH D+K N+L D+ + + D+GL ++ T GT +
Sbjct: 120 EALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG----TPSCYDGTLDYF 173
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
+PE ++ D D ++ GV+ +EL T K P+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFM 568
+G G+ G+V A VAVK SR S +IH+ R +E+ L+K ++H NV+ +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLL 80
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPP 625
T + E +L N K L + + RG+ Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG-- 138
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EPSD 683
IIHRDLK SN+ V++ +++ DFGL+R + TG +W APE++ N +
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYN 194
Query: 684 EKSDVYSFGVILWELATEKI 703
+ D++S G I+ EL K
Sbjct: 195 QTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 504 WEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLR 560
+E L IGQG+ G V+ A VA+K V E I + R E+ +++ L+
Sbjct: 14 YEKLAK---IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLK 69
Query: 561 HPNVLLFM---GAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDW---RRRILMA 609
H NV+ + +P +V EF L LL K ++ + M
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG-- 667
L+ G+ Y+H I+HRD+K++N+L+ K +K+ DFGL+R + +K K
Sbjct: 129 LN---GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNR 179
Query: 668 ------TPQWMAPEVLRNEPS-DEKSDVYSFGVILWELAT 700
T + PE+L E D++ G I+ E+ T
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 4/155 (2%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + D R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+I G+ LH I++RDLK N+L+D + +++ D GL+ ++ T + GT
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVG 166
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+MAPEV++NE D + G +++E+ K P+
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-11
Identities = 30/103 (29%), Positives = 54/103 (52%), Gaps = 2/103 (1%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKM 197
+ V + DL RI+Y N +AE L GYS EE +G+ ++L+ D + + + + +
Sbjct: 1 LPDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLI-HPEDREELRERLENLLSG 59
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
GE T + + K + V+ + TP D+ G ++G++ V D
Sbjct: 60 GEPVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 35/91 (38%), Positives = 55/91 (60%), Gaps = 4/91 (4%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP- 669
+A G+ +L N +HRDL + N+L+ + VK+ DFGL+R + ++ +K P
Sbjct: 248 VANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+WMAPE + N SDV+SFG++LWE+ T
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 568
+IG+G+ V A G A+K + S E +++ R E+ ++RL HPN+L +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLI 64
Query: 569 GAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ RL +V E L +L+ L++ L +R + + + ++H I
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--I 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFG-----LSRLKHETYLTTKTGKGTPQWM-APEVLRNE 680
HRD+K N+L+ +K+ DFG S+ + Y++T+ W APE L +
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-------WYRAPECLLTD 173
Query: 681 PS-DEKSDVYSFGVILWELAT 700
K D+++ G + +E+ +
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 34/89 (38%), Positives = 56/89 (62%), Gaps = 4/89 (4%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP- 669
+ARG+ +L N +HRDL + N+L+ + VK+ DFGL+R + H++ +K P
Sbjct: 246 VARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+WMAPE + + SDV+S+G++LWE+
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
Q+G G+ G+V A+ G VA+K SR S+ +E++L+K ++H NV+ +
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 570 AVTSPQRLCIVTEF-LPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
TS +F L + LQ+ L + + + G+ Y+H II
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--II 139
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS 686
HRDLK NL V++ +K+ DFGL+R H TG +W APEV+ N ++
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR--HAD--AEMTGYVVTRWYRAPEVILNWMHYNQT 195
Query: 687 -DVYSFGVILWELATEK 702
D++S G I+ E+ T K
Sbjct: 196 VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK---TGKGT 668
I G+ Y+H N ++HRDLK NLLV+ +K+ DFGL+R E T
Sbjct: 114 ILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 669 PQWM-APEVLRNEPSDEKS-DVYSFGVILWEL 698
+W APE++ + S K+ DV+S G IL EL
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 23/192 (11%)
Query: 528 GSDVAVKVFSR-QEYSDEVIHSF-RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585
GSD KV ++ +DE ++ R E+ + H ++ S +L ++ E+
Sbjct: 89 GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148
Query: 586 RGSLFRLL-QRNTTKLDWRR--------RILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
G L + + QR L ++ +I++ALD +H + ++HRDLKS+N+
Sbjct: 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD------EVH--SRKMMHRDLKSANI 200
Query: 637 LVDKHWTVKVGDFGLSRLKHETYLTTKTGK---GTPQWMAPEVLRNEPSDEKSDVYSFGV 693
+ +K+GDFG S+ ++ ++ GTP ++APE+ + +K+D++S GV
Sbjct: 201 FLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 694 ILWELATEKIPW 705
IL+EL T P+
Sbjct: 260 ILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 513 IGQGSCGTVY--HAVWYGSDVAVKVFSRQ----EYSDEVIHSFRQEVSLMKRLRHPNVLL 566
IG+G G VY G A+K ++ + + + + R +SL+ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
A +P +LC + + + G L L ++ + R A +I G+ ++H N +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR-FYATEIILGLEHMH--NRFV 118
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGL----SRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
++RDLK +N+L+D+H V++ D GL S+ K + GT +MAPEVL+ +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGTA 172
Query: 683 -DEKSDVYSFGVILWELATEKIPW 705
D +D +S G +L++L P+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587
G V V+ + + ++E++ + E+ + K HPN++ + + L +VT F+ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 588 SLFRLLQRNTTKLDWRRRILMA---LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV 644
S L+ T +D + +A + + + Y+HH +HR +K+S++L+ V
Sbjct: 85 SAKDLI--CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKV 140
Query: 645 KVGDF--GLSRLKHETYLTT-----KTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVIL 695
+ LS + H L K W++PEVL+ + D KSD+YS G+
Sbjct: 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 200
Query: 696 WELATEKIPWDNLNSMQ 712
ELA +P+ ++ + Q
Sbjct: 201 CELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGK 666
+ +A+G+ +L N IHRD+ + N+L+ K+ DFGL+R + Y+ +
Sbjct: 218 SSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+WMAPE + + +SDV+S+G++LWE+
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 48/164 (29%), Positives = 88/164 (53%), Gaps = 16/164 (9%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR--- 604
R E ++++ +R P ++ A + +L ++ +++ G +F L QR+ D R
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 605 -RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTT 662
I++AL+ +LH I++RD+K N+L+D V + DFGLS+ E T
Sbjct: 112 GEIILALE------HLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEKIPW 705
+ GT ++MAPE++R + K+ D +S G++++EL T P+
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 59.9 bits (143), Expect = 5e-10
Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 2/113 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ +L++ + + D RI+Y N +AE L GYS EE LG+ +L+ +
Sbjct: 112 ERLRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERREL 171
Query: 190 DIVHRIKMGER--WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ + G ++ + K ERV + + DDG +VG+V ++ D
Sbjct: 172 ELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDDGEIVGVVGIARD 224
|
Length = 232 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+I G+ LH N ++RDLK N+L+D + +++ D GL+ +K + + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+MAPEVL N+ D + G +++E+ + P+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 50/244 (20%)
Query: 478 SSCGSTSS----SAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--- 530
C +TSS S V + Y IL + GS G V+ +G +
Sbjct: 76 EPCETTSSSDPASVVR--------MQYNIL-------SSLTPGSEGEVFVCTKHGDEQRK 120
Query: 531 -VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP--RG 587
V VK + + + +E+ ++K + H ++ + A +C+V +P +
Sbjct: 121 KVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKC 170
Query: 588 SLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642
LF + R+ + +RR+L AL +YLH IIHRD+K+ N+ +D+
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEAL------AYLH--GRGIIHRDVKTENIFLDEPE 222
Query: 643 TVKVGDFGLS-RLKHETYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+GDFG + +L G GT + +PE+L +P K+D++S G++L+E++
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 701 EKIP 704
+ +
Sbjct: 283 KNVT 286
|
Length = 392 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 30/125 (24%), Positives = 60/125 (48%), Gaps = 4/125 (3%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLT-DGRDFDV 187
+ +Y I +S ++ + DL I+Y N + E ++GYSAEE +G++ +EL+ + R+
Sbjct: 2 EERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVR 61
Query: 188 AYDIVHRIKMGERWTGQ-FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
I R++ + + K + V + +P +G +G+V + D ++
Sbjct: 62 ER-IERRLEGEREPVSEERRVRRKDGSEIWVEVSVSP-IRTNGGELGVVGIVRDITERKQ 119
Query: 247 TRAAL 251
AL
Sbjct: 120 AEEAL 124
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNT-TKLDWRRRIL 607
R +SL+ P ++ A +P +L + + + G L + L Q ++ + R
Sbjct: 45 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR---F 101
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL----SRLKHETYLTTK 663
A +I G+ ++H N +++RDLK +N+L+D+H V++ D GL S+ K +
Sbjct: 102 YAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 664 TGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWEL 698
GT +MAPEVL + D +D +S G +L++L
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 512 QIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVL 565
+IG+G+ G V+ A G VA+K Q + + S +EV++++ L HPNV+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 566 LFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
T + +L +V E + + L + + M + RG+ +LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
+ ++HRDLK N+LV +K+ DFGL+R+ T T + APEVL
Sbjct: 128 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQS 184
Query: 681 PSDEKSDVYSFGVILWEL 698
D++S G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 15/190 (7%)
Query: 520 TVYHAVWYGSDVAVKVFSRQEYSDEVI------HSFRQEVSLMKRLRHPNVLLFMGAVTS 573
++ A+ GS+ V S +Y V+ S E L++RL HP VL +
Sbjct: 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVV 231
Query: 574 PQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 631
C+V LP R L+ L L + +A + + Y+H IIHRD+
Sbjct: 232 GGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDI 286
Query: 632 KSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTG-KGTPQWMAPEVLRNEPSDEKSDVY 689
K+ N+LV+ + +GDFG + ++ T G GT APEVL +P D++
Sbjct: 287 KTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIW 346
Query: 690 SFGVILWELA 699
S G++++E A
Sbjct: 347 SAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 577 LCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635
LC+V + G L F + D +R I A ++ G+ L I++RDLK N
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPEN 132
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
+L+D +++ D GL+ E T + GT +MAPEV+ NE D + G ++
Sbjct: 133 ILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLI 191
Query: 696 WELA---------TEKIPWDNLN 709
+E+ E++ + ++
Sbjct: 192 YEMIQGQSPFRKRKERVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A G VA+K +R E +E I +E+SL++ L ++
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 568 MGAVTSPQR------LCIVTEFLP----------RGSLFRLLQRNTTKLDWRRRILMALD 611
+ V + L +V E+L R L T K
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS-------FMYQ 118
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSR-----LKHETYLTTKTG 665
+ +GV++ H ++HRDLK NLLVDK + K+ D GL R +K T+
Sbjct: 119 LLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--- 173
Query: 666 KGTPQWMAPEVLRNEPSDEKS-DVYSFGVILWELAT 700
T + APEVL D++S G I E++
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 44/165 (26%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 607
R E +++ +R P ++ A + +L ++ +++ G LF L QR + + +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQI 109
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+ +I + +LH II+RD+K N+L+D + V + DFGLS+ + + +
Sbjct: 110 YSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK----EFHEDEVERA 163
Query: 667 ----GTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPW 705
GT ++MAP+++R D+ D +S GV+++EL T P+
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 44/195 (22%)
Query: 552 EVSLMKRLRHPNVLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQR---------NTTKL 600
EV++M+ L+H N++ ++ + Q+L I+ EF G L R +Q+ +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 601 DWRRRILMALDIARGVSYLHHCN-----PPIIHRDLKSSNLLVD---KHW---------- 642
D R++L AL +Y H+ ++HRDLK N+ + +H
Sbjct: 122 DITRQLLHAL------AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 643 ----TVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFGVIL 695
K+GDFGLS+ + E+ + GTP + +PE+L +E D+KSD+++ G I+
Sbjct: 176 NGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 696 WELATEKIPWDNLNS 710
+EL + K P+ N+
Sbjct: 234 YELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
ED I + IG+G+ G V +D A+K+ ++ E FR+E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIA-RGVSY 618
+ A L +V ++ G L LL + +L D R L + IA V
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVL 677
LH+ +HRD+K N+L+D + +++ DFG +L + + + GTP +++PE+L
Sbjct: 121 LHY-----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 678 RNEPSDE-----KSDVYSFGVILWELATEKIPW 705
+ + + D +S GV ++E+ + P+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 63/300 (21%)
Query: 423 WPWSHGDQDNESVQQKSPSYGT----KPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
WP E K+ G+ + + E RS NN A +++ + S
Sbjct: 4 WPIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS 63
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVK-V 535
S +G IG GS G VY A+ + VA+K V
Sbjct: 64 PNKS------------------------YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV 99
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL-----FMGAVTSPQR---LCIVTEFLPRG 587
+Y + +E+ +MK L H N++ + ++ L +V EF+P+
Sbjct: 100 LQDPQYKN-------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 588 --SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 644
+ RN L L + + R ++Y+H + I HRDLK NLL+D T+
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTL 210
Query: 645 KVGDFG-----LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 698
K+ DFG L+ + +Y+ ++ + APE++ + D++S G I+ E+
Sbjct: 211 KLCDFGSAKNLLAGQRSVSYICSRF------YRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I E IG+GS G V A+ G VA+K VF + SD +E+ L++ LRH
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDA--TRILREIKLLRLLRH 58
Query: 562 PNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
P+++ + P R + +V E L L ++++ N + + + R +
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL-YQLLRAL 116
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWM-A 673
Y+H N + HRDLK N+L + +K+ DFGL+R+ T T +W A
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 674 PEVLRNEPSDEKS--DVYSFGVILWELATEK 702
PE+ + S D++S G I E+ T K
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 44/211 (20%)
Query: 528 GSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585
G A+K + E ++V H R E ++ +P V+ + L ++ E+LP
Sbjct: 26 GHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
G + LL + T + R +A + + +H IHRD+K NLL+D +K
Sbjct: 85 GGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIK 141
Query: 646 VGDFGLS-------------RLKH-------ETYLTTKTGK------------------G 667
+ DFGL L H + + K G
Sbjct: 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG 201
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
TP ++APEV +++ D +S GVI++E+
Sbjct: 202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-08
Identities = 20/50 (40%), Positives = 31/50 (62%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ IL+S+ + + DL RI+Y N +AE L GYS EE +G+ +EL+
Sbjct: 1 ERLRAILESLPDGIFVLDLDGRILYANPAAEELLGYSPEELIGKSLLELI 50
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 38/157 (24%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L ++ EFLP G + LL + T + + +A + + +H IHRD+K NL
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDNL 132
Query: 637 LVDKHWTVKVGDFGL------------------------------SRLKHETYLTTK--- 663
L+D VK+ DFGL S+ K ET+ +
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 664 --TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+ GTP ++APEV ++ D +S GVI++E+
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 38/159 (23%)
Query: 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634
+ L ++ EFLP G + LL + T + + +A + + +H IHRD+K
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPD 130
Query: 635 NLLVDKHWTVKVGDFGL------------------------------SRLKHETYLTTK- 663
NLL+D VK+ DFGL S+ K ET+ +
Sbjct: 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR 190
Query: 664 ----TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+ GTP ++APEV ++ D +S GVI++E+
Sbjct: 191 QLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 511 EQIGQGSCGTVYHAV---------WYGSDVAVKVF--SRQEYSDEVIHSFRQEVSLMKRL 559
E +GQG+ ++ + + ++V +KV S + YS+ SF + S+M +L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE----SFFEAASMMSQL 56
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY- 618
H +++L G +V E++ GSL L++N ++ I L++A+ +++
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN----ISWKLEVAKQLAWA 112
Query: 619 LHHC-NPPIIHRDLKSSNLLV-----DKHWT---VKVGDFGLSRLKHETYLTTKTGKGTP 669
LH + + H ++ + N+L+ K +K+ D G+S T L +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS----ITVLPKEILLERI 168
Query: 670 QWMAPEVLRNEPS-DEKSDVYSFGVILWEL 698
W+ PE + N + +D +SFG LWE+
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 40/172 (23%), Positives = 66/172 (38%), Gaps = 46/172 (26%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L V +++P G + LL R + R +A ++ + +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH--KMGFIHRDIKPDNI 132
Query: 637 LVDKHWTVKVGDFGLS-------------------------------------------R 653
L+D+ +K+ DFGL R
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+ + GTP ++APEVL + D +S GVIL+E+ + P+
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|219845 pfam08448, PAS_4, PAS fold | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLT--DGRDFDVAYDIVH 193
L S+ ++ + D R+ Y N +A L+G EE LG+ ELL D + A
Sbjct: 1 LDSLPDALAVLDPDGRVRYANAAAAELFGLPPEELLGKTLAELLPPEDAARLERALRRA- 59
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ E EER + TP D DG ++G++ +S D
Sbjct: 60 -LEGEEPIDFLEELLLNGEERHYEL-RLTPLRDPDGEVIGVLVISRD 104
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 110 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 55/244 (22%)
Query: 505 EDLTIGEQIGQGSCGTV--YHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLR 560
ED + IG+G+ G V G A+K + E D++ H + E ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
P V+ + Q L ++ EFLP G L +L + T + R MA + + +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVH 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--------LTTKTGK------ 666
IHRD+K N+L+D+ +K+ DFGLS H+ + L K+ K
Sbjct: 119 KLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 667 ---------------------------------GTPQWMAPEVLRNEPSDEKSDVYSFGV 693
GTP ++APE+ + ++ D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 694 ILWE 697
I++E
Sbjct: 237 IMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 15/48 (31%), Positives = 29/48 (60%)
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
+ P +MAPEV++ + EK+D+YS G+ L+E ++P++ +
Sbjct: 63 QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 37/159 (23%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 548 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+F + S+M+++ H +++L G +V EF+ G L + R + L +
Sbjct: 50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYL 660
+A +A +SYL + ++H ++ + N+L+ + +K+ D G+ T L
Sbjct: 110 VAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVL 163
Query: 661 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 698
+ + W+APE + + + +D +SFG LWE+
Sbjct: 164 SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
E+ I + I +G+ G VY AVKV + + ++ ++H + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMALDIARGV 616
P ++ ++ S + +V E+L G + LL + + + +ALD
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD----- 118
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
YLH IIHRDLK N+L+ +K+ DFGLS++
Sbjct: 119 -YLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|226350 COG3829, RocR, Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-06
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 16/121 (13%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD---F 185
RQ L IL S+ + + D IIY+N++ L G S EE LG+ +++++ G D
Sbjct: 116 RQRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGEDSTLL 175
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245
+V ++V N DG L+G+V +S D +
Sbjct: 176 EVLRTGKPIRD----------VVQTYNGNKIIV--NVAPVYADGQLIGVVGISKDVSELE 223
Query: 246 E 246
Sbjct: 224 R 224
|
Length = 560 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ------------EVSLMK 557
G ++G+G+ G VY A R++ DE ++ +Q E++L++
Sbjct: 6 GCKVGRGTYGHVYKA------------KRKDGKDEKEYALKQIEGTGISMSACREIALLR 53
Query: 558 RLRHPNVLLFMGAVT--SPQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL 610
L+HPNV+ S +++ ++ ++ R + N + R ++ +L
Sbjct: 54 ELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 611 --DIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKT 664
I G+ YLH ++HRDLK +N+LV + VK+ D G +RL +
Sbjct: 114 LYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 665 GKG---TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEK 702
T + APE+L K+ D+++ G I EL T +
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 37/134 (27%), Positives = 68/134 (50%), Gaps = 20/134 (14%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKL--DWRR----RILMALDIARGVSYLHHCNPPIIHRD 630
L +V ++ G L LL + +L D R +++A+D V L + +HRD
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID---SVHQLGY-----VHRD 127
Query: 631 LKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS--- 686
+K N+L+DK+ +++ DFG RL + + + GTP +++PE+L+ +
Sbjct: 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187
Query: 687 --DVYSFGVILWEL 698
D +S GV ++E+
Sbjct: 188 ECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 48/213 (22%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
+D I + IG+G+ G V ++ A+K+ ++ E FR+E +++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIA-RGVSY 618
+ A L +V ++ G L LL + +L D R + + +A +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVL 677
LH+ +HRD+K N+L+D + +++ DFG ++ + + + GTP +++PE+L
Sbjct: 121 LHY-----VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 678 RNEPS-----DEKSDVYSFGVILWELATEKIPW 705
+ + D +S GV ++E+ + P+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|221967 pfam13188, PAS_8, PAS domain | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-05
Identities = 12/57 (21%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
+ + ++ + + D DRI+Y N +A L GY L + ++ L +
Sbjct: 1 ERLRALFENAPDGILVLD-GDRILYANPAALELLGYELLGELLGELLDDLEALAEEA 56
|
Length = 64 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 8e-05
Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 28/158 (17%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYS----DEVIHSFR--QEVSLMKRLRH----- 561
I +G+ +Y + G +K + Y DE I R +E +M R R
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V P+ IV E++ L L+ N + ++ +I R V LH
Sbjct: 64 PAVYFV-----DPENFIIVMEYIEGEPLKDLINSNGMEELE-----LSREIGRLVGKLHS 113
Query: 622 CNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHE 657
IIH DL +SN+++ K + + DFGL+ +
Sbjct: 114 AG--IIHGDLTTSNMILSGGKIYLI---DFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ------------EVSLMK 557
G ++G+G+ G VY A R++ D+ ++ +Q E++L++
Sbjct: 6 GCKVGRGTYGHVYKA------------KRKDGKDDRDYALKQIEGTGISMSACREIALLR 53
Query: 558 RLRHPNVLLFMGAVTS--PQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL 610
L+HPNV+ S +++ ++ ++ R + N + R ++ +L
Sbjct: 54 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 611 --DIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKT 664
I G+ YLH ++HRDLK +N+LV + VK+ D G +RL +
Sbjct: 114 LYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 665 GKG---TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEK 702
T + APE+L K+ D+++ G I EL T +
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE--------FLPRGSLFRLLQRNTTKLDWR 603
E+ + RL H N+L + S ++T+ F+ + L +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQ 268
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
R +M + V Y+H + +IHRD+K N+ ++ + +GDFG + +
Sbjct: 269 TRAIMK-QLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 664 TG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 703
G GT +PE+L + E +D++S G+IL ++ +
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|236901 PRK11360, PRK11360, sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/108 (17%), Positives = 43/108 (39%), Gaps = 4/108 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL+S+ V D +I N +AE++ G E +G+ EL F +
Sbjct: 266 LILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNTPF---ASPLL 322
Query: 194 R-IKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + + + + + + ++ G ++G + + +D
Sbjct: 323 DTLEHGTEHVDLEISFPGRDRTIELSVSTSLLHNTHGEMIGALVIFSD 370
|
Length = 607 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 33/151 (21%), Positives = 55/151 (36%), Gaps = 25/151 (16%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVI------HSFRQEVSLMKRLRHPNV-- 564
I QG+ +Y + G VK + Y + R+E ++ + R V
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPV 63
Query: 565 --LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ P IV E++ G L + R + ++ R V LH
Sbjct: 64 PIVYD----VDPDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKLHKA 111
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I+H DL +SN+++ + DFGL
Sbjct: 112 G--IVHGDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 38/127 (29%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG-------SD 530
S SS + +D L Y+ WE +L +G +G G+ G V A +G
Sbjct: 10 SVSSDGHEYIYVDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMK 69
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
VAVK+ S E + E+ +M L H N++ +GA T + I+TE+ G L
Sbjct: 70 VAVKMLKSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDL 128
Query: 590 FRLLQRN 596
L RN
Sbjct: 129 VDYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 44/176 (25%), Positives = 69/176 (39%), Gaps = 50/176 (28%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L V +++P G + LL R + R +A ++ + +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG--FIHRDIKPDNI 132
Query: 637 LVDKHWTVKVGDFGL---------------------------------------SRLKHE 657
L+D +K+ DFGL RLK
Sbjct: 133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTL 192
Query: 658 TYLTTKTGK--------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
TK + GTP ++APEVL + + D +S GVIL+E+ + P+
Sbjct: 193 EQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 45/177 (25%), Positives = 70/177 (39%), Gaps = 52/177 (29%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L V +++P G + LL R + R +A ++ V +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG--FIHRDIKPDNI 132
Query: 637 LVDKHWTVKVGDFGL---------------------------------------SRLK-- 655
L+D+ +K+ DFGL RLK
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 656 -------HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
H+ L + GTP ++APEVL + D +S GVIL+E+ + P+
Sbjct: 193 ERRAARQHQRCL-AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVI 546
L Y WE +L G+ +G G+ G V A +G VAVK+ ++DE
Sbjct: 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER- 85
Query: 547 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
+ E+ ++ L +H N++ +GA T + ++TE+ G L L++
Sbjct: 86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 548 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+F + SLM ++ H ++ G +V EF+ G L L++ ++ +I
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYL 660
+A +A +SYL N ++H ++ + N+L+ + +K+ D G+S T L
Sbjct: 122 VAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TAL 175
Query: 661 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 698
+ + W+APE + S +D +SFG L E+
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.001
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 25/100 (25%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH--------------RIKM 197
IIYW+ E + GY+ E EL + + D+VH +K
Sbjct: 1 IIYWSPRFEEILGYTPE--------ELKSSYEGW---LDLVHPEDRERVRRALQEFSLKK 49
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
GE ++G++ + K E V A P D++G V ++ V
Sbjct: 50 GEPYSGEYRIRRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 31/154 (20%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYS----DEVIHSFR--QEVSLMKRLRH----- 561
I +G+ +Y + G +K + Y DE I R E L+ R R
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNT 61
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V P IV E++ G + + D R +I R V LH
Sbjct: 62 PVVYDV-----DPDNKTIVMEYIE-GKPLKDV--IEEGNDELLR-----EIGRLVGKLHK 108
Query: 622 CNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSR 653
I+H DL +SN++V DK + + DFGL +
Sbjct: 109 AG--IVHGDLTTSNIIVRDDKLYLI---DFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|183097 PRK11359, PRK11359, cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW- 201
V + D RI+ NR+ ++GY EA G LL + ++
Sbjct: 149 VIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARD 208
Query: 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+F T+T E++ + A+ +P YD L +V +D
Sbjct: 209 QDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSD 247
|
Length = 799 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 716 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.58 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.49 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.49 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.47 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.47 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.43 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.25 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.22 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.2 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 99.13 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.12 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.12 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.95 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 98.94 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.94 | |
| COG5002 | 459 | VicK Signal transduction histidine kinase [Signal | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.9 | |
| COG3852 | 363 | NtrB Signal transduction histidine kinase, nitroge | 98.88 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.8 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.76 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.73 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 98.7 | |
| PRK11086 | 542 | sensory histidine kinase DcuS; Provisional | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| PRK11006 | 430 | phoR phosphate regulon sensor protein; Provisional | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.52 | |
| PRK10820 | 520 | DNA-binding transcriptional regulator TyrR; Provis | 98.5 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| COG5000 | 712 | NtrY Signal transduction histidine kinase involved | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.31 | |
| COG3290 | 537 | CitA Signal transduction histidine kinase regulati | 98.27 | |
| PF14598 | 111 | PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.16 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.11 | |
| PRK15053 | 545 | dpiB sensor histidine kinase DpiB; Provisional | 98.09 | |
| PF13188 | 64 | PAS_8: PAS domain; PDB: 2JHE_D 3VOL_A. | 98.08 | |
| COG2202 | 232 | AtoS FOG: PAS/PAC domain [Signal transduction mech | 98.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.01 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=375.81 Aligned_cols=202 Identities=30% Similarity=0.556 Sum_probs=186.4
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.+|.+.+.||.|+|++||+|++ .+..||||.+.+.....+..+-+..|+.+|+.++|||||.+++++..++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 6799999999999999999987 46789999999888788888889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC------CcEEEEecCCCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH------WTVKVGDFGLSRLKH 656 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~------~~vkL~DFGla~~~~ 656 (716)
||.||+|.+|+.+++ .+++..++.++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+...
T Consensus 90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999999998765 6999999999999999999999999 9999999999999764 468999999999887
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... ...+.||+|-|||||+++.+.|+.|+|+||+|+|+|+|++|+.||+..++
T Consensus 167 ~~~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 167 PGS-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred chh-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 543 44577999999999999999999999999999999999999999995554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.17 Aligned_cols=205 Identities=30% Similarity=0.501 Sum_probs=189.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|+++++||+|+||+||+++. +++-||+|++++...- .........|..+|..++||+||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 347899999999999999999986 5667999999887653 3456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
|+||+.||.|+.+|++. ..|++..+..++.+|+.||.|||+.| ||||||||+|||||.+|+|+|+|||+++......
T Consensus 103 Vld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999999874 46999999999999999999999999 9999999999999999999999999999777666
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..+.+.|||+.|||||++.+.+|+..+|+|||||+||+|++|.+||...+.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 667788999999999999999999999999999999999999999998774
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.50 Aligned_cols=206 Identities=28% Similarity=0.465 Sum_probs=187.4
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEec-eeccCCc-eEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG-AVTSPQR-LCI 579 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~-~~~~~~~-~~l 579 (716)
..+|+|.++||.|.||.||++.+ .+..||.|.+.......+..+.+..|+.+|++|+|||||++++ -|..+.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46799999999999999999986 6778999999988888888999999999999999999999998 4444444 899
Q ss_pred EEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 580 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNP--PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~--~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
|||||.+|+|..+++. ....+++..+|+++.||+.||..||..-+ -|+||||||.||+|+.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999864 45679999999999999999999998333 399999999999999999999999999999
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
...........+|||.||+||++.+.+|+.++||||+||++|||+.-++||.+.+
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 8877777778899999999999999999999999999999999999999999884
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=372.08 Aligned_cols=202 Identities=32% Similarity=0.511 Sum_probs=189.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+|+.++.||+|||+.||.+++ .+..||+|++.+... +....+++.+|++|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6899999999999999999987 678899999987654 4566788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+|..++|..++++ ..++++.+++.+++||+.||.|||+++ |||||||..||||+++.+|||+|||+|+....+...
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999984 567999999999999999999999999 999999999999999999999999999998877677
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..+.||||.|.|||++....++..+||||+|||||.||+|++||+..+
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 778899999999999999999999999999999999999999998653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=342.45 Aligned_cols=206 Identities=28% Similarity=0.476 Sum_probs=190.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
....+|++++.||.|+||+|.+++. .+..||+|+++++.. .-++.+...+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 3457899999999999999999987 466799999988765 4466788889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
|||||++||.|+.++++.+ +|++..++.++.||+.||+|||+++ |++|||||+|||||++|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998754 6999999999999999999999999 999999999999999999999999999987765
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
+.+.||||.|+|||++...+|+.++|+|+|||++|||+.|.+||...++++-
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 4577999999999999999999999999999999999999999999888753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.71 Aligned_cols=203 Identities=33% Similarity=0.478 Sum_probs=185.1
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc-
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~- 576 (716)
..+...+++.++.||+|..|+||+++++ ++-+|+|++. ....+...+++.+|+++++.++||+||.+|++|..+..
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3455678888999999999999999985 6679999993 44567778899999999999999999999999999995
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
++|+||||++|+|..+++.. ..+++.....++.++++||.|||. ++ ||||||||+||||+..|.|||||||.+...
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999999999875 469999999999999999999995 77 999999999999999999999999999887
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
.+. ...+++||..|||||.+.+..|+.++||||||++++||.+|++||...
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 766 445779999999999999999999999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.65 Aligned_cols=205 Identities=29% Similarity=0.476 Sum_probs=179.6
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-----HHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-----~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
+.+.+.|.+.+.||.|+||.|-+|.. .++.||||++++..... .....+.+|+++|++|+|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 34567899999999999999999976 67889999998765422 122346799999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC---CcEEEEecC
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFG 650 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFG 650 (716)
++..||||||++||.|++++-.+. .+.+...+.+++||+.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999999997754 4888889999999999999999999 9999999999999766 779999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~---~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+|+..+... ...+.||||.|.|||++.+..+ ..++|||||||+||-+|+|.+||...-
T Consensus 325 lAK~~g~~s-fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 325 LAKVSGEGS-FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred hhhccccce-ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999887544 4557899999999999987764 347899999999999999999998543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=354.29 Aligned_cols=215 Identities=53% Similarity=0.873 Sum_probs=193.6
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcCCe-EEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ- 575 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~- 575 (716)
..+.+....+.+.+.||.|+||+||++.+.+.. ||||++............|.+|+.+|.+++|||||+|++++..+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344555667778888999999999999999998 999999988776666889999999999999999999999999888
Q ss_pred ceEEEEeecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCc
Q 005054 576 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR 653 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~-~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~ 653 (716)
.++|||||+++|+|.+++.+ ....++...++.++.||++||.|||++++ ||||||||+||||+.++ ++||+|||+++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999988 46789999999999999999999999886 99999999999999998 99999999998
Q ss_pred ccccCccccccCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
.............||+.|||||++. ...|+.|+||||||++||||+||+.||....+++.
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~ 254 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV 254 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 7766543444468999999999999 56999999999999999999999999999987554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=351.95 Aligned_cols=205 Identities=28% Similarity=0.510 Sum_probs=182.5
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
...+|.+++.||+|+|++||+|+. .++.||||++.+.-. .......+..|...|.+| +||.|+++|..|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 347899999999999999999987 567899999977544 233345677899999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+|+||+++|+|.++|++. ..|++..++.++.||+.||+|||++| ||||||||+||||+.++++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999999886 46999999999999999999999999 999999999999999999999999999865432
Q ss_pred ccc-----------c--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLT-----------T--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~-----------~--~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... . ..++||..|.+||++.....+..+|||+||||||+|+.|++||.+.+.
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 111 1 457899999999999999999999999999999999999999998774
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=353.71 Aligned_cols=207 Identities=26% Similarity=0.438 Sum_probs=182.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
-.++|+++++||+|+||.||+|+. +|.-||+|++++... ...++.-+..|-.+|....+|.||++|..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 357899999999999999999976 677899999988765 34566778889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc--
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-- 657 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-- 657 (716)
||||++||++..+|.+.+ .|++..++.++.+++.|++.||++| +|||||||+|+|||..|+|||+|||+++-...
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999998754 6999999999999999999999999 99999999999999999999999999752110
Q ss_pred --------------------Cccc-------------------------cccCCCCCCccCcccccCCCCCchhHHHHHH
Q 005054 658 --------------------TYLT-------------------------TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFG 692 (716)
Q Consensus 658 --------------------~~~~-------------------------~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG 692 (716)
.... ....+|||.|||||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 1123599999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCccc
Q 005054 693 VILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 693 ~ll~elltG~~PF~~~~~l~ 712 (716)
|||||||.|.+||...++.+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~ 395 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQE 395 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.19 Aligned_cols=207 Identities=24% Similarity=0.359 Sum_probs=188.0
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|+.+.++|+|+||.||+|+. +|+-||||.|......+.......+|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5788899999999999999987 57789999998877777777888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||+. ++.+-+.+....++...++.++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9966 676777777777999999999999999999999999 9999999999999999999999999999877555555
Q ss_pred ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
...+.|..|+|||.+.| .+|+.++|||++||++.||++|.+.|.+..+++.+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL 211 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence 56678999999999988 78999999999999999999999999998877654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=352.18 Aligned_cols=207 Identities=28% Similarity=0.450 Sum_probs=186.7
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~ 576 (716)
....++|.++++||+|.||+|+++..+ ++.||||++++... .++..+..+.|.+|+... +||.++.++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345679999999999999999999885 45699999998765 566778889999999888 59999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+||||+.||++..+.. ...|++..+..|+..|+.||+|||++| |||||||.+|||||.+|++||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999999444433 456999999999999999999999999 9999999999999999999999999999776
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....+.++||||.|||||++.+..|+..+|+|+|||+|||||.|..||.+.+..
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 5556778999999999999999999999999999999999999999999987754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.78 Aligned_cols=200 Identities=34% Similarity=0.578 Sum_probs=185.6
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|.+.+.||+|.||+||||+.+ .+.||+|++.+....++.+..+.+|++|++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999875 4569999999888788888999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||.| +|+.++... ..++++.+..++.+++.||.|||+++ |+|||+||.|||++..+.+|+||||+|+.........
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9966 999999864 56999999999999999999999999 9999999999999999999999999999877665556
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
....|||.|||||++.+.+|+..+|+||||||+|||++|++||...
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 6678999999999999999999999999999999999999999754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.77 Aligned_cols=205 Identities=33% Similarity=0.565 Sum_probs=183.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC---HHHHHHHHHHHHHHHhcC-CCceeEEeceeccCC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~ 575 (716)
...+.|.+++.||+|+||+|+++.+ .+..||+|++.+.... ......+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4557999999999999999999987 5788999988775322 134556778999999998 999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~ 654 (716)
.+|+|||||.||+|++++.+ ..++.+..+..++.||+.|++|||++| |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999998 667999999999999999999999999 9999999999999999 9999999999987
Q ss_pred cccCccccccCCCCCCccCcccccCCC-C-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEP-S-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.........+.+||+.|+|||++.+.. | ..++||||+||+||.|++|..||+..+
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 753444566789999999999999987 7 478999999999999999999999855
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.28 Aligned_cols=209 Identities=27% Similarity=0.371 Sum_probs=186.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--CceE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~~ 578 (716)
..+.|+.+++||+|+||.||++++ .++.||+|.+..+...+.......+|+.||++|+||||+++.+..... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346799999999999999999988 567799999998877777777788999999999999999999998876 6899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||+|||+. +|..++....-.|++.+++.++.||+.||+|||.+| |+|||||.+|||||.+|.+||+|||+|++....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999966 999999888888999999999999999999999999 999999999999999999999999999965543
Q ss_pred c-cccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 659 Y-LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 659 ~-~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
. ......+-|..|++||++.|. .|+...|+||+||||.||+.|++.|.+.+.++.+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 3 234456779999999999876 5789999999999999999999999998877653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.58 Aligned_cols=208 Identities=26% Similarity=0.379 Sum_probs=190.7
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.+|...++||+|.||.||+|++ +++.||||.++.....+.......+|+++|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4788899999999999999998 57789999998877666555677899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|++ .+|+..++.....++..+++.|+.++++||+|||.+. |+||||||+|+||+.+|.+||+|||+|+....+....
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 995 5999999998889999999999999999999999999 9999999999999999999999999999888776666
Q ss_pred ccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 663 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
...+-|..|+|||.+.|. .|+...||||+|||+.||+-|.+-|.+.++++.++
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 555789999999998875 47889999999999999999999999999988765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.56 Aligned_cols=210 Identities=26% Similarity=0.439 Sum_probs=185.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC--CeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.+..++|++++.||.|.-|+||++...+ ..+|+|++.+.... .+...++..|-+||+.++||.++.+|..|+.+..+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 4456789999999999999999999866 57999999887653 45667888899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
|+|||||+||+|+.+++++. ..|++..++.++.+++.||+|||-.| ||+|||||+||||-++|+|.|+||.++....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999998754 56999999999999999999999999 9999999999999999999999999863100
Q ss_pred ------------------------------------c--------------------CccccccCCCCCCccCcccccCC
Q 005054 657 ------------------------------------E--------------------TYLTTKTGKGTPQWMAPEVLRNE 680 (716)
Q Consensus 657 ------------------------------------~--------------------~~~~~~~~~Gt~~Y~aPE~~~~~ 680 (716)
. .......++||-.|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 00123345799999999999999
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 681 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 681 ~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.++.++|+|.|||++||||+|..||.+.++.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~ 342 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE 342 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence 99999999999999999999999999988765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.70 Aligned_cols=205 Identities=28% Similarity=0.519 Sum_probs=188.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+..+|++.+.||+|.||+|-+++. .++.||||.+++.... .+.+-.+.+|++||..|+||||+.+|++|+..+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34557899999999999999999976 6888999999887764 45567789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
.|||||..+|.|++|+.+++ .+++..+..+++||+.|+.|||+++ ++|||||.+|||+|.++++||+|||++.++.+
T Consensus 129 vivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999998865 5999999999999999999999999 99999999999999999999999999987766
Q ss_pred CccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. ...++||+|-|.+||++.|.+| ++.+|.||||++||-|+.|..||++.+
T Consensus 206 ~k-fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 206 KK-FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred cc-HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 54 3457899999999999999999 678999999999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=341.48 Aligned_cols=201 Identities=37% Similarity=0.594 Sum_probs=183.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeecc-CCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~-~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.-|++++.||.|+.|.|-+|++ +|+.+|||++.+. .........+.+|+-||+.+.||||+++|++|+...++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4688999999999999999987 7889999999876 555666778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||++||-|++++.+++ ++++.++.+++.||+.|+.|||..+ |+||||||+|+||+..++|||+|||+|....... .
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-l 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-L 167 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCc-c
Confidence 9999999999998754 6999999999999999999999999 9999999999999999999999999998755443 3
Q ss_pred cccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..+.||+|.|++||+++|.+| +.++||||.|||||.||+|++||++.|
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 456799999999999999999 679999999999999999999999655
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.74 Aligned_cols=208 Identities=26% Similarity=0.394 Sum_probs=184.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCC-ceE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ-RLC 578 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~-~~~ 578 (716)
+-++|.++++||.|+||.||+|+. .+..||||.+++.....+.... .+|+..|++|+ |||||++.+++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 457899999999999999999986 5777999999887776554443 46999999998 999999999999988 899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||| ..+|+++++.++..|++..++.|+.||++||+|+|++| ++||||||+|||+.....|||+|||+|+.....
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccccC
Confidence 999999 55999999999999999999999999999999999999 999999999999998889999999999976543
Q ss_pred ccccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 659 YLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
...+ ..+-|..|+|||++. ...|+.+.|||++||||+|+++-++.|.+.+.++.++
T Consensus 164 pPYT-eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~ 220 (538)
T KOG0661|consen 164 PPYT-EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY 220 (538)
T ss_pred CCcc-hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence 3222 346799999999975 5567899999999999999999999999998877654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=327.27 Aligned_cols=214 Identities=42% Similarity=0.718 Sum_probs=191.5
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..|++..+.+.++..||+|.||+||+|.+.| .||||+++.....++..+.|++|+..|++-+|.||+-|++++..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 6789999999999999999999999999987 59999999999999999999999999999999999999999998877
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
.||.-||+|-+|+.++.....+|.....+.|+.||++||.|||.++ |||||||..||++.++++|||+|||++....-
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 9999999999999999888888999999999999999999999999 99999999999999999999999999864321
Q ss_pred --CccccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 658 --TYLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 658 --~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
.........|...|||||+++ ..+|+..+||||||||+|||++|.+||...+..|.|+
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif 603 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF 603 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE
Confidence 111222345788999999986 4467889999999999999999999999666655543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.91 Aligned_cols=214 Identities=31% Similarity=0.508 Sum_probs=189.2
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..|....++|++...||.|..+.||+|++ .+..||||++..+....+ ...+.+|+..|+.++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34556668999999999999999999988 567899999998876555 788999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|+||.||.+|++.++++.. ...+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeee
Confidence 999999999999999999864 344899999999999999999999999 99999999999999999999999998765
Q ss_pred cccCcc---cc-ccCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 655 KHETYL---TT-KTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 655 ~~~~~~---~~-~~~~Gt~~Y~aPE~~~--~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
...... .. ..++||+.|||||+++ ...|+.|+|||||||+..||.+|+.||....+|+.+
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL 241 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL 241 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 433321 12 5668999999999964 346899999999999999999999999999998864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=322.83 Aligned_cols=199 Identities=34% Similarity=0.571 Sum_probs=173.2
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC--ceEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RLCIV 580 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~--~~~lV 580 (716)
.+|..++.||+|+||.||++... +..+|||.+....... .+.+.+|+.+|.+++|||||++++...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45777899999999999999985 5789999987763222 677899999999999999999999855444 69999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCCccccc--
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHE-- 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~-- 657 (716)
|||+++|+|.+++.+.+..+++..++.+.+||++||.|||++| ||||||||+|||++. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999987667999999999999999999999999 999999999999999 79999999999986652
Q ss_pred -CccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 658 -TYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 658 -~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
.........||+.|||||++.+. ....++|||||||++.||+||+.||..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 22233456899999999999963 334599999999999999999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=328.64 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=178.0
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||+||++.. .++.||||+++.... .......+..|+.++..++||||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999987 467899999976433 2344567788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
|||++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999764 46899999999999999999999999 99999999999999999999999999875322100
Q ss_pred ----------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 661 ----------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 661 ----------------------------------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123479999999999999999999999999999999999999998
Q ss_pred CCCcc
Q 005054 707 NLNSM 711 (716)
Q Consensus 707 ~~~~l 711 (716)
..+..
T Consensus 238 ~~~~~ 242 (363)
T cd05628 238 SETPQ 242 (363)
T ss_pred CCCHH
Confidence 76643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.63 Aligned_cols=205 Identities=29% Similarity=0.441 Sum_probs=171.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH------------HHHHHHHHHHHHHHhcCCCceeEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD------------EVIHSFRQEVSLMKRLRHPNVLLF 567 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~------------~~~~~~~~E~~iL~~l~hpnIv~~ 567 (716)
...++|++++.||.|.||+|.++++ .++.||||++.+..... ..++..++|+.+|++|.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4468999999999999999999998 56789999997654322 123678899999999999999999
Q ss_pred eceeccC--CceEEEEeecCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcE
Q 005054 568 MGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV 644 (716)
Q Consensus 568 ~~~~~~~--~~~~lVmE~~~ggsL~~~l~~~~~~-l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~v 644 (716)
+++..++ +.+|||+|||..|.+...-. ..+ +++.++++|+.+++.||+|||.+| ||||||||+|+||+.+|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcE
Confidence 9999875 57999999998887654432 334 899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccccc-----CccccccCCCCCCccCcccccCCC---C-CchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 645 KVGDFGLSRLKHE-----TYLTTKTGKGTPQWMAPEVLRNEP---S-DEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 645 kL~DFGla~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~---~-~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+|||.+..... ........+|||.|+|||.+.++. + +.+.|||||||+||+|+.|+.||-+...
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999875522 222233458999999999987733 2 6689999999999999999999976543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=312.29 Aligned_cols=207 Identities=27% Similarity=0.352 Sum_probs=182.7
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCceEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIV 580 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~~~lV 580 (716)
+.|+.+..|++|+||.||+|+++ ++-||+|.++.+......--...+|+.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57899999999999999999984 5569999998876544444455789999999999999999888764 3569999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||||+. +|..++.....+|...+++.++.|+++||+|||.+. |+||||||+|+|++..|.+||+|||+|+....+..
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 999966 999999888889999999999999999999999999 99999999999999999999999999998887766
Q ss_pred ccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
.....+-|..|+|||++.|.. |+.+.|+||+||||.||+++++-|.+...++.+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 566667899999999998765 789999999999999999999999987766543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.59 Aligned_cols=204 Identities=30% Similarity=0.508 Sum_probs=189.8
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc-eEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~-~~lVm 581 (716)
++|..+++||+|+||.++++++ .+..|++|.+..........+...+|+.+++++.|||||.+++.|..++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 6799999999999999999987 45579999999888877777788999999999999999999999999988 99999
Q ss_pred eecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
+||+||+|.+.+.+.. ..|+++.++.|+.||+.||.|||+++ |+|||||+.||+++.++.|||.|||+|+.......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999998755 67999999999999999999999988 99999999999999999999999999999888765
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...+.+|||.||+||++.+.+|+.|+|||||||++|||++=+++|...+.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 66678999999999999999999999999999999999999999998774
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.23 Aligned_cols=212 Identities=38% Similarity=0.646 Sum_probs=189.9
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEEcCC-eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
...|++..+.+++++.||+|.||.||+|.+++. +||+|.++...... +.+.+|+++|++|+|+|||++++++..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 356677778899999999999999999999887 89999998765554 45668999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~-~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|||||||+.|+|.++|+. .+..+...+.+.++.|||+||+||++++ +|||||-+.||||++++.+||+|||+|+.
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999999987 5667999999999999999999999999 99999999999999999999999999996
Q ss_pred cccCcc-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 005054 655 KHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQD 713 (716)
Q Consensus 655 ~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~ 713 (716)
..+... ......-...|.|||.+....++.++|||||||+||||+| |+.||..+++.+.
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 555433 3334445679999999999999999999999999999999 9999999887654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.23 Aligned_cols=206 Identities=31% Similarity=0.495 Sum_probs=188.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
...|...++||+|+.|.||.+.. .++.||||.+....... .+-+.+|+.+|+..+|+|||.+++.|...+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45788889999999999999987 56679999998765544 356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|||+||+|.+.+.... +++.++..|.+++++||+|||.+| |+|||||.+|||++.+|.|||+|||++.........
T Consensus 350 Eym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 9999999999998654 999999999999999999999999 999999999999999999999999999877766656
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
..+.+|||.|||||++....|+.+.||||||++++||+-|.+||-..++++++.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence 667899999999999999999999999999999999999999999999998865
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=299.03 Aligned_cols=204 Identities=31% Similarity=0.532 Sum_probs=183.6
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcCC--eEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~--~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
...++|++++.||+|-||.||+++.+.. -||+|++.+... ......++.+|++|-..|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 4457999999999999999999987544 599999876654 3345578899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|++||..+|.|+..|... ...+++.....++.|++.||.|+|.++ ||||||||+|+|++..+.+||+|||++...+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999743 456999999999999999999999999 9999999999999999999999999998765
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....+.|||..|.+||+..+..++..+|+|++|++.|||+.|.+||+..+
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 334557799999999999999999999999999999999999999999766
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.26 Aligned_cols=209 Identities=29% Similarity=0.393 Sum_probs=182.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc-eeEEeceeccCC-----
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQ----- 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn-Iv~~~~~~~~~~----- 575 (716)
...|..+++||+|+||+||+|+. .++.||+|.+..+...+..-....+|+.+|+.++|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35677788999999999999987 5778999999876443223355678999999999999 999999998877
Q ss_pred -ceEEEEeecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~~---~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
.+++||||+ .-+|..++.... ..++...++.++.||+.||+|||+++ |+||||||.||||++.|.+||+|||+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 559999998766 35788899999999999999999999 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
|+...-+.......++|..|+|||++.|. .|+...||||+|||++||++++.-|.+....+.++
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~ 231 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF 231 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99776555555667899999999999988 67889999999999999999999999988766554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=308.25 Aligned_cols=207 Identities=30% Similarity=0.483 Sum_probs=187.7
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.+..++|..+++||+|.||+|.+|+- .++.||+|+++++.. ..+...--..|-++|+..+||.+..+...|+.++++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34457899999999999999999986 577899999988755 344555566789999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||..||.|+-+|.+. ..|++...+.+..+|+.||.|||+++ ||+||||.+|+|+|++|+|||.|||+++....
T Consensus 244 CFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999999999774 46999999999999999999999999 99999999999999999999999999987766
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......++||||.|+|||++....|+..+|+|.+|++||||++|++||.+.+.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 66777899999999999999999999999999999999999999999987664
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.23 Aligned_cols=204 Identities=25% Similarity=0.416 Sum_probs=177.8
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||.|+||.||++.+ .++.||||+++.... .......+.+|+.+|..++||||+++++++..++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999988 467899999976533 2344566788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
|||++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999997643 6899999999999999999999999 99999999999999999999999999864321110
Q ss_pred -------------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 005054 661 -------------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 703 (716)
Q Consensus 661 -------------------------------------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~ 703 (716)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 005054 704 PWDNLNSM 711 (716)
Q Consensus 704 PF~~~~~l 711 (716)
||...+..
T Consensus 238 Pf~~~~~~ 245 (364)
T cd05599 238 PFCSDNPQ 245 (364)
T ss_pred CCCCCCHH
Confidence 99876643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=328.52 Aligned_cols=206 Identities=29% Similarity=0.392 Sum_probs=180.7
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-C-----CceeEEeceec
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-H-----PNVLLFMGAVT 572 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-h-----pnIv~~~~~~~ 572 (716)
+.+.-+|+|.+.||+|+||.|.+|.+ +++.||||+++.. .....+...|+.+|..|+ | -|||+++++|.
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 34445899999999999999999998 4667999999865 455566778999999996 3 49999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC--CcEEEEec
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH--WTVKVGDF 649 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~--~~vkL~DF 649 (716)
..+++|||+|.+ ..+|+++++.+. ..++...++.++.||+.+|.+||+.+ |||+|||||||||..- ..|||+||
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEec
Confidence 999999999999 669999998754 56899999999999999999999999 9999999999999743 46999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
|.++....... ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+.+.
T Consensus 336 GSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 336 GSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred ccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 99998766543 4467899999999999999999999999999999999999999988766543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.49 Aligned_cols=200 Identities=27% Similarity=0.451 Sum_probs=177.8
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999984 77899999876443 2234567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999999764 46899999999999999999999999 999999999999999999999999998765432
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.50 Aligned_cols=203 Identities=26% Similarity=0.410 Sum_probs=176.1
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|.++++||.|+||.||++.. .++.||||++.+... .......+.+|+.+++.++||||+++++++.+...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999987 567899999876432 3345567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999764 46899999999999999999999999 99999999999999999999999999863211000
Q ss_pred ----------------------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHH
Q 005054 661 ----------------------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVI 694 (716)
Q Consensus 661 ----------------------------------------------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~l 694 (716)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCc
Q 005054 695 LWELATEKIPWDNLNS 710 (716)
Q Consensus 695 l~elltG~~PF~~~~~ 710 (716)
+|+|++|..||...+.
T Consensus 238 l~elltG~~Pf~~~~~ 253 (377)
T cd05629 238 MFECLIGWPPFCSENS 253 (377)
T ss_pred hhhhhcCCCCCCCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=324.09 Aligned_cols=202 Identities=23% Similarity=0.348 Sum_probs=176.0
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.|++++.||+|+||+||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999987 456799999976543 33456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc---
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--- 659 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--- 659 (716)
||++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999999764 35899999999999999999999999 9999999999999999999999999875321000
Q ss_pred --------------------------------------------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 005054 660 --------------------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695 (716)
Q Consensus 660 --------------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll 695 (716)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCc
Q 005054 696 WELATEKIPWDNLNS 710 (716)
Q Consensus 696 ~elltG~~PF~~~~~ 710 (716)
|+|++|..||...++
T Consensus 239 ~elltG~~Pf~~~~~ 253 (381)
T cd05626 239 FEMLVGQPPFLAPTP 253 (381)
T ss_pred HHHHhCCCCCcCCCH
Confidence 999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.50 Aligned_cols=203 Identities=24% Similarity=0.352 Sum_probs=176.0
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+|+++++||+|+||.||++.. .+..||+|++..... .......+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999987 466799999876433 23455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC----
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---- 658 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~---- 658 (716)
||++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999999764 45899999999999999999999999 999999999999999999999999997522100
Q ss_pred -------------------------------------------ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 005054 659 -------------------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695 (716)
Q Consensus 659 -------------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll 695 (716)
.......+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234699999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCcc
Q 005054 696 WELATEKIPWDNLNSM 711 (716)
Q Consensus 696 ~elltG~~PF~~~~~l 711 (716)
|+|++|+.||...++.
T Consensus 239 ~elltG~~Pf~~~~~~ 254 (382)
T cd05625 239 YEMLVGQPPFLAQTPL 254 (382)
T ss_pred HHHHhCCCCCCCCCHH
Confidence 9999999999876654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.91 Aligned_cols=201 Identities=30% Similarity=0.486 Sum_probs=179.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|++.+.||+|+||.||+|.+ .++.||||+++.... .......+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 47899999999999999999988 467899999976543 224456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999999764 46899999999999999999999999 9999999999999999999999999998654432
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...++
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 235799999999999999999999999999999999999999987654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.12 Aligned_cols=196 Identities=29% Similarity=0.514 Sum_probs=172.7
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
+.||+|+||.||++.. .++.||||+++.... .......+.+|+.+|+.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999986533 2344566778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCC
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (716)
+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999999764 46899999999999999999999999 999999999999999999999999998754333333345579
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 668 t~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.21 Aligned_cols=204 Identities=23% Similarity=0.338 Sum_probs=175.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+|++++.||+|+||.||++.. .++.||||++..... .......+.+|+.+|+.++||||+++++.+..++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3699999999999999999987 467899999875432 2233466788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC---
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--- 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--- 658 (716)
|||++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999764 45889999999999999999999999 999999999999999999999999997422100
Q ss_pred ----------------------------------------ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHH
Q 005054 659 ----------------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698 (716)
Q Consensus 659 ----------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~el 698 (716)
.......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134799999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcc
Q 005054 699 ATEKIPWDNLNSM 711 (716)
Q Consensus 699 ltG~~PF~~~~~l 711 (716)
++|+.||...++.
T Consensus 238 l~G~~Pf~~~~~~ 250 (376)
T cd05598 238 LVGQPPFLADTPA 250 (376)
T ss_pred hhCCCCCCCCCHH
Confidence 9999999876643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.18 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=178.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||+|.+ .++.||||+++..... ......+.+|+.++..++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4699999999999999999988 4678999999865432 234567788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 999999999999764 46899999999999999999999999 99999999999999999999999999976544 2
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 2345799999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.77 Aligned_cols=203 Identities=27% Similarity=0.471 Sum_probs=180.6
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|.+.+.||+|+||.||+|.+. ++.||||+++...... .....+..|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999985 7889999998654322 44567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (716)
||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999875 56899999999999999999999998 9999999999999999999999999987654432
Q ss_pred ---------------------------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 ---------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ---------------------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 122345799999999999999999999999999999999999999987664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=309.65 Aligned_cols=202 Identities=29% Similarity=0.431 Sum_probs=174.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||+|+||.||+|.+ .++.||||+++...... ....+.+|+.+++.++||||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 6899999999999999999998 46789999987543222 22356679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+. ++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 995 6888888776667899999999999999999999999 9999999999999999999999999987554333333
Q ss_pred ccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|++.|+|||++.+. .++.++|||||||++|+|++|..||....+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 455789999999998764 578899999999999999999999987544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.12 Aligned_cols=204 Identities=28% Similarity=0.484 Sum_probs=179.9
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC---CeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG---SDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
....++|++.+.||+|+||.||+|.+.+ ..||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 4455789999999999999999998643 4699999876433 23445678889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+||||+++++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999999997653 6899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...++
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 32 2245799999999999999999999999999999999999999987665
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=308.07 Aligned_cols=202 Identities=27% Similarity=0.403 Sum_probs=174.9
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||.|+||.||+|.. .+..||+|+++..... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 5799999999999999999987 4668999998754322 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 9965 999999876667899999999999999999999999 9999999999999999999999999987654433333
Q ss_pred ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34578999999999875 5678999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.78 Aligned_cols=201 Identities=23% Similarity=0.357 Sum_probs=175.1
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.|++.+.||+|+||.||++.+ .+..||+|++....... .....+.+|+.+++.++|+||+++++++...+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999987 57789999987654322 233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+++++|..++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-T 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-e
Confidence 99999999887643 346899999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 234578999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.77 Aligned_cols=207 Identities=33% Similarity=0.512 Sum_probs=188.8
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
..|.....||+|.||.||+|.+ .++.||+|++..+... ..+..+++|+.+|.+++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4567778999999999999998 5667999999876543 446788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||.||++.+.++... .+.+..+..++++++.||.|||..+ .+|||||+.|||+..+|.|||+|||++..........
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999998654 4588899999999999999999999 9999999999999999999999999998877776666
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
.+++|||.|||||++.+..|+.++||||||++.|||.+|.+||....+|..++
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 88999999999999999999999999999999999999999999999988764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=320.79 Aligned_cols=206 Identities=27% Similarity=0.427 Sum_probs=177.6
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
....++|++.+.||+|+||.||++.+. ++.||+|++.+... .......+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999884 56799999875432 223345677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+|||||++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999999754 4889999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-cccccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~~----~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 22 2223557999999999997643 67899999999999999999999987653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.58 Aligned_cols=204 Identities=25% Similarity=0.414 Sum_probs=177.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++.. .+..||||+++.... .......+..|+.++..++||||+++++.+...+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4689999999999999999987 467899999976432 2344567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (716)
|||++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999764 45899999999999999999999999 9999999999999999999999999986432110
Q ss_pred ---------------------------------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 660 ---------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 660 ---------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123479999999999999999999999999999999999999998
Q ss_pred CCCcc
Q 005054 707 NLNSM 711 (716)
Q Consensus 707 ~~~~l 711 (716)
..++.
T Consensus 238 ~~~~~ 242 (360)
T cd05627 238 SETPQ 242 (360)
T ss_pred CCCHH
Confidence 76653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=313.26 Aligned_cols=197 Identities=28% Similarity=0.487 Sum_probs=172.5
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
+.||+|+||.||++.. .+..||+|+++.... .......+.+|+.+++.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999976533 2344566778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCC
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (716)
+|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 999988764 46899999999999999999999999 999999999999999999999999998754333333334579
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 668 t~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 200 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=314.49 Aligned_cols=208 Identities=30% Similarity=0.545 Sum_probs=174.2
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE-------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEecee
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~ 571 (716)
|++..++|++.++||+|+||.||+|.+ .+..||||+++... .......+.+|+.+|..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 456678999999999999999999974 23469999987543 334456788999999999 899999999988
Q ss_pred ccC-CceEEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 005054 572 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (716)
Q Consensus 572 ~~~-~~~~lVmE~~~ggsL~~~l~~~~----------------------------------------------------- 597 (716)
... ..+|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 45899999999999999987532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC--ccccccCCC
Q 005054 598 --------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKG 667 (716)
Q Consensus 598 --------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~G 667 (716)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 24778889999999999999999999 999999999999999999999999999754322 112223346
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 668 t~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
++.|+|||++.+..++.++|||||||+||+|++ |..||.....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 788999999999999999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=315.51 Aligned_cols=207 Identities=40% Similarity=0.621 Sum_probs=179.9
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-ceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~-~~~ 578 (716)
....++|.-...||+|+||.||+|...+ ..||||.+....... ..+|.+|+.+|.+++|||+|++++||.+.+ ..+
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 3446789999999999999999999865 789999877654432 345999999999999999999999999988 499
Q ss_pred EEEeecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC-CCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCN-PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~-~l~~~~v~~i~~ql~~aL~yLH~~~-~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
||+|||+.|+|.++|..... +++|..+++|+.++++||+|||... ++|||||||++|||||.+.+.||+|||+|+..+
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 99999999999999987665 8999999999999999999999844 479999999999999999999999999997665
Q ss_pred c-CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 657 E-TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 657 ~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
. .........||.+|++||.+..+..+.++||||||++|+||++|+.|.+...
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred ccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 4 2211111179999999999999889999999999999999999999888543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.21 Aligned_cols=204 Identities=23% Similarity=0.371 Sum_probs=176.4
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++.. .++.||+|++.+... .......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 467899999976332 2334566788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999876667999999999999999999999999 99999999999999999999999999875443221
Q ss_pred ccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 2223469999999999873 4567899999999999999999999987553
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.90 Aligned_cols=202 Identities=28% Similarity=0.437 Sum_probs=174.4
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCC-ceeEEeceeccCCceEEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hp-nIv~~~~~~~~~~~~~lVm 581 (716)
+|++.+.||+|+||.||+|.+. ++.||||++++... .......+..|+.++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999884 45799999986533 234456677899999998764 6888999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999999764 45899999999999999999999999 999999999999999999999999998754322223
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 3345799999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.61 Aligned_cols=207 Identities=28% Similarity=0.429 Sum_probs=187.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+..-|.+.+.||+|-|..|.++++ .|..||||++.+.+...-....+.+|++.|+.++|||||++|++...+..+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345688899999999999999975 899999999998887766566788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE-ccCCcEEEEecCCCcccccCc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-DKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl-~~~~~vkL~DFGla~~~~~~~ 659 (716)
+|+-++|+|++||.++...+.+...++++.||+.|+.|+|+.. +|||||||+||++ .+-|-|||.|||++..+...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 9999999999999999888999999999999999999999999 9999999999776 56688999999999766544
Q ss_pred cccccCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~-~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
....+.||+..|.|||++.|..|+ +++||||||||||.|++|++||+..++-+
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 445577999999999999999996 57899999999999999999999877544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.86 Aligned_cols=207 Identities=26% Similarity=0.401 Sum_probs=178.1
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
.+...++|++.+.||+|+||.||++.+ .++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 345568999999999999999999988 466799999875432 23334567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+|||||++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999999999754 4889999999999999999999999 9999999999999999999999999997654
Q ss_pred cCc-cccccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~----~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 322 2223557999999999987643 67899999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.64 Aligned_cols=204 Identities=37% Similarity=0.625 Sum_probs=183.6
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..|++.++...-++-||.|+.|.||+++..++.||||.++.. -..+++-|++|+||||+.|.++|.....+
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 467888888888889999999999999999999999976432 12467889999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||..|.|+..|+.. ..+.......|..+|+.||.|||.++ |||||||.-||||..+..|||+|||.++...+
T Consensus 188 CIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999999764 56888999999999999999999999 99999999999999999999999999987665
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
. .....++||-.|||||++.+.+.+.|+|||||||||||||||..||.+.+.+..|
T Consensus 265 ~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII 320 (904)
T KOG4721|consen 265 K-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII 320 (904)
T ss_pred h-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE
Confidence 5 3455789999999999999999999999999999999999999999988876544
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.51 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=174.7
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVm 581 (716)
+|.+.+.||+|+||.||++.+. +..||||++++... .......+..|..++..+ .|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999884 45799999986533 223345566778888777 5899999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998764 45899999999999999999999999 999999999999999999999999998754433333
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 4456799999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.12 Aligned_cols=200 Identities=27% Similarity=0.452 Sum_probs=172.6
Q ss_pred eeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHH---HhcCCCceeEEeceeccCCceEEE
Q 005054 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLM---KRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL---~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
|++.+.||+|+||.||++.+ .++.||||+++.... .......+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999987 467899999986542 223345666666655 456799999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999988864 35899999999999999999999999 99999999999999999999999999875443333
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 33456799999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=314.30 Aligned_cols=204 Identities=22% Similarity=0.358 Sum_probs=176.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++.. .++.||+|++.+... .......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 456799999876332 2333456778899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
||+++++|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999876667999999999999999999999999 99999999999999999999999999876543322
Q ss_pred ccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 2223579999999999876 4578899999999999999999999986653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.93 Aligned_cols=197 Identities=29% Similarity=0.498 Sum_probs=172.8
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
+.||+|+||.||++.. .+..||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 467899999976533 2344567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCC
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (716)
+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 999988764 46899999999999999999999999 999999999999999999999999998754333233334579
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 668 t~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 9999999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.35 Aligned_cols=194 Identities=29% Similarity=0.461 Sum_probs=171.1
Q ss_pred eecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 513 LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
||+|+||.||++.+. ++.||+|+++.... .......+.+|+.+|+.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999884 66799999876432 334456778899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCC
Q 005054 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (716)
Q Consensus 590 ~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (716)
.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 9999764 46899999999999999999999999 99999999999999999999999999876443333334557999
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 670 ~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 9999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=301.98 Aligned_cols=205 Identities=29% Similarity=0.491 Sum_probs=191.1
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+-|.++.+||+|+||.||++.+ .|..+|||.+..+ ..++++.+|+.||++++.|++|++|+.|.....+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4577889999999999999987 5677999987543 336788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||..|++.++++.++.++++.++..+++..++||+|||... -||||||..|||++.+|..||+|||.|-...+.....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 99999999999988889999999999999999999999988 8999999999999999999999999999888888888
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
.+..|||.|||||++....|++++||||||++..||.-|++||....+|.+++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF 239 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF 239 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence 88899999999999999999999999999999999999999999999998875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.73 Aligned_cols=205 Identities=32% Similarity=0.528 Sum_probs=184.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcC-CCceeEEeceeccCCc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~ 576 (716)
+.....|++.+.||.|.||.||+|+. +++.||+|++++..... .....+.+|+.+|+++. |||||.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34457899999999999999999987 47789999998776533 24567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc----CCcEEEEecCCC
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFGLS 652 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~----~~~vkL~DFGla 652 (716)
+++|||+|.||.|++.+.+. .+++..+..++.|++.++.|||+.| |+||||||+|||+.. ++.+|++|||++
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999999876 3999999999999999999999999 999999999999963 357999999999
Q ss_pred cccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... .......+||+.|+|||++...+|+..+||||+|+++|.|++|..||.+.+.
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 98777 4455677999999999999999999999999999999999999999998774
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.22 Aligned_cols=206 Identities=25% Similarity=0.389 Sum_probs=177.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
....++|++.+.||+|+||.||++.. .+..||+|++++... .......+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 44567999999999999999999987 466899999976432 223345577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+|||||++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999999754 4889999999999999999999999 99999999999999999999999999876543
Q ss_pred Cc-cccccCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNE----PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~----~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 22 122345799999999998754 367899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.88 Aligned_cols=197 Identities=27% Similarity=0.429 Sum_probs=171.7
Q ss_pred eeeecCCcEEEEEEEE-----cCCeEEEEEeeccCC--CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 511 EQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
++||+|+||.||++.. .++.||||+++.... .......+..|+.+|+.++||||+++++++...+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 456799999976432 123345667899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+++++|.+++.+. ..+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 9999999999764 45888999999999999999999999 99999999999999999999999999875443333334
Q ss_pred cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~ 205 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR 205 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH
Confidence 55799999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.46 Aligned_cols=203 Identities=23% Similarity=0.352 Sum_probs=176.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||+|+||.||++++. +..||||+++...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999984 5679999998765444556677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-cc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 661 (716)
|++++.|..+. .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99886665444 44456899999999999999999999999 9999999999999999999999999998654322 12
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 2234689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.88 Aligned_cols=197 Identities=30% Similarity=0.475 Sum_probs=168.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
...+|+++++||+|+||.||++.+ .++.||||++.... .......+.+|+.+|+.++|+||+++++++...+.+|+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 346788899999999999999987 46789999986543 344557788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|... ....+..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 151 ~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999999998643 23567788899999999999999999 99999999999999999999999999986654433
Q ss_pred ccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 661 TTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
......||..|+|||++.. ...+.++|||||||++|+|++|+.||..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 3345579999999998743 3345689999999999999999999973
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.83 Aligned_cols=204 Identities=23% Similarity=0.380 Sum_probs=175.7
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.++||+|+||.||++... ++.||+|++.+... .......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999874 55799999865332 2333455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC-cc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YL 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~ 660 (716)
||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999876667999999999999999999999999 999999999999999999999999998754322 22
Q ss_pred ccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 223457999999999986 34578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.34 Aligned_cols=197 Identities=29% Similarity=0.488 Sum_probs=171.6
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
+.||+|+||.||++.+ .+..||+|+++.... .......+.+|+.+++.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999986543 2334566778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
+|..++.+. ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999988764 468999999999999999999997 68 99999999999999999999999999875433333333457
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 99999999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.09 Aligned_cols=204 Identities=26% Similarity=0.437 Sum_probs=178.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|.+.+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4699999999999999999987 567899999986543 2344567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-c
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-L 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~ 660 (716)
||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999887667999999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred ccccCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLR------NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~------~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 223447899999999987 45677899999999999999999999986553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=323.48 Aligned_cols=213 Identities=25% Similarity=0.448 Sum_probs=179.2
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc-C-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEec-eecc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-G-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG-AVTS 573 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~-~~~~ 573 (716)
..+++-..+++|.+.|.+|||+.||+|.+. + ..||+|.+-.. .+..++.+.+|+.+|+.|+ |+|||.|++ ....
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 456677789999999999999999999983 3 68999987654 4667889999999999995 999999999 3321
Q ss_pred ---C---CceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEE
Q 005054 574 ---P---QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV 646 (716)
Q Consensus 574 ---~---~~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL 646 (716)
. -.++|.||||.||.|-++|.++ ...|++.+|++|+.|+++||.+||.+.++|||||||-|||||+.+|++||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 2478999999999999999753 24499999999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccCccc---------cccCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 647 GDFGLSRLKHETYLT---------TKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 647 ~DFGla~~~~~~~~~---------~~~~~Gt~~Y~aPE~~---~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
||||.|+........ .....-|+.|+|||++ .+.+.+.|+|||+|||+||.|++...||+....+.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 999988743222110 1112359999999986 68889999999999999999999999999876554
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.34 Aligned_cols=197 Identities=29% Similarity=0.467 Sum_probs=168.7
Q ss_pred eeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++.+. ++.||||+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 55799999986532 223344455666666654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999999764 46899999999999999999999999 99999999999999999999999999976543333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=306.90 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=174.5
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVm 581 (716)
+|++.+.||+|+||.||++.+ .++.||+|++++... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478889999999999999987 467899999986532 2334456777888888885 577888999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999999764 45999999999999999999999999 999999999999999999999999998754433333
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 3455799999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=307.53 Aligned_cols=200 Identities=24% Similarity=0.393 Sum_probs=171.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCC--CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+|++++.||+|+||.||++.. .+..||+|++.+... .......+..|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 489999999999999999876 466799999976432 223345677899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999999764 45899999999999999999999999 99999999999999999999999999875432
Q ss_pred C-ccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 T-YLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~-~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
. ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 2 22233457999999999998754 788999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.59 Aligned_cols=197 Identities=28% Similarity=0.449 Sum_probs=171.2
Q ss_pred eeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
++||+|+||.||+|.+. ++.||||+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999884 56799999976532 233455667788888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999998764 46899999999999999999999999 99999999999999999999999999876443333344557
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.23 Aligned_cols=197 Identities=30% Similarity=0.463 Sum_probs=170.8
Q ss_pred eeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++.+. ++.||||++++... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 66799999876432 233455667788888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999998764 46899999999999999999999999 99999999999999999999999999875433333334557
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 99999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=307.83 Aligned_cols=194 Identities=30% Similarity=0.444 Sum_probs=170.4
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
++||+|+||.||++.+ .+..||||+++..... ......+..|..++..+ +||||+++++++...+.+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999987 4667999999875432 33456678899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999988764 46999999999999999999999999 99999999999999999999999999875333223334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 99999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.28 Aligned_cols=201 Identities=27% Similarity=0.425 Sum_probs=170.0
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-----CceE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QRLC 578 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~-----~~~~ 578 (716)
+|++.++||+|+||.||++++ .+..||||.++...........+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999987 467899999875433333445678899999999999999999987543 2479
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||| +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecC-CCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999999 56899988764 35899999999999999999999999 999999999999999999999999998754322
Q ss_pred c---cccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 Y---LTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~---~~~~~~~Gt~~Y~aPE~~~~--~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 1 11234578999999999876 6788999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.09 Aligned_cols=197 Identities=27% Similarity=0.438 Sum_probs=173.9
Q ss_pred eeeecCCcEEEEEEEE-----cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 511 EQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
+.||+|+||.||++.. .++.||+|+++...........+.+|+.+|++++||||+++++++...+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 46789999998755444444567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccC
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (716)
+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999764 46899999999999999999999999 9999999999999999999999999987655443334456
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 666 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 666 ~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 203 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence 799999999999998899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.93 Aligned_cols=197 Identities=32% Similarity=0.473 Sum_probs=166.8
Q ss_pred eeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHH-HHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEV-SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~-~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++.+. +..||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999884 557999998764321 12223333343 457788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999999764 45888999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.68 Aligned_cols=202 Identities=26% Similarity=0.400 Sum_probs=178.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
+..++|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+|+.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999984 6679999987643 34556778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999997643 589999999999999999999974 5 999999999999999999999999998765433
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 158 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 M--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred c--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 234578999999999999999999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=306.10 Aligned_cols=197 Identities=34% Similarity=0.503 Sum_probs=168.2
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHH-HHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~-iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||+||++.+ .++.||||++...... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999998 5678999999765332 222334444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999999764 46899999999999999999999999 99999999999999999999999999875433333344557
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 201 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH
Confidence 99999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=305.37 Aligned_cols=196 Identities=35% Similarity=0.504 Sum_probs=167.5
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHH-HHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEV-SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~-~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
++||+|+||.||++.+ .+..||+|++.+... .......+..|. .+++.++||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988 466799999876433 222233444454 467889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9999888754 46889999999999999999999999 99999999999999999999999999875433333334557
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 9999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=290.91 Aligned_cols=202 Identities=25% Similarity=0.431 Sum_probs=180.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+.|.+.+.||+|.|+.||.+.. .|+.+|+|++..........+.+.+|++|.+.|+|||||++.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46789999999999999999976 5778999998877666556788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecCCCcccccC
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~~ 658 (716)
|+++|++|..-+-++ ..+++..+-.+++||+++|.|+|.++ |||||+||+|+|+.. ..-|||+|||+|.... .
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 999999996555443 35789999999999999999999999 999999999999953 3459999999998877 4
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
........|||.|||||++...+|+.++|||+.|+|||-|+.|.+||.+.+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 455567799999999999999999999999999999999999999999854
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.04 Aligned_cols=195 Identities=26% Similarity=0.395 Sum_probs=169.7
Q ss_pred eecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 513 LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
||+|+||+||++.+ .++.||+|++...... ......+..|+.+++.++|+||+++++++.....+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999987 4678999998765432 23345677899999999999999999999999999999999999999
Q ss_pred HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 590 FRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 590 ~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 888743 2346899999999999999999999999 99999999999999999999999999876554433334457
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 8999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.98 Aligned_cols=194 Identities=29% Similarity=0.436 Sum_probs=170.2
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++.. .++.||+|++++.... ......+.+|+.++..+ +||||+.+++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 4567999999875432 34456678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999988764 46999999999999999999999999 99999999999999999999999999875433333334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.98 Aligned_cols=194 Identities=30% Similarity=0.445 Sum_probs=169.4
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++.+ .++.||+|++++... .......+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 456799999987543 234456677888888776 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999888664 46899999999999999999999999 99999999999999999999999999875433333334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 99999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.53 Aligned_cols=203 Identities=28% Similarity=0.396 Sum_probs=169.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc---CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeceec-----c
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT-----S 573 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l---~hpnIv~~~~~~~-----~ 573 (716)
.+|++.+.||+|+||.||+|.+. +..||+|+++...........+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37999999999999999999872 46799999876544333334455677776665 6999999999875 3
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
...+++||||++ ++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999995 58999887543 45899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|++||...+..
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~ 215 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH
Confidence 765433 2233457899999999999999999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=295.90 Aligned_cols=208 Identities=27% Similarity=0.375 Sum_probs=178.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-----CC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-----~~ 575 (716)
+...|...+.||.|+||.|+.+.+ .+..||||.+.......-..++..+|+.+|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345677789999999999999987 57789999887554455567888899999999999999999999876 34
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|+|+|+| +.+|...++.. ..++...+..++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+|+..
T Consensus 100 DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeec
Confidence 589999999 66999999764 35999999999999999999999999 999999999999999999999999999976
Q ss_pred ccC--ccccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 656 HET--YLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 656 ~~~--~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
... .......+-|..|+|||++. ...|+...||||+||||.||++|++-|.+.+.++.+
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql 237 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL 237 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH
Confidence 531 12223446799999999875 556889999999999999999999999998877654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=335.62 Aligned_cols=206 Identities=25% Similarity=0.399 Sum_probs=183.7
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
...++|+|+++||+|+||.|.+++.+ ++-||+|++++... .......|+.|-.+|...+.+=|+.++.+|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34679999999999999999999884 55699999887543 2344567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc-c
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-E 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~ 657 (716)
+||||++||+|..+|.+.. ++++..+++|+..|+.||..||+.| +|||||||+|||||..|+|||+|||.+-... +
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999999877 8999999999999999999999999 9999999999999999999999999876555 5
Q ss_pred CccccccCCCCCCccCccccc----C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLR----N-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~----~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........+|||.|.+||++. + +.|+..+|+|||||++|||++|..||....-
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl 286 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL 286 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH
Confidence 666677889999999999985 3 5688999999999999999999999986553
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.55 Aligned_cols=197 Identities=28% Similarity=0.439 Sum_probs=168.7
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++.+ .+..||+|+++..... ......+..|..++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999988 4668999999765321 22344556677777754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999998764 46899999999999999999999999 99999999999999999999999999875332222334557
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.80 Aligned_cols=207 Identities=29% Similarity=0.446 Sum_probs=183.8
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcCC--eEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~--~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+...+|..+.+||+|+||+|.++..++. .||||+++++.. +++..+--+.|.++|... +-|.++.++.+|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 4456899999999999999999988665 499999988654 333344445677888766 578999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+.||+|...+++-+ ++.+..+..++.+|+-||-|||++| ||+||||.+|||++.+|+|||+|||+++...-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999998754 6899999999999999999999999 99999999999999999999999999987766
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....+.+++|||.|+|||++..++|+.++|+||+|++|||||.|++||++.+..
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 677788999999999999999999999999999999999999999999988753
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=305.67 Aligned_cols=197 Identities=33% Similarity=0.487 Sum_probs=168.2
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHH-HHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~-iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++.+ .++.||+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 467899999976532 2223344445544 57778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9999888754 46899999999999999999999999 99999999999999999999999999875433333334557
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 99999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.03 Aligned_cols=197 Identities=28% Similarity=0.456 Sum_probs=168.6
Q ss_pred eeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||+|.+. +..||||+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 56799999986532 122334556677777764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999764 45899999999999999999999999 99999999999999999999999999875433322333557
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=311.93 Aligned_cols=199 Identities=27% Similarity=0.397 Sum_probs=164.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------ 574 (716)
..++|+++++||+|+||.||+|.+ .++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346899999999999999999987 56789999875432 2234699999999999999998876432
Q ss_pred --CceEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEe
Q 005054 575 --QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGD 648 (716)
Q Consensus 575 --~~~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~D 648 (716)
..+++||||+++ +|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 246799999965 78777653 3456899999999999999999999999 99999999999998654 699999
Q ss_pred cCCCcccccCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 649 FGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
||+++....... .....||+.|+|||++.+. .++.++|||||||+||+|++|.+||.+.+..
T Consensus 215 FGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 277 (440)
T PTZ00036 215 FGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277 (440)
T ss_pred cccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999986543322 2245789999999998764 6899999999999999999999999876543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=310.63 Aligned_cols=200 Identities=21% Similarity=0.330 Sum_probs=165.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC------CCceeEEeceecc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR------HPNVLLFMGAVTS 573 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~------hpnIv~~~~~~~~ 573 (716)
...++|++.++||+|+||+||++.+ .+..||||+++... .....+..|+.+++.+. |.+|++++++|..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3457899999999999999999987 46679999986432 22334556777777664 4568899888875
Q ss_pred C-CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCC---------
Q 005054 574 P-QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW--------- 642 (716)
Q Consensus 574 ~-~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~--------- 642 (716)
. ..+|||||++ +++|.+++.+. ..+++..++.++.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccc
Confidence 4 5789999998 77899988764 469999999999999999999997 58 99999999999998665
Q ss_pred -------cEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 643 -------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 643 -------~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764322 223457999999999999999999999999999999999999999877654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.87 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=165.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----ce
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RL 577 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~-----~~ 577 (716)
-.|.-.+++|.|.||.||++.. .+..||||.+-.+.. .-.+|+.+|+.++|||||+++.+|.... ..
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3688889999999999999987 456799987654321 2236899999999999999988886432 45
Q ss_pred EEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecCCCc
Q 005054 578 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR 653 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~ 653 (716)
.+||||++. +|++.++. .+..++...++.+..||++||.|||..| |+||||||.|||+|.+ |.+||||||.|+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 789999955 99999874 3566899999999999999999999988 9999999999999975 899999999998
Q ss_pred ccccCccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
........ ....-|..|+|||.+.|.. |+.+.||||.||||.||+-|++-|.+.+..+.+
T Consensus 175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL 235 (364)
T KOG0658|consen 175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL 235 (364)
T ss_pred eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH
Confidence 75433222 2334588999999998764 789999999999999999999999998765543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=314.44 Aligned_cols=208 Identities=28% Similarity=0.408 Sum_probs=180.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC---
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--- 575 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~--- 575 (716)
+...++|.+.+.||+|+||+||++.+ .++.||||++............+.+|+.++..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999987 5778999999887766667778889999999999999999988765332
Q ss_pred -----ceEEEEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEE
Q 005054 576 -----RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (716)
Q Consensus 576 -----~~~lVmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~ 647 (716)
.+++||||+++++|.+++... ...+++..++.++.||+.+|.|||+++ |+||||||+|||++.++.+||+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999998653 346899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCcccccC--ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 648 DFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 648 DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99998764432 1122345799999999999999999999999999999999999999986553
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.87 Aligned_cols=197 Identities=30% Similarity=0.478 Sum_probs=171.0
Q ss_pred eeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||+||++.+. +..||||++++... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999884 56799999986532 233455667888888887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999998765 36999999999999999999999999 99999999999999999999999999875433333334457
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~ 201 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence 99999999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=293.16 Aligned_cols=201 Identities=24% Similarity=0.356 Sum_probs=174.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.|++.++||+|+||.||++.+ .++.||||++....... .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999987 46789999987654332 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+++++|..++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 99999999888653 346899999999999999999999999 99999999999999999999999999876543222
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 224478999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=303.36 Aligned_cols=201 Identities=28% Similarity=0.422 Sum_probs=172.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----- 575 (716)
+.++|++.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999987 4678999999765544555667788999999999999999999986543
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|+||||+++ +|...+.. .++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 47999999965 67766643 3788999999999999999999999 99999999999999999999999999975
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 173 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 173 ACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred cccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 44322 22345789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.79 Aligned_cols=205 Identities=29% Similarity=0.504 Sum_probs=187.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
......|.+.+.||+|.|++|.++++ .+..||||++.+.......++.+.+|+++|+.++|||||+++.+.+....+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 44457899999999999999999987 6788999999988887777778999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+.++.+++++.++.. ..+..+..++.|++.+++|||+++ |||||||++||||+.+-++||+|||++..+..
T Consensus 132 lV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecc-
Confidence 99999999999999988764 556899999999999999999999 99999999999999999999999999988764
Q ss_pred ccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....+.+|++.|.|||++.+..| ...+|+||+|+++|.|+.|.+||++.+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 345567899999999999999988 568999999999999999999999654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=289.94 Aligned_cols=205 Identities=24% Similarity=0.436 Sum_probs=175.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..++|++.+.||+|+||.||++.+. +..||+|.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 3468999999999999999999753 4469999987643 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++......+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999999999876667899999999999999999999999 99999999999999999999999998765332
Q ss_pred Cc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 21 11122345678999999999999999999999999999875 9999986653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=295.75 Aligned_cols=205 Identities=30% Similarity=0.528 Sum_probs=173.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc------------------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCce
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnI 564 (716)
...+|.+.++||+|+||.||+|.+. +..||+|++.... .......+.+|+.+|..++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 3468999999999999999999752 2259999987543 34456678899999999999999
Q ss_pred eEEeceeccCCceEEEEeecCCCCHHHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 005054 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT------------------TKLDWRRRILMALDIARGVSYLHHCNPPI 626 (716)
Q Consensus 565 v~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~I 626 (716)
+++++++...+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--F 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 999999999999999999999999999986532 23677889999999999999999999 9
Q ss_pred EEcCCCCCcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CC
Q 005054 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EK 702 (716)
Q Consensus 627 vHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt--G~ 702 (716)
+||||||+|||++.++.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999987543322 11223356789999999998899999999999999999986 67
Q ss_pred CCCCCCCc
Q 005054 703 IPWDNLNS 710 (716)
Q Consensus 703 ~PF~~~~~ 710 (716)
.||...+.
T Consensus 240 ~p~~~~~~ 247 (304)
T cd05096 240 QPYGELTD 247 (304)
T ss_pred CCCCcCCH
Confidence 89986553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=299.81 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=177.3
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
+..++|++.++||+|+||.||++.+. +..+|+|++.... .......+.+|+++|+.++||||+++++++..++.+|+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 44578999999999999999999984 5678999887643 34456678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||+++++|.+++.+. ..+++..+..++.||+.+|.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999999764 3588999999999999999999974 6 999999999999999999999999998755432
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 M--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred c--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 2 224478999999999999999999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=307.17 Aligned_cols=195 Identities=24% Similarity=0.373 Sum_probs=169.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
+...+|++.+.||+|+||.||++.+ .++.||+|.... ..+.+|+.+|+.++||||++++++|......|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 3456899999999999999999987 466799996432 345689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC-
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET- 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~- 658 (716)
|||++ +++|..++... ..+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++......
T Consensus 161 v~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 99999 46898888664 45899999999999999999999999 999999999999999999999999998753321
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
........||+.|+|||++.+..++.++|||||||++|+|++|..||-..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 12223457999999999999999999999999999999999999887544
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=297.26 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=174.1
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|.+.++||+|+||.||++++ .+..||+|.++..... .....+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 6799999999999999999987 4667999998754322 222356679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++ +|..++......++...++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 9965 898888776667899999999999999999999999 9999999999999999999999999987654433333
Q ss_pred ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 34568999999999865 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=312.60 Aligned_cols=202 Identities=22% Similarity=0.360 Sum_probs=175.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc---CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
..|.+.+.||+|+||.||++... +..|++|.+.... ......+.+|+.+|+.++|||||++++++...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45999999999999999999863 4568888765432 344456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 582 EFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||+++++|.+++... ..++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999999888542 346889999999999999999999998 999999999999999999999999999865433
Q ss_pred cc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 23345799999999999999999999999999999999999999986653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=299.20 Aligned_cols=202 Identities=26% Similarity=0.389 Sum_probs=179.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.+.|..-++||+|+||.||-|+. +|+.||+|.+.+..... .......+|..||++++.+.||.+-.+|+..+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 46788889999999999998864 78889999887665533 3345667899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 581 TEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
|..|.||+|.-+|-+.+ ..|++..++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+|+|+|+|+|.......
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999988886644 45999999999999999999999998 9999999999999999999999999999877654
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
... ..+||.+|||||++.+..|+...|+|||||++|+|+.|+.||...
T Consensus 342 ~~~-~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 342 PIR-GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred ccc-cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 333 448999999999999999999999999999999999999999753
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=325.40 Aligned_cols=214 Identities=27% Similarity=0.455 Sum_probs=179.2
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-- 573 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-- 573 (716)
.+.+...++|+++++||.|+||.||++.+. +..||+|++............+..|+.+|+.|.|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344666789999999999999999999884 5569999998776666667788999999999999999999998854
Q ss_pred CCceEEEEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEEcCCCCCcEEEcc-----
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN-----PPIIHRDLKSSNLLVDK----- 640 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~-----~~IvHrDIKp~NILl~~----- 640 (716)
...+|||||||++++|.++|... ...+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 45689999999999999999753 246999999999999999999999843 34999999999999964
Q ss_pred ------------CCcEEEEecCCCcccccCccccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 641 ------------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 641 ------------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||||||+|++|..||.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 23489999999976543322 234579999999999864 457889999999999999999999998
Q ss_pred CCCccc
Q 005054 707 NLNSMQ 712 (716)
Q Consensus 707 ~~~~l~ 712 (716)
..+.+.
T Consensus 245 ~~~~~~ 250 (1021)
T PTZ00266 245 KANNFS 250 (1021)
T ss_pred cCCcHH
Confidence 765543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.50 Aligned_cols=202 Identities=29% Similarity=0.415 Sum_probs=173.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------ 574 (716)
..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999987 467799999876554445556778899999999999999999987643
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+|+||||+++ +|...+.. .++...++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999955 78777753 3788999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 176 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 231 (364)
T cd07875 176 AGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231 (364)
T ss_pred cCCCCc-ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 544322 23457899999999999999999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=301.41 Aligned_cols=197 Identities=23% Similarity=0.372 Sum_probs=170.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
+...+|++++.||+|+||.||++... +..|++|.+.... ...+|+.+|+.++||||+++++++.....+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34568999999999999999999763 3468889876432 245799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+|||++. ++|..++.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999994 689888844 456999999999999999999999999 99999999999999999999999999876543
Q ss_pred Ccc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 321 2234579999999999999999999999999999999999999997654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.06 Aligned_cols=200 Identities=32% Similarity=0.532 Sum_probs=179.7
Q ss_pred eeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
.+.||.|.||+||-+.+ .|+.||||++.+.....+....+++|+.||+++.||.||.+...|+..+.+++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999976 6889999999998887777788999999999999999999999999999999999999775
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC---CcEEEEecCCCcccccCcccccc
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHETYLTTKT 664 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~ 664 (716)
-|.-+|.....++++...+.++.||+.||.|||-++ |+|+||||+|||+... -++||||||+|+......... .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr-s 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR-S 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh-h
Confidence 566666666678999999999999999999999999 9999999999999653 469999999999988765443 5
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 665 ~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.+|||.|+|||++.++.|+..-|+||+|+|+|--+.|..||.....+.
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh
Confidence 689999999999999999999999999999999999999998766543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=305.21 Aligned_cols=209 Identities=27% Similarity=0.494 Sum_probs=175.9
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEece
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~ 570 (716)
.|....++|++.+.||+|+||.||++.+. ...||||+++.... ......+.+|+.+++.+ +|+|||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 34556679999999999999999999752 23699999876543 34456788899999999 89999999999
Q ss_pred eccCCceEEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 005054 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (716)
Q Consensus 571 ~~~~~~~~lVmE~~~ggsL~~~l~~~~----------------------------------------------------- 597 (716)
+...+.+|+|||||++++|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999986431
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 598 ----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 598 ----------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
.++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24678889999999999999999999 99999999999999999999999999875443221
Q ss_pred -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 661 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 661 -~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 1112235678999999999999999999999999999997 9999986543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.22 Aligned_cols=213 Identities=35% Similarity=0.575 Sum_probs=187.6
Q ss_pred ccccchhcccceeEeeeeecCCcEEEEEEEEcC-----Ce-EEEEEeec-cCCCHHHHHHHHHHHHHHHhcCCCceeEEe
Q 005054 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SD-VAVKVFSR-QEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568 (716)
Q Consensus 496 ~~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~-vAvK~~~~-~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~ 568 (716)
....|++..++..+.++||+|+||.||+|...- .. ||||..+. .....+.+.++.+|.++|++++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 345788888999999999999999999998632 13 89998886 335678889999999999999999999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEe
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~D 648 (716)
|+......++||||+|.||+|.++|++....++..+...++.+.+.||+|||+++ +|||||-..|+|++.++.+||+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999998777999999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCccccc-cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 649 FGLSRLKHETYLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 649 FGla~~~~~~~~~~~-~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
||+++... .+.... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+...-
T Consensus 306 FGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 306 FGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred cccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence 99987654 222222 2234679999999999999999999999999999999 89999987754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.41 Aligned_cols=208 Identities=24% Similarity=0.376 Sum_probs=189.4
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcCCe--EEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~--vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
....+++++..||-|+||.|-++..++.. +|+|++++... ..++..-+..|-.||..+..|.||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34567888899999999999999987776 89999887654 4556677788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
++||-|-||.|+.+|..++ .|.....+.++..+++|++|||++| ||+|||||+|+|++.+|-+||.|||+|+.....
T Consensus 497 mLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999998754 6999999999999999999999999 999999999999999999999999999988765
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
. .+-++||||.|.|||++.+..++.++|+|+||+++||||+|.+||.+.++|.-
T Consensus 574 ~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 574 R-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT 627 (732)
T ss_pred C-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 4 44578999999999999999999999999999999999999999999999864
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=281.77 Aligned_cols=203 Identities=31% Similarity=0.479 Sum_probs=181.7
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|.+.+.||+|++|.||++.. .+..|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 488899999999999999987 567899999887666666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
+++++|.+++... ...++...++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999999764 456899999999999999999999998 9999999999999999999999999988665544333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 206 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 455789999999999999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.00 Aligned_cols=207 Identities=30% Similarity=0.496 Sum_probs=186.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEcCCe--EEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~~~--vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+.|+|+..||.|+||+||++..+... .|.|++... ..+.+..+.-|+.||..++||+||++++.|...+.++|+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 45788899999999999999876443 566776543 35667888899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||.||-+..++-.-+..+.+.++..+.+|++.||.|||+++ |||||||+.|||++.+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999999888889999999999999999999999999 9999999999999999999999999988766655666
Q ss_pred ccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 663 KTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
..++|||+|||||+++ ..+|++++||||||++|.+|..+.+|-...++|..+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll 245 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 245 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH
Confidence 7889999999999975 5689999999999999999999999999999987754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=301.19 Aligned_cols=201 Identities=29% Similarity=0.424 Sum_probs=173.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------ 574 (716)
..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457999999999999999999987 467899999876655555567788899999999999999999988643
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
...|+||||+++ +|...+.. .++...++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 347999999965 77777653 3888999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 169 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 223 (355)
T cd07874 169 AGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_pred CCCccc-cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 544322 2345789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=285.73 Aligned_cols=199 Identities=36% Similarity=0.586 Sum_probs=177.2
Q ss_pred eeEeeeeecCCcEEEEEEEEcCC--eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|++++.||+|+||+||++...+. .||+|++..............+|+.+++.++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999999544 6999999887655554445566999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccccc
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (716)
.+++|.+++.+ ...+++..++.++.||+.+|.+||+++ |+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999984 346899999999999999999999999 999999999999999999999999998764333334446
Q ss_pred CCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 665 GKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 665 ~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
..+++.|+|||++. +..++.++||||||+++|+|++|..||...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 67899999999998 888899999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.64 Aligned_cols=203 Identities=27% Similarity=0.430 Sum_probs=172.8
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----ceE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~-----~~~ 578 (716)
+|++.++||+|+||.||++.+ .++.||||.+............+.+|+.+|+.++||||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 5778999998654433444567889999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+. ++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999995 5888887653 46899999999999999999999999 999999999999999999999999998764432
Q ss_pred c-cccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 659 Y-LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 659 ~-~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...++.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 1 122234679999999999875 47889999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=320.88 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=174.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.++||+|+||.||+|.+ .++.||||+++.... ......++.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5899999999999999999987 467899999876433 2345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 582 EFLPRGSLFRLLQRN----------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 582 E~~~ggsL~~~l~~~----------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
||++|++|.+++... ...++...++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999998642 123456778899999999999999999 99999999999999999999999999
Q ss_pred CcccccC------------------ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 652 SRLKHET------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 8755211 011122469999999999999999999999999999999999999997644
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.60 Aligned_cols=206 Identities=23% Similarity=0.357 Sum_probs=179.5
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+.+....|+++++||.||.+.||++... .+.||+|.+.....+++.+.-+.+|+.+|.+| .|.+||++|+|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3556788999999999999999999874 45688888887777888899999999999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
||||||- ..+|..+|++....++...++.+..||+.++.++|++| |||.||||.|||+- .|.+||+|||+|.....
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9999987 55999999988777776789999999999999999999 99999999999996 46999999999986554
Q ss_pred C--ccccccCCCCCCccCcccccCCC-----------CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 T--YLTTKTGKGTPQWMAPEVLRNEP-----------SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~--~~~~~~~~Gt~~Y~aPE~~~~~~-----------~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+ .......+||+.||+||.+.... .++++||||||||||+|+.|+.||....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 3 33445668999999999985433 3568999999999999999999998654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.04 Aligned_cols=195 Identities=28% Similarity=0.444 Sum_probs=165.0
Q ss_pred eecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc---CCCceeEEeceeccCCceEEEEeecCC
Q 005054 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 513 LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l---~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
||+|+||+||++.+ .+..||||++.+... ..........|..++..+ .||||++++.++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 467899999875432 222334445566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999998764 46899999999999999999999999 99999999999999999999999999876443333344567
Q ss_pred CCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 99999999998765 478899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.00 Aligned_cols=208 Identities=29% Similarity=0.476 Sum_probs=175.1
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE-------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEece
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~ 570 (716)
.+.+..++|++.+.||+|+||.||+|.+ .+..||||+++.... ......+.+|+.+|..+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 3455567899999999999999999974 234699999875433 23346788899999999 89999999999
Q ss_pred eccCCceEEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 005054 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (716)
Q Consensus 571 ~~~~~~~~lVmE~~~ggsL~~~l~~~~----------------------------------------------------- 597 (716)
+...+..++|||||++|+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999986432
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 598 ---------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 598 ---------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 14678889999999999999999999 9999999999999999999999999987654
Q ss_pred cCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 657 ETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 657 ~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
.... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 3221 1112345678999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.56 Aligned_cols=194 Identities=24% Similarity=0.466 Sum_probs=169.8
Q ss_pred eeeecCCcEEEEEEEEcCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceecc----CCceEEEEeecC
Q 005054 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIVTEFLP 585 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----~~~~~lVmE~~~ 585 (716)
..||+|+++.||+|.+.++.||||.++..... ....+.+.+|+.+|++++||||+++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 57899999999999999999999999765443 3445778899999999999999999999876 356899999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccccc
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (716)
+|+|.+++.+. ..+++...+.++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++....... ..
T Consensus 106 ~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 99999999764 4688999999999999999999984 7 8999999999999999999999999987644322 23
Q ss_pred CCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 665 GKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 665 ~~Gt~~Y~aPE~~~~--~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 468999999999976 6789999999999999999999999987754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=285.96 Aligned_cols=201 Identities=24% Similarity=0.374 Sum_probs=173.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.|++.+.||+|+||.||++.+ .++.||||.+...... ......+.+|+.+++.++|++|+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999988 4668999998765433 2334556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999988543 345899999999999999999999999 99999999999999999999999999876543222
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 223478999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=285.29 Aligned_cols=193 Identities=24% Similarity=0.414 Sum_probs=166.4
Q ss_pred eecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 513 LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
||+|+||.||++.. .++.||+|.+....... .....+..|+.+++.++||||+++++++.....+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999987 47789999987544322 2233456699999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCC
Q 005054 590 FRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668 (716)
Q Consensus 590 ~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt 668 (716)
..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 9888653 345889999999999999999999999 9999999999999999999999999987654432 22244689
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 669 ~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.15 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=171.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------ 574 (716)
+.++|.+.+.||.|+||.||++.+ .+..||||++............+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 357899999999999999999987 456799999876543334456677899999999999999999987543
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+|++|+++ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 3579999998 7799988864 35999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 5442 224478999999999977 5678899999999999999999999987554
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.07 Aligned_cols=205 Identities=27% Similarity=0.469 Sum_probs=178.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC------CHHHHHHHHHHHHHHHhc-CCCceeEEecee
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY------SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~ 571 (716)
+-.+..|.-.+.||.|..+.|..|.. .+..+|+|++..... ....++.-.+|+.||+++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 44567899999999999999999876 567899998854221 234566677899999998 799999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
+.+..+++|+|.|+.|.|++++...- .++++....|++||+++++|||.++ ||||||||+|||++++.+|||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999997643 5899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
++...... .....||||+|+|||.+.. ..|+...|+|++|+|||.|+.|.+||....
T Consensus 170 a~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 170 ACQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred eeccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 99876653 4446799999999999853 346778999999999999999999998654
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=285.38 Aligned_cols=202 Identities=23% Similarity=0.343 Sum_probs=174.6
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.|++.+.||.|+||+||++.+ .++.||+|++....... .....+.+|+.+|+.++|+||+.+++++...+.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999988 46789999987654432 234556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+++++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999999888653 346999999999999999999999999 99999999999999999999999999875433221
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 2244789999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=281.23 Aligned_cols=202 Identities=34% Similarity=0.597 Sum_probs=174.6
Q ss_pred cceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
++|++.+.||+|+||.||++.+.. ..+++|.+....... ..+.+|+.+|+.++||||+++++++.....+|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccH---HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 578999999999999999998854 479999877554332 4577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc-c
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-T 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 662 (716)
+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999999765556899999999999999999999999 999999999999999999999999998765432221 1
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 22235668999999998889999999999999999999 99999876643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=287.79 Aligned_cols=201 Identities=31% Similarity=0.388 Sum_probs=166.2
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeceecc-----CC
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS-----PQ 575 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l---~hpnIv~~~~~~~~-----~~ 575 (716)
+|++.+.||+|+||.||++.+ .++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999987 466799999876433322223345566666655 79999999998764 34
Q ss_pred ceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+++||||+.+ +|..++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999964 8988887643 45899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|++||.....
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 158 YSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred ccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 54332 22234689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=280.87 Aligned_cols=204 Identities=35% Similarity=0.522 Sum_probs=180.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++.+.||.|+||.||++.. .+..+++|++...... ....+.+|+.+++.++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36899999999999999999987 4567999998765432 4577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++......+++..++.++.|++.+|.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999876567999999999999999999999999 999999999999999999999999998765543333
Q ss_pred cccCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~---~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....++..|++||.+.+. .++.++|+|||||++|+|++|..||...++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~ 210 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM 210 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 3445788999999999877 7889999999999999999999999876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.57 Aligned_cols=200 Identities=33% Similarity=0.566 Sum_probs=174.6
Q ss_pred eEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC--CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc--eEEEE
Q 005054 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR--LCIVT 581 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~--~~lVm 581 (716)
+...+||+|+|-+||+|.+. |-.||.-.++..+. .+..++++..|+.+|+.|+||||++||+.|.+... +.+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44568999999999999884 55566554444333 45667899999999999999999999999998766 78899
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCCcccccCcc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~ 660 (716)
|++..|+|..|+++.+ .++.+.++.|++||++||.|||++.++|||||||.+||+|+. .|.|||+|+|+|+.......
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999998864 589999999999999999999999999999999999999974 58999999999998877655
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.. .+|||.|||||++. ..|+..+||||||++|+||.|+.+||....+-
T Consensus 202 ks--vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~ 249 (632)
T KOG0584|consen 202 KS--VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP 249 (632)
T ss_pred ce--eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH
Confidence 43 68999999999998 77999999999999999999999999865543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=315.34 Aligned_cols=215 Identities=33% Similarity=0.584 Sum_probs=186.9
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEec
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~ 569 (716)
....++...+.+..+.||+|.||+||++...+ .-||||.++... ..+..++|++|+.+|..++|||||++++
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34456777889999999999999999997632 249999987654 4557889999999999999999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcE
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT-------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~-------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NI 636 (716)
++..++.+|||+|||..|+|.+||..+. .+++..+.+.|+.||+.||.||-++. +|||||-..|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC 634 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence 9999999999999999999999996431 23889999999999999999999988 99999999999
Q ss_pred EEccCCcEEEEecCCCcccccC-ccccc-cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 005054 637 LVDKHWTVKVGDFGLSRLKHET-YLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQD 713 (716)
Q Consensus 637 Ll~~~~~vkL~DFGla~~~~~~-~~~~~-~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~ 713 (716)
||+++..|||+|||+++..... ++... ...-..+||+||.++...++.++||||+||+|||+++ |+.||.++.+-|+
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 9999999999999999865433 33222 2345679999999999999999999999999999999 9999999988776
Q ss_pred c
Q 005054 714 S 714 (716)
Q Consensus 714 ~ 714 (716)
|
T Consensus 715 I 715 (774)
T KOG1026|consen 715 I 715 (774)
T ss_pred H
Confidence 4
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=286.89 Aligned_cols=204 Identities=32% Similarity=0.521 Sum_probs=177.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+.|+++++||.|+||.||++.. .+..|++|++... .......+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 46799999999999999999987 4567999998654 3445677888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|..++.+....+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999999999988766667999999999999999999999998 999999999999999999999999998764443333
Q ss_pred cccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||...++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 221 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH
Confidence 33456889999999985 344678999999999999999999999876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=299.95 Aligned_cols=209 Identities=29% Similarity=0.505 Sum_probs=177.1
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~ 569 (716)
..|+...++|.++++||+|+||.||+|.+.+ ..||||+++... .....+.+.+|+.+|+.+. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4566777899999999999999999998632 259999986543 3444567889999999996 999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcC----------------------------------------------------
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------------------------------------------- 597 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------------------------------------------- 597 (716)
++.....+|||||||++|+|.+++.++.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999886531
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCC
Q 005054 598 -------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (716)
Q Consensus 598 -------------------------------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~ 634 (716)
..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~ 266 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR 266 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence 23677888999999999999999998 999999999
Q ss_pred cEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 635 NLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|||++.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 9999999999999999987643321 12223356788999999999999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=287.66 Aligned_cols=203 Identities=26% Similarity=0.407 Sum_probs=174.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|.+.+.||.|+||.||++.+ .+..||+|.++...... ....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 36899999999999999999987 46789999987543221 2345667999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||++ ++|..++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9996 5999998876667899999999999999999999999 999999999999999999999999998765443333
Q ss_pred cccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3344678999999998764 478899999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=285.17 Aligned_cols=202 Identities=31% Similarity=0.417 Sum_probs=173.1
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||.|++|.||++.. .+..|+||+++...........+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 467899999876543333445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 584 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 584 ~~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
++ ++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 96 58988886533 56899999999999999999999999 999999999999999999999999998765443333
Q ss_pred cccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3344678999999998754 468899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=284.58 Aligned_cols=204 Identities=34% Similarity=0.612 Sum_probs=175.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
.++|++.+.||+|+||.||++...+ ..|++|.++... .......+.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 4689999999999999999998743 348999886543 34556678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 577 LCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
.|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.+
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEG 160 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCC
Confidence 999999999999999997642 35788899999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 642 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999987543321 12233456889999999998899999999999999999998 9999987553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=306.53 Aligned_cols=202 Identities=27% Similarity=0.437 Sum_probs=173.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC------ce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------RL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~------~~ 577 (716)
-|...+.||+|+||.||+++. .|+.||||.++... .....+...+|+++|++++|+|||+++++-+... ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 355667899999999999986 68889999998754 3344677889999999999999999999876544 45
Q ss_pred EEEEeecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc--cCCc--EEEEecCC
Q 005054 578 CIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWT--VKVGDFGL 651 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~--~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~--~~~~--vkL~DFGl 651 (716)
.+|||||.||+|+..|.+. -..+++..++.++.+++.||.|||++| ||||||||.||++- .+|+ .||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 8999999999999999763 245999999999999999999999999 99999999999984 3343 79999999
Q ss_pred CcccccCccccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
|+...+.. .....+||+.|++||++. ...|+..+|.|||||++|++.||..||......
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99877665 556779999999999998 488888999999999999999999999876544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=282.76 Aligned_cols=208 Identities=35% Similarity=0.584 Sum_probs=175.1
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
|++..++|++.+.||+|+||.||++.+.+ ..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 45567899999999999999999997643 459999876533 2334556888999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~---------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
.....++||||+++++|.+++.+.. ..++...++.++.|++.+|.|||+++ ++|+||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 9999999999999999999996532 23567889999999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccCccc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 644 VKVGDFGLSRLKHETYLT--TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 644 vkL~DFGla~~~~~~~~~--~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
++|+|||++......... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999998754332211 112345788999999999999999999999999999999 7899987653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=279.73 Aligned_cols=202 Identities=27% Similarity=0.463 Sum_probs=177.2
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||+++. .++.||||.++.... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999987 577899998865432 4455667888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988853 3345889999999999999999999999 999999999999999999999999998866544
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 33333457899999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=276.04 Aligned_cols=202 Identities=29% Similarity=0.474 Sum_probs=176.8
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-CCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-~~~~~lVmE 582 (716)
.|++.+.||.|++|.||++.. .++.|++|.+............+.+|+.+++.++|+||+++++.+.. ...+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 489999999999999999987 45679999987766555566778899999999999999999988764 446899999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+++++|.+++... ...+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999999764 345899999999999999999999999 999999999999999999999999998765443333
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 345568999999999999999999999999999999999999998655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=279.94 Aligned_cols=206 Identities=33% Similarity=0.592 Sum_probs=176.8
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|++..++|++.++||+|+||.||++... +..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 3556789999999999999999999874 45699998765432 2467888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++|||+++++|.+++... ...+++..++.++.||+.+|.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999999753 356888999999999999999999998 99999999999999999999999999986544
Q ss_pred Cccc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~-~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 3211 122345678999999998889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=289.44 Aligned_cols=202 Identities=29% Similarity=0.533 Sum_probs=172.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+|++.+.||+|+||.||+|.+ .+. .||+|+++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46799999999999999999986 233 38999986432 344556788999999999999999999998764 57
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++|+||+++|+|.+++......++...++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccccC
Confidence 8999999999999999887667899999999999999999999999 99999999999999999999999999986543
Q ss_pred Ccc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 658 ~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
... ......++..|++||++.+..++.++|||||||++|+|++ |..||....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 222 1122234678999999999999999999999999999997 999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=279.08 Aligned_cols=202 Identities=34% Similarity=0.608 Sum_probs=174.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCC-eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.++|++.+.||+|+||.||++.+.+. .||+|.++...... ..+.+|+.+++.++||||+++++++.....+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccH---HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 35799999999999999999987554 59999887544332 457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-c
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (716)
|+.+++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999999876667899999999999999999999999 99999999999999999999999999876543321 1
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.....++..|++||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 112245678999999998889999999999999999998 9999986653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=278.95 Aligned_cols=204 Identities=34% Similarity=0.560 Sum_probs=176.7
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC---HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
+.|++.+.||+|++|.||++.. .+.+|++|++...... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5689999999999999999986 5678999998754332 2234678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999999764 45889999999999999999999999 9999999999999999999999999987543321
Q ss_pred ccc---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 660 LTT---KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 660 ~~~---~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 213 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH
Confidence 111 2345788999999999999999999999999999999999999876554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=278.12 Aligned_cols=201 Identities=28% Similarity=0.468 Sum_probs=177.0
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.++||.|+||.||++.+ .+..|++|.++.... ....+.+.+|+.+++.++|+||+++++.+...+.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999987 467799999875432 33456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999999988653 345889999999999999999999999 9999999999999999999999999987665443333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 34578999999999999999999999999999999999999998655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=284.67 Aligned_cols=199 Identities=28% Similarity=0.378 Sum_probs=171.8
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||+|+||.||++.+ .+..|++|.++...........+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999988 577899999876544333345667899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
++ ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 5888888766667999999999999999999999999 99999999999999999999999999876544333333
Q ss_pred cCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 664 TGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
...+++.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 456789999999987754 68899999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=276.62 Aligned_cols=203 Identities=27% Similarity=0.441 Sum_probs=180.6
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||.|+||.||.+.. .+..+++|.+............+.+|+.++++++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999988876 567899999887666666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
+++++|.+++.+. ...+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999765 456899999999999999999999999 9999999999999999999999999987655443233
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 445789999999999988888999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=282.86 Aligned_cols=200 Identities=27% Similarity=0.485 Sum_probs=178.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++.+ .++.||+|+++.... .......+.+|+.+++++.||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999987 467899999876543 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++.+. ..+++..++.++.||+.+|.|||+++ |+|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999765 46899999999999999999999999 999999999999999999999999998866544
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....|++.|++||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 203 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2344689999999999988889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=276.69 Aligned_cols=207 Identities=28% Similarity=0.413 Sum_probs=185.7
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhc-CCCceeEEeceecc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~ 573 (716)
..+.....+|.++.+||+|+|.+|.+++.. .+-||+|+++++...+ +.+.-.+.|..++.+. +||.+|-+..+|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 445566789999999999999999999874 4469999998876543 4455566778888777 79999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
...+++|.||++||+|.-++++. ++++++.+..+..+|+.||.|||++| ||+||||.+|+|++..|++||.|+|+.+
T Consensus 323 esrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhh
Confidence 99999999999999998888764 46999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
....+...+.+++|||.|.|||++.|..|....|+|+||++|+||+.|+.||+-
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 877777778899999999999999999999999999999999999999999983
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=280.34 Aligned_cols=203 Identities=30% Similarity=0.463 Sum_probs=174.4
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++.+.||+|+||.||++.. .+..|++|++..... .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46799999999999999999987 566799999875432 22346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999998754 46899999999999999999999998 999999999999999999999999998865433333
Q ss_pred cccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....|++.|+|||.+. ...++.++|+|||||++|+|++|..||...++.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 33456889999999885 344678999999999999999999999765543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=284.40 Aligned_cols=204 Identities=32% Similarity=0.507 Sum_probs=178.6
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++.+.||.|+||.||++.+ .+..|++|+++.. .......+..|+.+++.++||||+++++++..+..+|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35799999999999999999987 4677999998654 2444567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++.+....+++..++.++.|++.+|.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999876667999999999999999999999999 999999999999999999999999998765444333
Q ss_pred cccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....|++.|++||++. +..++.++|+|||||++|+|++|+.||...+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~ 214 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH
Confidence 34557899999999975 344677999999999999999999999877644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=293.92 Aligned_cols=207 Identities=29% Similarity=0.522 Sum_probs=173.5
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEecee
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~ 571 (716)
|++..++|++.+.||+|+||.||+|... ++.||+|+++... .......+..|+.+++++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 5566789999999999999999999642 3569999987543 233456677899999999 899999999987
Q ss_pred cc-CCceEEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 005054 572 TS-PQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (716)
Q Consensus 572 ~~-~~~~~lVmE~~~ggsL~~~l~~~~----------------------------------------------------- 597 (716)
.. ...++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 456899999999999999986422
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--cccccCCCC
Q 005054 598 -------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGT 668 (716)
Q Consensus 598 -------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt 668 (716)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999998 9999999999999999999999999997643221 122234567
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 669 ~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 78999999999999999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-30 Score=292.24 Aligned_cols=192 Identities=27% Similarity=0.379 Sum_probs=166.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
...|.+.+.||+|+||.||++.+. +..||||.... ..+.+|+.+|++++|+|||++++++...+..|+||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999984 56799996322 23467999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
|++ .++|..++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999 56999998776667999999999999999999999999 99999999999999999999999999976533211
Q ss_pred -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 661 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 661 -~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
......||+.|+|||++.+..++.++|||||||+||||++|..|+-
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 1223469999999999999999999999999999999999876543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=277.85 Aligned_cols=206 Identities=34% Similarity=0.564 Sum_probs=176.4
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|++..++|++.+.||+|+||.||++.+. +..|++|.++..... ...+.+|+.++++++||||+++++++...+..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 3456678999999999999999999874 456999998764432 355778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+||||+++++|.+++.... ..+++..+..++.|++.+|.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999999997643 46899999999999999999999999 99999999999999999999999999876553
Q ss_pred Cccc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~-~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.... ......+..|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 3211 111223457999999999999999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=281.59 Aligned_cols=202 Identities=31% Similarity=0.474 Sum_probs=175.4
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|.+.+.||+|+||.||++.+ .++.|++|+++.... .....+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35789999999999999999987 467899999876532 23356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++... ..+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 999999999998764 46899999999999999999999999 999999999999999999999999998765444333
Q ss_pred cccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....|++.|+|||++. +..++.++|+|||||++|+|++|..||....+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 34557899999999974 45578899999999999999999999976544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=300.96 Aligned_cols=199 Identities=33% Similarity=0.525 Sum_probs=174.8
Q ss_pred eeeecCCcEEEEEEEEcCC--eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCC
Q 005054 511 EQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggs 588 (716)
-+||+|.||+||-|++..+ +.|||-+.... ....+-+..|+.+.+.|+|.|||++++.+..++.+-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 4799999999999998655 46778765433 3445778899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-cCCcEEEEecCCCcccccCccccccC
Q 005054 589 LFRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTG 665 (716)
Q Consensus 589 L~~~l~~~~~~l--~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (716)
|..++...=.++ .+..+-.+.+||++||.|||.+. |||||||-+||||+ -.|.+||+|||.++....-...+.++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999998776667 78889999999999999999999 99999999999997 46899999999998876655667788
Q ss_pred CCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 666 KGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 666 ~Gt~~Y~aPE~~~~~~--~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
.||..|||||++..++ |+.++|||||||++.||.||++||..+..-|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 9999999999997654 78899999999999999999999998776553
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=284.48 Aligned_cols=199 Identities=26% Similarity=0.426 Sum_probs=175.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||+|+||.||++.+. +..|++|.++.. ........+.+|+++++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36999999999999999999874 566888887654 234556678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+++++|.+++.+. ..+++..+..++.||+.+|.|||+ ++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999765 468999999999999999999997 57 9999999999999999999999999987654332
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....|++.|++||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 234578999999999988889999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=280.42 Aligned_cols=195 Identities=33% Similarity=0.496 Sum_probs=171.2
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||+|+||.||++.+ .+..||+|++.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999987 56779999987643 34445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|..+. .+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++....... .
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--A 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--c
Confidence 99999986542 3788899999999999999999999 9999999999999999999999999987654432 2
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....|+..|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 24578999999999999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=281.40 Aligned_cols=203 Identities=26% Similarity=0.371 Sum_probs=174.8
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||+|+||.||++.+. ++.|++|++............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999884 6789999987654333334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|++++.|..++.. ...+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9998888777654 346899999999999999999999998 9999999999999999999999999998765443233
Q ss_pred ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....++..|++||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 34467889999999876 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=278.10 Aligned_cols=203 Identities=35% Similarity=0.570 Sum_probs=175.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
.++|++.+.||+|+||.||+|.+. ...|+||+++... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 367999999999999999999873 2368999886543 3445567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999999876667999999999999999999999998 999999999999999999999999999876422
Q ss_pred --ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 659 --YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 659 --~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
........+++.|++||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 112222345678999999999889999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=277.30 Aligned_cols=205 Identities=34% Similarity=0.606 Sum_probs=175.7
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|++..++|++.++||.|+||.||++.. .++.||+|.+....... ..+.+|+.+++.++|+||+++++++. .+..|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 467778999999999999999999987 55789999987655433 46778999999999999999999874 56789
Q ss_pred EEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++|||+.+++|.+++... ...+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999998653 346889999999999999999999998 99999999999999999999999999876552
Q ss_pred C-ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 T-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
. ........++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 2 222223346778999999998889999999999999999998 9999986653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=290.69 Aligned_cols=192 Identities=25% Similarity=0.400 Sum_probs=165.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
...|++++.||+|+||.||+|.+. +..||+|+..... ...|+.+++.++||||+++++++......|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 357999999999999999999984 4579999754322 245899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|++ .++|..++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++....... .
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 212 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-A 212 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc-c
Confidence 999 45899998877778999999999999999999999999 9999999999999999999999999987543322 2
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK-IPWDN 707 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~-~PF~~ 707 (716)
.....||+.|+|||++.+..++.++|||||||++|+|+++. .+|..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 22456899999999999999999999999999999999854 44443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=283.52 Aligned_cols=203 Identities=30% Similarity=0.468 Sum_probs=177.8
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
....+|++.+.||+|+||.||++.+ .+..|++|.+....... ...+.+|+.+++.+.|+||+++++.+......|+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 3457899999999999999999986 56789999987655432 3567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred eecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999999998653 4889999999999999999999999 9999999999999999999999999987654333
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 233345789999999999988889999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=277.36 Aligned_cols=201 Identities=34% Similarity=0.612 Sum_probs=173.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
.+|++.+.||+|+||.||++.+.. ..+++|++....... ..+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 468899999999999999998754 479999987544333 3567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc-
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 662 (716)
+++++|.+++......+++..++.++.||+.+|.|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999999876667899999999999999999999999 9999999999999999999999999987654332211
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...++
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 11223457999999999999999999999999999999 8999986553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=284.54 Aligned_cols=208 Identities=33% Similarity=0.598 Sum_probs=176.2
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC---------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~ 568 (716)
.+++..++|.+.+.||+|+||.||++.+.+ ..||+|+++... .......+.+|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 566777899999999999999999997532 359999987643 334456788899999999 799999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
+++...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 99999999999999999999999997642 24788999999999999999999998 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+|||++.++.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999999999875543211 1112234578999999999989999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=280.38 Aligned_cols=206 Identities=33% Similarity=0.588 Sum_probs=178.5
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
+....+|++.++||.|+||.||++.+. +..+++|++..... .....+..|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 344567999999999999999999874 56799999876542 234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999999763 345899999999999999999999999 999999999999999999999999999766544
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
........++..|++||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 333334456778999999998889999999999999999998 8999987654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=286.43 Aligned_cols=193 Identities=27% Similarity=0.423 Sum_probs=159.5
Q ss_pred eeeeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCceEEEEee
Q 005054 510 GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVTEF 583 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~~~lVmE~ 583 (716)
+++||+|+||.||+|.+. +..||+|.+...... ..+.+|+.+|+.++||||+++++++.. ...+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999863 456999998765432 345679999999999999999998854 4568999999
Q ss_pred cCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE----ccCCcEEEEecCC
Q 005054 584 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (716)
Q Consensus 584 ~~ggsL~~~l~~~--------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGl 651 (716)
+. ++|..++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 94 5888887532 235889999999999999999999999 9999999999999 4567899999999
Q ss_pred CcccccCc---cccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 652 SRLKHETY---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 97654322 122345789999999999874 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=279.77 Aligned_cols=204 Identities=30% Similarity=0.542 Sum_probs=173.4
Q ss_pred ccceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+|++.+.||+|+||.||+|.. .+..|++|.++... .......+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 46799999999999999999974 34569999887543 344456788899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 578 CIVTEFLPRGSLFRLLQRNT----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~----------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
|+||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ |+|+||||+|||++.+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~ 160 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC
Confidence 99999999999999985321 24788889999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 642 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...++
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999997653321 12223345778999999998889999999999999999998 9999977553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=275.73 Aligned_cols=203 Identities=33% Similarity=0.564 Sum_probs=173.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC---CHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--Cce
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~ 577 (716)
.+|++.+.||+|+||.||++.+ .+..|+||++..... .......+.+|+.+++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999987 467899998864322 234567888999999999999999999988764 468
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++||||+++++|.+++.+. ..+++..++.++.||+.+|.|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999999764 35889999999999999999999999 99999999999999999999999999875432
Q ss_pred Cc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 214 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch
Confidence 11 112234688999999999988899999999999999999999999986543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=282.04 Aligned_cols=203 Identities=30% Similarity=0.484 Sum_probs=178.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
...+|.+.+.||.|+||.||++.. .+..||+|.+....... ...+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 347899999999999999999986 57789999987654332 35678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++.+. .+++..+..++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred ecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999999753 4889999999999999999999998 99999999999999999999999999876544333
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......+++.|++||.+.+..++.++|+|||||++|+|++|..||...++.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~ 221 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 333457899999999999988999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=275.17 Aligned_cols=202 Identities=28% Similarity=0.481 Sum_probs=177.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++.. .++.|++|.++.... .......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 477899999875433 3344677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||+++++|..++.. ....+++..++.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999864 2345899999999999999999999999 999999999999999999999999998765443
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
........+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 33333456889999999999988999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=281.20 Aligned_cols=202 Identities=27% Similarity=0.411 Sum_probs=172.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++.+.||.|++|.||++.. .++.|+||.+....... ....+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 46789999987543221 2234567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+.+ +|.+++.+....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99975 999999876667899999999999999999999999 999999999999999999999999998754433222
Q ss_pred cccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 223357889999999876 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=293.10 Aligned_cols=207 Identities=23% Similarity=0.360 Sum_probs=178.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
...|..++.||-|+||.|+++... ...||+|.+.+.+. ...+..-++.|-.||.....+-||++|..|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 356899999999999999999764 44599998877654 344556677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc---cc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK---HE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~---~~ 657 (716)
|+|++||++..+|-+.+ .|.+..+++++.+|..|++++|..| +|||||||+|||||.+|+|||.|||+++-+ ++
T Consensus 708 MdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999997754 5889999999999999999999999 999999999999999999999999997511 10
Q ss_pred Cc---------------------------------------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHH
Q 005054 658 TY---------------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698 (716)
Q Consensus 658 ~~---------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~el 698 (716)
.. ......+||+.|+|||++....|+..+|+||.|||||+|
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00 011234599999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcccc
Q 005054 699 ATEKIPWDNLNSMQD 713 (716)
Q Consensus 699 ltG~~PF~~~~~l~~ 713 (716)
+.|+.||....+.+-
T Consensus 865 ~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGET 879 (1034)
T ss_pred hhCCCCccCCCCCcc
Confidence 999999998887653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=276.25 Aligned_cols=205 Identities=36% Similarity=0.623 Sum_probs=175.8
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
|++...+|.+.++||.|+||.||++.+. ++.|++|+++... .....+.+|+.+++.++||||+++++++.....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 3455678999999999999999999874 6679999987543 2245678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
++||||+++++|.+++.... ..+++..++.++.|++.+|.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 99999999999999997543 45889999999999999999999998 9999999999999999999999999987654
Q ss_pred cCcccc-ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 657 ETYLTT-KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 657 ~~~~~~-~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
...... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 432211 12234668999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=280.26 Aligned_cols=202 Identities=32% Similarity=0.501 Sum_probs=174.4
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
.|++.+.||.|+||.||++.+. +..+++|.+... .......+.+|+.+++.++||||+++++++......|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4688899999999999999984 456788887543 244556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+++++|..++.+...++++..++.++.||+.+|.|||+.+ |+|+||||+|||++.++.+||+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999999988765667999999999999999999999999 99999999999999999999999999876544333334
Q ss_pred cCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 664 TGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...+++.|+|||++. +..++.++|||||||++|+|++|+.||...++.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 214 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence 457899999999984 445678999999999999999999999876643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=280.02 Aligned_cols=202 Identities=26% Similarity=0.385 Sum_probs=177.4
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||.|+||.||++.+ .++.|++|++............+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999987 567899999987665455566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-cc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 662 (716)
+ +++|.+++......+++..++.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999876677999999999999999999999999 99999999999999999999999999876544321 12
Q ss_pred ccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|+..|+|||++.+.. ++.++|||||||++|+|++|.+||...++
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 3446899999999986544 58899999999999999999999976654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=278.27 Aligned_cols=207 Identities=36% Similarity=0.578 Sum_probs=176.4
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
|++..++|.+.+.||+|+||.||++...+ ..|++|.+.... .......+.+|+.+|+.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45667899999999999999999998743 469999976543 2334566788999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~---------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
.....|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 9999999999999999999996532 23678899999999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 644 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 644 vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999999987544332 12233456789999999988889999999999999999998 999997655
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=280.41 Aligned_cols=204 Identities=32% Similarity=0.563 Sum_probs=174.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..+|.+.+.||+|+||.||++... +..||||+++... ..+....+.+|+.+|+.+.|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 467899999999999999999763 3569999987543 23355788899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNT-------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~-------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
.|+||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ |+||||||+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCe
Confidence 999999999999999997542 34788899999999999999999999 999999999999999999
Q ss_pred EEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 644 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 644 vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999987543221 11223346788999999999999999999999999999998 9999976553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=274.48 Aligned_cols=206 Identities=34% Similarity=0.602 Sum_probs=177.1
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|++..++|.+.++||.|+||.||++... +..|+||.+....... ..+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH---HHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 4566789999999999999999999874 4569999987654433 46788999999999999999999999889999
Q ss_pred EEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999997643 46899999999999999999999999 99999999999999999999999999876543
Q ss_pred Cc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 21 11112234678999999999889999999999999999998 9999976553
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=276.03 Aligned_cols=204 Identities=36% Similarity=0.611 Sum_probs=172.9
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
.+..++|++.++||+|+||.||++.+.+ ..|++|+++...... ..+.+|+.+++.++||||+++++.+. ....|+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 4556789999999999999999998744 469999987644333 46788999999999999999998875 456899
Q ss_pred EEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||+++++|.+++.+. ...+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999763 345789999999999999999999998 999999999999999999999999998765433
Q ss_pred ccc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 659 YLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 659 ~~~-~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
... .....++..|++||++.+..++.++|||||||++|+|++ |..||....+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 221 123346678999999999899999999999999999999 8999986543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=276.84 Aligned_cols=204 Identities=31% Similarity=0.527 Sum_probs=175.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
..+|++.+.||+|+||.||++... +..|++|.++... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 368999999999999999999863 2258999886543 3445678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++.+....+++..++.++.|++.+|.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999877667899999999999999999999999 999999999999999999999999998765432
Q ss_pred ccc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 659 YLT---TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 659 ~~~---~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
... .....++..|++||.+.+..++.++|+|||||++|++++ |..||...+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 211 112234568999999999889999999999999999886 9999986653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=273.31 Aligned_cols=200 Identities=36% Similarity=0.653 Sum_probs=177.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
+..++|++.+.||.|+||.||++...++.|++|.++.... ....+.+|+.+++.++|+||+++++++......|+||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4457899999999999999999999999999999876542 4567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||+++++|.+++.... ..+++..++.++.|++.+|.|||.++ |+|+||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999997654 36899999999999999999999999 99999999999999999999999999886643221
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2344668999999998889999999999999999997 999997664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=302.38 Aligned_cols=202 Identities=19% Similarity=0.308 Sum_probs=161.3
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcCC---eEEEEE--------------e-eccCCCHHHHHHHHHHHHHHHhcCCCc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS---DVAVKV--------------F-SRQEYSDEVIHSFRQEVSLMKRLRHPN 563 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~---~vAvK~--------------~-~~~~~~~~~~~~~~~E~~iL~~l~hpn 563 (716)
.+.++|+++++||+|+||+||+|..... .+++|. + +...........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999865321 122221 1 111112234566789999999999999
Q ss_pred eeEEeceeccCCceEEEEeecCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc
Q 005054 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639 (716)
Q Consensus 564 Iv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~----~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~ 639 (716)
||++++++...+..|+||+++ +++|..++.... .......++.++.||+.||.|||+++ ||||||||+||||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 999999999999999999999 557877775432 22346678889999999999999999 99999999999999
Q ss_pred cCCcEEEEecCCCcccccCcc-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC-CCC
Q 005054 640 KHWTVKVGDFGLSRLKHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWD 706 (716)
Q Consensus 640 ~~~~vkL~DFGla~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~-PF~ 706 (716)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||+||+|++|.. ||.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 999999999999986543322 2234579999999999999999999999999999999999875 444
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=274.58 Aligned_cols=201 Identities=32% Similarity=0.552 Sum_probs=179.8
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||.|+||.||++... +..|++|.++.... ...+.+|+.+++.++||||+++++++.....+|++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 67999999999999999999884 57899999865422 5778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|.+++......+++..++.++.||+.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 99999999999876778999999999999999999999999 9999999999999999999999999988765544333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....|+..|++||++.+..++.++|||||||++|+|++|+.||...++.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 3456889999999999999999999999999999999999999866543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=279.12 Aligned_cols=207 Identities=34% Similarity=0.546 Sum_probs=173.6
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
|++..++|++.++||+|+||.||+|... +..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566789999999999999999998753 3369999876543 2333456778999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~---------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
.....|+||||+++++|.+++.+.. ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 9999999999999999999997532 23467788999999999999999999 999999999999999999
Q ss_pred EEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 644 VKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 644 vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999875433221 1122345778999999999899999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=273.87 Aligned_cols=197 Identities=32% Similarity=0.573 Sum_probs=168.7
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggs 588 (716)
+.||+|+||.||++.+ .++.||+|.+... ...+....+.+|+.+++.++||||+++++++.....+|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999987 5778999987643 334555778899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc--ccCC
Q 005054 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGK 666 (716)
Q Consensus 589 L~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~ 666 (716)
|.+++......+++..++.++.|++.+|.|||+++ |+|+||||+|||++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99999776667899999999999999999999998 9999999999999999999999999987544321111 1112
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.+..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 3457999999999889999999999999999997 9999976553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=279.18 Aligned_cols=201 Identities=28% Similarity=0.415 Sum_probs=171.0
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|.+.+.||+|+||.||+|.. .+..|++|++...... .....+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999986 4778999998654322 222355679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+. ++|..++......+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 995 6887777665556888899999999999999999998 9999999999999999999999999987644333333
Q ss_pred ccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....+++.|+|||++.+. .++.++|||||||++|+|++|..||...+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 344678999999998764 47889999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=281.95 Aligned_cols=204 Identities=26% Similarity=0.470 Sum_probs=177.4
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++... +..|++|.+....... .....+..|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999884 6789999998765443 45667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-
Q 005054 582 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY- 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 659 (716)
||+.+++|.+++.+. ...+++..++.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999999764 356899999999999999999999999 9999999999999999999999999876432211
Q ss_pred ----------------------------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 ----------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ----------------------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 011234688999999999999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=278.69 Aligned_cols=202 Identities=36% Similarity=0.562 Sum_probs=178.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||.|+||.||++.+ .+..|++|++..... ......+.+|+.+++.++|+||+++++++..+..+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4688899999999999999987 467899999876542 3334667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|.+++... ++++..++.++.||+.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999765 6899999999999999999999998 9999999999999999999999999998765543333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....+++.|++||.+.+..++.++|||||||++|+|++|+.||...++.
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~ 204 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM 204 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH
Confidence 4557889999999999988999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=275.04 Aligned_cols=194 Identities=28% Similarity=0.421 Sum_probs=165.8
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecCCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
+.||+|+|+.|-.+.. .+..||||++.++. ...+.++.+|++++..+ .|+||+.++++|+++..+|||||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 5799999999998865 78889999998763 34467788999999998 5999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---cEEEEecCCCcccc-------c
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKH-------E 657 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~---~vkL~DFGla~~~~-------~ 657 (716)
+|..+|.++. .|++.++..+..+|+.||.|||.+| |.||||||+|||..... -||||||.+..-.. .
T Consensus 162 plLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999998754 5999999999999999999999999 99999999999997544 48999999865321 1
Q ss_pred CccccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
......+.+|+..|||||+.. ...|+.++|.||||+|+|-||.|.+||.+.=
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 112234568999999999863 3457899999999999999999999998653
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=280.19 Aligned_cols=202 Identities=31% Similarity=0.489 Sum_probs=177.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
...+|++.+.||.|+||.||++.+ .++.|++|.+...... ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 346799999999999999999986 5778999998765432 245678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|..++... .+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 95 MEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999999998754 4899999999999999999999999 99999999999999999999999999876544333
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 33345689999999999998899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=276.85 Aligned_cols=202 Identities=32% Similarity=0.561 Sum_probs=172.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+|++.++||+|+||+||+|.+ .+. .||+|+++... .......+.+|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 46899999999999999999986 333 48999887543 34445678889999999999999999998875 457
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+++|||+++++|.+++..+...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 8999999999999999876667999999999999999999999999 99999999999999999999999999876543
Q ss_pred Ccc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 658 ~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 221 1112235678999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=278.75 Aligned_cols=204 Identities=32% Similarity=0.554 Sum_probs=173.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
...+|.+.+.||+|+||.||++... +..|++|.+... .......+.+|+.+++++.||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3568999999999999999999752 234888887643 2445567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
.+++||||+++++|.+++.... ..+++..++.++.||+.+|+|||+++ |+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCc
Confidence 9999999999999999997532 24899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 644 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 644 vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999987553321 11223345778999999999999999999999999999998 9999976553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=282.36 Aligned_cols=206 Identities=27% Similarity=0.375 Sum_probs=177.5
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC--C----ceeEEecee
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--P----NVLLFMGAV 571 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h--p----nIv~~~~~~ 571 (716)
-+++.++|++++.+|+|.||.|.++.+. +..||||+++.- ....+..+-|+++|+++.+ | -+|.+.+||
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 3667899999999999999999999874 457999998643 3444566679999999932 2 477888999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-----------
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD----------- 639 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~----------- 639 (716)
...+++|||+|.+ |.+++++|..+ ..+++...++.++.||++++.|||+++ ++|.||||+|||+.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccC
Confidence 9999999999999 77999999874 467999999999999999999999999 99999999999994
Q ss_pred ---------cCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 640 ---------KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 640 ---------~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.+..|+|+|||.|+...... ...+.|..|+|||++.+.+|+.++||||+||||+||++|...|+..++
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 13469999999998876654 345679999999999999999999999999999999999999998887
Q ss_pred cccc
Q 005054 711 MQDS 714 (716)
Q Consensus 711 l~~~ 714 (716)
.+.+
T Consensus 315 ~EHL 318 (415)
T KOG0671|consen 315 LEHL 318 (415)
T ss_pred HHHH
Confidence 6654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=286.66 Aligned_cols=213 Identities=31% Similarity=0.522 Sum_probs=185.1
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..-++......++++||+|-||.|.+|...+ ..||||.++.... ......|.+|+++|.+|+|||||.++++|..++.
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3446667789999999999999999999876 8899999987553 4456889999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKL-DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l-~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+|+|+||++.|+|.+++.++..+. .......|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++..
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccc
Confidence 999999999999999999875443 55667789999999999999999 999999999999999999999999999854
Q ss_pred c--cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCcccc
Q 005054 656 H--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQD 713 (716)
Q Consensus 656 ~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt--G~~PF~~~~~l~~ 713 (716)
. +.+......+-..+|||||.+..+.++.++|+|+||++|||+++ ...||..+.+.|.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 3 22333334456789999999999999999999999999999776 7899998887664
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=277.41 Aligned_cols=203 Identities=27% Similarity=0.479 Sum_probs=170.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+|++.+.||+|+||.||++.+ .+. .|++|.+... ........+..|+.++..+.||||+++++++. ....
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 35789999999999999999987 344 3677776432 22344567778888999999999999999875 4567
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+++|||+++++|.+++......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 8999999999999999877677999999999999999999999998 99999999999999999999999999976533
Q ss_pred Cc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.. .......++..|++||.+.+..++.++|||||||++|+|++ |..||....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 21 11223356778999999998899999999999999999998 9999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=264.78 Aligned_cols=207 Identities=22% Similarity=0.325 Sum_probs=174.8
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc-
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~- 576 (716)
.-+..++|+|.+.||+|||+.||++.. .+..||+|.+.... .+..+..++|++..++++||||++++++...+..
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 345678999999999999999999975 66779999987765 4556788899999999999999999998765544
Q ss_pred ----eEEEEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 577 ----LCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 577 ----~~lVmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
.||+++|...|+|.+.+... +..+++.+++.|+.+|++||++||...++++||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 89999999999999988653 45689999999999999999999999889999999999999999999999999
Q ss_pred CCCcccccCcc---------ccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 650 GLSRLKHETYL---------TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 650 Gla~~~~~~~~---------~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
|.++....... ......-|..|+|||.+. +...+.++|||||||+||.||+|..||+..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 98864332111 111223588999999985 445588999999999999999999999743
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=276.82 Aligned_cols=203 Identities=27% Similarity=0.466 Sum_probs=177.0
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||.|+||.||++.. .+..|+||.+..... .......+.+|+.+++.+.||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788999999999999999986 677899998865433 3345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||+++++|.+++.. ....+++..++.++.||+.+|.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998864 2345899999999999999999999999 999999999999999999999999998765443
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 333334578999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-33 Score=298.32 Aligned_cols=202 Identities=34% Similarity=0.487 Sum_probs=179.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.|.=++.||-|+||.||.+++ +...||||.+..... ..+..+.+.+|+.+|++++|||++.+-++|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 456678899999999999987 455699999987654 34556888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|| -|+-.+++.-...++-+..+..|..+.+.||.|||+++ .||||||+.|||+++.|.|||+|||.|....+.
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 99 56999999888888999999999999999999999999 999999999999999999999999998766543
Q ss_pred ccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 663 KTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
..++|||.|||||++. .+.|+-++|||||||+..||.-.++|+-++|-|-++
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL 234 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 234 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH
Confidence 3679999999999985 567899999999999999999999999888877554
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=273.01 Aligned_cols=199 Identities=35% Similarity=0.620 Sum_probs=172.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee-ccCCceEEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRLCIV 580 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~-~~~~~~~lV 580 (716)
+..++|++.+.||+|+||.||++...+..|++|.++... ....+.+|+.+++.++|+||+++++++ ......|+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 345689999999999999999999999999999986432 235678899999999999999999875 455678999
Q ss_pred EeecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 581 TEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~-~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
|||+++++|.+++.+... .+++..++.++.||+.+|.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999976543 4789999999999999999999999 9999999999999999999999999987544322
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 12344678999999999889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=280.01 Aligned_cols=203 Identities=33% Similarity=0.596 Sum_probs=170.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcC--C--eEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYG--S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~--~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
+++|++.+.||+|+||.||++.... . .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.....+|
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 3689999999999999999998743 2 3688877632 2334456788899999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 579 IVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996532 24788999999999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 644 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+||+|||++....... .......+..|++||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999986433221 1112233567999999999999999999999999999997 9999976653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=274.71 Aligned_cols=205 Identities=35% Similarity=0.609 Sum_probs=174.3
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|++..++|++.++||+|+||.||++... +..|++|.++...... ..+.+|+.++++++|+||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 3556678999999999999999999874 4579999987655433 45788999999999999999999875 45689
Q ss_pred EEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++|||+++++|.+++... ...+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999999764 345899999999999999999999999 99999999999999999999999999876543
Q ss_pred Ccc-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~~-~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 221 1122345668999999998889999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=271.67 Aligned_cols=202 Identities=27% Similarity=0.484 Sum_probs=178.7
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||+|+||.||++.. .++.|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999987 567899999876655555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
+.+++|.+++.... ..+++..++.++.|++.+|.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 99999999987643 45789999999999999999999998 9999999999999999999999999987665443333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 34468899999999999889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=273.09 Aligned_cols=197 Identities=36% Similarity=0.632 Sum_probs=174.0
Q ss_pred eeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 511 EQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
+.||+|+||.||++... +..|++|+++...... ....+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999885 6679999987765433 46788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 586 RGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 586 ggsL~~~l~~~--------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999876 467999999999999999999999998 99999999999999999999999999987654
Q ss_pred Cc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 32 22334467889999999998889999999999999999999 6999987643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=271.66 Aligned_cols=202 Identities=30% Similarity=0.484 Sum_probs=177.5
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCceEEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVT 581 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~~~lVm 581 (716)
+|++.+.||.|+||.||++.+ .+..|++|++............+..|+.+++.++||||+++++++.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999987 45679999998766666667788899999999999999999997754 45689999
Q ss_pred eecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 582 EFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLH-----HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 582 E~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH-----~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
||+++++|.+++... ..++++..++.++.||+.+|.||| +.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999999754 456899999999999999999999 777 9999999999999999999999999998
Q ss_pred ccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.............+++.|++||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 76554432334578999999999999889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=285.28 Aligned_cols=199 Identities=24% Similarity=0.403 Sum_probs=168.7
Q ss_pred EeeeeecC--CcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 509 IGEQIGQG--SCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 509 i~~~LG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
++++||+| +|++||++.+ .+..||+|.++...........+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6889999987 5678999999876655666677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc---
Q 005054 585 PRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--- 660 (716)
Q Consensus 585 ~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--- 660 (716)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999999764 345899999999999999999999999 99999999999999999999999986543221100
Q ss_pred ----ccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 661 ----TTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 661 ----~~~~~~Gt~~Y~aPE~~~~--~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 1112356778999999976 458899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=276.76 Aligned_cols=200 Identities=39% Similarity=0.667 Sum_probs=170.4
Q ss_pred eEeeeeecCCcEEEEEEEEc------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 508 TIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++.+.||.|.||.||+|.+. +..|+||+++.. ........+.+|+.++++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999987 456999999553 34555788899999999999999999999999888899999
Q ss_pred eecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc--C
Q 005054 582 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--T 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~--~ 658 (716)
|||++++|.+++... ...+++..++.|+.||+.||.|||+++ |+|+||++.||+++.++.+||+|||++..... .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 567999999999999999999999999 99999999999999999999999999876522 1
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 122233356779999999999989999999999999999999 7899987754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=280.04 Aligned_cols=203 Identities=27% Similarity=0.368 Sum_probs=175.3
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC---HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+|++.+.||.|+||.||+|.+ .++.|+||.++..... ......+..|+.+++.++|+||+++++++...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999987 4678999999766543 33445667899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+ +++|..++......+++..++.++.||++||.|||+++ |+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999999765557999999999999999999999999 99999999999999999999999999986654433
Q ss_pred ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 3334457889999998865 45688999999999999999998888766643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=276.29 Aligned_cols=201 Identities=32% Similarity=0.493 Sum_probs=170.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccC------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~------ 574 (716)
.+.|++.+.||+|+||.||++.. .+..||+|++...... ...+..|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46788899999999999999987 4667999998754322 24567889999988 799999999998653
Q ss_pred CceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
..+|+||||+.+++|.+++... ...+++..++.++.|++.+|.|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4589999999999999999764 346899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCccccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.............|++.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 6544333334557899999999986 3457889999999999999999999997654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=274.88 Aligned_cols=202 Identities=32% Similarity=0.522 Sum_probs=171.2
Q ss_pred eeEeeeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc-----
Q 005054 507 LTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR----- 576 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~----- 576 (716)
|++++.||+|+||.||++.... ..||+|.++...........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5788999999999999998632 569999998766555666788999999999999999999998765544
Q ss_pred -eEEEEeecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecC
Q 005054 577 -LCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (716)
Q Consensus 577 -~~lVmE~~~ggsL~~~l~~~-----~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 650 (716)
.++||||+++++|..++... ...+++..++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999988542 235889999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 651 LSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+++....... ......++..|++||.+.+..++.++|||||||++|+|++ |..||...++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9876543221 1122235678999999998899999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=274.38 Aligned_cols=203 Identities=32% Similarity=0.558 Sum_probs=174.8
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-------HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
+|.+.+.||.|+||.||+|.+ .+..|++|.+...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999987 4678999988654332 1344678889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.++||||+++++|.+++... ..+++..++.++.||+.+|.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999764 45889999999999999999999999 9999999999999999999999999987654
Q ss_pred cCcc------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 657 ETYL------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 657 ~~~~------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.... ......|+..|++||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 2211 111235788999999999988999999999999999999999999876544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=281.08 Aligned_cols=209 Identities=31% Similarity=0.574 Sum_probs=176.7
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~ 568 (716)
.|++...+|.+.+.||+|+||.||++... +..|++|+++... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 45677789999999999999999999742 2358999886543 334457788999999999 899999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
+++......|+||||+++++|.+++.+.. ..++...++.++.||+.||.|||+++ |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999997642 24778889999999999999999999 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+|||++.++.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999876543221 1223346778999999999889999999999999999998 8899976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=281.16 Aligned_cols=208 Identities=32% Similarity=0.604 Sum_probs=175.5
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~ 568 (716)
.|+...++|.+.++||+|+||.||++... ...||+|+++... .......+.+|+.+++.+ .||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34556689999999999999999999752 2358999887543 344466788899999999 699999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
+++.....+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999997532 34788999999999999999999999 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999976543211 1122234568999999999999999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=273.05 Aligned_cols=205 Identities=33% Similarity=0.527 Sum_probs=178.2
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||.|+||.||++.. .+..+++|++....... ....+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4799999999999999999987 56679999987654433 56778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 583 FLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
++++++|.+++.... ..+++..+..++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999997642 46899999999999999999999999 99999999999999999999999999876544322
Q ss_pred c----cccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 661 T----TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 661 ~----~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
. .....|++.|++||++... .++.++|+|||||++|+|++|+.||...++.+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 2 2334689999999998877 77889999999999999999999998776543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.93 Aligned_cols=201 Identities=25% Similarity=0.392 Sum_probs=179.1
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+|++.+.||.|+||.||++.+. +..|++|++...... ......+.+|+.++++++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999884 778999999865442 2456788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+.+++|.+++... ..+++..++.++.||+++|.|||+++ |+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999775 56899999999999999999999999 9999999999999999999999999987654432 22
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|+..|++||++.+..++.++|+|||||++|+|++|..||...+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 345688999999999988899999999999999999999999987663
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=280.16 Aligned_cols=204 Identities=25% Similarity=0.475 Sum_probs=173.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..+|++.++||+|+||.||++... +..||+|+++... .......+.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 457888999999999999999863 3569999987543 34455678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 577 LCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~---------------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
.++++||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDK 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCC
Confidence 99999999999999998532 134788889999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 642 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999987543322 11223356789999999988889999999999999999998 8999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=273.07 Aligned_cols=202 Identities=33% Similarity=0.570 Sum_probs=173.3
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--C---CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
.+|++.+.||+|+||.||+|... + ..|+||+++.. ........+..|+.+++.+.||||+++++++.....+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 57899999999999999999873 2 25999998654 245556788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+++++|.+++......+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999999876667899999999999999999999999 9999999999999999999999999987543321
Q ss_pred cc---c--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 660 LT---T--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 660 ~~---~--~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
.. . .....+..|++||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 11 1 11112457999999999999999999999999999886 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=271.76 Aligned_cols=195 Identities=28% Similarity=0.522 Sum_probs=167.1
Q ss_pred eeecCCcEEEEEEEE----cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 512 QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 512 ~LG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
.||+|+||.||+|.+ .+..||+|+++...........+.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 3567999998766555566778899999999999999999999875 45679999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc---cccc
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---TTKT 664 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~ 664 (716)
+|.+++... ..+++..++.++.||+.+|.|||+++ |+||||||.|||++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999754 46899999999999999999999999 99999999999999999999999999876543321 1122
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 665 ~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 234679999999988889999999999999999998 9999987643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=278.90 Aligned_cols=209 Identities=33% Similarity=0.597 Sum_probs=177.3
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEece
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~ 570 (716)
.+++..++|++.+.||+|+||.||++...+ ..|++|.+.... .......+.+|+.+++.+ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345566789999999999999999998642 458999887543 334456788899999999 89999999999
Q ss_pred eccCCceEEEEeecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCc
Q 005054 571 VTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (716)
Q Consensus 571 ~~~~~~~~lVmE~~~ggsL~~~l~~~---------------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~N 635 (716)
+...+.++++|||+++++|..++... ...+++..++.++.||+.||.|||+++ |+|+||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999999642 245889999999999999999999998 9999999999
Q ss_pred EEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 636 LLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999999986543321 1222345678999999999999999999999999999997 9999986653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=273.65 Aligned_cols=202 Identities=30% Similarity=0.508 Sum_probs=168.8
Q ss_pred eeEeeeeecCCcEEEEEEEEcCC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------Cc
Q 005054 507 LTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------QR 576 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------~~ 576 (716)
|.++++||+|+||.||+|.+... .||+|.++...........+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987432 589998877655566677888999999999999999999876432 24
Q ss_pred eEEEEeecCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 577 LCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~-----~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
.+++|||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 6899999999999988743 2244789999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 652 SRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+........ ......+++.|++||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 886543221 1223346778999999999999999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=279.17 Aligned_cols=203 Identities=29% Similarity=0.378 Sum_probs=174.7
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||+|+||.||++.+. ++.||+|++............+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999984 6789999987654444445667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|..+.... ..+++..++.++.||+.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99998888876543 35899999999999999999999998 9999999999999999999999999987654433333
Q ss_pred ccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....++..|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 345688999999998764 467899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=280.98 Aligned_cols=203 Identities=32% Similarity=0.610 Sum_probs=170.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCe--EEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~--vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
+++|++.+.||+|+||.||+|.+. +.. +++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 468999999999999999999863 333 566665432 2344556788899999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 579 IVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCc
Confidence 9999999999999997542 24789999999999999999999999 999999999999999999
Q ss_pred EEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 644 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 999999998643221 11222334678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.44 Aligned_cols=204 Identities=28% Similarity=0.500 Sum_probs=171.2
Q ss_pred cccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..++|.+.+.||+|+||.||++.+.+ ..|++|.+.... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45789999999999999999998854 458888775433 2334456788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---cEEE
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKV 646 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~---~vkL 646 (716)
..++||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ ++|+||||+|||++.++ .+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999997643 25889999999999999999999999 99999999999998654 5999
Q ss_pred EecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 647 GDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 647 ~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+|||+++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999886532211 1112234568999999999999999999999999999997 999998754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=276.16 Aligned_cols=207 Identities=31% Similarity=0.473 Sum_probs=172.5
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceec-----
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT----- 572 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~----- 572 (716)
....++|++.+.||+|+||.||++.. .++.|++|+++.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34567999999999999999999987 467899998764322 224567799999999 6999999999873
Q ss_pred cCCceEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
..+.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 44578999999999999998753 2346889999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
|++..............|++.|+|||++.. ..++.++|||||||++|+|++|+.||...++..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 998765443333334568999999999853 446889999999999999999999998766543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=275.40 Aligned_cols=199 Identities=32% Similarity=0.527 Sum_probs=167.9
Q ss_pred cce-eEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--C
Q 005054 505 EDL-TIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--Q 575 (716)
Q Consensus 505 ~~y-~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~ 575 (716)
++| ++.+.||+|+||+||++.+ .+..||+|+++... .......+.+|+.+|+.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 8999999999999988753 35579999987643 233456778899999999999999999987653 4
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+++||||+++++|.+++... .+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccccc
Confidence 589999999999999999764 4899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCccc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 656 HETYLT---TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 656 ~~~~~~---~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
...... .....++..|++||.+.+..++.++|||||||++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 432211 12234566799999999888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=277.59 Aligned_cols=200 Identities=26% Similarity=0.460 Sum_probs=172.3
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++++.||+|+||.||++.+. +..||+|.++... .......+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 46889999999999999999884 7789999887542 34445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 583 FLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 583 ~~~ggsL~~~l~~~--~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
|+++++|..++... ...+++..+..++.||+.+|.|||. ++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999998764 2368999999999999999999996 57 9999999999999999999999999987654332
Q ss_pred cccccCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~------~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....+++.|++||++.+.. ++.++|||||||++|+|++|+.||...+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 22346888999999985543 4789999999999999999999997544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=279.85 Aligned_cols=192 Identities=27% Similarity=0.420 Sum_probs=158.1
Q ss_pred eeeeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec--cCCceEEEEee
Q 005054 510 GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRLCIVTEF 583 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~--~~~~~~lVmE~ 583 (716)
+.+||+|+||.||+|... +..||+|.+...... ..+.+|+.+|+.++||||+++++++. .+..+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 356999988754432 34668999999999999999999885 35678999999
Q ss_pred cCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE----ccCCcEEEEecCC
Q 005054 584 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (716)
Q Consensus 584 ~~ggsL~~~l~~~--------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGl 651 (716)
+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 95 5888777432 234789999999999999999999999 9999999999999 4567899999999
Q ss_pred CcccccCcc---ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 652 SRLKHETYL---TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 652 a~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 986543321 22244689999999998774 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.53 Aligned_cols=204 Identities=35% Similarity=0.607 Sum_probs=172.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
++..++|.+.++||.|+||.||++.+.+ ..+++|.+...... ...+.+|+.+++.++|+||+++++++. .+..|+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4556789999999999999999998754 46999987654332 356778999999999999999998875 456899
Q ss_pred EEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999997643 44789999999999999999999998 999999999999999999999999999765432
Q ss_pred cc-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 659 YL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 659 ~~-~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.. ......++..|++||.+.+..++.++|||||||++|+|++ |..||....+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 21 1122345678999999998889999999999999999999 9999987653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=279.50 Aligned_cols=205 Identities=32% Similarity=0.558 Sum_probs=173.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEEcC----------------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWYG----------------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~~----------------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~ 566 (716)
..++|++.++||+|+||.||++...+ ..||+|.++.. ........+.+|+++++.++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45689999999999999999987632 23899988754 33455667889999999999999999
Q ss_pred EeceeccCCceEEEEeecCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCc
Q 005054 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (716)
Q Consensus 567 ~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~N 635 (716)
+++++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhh
Confidence 9999999999999999999999999986532 23678899999999999999999999 9999999999
Q ss_pred EEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCc
Q 005054 636 LLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNS 710 (716)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt--G~~PF~~~~~ 710 (716)
|+++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999875433211 1122345778999999998889999999999999999988 7789986543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=286.57 Aligned_cols=207 Identities=29% Similarity=0.510 Sum_probs=171.8
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE-------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEecee
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~ 571 (716)
|+...++|++.+.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.+|..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 455667999999999999999999974 345799999875432 34456788899999999 689999999987
Q ss_pred ccC-CceEEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 005054 572 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (716)
Q Consensus 572 ~~~-~~~~lVmE~~~ggsL~~~l~~~~----------------------------------------------------- 597 (716)
... ..+++|||||++++|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 56899999999999999986432
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--ccc
Q 005054 598 -------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTT 662 (716)
Q Consensus 598 -------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~ 662 (716)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 23677888999999999999999999 9999999999999999999999999987643221 112
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 22345678999999999999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=290.32 Aligned_cols=209 Identities=31% Similarity=0.518 Sum_probs=176.9
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~ 569 (716)
..|++..++|.+.++||+|+||.||+|++.+ ..||||+++.... ....+.+.+|+.+|..+. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3467778899999999999999999998643 4699999976432 334457889999999997 999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcC----------------------------------------------------
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------------------------------------------- 597 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------------------------------------------- 597 (716)
++.....+++|||||++|+|.+++.++.
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999996532
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC
Q 005054 598 ---------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (716)
Q Consensus 598 ---------------------------------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK 632 (716)
..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk 266 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA 266 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence 13567788899999999999999988 9999999
Q ss_pred CCcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 633 SSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|+|||++.++.+||+|||+++...... .......+++.|++||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999987543221 11223457889999999999889999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.24 Aligned_cols=195 Identities=27% Similarity=0.522 Sum_probs=165.1
Q ss_pred eeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 512 QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 512 ~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
.||+|+||.||+|.+. +..||+|++.... .......+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999763 3358999886543 3445567889999999999999999999886 45789999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc---cccc
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---TTKT 664 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~ 664 (716)
+|.+++......+++..++.++.||+.+|.|||+++ ++|+||||+|||++.++.+||+|||++........ ....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999999866667999999999999999999999998 99999999999999999999999999875433211 1112
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 665 ~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
..+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 234578999999998889999999999999999996 9999987654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=272.26 Aligned_cols=203 Identities=33% Similarity=0.536 Sum_probs=174.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCC----CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY----SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~----~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+|++.+.||.|+||.||++.. .+..+|+|.++.... .......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478899999999999999987 567799998875432 223456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC--
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 658 (716)
|||+++++|.+++.+. ..+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999764 35889999999999999999999998 999999999999999999999999988754211
Q ss_pred ----ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 659 ----YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 659 ----~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 11122346899999999999988999999999999999999999999876543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=279.05 Aligned_cols=204 Identities=26% Similarity=0.366 Sum_probs=175.7
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--CceEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIV 580 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~~lV 580 (716)
++|++.+.||.|+||.||+|.+. ++.|++|.++...........+.+|+.++..++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999984 67799999876554443444567899999999999999999998877 889999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||++ ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99996 4999999876667999999999999999999999999 99999999999999999999999999886655433
Q ss_pred ccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.+
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 333456789999999987654 588999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=281.09 Aligned_cols=206 Identities=30% Similarity=0.392 Sum_probs=173.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--CceEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCI 579 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~~l 579 (716)
.++|++.+.||+|+||.||++.+ .+..||+|+++...........+.+|+.+++.++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46899999999999999999987 467899999876543333233456799999999999999999998754 56899
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+. ++|.+++......+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999995 4899988776667999999999999999999999999 9999999999999999999999999988665432
Q ss_pred cccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 660 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~ 216 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 22223356888999999875 457889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=276.90 Aligned_cols=202 Identities=33% Similarity=0.580 Sum_probs=171.0
Q ss_pred ceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+|++.+.||+|+||.||+|.... ..+++|++.... .......+.+|+.+++.+.||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47889999999999999998632 358888876543 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCc
Q 005054 579 IVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~-----------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~N 635 (716)
+||||+.+++|.+++.... ..+++..++.++.|++.+|.|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 9999999999999986421 34788999999999999999999998 9999999999
Q ss_pred EEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 636 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
||++.++.+||+|||++....... .......++..|++||.+.+..++.++|||||||++|+|++ |..||....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999987543221 12223346778999999999889999999999999999998 9999986553
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=277.93 Aligned_cols=205 Identities=32% Similarity=0.557 Sum_probs=172.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc------------------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCce
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnI 564 (716)
..++|++.++||+|+||.||++.+. ...||+|+++... .......+.+|+.+|+.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998542 2248999886543 34455678899999999999999
Q ss_pred eEEeceeccCCceEEEEeecCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCC
Q 005054 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (716)
Q Consensus 565 v~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~----------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~ 634 (716)
+++++++...+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~ 159 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR 159 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence 999999999999999999999999999997643 23667889999999999999999999 999999999
Q ss_pred cEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCc
Q 005054 635 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNS 710 (716)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt--G~~PF~~~~~ 710 (716)
|||++.++.++|+|||++........ ......+++.|++||+..+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999875433211 1122344678999999988889999999999999999998 7899976554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=277.95 Aligned_cols=208 Identities=29% Similarity=0.509 Sum_probs=176.9
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEece
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~ 570 (716)
.++...++|.+.+.||+|+||.||++... +..||||+++... .......+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 45666789999999999999999999752 2358999887543 234456788999999999 79999999999
Q ss_pred eccCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 571 ~~~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
+...+..|+||||+.+++|.+++.... ..+++..++.++.||+.+|.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999997643 34899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 650 GLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 650 Gla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 99875433211 1222345788999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=278.18 Aligned_cols=204 Identities=35% Similarity=0.577 Sum_probs=174.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcC------------------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCcee
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYG------------------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~------------------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv 565 (716)
..+|++++.||+|+||.||++.... ..|++|++.... .......+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4689999999999999999987643 348999887543 235567888999999999999999
Q ss_pred EEeceeccCCceEEEEeecCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCc
Q 005054 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (716)
Q Consensus 566 ~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~----------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~N 635 (716)
++++++..+...++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhc
Confidence 99999999999999999999999999997643 25899999999999999999999999 9999999999
Q ss_pred EEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCc
Q 005054 636 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNS 710 (716)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt--G~~PF~~~~~ 710 (716)
|+++.++.++|+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999987543322 12223456789999999998889999999999999999998 7889976543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.84 Aligned_cols=205 Identities=32% Similarity=0.540 Sum_probs=174.1
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC---CHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCce
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRL 577 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~~ 577 (716)
.+|++.+.||+|+||.||++.. .+..|++|+++.... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999987 467899998875432 22445678889999999999999999998865 3568
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+++|||+++++|.+++.... .+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999999997643 5889999999999999999999998 99999999999999999999999999875432
Q ss_pred Cc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 658 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 11 11123457889999999999889999999999999999999999998765443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=310.05 Aligned_cols=209 Identities=33% Similarity=0.615 Sum_probs=182.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc---CC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY---GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
+.....++...||+|.||.||.|... +. .||||.+++.. +.+...+|.+|..+|+.++|||||++++++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 44567889999999999999999873 22 37888776543 456678899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEe
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~D 648 (716)
...+|++|||.||+|..+|++. ...++....+.++.||++|+.||++++ +|||||-..|+||+....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999987 667999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccccc-CccccccC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 005054 649 FGLSRLKHE-TYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQD 713 (716)
Q Consensus 649 FGla~~~~~-~~~~~~~~-~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~ 713 (716)
||+|+.... .+...... .-...|||||.+....++.++|||||||+|||+++ |..||.+.++.+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v 913 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV 913 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence 999994433 33332222 33459999999999999999999999999999999 9999999887664
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.86 Aligned_cols=203 Identities=33% Similarity=0.551 Sum_probs=172.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..+|.+.+.||+|+||.||++... ...+++|.++... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 467999999999999999999753 2348888875433 3334678889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 577 LCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
.++||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ |+||||||+|||++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN 159 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC
Confidence 999999999999999997532 24788999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 642 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999987544321 11223456889999999999999999999999999999998 9999976553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.20 Aligned_cols=206 Identities=35% Similarity=0.597 Sum_probs=174.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
++..++|.+.+.||+|+||.||+|.+.. ..|+||...... .....+.+.+|+.+++.+.||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3445789999999999999999998643 258889876443 24456788899999999999999999998875 5
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
..|+||||+++++|.+++.+....+++..++.++.||+.+|.|||+++ ++|+||||+|||++.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 678999999999999999876667899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCcc-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 656 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
..... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 43321 1112234568999999988889999999999999999986 9999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.18 Aligned_cols=205 Identities=32% Similarity=0.581 Sum_probs=174.7
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|++..++|++.++||+|+||.||++.+ .+..+++|.++... .....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 567788999999999999999999986 44569999876532 234677889999999999999999999887 7889
Q ss_pred EEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++|||+++++|.+++.+. ...+++..++.++.||+.+|.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999999763 345788899999999999999999998 99999999999999999999999999876543
Q ss_pred Cc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.. .......++..|++||++.+..++.++|+|||||++|+|++ |+.||...+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 22 11222345678999999998889999999999999999998 9999987553
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=276.67 Aligned_cols=203 Identities=29% Similarity=0.400 Sum_probs=170.9
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||+|++|.||++.+ .++.|++|.+............+.+|+.+++.++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999987 46689999987654433444667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCCcccccCcc
Q 005054 583 FLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~ 660 (716)
|++ ++|..++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 995 58888876543 33678889999999999999999998 999999999999985 56799999999976544332
Q ss_pred ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+++.|++||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~ 209 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2334467889999999876 4578899999999999999999999986654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=268.31 Aligned_cols=200 Identities=34% Similarity=0.637 Sum_probs=174.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
.+|++.+.||.|+||.||++.+. +..+++|.++...... ..+.+|+.+++.+.||||+++++++......|+||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 57899999999999999999875 6789999887654433 4577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-cc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 662 (716)
+++++|.+++......+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999999999876667899999999999999999999999 99999999999999999999999999875543221 11
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 22235678999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=270.49 Aligned_cols=205 Identities=31% Similarity=0.525 Sum_probs=174.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CC---eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
...+|+..+.||+|+||.||++... +. .+++|.++... .....+.+..|+.+++.+.||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3467899999999999999999873 22 58888876542 344456788899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999999999876677899999999999999999999999 99999999999999999999999999875543
Q ss_pred Ccccc---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TYLTT---KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~---~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
..... .....++.|++||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 21111 11223457999999998889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=283.99 Aligned_cols=201 Identities=29% Similarity=0.420 Sum_probs=173.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------ 574 (716)
+.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999987 577899999876544444556677899999999999999999988644
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
...|+||||+. ++|.+.+... ++...+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999995 5888888643 889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 222 (353)
T cd07850 168 AGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH 222 (353)
T ss_pred CCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 554322 2234688999999999999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=281.66 Aligned_cols=209 Identities=33% Similarity=0.590 Sum_probs=176.5
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC---------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEE
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~ 567 (716)
..|++...+|++++.||+|+||.||++.+.+ ..|++|+++.. ........+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3567777899999999999999999997521 25899987643 2344567788999999999 79999999
Q ss_pred eceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC
Q 005054 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (716)
Q Consensus 568 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK 632 (716)
++++...+.++++|||+++++|.+++.+.. ..++...++.++.||+.||.|||+++ |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 999999999999999999999999997532 24778889999999999999999999 9999999
Q ss_pred CCcEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 633 SSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999876543221 1222334578999999999999999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.68 Aligned_cols=203 Identities=31% Similarity=0.564 Sum_probs=174.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+|++.+.||+|+||.||++.+. +. .|++|+++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 468999999999999999999863 22 488998765543 4455678889999999999999999999887 789
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999999887667999999999999999999999998 99999999999999999999999999976543
Q ss_pred Cccc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TYLT--TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~--~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.... .....++..|++||.+....++.++|+|||||++|+|++ |+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 2211 112234568999999988889999999999999999998 9999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.44 Aligned_cols=204 Identities=33% Similarity=0.545 Sum_probs=173.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEE-------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..++|.+.++||+|+||.||++.. .+..+++|.++.. .......+.+|+.+++.+.|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 356889999999999999999964 2346888887643 3445667889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~--------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
..|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC
Confidence 9999999999999999997643 24788999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 642 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 999999999987543221 11222345788999999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.12 Aligned_cols=205 Identities=34% Similarity=0.576 Sum_probs=174.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccC---CCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--Cce
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~ 577 (716)
.+|.+.+.||+|+||.||++.+ .+..|++|.+.... ........+.+|+.+++.++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999986 56789999875432 1234556888999999999999999999998764 458
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++||||+++++|.+++.... .+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999997644 4889999999999999999999999 99999999999999999999999999875432
Q ss_pred Cc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 658 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.. .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 216 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA 216 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH
Confidence 11 11123468899999999999888999999999999999999999998765443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.24 Aligned_cols=201 Identities=33% Similarity=0.540 Sum_probs=176.2
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
..|+..+.||.|+||.||++.+ .+..||+|+++.... ......+.+|+.+++.+.||||+++++++..+..+|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4577889999999999999987 466899999876533 3445778889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|.+++.. .++++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999875 35889999999999999999999998 9999999999999999999999999987654433333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....++..|+|||++.+..++.++|+|||||++|+|++|+.||...++
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 344678899999999988899999999999999999999999986654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=267.85 Aligned_cols=201 Identities=29% Similarity=0.488 Sum_probs=177.1
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||+|+||.||++.. .+..+++|.+............+.+|+.+|+.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999987 566799999987666566678889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecCCCcccccCccc
Q 005054 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~~ 661 (716)
+++++|.+++... ...+++..++.++.|++.+|.|||+++ |+|+||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 9999999999764 345899999999999999999999999 9999999999999855 4589999999986654322
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 223468999999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=277.39 Aligned_cols=201 Identities=33% Similarity=0.536 Sum_probs=175.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+.|.+.+.||.|+||.||++.+ .+..||+|+++.... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4577788999999999999987 456799998875432 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|.+++.. ..+++..++.++.||+.+|.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999999864 35899999999999999999999998 9999999999999999999999999987655433333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|+..|++||.+.+..++.++|+|||||++|+|++|+.||....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 345688999999999998899999999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=276.26 Aligned_cols=203 Identities=27% Similarity=0.432 Sum_probs=174.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++... ++.|++|.+...... ......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999874 567999998765432 234567788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (716)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999765 46899999999999999999999998 9999999999999999999999999886321110
Q ss_pred -------------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 -------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 -------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 011123578899999999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=253.32 Aligned_cols=206 Identities=28% Similarity=0.371 Sum_probs=181.4
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|.-.++||+|.||+||+++. ...-||+|.++.++..+..-....+|+-+|+.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455678999999999999986 455699999988776665666778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
|+. +|..+....+..++.+.++.++.|+++||.|+|+++ +.|||+||.|+||+.+|.+||+|||+++....+..-..
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 954 899999888888999999999999999999999999 99999999999999999999999999998777654445
Q ss_pred cCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 005054 664 TGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELAT-EKIPWDNLNSMQDS 714 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~~ 714 (716)
..+-|..|++|.++.|.. |+...|+||-||++.|+.. |.+.|.+.+-.+.+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 567799999999998765 6889999999999999998 88888887755443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=275.13 Aligned_cols=203 Identities=27% Similarity=0.364 Sum_probs=175.5
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||+|+||.||++.+. +..|++|+++...........+.+|+.+++.+.|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 37999999999999999999874 6689999987655445556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-c
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (716)
|++++.|..++.+ ...+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9988666555543 456899999999999999999999999 99999999999999999999999999886554432 2
Q ss_pred cccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2345678899999999888 788999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.45 Aligned_cols=198 Identities=30% Similarity=0.473 Sum_probs=161.0
Q ss_pred eeeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 36899999999999752 2357777765432 344456678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--c
Q 005054 587 GSLFRLLQRNTT----KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--L 660 (716)
Q Consensus 587 gsL~~~l~~~~~----~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~ 660 (716)
++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999976432 2457788899999999999999999 9999999999999999999999999986533221 1
Q ss_pred ccccCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
......+++.|+|||++.. ..++.++|||||||++|+|++ |..||....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 216 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 1223346778999999743 356789999999999999999 88999876543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.14 Aligned_cols=204 Identities=26% Similarity=0.349 Sum_probs=170.0
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCc-----
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR----- 576 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~----- 576 (716)
++|++.+.||+|+||.||++.+ .++.||||+++...........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999987 4678999988665433333456778999999995 6999999999887665
Q ss_pred eEEEEeecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCC
Q 005054 577 LCIVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 651 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~----~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGl 651 (716)
.|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999975 888887643 235899999999999999999999999 999999999999998 88999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
+..............+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 218 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 8765443333334467889999998865 45688999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.95 Aligned_cols=199 Identities=35% Similarity=0.574 Sum_probs=168.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCc
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 576 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~ 576 (716)
.+|++.+.||+|+||.||++.. .+..|++|.+.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5789999999999999999974 35679999986543 4445678899999999999999999987653 346
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999876667899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCccc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 657 ETYLT---TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 657 ~~~~~---~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..|+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 32211 1122334569999999998899999999999999999998777643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=268.28 Aligned_cols=201 Identities=32% Similarity=0.468 Sum_probs=179.2
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||.|++|.||++.+. +..|+||++...... .....+.+|+..+..++|+||+++++++.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36899999999999999999884 678999998765432 456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+++++|.+++... ..+++..++.++.||+.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999765 568999999999999999999999 99 999999999999999999999999998866544333
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 334467899999999999989999999999999999999999998775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=269.09 Aligned_cols=196 Identities=30% Similarity=0.540 Sum_probs=166.2
Q ss_pred eeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 511 EQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
++||+|+||.||+|.+.. ..|++|.+...... .....+.+|+.+++.+.||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 479999999999997632 46999998766543 44567888999999999999999999876 456899999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc---c
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---T 662 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~ 662 (716)
+++|.+++.+.. .+++..++.++.|++.+|.|||.++ ++|+||||+|||++.++.+||+|||++......... .
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999998754 6899999999999999999999998 999999999999999999999999998765432211 1
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 11223568999999999999999999999999999998 99999876643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.38 Aligned_cols=202 Identities=31% Similarity=0.492 Sum_probs=176.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
..+|++.+.||.|+||.||++.. .+..|++|.+..... .....+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47899999999999999999986 567799999865432 22466788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++.+. .+++..+..++.||+.+|.|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999999999754 4789999999999999999999999 999999999999999999999999988755443333
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....|++.|++||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 33456889999999998888899999999999999999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=266.50 Aligned_cols=196 Identities=32% Similarity=0.583 Sum_probs=168.2
Q ss_pred eeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 511 EQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
+.||+|+||.||++.. .+..||+|+++... .......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999986 45679999876543 344455688899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc-ccCCCC
Q 005054 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT-KTGKGT 668 (716)
Q Consensus 590 ~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~Gt 668 (716)
.+++......+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++.......... ....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9999776667899999999999999999999999 9999999999999999999999999987543322111 122346
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 669 ~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 67999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.25 Aligned_cols=201 Identities=32% Similarity=0.583 Sum_probs=177.6
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|.+.+.||+|+||.||++.. .+..|++|+++...........+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999987 567899999987765556778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc-
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 662 (716)
+++++|.+++... ..+++..++.++.|++.+|.|||+++ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999764 35789999999999999999999999 9999999999999999999999999987654432221
Q ss_pred ---ccCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 663 ---KTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 663 ---~~~~Gt~~Y~aPE~~~~~~---~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....+++.|++||++.+.. ++.++|||||||++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 1346788999999998776 7889999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=268.22 Aligned_cols=202 Identities=31% Similarity=0.499 Sum_probs=169.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+.+.....||+|+||.||++.+. +..|++|.+.... ......+.+|+.+++.++|+||+++++++...+.+++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344445568999999999999873 5569999876543 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCCcccccC
Q 005054 582 EFLPRGSLFRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l--~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~ 658 (716)
||+++++|.+++......+ +...+..++.||+.||.|||+++ |+|+||||+||+++. .+.++|+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999998654455 88889999999999999999998 999999999999976 678999999998765433
Q ss_pred ccccccCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
........|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 22233446899999999987644 6789999999999999999999997544
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=271.65 Aligned_cols=199 Identities=30% Similarity=0.464 Sum_probs=165.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHH-HHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~-iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++.+.||+|+||.||++.+ .+..||+|.++......... .+..|+. .++.++||||+++++++..+..+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999988 47789999987654433333 3444555 466678999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
||++ ++|.+++.. ....+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9995 588887754 234689999999999999999999986 7 99999999999999999999999999876543
Q ss_pred CccccccCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRN----EPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
.... ....|+..|++||++.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 157 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 157 SVAK-TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccc-ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 3221 23468899999998865 45678999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=275.09 Aligned_cols=202 Identities=27% Similarity=0.428 Sum_probs=172.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||.|++|.||++++ .+..|+||.++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999987 467899998876544444445778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
+. ++|..++... ...+++..++.++.||+.||+|||+++ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 95 5898888653 356899999999999999999999998 9999999999999999999999999987654433333
Q ss_pred ccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 206 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3446788999999887654 58899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=272.59 Aligned_cols=204 Identities=33% Similarity=0.481 Sum_probs=171.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccC-----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP----- 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~----- 574 (716)
..++|.+.+.||+|+||.||++.. .++.|++|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 457899999999999999999987 467899999865432 234566788999988 899999999998654
Q ss_pred CceEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
..+|+||||+++++|.+++.. ....+++..++.++.|++.+|.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998863 3456899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
+..............|+..|+|||++.... ++.++|||||||++|+|++|+.||...++.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 876544333333457899999999986443 578999999999999999999999876543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=271.73 Aligned_cols=201 Identities=27% Similarity=0.410 Sum_probs=171.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.++||.|++|.||++++ .+..|+||+++..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999998 4678999998765432 2234566799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 584 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 584 ~~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
+++ +|.+++.... ..+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8988886544 45899999999999999999999999 999999999999999999999999998765443333
Q ss_pred cccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....+++.|++||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 3344678899999998664 468899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=265.92 Aligned_cols=198 Identities=32% Similarity=0.432 Sum_probs=169.9
Q ss_pred cccceeEee-eeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccC----
Q 005054 503 LWEDLTIGE-QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP---- 574 (716)
Q Consensus 503 ~~~~y~i~~-~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~---- 574 (716)
+.++|.|.. +||-|-.|+|..|.. .+.++|+|++... ...++|+++.-.. .|||||.++++|+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 456777764 689999999999987 5778999987542 4456788876666 699999999998743
Q ss_pred CceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFG 650 (716)
..+.+|||.|+||.|+..+..++ ..|++.++..|+.||+.|+.|||+.+ |.||||||+|+|+.. +..+||+|||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccc
Confidence 45788999999999999998765 46999999999999999999999999 999999999999964 4569999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+|+..... ....+.+-||.|.|||++....|+..+|+||+||+||-||+|.+||.....
T Consensus 210 FAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 210 FAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred cccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 99876543 345577899999999999999999999999999999999999999987654
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=266.27 Aligned_cols=196 Identities=34% Similarity=0.614 Sum_probs=169.7
Q ss_pred eeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
++||.|+||.||++.+. ++.|++|.++..... .....+.+|+.+++.+.|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999875 788999988765443 4556788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc--ccCCC
Q 005054 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKG 667 (716)
Q Consensus 590 ~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~G 667 (716)
.+++.+....++...++.++.+++.+|.|||+++ ++||||||+|||++.++.+||+|||++.......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999776667899999999999999999999999 9999999999999999999999999987654221111 12233
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 668 t~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 567999999998889999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=268.29 Aligned_cols=197 Identities=33% Similarity=0.616 Sum_probs=170.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
..+|++.+.||+|+||.||++...++.|++|.++... ....+.+|+.+++.++||||+++++++..+ ..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4689999999999999999999999999999986532 235678899999999999999999998754 57999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
+++++|.+++.... ..+++..++.++.|++.+|.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999999997643 35789999999999999999999998 9999999999999999999999999987644321
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.....+..|++||.+.+..++.++|+|||||++|+|++ |+.||...+.
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 12234678999999998889999999999999999997 9999986653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=269.50 Aligned_cols=201 Identities=33% Similarity=0.543 Sum_probs=173.3
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC----HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
+|+..+.||+|+||.||++.. .+..|++|+++..... ......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 5678999998754321 2345788899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~ 658 (716)
||||+++++|.+++.+. .++++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999764 46899999999999999999999999 99999999999998765 5999999998765432
Q ss_pred cc----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YL----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~----~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1123467889999999998889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=278.67 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=174.6
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+.|.....||+|+||.||++.. .+..|+||.+.... ......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34566667899999999999987 46789999886533 334566888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++... .+++..++.++.||+.+|.|||+++ |+||||||+||+++.++.++|+|||++.........
T Consensus 99 e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 99 EFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred eCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999999988643 4889999999999999999999999 999999999999999999999999998755433333
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 33456899999999999988999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.84 Aligned_cols=199 Identities=30% Similarity=0.489 Sum_probs=176.6
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.+.||.|+||.||++.+. ++.|++|.+..... ......+.+|+.+++.+.||||+++++.+...+.++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999885 67899999876543 3455678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|+++++|.+++......+++..++.++.||+.+|.|||+ .+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999998765679999999999999999999999 88 999999999999999999999999998765433222
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
...++..|++||.+.+..++.++|||||||++|+|++|..||...
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 257889999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.58 Aligned_cols=201 Identities=36% Similarity=0.607 Sum_probs=175.7
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC---CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+|+..+.||+|+||.||+|.. .+..|++|++..... ..+....+.+|+.+++.++|+||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477789999999999999987 477899999865432 244567888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++.+. ..+++..++.++.||+.+|.|||+++ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999999765 35889999999999999999999999 9999999999999999999999999987654433
Q ss_pred ccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......|++.|++||.+.... ++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 223456899999999987776 88999999999999999999999987654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=269.18 Aligned_cols=196 Identities=35% Similarity=0.596 Sum_probs=169.8
Q ss_pred eeeecCCcEEEEEEEEcC---C--eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 511 EQIGQGSCGTVYHAVWYG---S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~---~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
++||+|++|.||++.+.. + .||||++...... .....+.+|+.++++++||||+++++++.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998732 2 5899998776544 566788999999999999999999999988 88999999999
Q ss_pred CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc---cc
Q 005054 586 RGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---LT 661 (716)
Q Consensus 586 ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~ 661 (716)
+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997755 56899999999999999999999999 9999999999999999999999999987654321 11
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.....++..|++||.+.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 206 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG 206 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 223456789999999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=318.67 Aligned_cols=205 Identities=31% Similarity=0.501 Sum_probs=178.8
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
-++.-+.+||.|.||.||.|.. +|.-.|+|-++.+.........+.+|+.+|..++|||+|++|++-.+.+.++|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3567778999999999999986 56678999887776666666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc--
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 660 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 660 (716)
||++|+|.+++.. ++..++.....+..|++.|+.|||++| ||||||||+||+|+.+|.+|++|||.|........
T Consensus 1315 yC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999999975 445777788888899999999999999 99999999999999999999999999987655432
Q ss_pred --ccccCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 661 --TTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 661 --~~~~~~Gt~~Y~aPE~~~~~---~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.....+||+.|||||++.+. ....++||||||||+.||+||+.||..+++.-
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 23345799999999999764 45778999999999999999999999887643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.67 Aligned_cols=203 Identities=34% Similarity=0.518 Sum_probs=172.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCC-----
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ----- 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~----- 575 (716)
.++|++.+.||.|+||.||++.. .+..|++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 47899999999999999999998 456799999876532 235678899999998 7999999999986544
Q ss_pred -ceEEEEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||+|+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998653 356899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
+..............|++.|+|||++.. ..++.++|||||||+||+|++|+.||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 224 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH
Confidence 8765544333445578999999998754 33577899999999999999999999866543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=271.11 Aligned_cols=202 Identities=27% Similarity=0.406 Sum_probs=171.9
Q ss_pred cceeEeeeeecCCcEEEEEEEEc------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-CCce
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRL 577 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-~~~~ 577 (716)
..|++++.||+|+||.||++... ...||||.|+.+...........+|+.+++.++||||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 57999999999999999999652 2259999998775444555677889999999999999999999887 7789
Q ss_pred EEEEeecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC----CcEEEEec
Q 005054 578 CIVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDF 649 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~----~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~----~~vkL~DF 649 (716)
+|++||.+. +|..+++-. ...++...++.|+.||+.|+.|||++- |+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999966 898888542 246899999999999999999999999 9999999999999876 89999999
Q ss_pred CCCcccccCccc---cccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 650 GLSRLKHETYLT---TKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 650 Gla~~~~~~~~~---~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
|+++...++... ....+-|..|+|||.+.|.. |+.+.|||++|||+.||++-.+.|.+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999987655332 23335688999999998876 5778999999999999999999887643
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=272.61 Aligned_cols=204 Identities=29% Similarity=0.542 Sum_probs=172.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..++|++.+.||+|+||.||++.+. +..|++|+++... .......+.+|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 3468999999999999999999863 4569999887543 3445567888999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT---------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~---------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~ 634 (716)
..|+||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 9999999999999999996432 24678889999999999999999998 999999999
Q ss_pred cEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 635 NLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
||+++.++.++|+|||++....... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987543221 11222345678999999999999999999999999999997 889997654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=278.66 Aligned_cols=200 Identities=29% Similarity=0.454 Sum_probs=173.2
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
..|.....||.|+||.||++.. .+..|++|++...... ....+.+|+.+++.+.||||+++++++...+..|+|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3455566899999999999987 4778999998654322 23567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|..++.. ..+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++..........
T Consensus 99 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 9999999998865 34899999999999999999999999 9999999999999999999999999987554433333
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 222 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 345789999999999998899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=269.18 Aligned_cols=198 Identities=31% Similarity=0.434 Sum_probs=162.8
Q ss_pred eeeecCCcEEEEEEEEcC----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWYG----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++...+ ..+++|.++.... ......+.+|+.+++.++||||+++++++.....+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999997633 3589998765543 23335678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc--
Q 005054 587 GSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 660 (716)
Q Consensus 587 gsL~~~l~~~~----~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 660 (716)
++|.+++.... ..+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999996532 23567788889999999999999999 99999999999999999999999999875433221
Q ss_pred ccccCCCCCCccCcccccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNE-------PSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~-------~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 216 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE 216 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence 12234578899999998643 34779999999999999996 99999866543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=274.74 Aligned_cols=206 Identities=24% Similarity=0.296 Sum_probs=171.3
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC----
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~---- 575 (716)
...++|++.++||+|+||.||++.. .+..||||.+............+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 3446899999999999999999987 4678999998765433333345567999999999999999999876543
Q ss_pred ----ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 576 ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 576 ----~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
..|+||||+. ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 5898888776667899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCcc----ccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYL----TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+........ ......++..|+|||++.+.. ++.++||||||+++|+|++|..||...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 875543221 112345788999999887654 68899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=271.29 Aligned_cols=204 Identities=31% Similarity=0.492 Sum_probs=171.5
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceecc------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS------ 573 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~------ 573 (716)
..+.|++.+.||.|+||.||++.+ .+..|++|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346899999999999999999988 45679999986542 2345677889999988 79999999999853
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
...+|++|||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 457899999999999999997633 45888899999999999999999999 999999999999999999999999998
Q ss_pred cccccCccccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..............|++.|+|||++. +..++.++|||||||++|+|++|..||....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 76543332333457899999999986 345788999999999999999999999766543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=273.90 Aligned_cols=201 Identities=31% Similarity=0.475 Sum_probs=176.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 468999999999999999999874 7789999886543 2445577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||+++++|..++.+. ..+++..+..++.+++.+|.|||+ ++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred ecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999998764 458999999999999999999997 57 9999999999999999999999999986543322
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 2245789999999999888899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=270.15 Aligned_cols=205 Identities=28% Similarity=0.466 Sum_probs=173.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEEcC------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-CC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-~~ 575 (716)
..++|++.+.||+|+||.||+|.+.. ..|++|.++.. ........+.+|+.+++.++||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 45789999999999999999998754 56899987643 344556778899999999999999999998765 56
Q ss_pred ceEEEEeecCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEe
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT-------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~-------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~D 648 (716)
..+++++|+++++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECC
Confidence 7899999999999999987642 35889999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 649 FGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 649 FGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
||+++....... ......++..|+|||++.+..++.++|||||||++|++++ |+.||...++
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 999975432211 1112345678999999999999999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=267.58 Aligned_cols=189 Identities=25% Similarity=0.429 Sum_probs=162.3
Q ss_pred eeeecCCcEEEEEEEEcCCe------------EEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 511 EQIGQGSCGTVYHAVWYGSD------------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~~~------------vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+.||+|+||.||++.+.... |++|++...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999885433 777776544321 4677889999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-------cEEEEecCC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-------TVKVGDFGL 651 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-------~vkL~DFGl 651 (716)
+||||+++++|.+++......++...++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999876657899999999999999999999998 99999999999999887 799999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 876543 2234567889999999877 78899999999999999999 688887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=260.03 Aligned_cols=205 Identities=27% Similarity=0.425 Sum_probs=173.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC--CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
..-.++.+++..||.|..|.|++++... .-.|||.+.+.....+ ..++...+.++... .+|+||+++++|..+..+
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 3445677888999999999999999854 6789999988765443 45566667766555 489999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+|.||.| ...+..++++-..++++..+-++..-++.||.||..+. +|||||+||+|||+|..|+|||||||++-+..+
T Consensus 167 ~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999 55778888877788999999999999999999998643 599999999999999999999999999988776
Q ss_pred CccccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+...+ ...|.+.|||||.+. ...|+.++||||||++++||.||+.||.+.+
T Consensus 245 SkAht-rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 245 SKAHT-RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred ccccc-cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 65444 347999999999985 4468899999999999999999999999754
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=268.62 Aligned_cols=191 Identities=23% Similarity=0.453 Sum_probs=161.4
Q ss_pred eeeecCCcEEEEEEEEc--------------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 511 EQIGQGSCGTVYHAVWY--------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~--------------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
+.||+|+||.||++... ...|++|++.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 36899999999999742 2248888875532 3344567888999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc-------EEEEec
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDF 649 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~-------vkL~DF 649 (716)
.++||||+++++|..++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999998876667999999999999999999999999 999999999999986654 899999
Q ss_pred CCCcccccCccccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCC
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELA-TEKIPWDNLN 709 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~ell-tG~~PF~~~~ 709 (716)
|++...... ....++..|+|||++. +..++.++|||||||++|+|+ .|..||....
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 988654322 2345788999999886 566888999999999999998 5899997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=263.88 Aligned_cols=202 Identities=32% Similarity=0.542 Sum_probs=181.6
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|.+.+.||.|+||.||++.+. +..|++|++............+.+|+++++.++|||++++++.+......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999985 77899999987666556677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 584 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 584 ~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
+++++|.+++... ...+++..++.++.+|+.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999765 367999999999999999999999998 99999999999999999999999999887655443
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 3344578999999999999989999999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=264.99 Aligned_cols=200 Identities=40% Similarity=0.699 Sum_probs=172.9
Q ss_pred eeEeeeeecCCcEEEEEEEEcC------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 507 LTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+++.+.||.|+||.||++.+.. ..||+|+++.... ......+..|+.+++.++|+||+++++++...+..|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 4567899999999999998854 6799999865432 33567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 581 TEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~-l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
|||+++++|.+++...... +++..++.++.||+.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999765544 899999999999999999999998 9999999999999999999999999987655432
Q ss_pred cccc-cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 660 LTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 660 ~~~~-~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
.... ...+++.|++||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1111 2346789999999988889999999999999999998 899997654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=275.03 Aligned_cols=202 Identities=26% Similarity=0.403 Sum_probs=168.7
Q ss_pred ceeEeeeeecCCcEEEEEEEE----cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--CceE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW----YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~~ 578 (716)
+|.+.++||+|+||.||+|.+ .+..||+|++..... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488999999999999999998 357899999887431 122335567899999999999999999999988 7899
Q ss_pred EEEeecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc----CCcEEEEecC
Q 005054 579 IVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFG 650 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~----~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~----~~~vkL~DFG 650 (716)
+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999964 777776432 236889999999999999999999999 999999999999998 8999999999
Q ss_pred CCcccccCcc---ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 651 LSRLKHETYL---TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 9886543322 22234678899999988764 578899999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=270.04 Aligned_cols=195 Identities=26% Similarity=0.403 Sum_probs=168.4
Q ss_pred eecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 513 LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
||+|+||+||++.+ .++.|++|++...... ......+..|+.+|+.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999986 4778999998764432 23345567899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCC
Q 005054 590 FRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668 (716)
Q Consensus 590 ~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt 668 (716)
.+++.+.. ..+++..++.++.||+.+|.|||+++ |+|+||+|+||+++.++.+||+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99987644 35899999999999999999999999 999999999999999999999999998755432 222344678
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 669 ~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..|++||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 899999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=270.06 Aligned_cols=202 Identities=31% Similarity=0.558 Sum_probs=174.7
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC---CCceeEEeceeccCCceEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~---hpnIv~~~~~~~~~~~~~lV 580 (716)
.|++.+.||.|+||.||+|.+ .+..|++|+++.... ......+.+|+.+++.+. ||||+++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999987 567899999875432 334566778999999986 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++... .+++..++.++.||+.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999998653 6899999999999999999999999 99999999999999999999999999887655443
Q ss_pred ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 3445578999999998865 456889999999999999999999998765543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=268.65 Aligned_cols=201 Identities=34% Similarity=0.563 Sum_probs=174.9
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+-|++.+.||.|+||.||++.. .+..||||++..... ......+.+|+.++..++||||+++++++......|+|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3577889999999999999986 466899998865433 3345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++++|..++... .+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 99999999998753 5899999999999999999999998 9999999999999999999999999987654433233
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....++..|++||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 206 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch
Confidence 345688999999999888889999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=271.90 Aligned_cols=198 Identities=32% Similarity=0.516 Sum_probs=169.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--Cc
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QR 576 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~ 576 (716)
+-|++++.||+|+||.||++.+ .+..|++|.++... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4578999999999999999974 35579999986543 344456788999999999999999999988765 56
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.++||||+++++|.+++.+....+++..++.++.||+.+|.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999999776556899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005054 657 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705 (716)
Q Consensus 657 ~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF 705 (716)
.... ......++..|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 3221 112345677899999999888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=267.84 Aligned_cols=195 Identities=32% Similarity=0.591 Sum_probs=162.9
Q ss_pred eeeecCCcEEEEEEEEcC--C--eEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeecC
Q 005054 511 EQIGQGSCGTVYHAVWYG--S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~--~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
+.||+|+||.||++.+.+ . .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998743 2 3677877643 2344456788899999999 79999999999999999999999999
Q ss_pred CCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecC
Q 005054 586 RGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (716)
Q Consensus 586 ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 650 (716)
+++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+|||++.++.+||+|||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCC
Confidence 999999997532 24788999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 158 l~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 98633221 11112234667999999998889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=262.97 Aligned_cols=202 Identities=32% Similarity=0.599 Sum_probs=181.1
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.+.||+|++|.||++.. .+..|++|.+............+.+|+.++..++|+||+++++++.....+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999987 466899999987766556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+++++|.+++... ..+++..++.++.|++.+|.|||+++ |+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999765 56899999999999999999999999 99999999999999999999999999987665544334
Q ss_pred cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...++..|++||.+.+..++.++|||+||+++|+|++|..||...+.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~ 204 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence 45789999999999888888999999999999999999999986554
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=265.62 Aligned_cols=202 Identities=30% Similarity=0.539 Sum_probs=176.0
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|.+.+.||.|+||.||++.. .+..|++|.+............+.+|+.+++.++|+||+++++.+......|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999988 467799999877544444456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc-EEEEecCCCcccccCccc
Q 005054 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-VKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~-vkL~DFGla~~~~~~~~~ 661 (716)
+++++|.+++.+.. ..+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++. +||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999997643 35789999999999999999999998 999999999999988754 699999998766544333
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 334468999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.60 Aligned_cols=201 Identities=30% Similarity=0.428 Sum_probs=172.1
Q ss_pred eeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|++.+.||.|++|.||++.+ .+..|++|++............+.+|+.+++.++||||+++++++...+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67789999999999999987 5778999998765444334456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 585 PRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 585 ~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+ ++|.+++.... ..+++..++.++.||+.+|.|||+++ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68999987644 46899999999999999999999998 99999999999999999999999999876543332223
Q ss_pred cCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 664 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34568899999988664 568899999999999999999999986654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=268.58 Aligned_cols=203 Identities=31% Similarity=0.568 Sum_probs=173.0
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC--------CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY--------SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--------~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
+|.+.+.||.|+||.||++.. .+..||+|.++.... .....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999976 567899998764221 1123456788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+++||||+++++|.+++.+. ..+++..+..++.||+.+|.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999775 46899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCcc--ccccCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 656 HETYL--TTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~~~--~~~~~~Gt~~Y~aPE~~~~~~--~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..... ......|+..|++||++.... ++.++|+||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 218 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH
Confidence 43211 122346889999999987655 788999999999999999999999765543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=265.95 Aligned_cols=193 Identities=26% Similarity=0.398 Sum_probs=171.5
Q ss_pred eecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 513 LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
||.|+||.||++... +..|++|++...... ......+.+|+.+++.++||||+++++.+..+..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 778999999765443 34456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCC
Q 005054 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (716)
Q Consensus 590 ~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (716)
.+++.+. ..++...+..++.||+.+|.|||+++ ++|+||||+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 9999764 35899999999999999999999998 9999999999999999999999999988665432 223446899
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 670 ~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.|++||.+.+..++.++|+|||||++|+|++|..||...+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 9999999988889999999999999999999999998766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=273.12 Aligned_cols=202 Identities=31% Similarity=0.592 Sum_probs=170.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.++|++.+.||+|+||.||++.+ .+. .|++|++.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 46789999999999999999986 333 47888876543 233445678899999999999999999998754 57
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++++||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccccC
Confidence 8999999999999999877667899999999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 658 ~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
... ......++..|++||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 221 1222345778999999999999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=270.62 Aligned_cols=201 Identities=33% Similarity=0.558 Sum_probs=173.6
Q ss_pred cceeEeeeeecCCcEEEEEEEEc------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCc
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 576 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~ 576 (716)
++|++.+.||+|+||.||++.+. +..||||+++..... .....+.+|+.+++.+.|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 57888899999999999999863 457999998765443 456788999999999999999999999877 557
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 89999999999999999876667999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 657 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 657 ~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
.... ......++..|++||.+.+..++.++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 3211 111223456799999999888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=260.57 Aligned_cols=200 Identities=37% Similarity=0.597 Sum_probs=178.2
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|.+.+.||.|++|.||++... +..|++|++..... .....+.+|+.+++.++|+||+++++++..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788999999999999999985 67899999876543 3457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+++++|.+++......+++..+..++.|++.+|.|||.++ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999876567999999999999999999999988 99999999999999999999999999876654432 33
Q ss_pred cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...++..|++||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 202 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence 45789999999999988889999999999999999999999987643
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=270.86 Aligned_cols=203 Identities=30% Similarity=0.505 Sum_probs=179.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..+.|++.+.||+|+||.||++.+. +..|++|+++.... ....+.+|+.+++.++|+||+++++.+......|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567889999999999999999985 77899999876543 446678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++......+++..++.++.||+.+|.|||+.| |+|+||||+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999876557999999999999999999999998 99999999999999999999999998875544333
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+++.|++||++.+..++.++|+|||||++|+|++|+.||...++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 33344678899999999988899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=260.51 Aligned_cols=201 Identities=36% Similarity=0.593 Sum_probs=180.4
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--CceEEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVT 581 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~~lVm 581 (716)
+|.+.+.||+|++|.||++... +..|++|++............+.+|+.++++++||||+++++.+... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999985 77899999987665556678889999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
||+++++|.+++.+.. .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998755 7999999999999999999999998 99999999999999999999999999887655432
Q ss_pred -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 661 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 661 -~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
......++..|++||.+.+...+.++||||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1234578999999999998889999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=270.81 Aligned_cols=205 Identities=18% Similarity=0.221 Sum_probs=158.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCC-----eEEEEEeeccCCCH--HH-------HHHHHHHHHHHHhcCCCceeE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSD--EV-------IHSFRQEVSLMKRLRHPNVLL 566 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~vAvK~~~~~~~~~--~~-------~~~~~~E~~iL~~l~hpnIv~ 566 (716)
++..++|++.++||+|+||.||+|.+.+. .+++|+........ +. ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 45568999999999999999999987543 56777543322111 00 011122334455678999999
Q ss_pred EeceeccCC----ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC
Q 005054 567 FMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 567 ~~~~~~~~~----~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~ 642 (716)
+++++.... ..+++|+++ ..++.+.+... ...++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998765443 347888888 44777777653 34678889999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCcccccCc-------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 643 TVKVGDFGLSRLKHETY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 643 ~vkL~DFGla~~~~~~~-------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||+||+|++|+.||....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999987543211 11223469999999999999999999999999999999999999998774
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=265.38 Aligned_cols=196 Identities=35% Similarity=0.563 Sum_probs=162.2
Q ss_pred eeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec-cCCceEEEEeec
Q 005054 511 EQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLCIVTEFL 584 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~-~~~~~~lVmE~~ 584 (716)
+.||+|+||.||+|.+. ...||+|.+.... .......+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999863 2358999875432 3344567888999999999999999999765 455689999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc----c
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----L 660 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----~ 660 (716)
.+++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999876666788888999999999999999998 9999999999999999999999999987543221 1
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1113346778999999998899999999999999999999 567776544
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=268.19 Aligned_cols=193 Identities=25% Similarity=0.414 Sum_probs=159.6
Q ss_pred eeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHH-HHHHHHHHHHH---HHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 512 QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSL---MKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 512 ~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~E~~i---L~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
.||+|+||.||++.+ .++.||+|++........ ....+.+|..+ +....||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 467899999876543221 12223334433 334479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccC
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (716)
+++|..++... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCc
Confidence 99999998764 35999999999999999999999999 9999999999999999999999999986543322 2234
Q ss_pred CCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 666 KGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 666 ~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.|++.|+|||.+. +..++.++|||||||++|+|++|..||....
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 6899999999986 4567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=267.03 Aligned_cols=204 Identities=27% Similarity=0.506 Sum_probs=173.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
.++|++.+.||.|+||.||+++.. ...|++|.+.... .......+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 368999999999999999999863 3458999876543 23356778899999999999999999999999899
Q ss_pred eEEEEeecCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEe
Q 005054 577 LCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~--------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~D 648 (716)
.|+||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ |+|+||||+|||++.++.++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999997543 15899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccC-ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 649 FGLSRLKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 649 FGla~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
||++...... ........++..|++||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~ 224 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence 9998643322 222223356778999999988888999999999999999998 8899976543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=262.39 Aligned_cols=201 Identities=31% Similarity=0.542 Sum_probs=178.5
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|++.++||.|+||.||++.. .+..|++|.+............+.+|+.+++.++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999987 456799999887655555567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 584 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 584 ~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
+++++|..++.+. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999998652 345899999999999999999999999 999999999999999999999999999876554
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22235689999999999999899999999999999999999999987664
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=269.17 Aligned_cols=191 Identities=23% Similarity=0.403 Sum_probs=159.8
Q ss_pred eeecCCcEEEEEEEEc--------------------------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCcee
Q 005054 512 QIGQGSCGTVYHAVWY--------------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565 (716)
Q Consensus 512 ~LG~G~fg~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv 565 (716)
+||+|+||.||++... ...|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6999999999998641 1248888875432 33445678889999999999999
Q ss_pred EEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---
Q 005054 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW--- 642 (716)
Q Consensus 566 ~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~--- 642 (716)
++++++......|+||||+++++|..++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999776667899999999999999999999998 99999999999997543
Q ss_pred ----cEEEEecCCCcccccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCCc
Q 005054 643 ----TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELA-TEKIPWDNLNS 710 (716)
Q Consensus 643 ----~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~ell-tG~~PF~~~~~ 710 (716)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|+.||....+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4899999987643322 12357888999998875 56789999999999999985 69999986653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.67 Aligned_cols=215 Identities=27% Similarity=0.407 Sum_probs=179.0
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-----HHHHHHHHHHHHHHHhcCCCceeEEecee
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-----DEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-----~~~~~~~~~E~~iL~~l~hpnIv~~~~~~ 571 (716)
+...+.++|-++..||+|||+.||++.+ ..+.||||+-...... .....-..+|.+|.+.|.||.||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3355678999999999999999999987 5667999986543322 22344567899999999999999999999
Q ss_pred cc-CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc---cCCcEEEE
Q 005054 572 TS-PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVG 647 (716)
Q Consensus 572 ~~-~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~---~~~~vkL~ 647 (716)
.- .+.+|-|+|||+|.+|.-+|+.+. .+++..+..|+.||+.||.||....++|||-||||.|||+- ..|.|||.
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 74 467899999999999999998754 68999999999999999999999999999999999999995 45789999
Q ss_pred ecCCCcccccCccc-------cccCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 648 DFGLSRLKHETYLT-------TKTGKGTPQWMAPEVLRNE----PSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 648 DFGla~~~~~~~~~-------~~~~~Gt~~Y~aPE~~~~~----~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
|||+++...+.... +.-..||..|++||++.-. ..+.++||||+|||+|.++.|+.||...-.-|+|
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 99999976654332 3345799999999987533 3478999999999999999999999876655543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=271.60 Aligned_cols=206 Identities=28% Similarity=0.382 Sum_probs=172.9
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC----
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~---- 575 (716)
...++|++.+.||+|+||.||++.. .+..|++|+++...........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4457899999999999999999998 4678999998765433333456678999999999999999999987654
Q ss_pred ------ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 576 ------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 576 ------~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
.+|+||||+++ +|..++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999965 788888766567999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccCcc-ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 650 GLSRLKHETYL-TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 650 Gla~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|++........ ......++..|++||++.+. .++.++|||||||++|+|++|++||...+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99876544321 12233567889999988654 568899999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=268.41 Aligned_cols=202 Identities=27% Similarity=0.399 Sum_probs=176.3
Q ss_pred eeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|++.+.||.|++|.||++.. .+..+++|.++...........+.+|+.+++.++|+||+++++++..+..+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56788999999999999987 4677999998776555445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccccc
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (716)
++ +|..++......+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||.+............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 65 898888776667999999999999999999999999 999999999999999999999999998766554322333
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 665 GKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 665 ~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..++..|++||.+.+. .++.++|+|||||++|+|++|+.||...+.+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 205 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4678899999999877 7789999999999999999999999876643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=265.92 Aligned_cols=199 Identities=28% Similarity=0.450 Sum_probs=171.9
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCceEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIV 580 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~~~lV 580 (716)
++|++.+.||.|++|.||++.+ .++.|++|.+..... ......+.+|+++++.++||||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4689999999999999999998 467799999875433 3445778899999999999999999998854 3468999
Q ss_pred EeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||+++++|.+++.. ....+++..+..++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999888753 3456889999999999999999999999 99999999999999999999999999875543
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
... ....++..|++||.+.+..++.++|||||||++|+|++|..||...
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 322 2345788999999999999999999999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=268.44 Aligned_cols=199 Identities=30% Similarity=0.486 Sum_probs=172.6
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
+|...+.||+|++|.||++.. .+..|++|++.... ......+.+|+.+++.+.||||+++++++...+..|+||||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567999999999999986 45679999886433 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+++++|.+++.. ..++...+..++.||+.+|.|||+++ |+||||||+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999976 45899999999999999999999999 99999999999999999999999998875544333333
Q ss_pred cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...|++.|++||.+.+..++.++|||||||++|+|++|+.||...++
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~ 220 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence 45689999999999998899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=267.93 Aligned_cols=200 Identities=26% Similarity=0.417 Sum_probs=170.2
Q ss_pred ceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCCC--HHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~--~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+|++.+.||.|+||.||++.. .+..||+|+++..... ......+.+|+.+++.+ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999986 4678999998764321 23346677899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++... ..+++..+..++.||+.+|.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999999764 45889999999999999999999999 99999999999999999999999999876443
Q ss_pred Cc-cccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~--~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
.. .......|+..|++||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 21 122234689999999998753 4678899999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=266.56 Aligned_cols=192 Identities=26% Similarity=0.404 Sum_probs=159.9
Q ss_pred eeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHH---HHHHHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 512 QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQE---VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 512 ~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E---~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
.||+|+||.||++.+ .++.||+|++....... .....+..| +.+++...||+|+++++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 46789999987654322 111122233 344555689999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccC
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (716)
|++|..++.+. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS 155 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCc
Confidence 99999988754 46899999999999999999999998 9999999999999999999999999987544322 2244
Q ss_pred CCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 666 KGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 666 ~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
.|+..|++||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 789999999999754 6789999999999999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=271.86 Aligned_cols=205 Identities=27% Similarity=0.423 Sum_probs=169.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------- 574 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------- 574 (716)
.++|++.++||.|+||.||++.+ .+..|+||++............+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999987 467799999876543332334566899999999999999999887543
Q ss_pred -CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 575 -~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
..+|+||||+.+ +|...+......+++..++.++.||+++|.|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999954 788877765667999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCccc-----------cccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 654 LKHETYLT-----------TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 654 ~~~~~~~~-----------~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
........ .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 54332211 1123568889999988654 5788999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=275.78 Aligned_cols=202 Identities=28% Similarity=0.375 Sum_probs=171.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-----Cc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~-----~~ 576 (716)
.++|.+.+.||+|+||.||++.+ .+..|+||.++...........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999987 467899999876433333345667899999999999999999987654 34
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 799999995 6899988764 46999999999999999999999999 9999999999999999999999999998665
Q ss_pred cCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 43233334468899999998865 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=274.75 Aligned_cols=200 Identities=28% Similarity=0.459 Sum_probs=167.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-----Cc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~-----~~ 576 (716)
.++|++.++||+|+||.||++.+ .+..||||+++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 47899999999999999999987 56789999986432 223456677899999999999999999886544 35
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.|+||||+. ++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588888864 35899999999999999999999999 9999999999999999999999999987543
Q ss_pred cCcc---ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 657 ETYL---TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 657 ~~~~---~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3211 1123468999999998755 567889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=269.01 Aligned_cols=202 Identities=34% Similarity=0.468 Sum_probs=173.9
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
...+.|.+.+.||+|+||.||++.. .+..|++|++..... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 3346799999999999999999987 477899999875433 3445567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+. ++|.+++......+++..+..++.||+.+|.|||+++ |+|+||+|+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9999996 5888887665667999999999999999999999999 999999999999999999999999998754432
Q ss_pred ccccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+++.|+|||++. ...++.++||||||+++|+|++|+.||...+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 2346788999999884 35578899999999999999999999986553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=265.10 Aligned_cols=198 Identities=25% Similarity=0.356 Sum_probs=166.1
Q ss_pred eeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccC--CceEEEE
Q 005054 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVT 581 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~--~~~~lVm 581 (716)
|++.++||+|+||.||++.. .++.||+|.++......... ...+|+.++.++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67899999999999999987 56789999987643333222 3346888888885 99999999999987 8899999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++. +.+||+|||++.........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 9996 5888888765567899999999999999999999999 999999999999999 99999999998765433222
Q ss_pred cccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+++.|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 2346789999999765 45568899999999999999999999987654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=264.88 Aligned_cols=203 Identities=29% Similarity=0.543 Sum_probs=177.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lV 580 (716)
++|.+.+.||.|+||.||++.. .+..|++|++..... .......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 577899999876433 2344467788999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY- 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 659 (716)
|||+++++|.+++.+.. .+++..++.++.||+.+|.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999998753 6999999999999999999999999 9999999999999999999999999987554322
Q ss_pred -------------------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 -------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 -------------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.......++..|++||++.+..++.++|+|||||++|+|++|..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 222334678999999999988899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=263.12 Aligned_cols=192 Identities=23% Similarity=0.378 Sum_probs=162.7
Q ss_pred ccceeEeeee--ecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 504 WEDLTIGEQI--GQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~L--G~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
.++|++.+.+ |.|+||.||++.. .+..+++|++........ |+.....+ +||||+++++.+...+.+|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 3566776766 9999999999987 466799999876533221 22222222 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 657 (716)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999998754 7999999999999999999999999 99999999999999988 999999999876543
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
. ....|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 163 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 163 P----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred C----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 23468999999999999999999999999999999999999998543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=278.95 Aligned_cols=213 Identities=34% Similarity=0.577 Sum_probs=186.0
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc----CC--eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY----GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~----~~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~ 571 (716)
..|++..+...+.++||+|.||.||+|.+. +. .||||..+.+...+ ..+.|..|.-+|++++||||+++++++
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeee
Confidence 356666677888899999999999999873 22 38999887755433 378899999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
.+ ..+|||||+++-|.|..|++.+...++......+..||+.+|.|||+.+ +|||||-..|||+.....|||+|||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 74 5789999999999999999999889999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccC-ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 005054 652 SRLKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQDS 714 (716)
Q Consensus 652 a~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~~ 714 (716)
++...+. ++......-...|||||.+.-..++.++|||.||+.|||++. |..||.+..+-+.+
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI 602 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI 602 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence 9987654 344444455779999999999999999999999999999887 99999987765554
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=272.50 Aligned_cols=200 Identities=30% Similarity=0.427 Sum_probs=171.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----- 575 (716)
+.++|++.+.||+|+||.||++.. .+..||||++............+.+|+.+|+.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 567899999999999999999987 4678999998665444445567889999999999999999999987654
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 7799988864 35899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.... .....+++.|++||++.+ ..++.++|+|||||++|+|++|..||...+.
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 168 TDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred cccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5432 223467899999999876 4578899999999999999999999986653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=264.73 Aligned_cols=201 Identities=29% Similarity=0.398 Sum_probs=172.5
Q ss_pred eeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--CceEEEEe
Q 005054 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTE 582 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~~lVmE 582 (716)
|++.++||.|+||.||++... +..|++|.+............+.+|+.+++.++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678999999999999999874 57899999987643344456677899999999999999999999888 88999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-c
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (716)
|+++ +|..++......+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9965 899998776567999999999999999999999998 99999999999999999999999999876554321 1
Q ss_pred cccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 223356889999998765 4578899999999999999999999986653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=266.49 Aligned_cols=192 Identities=24% Similarity=0.426 Sum_probs=161.6
Q ss_pred eeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 511 EQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
+.||.|+||.||++... ..+|++|.+.... ....+.+.+|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 36899999999999763 2247888765432 334567788999999999999999999999989999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc--------EEEEecCCCc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSR 653 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~--------vkL~DFGla~ 653 (716)
||+++++|..++..+...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++|||++.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999876667899999999999999999999999 999999999999987654 6999999886
Q ss_pred ccccCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcC-CCCCCCCCc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATE-KIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG-~~PF~~~~~ 710 (716)
..... ....++..|+|||++.+. .++.++|||||||++|+|++| ..||...++
T Consensus 157 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 157 TVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred ccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 54332 234678899999999864 578899999999999999998 577765543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=263.30 Aligned_cols=202 Identities=31% Similarity=0.523 Sum_probs=169.6
Q ss_pred eeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC------
Q 005054 507 LTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~------ 575 (716)
|.+.+.||+|+||.||++.+. +..||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999752 467999999876666666778889999999999999999999876532
Q ss_pred ceEEEEeecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~-----~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 650 (716)
..+++++|+.+++|..++... ...++...++.++.||+.+|+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 247899999999999887432 224788999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 651 LSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
++....... .......+++.|++||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 988653321 11223345678999999999999999999999999999999 8999986654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=273.53 Aligned_cols=202 Identities=30% Similarity=0.408 Sum_probs=171.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC----
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP---- 574 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~---- 574 (716)
....++|.+.+.||+|+||.||++.+ .+..||+|+++...........+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34568999999999999999999986 467899999876543344456677899999999999999999987543
Q ss_pred --CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 575 --QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 575 --~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
..+|++++++ +++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccc
Confidence 3478899988 78999888643 4899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 168 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred cccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 765432 223467899999999876 5678899999999999999999999976654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=262.11 Aligned_cols=202 Identities=28% Similarity=0.497 Sum_probs=171.8
Q ss_pred ceeEeeeeecCCcEEEEEEEEcC---CeEEEEEeeccC--------CCHHHHHHHHHHHHHHHh-cCCCceeEEeceecc
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWYG---SDVAVKVFSRQE--------YSDEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTS 573 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~~---~~vAvK~~~~~~--------~~~~~~~~~~~E~~iL~~-l~hpnIv~~~~~~~~ 573 (716)
.|++.+.||+|+||.||++.+.. ..+++|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37888999999999999999854 679999876432 223445567778888765 699999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
++..|+||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .+ |+|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 34568999999999999999999996 66 999999999999999999999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~ 218 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH
Confidence 9987655433 23345689999999999998899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=260.97 Aligned_cols=193 Identities=30% Similarity=0.440 Sum_probs=163.4
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHH-HhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL-~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||.|+||.||+|.. .++.||+|++++.... ......+..|..++ ...+|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999987 5678999998764432 22223344454443 455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||+|+||+++.++.+||+|||++..... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999999764 46899999999999999999999999 99999999999999999999999998875433 22446
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|++.|++||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 88999999999988889999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=269.58 Aligned_cols=200 Identities=34% Similarity=0.480 Sum_probs=172.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.+.|...+.||+|+||.||++.. .+..|++|++..... ..+....+.+|+.+++.++|||++++++++......|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 35588899999999999999987 467899999875433 334556788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+.+ +|.+++.....++++..+..++.||+.+|.|||+++ |+|+||+|+||+++.++.+||+|||++......
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 999965 888888766667999999999999999999999999 999999999999999999999999988654332
Q ss_pred ccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|++.|+|||++. +..++.++|||||||++|+|++|+.||...+.
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 2446889999999974 45678899999999999999999999977654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=273.90 Aligned_cols=201 Identities=30% Similarity=0.411 Sum_probs=174.4
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----ceE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~-----~~~ 578 (716)
+|++.+.||.|+||.||++... +..|+||++............+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999974 678999998765433445567888999999999999999999988775 789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+. ++|.+++.+.. .+++..++.++.||+.+|.|||+++ |+|+||||.|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999996 58999887644 7999999999999999999999999 999999999999999999999999999876544
Q ss_pred c---cccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 Y---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~---~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .......+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 2 122334678999999999888 789999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=275.55 Aligned_cols=202 Identities=24% Similarity=0.397 Sum_probs=170.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc----CCceE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLC 578 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----~~~~~ 578 (716)
.+|++.+.||.|+||.||++.. .+..|++|++............+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999987 47789999987654333445667789999999999999999998763 34689
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 5899988654 45899999999999999999999999 999999999999999999999999998754332
Q ss_pred cc----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YL----TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~----~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ......|+..|++||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 11 1123468899999999866 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=261.33 Aligned_cols=195 Identities=30% Similarity=0.479 Sum_probs=170.2
Q ss_pred eecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 513 LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
||.|+||.||++.+. ++.|++|++..... .......+.+|+.+++.++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 77899999876543 234567788899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc--------c
Q 005054 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--------T 661 (716)
Q Consensus 590 ~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--------~ 661 (716)
.+++.+.. .+++..++.++.||+.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99997754 6899999999999999999999999 99999999999999999999999999875433311 2
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....++..|++||.+.+..++.++|+|||||++|+|++|..||...++
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 2344678899999999888889999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=263.50 Aligned_cols=197 Identities=29% Similarity=0.464 Sum_probs=158.9
Q ss_pred eeeecCCcEEEEEEEEc-CC---eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWY-GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~-~~---~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+.||+|+||.||++... +. .+++|.++... .......+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 36999999999999752 32 35566554432 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--cc
Q 005054 587 GSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LT 661 (716)
Q Consensus 587 gsL~~~l~~~~---~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~ 661 (716)
++|.+++.+.. ..++...++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999997642 34567788899999999999999998 9999999999999999999999999976432211 12
Q ss_pred cccCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||...++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 234568899999999753 234678999999999999997 6789976554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=264.27 Aligned_cols=197 Identities=34% Similarity=0.579 Sum_probs=165.3
Q ss_pred eeeecCCcEEEEEEEEcC--------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 511 EQIGQGSCGTVYHAVWYG--------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+.||+|+||.||++.... ..|++|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998643 468999876543 22345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-----cEEEEecCC
Q 005054 583 FLPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-----TVKVGDFGL 651 (716)
Q Consensus 583 ~~~ggsL~~~l~~~------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-----~vkL~DFGl 651 (716)
|+++++|.+++... ...+++..++.++.||+.+|.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999999652 234788999999999999999999998 99999999999999877 899999999
Q ss_pred CcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 652 SRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+....... .......++..|++||++.+..++.++|||||||++|+|++ |+.||...++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~ 219 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH
Confidence 87543221 11223345788999999999999999999999999999998 9999986654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=265.74 Aligned_cols=200 Identities=29% Similarity=0.423 Sum_probs=166.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|+..+.||+|+||.||++.+ .+..||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4667778999999999999987 4678999998765433 34567788999999995 999999999999999999999
Q ss_pred eecCCCCHHHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 582 EFLPRGSLFRLLQ----RNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 582 E~~~ggsL~~~l~----~~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
||+. ++|.++.. .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9995 46655432 2235689999999999999999999974 7 9999999999999999999999999987654
Q ss_pred cCccccccCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..... ....|++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 160 DSIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred cCCcc-ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 33222 233688999999999776 67889999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=268.67 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=171.0
Q ss_pred eeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
|.+++.+|.|+++.||++...++.||||+++...........+.+|+.+++.++|+||+++++++...+..|++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45566677777888888877889999999987655556677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-----
Q 005054 587 GSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL----- 660 (716)
Q Consensus 587 gsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----- 660 (716)
++|.+++... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999999764 345889999999999999999999999 99999999999999999999999998764332111
Q ss_pred --ccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 661 --TTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 661 --~~~~~~Gt~~Y~aPE~~~~~--~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12233567889999998763 57889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=273.51 Aligned_cols=203 Identities=25% Similarity=0.401 Sum_probs=169.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccC--Cce
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP--QRL 577 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~--~~~ 577 (716)
+.++|++.+.||+|+||.||+|.+ .+..|++|.+............+.+|+.+++.+ +||||+++++++... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 457899999999999999999987 467899998865433334445677899999999 999999999988654 358
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||++ ++|..++... .+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999996 5999998764 6888999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccc-----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYL-----TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~-----~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... ......|++.|++||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 221 2223468999999998765 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=262.08 Aligned_cols=200 Identities=30% Similarity=0.408 Sum_probs=169.1
Q ss_pred eeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeceeccCCc-----
Q 005054 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQR----- 576 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l---~hpnIv~~~~~~~~~~~----- 576 (716)
|++.+.||+|+||.||++.+. +..||+|+++...........+.+|+.+++.+ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999984 67899999976544333344566677777666 59999999999988776
Q ss_pred eEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
++++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999965 8998887643 35899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...... ....++..|++||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 158 ~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 158 SFEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred cCCccc-ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 433221 233578899999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=279.52 Aligned_cols=199 Identities=25% Similarity=0.421 Sum_probs=172.6
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCC--eEEEEEeeccCCCH------HHHHHHHHHHHHHHhcC---CCceeEEeceec
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLR---HPNVLLFMGAVT 572 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~--~vAvK~~~~~~~~~------~~~~~~~~E~~iL~~l~---hpnIv~~~~~~~ 572 (716)
..+|..++.+|.|+||.|++|.++.+ .|+||.+.+++.-. ..+-.+--|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 35699999999999999999998544 58999887765421 11123445899999997 999999999999
Q ss_pred cCCceEEEEeec-CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 573 SPQRLCIVTEFL-PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 573 ~~~~~~lVmE~~-~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
+++++||+||.- +|.+|++++..+ ..+++..++.|++|++.|+++||++| |||||||-+||+++.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 999999999975 567999999765 45999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
+.+..... ...++||..|.|||++.|.+| +..-|||+||++||.++....||.+
T Consensus 717 aa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98766543 336789999999999999998 6678999999999999999999975
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.87 Aligned_cols=197 Identities=26% Similarity=0.429 Sum_probs=165.6
Q ss_pred eeeecC--CcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQG--SCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
..||.| +||+||++.+ .++.||+|++..........+.+.+|+.+++.++||||++++++|...+.+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999988 678899999987665566678889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-----
Q 005054 587 GSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL----- 660 (716)
Q Consensus 587 gsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----- 660 (716)
++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999987643 35889999999999999999999998 99999999999999999999999986432211100
Q ss_pred --ccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 661 --TTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 661 --~~~~~~Gt~~Y~aPE~~~~~--~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
......++..|++||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 01112346679999999764 46789999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=263.96 Aligned_cols=204 Identities=29% Similarity=0.445 Sum_probs=170.7
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCc
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~ 576 (716)
+.+..++|++.+.||.|+||.||++.+. +..||||.++...... ....+..|+.++..+ .||||+++++++.....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3455688999999999999999999986 7889999997654333 334555667666666 59999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+|+||||+ +++|.+++......+++..+..++.||+.+|.|||+ ++ |+|+||+|+||+++.++.+||+|||++...
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999999 458888887656679999999999999999999997 57 999999999999999999999999998765
Q ss_pred ccCccccccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
...... ....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...
T Consensus 166 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 166 VDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred cCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 433222 2335788999999987654 788999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=267.06 Aligned_cols=200 Identities=28% Similarity=0.427 Sum_probs=170.2
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-CCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-~~~~~l 579 (716)
..++|.+.+.||.|+||.||++.+ .+..||||.+............+..|+.+++.++||||+++++++.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 457899999999999999999986 46679999886544334445667789999999999999999999865 567899
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+ +++|..++... .+++..+..++.||+.||.|||+++ |+|+||||.|||++.++.+||+|||++.......
T Consensus 88 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 88 VTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred Eeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 99999 66899888643 4788889999999999999999999 9999999999999999999999999987543321
Q ss_pred cccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+++.|++||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 163 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred ---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 23467889999998866 5688999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=263.75 Aligned_cols=201 Identities=28% Similarity=0.413 Sum_probs=174.7
Q ss_pred eeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|++.+.||+|+||.||++... ++.|++|++............+..|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567889999999999999884 678999999876433444566778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccccc
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (716)
+ ++|.+++.+....+++..++.++.|++.+|.|||+++ |+|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 6 5999999876557999999999999999999999999 999999999999999999999999998765544333334
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 665 GKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 665 ~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 204 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 4567889999998776 788899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=266.42 Aligned_cols=195 Identities=29% Similarity=0.464 Sum_probs=169.0
Q ss_pred eeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCC
Q 005054 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
..+||+|+||.||++.. .+..|+||++.... ......+.+|+.+++.++|+||+++++.+...+..|+||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 46899999999999987 46789999875432 234566888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCC
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (716)
+|.+++... .+++..++.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++..............|
T Consensus 103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 999988643 4889999999999999999999998 999999999999999999999999988755433222334568
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 668 t~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++.|++||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~ 221 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999888889999999999999999999999986653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=270.18 Aligned_cols=199 Identities=29% Similarity=0.429 Sum_probs=168.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~------ 575 (716)
..+|.+.+.||+|+||.||+|.+ .+..||||++............+.+|+.+++.+.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999986 4778999998765433444456788999999999999999999987543
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|+||||+. .+|..++. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999995 47777653 35899999999999999999999999 999999999999999999999999998764
Q ss_pred ccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.+
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~ 221 (342)
T cd07879 168 DAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221 (342)
T ss_pred CCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 332 123467889999999876 45788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=263.38 Aligned_cols=199 Identities=34% Similarity=0.498 Sum_probs=171.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
+.|...++||+|+||.||++.. .+..|++|++..... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3477778899999999999987 567899999876543 3344567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+. ++|.+++.....++++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 9995 5888888776667999999999999999999999999 99999999999999999999999998864332
Q ss_pred cccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 22456889999999984 45678899999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=266.79 Aligned_cols=200 Identities=26% Similarity=0.348 Sum_probs=166.1
Q ss_pred ceeEeeeeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceecc----CCc
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS----PQR 576 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~----~~~ 576 (716)
+|++.+.||+|+||.||++.+. +..||+|.+............+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4889999999999999999985 45799999875433333456677899999999 59999999987532 245
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|++|+|+. ++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999995 6899988653 46899999999999999999999999 9999999999999999999999999987544
Q ss_pred cCcc----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 657 ETYL----TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 657 ~~~~----~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 3211 1223468999999998765 568899999999999999999999998755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=270.69 Aligned_cols=201 Identities=29% Similarity=0.422 Sum_probs=172.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR---- 576 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~---- 576 (716)
+.++|++.+.||+|+||.||++.+ .+..|++|++............+.+|+.+++.+.||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457899999999999999999988 46679999987654444455667789999999999999999998876654
Q ss_pred --eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 577 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 577 --~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+|+|+||+ +++|.+++.. ..+++..++.++.||+.+|.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 6799999875 35899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~ 222 (343)
T cd07851 168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI 222 (343)
T ss_pred cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 5433 223467889999999865 36788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=281.01 Aligned_cols=208 Identities=32% Similarity=0.497 Sum_probs=182.6
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceec-----cCC
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT-----SPQ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~-----~~~ 575 (716)
.+.|+|...||.|.+|.||+++. .++.+|+|++......+ .++..|.++|+.+ .|||++.+|++|. .++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 35789999999999999999975 67789999987765443 4556688888887 6999999999986 357
Q ss_pred ceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
++|||||||.||+.-+++++. +..+.+..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||+|||++..
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 899999999999999999763 466899999999999999999999998 99999999999999999999999999988
Q ss_pred cccCccccccCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCccccccC
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNE-----PSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSCR 716 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~~ 716 (716)
....-....+.+|||.|||||++... .|+.++|+||||++..||--|.+|+-++.++..+++
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~ 239 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 239 (953)
T ss_pred eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc
Confidence 87777777788999999999998643 357789999999999999999999999999887763
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=288.58 Aligned_cols=147 Identities=28% Similarity=0.445 Sum_probs=133.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|.++++||+|+||.||+|.+. ++.||||+++.... .......+..|+.++..++||||++++.++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999985 77899999976543 345567788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
|||+.+++|.+++... ..+++..++.++.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999764 35889999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=260.56 Aligned_cols=200 Identities=26% Similarity=0.383 Sum_probs=169.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCCC--HHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~--~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+|++.+.||+|+||.||++.. .++.|+||++++.... ......+.+|+.++..+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999875 3567999998754321 23345677899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+.+++|.+++... ..+++..++.++.|++.+|.|||+.+ ++|+||||.||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999998764 45889999999999999999999988 99999999999999999999999999875433
Q ss_pred Ccc-ccccCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TYL-TTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~~-~~~~~~Gt~~Y~aPE~~~~~~--~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
... ......|+..|++||.+.+.. .+.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 221 122346899999999987765 678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=242.92 Aligned_cols=204 Identities=26% Similarity=0.414 Sum_probs=170.5
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCc
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~ 576 (716)
+++..++...+..||+|++|.|-+.++ .|.-.|+|.+..... .+...++..|+.+..+. .+|.+|.||+.+.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 556667777788999999999888876 677789998866543 44455666777765554 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 577 LCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
++|.||.| ..+|..+.++ .+..+++..+-+|+..++.||.|||++ ..|||||+||+||||+.+|+||+||||.+-
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999 5588766543 466789999999999999999999985 259999999999999999999999999998
Q ss_pred ccccCccccccCCCCCCccCccccc----CCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLR----NEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
...++...+ ...|...|||||.+. ...|+.++||||||++++||.++++||+.
T Consensus 198 ~L~dSiAkt-~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIAKT-MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhHHH-HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 877765444 346888999999985 34688999999999999999999999984
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=267.34 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=167.5
Q ss_pred ccee-EeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHH------------HHHHHHHHHHHHHhcCCCceeEEec
Q 005054 505 EDLT-IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE------------VIHSFRQEVSLMKRLRHPNVLLFMG 569 (716)
Q Consensus 505 ~~y~-i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~------------~~~~~~~E~~iL~~l~hpnIv~~~~ 569 (716)
++|. +.+.||.|+||.||++.+ .++.||||+++....... ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 457799999999999986 467899999876433210 0124678999999999999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
++...+..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 5899998653 45899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccC--------------ccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 650 GLSRLKHET--------------YLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 650 Gla~~~~~~--------------~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|++...... ........+++.|++||.+.+.. ++.++|||||||++|+|++|+.||...++
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 998755411 11112335688999999987654 68899999999999999999999987654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=252.99 Aligned_cols=194 Identities=31% Similarity=0.494 Sum_probs=171.5
Q ss_pred eecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 513 LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
||.|+||.||++... +..|++|++...... ......+..|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999874 678999998776442 33566788899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCC
Q 005054 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (716)
Q Consensus 590 ~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (716)
.+++.... .+++..++.++.||+.+|.|||+++ ++|+||||+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99997653 5899999999999999999999998 99999999999999999999999999876554322334556889
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 670 ~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.|++||.+.+...+.++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999998888999999999999999999999997665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=268.34 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=165.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------- 574 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------- 574 (716)
..+|.+.+.||.|+||.||++.+ .+..|++|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 47899999999999999999987 467899999876543 3345677899999999999999999876644
Q ss_pred -------CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEE
Q 005054 575 -------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKV 646 (716)
Q Consensus 575 -------~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL 646 (716)
...|+||||++ ++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 35799999996 5898888643 5899999999999999999999999 999999999999974 567899
Q ss_pred EecCCCcccccCcc---ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 647 GDFGLSRLKHETYL---TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 647 ~DFGla~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...++
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 224 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999875432211 1122357889999998754 5578899999999999999999999986654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=257.41 Aligned_cols=209 Identities=30% Similarity=0.416 Sum_probs=171.1
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHH-HHhcCCCceeEEeceeccC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~i-L~~l~hpnIv~~~~~~~~~ 574 (716)
..++...++.+-+..||.|+||+|+|..+ .++..|||.++...... ...++..|... ++.-++||||+||++....
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34455556677778999999999999988 46679999998766533 34556666664 4555899999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~----~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 650 (716)
+..||.||+| ..+|..+.+. ....+++..+-.|..-.+.||.||... ..||||||||+|||++..|.|||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeeccc
Confidence 9999999999 5577665542 345689999999999999999999764 249999999999999999999999999
Q ss_pred CCcccccCccccccCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++-...++...+ ...|...|||||.+. +..|+.++|+||||++|||+.||..||..-+.
T Consensus 214 IcGqLv~SiAkT-~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 214 ICGQLVDSIAKT-VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred chHhHHHHHHhh-hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 987766665444 447899999999985 44589999999999999999999999987664
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=255.17 Aligned_cols=201 Identities=30% Similarity=0.496 Sum_probs=169.5
Q ss_pred ceeEeeeeecCCcEEEEEEEEcC--CeEEEEEeeccC---CCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~~--~~vAvK~~~~~~---~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+|.+.+.||+|+||.||++.+.. ..+++|+++... ........+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999998743 346666665422 2223334566789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||+++++|.+++.. ....+++..++.++.||+.+|.|||+++ ++|+||||+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998864 3356899999999999999999999999 999999999999975 5799999999876654
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.........|++.|++||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 4434445568999999999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=256.06 Aligned_cols=198 Identities=28% Similarity=0.411 Sum_probs=168.0
Q ss_pred eeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEEee
Q 005054 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
|.+.+.||.|+||.||+|.. .++.|+||.+........ .....+|+..++.+. |+||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999998 456799998865433222 223456889999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
+ +++|.+++.... ..+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-Y 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-c
Confidence 9 779999887654 46899999999999999999999999 99999999999999999999999999876544322 2
Q ss_pred ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 23467889999998854 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=262.17 Aligned_cols=200 Identities=35% Similarity=0.491 Sum_probs=171.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.+.|...+.||+|+||.||++.. .+..|++|.+..... .......+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 35688889999999999999987 466799998875422 334456778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+. ++|.+++......+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 99996 5888887665667899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 2346789999999975 34577899999999999999999999976653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=275.14 Aligned_cols=209 Identities=35% Similarity=0.569 Sum_probs=180.4
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc---CC--eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
|..++.++.++||+|.||.|+.|.|+ ++ .||||+++...... ....|.+|+.+|.+|.|+|++++|++..+ ..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34467788899999999999999984 33 49999998766543 67889999999999999999999999987 77
Q ss_pred eEEEEeecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~-~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+.||||++++|+|.+.|.+ ....|.......|+.||+.||.||..++ +|||||-..||||-....|||+|||+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceecc
Confidence 8999999999999999987 5566888899999999999999999999 999999999999998889999999999865
Q ss_pred ccC---ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 005054 656 HET---YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQDS 714 (716)
Q Consensus 656 ~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~~ 714 (716)
... +.......-...|||||.+....++-++|+|+|||++|||++ |..||-+....|.+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL 325 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL 325 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH
Confidence 533 222222334668999999999999999999999999999999 89999988766554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=280.92 Aligned_cols=213 Identities=32% Similarity=0.536 Sum_probs=187.7
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc--C---CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
+..|+-....+|.++||.|-||.||+|+.+ + ..||||.++. .+.++++..|..|..||-++.||||+++.++..
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 344666678899999999999999999873 3 3499999875 456777889999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
....++||.|||+.|+|..||+++...|...++..+++-|+.||.||-+.+ +|||||-+.|||++.+...|++|||++
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999999999999999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 005054 653 RLKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQD 713 (716)
Q Consensus 653 ~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~ 713 (716)
+...++.. .+....-..+|.|||.+....++.++||||+||+|||.|+ |..||.++.+-+.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 97754432 2222233569999999999999999999999999999887 9999998876544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=268.99 Aligned_cols=212 Identities=35% Similarity=0.579 Sum_probs=184.4
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEEcCC--eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
...|++-..+..+..+||-|.||.||.+.|+.- .||||.++.+. ..+.+|..|..+|+.++|||+|+++++|...
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 356777778889999999999999999999644 58999887653 3467899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~-l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
..+|||.|||..|+|.+||++++.. ++.-..+.++.||..||+||..++ +|||||-..|+|+.++..|||+|||+++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999999987644 555666788899999999999999 9999999999999999999999999999
Q ss_pred ccccCccc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 005054 654 LKHETYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQD 713 (716)
Q Consensus 654 ~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~~ 713 (716)
+...+.+. .....-...|.|||-+....++.|+|||+|||+|||+.| |..||.+.+.-|.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV 475 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 475 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH
Confidence 87655333 223345678999999999999999999999999999999 9999998875543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=288.73 Aligned_cols=194 Identities=31% Similarity=0.491 Sum_probs=162.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-------- 573 (716)
..+|+.++.||+||||.||+++. .|+.||||.+.... .......+.+|+.+|.+|+|||||++|..|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 36788899999999999999986 79999999988766 66777889999999999999999999865200
Q ss_pred ----------------------------------------------------------------------C---------
Q 005054 574 ----------------------------------------------------------------------P--------- 574 (716)
Q Consensus 574 ----------------------------------------------------------------------~--------- 574 (716)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005054 575 --------------------------------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622 (716)
Q Consensus 575 --------------------------------~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~ 622 (716)
-.+||-||||+..+|.+++.++...-.....|.+++||+.||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 125899999999888888876542224778899999999999999999
Q ss_pred CCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc------------------cCccccccCCCCCCccCcccccCCC---
Q 005054 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH------------------ETYLTTKTGKGTPQWMAPEVLRNEP--- 681 (716)
Q Consensus 623 ~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~--- 681 (716)
| ||||||||.||+++.++.|||+|||+|+... .........+||.-|+|||++.+..
T Consensus 717 g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred c--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 9999999999999999999999999997511 1111334558999999999997655
Q ss_pred CCchhHHHHHHHHHHHHHc
Q 005054 682 SDEKSDVYSFGVILWELAT 700 (716)
Q Consensus 682 ~~~~sDIwSlG~ll~ellt 700 (716)
|+.|+|+|||||||+||+.
T Consensus 795 Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc
Confidence 8999999999999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=260.63 Aligned_cols=191 Identities=39% Similarity=0.613 Sum_probs=163.2
Q ss_pred cceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc--CCCceeEEeceeccCC----ceE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSPQ----RLC 578 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l--~hpnIv~~~~~~~~~~----~~~ 578 (716)
...++.+.||+|.||.||+|...++.||||+|..+ ..+.+..|.+|+... +|+||++|+++-+... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34566789999999999999999999999998653 457788888888865 7999999999877655 789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-------NPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-------~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
||++|.+.|+|.++|+.+. +++....+++.-|++||+|||+- +++|+|||||..||||..++...|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999765 89999999999999999999973 35699999999999999999999999999
Q ss_pred CcccccC--ccccccCCCCCCccCcccccCCCC------CchhHHHHHHHHHHHHHcCC
Q 005054 652 SRLKHET--YLTTKTGKGTPQWMAPEVLRNEPS------DEKSDVYSFGVILWELATEK 702 (716)
Q Consensus 652 a~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~------~~~sDIwSlG~ll~elltG~ 702 (716)
|...... .......+||.+|||||++.|.-. -.+.||||+|.|||||++.-
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 9865432 333445689999999999976533 13689999999999999853
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-30 Score=254.39 Aligned_cols=210 Identities=23% Similarity=0.315 Sum_probs=172.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC----
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP---- 574 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~---- 574 (716)
-.....|+-..+||+|.||.||+++. .++.||+|++-.+......-....+|+.+|+.|+|+|++.++++|...
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 33456788889999999999999986 456688876543322222234456799999999999999999987532
Q ss_pred ----CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecC
Q 005054 575 ----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (716)
Q Consensus 575 ----~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 650 (716)
..+|+||.+|+. +|..++.....+++..++++++.++..||.|+|++. |+|||+||.|+||+.+|.+||+|||
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccc
Confidence 248999999955 999999887788999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCcc----ccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 651 LSRLKHETYL----TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 651 la~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
+++....+.. .....+-|..|++||.+.|.. |+++.|||+-||||.+|+++.+-|.+....|.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq 237 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ 237 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH
Confidence 9964332211 122335699999999988765 68899999999999999999999998877664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=267.68 Aligned_cols=194 Identities=26% Similarity=0.383 Sum_probs=166.2
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~l 579 (716)
..+.|++...+|.|+|+.|-.+.+ ++..+++|++.+... ...+|+.++... +||||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 457889999999999999999987 566799999987632 223466555544 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE-ccCCcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-DKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl-~~~~~vkL~DFGla~~~~~~ 658 (716)
|||++.|+-|.+.+.... .....+..|+.+|+.++.|||.+| ||||||||+|||+ +..++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999998888876544 233777789999999999999998 9999999999999 68899999999999877665
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....+-|..|.|||++....|+.++||||||++||+||+|+.||....
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 334577999999999999999999999999999999999999998544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=251.91 Aligned_cols=209 Identities=35% Similarity=0.617 Sum_probs=172.2
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHh--cCCCceeEEeceeccCC-
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSPQ- 575 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~--l~hpnIv~~~~~~~~~~- 575 (716)
.-..+..+..+.+.||+|-||.||+|.+.|..||||+|...+ .+.+.+|.+|++. |+|+||+.|++.-..++
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 335567889999999999999999999999999999997543 1456677777775 59999999998876553
Q ss_pred ---ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEEcCCCCCcEEEccCCcEEE
Q 005054 576 ---RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKV 646 (716)
Q Consensus 576 ---~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~------~~~IvHrDIKp~NILl~~~~~vkL 646 (716)
++|||.+|.+.|+|++||.++ .++.+..++++..++.||++||.. ++.|.|||||..|||+.+++...|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 589999999999999999874 489999999999999999999962 346999999999999999999999
Q ss_pred EecCCCcccccC----ccccccCCCCCCccCcccccCCCC------CchhHHHHHHHHHHHHHc----------CCCCCC
Q 005054 647 GDFGLSRLKHET----YLTTKTGKGTPQWMAPEVLRNEPS------DEKSDVYSFGVILWELAT----------EKIPWD 706 (716)
Q Consensus 647 ~DFGla~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~------~~~sDIwSlG~ll~ellt----------G~~PF~ 706 (716)
+|+|+|...... .......+||-+|||||++...-. ...+||||||.||||+.- -++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999764433 233456689999999999854321 346999999999999864 268998
Q ss_pred CCCccccc
Q 005054 707 NLNSMQDS 714 (716)
Q Consensus 707 ~~~~l~~~ 714 (716)
+.-+.++.
T Consensus 438 d~Vp~DPs 445 (513)
T KOG2052|consen 438 DVVPSDPS 445 (513)
T ss_pred cCCCCCCC
Confidence 77665543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=244.19 Aligned_cols=201 Identities=21% Similarity=0.356 Sum_probs=176.4
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
+..-.|+++++||+|.||.+|.|.. ++.+||||.-..... ..++..|.+..+.| ..++|..+|.+.....+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 4456899999999999999999975 889999998654432 24456678888877 5899999999998888899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-----CCcEEEEecCCCc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 653 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-----~~~vkL~DFGla~ 653 (716)
||||++ |.+|++++.-+++.|+.+.+..++.||+.-++|+|+++ +|+|||||+|+||.. ...|.|+|||+|+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999999 99999999999999999999999999999999999999 999999999999974 3459999999998
Q ss_pred cc-------ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 654 LK-------HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 654 ~~-------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. +.++.......||.+||+-..+.|...+.+.|+-|||-+++++|-|.+||+++.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 54 344555667789999999999999999999999999999999999999999764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=244.03 Aligned_cols=179 Identities=20% Similarity=0.227 Sum_probs=153.0
Q ss_pred CCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCHHHHH
Q 005054 516 GSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 593 (716)
Q Consensus 516 G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l 593 (716)
|.+|.||++.+ .++.||+|.++.... ..+|...+....||||+++++++...+.+|+||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999988 567799999876421 223444455567999999999999999999999999999999998
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCCCccC
Q 005054 594 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673 (716)
Q Consensus 594 ~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~a 673 (716)
.+.. .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||.+....... ....++..|+|
T Consensus 77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~a 150 (237)
T cd05576 77 SKFL-NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCA 150 (237)
T ss_pred HHhc-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccC
Confidence 7643 5899999999999999999999998 9999999999999999999999999876544321 23345778999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 674 PE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
||.+.+..++.++|+||+||++|+|++|..||..
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=263.43 Aligned_cols=204 Identities=26% Similarity=0.373 Sum_probs=174.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC------CCceeEEeceec
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR------HPNVLLFMGAVT 572 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~------hpnIv~~~~~~~ 572 (716)
+.+-.+|.+....|+|-|++|..|.+ .+..||||++....... ..=..|+.||++|+ --|+++++..|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 66778999999999999999999987 46689999998765433 23356899999995 248899999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEec
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDF 649 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~~--~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DF 649 (716)
..+++|||||-+ ..+|.+.|++.+. .|....+..|+.||+.||..|-.+| |+|.||||+||||+.. ..+|||||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccC
Confidence 999999999999 7799999988653 3678899999999999999999999 9999999999999865 55899999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
|.|........... .-+..|.|||++.|.+|++..|+||+||+||||+||+..|.+.++-+
T Consensus 582 GSA~~~~eneitPY--LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 582 GSASFASENEITPY--LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred ccccccccccccHH--HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 99877655433221 23568999999999999999999999999999999999999877644
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=246.24 Aligned_cols=196 Identities=27% Similarity=0.419 Sum_probs=164.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC--------CCceeEEeceecc-
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--------HPNVLLFMGAVTS- 573 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~--------hpnIv~~~~~~~~- 573 (716)
.+|.+.++||.|-|++||+|.+ ..+.||+|+++.. ....+....|+.+|+++. ...||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 7999999999999999999988 4566999998754 234466778999999883 2489999999974
Q ss_pred ---CCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEc---------
Q 005054 574 ---PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVD--------- 639 (716)
Q Consensus 574 ---~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~--------- 639 (716)
..++|||+|++ |.+|..+|.+.. +.++...|+.|++||+.||.|||. +| |||.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhh
Confidence 45799999999 889999987754 558999999999999999999997 45 99999999999984
Q ss_pred --------------------------------------------------------------------------------
Q 005054 640 -------------------------------------------------------------------------------- 639 (716)
Q Consensus 640 -------------------------------------------------------------------------------- 639 (716)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------cC----------------------------------------------------C
Q 005054 640 -------------------------KH----------------------------------------------------W 642 (716)
Q Consensus 640 -------------------------~~----------------------------------------------------~ 642 (716)
.. -
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 00 0
Q ss_pred cEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 643 TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 643 ~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+|||+|||.|++.+..+. ..+.|..|+|||++.|..|++.+||||++|++|||.||...|+...
T Consensus 392 ~vKIaDlGNACW~~khFT---~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKHFT---EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred eEEEeeccchhhhhhhhc---hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 368888888887665432 3357999999999999999999999999999999999999998544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=233.43 Aligned_cols=198 Identities=36% Similarity=0.614 Sum_probs=172.5
Q ss_pred eeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|.+.+.||.|++|.||++... +..+++|.+...... .....+.+|+..++.++|+||+++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567899999999999999985 578999998765433 24578888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-cccc
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTK 663 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 663 (716)
++++|.+++......+++..++.++.+++.++.+||+++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999875433889999999999999999999998 9999999999999999999999999988665432 1122
Q ss_pred cCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 664 TGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~-~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
...++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34678899999998 667778899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=249.78 Aligned_cols=205 Identities=27% Similarity=0.435 Sum_probs=170.0
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----ceE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~-----~~~ 578 (716)
+.+-.+.||-|+||.||.+++ .++.|++|.+..-...--...++-+|+.+|.-++|.|++..+++..-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344557899999999999987 6888999987543322233466778999999999999999988876443 468
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
++.|+| ..+|..++-. ...++...++.++.||++||.|||+.+ |.||||||.|+|++.+..+||||||+++.....
T Consensus 134 V~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchh
Confidence 899999 5588888865 457999999999999999999999999 999999999999999999999999999865443
Q ss_pred cc-ccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005054 659 YL-TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714 (716)
Q Consensus 659 ~~-~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~ 714 (716)
.. .....+-|..|+|||+++|.. |+.+.||||+|||+.||+-.+..|+..+++|.+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL 267 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL 267 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH
Confidence 22 222335688999999999876 678899999999999999999999999988764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=235.36 Aligned_cols=199 Identities=20% Similarity=0.398 Sum_probs=167.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCC--ceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--RLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~--~~~ 578 (716)
.++|++.+++|+|.++.||.|.. ++.+++||++++-. ...+.+|+.||+.|. ||||++++++..++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 47899999999999999999984 67789999987543 367889999999995 999999999998764 468
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~ 657 (716)
||+||+...+...+.. .++...+..++.+|+.||.|||+.| |+|||+||.|+||+.. -.++|+|+|+|.+.+.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998877766654 3778899999999999999999999 9999999999999964 5699999999998776
Q ss_pred CccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCC-CCCccccc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWD-NLNSMQDS 714 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~-~~~~l~~~ 714 (716)
.... ...+.+..|--||.+...+ |+.+-|+|||||+|..|++.+.||- +.++-+.+
T Consensus 186 ~~eY-nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL 243 (338)
T KOG0668|consen 186 GKEY-NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 243 (338)
T ss_pred Ccee-eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence 5433 3456788899999987654 6889999999999999999988864 44444433
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=270.62 Aligned_cols=208 Identities=34% Similarity=0.634 Sum_probs=180.9
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~ 568 (716)
.|++..++..+.+.||+|.||.|+++... ...||||.++..... .....+..|+.+|+.+ .|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 67888888889999999999999999742 335999998876555 6678899999999999 599999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
+++...+.+++|+||+..|+|..++..+. ..++....+.++.||+.||+||++.. +|||||-+
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998776 34889999999999999999999988 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccC-ccccccCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~G--t~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
.|||+..+..+||+|||+++..... +.......| ...|||||.+....|+.++||||+|++|||+++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999864443 222222232 446999999999999999999999999999999 999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=286.47 Aligned_cols=189 Identities=27% Similarity=0.450 Sum_probs=158.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
...|...+.||+|+||.||+|.. .+..||||.++..... ...|+.++++++|||||++++++......|+||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 34567778999999999999986 5678999988653321 123588899999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||+++++|.+++.. +++..+..++.||+.||+|||.. ..+|+||||||+||+++.++..++. ||........
T Consensus 763 Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 763 EYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred eCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999999963 78999999999999999999943 2239999999999999988887775 6655432221
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 123678999999999999999999999999999999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=254.30 Aligned_cols=203 Identities=22% Similarity=0.305 Sum_probs=151.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEE------------------cCCeEEEEEeeccCCCH--H----------HHHHHHHH
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW------------------YGSDVAVKVFSRQEYSD--E----------VIHSFRQE 552 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~------------------~~~~vAvK~~~~~~~~~--~----------~~~~~~~E 552 (716)
..++|.+.++||+|+||.||+|.+ .++.||||.++...... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999964 23569999986532110 0 01122346
Q ss_pred HHHHHhcCCCce-----eEEeceecc--------CCceEEEEeecCCCCHHHHHhhcC----------------------
Q 005054 553 VSLMKRLRHPNV-----LLFMGAVTS--------PQRLCIVTEFLPRGSLFRLLQRNT---------------------- 597 (716)
Q Consensus 553 ~~iL~~l~hpnI-----v~~~~~~~~--------~~~~~lVmE~~~ggsL~~~l~~~~---------------------- 597 (716)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 566666643 356899999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-cccccCCCCCCccCcc
Q 005054 598 -TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTKTGKGTPQWMAPE 675 (716)
Q Consensus 598 -~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~Gt~~Y~aPE 675 (716)
..+++..++.++.||+.+|.|||+.+ |+||||||+|||++.++.+||+|||++....... .......+|+.|++||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12356778899999999999999998 9999999999999999999999999986543321 1122234589999999
Q ss_pred cccCCC--------------------C--CchhHHHHHHHHHHHHHcCCC-CCCC
Q 005054 676 VLRNEP--------------------S--DEKSDVYSFGVILWELATEKI-PWDN 707 (716)
Q Consensus 676 ~~~~~~--------------------~--~~~sDIwSlG~ll~elltG~~-PF~~ 707 (716)
++.... + ..+.||||+||++|+|++|.+ ||..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 985432 1 124699999999999999885 8764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=261.39 Aligned_cols=197 Identities=20% Similarity=0.280 Sum_probs=141.7
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEece-----
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA----- 570 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~----- 570 (716)
...++|.+.++||+|+||.||+|++. +..||||.+....... ....+ .+....+.+++.++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 34578999999999999999999874 5679999875432111 11111 1122222222222222
Q ss_pred -eccCCceEEEEeecCCCCHHHHHhhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCCCeEEcC
Q 005054 571 -VTSPQRLCIVTEFLPRGSLFRLLQRNTTKL-------------------DWRRRILMALDIARGVSYLHHCNPPIIHRD 630 (716)
Q Consensus 571 -~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l-------------------~~~~v~~i~~ql~~aL~yLH~~~~~IvHrD 630 (716)
......++|||||+.+++|.+++....... ....+..++.||+.||.|||+++ |+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 234567899999999999999987543211 23346689999999999999998 99999
Q ss_pred CCCCcEEEcc-CCcEEEEecCCCcccccC-ccccccCCCCCCccCcccccCCC----------------------CCchh
Q 005054 631 LKSSNLLVDK-HWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAPEVLRNEP----------------------SDEKS 686 (716)
Q Consensus 631 IKp~NILl~~-~~~vkL~DFGla~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~----------------------~~~~s 686 (716)
|||+|||++. ++.+||+|||+++..... .......++++.|+|||.+.... ++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 578999999999754322 22233557899999999764322 23456
Q ss_pred HHHHHHHHHHHHHcCCCCCC
Q 005054 687 DVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 687 DIwSlG~ll~elltG~~PF~ 706 (716)
|||||||+||+|+++..|++
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999999877765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=258.82 Aligned_cols=199 Identities=34% Similarity=0.574 Sum_probs=173.0
Q ss_pred eeEeeeeecCCcEEEEEEEE--cC----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 507 LTIGEQIGQGSCGTVYHAVW--YG----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~--~~----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.+..++||.|+||+||+|.+ ++ -+||+|++.... ..+...++..|+-+|.++.|||++++++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 45568999999999999987 33 259999886544 3344567888999999999999999999998765 8899
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
++|++.|.|.++++.++.++-....+.|..||++||.|||.+. +|||||-..||||..-.+|||.|||+++.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999999889999999999999999999999988 99999999999999999999999999997654433
Q ss_pred cc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 661 TT--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 661 ~~--~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
.. ....-.+.|||-|.+....|+.++|||||||++||+|| |..||++..
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 22 22234678999999999999999999999999999999 999998765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-27 Score=238.00 Aligned_cols=202 Identities=27% Similarity=0.390 Sum_probs=173.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~------ 575 (716)
..+|.-++.+|.|.- .|.-+.+ .+++|++|.+..........++..+|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 367888899999998 7777765 6889999987666444444577889999999999999999999997554
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|+|||+| ..+|...+.. .++-..+..++.|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|+..
T Consensus 95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhccc
Confidence 479999999 5589888862 3777899999999999999999999 999999999999999999999999999876
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
... ......+.|..|.|||++.+..|...+||||+||++.||++|+..|.+.+.+..
T Consensus 169 ~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 169 DTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred Ccc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 665 233355789999999999999999999999999999999999999998776543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=227.52 Aligned_cols=187 Identities=37% Similarity=0.566 Sum_probs=164.8
Q ss_pred CcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCHHHHHh
Q 005054 517 SCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 594 (716)
Q Consensus 517 ~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~ 594 (716)
+||.||++... +..+++|++........ ...+.+|+..++.++|+||+++++++......+++|||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999985 57899999876543322 5778899999999999999999999999999999999999999999997
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCCCccCc
Q 005054 595 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674 (716)
Q Consensus 595 ~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aP 674 (716)
.... ++...++.++.+++.++.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRGR-LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hccC-CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 6543 899999999999999999999998 9999999999999999999999999988765542 23345688999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 675 E~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
|.+.+..++.++|||+||+++|+|++|..||...
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999888899999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-27 Score=233.23 Aligned_cols=199 Identities=25% Similarity=0.417 Sum_probs=161.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEEcC--CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEece-eccCCceE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA-VTSPQRLC 578 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~-~~~~~~~~ 578 (716)
+.+.|.|.+.||+|.||.+.++.+.+ +.+++|.+..... ....|.+|...--.| .|.||+.-|++ |+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 34789999999999999999999854 4699999876543 246777787765555 58999987664 67778889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc--cCCcEEEEecCCCcccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~--~~~~vkL~DFGla~~~~ 656 (716)
++|||++.|+|..-+...+ +-+...+.++.|++.|+.|||+.+ +||||||.+||||- +..+|||||||..+..+
T Consensus 99 F~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999998887544 888999999999999999999999 99999999999993 34579999999988665
Q ss_pred cCccccccCCCCCCccCcccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..-... ..+..|.+||++.... .++.+|+|.||+++|.+|+|.+||+....+
T Consensus 175 ~tV~~~---~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~ 231 (378)
T KOG1345|consen 175 TTVKYL---EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM 231 (378)
T ss_pred ceehhh---hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence 443222 2356799999875332 367899999999999999999999855433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=217.76 Aligned_cols=202 Identities=23% Similarity=0.350 Sum_probs=174.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~ 577 (716)
.+...+|.++++||.|+||.+|++.. .+..||||+-+.....+ .+..|..+...|. ...|+.+..++.+...-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45678999999999999999999986 68899999876544333 3456778888885 56888888888888889
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecCCCcc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRL 654 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~ 654 (716)
.+||+++ |.+|.+++.-+...++..+++.++-|++.-++|+|.++ +|||||||+|+|+.- ..++.|+|||+|+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhh
Confidence 9999999 99999999988889999999999999999999999999 999999999999963 45799999999985
Q ss_pred c-------ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 655 K-------HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 655 ~-------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
. +.++.......||.+|.+-..+.+...+.+.|+-|+|.+|.++.-|.+||++..
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 3 334445556689999999999999989999999999999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-26 Score=253.40 Aligned_cols=195 Identities=31% Similarity=0.502 Sum_probs=161.1
Q ss_pred eeEeeeeecCCcE-EEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCG-TVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg-~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|.-.+.+|.|+.| .||+|.+.++.||||.+-. +......+|+.+|+.- .|||||++|+.-.+....||.+|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4445678999987 5899999999999997643 3345678899999988 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCC---CHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---C--CcEEEEecCCCcccc
Q 005054 585 PRGSLFRLLQRNTTKL---DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---H--WTVKVGDFGLSRLKH 656 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l---~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~--~~vkL~DFGla~~~~ 656 (716)
..+|.+++......+ .....+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++...
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 559999998731111 11345778889999999999999 999999999999975 3 468999999998765
Q ss_pred cC---ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCC
Q 005054 657 ET---YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709 (716)
Q Consensus 657 ~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG-~~PF~~~~ 709 (716)
.. ........||.+|+|||++.......++||||||||+|+.++| .+||...-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 43 2233455799999999999999888999999999999999995 99998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=253.33 Aligned_cols=208 Identities=30% Similarity=0.477 Sum_probs=186.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..++|+++..+|.|+||.||++++ .++..|+|+++.+.. +...-+++|+-+++.++|||||.+++.|...+.++|.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 346899999999999999999987 577899999987643 2346677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||||.||+|.+...-. .++++.++..+.++.+++|+|||+.+ -+|||||-.|||+++.|.||+.|||.+..+.....
T Consensus 91 MEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999999887653 57999999999999999999999998 99999999999999999999999999988877777
Q ss_pred ccccCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005054 661 TTKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDSC 715 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~---~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~~~ 715 (716)
....+.||+.|||||+. ..+.|+..+|||++|+...|+---+.|--...+|++++
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~ 225 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF 225 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH
Confidence 77888999999999986 46678999999999999999998899988888888764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-24 Score=209.10 Aligned_cols=183 Identities=42% Similarity=0.663 Sum_probs=160.8
Q ss_pred eecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCHH
Q 005054 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590 (716)
Q Consensus 513 LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~ 590 (716)
||+|.+|.||++... +..+++|++....... ....+.+|+..++.+.|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 7889999987665432 3467889999999999999999999999999999999999989999
Q ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCCcccccCccccccCCCCC
Q 005054 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (716)
Q Consensus 591 ~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (716)
.++......++...++.++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999876456899999999999999999999998 999999999999999 89999999999886655432233456788
Q ss_pred CccCcccccCC-CCCchhHHHHHHHHHHHH
Q 005054 670 QWMAPEVLRNE-PSDEKSDVYSFGVILWEL 698 (716)
Q Consensus 670 ~Y~aPE~~~~~-~~~~~sDIwSlG~ll~el 698 (716)
.|++||.+... .++.+.|+|+||+++|+|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 99999999887 778899999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=226.04 Aligned_cols=200 Identities=24% Similarity=0.348 Sum_probs=166.6
Q ss_pred ceeEeeeeecCCcEEEEEEEEcCC---eEEEEEeeccCCCHHHHHHHHHHHHHHHhcC----CCceeEEecee-ccCCce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWYGS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR----HPNVLLFMGAV-TSPQRL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~----hpnIv~~~~~~-~~~~~~ 577 (716)
+|++.++||+|+||.||++.+... .+|+|+......... ..+..|+.+|..+. ..++..+++.+ ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 899999999999999999998554 589998765432211 14566788888775 36899999998 577788
Q ss_pred EEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-----CcEEEEecCC
Q 005054 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-----WTVKVGDFGL 651 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-----~~vkL~DFGl 651 (716)
||||+.+ |.+|.++..... ..++...+..++.|++.+|++||+.| ++||||||.|+++... ..+.|+|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999999 889999997665 78999999999999999999999999 9999999999999864 4699999999
Q ss_pred Cc--ccc-cC------ccc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SR--LKH-ET------YLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~--~~~-~~------~~~-~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++ ... .. ... .....||..|+++.++.+...+.+.|+||++.++.+|+.|.+||.....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 98 321 11 111 2245699999999999999999999999999999999999999977653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=216.64 Aligned_cols=209 Identities=27% Similarity=0.441 Sum_probs=170.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCC-------eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-------~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
.+-..++++.-.+.+|.||.||.|.+..+ .|.+|.++.. .++-+...+..|.-+|..+.|||+..+.++...
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 44456789999999999999999966322 3666766543 344556778888999999999999999988754
Q ss_pred -CCceEEEEeecCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEE
Q 005054 574 -PQRLCIVTEFLPRGSLFRLLQRNT-------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (716)
Q Consensus 574 -~~~~~lVmE~~~ggsL~~~l~~~~-------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vk 645 (716)
....++++.++.-|+|..++..++ ..++..+...++.|++.||+|||+++ |||.||-..|++|++..+||
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEE
Confidence 456788899999999999997432 34677888899999999999999999 99999999999999999999
Q ss_pred EEecCCCcccccCcccc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 646 VGDFGLSRLKHETYLTT--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 646 L~DFGla~~~~~~~~~~--~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
|+|=.+++......... ........||+||.+.+..|+..+|+||||++||||+| |+.||-..+|.+
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 99999998654332211 11123568999999999999999999999999999999 999999988765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=225.84 Aligned_cols=198 Identities=26% Similarity=0.406 Sum_probs=165.1
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceecc
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~ 573 (716)
...+.+.|.++++||+|.|++||++++ ..+.||+|.+..... ..++.+|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 445567899999999999999999976 345699998765432 25678899999999 69999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCC
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLS 652 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla 652 (716)
+++.++||||++.....+++.. ++...+..++..++.||.++|.+| ||||||||.|||++. .++-.|+|||+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999888888764 678999999999999999999999 999999999999985 467899999998
Q ss_pred cccc-----------------c----------------C--c---------cccccCCCCCCccCcccccCCCC-CchhH
Q 005054 653 RLKH-----------------E----------------T--Y---------LTTKTGKGTPQWMAPEVLRNEPS-DEKSD 687 (716)
Q Consensus 653 ~~~~-----------------~----------------~--~---------~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sD 687 (716)
.... . + + .......||++|+|||++...+- +.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6100 0 0 0 00112249999999999987764 88999
Q ss_pred HHHHHHHHHHHHcCCCCCCC
Q 005054 688 VYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 688 IwSlG~ll~elltG~~PF~~ 707 (716)
|||.|+|++.++++++||-.
T Consensus 261 iws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eeeccceeehhhcccccccc
Confidence 99999999999999999853
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=218.60 Aligned_cols=167 Identities=18% Similarity=0.140 Sum_probs=129.5
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE---cCCeEEEEEeeccCC---CHHHHHHHHHHHHHHHhcCCCceeE-Eeceec
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW---YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLL-FMGAVT 572 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~---~~~~~~~~~~E~~iL~~l~hpnIv~-~~~~~~ 572 (716)
...+.++|.+.+.||+|+||+||+|.+ .+..||||++..... .......+.+|+.+|+.++|+||+. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 345668899999999999999999987 345679998653311 2344567899999999999999984 5442
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCC-CCCcEEEccCCcEEEEecCC
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDI-Kp~NILl~~~~~vkL~DFGl 651 (716)
+..|||||||+|++|... .. .. ...++.|++++|.|||++| |+|||| ||+|||++.++.+||+|||+
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999732 11 11 1467889999999999999 999999 99999999999999999999
Q ss_pred CcccccCcc--------ccccCCCCCCccCcccccCC
Q 005054 652 SRLKHETYL--------TTKTGKGTPQWMAPEVLRNE 680 (716)
Q Consensus 652 a~~~~~~~~--------~~~~~~Gt~~Y~aPE~~~~~ 680 (716)
++....... .....++++.|++||.+.-.
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 986543321 11244678889999998644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=204.44 Aligned_cols=201 Identities=33% Similarity=0.522 Sum_probs=174.7
Q ss_pred eeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHH-HHHHHHHHHHHHHhcCCC-ceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~E~~iL~~l~hp-nIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|.+.+.||.|+|+.||++.+. ..+++|++........ ....+.+|+.++..+.|+ +|+++++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 788899999999999999988 7799999887665443 567888999999999988 7999999998777789999999
Q ss_pred CCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCcccccCcc-
Q 005054 585 PRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 585 ~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~- 660 (716)
.+++|.+++.... ..+....+..++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999997776654 26899999999999999999999999 99999999999999988 799999999875544331
Q ss_pred -----ccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 -----TTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 -----~~~~~~Gt~~Y~aPE~~~~---~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......|+..|++||.+.+ ..+....|+|++|++++++++|..||.....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2346689999999999988 5778899999999999999999999876653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=240.32 Aligned_cols=148 Identities=20% Similarity=0.212 Sum_probs=115.3
Q ss_pred hcCC-CceeEEecee-------ccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEc
Q 005054 558 RLRH-PNVLLFMGAV-------TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629 (716)
Q Consensus 558 ~l~h-pnIv~~~~~~-------~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHr 629 (716)
.+.| +||+.++++| .....++++|||+ +++|.+++......+++..++.++.||+.||.|||++| ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 3445 5777777766 2334678889988 66999999876667999999999999999999999999 9999
Q ss_pred CCCCCcEEEccCCc-------------------EEEEecCCCcccccCc----------------cccccCCCCCCccCc
Q 005054 630 DLKSSNLLVDKHWT-------------------VKVGDFGLSRLKHETY----------------LTTKTGKGTPQWMAP 674 (716)
Q Consensus 630 DIKp~NILl~~~~~-------------------vkL~DFGla~~~~~~~----------------~~~~~~~Gt~~Y~aP 674 (716)
||||+||||+..+. +||+|||+++...... ......+||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999965444 5555666554321000 001123588999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 675 E~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
|++.+..++.++|||||||+||||++|..||...
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 9999999999999999999999999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=196.63 Aligned_cols=175 Identities=13% Similarity=0.122 Sum_probs=137.6
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCH-HHHHH------HHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD-EVIHS------FRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~-~~~~~------~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
+++.++|++.+.||.|+||.||+....+..+|||++....... ..... +.+|+..+.++.|++|..+.+++..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 5667899999999999999999987777889999997655433 22233 5789999999999999999888654
Q ss_pred C--------CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEE
Q 005054 574 P--------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (716)
Q Consensus 574 ~--------~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vk 645 (716)
. ...+|||||++|.+|.++.. +++ ....+++.+|..||..| |+|+||||+||+++.+| ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EE
Confidence 3 35799999999999988742 333 23558999999999999 99999999999999988 99
Q ss_pred EEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHH
Q 005054 646 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELA 699 (716)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ell 699 (716)
|+|||........... .-.+....++.++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999987654322111 11344555677899999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=184.10 Aligned_cols=188 Identities=16% Similarity=0.173 Sum_probs=144.4
Q ss_pred eEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCC--HHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEEeec
Q 005054 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
.+...|+.|+||+||.+...+.+++.+.+...... .-....+.+|+++|++|. |++|++++++ +..|++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 35678999999999999888888887777654431 112335789999999995 5889999886 4579999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCC-CCCcEEEccCCcEEEEecCCCcccccCccc--
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGLSRLKHETYLT-- 661 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDI-Kp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 661 (716)
.|.+|...+.. ....++.|++.+|.+||++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99998755421 11346789999999999999 999999 799999999999999999999855433210
Q ss_pred -----------cccCCCCCCccCcccccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 662 -----------TKTGKGTPQWMAPEVLRNE-PSD-EKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 662 -----------~~~~~Gt~~Y~aPE~~~~~-~~~-~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..-..+++.|+.|+...-. ..+ ...++++.|+-+|.|+|+..|+...+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1112368899999865432 222 56799999999999999998876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=185.78 Aligned_cols=142 Identities=20% Similarity=0.219 Sum_probs=108.4
Q ss_pred eeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHH------------------------HHHHHHHHHHHHhcCCCce
Q 005054 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEV------------------------IHSFRQEVSLMKRLRHPNV 564 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~------------------------~~~~~~E~~iL~~l~hpnI 564 (716)
...||+|+||.||+|.. .++.||||+++........ .....+|+.+|..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 5889999999765321100 1223458999999977766
Q ss_pred eEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEEcCCCCCcEEEccCCc
Q 005054 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 565 v~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yL-H~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
.....+.. ...+|||||++|++|...+.+ ...++...+..++.||+.+|.|| |+.| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 43322221 223899999988777655433 34689999999999999999999 6888 99999999999998 478
Q ss_pred EEEEecCCCccccc
Q 005054 644 VKVGDFGLSRLKHE 657 (716)
Q Consensus 644 vkL~DFGla~~~~~ 657 (716)
++|+|||+|.....
T Consensus 156 v~LiDFG~a~~~~~ 169 (190)
T cd05147 156 LYIIDVSQSVEHDH 169 (190)
T ss_pred EEEEEccccccCCC
Confidence 99999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=212.11 Aligned_cols=187 Identities=27% Similarity=0.397 Sum_probs=160.7
Q ss_pred eeecCCcEEEEEEEE-----cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEEeecC
Q 005054 512 QIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 512 ~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
.+|+|.||.|+++.. .+.-|++|+.++.............|..++..++ ||.+|++...++.+..+++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998853 4556999988776543332335556788888886 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccC
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (716)
++.|...+.+. ..+.+..+..+...++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-.... .
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----A 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----c
Confidence 99999998764 45888888999999999999999999 99999999999999999999999999886544322 2
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 666 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 666 ~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
|||..|||||++. .+...+|+||||+++|+|++|..||..
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999998 566789999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=177.55 Aligned_cols=110 Identities=27% Similarity=0.415 Sum_probs=98.0
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (716)
|+|.+++......+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876777999999999999999999999876 999999999999999 9998765442 226
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 667 Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.....+
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 110 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL 110 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 899999999999999999999999999999999999999765543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=177.66 Aligned_cols=141 Identities=21% Similarity=0.208 Sum_probs=110.0
Q ss_pred eeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCC----------------------H--HHHHHHHHHHHHHHhcCCCce
Q 005054 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS----------------------D--EVIHSFRQEVSLMKRLRHPNV 564 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~----------------------~--~~~~~~~~E~~iL~~l~hpnI 564 (716)
.+.||+|+||.||+|.+ +++.||||+++..... . .....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999987 4889999998865321 0 012234578899999988887
Q ss_pred eEEeceeccCCceEEEEeecCCCCHHHH-HhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCC
Q 005054 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRL-LQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 565 v~~~~~~~~~~~~~lVmE~~~ggsL~~~-l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~ 642 (716)
.....+... ..||||||++|+++... +.. ..++...+..++.|++.+|.+||. .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 543333322 24899999988755433 432 357888999999999999999999 88 99999999999998 78
Q ss_pred cEEEEecCCCccccc
Q 005054 643 TVKVGDFGLSRLKHE 657 (716)
Q Consensus 643 ~vkL~DFGla~~~~~ 657 (716)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=213.08 Aligned_cols=202 Identities=28% Similarity=0.400 Sum_probs=160.8
Q ss_pred eEeeeeecCCcEEEEEEEE--cCCeEEEEEee----ccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~----~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.....+|.|++|.|+.+.. ....++.|.+. ......+....+..|+-+-..+.|||++..+..+.+...++-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3457899999998777754 22334444333 22222222233666777778889999999888888777776679
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
|||++ +|+.++... ..+....+-.++.||+.||.|||..| |.||||||+|+++..+|.+||+|||.+.....+..
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999999875 35889999999999999999999999 99999999999999999999999999876554433
Q ss_pred ---ccccCCCCCCccCcccccCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 661 ---TTKTGKGTPQWMAPEVLRNEPSDE-KSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 661 ---~~~~~~Gt~~Y~aPE~~~~~~~~~-~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
.....+|+..|+|||++.+..|++ ..||||.|+++++|++|+.||.....-++
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 345668999999999999999965 58999999999999999999986655433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=209.44 Aligned_cols=198 Identities=25% Similarity=0.318 Sum_probs=161.0
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC---CCceeEEeceecc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTS 573 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~---hpnIv~~~~~~~~ 573 (716)
..++.-.+.|.|.+.||+|+||+||+|.. +++.||||+-+.....+-.+ -.+++.+|+ -+.|..+..++..
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHcc
Confidence 34566778999999999999999999986 67789999977655432111 123344443 3456667777777
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-------CCcEEE
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-------HWTVKV 646 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-------~~~vkL 646 (716)
.+..+||+||.+.|+|.+++. ....+++..+..+..||+..|+.||..+ |||+||||+|+||.. .--++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence 888999999999999999998 4556899999999999999999999999 999999999999952 234999
Q ss_pred EecCCCccc--ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 005054 647 GDFGLSRLK--HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 703 (716)
Q Consensus 647 ~DFGla~~~--~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~ 703 (716)
+|||.+... ..........++|-.+-++|+..|.+|++..|.|.|+.+++.||+|++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999988632 222345556688999999999999999999999999999999999964
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.3e-18 Score=169.75 Aligned_cols=136 Identities=17% Similarity=0.271 Sum_probs=104.3
Q ss_pred eeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-----CCCceeEEeceeccCC---ce-EEE
Q 005054 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-----RHPNVLLFMGAVTSPQ---RL-CIV 580 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-----~hpnIv~~~~~~~~~~---~~-~lV 580 (716)
.+.||+|+||.||.-.... ..+||++...... ....+.+|+.+++.+ .||||++++++++++. .+ .+|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~-~k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDA-QRCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCc-CeEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 4689999999999622222 3468887654322 346788999999999 5799999999999874 33 378
Q ss_pred Eee--cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEEcCCCCCcEEEcc----CCcEEEEe-cCCC
Q 005054 581 TEF--LPRGSLFRLLQRNTTKLDWRRRILMALDIARGV-SYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGD-FGLS 652 (716)
Q Consensus 581 mE~--~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL-~yLH~~~~~IvHrDIKp~NILl~~----~~~vkL~D-FGla 652 (716)
||| +.+++|.+++++. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. ++.++|+| ||..
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 999 5579999999763 35555 35577888777 9999999 999999999999974 33799999 5554
Q ss_pred cc
Q 005054 653 RL 654 (716)
Q Consensus 653 ~~ 654 (716)
..
T Consensus 158 ~~ 159 (210)
T PRK10345 158 TF 159 (210)
T ss_pred ce
Confidence 43
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-17 Score=165.34 Aligned_cols=137 Identities=26% Similarity=0.390 Sum_probs=115.6
Q ss_pred eeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHH------HHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
+.||+|++|.||++.+.+..|++|+......... ....+.+|+.++..+.|++|+....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998765433211 1245778999999999998877666666777889999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+|++|.+++.... . .+..++.+|+.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++...
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999986532 2 77889999999999999999 99999999999999 789999999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=164.94 Aligned_cols=134 Identities=25% Similarity=0.353 Sum_probs=109.1
Q ss_pred eeecCCcEEEEEEEEcCCeEEEEEeeccCCCH------HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 512 QIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 512 ~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
.||+|+||.||++.+.+.+|++|+........ ....++.+|+.++..+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999865433211 123567789999999988766554444555667899999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||++....
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998865321 77889999999999999 99999999999999 7899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-18 Score=170.61 Aligned_cols=202 Identities=30% Similarity=0.692 Sum_probs=167.4
Q ss_pred ceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecC
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ 585 (716)
+..+.-+|.+...|..|++++.+..+++|+++-........+.|..|.-.|+-+.||||+.+++.+..+.++.++..||+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34455678899999999999999999999998877777677888889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEc-CCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 586 RGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHR-DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 586 ggsL~~~l~~~~~-~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHr-DIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
.++|+..+..... ..+..++..++.++++|+.|||+..+ ++-| -|....++|+++.+.+|. ++-+++..+. .
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfsfqe----~ 344 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE----V 344 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceeeeec----c
Confidence 9999999986543 35677899999999999999999874 4444 688889999998776664 2222222221 1
Q ss_pred cCCCCCCccCcccccCCCCC---chhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 664 TGKGTPQWMAPEVLRNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~~~---~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
.....|.||+||.++..+.+ .++|+|||++++|||.|...||....+|+.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec 397 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence 33458899999999888764 479999999999999999999999999875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=170.24 Aligned_cols=200 Identities=22% Similarity=0.349 Sum_probs=131.6
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcC----------CCceeEEecee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLR----------HPNVLLFMGAV 571 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~----------hpnIv~~~~~~ 571 (716)
..+..+..||.|+++.||.+++. +.+++||++...... ....+.+++|.-....+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 46778899999999999999994 578999998665432 234566666654444422 22233322222
Q ss_pred cc---------C---C-----ceEEEEeecCCCCHHHHHhh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEE
Q 005054 572 TS---------P---Q-----RLCIVTEFLPRGSLFRLLQR---NTTK---LDWRRRILMALDIARGVSYLHHCNPPIIH 628 (716)
Q Consensus 572 ~~---------~---~-----~~~lVmE~~~ggsL~~~l~~---~~~~---l~~~~v~~i~~ql~~aL~yLH~~~~~IvH 628 (716)
.. . . +.+++|+.+ .++|.+++.- .... +.......+..|+++.+++||..| |||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 11 1 1 347788888 5588887642 2211 223333455589999999999999 999
Q ss_pred cCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHc
Q 005054 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--------EPSDEKSDVYSFGVILWELAT 700 (716)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~sDIwSlG~ll~ellt 700 (716)
+||||+||+++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999987766654432 233577999997643 246789999999999999999
Q ss_pred CCCCCCCCCc
Q 005054 701 EKIPWDNLNS 710 (716)
Q Consensus 701 G~~PF~~~~~ 710 (716)
|..||....+
T Consensus 246 ~~lPf~~~~~ 255 (288)
T PF14531_consen 246 GRLPFGLSSP 255 (288)
T ss_dssp SS-STCCCGG
T ss_pred ccCCCCCCCc
Confidence 9999986543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-17 Score=192.80 Aligned_cols=195 Identities=21% Similarity=0.284 Sum_probs=153.5
Q ss_pred ceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCC---HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+|...+.||.+-|=+|.++++....|+||+|-+.+.. ....+++ .+++ ...+++||++.+.-+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6888899999999999999987777999999776532 2223333 3444 556689999999999888888999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc--ccCcc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--HETYL 660 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~--~~~~~ 660 (716)
|+ .-+|++.+..+. .+...+.+.|+.||+.||.-+|..| |+|+|||.+||||+.=+=+.|+||..-+.. +.++.
T Consensus 102 yv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99 559999997643 4778888999999999999999999 999999999999998877999999865432 11111
Q ss_pred -----ccccCCCCCCccCcccccCCC-----------CCchhHHHHHHHHHHHHHc-CCCCCC
Q 005054 661 -----TTKTGKGTPQWMAPEVLRNEP-----------SDEKSDVYSFGVILWELAT-EKIPWD 706 (716)
Q Consensus 661 -----~~~~~~Gt~~Y~aPE~~~~~~-----------~~~~sDIwSlG~ll~ellt-G~~PF~ 706 (716)
...+......|.|||.+.... ..++-||||+||+++||++ |.+||.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 111112345899999875421 3567899999999999999 899996
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=164.58 Aligned_cols=146 Identities=23% Similarity=0.234 Sum_probs=112.3
Q ss_pred ceeEeeeeecCCcEEEEEEE-E--cCCeEEEEEeeccCCC--------------------H--HHHHHHHHHHHHHHhcC
Q 005054 506 DLTIGEQIGQGSCGTVYHAV-W--YGSDVAVKVFSRQEYS--------------------D--EVIHSFRQEVSLMKRLR 560 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~-~--~~~~vAvK~~~~~~~~--------------------~--~~~~~~~~E~~iL~~l~ 560 (716)
-|.+.+.||+|+||.||+|. + .+..||||+++..... . .....+.+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 3 6789999998754311 0 01234568999999996
Q ss_pred CC--ceeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE
Q 005054 561 HP--NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (716)
Q Consensus 561 hp--nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl 638 (716)
+. .+++++.+ ...+|||||++|.+|..++... ..+....+..++.||+.+|.+||++| .|+|+||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 53 34445443 2358999999998887655332 34566677889999999999999865 49999999999999
Q ss_pred ccCCcEEEEecCCCcccccC
Q 005054 639 DKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~ 658 (716)
+ ++.++|+|||.+.....+
T Consensus 183 ~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred E-CCCEEEEEChhhhccCCc
Confidence 9 889999999998755443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=182.19 Aligned_cols=140 Identities=23% Similarity=0.315 Sum_probs=115.8
Q ss_pred cceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCH------HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
..|...+.||+|+||.||++.+.+..+++|+........ ....++.+|+.+++.++|++|+..+.++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345667899999999999999888777776543322111 12356788999999999999988777777777889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+||||++|++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.++|+|||+++...
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999999885 34678899999999999999 9999999999999 57799999999997643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-17 Score=189.59 Aligned_cols=166 Identities=30% Similarity=0.460 Sum_probs=123.3
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.+|..++.|-.|+||.||.++++ .+++|+|+-+...+ +++ +|.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-------lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-------LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccchh-------hhc---cccccCCccee-----------------
Confidence 46888999999999999999875 66788865332211 111 33333444444
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc------
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH------ 656 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~------ 656 (716)
|+-...++.- .+++.. ++.+++|||+.+ |+|||+||+|++|+.-|++|+.|||+++...
T Consensus 136 ----gDc~tllk~~-g~lPvd--------mvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-GPLPVD--------MVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccC-CCCcch--------hhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3444455432 233332 377899999988 9999999999999999999999999876311
Q ss_pred --cCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 657 --ETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 657 --~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
..+. .....+|||.|.|||++..+.|...+|||+||+|+|+++.|..||.+.++.+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 1111 1223479999999999999999999999999999999999999999886643
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.4e-16 Score=135.03 Aligned_cols=104 Identities=27% Similarity=0.522 Sum_probs=95.2
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEEE
Q 005054 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (716)
Q Consensus 140 ~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (716)
|++|+++|++|+|+++|++|++++||++++++|+++.+++++.........+.+.+..+..+..++.+++++|+.+|+.+
T Consensus 1 p~~i~i~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~ 80 (104)
T PF13426_consen 1 PDGIFILDPDGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFWVEV 80 (104)
T ss_dssp -SEEEEEETTSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEEEEE
T ss_pred CEEEEEECCcCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEEEEE
Confidence 68999999999999999999999999999999999999998777666777888899988889999999999999999999
Q ss_pred EEEEEECCCCCEEEEEEEEEchhH
Q 005054 220 TNTPFYDDDGTLVGIVCVSTDSRP 243 (716)
Q Consensus 220 ~~~PI~d~~G~i~g~i~i~~DITe 243 (716)
++.|+.+++|++.+++++++||||
T Consensus 81 ~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 81 SASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999996
|
... |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-16 Score=165.36 Aligned_cols=146 Identities=25% Similarity=0.415 Sum_probs=113.8
Q ss_pred CCCceeEEeceeccC---------------------------CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHH
Q 005054 560 RHPNVLLFMGAVTSP---------------------------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612 (716)
Q Consensus 560 ~hpnIv~~~~~~~~~---------------------------~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql 612 (716)
+|||||++..+|.+. ..+|+||...+. +|..++-.+. .+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999999887432 347999999855 9999997644 7788888899999
Q ss_pred HHHHHHHHhCCCCeEEcCCCCCcEEEc--cC--CcEEEEecCCCccccc-----Ccc-ccccCCCCCCccCcccccCCCC
Q 005054 613 ARGVSYLHHCNPPIIHRDLKSSNLLVD--KH--WTVKVGDFGLSRLKHE-----TYL-TTKTGKGTPQWMAPEVLRNEPS 682 (716)
Q Consensus 613 ~~aL~yLH~~~~~IvHrDIKp~NILl~--~~--~~vkL~DFGla~~~~~-----~~~-~~~~~~Gt~~Y~aPE~~~~~~~ 682 (716)
++|+.|||++| |.|||+|.+||||. ++ -.+.|+|||++--... ++. .....-|....||||+....+-
T Consensus 351 LEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 351 LEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 99999999999994 33 3489999997632111 111 1123347888999999865432
Q ss_pred ------CchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 683 ------DEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 683 ------~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..++|.|+.|.+.||++....||.....
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 3589999999999999999999997543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-16 Score=155.99 Aligned_cols=139 Identities=24% Similarity=0.214 Sum_probs=107.7
Q ss_pred ceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCH--------------------HHHHHHHHHHHHHHhcCCCc-
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD--------------------EVIHSFRQEVSLMKRLRHPN- 563 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~--------------------~~~~~~~~E~~iL~~l~hpn- 563 (716)
.|.+.+.||+|+||.||++.. .++.||||++....... ........|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 378889999999999999987 58899999876532110 01123567888888887764
Q ss_pred -eeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC
Q 005054 564 -VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 564 -Iv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~ 642 (716)
++.+++ ....++||||++|++|..+... .....++.+|+.++.++|+.+ |+|+||||+||+++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCC
Confidence 444443 2456999999999998765431 345678889999999999998 99999999999999999
Q ss_pred cEEEEecCCCccccc
Q 005054 643 TVKVGDFGLSRLKHE 657 (716)
Q Consensus 643 ~vkL~DFGla~~~~~ 657 (716)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=148.30 Aligned_cols=138 Identities=25% Similarity=0.239 Sum_probs=97.4
Q ss_pred eeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHH----------------------HHHHHHHHHhcCCC--ce
Q 005054 510 GEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHS----------------------FRQEVSLMKRLRHP--NV 564 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~----------------------~~~E~~iL~~l~hp--nI 564 (716)
.+.||+|+||.||++.+. ++.||||++............ ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 578999999999999885 888999998764322111111 13455556555433 23
Q ss_pred eEEeceeccCCceEEEEeecCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCC
Q 005054 565 LLFMGAVTSPQRLCIVTEFLPRGSLFR-LLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 565 v~~~~~~~~~~~~~lVmE~~~ggsL~~-~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~ 642 (716)
++++.+ ...++||||++++.+.. .+.... . ......++.+++.++.++|. ++ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 444433 24599999998844321 111111 1 15678889999999999999 88 99999999999999 88
Q ss_pred cEEEEecCCCccccc
Q 005054 643 TVKVGDFGLSRLKHE 657 (716)
Q Consensus 643 ~vkL~DFGla~~~~~ 657 (716)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.1e-14 Score=129.74 Aligned_cols=110 Identities=24% Similarity=0.357 Sum_probs=98.8
Q ss_pred HHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEE
Q 005054 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (716)
Q Consensus 136 ld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 215 (716)
|+++|++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+.+++..+.....+..... +|..+
T Consensus 1 l~~~p~~i~v~D~~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 79 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DGEER 79 (110)
T ss_dssp HHHCSSEEEEEETTSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TSCEE
T ss_pred CCCCCceeEEECCCCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cCCcE
Confidence 68999999999999999999999999999999999999999999987666666778888888887776666555 89999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEchhHHHH
Q 005054 216 LVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (716)
Q Consensus 216 ~v~~~~~PI~d~~G~i~g~i~i~~DITerk~ 246 (716)
|+.+++.|+.|.+|++.|++++++|||++|+
T Consensus 80 ~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 80 WFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp EEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred EEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.1e-15 Score=138.16 Aligned_cols=134 Identities=19% Similarity=0.173 Sum_probs=112.4
Q ss_pred EeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC--CceeEEeceeccCCceEEEEeecCC
Q 005054 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 509 i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h--pnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
+++.||.|.++.||++...+..+++|++..... ...+.+|+.+++.+.+ .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457899999999999999888999999866532 3567789999999976 5889999888888889999999988
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~-~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+..+ +......++.+++.+|.+||... .+++|+||+|.||+++..+.++|+|||.+..
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766544 45566778889999999999842 2399999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=150.17 Aligned_cols=138 Identities=20% Similarity=0.237 Sum_probs=106.7
Q ss_pred eeee-cCCcEEEEEEEEcCCeEEEEEeeccCC-----------CHHHHHHHHHHHHHHHhcCCCce--eEEeceeccCC-
Q 005054 511 EQIG-QGSCGTVYHAVWYGSDVAVKVFSRQEY-----------SDEVIHSFRQEVSLMKRLRHPNV--LLFMGAVTSPQ- 575 (716)
Q Consensus 511 ~~LG-~G~fg~Vy~~~~~~~~vAvK~~~~~~~-----------~~~~~~~~~~E~~iL~~l~hpnI--v~~~~~~~~~~- 575 (716)
..|| .|+.|+||.+...+..++||.+..... ......++.+|+.++..|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 888899999988899999998864321 11233567889999999988775 56666543322
Q ss_pred ---ceEEEEeecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 576 ---RLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 576 ---~~~lVmE~~~g-gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
..+||||+++| .+|.+++... .++... +.+|+.+|.+||++| |+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 23599999997 6899988653 355443 568999999999999 99999999999999888999999998
Q ss_pred Ccccc
Q 005054 652 SRLKH 656 (716)
Q Consensus 652 a~~~~ 656 (716)
+....
T Consensus 189 ~~~~~ 193 (239)
T PRK01723 189 GELRT 193 (239)
T ss_pred cccCC
Confidence 87543
|
|
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.7e-14 Score=127.79 Aligned_cols=112 Identities=25% Similarity=0.437 Sum_probs=95.3
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe-eEEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~ 208 (716)
++|++++++++++|+++|.+|+|+|+|++++++|||+.++++|+++.+++++++.......+...+..+.. ...+....
T Consensus 1 e~~~~i~~~~~~~i~~~d~~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDEDGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVRFR 80 (113)
T ss_dssp HHHHHHHHCSSSEEEEEETTSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEEEE
T ss_pred CHHHHHHhcCCceEEEEeCcCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEEEE
Confidence 57899999999999999999999999999999999999999999999999877654455567777766665 33344444
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEch
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DI 241 (716)
.++|..+|+.+.+.|+++.+|.+.|++++++||
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 81 LRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp ETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred ecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 579999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.1e-13 Score=159.57 Aligned_cols=186 Identities=15% Similarity=0.217 Sum_probs=141.8
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-chhHHHHHHHHHcCCeeEEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
.+++.+++..+++|+++|.+|+|+++|++|++++||+.++++|+++.+++.+... ......+...+..+..+..+..++
T Consensus 111 ~~~~~v~~~~~~gI~i~D~~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 190 (663)
T PRK10060 111 SFAEQVVSEANSVIVILDSRGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWIK 190 (663)
T ss_pred HHHHHHHhhCCceEEEEeCCCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEEE
Confidence 4567799999999999999999999999999999999999999998887654432 233345566678888888999999
Q ss_pred cCCCCEEEEEEEEEEEECCCC-CEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhC----CCch----
Q 005054 209 TKTEERVLVVATNTPFYDDDG-TLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLG----LDSQ---- 279 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G-~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~----~d~~---- 279 (716)
+++|..+|+.... ++.+.+| ...+++++.+|||++++.+++|++++.+|++|++.++.. |...+. ....
T Consensus 191 ~~~G~~~~~~~~~-~~~~~~g~~~~~~i~~~~DITe~k~~e~~l~~~a~~D~LTGL~NR~~-f~~~l~~~l~~~~~~~~~ 268 (663)
T PRK10060 191 TRKGQRLFLFRNK-FVHSGSGKNEIFLICSGTDITEERRAQERLRILANTDSITGLPNRNA-IQELIDHAINAADNNQVG 268 (663)
T ss_pred eCCCCEEEEEeee-EEEcCCCCceEEEEEEEEechHHHHHHHHHHHHhhcCccCCCcCHHH-HHHHHHHHHHhCCCCcEE
Confidence 9999999986554 4444444 446688999999999999999999999999999999765 544331 1111
Q ss_pred ---------hHHHHHHHHHH-HhhHHHHHhhhhccccCCCccccCCCC
Q 005054 280 ---------QPLQATIASKI-SNLATKVSNKVKSRIRTGDNFMDREGG 317 (716)
Q Consensus 280 ---------q~l~~~i~~~I-~~La~~v~n~~~s~~~~~~~~~~~~g~ 317 (716)
..++....... +.|..++.++++..++.++...++.|+
T Consensus 269 ll~idld~fk~iNd~~G~~~gD~lL~~va~~L~~~~~~~d~vaRlggd 316 (663)
T PRK10060 269 IVYLDLDNFKKVNDAYGHMFGDQLLQDVSLAILSCLEEDQTLARLGGD 316 (663)
T ss_pred EEEEECcchhHHHHhhCcHHHHHHHHHHHHHHHHhCCCCCEEEEEcCC
Confidence 12223322222 458888999999999887766665553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-15 Score=175.20 Aligned_cols=203 Identities=28% Similarity=0.428 Sum_probs=164.5
Q ss_pred ceeEeeeeecCCcEEEEEEEEc---CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVm 581 (716)
.|.+.+.||+|.|+.|-..... ...+++|.+............+..|..+-+.+. |+|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4666777999999999888653 223666665544333344455556777777776 999999999999999999999
Q ss_pred eecCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCccccc-
Q 005054 582 EFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE- 657 (716)
Q Consensus 582 E~~~ggsL~~~l-~~~~~~l~~~~v~~i~~ql~~aL~yLH-~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~- 657 (716)
+|..|++++..+ .......+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999998 443335777888889999999999999 888 99999999999999999 999999999986544
Q ss_pred --CccccccCCC-CCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 --TYLTTKTGKG-TPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 --~~~~~~~~~G-t~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........+| ++.|++||...+. ......|+||.|+++..+++|..||.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 2333445578 9999999999885 446789999999999999999999986543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.8e-15 Score=158.71 Aligned_cols=120 Identities=32% Similarity=0.467 Sum_probs=104.6
Q ss_pred ceEEEEeecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~--~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
++||.|++|...+|.++|..+ ....+....+.++.|++.+++| ++ .+|+|+||.||++..+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence 579999999999999999643 3456778889999999999999 67 9999999999999999999999999987
Q ss_pred ccccCc------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc
Q 005054 654 LKHETY------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700 (716)
Q Consensus 654 ~~~~~~------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt 700 (716)
...... .......||..||+||.+.+..|+.++|||+||+||+||+.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 544332 23345579999999999999999999999999999999998
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.5e-13 Score=161.48 Aligned_cols=149 Identities=16% Similarity=0.158 Sum_probs=129.2
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
+++++.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.+++++.............+..+.....+..+.
T Consensus 154 ~~~l~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 233 (779)
T PRK11091 154 SSLLRSFLDASPDLVYYRNEDGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVIETDEKVFRHNVSLTYEQWLD 233 (779)
T ss_pred HHHHHHHHhcCcceEEEECCCCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHHHHHHHHHhcCCCeEEEEEEE
Confidence 36789999999999999999999999999999999999999999999999887654444445566677788888888889
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~i 286 (716)
.++|..+|+.++..|+.+.+|.+.|++++++|||++|+++++++.... .+..|++.++|+.++||..++
T Consensus 234 ~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~~a~~---------~~~~~~a~isHelrtPL~~I~ 302 (779)
T PRK11091 234 YPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALEKASR---------DKTTFISTISHELRTPLNGIV 302 (779)
T ss_pred cCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHHHHHH---------HHHHHHHHhhHhhcCcHHHHH
Confidence 999999999999999999999999999999999999999998876533 234588889999999988754
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-12 Score=150.43 Aligned_cols=150 Identities=18% Similarity=0.230 Sum_probs=126.6
Q ss_pred HHHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (716)
+..|..+++.++++|+++|. +|+|+|+|++|++++||+.+|++|+++..++++.........++..+..+..+..++
T Consensus 29 ~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (540)
T PRK13557 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEI 108 (540)
T ss_pred hHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEE
Confidence 47799999999999999995 799999999999999999999999999998877665556667778888888788888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHH
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~ 285 (716)
..++++|..+|+.+++.|+++.+|.+++++++.+|||++++++++++....... ...+...+.|+.++||+..
T Consensus 109 ~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~~~~~~~-------l~~~~~~i~h~l~~pl~~i 181 (540)
T PRK13557 109 LNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQAQKMEA-------LGQLTGGIAHDFNNLLQVM 181 (540)
T ss_pred EEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHHHHHHHH-------hhhhhhhhhHHhhhHHHHH
Confidence 888999999999999999999999999999999999999999988765433211 1125566778888888653
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.6e-13 Score=143.82 Aligned_cols=123 Identities=21% Similarity=0.177 Sum_probs=107.0
Q ss_pred HHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (716)
+.|+.+|+..+++|+++|. +|+|+++|+++++++||+.++++|+++..+..+.........+...+..+..+..+..
T Consensus 43 ~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 122 (361)
T PRK13559 43 RLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVELL 122 (361)
T ss_pred hHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEEE
Confidence 6688999999999999997 5789999999999999999999999988776655444445566777888887888888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHH
Q 005054 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (716)
Q Consensus 207 ~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~ 252 (716)
.+++||..+|+.++..|+++.+|.+.+++++++|||++|++++.++
T Consensus 123 ~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~~ 168 (361)
T PRK13559 123 NYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALEA 168 (361)
T ss_pred EEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHHH
Confidence 8899999999999999999999999999999999999998876544
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-12 Score=161.04 Aligned_cols=188 Identities=19% Similarity=0.214 Sum_probs=146.6
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc--chhHHHHHHHHHcCCe--eEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD--FDVAYDIVHRIKMGER--WTGQ 204 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~--~~~~~~i~~~l~~g~~--~~~e 204 (716)
+++++.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.+++..... ......+......+.. ...+
T Consensus 535 ~~~l~~~l~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (1092)
T PRK09776 535 KERLHITLDSIGEAVVCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQD 614 (1092)
T ss_pred HHHHHHHHhccccEEEEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccce
Confidence 45678899999999999999999999999999999999999999998887753322 1222234444444443 4567
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHh----------
Q 005054 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKL---------- 274 (716)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~---------- 274 (716)
....+++|..+|+..+..|+.+.+|.+.|++++++|||++|+.+++|++++.+|+.|++.++.. |...+
T Consensus 615 ~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~L~~~a~~D~lTgl~nr~~-f~~~l~~~~~~~~~~ 693 (1092)
T PRK09776 615 VVLHCRSGGSYDVHYSITPLSTLDGENIGSVLVIQDVTESRKMLRQLSYSASHDALTHLANRAS-FEKQLRRLLQTVNST 693 (1092)
T ss_pred EEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEEEEecchHHHHHHHHHhhcCCCcccCCccHHH-HHHHHHHHHHHHHhc
Confidence 7788999999999999999999999999999999999999999999999999999999999766 54332
Q ss_pred ---------CCCchhHHHHHHHHHH-HhhHHHHHhhhhccccCCCccccCCCC
Q 005054 275 ---------GLDSQQPLQATIASKI-SNLATKVSNKVKSRIRTGDNFMDREGG 317 (716)
Q Consensus 275 ---------~~d~~q~l~~~i~~~I-~~La~~v~n~~~s~~~~~~~~~~~~g~ 317 (716)
..|--..++....... +.+..++.+++++.++..+.+.++.|+
T Consensus 694 ~~~~~l~~idid~fk~in~~~G~~~gd~~L~~~a~~l~~~~~~~~~~~R~~gd 746 (1092)
T PRK09776 694 HQRHALVFIDLDRFKAVNDSAGHAAGDALLRELASLMLSMLRSSDVLARLGGD 746 (1092)
T ss_pred CCcEEEEEEECcchHHHHHhhChhhHHHHHHHHHHHHHHhCCCcCEEEEecCc
Confidence 1122233333332322 558888999999998887766655554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-13 Score=150.66 Aligned_cols=152 Identities=37% Similarity=0.634 Sum_probs=128.1
Q ss_pred HHhcCCCceeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-EEcCCCCC
Q 005054 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI-IHRDLKSS 634 (716)
Q Consensus 556 L~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~I-vHrDIKp~ 634 (716)
|+.+.|.|+.+|++.+.++..+++|.+||..|+|.+.+......+++.....++++|+.||.|||.-- | .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 45678999999999999999999999999999999999987778899999999999999999999865 4 99999999
Q ss_pred cEEEccCCcEEEEecCCCccccc--CccccccCCCCCCccCcccccCCC-------CCchhHHHHHHHHHHHHHcCCCCC
Q 005054 635 NLLVDKHWTVKVGDFGLSRLKHE--TYLTTKTGKGTPQWMAPEVLRNEP-------SDEKSDVYSFGVILWELATEKIPW 705 (716)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~-------~~~~sDIwSlG~ll~elltG~~PF 705 (716)
|++++....+||+|||+...... .........-..-|.|||.+.+.. .+.+.||||+|++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999876532 111111112345799999997642 255699999999999999999999
Q ss_pred CCCC
Q 005054 706 DNLN 709 (716)
Q Consensus 706 ~~~~ 709 (716)
....
T Consensus 159 ~~~~ 162 (484)
T KOG1023|consen 159 DLRN 162 (484)
T ss_pred cccc
Confidence 8643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.2e-12 Score=140.22 Aligned_cols=148 Identities=22% Similarity=0.261 Sum_probs=98.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCH--------------------------------HHHH---
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD--------------------------------EVIH--- 547 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~--------------------------------~~~~--- 547 (716)
+..|. .+.||.|++|.||+|+. .|+.||||+.+...... +...
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 34444 36799999999999987 68899999986532100 0000
Q ss_pred ---HHHHHHHHHHhc----C-CCceeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH-HHHH
Q 005054 548 ---SFRQEVSLMKRL----R-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR-GVSY 618 (716)
Q Consensus 548 ---~~~~E~~iL~~l----~-hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~-aL~y 618 (716)
.+.+|...+.++ . +++|.-..-++......+|||||++|.+|.++.......+. ...++.+++. .+..
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHH
Confidence 133344444444 2 34433222222234457999999999999887754322222 2345555555 4678
Q ss_pred HHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 619 LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+|..| ++|+|+||.||+++.++.++|+|||++.....
T Consensus 273 l~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 273 VLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 89988 99999999999999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=7e-12 Score=121.55 Aligned_cols=130 Identities=15% Similarity=0.068 Sum_probs=96.0
Q ss_pred eeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc-eeEEeceeccCCceEEEEeecCCCC
Q 005054 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIVTEFLPRGS 588 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn-Iv~~~~~~~~~~~~~lVmE~~~ggs 588 (716)
++.|+.|.++.||++...+..|++|+....... ...+..|+.+++.+.+.+ +++++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 467899999999999998999999987554211 123467888888875444 345555443 34589999999987
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP---PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 589 L~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~---~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+.... .....++.+++++|..||..+. .++|+|++|.||+++ ++.++|+||+.+..
T Consensus 78 l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75430 1113456789999999998861 149999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.4e-11 Score=119.55 Aligned_cols=139 Identities=21% Similarity=0.192 Sum_probs=99.6
Q ss_pred eeeeecCCcEEEEEEEEc--------CCeEEEEEeeccCC--------------------CHHHHHHHH----HHHHHHH
Q 005054 510 GEQIGQGSCGTVYHAVWY--------GSDVAVKVFSRQEY--------------------SDEVIHSFR----QEVSLMK 557 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~--------~~~vAvK~~~~~~~--------------------~~~~~~~~~----~E~~iL~ 557 (716)
...||.|--+.||.|... +..+|||+++.... .......+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357999999999999764 36899999753210 001122233 7899999
Q ss_pred hcC--CCceeEEeceeccCCceEEEEeecCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEEcCCCC
Q 005054 558 RLR--HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-LLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKS 633 (716)
Q Consensus 558 ~l~--hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~-~l~~~~~~l~~~~v~~i~~ql~~aL~yL-H~~~~~IvHrDIKp 633 (716)
++. .-++++++.+ ...+|||||+.+..+.. .++. ..++......+..+++.+|..| |+.| |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 884 2455566654 45699999997654422 2322 2355566777788999999998 8888 99999999
Q ss_pred CcEEEccCCcEEEEecCCCccccc
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
.|||+. ++.+.|+|||.+.....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCCC
Confidence 999997 46899999998876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.5e-11 Score=137.31 Aligned_cols=126 Identities=18% Similarity=0.298 Sum_probs=110.6
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
.+.|+.+++.++++|+++|.+|+|+|+|+++++++||++++++|+....+..+.........+...+..+.++..++...
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDLKANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred hHHHHHHHHhCCceEEEECCCCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 46799999999999999999999999999999999999999999987777665544444556677777788788888888
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~l 254 (716)
+++|..+|+.....|+++.+|.+.+++++++|||++++++++|+..
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~ 128 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ 128 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999887643
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.6e-11 Score=133.73 Aligned_cols=163 Identities=24% Similarity=0.335 Sum_probs=126.1
Q ss_pred cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHH
Q 005054 527 YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606 (716)
Q Consensus 527 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~ 606 (716)
.+.+|.|.+++.... .......+-++.|+.++||||+++++.++..+.+|||.|.+ ..|..++++.. ...+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHH
Confidence 466788888776543 33455667788999999999999999999999999999998 36777777633 66777
Q ss_pred HHHHHHHHHHHHHH-hCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCch
Q 005054 607 LMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685 (716)
Q Consensus 607 ~i~~ql~~aL~yLH-~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ 685 (716)
.-+.||+.||.||| +++ ++|++|....|+|+..|..||.+|-++..............--..|..|+.+.... ..
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 78899999999997 556 99999999999999999999999998755433321111222233466776654333 34
Q ss_pred hHHHHHHHHHHHHHcC
Q 005054 686 SDVYSFGVILWELATE 701 (716)
Q Consensus 686 sDIwSlG~ll~elltG 701 (716)
.|.|.|||++++++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-11 Score=136.19 Aligned_cols=200 Identities=23% Similarity=0.190 Sum_probs=158.7
Q ss_pred cccceeEeeeeec--CCcEEEEEEEE----cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCC
Q 005054 503 LWEDLTIGEQIGQ--GSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~--G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~ 575 (716)
.-..|.+.+.+|. |.+|.||.+.. .+..+|+|.-+.....+....+-.+|+.....+ .|+|.++.+..++..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456788899999 99999999876 345688886433322222223334566666666 4999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR----GVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFG 650 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~----aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFG 650 (716)
..++-+|+| +.+|..+.......++...++.++.+... ||.++|.++ |+|.|+||.||++..+ ...+++|||
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcc
Confidence 999999999 57888888776666888999999999999 999999999 9999999999999988 789999999
Q ss_pred CCcccccCccccc-----cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 651 LSRLKHETYLTTK-----TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 651 la~~~~~~~~~~~-----~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
+............ ...|...|++||...+. ++...|||+||.++.+..++..++.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhccccc
Confidence 9887665542222 22688899999987766 5678999999999999988866644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.7e-11 Score=114.46 Aligned_cols=135 Identities=24% Similarity=0.331 Sum_probs=104.5
Q ss_pred eeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHH------HHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEV------IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~------~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
..|++|+-+.||.+.+.+.++++|.-.+..+.... ..+-.+|..++..++--.|...+-++.+++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999888888888876555443221 245567899999886555554455556677889999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|..|.+++.... ..++..+-.-+.-||..| |||+||.++||++..+ .+.++|||++....
T Consensus 82 ~G~~lkd~l~~~~--------~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~-~i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEAR--------PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG-RIYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhcc--------hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC-cEEEEECCcccccc
Confidence 9999998987651 345566777788899999 9999999999999766 49999999987543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-11 Score=140.47 Aligned_cols=147 Identities=19% Similarity=0.197 Sum_probs=94.7
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC---------------------------C-H----HH
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY---------------------------S-D----EV 545 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---------------------------~-~----~~ 545 (716)
++..+..|.. +.||.|++|.||+|+.. |+.||||+.++... . . +.
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 3445567887 78999999999999873 78999999875421 0 0 11
Q ss_pred HHHHHHHHH------HHHhc----CCCceeEEeceec-cCCceEEEEeecCCCCHHHH--HhhcCC---CCCHHHHHHHH
Q 005054 546 IHSFRQEVS------LMKRL----RHPNVLLFMGAVT-SPQRLCIVTEFLPRGSLFRL--LQRNTT---KLDWRRRILMA 609 (716)
Q Consensus 546 ~~~~~~E~~------iL~~l----~hpnIv~~~~~~~-~~~~~~lVmE~~~ggsL~~~--l~~~~~---~l~~~~v~~i~ 609 (716)
...+.+|+. .+.++ .+.+.+.+-.++. .....+|||||++|+.|.++ +...+. .+....+..++
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 222333333 33333 2333233222222 23456899999999999875 333221 23344444455
Q ss_pred HHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC----cEEEEecCCCcccc
Q 005054 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSRLKH 656 (716)
Q Consensus 610 ~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGla~~~~ 656 (716)
.|++ ..| ++|+|+||.||+++.++ +++++|||++....
T Consensus 274 ~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5544 467 99999999999999888 99999999986543
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-10 Score=100.30 Aligned_cols=120 Identities=24% Similarity=0.405 Sum_probs=97.1
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcC-CeeEEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG-ERWTGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g-~~~~~e~~~~ 208 (716)
+.+..+++.++++++++|.+|+|+++|+++++++|++..+++|+.+..++++.........+...+..+ ......+.+.
T Consensus 3 ~~~~~~~~~~~~~~~~~d~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (124)
T TIGR00229 3 ERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRVR 82 (124)
T ss_pred hHHHHHHhhCCceEEEEcCCCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeeeE
Confidence 568899999999999999999999999999999999999999999888776655433333344444423 2234455556
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~ 250 (716)
..+|..+|+.....|+. .+|...++++++.|||++++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 83 RKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred cCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 78999999999999997 788899999999999999988764
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-10 Score=140.01 Aligned_cols=126 Identities=15% Similarity=0.129 Sum_probs=104.9
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
++.|+.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.+++++.............+..+.....+..++
T Consensus 203 ~~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 282 (807)
T PRK13560 203 LHFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFDADGSQIIEAEFQ 282 (807)
T ss_pred HHHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhccCCceEEEEEEE
Confidence 35588899999999999999999999999999999999999999999998876543333233345555666677788889
Q ss_pred cCCCCEEEEEEE--EEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHH
Q 005054 209 TKTEERVLVVAT--NTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (716)
Q Consensus 209 ~kdG~~~~v~~~--~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~l 254 (716)
++||..+|+.+. ..|+.+.+|.+.|++++++|||++|+++++|+..
T Consensus 283 ~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~s 330 (807)
T PRK13560 283 NKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEK 330 (807)
T ss_pred cCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHH
Confidence 999999966554 4566788999999999999999999999988754
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.4e-10 Score=132.45 Aligned_cols=126 Identities=22% Similarity=0.260 Sum_probs=110.9
Q ss_pred HHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (716)
+.++.+++..+++|+++|. +|+|+|+|+++++++||+.++++|+++..++++.........+...+..+.....++.
T Consensus 148 r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 227 (665)
T PRK13558 148 RLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELR 227 (665)
T ss_pred HHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEE
Confidence 3457899999999999984 7999999999999999999999999988887766554555566777888888888999
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHH
Q 005054 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (716)
Q Consensus 207 ~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la 255 (716)
.++++|..+|+.++..|+.+.+|.+.+++++++|||++|+.|++|+...
T Consensus 228 ~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~~~ 276 (665)
T PRK13558 228 NYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQRER 276 (665)
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999887543
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.9e-10 Score=128.11 Aligned_cols=114 Identities=15% Similarity=0.030 Sum_probs=90.9
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCC-hhhHcCCCccccccccccchhHHHHHHHH-HcCCeeEEEEEEE
Q 005054 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS-AEEALGQDAIELLTDGRDFDVAYDIVHRI-KMGERWTGQFPAK 208 (716)
Q Consensus 131 ~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys-~eEliGk~~~~l~~~~~~~~~~~~i~~~l-~~g~~~~~e~~~~ 208 (716)
.|+.+|+.++++|+++|.+|+|+++|++|++++||+ .++++|+++.+++..... . ...+...+ ..|.....+..+.
T Consensus 253 ~~~~l~e~~~d~I~v~D~~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~-~-~~~~~~~~~~~g~~~~~~~~~~ 330 (442)
T TIGR02040 253 NLARLYHEAPDAIVFSDADGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGV-D-LRVLLSNVRRTGQVRLYATTLT 330 (442)
T ss_pred HHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcc-c-HHHHHHHHhhcCceEEEEEEEE
Confidence 588999999999999999999999999999999997 578999999887764332 1 23333444 3444445566778
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETR 248 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e 248 (716)
+++|..+|+.+++.|+.+.++ ..++++++|||++++.+
T Consensus 331 ~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDITeR~~~~ 368 (442)
T TIGR02040 331 GEFGAQTEVEISAAWVDQGER--PLIVLVIRDISRRLTMR 368 (442)
T ss_pred cCCCCEEEEEEEEEEeccCCc--eEEEEEEecchhhccCC
Confidence 999999999999999976544 45788999999988774
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-10 Score=110.18 Aligned_cols=145 Identities=23% Similarity=0.207 Sum_probs=108.9
Q ss_pred EeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCH------HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 509 i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.+..|-+|+-+.|+++.+.|+.++||.-....+.. -...+..+|.++|.++.--.|.-..-++.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 46788999999999999999999998644433322 123566789999988854444433344556667789999
Q ss_pred ecCC-CCHHHHHhhcCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---cEEEEecCCCccc
Q 005054 583 FLPR-GSLFRLLQRNTTKLDW-RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLK 655 (716)
Q Consensus 583 ~~~g-gsL~~~l~~~~~~l~~-~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~---~vkL~DFGla~~~ 655 (716)
|++| .++.+++......-.. .....++.+|-+.+.-||.++ |||+||..+||++..++ .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9977 4788888665433333 334788899999999999999 99999999999997654 3589999998654
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.2e-10 Score=120.40 Aligned_cols=142 Identities=15% Similarity=0.086 Sum_probs=109.8
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
..+..+|++++++++++|.+|+|+++|++|++++||+.++++|+++.++++.... ....+...+..+..+........
T Consensus 7 ~~~~~il~~~~~gi~~~d~~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 84 (348)
T PRK11073 7 PDAGQILNSLINSILLLDDDLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFSL--NIELMRESLQAGQGFTDNEVTLV 84 (348)
T ss_pred chHHHHHhcCcCeEEEECCCCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcchh--hHHHHHHHHHcCCcccccceEEE
Confidence 4579999999999999999999999999999999999999999999998865331 22344566666665444444456
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHH
Q 005054 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~ 285 (716)
+||..+|+.++..|+. . .+++..++|||+++++++++...+... ....+...+.|+.++||...
T Consensus 85 ~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~~~~~~~-------~~~~~~~~iaHelr~pL~~i 148 (348)
T PRK11073 85 IDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQLQHAQQV-------AARDLVRGLAHEIKNPLGGL 148 (348)
T ss_pred ECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHHHHHHHH-------HHHHHHHhhhHhhcChHHHH
Confidence 7999999999999986 2 246778999999999988776554421 11236777888888888764
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.5e-10 Score=141.39 Aligned_cols=129 Identities=13% Similarity=0.098 Sum_probs=109.0
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcC-CeeEEEEE
Q 005054 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG-ERWTGQFP 206 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g-~~~~~e~~ 206 (716)
.+++++.+++..+++|+++|.+|+|+++|+++++++||+.+|++|+++.++.++++.......+...+..+ .....+.+
T Consensus 281 ~e~r~~~l~e~~~~~i~~~d~dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~e~~ 360 (1092)
T PRK09776 281 SETRFRNAMEYSAIGMALVGTEGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEKLLSGEINSYSMEKR 360 (1092)
T ss_pred HHHHHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHHHHcCCccceeeeeE
Confidence 34678999999999999999999999999999999999999999999998887766444333333333332 23667888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 207 ~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
+.++||+.+|+..+..|+++.+|.+.+++++++|||++|++|++++....
T Consensus 361 ~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~~ 410 (1092)
T PRK09776 361 YYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLME 410 (1092)
T ss_pred EEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999999999999999876543
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-09 Score=131.55 Aligned_cols=120 Identities=24% Similarity=0.300 Sum_probs=100.9
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-chhHHHHHHHHHcCCeeEEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
+.+..+++.++++|+++|.+|+|+++|+++++++||+.++++|+.+.+++..... ......+...+..+..+..+....
T Consensus 136 ~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 215 (799)
T PRK11359 136 RQLIIAVDHLDRPVIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLLL 215 (799)
T ss_pred HHHHHHHhcCCCcEEEEcCCCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEEe
Confidence 4456678999999999999999999999999999999999999998887654332 233334555666666677788888
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~ 249 (716)
.++|..+|+.++..|+.+.+|.+.+++++.+|||+++++++
T Consensus 216 ~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~ 256 (799)
T PRK11359 216 TRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQ 256 (799)
T ss_pred CCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHH
Confidence 99999999999999999999999999999999999987654
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.9e-09 Score=122.35 Aligned_cols=145 Identities=16% Similarity=0.225 Sum_probs=112.5
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe-eEEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~ 208 (716)
..++.+++.++++++++|.+|+|+++|+++++++||+.++++|+++.+++++... ....+...+..+.. ...++.+.
T Consensus 262 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 339 (607)
T PRK11360 262 SLNELILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNTP--FASPLLDTLEHGTEHVDLEISFP 339 (607)
T ss_pred HHHHHHHHhccCeEEEEcCCCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCchh--HHHHHHHHHhcCCCccceEEEEE
Confidence 4567889999999999999999999999999999999999999999998875432 23345556665554 34456667
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~ 284 (716)
.++|..+ +.++..|+.+.+|.+.|++++++|||+++++++++++...... ...++..+.|+..+||..
T Consensus 340 ~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~~~~~~~-------l~~~~~~~~hel~~~l~~ 407 (607)
T PRK11360 340 GRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVARQERLAA-------LGELVAGVAHEIRNPLTA 407 (607)
T ss_pred cCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHHHHHHHH-------HHHHHHHHHHHhhhHHHH
Confidence 7788776 8899999999999999999999999999999999887644211 112445555555555543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=8e-10 Score=111.64 Aligned_cols=141 Identities=21% Similarity=0.247 Sum_probs=104.5
Q ss_pred eeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC--CceeEEeceeccC---CceEEEEeec
Q 005054 511 EQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSP---QRLCIVTEFL 584 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h--pnIv~~~~~~~~~---~~~~lVmE~~ 584 (716)
+.|+.|.++.||++...+ ..|++|+....... .....+.+|+.+++.+.+ ..+++++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998865 78999987654321 123467789999999865 3456677666553 3678999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005054 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------------ 622 (716)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~------------------------------------------ 622 (716)
+|.+|...+.. ..++......++.++++.|..||+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99887665432 2366666777777777777777742
Q ss_pred ------------CCCeEEcCCCCCcEEEcc--CCcEEEEecCCCcc
Q 005054 623 ------------NPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRL 654 (716)
Q Consensus 623 ------------~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~ 654 (716)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 123799999999999998 56789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.3e-11 Score=138.25 Aligned_cols=210 Identities=23% Similarity=0.269 Sum_probs=154.7
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
|..-.+.+.+.+-+-.|.++.++.+.-. +.-.+.|+...... .....+.+..+-.++-...+|-++.....+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 5556678888899999999999987542 22233443322111 11112223333344434456777777666667788
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.+|+|+|+.+++|...+...+ ..+.+....++..+..+++|||... ++|+|++|.|+++..+++.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999997654 4666666777778999999999987 9999999999999999999999998432110
Q ss_pred -------------------------------cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005054 657 -------------------------------ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705 (716)
Q Consensus 657 -------------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF 705 (716)
+.........||+.|.+||...+......+|+|++|+++++.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0001123446999999999999999999999999999999999999999
Q ss_pred CCCCccc
Q 005054 706 DNLNSMQ 712 (716)
Q Consensus 706 ~~~~~l~ 712 (716)
....+-+
T Consensus 1036 na~tpq~ 1042 (1205)
T KOG0606|consen 1036 NAETPQQ 1042 (1205)
T ss_pred CCcchhh
Confidence 8776543
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.2e-09 Score=113.48 Aligned_cols=127 Identities=17% Similarity=0.275 Sum_probs=97.8
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
.+.|+.+++.++++|+++|.+|+|+++|++|++++||++++++|+++.+++... .+...+..+.. ...+.+.
T Consensus 5 ~~~l~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~-------~~~~~l~~~~~-~~~~~~~ 76 (333)
T TIGR02966 5 LSRFRAAAQALPDAVVVLDEEGQIEWCNPAAERLLGLRWPDDLGQRITNLIRHP-------EFVEYLAAGRF-SEPLELP 76 (333)
T ss_pred HHHHHHHHHhCcCcEEEECCCCcEEEEcHHHHHHhCCChHHHcCCcHHHHccCH-------HHHHHHHhccc-CCCeEee
Confidence 467899999999999999999999999999999999999999999988886542 24444444432 3335555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~ 284 (716)
.++|..+|+.+...|+.+.. ++++++|||+++++++..+. +...+.|+..+||..
T Consensus 77 ~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~~~----------------~~~~l~h~l~~pL~~ 131 (333)
T TIGR02966 77 SPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMRRD----------------FVANVSHELRTPLTV 131 (333)
T ss_pred cCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHHHH----------------HHHhhhhhhcccHHH
Confidence 67889999999999986542 67889999999988765442 444555666666644
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-10 Score=127.39 Aligned_cols=194 Identities=21% Similarity=0.170 Sum_probs=148.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE---cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW---YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~l 579 (716)
..+|..+..||.|.|+.|+++.. .+..|++|-+............-..|+.+...+ .|.+++.++..|....+.||
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45789999999999999999865 345688887766554433223334566666666 58999999999988889999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~ 658 (716)
-.|||.++++...+ .....+.+..++.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||+.+...-.
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999887666 22345778888999999999999999988 9999999999999876 77899999988642211
Q ss_pred ccccccCCCCCCcc--CcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 005054 659 YLTTKTGKGTPQWM--APEVLRNEPSDEKSDVYSFGVILWELATEKI 703 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~--aPE~~~~~~~~~~sDIwSlG~ll~elltG~~ 703 (716)
.......-+++ ++.......+..+.|+++||..+.+.+++..
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 11222233444 5555667777889999999999999999764
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.2e-09 Score=93.66 Aligned_cols=106 Identities=22% Similarity=0.317 Sum_probs=77.7
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCC
Q 005054 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (716)
+..+|++++.+++++|.+++|+|+|+++.++|+... ..+|+++.++.++.. ......+.+.+..|+....+.... .+
T Consensus 1 L~~il~s~~~~i~~vD~~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~~-~~~l~~~i~~~~~~~~~~~~~~~~-~~ 77 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDRNLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPLS-YPNLKKIIEQVRSGKEEEFEIVIP-NG 77 (106)
T ss_dssp HHHHHHHSSSEEEEEETTSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HHH-HHHHHHHHHHHHTTSBSEEEEEEE-ET
T ss_pred ChHHHhcCCCCEEEEcCCCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCccc-hHHHHHHHHHHHcCCCceEEEEec-CC
Confidence 468999999999999999999999999999999764 568999999987743 334445667777777644444443 34
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 212 G~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
| .|+.+...|+++++|+..|++.++.|||
T Consensus 78 ~--~~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 78 G--RWYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp T--EEEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred C--EEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 4 5777799999999999999999999997
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.2e-09 Score=125.60 Aligned_cols=128 Identities=18% Similarity=0.238 Sum_probs=102.6
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEe-cHHHHHHhCCChhhHcCCCccccccccccch-----------------hHH
Q 005054 128 TDRQYLNILQSMGQSVHIFDLSDRIIYW-NRSAELLYGYSAEEALGQDAIELLTDGRDFD-----------------VAY 189 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D~dG~Ii~v-N~aae~l~Gys~eEliGk~~~~l~~~~~~~~-----------------~~~ 189 (716)
.++.|+.++++++++|+++|.+|+|+++ |+++++++||+.++++|+++..+.+...... ...
T Consensus 330 se~~l~~l~~~~~~~i~~~d~~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (807)
T PRK13560 330 KEDMLRAIIEAAPIAAIGLDADGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPDGRPMAFDAC 409 (807)
T ss_pred HHHHHHHHHHhCcccEEEEcCCCCEEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCcCCcchhhhh
Confidence 4566899999999999999999999987 6888889999999999998776654321110 001
Q ss_pred HHHHHHHcCCeeE-EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHH
Q 005054 190 DIVHRIKMGERWT-GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (716)
Q Consensus 190 ~i~~~l~~g~~~~-~e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la 255 (716)
.+...+..+.... .++.+.+++|..+|+.++..|+++.+|.+.+++++++|||++|++|++|+...
T Consensus 410 ~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk~~E~~L~~~~ 476 (807)
T PRK13560 410 PMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERKQVEEQLLLAN 476 (807)
T ss_pred hHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHHHHHHHHHHHH
Confidence 1234456666533 46777889999999999999999999999999999999999999999998653
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.94 E-value=3e-08 Score=80.76 Aligned_cols=103 Identities=28% Similarity=0.460 Sum_probs=85.9
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEE
Q 005054 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (716)
Q Consensus 139 l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (716)
++++++++|.+|.++++|.+++.++|++..+++|+.+..++.+.........+...+..+.....++.+...+|..+|+.
T Consensus 1 ~~~~i~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (103)
T cd00130 1 LPDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVIWVL 80 (103)
T ss_pred CCceEEEECCCCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEEEEE
Confidence 36789999999999999999999999999999999988888776654444445555555555777788888889999999
Q ss_pred EEEEEEECCCCCEEEEEEEEEch
Q 005054 219 ATNTPFYDDDGTLVGIVCVSTDS 241 (716)
Q Consensus 219 ~~~~PI~d~~G~i~g~i~i~~DI 241 (716)
+...++.+..|...+++++++||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 81 VSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEecCCCCEEEEEEEEecC
Confidence 99999988888999999998886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >COG5002 VicK Signal transduction histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.5e-08 Score=105.04 Aligned_cols=140 Identities=21% Similarity=0.315 Sum_probs=110.2
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE-
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK- 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~- 208 (716)
+.+..++-.+.|||+-+|..|+|+.+|..|++++|.+.++++|+++.+++.-++... +...+.... .+.+-
T Consensus 111 ~kL~SvlayMtDGViATdRrG~iI~iN~~A~k~L~~~~E~~~~~~i~elL~i~d~y~----~~dL~e~~~----s~lld~ 182 (459)
T COG5002 111 RKLDSVLAYMTDGVIATDRRGKIILINKPALKMLGVSKEDALGRSILELLKIEDTYT----FEDLVEKND----SLLLDS 182 (459)
T ss_pred HHHHHHHHHHcCceEeecCCCcEEEeccHHHHHhCcCHHHHhcccHHHHhCCcccee----HHHHHhcCC----cEEEee
Confidence 557889999999999999999999999999999999999999999999988766432 233333222 22222
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIAS 288 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~i~~ 288 (716)
...++.+.+.++.+.|.-+.|.+.|+|++++|+||+.+.|++.|. |.+.++|++++||-+ +.+
T Consensus 183 ~~~~E~~~lrv~Fs~i~rEsGfisGlIaVlhDvTEqek~e~ErRe----------------fvanvSHElRTPlts-mks 245 (459)
T COG5002 183 SDEEEGYVLRVNFSVIQRESGFISGLIAVLHDVTEQEKVERERRE----------------FVANVSHELRTPLTS-MKS 245 (459)
T ss_pred cCCCccEEEEEEEEEEeecccccceeEEEEecccHHHHHHHHHHH----------------HHHhcchhhcCchHH-HHH
Confidence 226788888899999998999999999999999999999988763 566778888888754 344
Q ss_pred HHHhhH
Q 005054 289 KISNLA 294 (716)
Q Consensus 289 ~I~~La 294 (716)
.+.+|.
T Consensus 246 yLEALe 251 (459)
T COG5002 246 YLEALE 251 (459)
T ss_pred HHHHHh
Confidence 444443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.5e-08 Score=104.31 Aligned_cols=140 Identities=18% Similarity=0.130 Sum_probs=97.0
Q ss_pred eecCCcEEEEEEEEcCCeEEEEEeeccCCCHHH---------HHHHHHHHHHHHhcCCCce--eEEeceecc-----CCc
Q 005054 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEV---------IHSFRQEVSLMKRLRHPNV--LLFMGAVTS-----PQR 576 (716)
Q Consensus 513 LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~---------~~~~~~E~~iL~~l~hpnI--v~~~~~~~~-----~~~ 576 (716)
+-.-....|+++...|+.|.||.........-. ...+.+|...+..|..-+| +.++.+++. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 333444457777788889999976433211100 0136678887777732222 223333322 235
Q ss_pred eEEEEeecCCC-CHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-------CCcEEEE
Q 005054 577 LCIVTEFLPRG-SLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-------HWTVKVG 647 (716)
Q Consensus 577 ~~lVmE~~~gg-sL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-------~~~vkL~ 647 (716)
.+||||++++. +|.+++... ....+......++.+++..+.-||..| |+|+|+++.|||++. +..+.|+
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEE
Confidence 78999999876 899998642 234566777889999999999999999 999999999999975 4679999
Q ss_pred ecCCCcc
Q 005054 648 DFGLSRL 654 (716)
Q Consensus 648 DFGla~~ 654 (716)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998753
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.6e-08 Score=87.21 Aligned_cols=86 Identities=26% Similarity=0.471 Sum_probs=72.0
Q ss_pred EEEecHHHHHHhCCChhhHcCCC----ccccccccccchhHHHHHH-HHHcCCeeEEEEEEEcCCCCEEEEEEEEEEEEC
Q 005054 152 IIYWNRSAELLYGYSAEEALGQD----AIELLTDGRDFDVAYDIVH-RIKMGERWTGQFPAKTKTEERVLVVATNTPFYD 226 (716)
Q Consensus 152 Ii~vN~aae~l~Gys~eEliGk~----~~~l~~~~~~~~~~~~i~~-~l~~g~~~~~e~~~~~kdG~~~~v~~~~~PI~d 226 (716)
|+|+|+.+++++||+.+++ +.. +..++++++.......+.. .+..+..+..+++++++||+.+|+..++.+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 7899999999999999999 777 7778888887777777777 677888899999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 005054 227 DDGTLVGIVCVS 238 (716)
Q Consensus 227 ~~G~i~g~i~i~ 238 (716)
++|.+..++|+.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >COG3852 NtrB Signal transduction histidine kinase, nitrogen specific [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-08 Score=102.57 Aligned_cols=140 Identities=19% Similarity=0.136 Sum_probs=108.7
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCC
Q 005054 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (716)
Q Consensus 133 ~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 212 (716)
..+|+++..+|+++|.+|.|.|+|++|+.+||.+...+.|..+.++++.... ....+.+....+.+....-.-...+|
T Consensus 10 ~~~Ln~~~~pVl~vd~~~~i~yaN~aAe~~~~~Sa~~L~~~~l~~l~~~gs~--ll~ll~q~~~~~~~~~~~~v~l~~~g 87 (363)
T COG3852 10 GAILNNLINPVLLVDDELAIHYANPAAEQLLAVSARRLAGTRLSELLPFGSL--LLSLLDQVLERGQPVTEYEVTLVILG 87 (363)
T ss_pred HhHHhccCCceEEEcCCCcEEecCHHHHHHHHHHHHHHhcCChHHHcCCCcH--HHHHHHHHHHhcCCcccceeeeeecC
Confidence 5789999999999999999999999999999999999999999999987653 44566777788877444333333789
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHHHHHHHHh
Q 005054 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISN 292 (716)
Q Consensus 213 ~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~i~~~I~~ 292 (716)
....+..++.||....|. ++..++.+....++.+++.+.+. +.+....+..
T Consensus 88 ~~~~v~~~v~~v~~~~G~---vlle~~~~~~~~ridre~~q~a~--------------------------~~a~~~L~r~ 138 (363)
T COG3852 88 RSHIVDLTVAPVPEEPGS---VLLEFHPRDMQRRLDREQTQHAQ--------------------------QRAVKGLVRG 138 (363)
T ss_pred ccceEEEEEeeccCCCCe---EEEEechhHHHhHhhHHHHHHHH--------------------------HHHHHHHHHH
Confidence 999999999999665663 46678888888888777665544 3344555667
Q ss_pred hHHHHHhhhhc
Q 005054 293 LATKVSNKVKS 303 (716)
Q Consensus 293 La~~v~n~~~s 303 (716)
|||||+|++..
T Consensus 139 LAHEIKNPL~G 149 (363)
T COG3852 139 LAHEIKNPLGG 149 (363)
T ss_pred HHHHhcCcccc
Confidence 77777776643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3e-09 Score=109.78 Aligned_cols=148 Identities=28% Similarity=0.478 Sum_probs=114.7
Q ss_pred HHHhcCCCceeEEeceeccCC-----ceEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 005054 555 LMKRLRHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPI 626 (716)
Q Consensus 555 iL~~l~hpnIv~~~~~~~~~~-----~~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~I 626 (716)
-|-.+-|.|||+++.||.+.. ...++.||+..|+|..+|++ +...+....-.+|..||+.||.|||++.++|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344556999999999987654 47899999999999999975 3345778888899999999999999999999
Q ss_pred EEcCCCCCcEEEccCCcEEEEecCCCcccccC-----ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC
Q 005054 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE 701 (716)
Q Consensus 627 vHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG 701 (716)
+|+++..+-|++..+|-||+.---.. ..+.. ........+-++|.+||.=.....+.++|||++|+..++|--+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999988887422211 11111 1112233567899999976666677889999999999998776
Q ss_pred CC
Q 005054 702 KI 703 (716)
Q Consensus 702 ~~ 703 (716)
..
T Consensus 279 Ei 280 (458)
T KOG1266|consen 279 EI 280 (458)
T ss_pred ee
Confidence 53
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.5e-08 Score=105.13 Aligned_cols=195 Identities=14% Similarity=0.229 Sum_probs=133.7
Q ss_pred ceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEece----e---ccCCce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA----V---TSPQRL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~----~---~~~~~~ 577 (716)
-...++.||+|+-+.+|-.-.-...|| |++.......+ . +.+..|... .||-+..-+.| . .....+
T Consensus 12 ~i~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 12 PIPPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred ccCCCccccCCccceeeecchhhchhh-eeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 344567899999999997644333344 77765432211 1 123333333 46543331111 1 112237
Q ss_pred EEEEeecCCCC-HHHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 578 CIVTEFLPRGS-LFRLLQ-----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 578 ~lVmE~~~ggs-L~~~l~-----~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
.++|..+.|.. +..++. +......+...+.+++.|+.+...||..| .+-+|+.++|||+.+++.|.|+|-..
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccc
Confidence 88999887652 333332 12234678999999999999999999999 99999999999999999999999764
Q ss_pred CcccccCccccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG-~~PF~~~~ 709 (716)
-... .......+.+|.+.|.+||... +..-+...|.|.||+++|+++.| ++||.+.-
T Consensus 164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 4332 3333445778999999999865 33345678999999999999996 99998653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.3e-08 Score=98.97 Aligned_cols=128 Identities=29% Similarity=0.330 Sum_probs=81.9
Q ss_pred EEEEEEE-cCCeEEEEEeeccC------------------------CCHHHHHHHHHHHHHHHhcCCC--ceeEEeceec
Q 005054 520 TVYHAVW-YGSDVAVKVFSRQE------------------------YSDEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT 572 (716)
Q Consensus 520 ~Vy~~~~-~~~~vAvK~~~~~~------------------------~~~~~~~~~~~E~~iL~~l~hp--nIv~~~~~~~ 572 (716)
.||.|.. .+..+|||+.+... ..........+|.+.|..+..- ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 57789999874320 0012234567899999999654 566776553
Q ss_pred cCCceEEEEeecC--CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 573 SPQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSY-LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 573 ~~~~~~lVmE~~~--ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~y-LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |||+||.+.|||++.+ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 3489999998 65554443322 1133455666677775555 57888 9999999999999887 9999999
Q ss_pred CCCccccc
Q 005054 650 GLSRLKHE 657 (716)
Q Consensus 650 Gla~~~~~ 657 (716)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 98865443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-08 Score=91.48 Aligned_cols=105 Identities=24% Similarity=0.358 Sum_probs=75.7
Q ss_pred HHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhH-cCCCcccccccc------ccchhHHHHHHH---HHcCCeeEEEE
Q 005054 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA-LGQDAIELLTDG------RDFDVAYDIVHR---IKMGERWTGQF 205 (716)
Q Consensus 136 ld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEl-iGk~~~~l~~~~------~~~~~~~~i~~~---l~~g~~~~~e~ 205 (716)
|+++++||+++|.+|+++++|++|.+|++++.+.+ .|.++.+++... ........+.+. +...... .+
T Consensus 1 Ld~l~~Gv~v~D~~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~ 78 (115)
T PF12860_consen 1 LDSLPQGVAVFDSDGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPR--SF 78 (115)
T ss_pred CCCcCceEEEEcCCCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCc--ee
Confidence 47899999999999999999999999999999988 799888776321 111112222222 3333322 33
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHH
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~ 249 (716)
.....|| .|+.++..|+ ++| |+|.++.|||++++.|+
T Consensus 79 ~~~~~dg--r~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 79 ELRLPDG--RWLEVRAQPL--PDG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred EEECCCC--EEEEEEeEEC--CCC---CEEEEEEeCCHHHHhcC
Confidence 4456777 5777788888 556 68899999999999874
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.4e-08 Score=117.69 Aligned_cols=126 Identities=15% Similarity=0.230 Sum_probs=99.4
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCC----eeEE
Q 005054 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE----RWTG 203 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~----~~~~ 203 (716)
++..+..+++..+++++++|.+|+|+++|+++++++||+.+|++|+++.+++++.........+......+. .+..
T Consensus 10 ~~~~~~~~le~~~~~i~~~d~~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (799)
T PRK11359 10 ADGIFFPALEQNMMGAVLINENDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSR 89 (799)
T ss_pred hhhhHHHHHHhhcCcEEEEcCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCccccccce
Confidence 345567889999999999999999999999999999999999999999998887654433333444444333 2445
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHH
Q 005054 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (716)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la 255 (716)
++..+++||..+|+.+...|+ +.+|.. +++++.+|||++++.+++++.+.
T Consensus 90 e~~~~~~dG~~~~v~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~~~~~~~~~ 139 (799)
T PRK11359 90 ELQLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQTRQLI 139 (799)
T ss_pred eeEEecCCcCEEEEEEEeeee-ccCCce-EEEEEEeeccchhhhHHHHHHHH
Confidence 788889999999999999887 345554 57889999999988887766543
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.8e-08 Score=107.23 Aligned_cols=117 Identities=23% Similarity=0.453 Sum_probs=94.9
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
+.|+.+++.+.++++++|.+|+|+++|.++..++|++.++++|+++.+++.... ...+..++..+++.......+.
T Consensus 117 ~~l~~il~~~~~~l~vvD~~G~~i~~N~~~~~~~gl~~e~~~gk~~~~v~~~~~----~s~~l~vl~~~kp~~~~~~~~~ 192 (560)
T COG3829 117 QRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGE----DSTLLEVLRTGKPIRDVVQTYN 192 (560)
T ss_pred HHHHHHHhhccCceEEEcCCCcEEEEcHHHHHHhCCCHHHHcCCcHHHHHhccC----CceehhhhhcCCcceeeeeeec
Confidence 568899999999999999999999999999999999999999999998872111 1246778889998777666654
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHH
Q 005054 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la 255 (716)
.+.. ..+..|+. .+|.+.|.|.+++|+++.+.+..+++...
T Consensus 193 ~~~~----i~~~~pv~-~~g~l~G~v~~~~~~~~l~~l~~~~~~~~ 233 (560)
T COG3829 193 GNKI----IVNVAPVY-ADGQLIGVVGISKDVSELERLTRELEESE 233 (560)
T ss_pred CCce----eEeeccEe-cCCcEEEEEEeecchHHHHHHHHHHHHHh
Confidence 4332 44566775 66799999999999999999988877653
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=98.70 E-value=2e-07 Score=105.12 Aligned_cols=119 Identities=17% Similarity=0.234 Sum_probs=87.7
Q ss_pred HHHHHHHHHHcCceeEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~-dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (716)
++.|+.+++.++++|+++|. +|+|+++|+++++++||+.++++|+++.++++++........+...+..|.....++.
T Consensus 132 e~r~~~l~e~~~~~i~~~d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~~~~- 210 (442)
T TIGR02040 132 ETRYRVVLEVSSDAVLLVDMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGSAAPVRIL- 210 (442)
T ss_pred HHHHHHHHhhCCceEEEEECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCCcceEEE-
Confidence 35789999999999999998 7999999999999999999999999999988776644444455555666665444444
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHH
Q 005054 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (716)
Q Consensus 208 ~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~ 252 (716)
..++| ..| .+...++.. +|.. .+++.+.|||++++++++++
T Consensus 211 ~~~~~-~~~-~~~~~~~~~-~~~~-~~l~~~~dit~~~~~e~~~~ 251 (442)
T TIGR02040 211 LRRSQ-KRL-LVVVSVFRQ-DGES-LFLCQLSPAGATQPVGDELS 251 (442)
T ss_pred EcCCC-eEE-EEEEEEEEe-CCce-EEEEEEcccchhhhhhHHHH
Confidence 23334 333 335556653 3333 57788899999998876554
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PRK11086 sensory histidine kinase DcuS; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.5e-07 Score=106.61 Aligned_cols=134 Identities=16% Similarity=0.240 Sum_probs=97.1
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCC---hhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEE
Q 005054 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS---AEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (716)
Q Consensus 131 ~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys---~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (716)
.+++++++++++|+++|.+|+|+++|++|++++|++ ..+.+|+.+.++.+.. .+...+..+.+......
T Consensus 222 ~~~~il~~~~~gIi~~D~~g~I~~~N~~a~~llg~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~- 293 (542)
T PRK11086 222 QRQAMLQSIKEGVIAVDDRGEVTLINDEAKRLFNYKKGLEDDPLGTDVESWMPVS-------RLKEVLRTGTPRRDEEI- 293 (542)
T ss_pred HHHHHHHHhcCcEEEECCCCeEEEEhHHHHHHhCCCcCCcccccCCcHHHhCCch-------hHHHHHhcCCCccceEE-
Confidence 357889999999999999999999999999999875 3467787776665422 24455666665432222
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHHH
Q 005054 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (716)
Q Consensus 208 ~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~i 286 (716)
..+|. ++.+...|+.+ +|.+.|++.+++|+|+.+++++++..+.... ..+....|+...||..+.
T Consensus 294 -~~~g~--~~~~~~~pi~~-~g~~~g~v~~~rDite~~~l~~~l~~~~~~~----------~~l~~~sHel~npL~~I~ 358 (542)
T PRK11086 294 -NINGR--LLLTNTVPVRV-NGEIIGAIATFRDKTEVRQLAQRLDGMVNYA----------DALRAQSHEFMNKLHVIL 358 (542)
T ss_pred -EECCE--EEEEEEEEEeE-CCEEEEEEEEEEEchHHHHHHHHHHHHHHHH----------HHHHhhchhhcCHHHHHH
Confidence 12454 44456779987 8899999999999999999998887654321 134556777777776653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.2e-07 Score=96.92 Aligned_cols=138 Identities=26% Similarity=0.233 Sum_probs=98.5
Q ss_pred eeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccC------------------CC--HHHHHHHHHHHHHHHhcCCC--c
Q 005054 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQE------------------YS--DEVIHSFRQEVSLMKRLRHP--N 563 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~------------------~~--~~~~~~~~~E~~iL~~l~hp--n 563 (716)
+.++.+||.|--+.||.|.+ ++.+++||+-+... .+ .-.+....+|..+|++|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 56788999999999999998 58899999742210 01 11234567899999998544 5
Q ss_pred eeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 564 Iv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
|++.+++ +..++|||+++|..|...-- +.+....++..|+.-+.-+-..| |||+|+.+-|||++.+|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 6666543 56689999999977655431 22333344445555555445677 999999999999999999
Q ss_pred EEEEecCCCcccc
Q 005054 644 VKVGDFGLSRLKH 656 (716)
Q Consensus 644 vkL~DFGla~~~~ 656 (716)
+.++||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999998665433
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.6e-07 Score=99.97 Aligned_cols=165 Identities=19% Similarity=0.268 Sum_probs=123.1
Q ss_pred cEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc----CCceEEEEeecCC-CCHH
Q 005054 518 CGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIVTEFLPR-GSLF 590 (716)
Q Consensus 518 fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----~~~~~lVmE~~~g-gsL~ 590 (716)
-.+.|++.. +|..|++|.+....... ......-+++++++.|+|||+|.++|.. +..+++|++|.++ ++|+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 357888876 68889999884332211 1122335788999999999999998873 4568999999865 4677
Q ss_pred HHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 591 RLLQR--------------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 591 ~~l~~--------------~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
++... .+...++..+|.++.||..||.++|+.| +.-+-|.|.+||++.+-+|+|+.+|......
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 76532 1234678999999999999999999999 8889999999999988899999888766544
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 703 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~ 703 (716)
.... +-+.+. .+.|.=.||.+++.|.||..
T Consensus 445 ~d~~--------------~~le~~---Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT--------------EPLESQ---QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC--------------cchhHH---hhhhHHHHHHHHHHHhhccc
Confidence 3320 111111 35688999999999999853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.2e-07 Score=92.53 Aligned_cols=106 Identities=29% Similarity=0.309 Sum_probs=80.0
Q ss_pred HHHHHHHHHHHhcCCC--ceeEEeceeccC----CceEEEEeecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 005054 547 HSFRQEVSLMKRLRHP--NVLLFMGAVTSP----QRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619 (716)
Q Consensus 547 ~~~~~E~~iL~~l~hp--nIv~~~~~~~~~----~~~~lVmE~~~gg-sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yL 619 (716)
.+..+|...+..|..- .+++.+.+.+.. ...+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4566777776666321 233444444332 2458999999874 79999976333 66677888999999999999
Q ss_pred HhCCCCeEEcCCCCCcEEEccCC---cEEEEecCCCccc
Q 005054 620 HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLK 655 (716)
Q Consensus 620 H~~~~~IvHrDIKp~NILl~~~~---~vkL~DFGla~~~ 655 (716)
|.+| |+|+|+++.|||++.++ .+.|+||+-+...
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 99999999999999887 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK11006 phoR phosphate regulon sensor protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=7.5e-07 Score=100.00 Aligned_cols=109 Identities=17% Similarity=0.277 Sum_probs=78.9
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
+.|+.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.+++..++ +...+.... .........
T Consensus 98 ~~~~~~~~~~~~~i~~~d~~g~i~~~N~~a~~l~g~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~~ 169 (430)
T PRK11006 98 KRFRSGAESLPDAVVLTTEEGNIFWCNGLAQQLLGFRWPEDNGQNILNLLRYPE-------FTQYLKTRD-FSRPLTLVL 169 (430)
T ss_pred HHHHHHHHhCCCeEEEEcCCCceeHHHHHHHHHhCCCChHhCCCcHHHHhcCHH-------HHHHHHhcc-cCCCeEEEc
Confidence 568899999999999999999999999999999999999999999888775432 112222222 122233334
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHH
Q 005054 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~ 253 (716)
.+|. ++.+...|+. ++ +++.+++|||+++++++..+.
T Consensus 170 ~~~~--~~~~~~~~~~--~~---~~~~~~~dit~~~~~e~~~~~ 206 (430)
T PRK11006 170 NNGR--HLEIRVMPYT--EG---QLLMVARDVTQMHQLEGARRN 206 (430)
T ss_pred CCCC--EEEEEEEEcC--CC---cEEEEEehhhHHHHHHHHHHH
Confidence 5554 4555666663 23 356789999999998876653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.1e-06 Score=88.05 Aligned_cols=141 Identities=16% Similarity=0.144 Sum_probs=95.6
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHH-HHHH------HHHHHHHHHhc---CCCceeEEece
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE-VIHS------FRQEVSLMKRL---RHPNVLLFMGA 570 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~-~~~~------~~~E~~iL~~l---~hpnIv~~~~~ 570 (716)
.++..+|++.+.+-......|.+....+..+++|..+......+ .... ..+.+..+..+ ....++.++.+
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45678899999999999999999999999999998766432221 1111 12222222222 33333333333
Q ss_pred ec-----cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEE
Q 005054 571 VT-----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (716)
Q Consensus 571 ~~-----~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vk 645 (716)
.+ .....+|+|||++|..|.++.. +++ .+...|.+++.-||+.| ++|+|+.|.|++++.+ .++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC-cEE
Confidence 22 2344578999999988766542 222 23346777889999999 9999999999999855 599
Q ss_pred EEecCCCc
Q 005054 646 VGDFGLSR 653 (716)
Q Consensus 646 L~DFGla~ 653 (716)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK10820 DNA-binding transcriptional regulator TyrR; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.3e-06 Score=100.15 Aligned_cols=108 Identities=18% Similarity=0.253 Sum_probs=81.7
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
...+.++|+++++||+++|.+|+|+++|++|+++||++.++++|+++.++++... +...+..+....... ..
T Consensus 79 ~~~L~aIL~sm~eGVi~vD~~G~I~~iN~aA~~Llg~~~eel~Gk~i~eli~~~~-------l~~~le~~~~~~~~~-~v 150 (520)
T PRK10820 79 HRALSALLEALPEPVLSIDMKGKVELANPASCQLFGQSEEKLRNHTAAQLINGFN-------FLRWLESEPQDSHNE-HV 150 (520)
T ss_pred HHHHHHHHHhCCCcEEEECCCCeeeHhHHHHHHHHCcCHHHHCCCcHHHHcCcch-------HHHHHHcCCCccceE-EE
Confidence 3558899999999999999999999999999999999999999999999887532 334555555421111 22
Q ss_pred cCCCCEEEEEEEEEEEE--CCCCCE--EEEEEEEEchhHHHH
Q 005054 209 TKTEERVLVVATNTPFY--DDDGTL--VGIVCVSTDSRPFQE 246 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~--d~~G~i--~g~i~i~~DITerk~ 246 (716)
..+|..++ +...||. +++|.. .|+|.+++|+++..+
T Consensus 151 ~~~g~~~~--v~~~PI~~~d~~g~~~~~GaVivlrd~~~l~~ 190 (520)
T PRK10820 151 VINGQDFL--MEITPVYLQDENDQHVLVGAVVMLRSTARMGR 190 (520)
T ss_pred EECCEEEE--EEEEeeeecCCCCceeEEEEEEEeccHHHHHH
Confidence 33566555 4567776 666653 899999999998643
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.2e-07 Score=105.06 Aligned_cols=124 Identities=8% Similarity=0.014 Sum_probs=86.4
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCee-EEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~-~~e~~~~ 208 (716)
..++.++++++++|+++|.+|+|+++|++|++++|+...+..+..+.+++.+.... .+......+... ..+....
T Consensus 130 ~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 205 (494)
T TIGR02938 130 LLIESVVDAAPVAFVLLDPTGRVILDNQEYKKLATDLRVKEPAHTVLDLLREAWRE----ALAENWPQQLAFSNREARFD 205 (494)
T ss_pred HHHHHHHhcccceEEEEcCCCCEEEechhHHHhhchhhhhHHHHHHHHHhhHHhhh----hhhhcchhhhccccceeeec
Confidence 45788999999999999999999999999999999998887776655554432211 111111112121 2234444
Q ss_pred cCCCC-EEEEEEEEEEEECCCCCE---------EEEEEEEEchhHHHHHHHHHHHHHhh
Q 005054 209 TKTEE-RVLVVATNTPFYDDDGTL---------VGIVCVSTDSRPFQETRAALWDTKNS 257 (716)
Q Consensus 209 ~kdG~-~~~v~~~~~PI~d~~G~i---------~g~i~i~~DITerk~~e~~L~~la~~ 257 (716)
..+|. .+|+.....++.+..|.. .+++++++|||++|+.+++++..+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~DITe~k~~ee~l~~~al~ 264 (494)
T TIGR02938 206 RGGGRPARWLSCTGSVIGMESDCADSFFCAAEQPYLLLTIADISNLREEQERARLSALQ 264 (494)
T ss_pred cCCCceeeEEEecCceEEeecchhhheeccCCCchheehHHHHHHHHHHHHHHHHHHHH
Confidence 45554 789998888887655543 34567889999999999988765543
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.7e-06 Score=83.40 Aligned_cols=139 Identities=18% Similarity=0.103 Sum_probs=100.9
Q ss_pred ecCCcEEEEEEEEcCCeEEEEEeeccCC---C-HHHHHHHHHHHHHHHhcCCC--ceeEEece--eccC--CceEEEEee
Q 005054 514 GQGSCGTVYHAVWYGSDVAVKVFSRQEY---S-DEVIHSFRQEVSLMKRLRHP--NVLLFMGA--VTSP--QRLCIVTEF 583 (716)
Q Consensus 514 G~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~-~~~~~~~~~E~~iL~~l~hp--nIv~~~~~--~~~~--~~~~lVmE~ 583 (716)
|+||.+-|+.....+..|-+|.-..... . +--...+.+|+..|+.|..- .++++... ...+ ...+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 6799999999988888888886531110 0 22346788899888887422 24444411 1111 235899998
Q ss_pred cCC-CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc--EEEEecCCCcc
Q 005054 584 LPR-GSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRL 654 (716)
Q Consensus 584 ~~g-gsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~--vkL~DFGla~~ 654 (716)
+++ .+|.+++.... .+.+......++.+++..+.-||+.| +.|+|+-+.||+++.++. |+++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 853 48988886532 34677777889999999999999999 999999999999986667 99999987654
|
|
| >COG5000 NtrY Signal transduction histidine kinase involved in nitrogen fixation and metabolism regulation [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.8e-06 Score=95.97 Aligned_cols=143 Identities=17% Similarity=0.105 Sum_probs=95.0
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe-eEEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~ 208 (716)
++++++|+.++.||+.+|.+|+|.-+|++++.|||.+..+++|+++..+.+.-. +.+...-..++. ...++.+.
T Consensus 370 ~f~E~VLsgvtaGVi~~d~~g~i~t~N~~ae~~l~~~~~~~~G~~lsa~ap~~~-----~vf~~~~a~~~~~~~~ev~~~ 444 (712)
T COG5000 370 RFLEAVLSGLTAGVIGFDNRGCITTVNPSAEQILGKPFDQLLGQSLSAIAPELE-----EVFAEAGAAARTDKRVEVKLA 444 (712)
T ss_pred HHHHHHHhcCceeEEEEcCCCeeEeecchHHHHhcCChhHhhcchhhhhhhHHH-----HHHHHhhhhcCCCccceeecc
Confidence 457889999999999999999999999999999999999999999777665321 112222223333 33344444
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHH------HHHHhh--cCcCCcCCchhHHHHHhCCCchh
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAAL------WDTKNS--DTDSNINRPRNTVTAKLGLDSQQ 280 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L------~~la~~--D~~~~l~~~~~~l~~~~~~d~~q 280 (716)
..|+.+.+.+.++-.. ++ .-.|+|.++-|||....+++.. +++|++ .++|.+.-..+.+..+++....+
T Consensus 445 -r~g~~rtl~Vq~t~~~-~d-~~~gyVvt~DDITdLV~AQRs~AW~dVArRIAHEIKNPLTPIQLSAERl~rk~gk~i~e 521 (712)
T COG5000 445 -REGEERTLNVQATREP-ED-NGNGYVVTFDDITDLVIAQRSAAWGDVARRIAHEIKNPLTPIQLSAERLLRKLGKEIDE 521 (712)
T ss_pred -cCCCceeeeeeeeecc-cc-cCCceEEEecchHHHHHHHHHHHHHHHHHHHHHHhcCCCchhhhhHHHHHHHhccccch
Confidence 4456666666655442 22 2237999999999998887654 344443 35555555555455555444444
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.7e-06 Score=86.10 Aligned_cols=137 Identities=13% Similarity=0.181 Sum_probs=84.0
Q ss_pred eeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeceeccCCceEEEEeecCCCC
Q 005054 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGAVTSPQRLCIVTEFLPRGS 588 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn--Iv~~~~~~~~~~~~~lVmE~~~ggs 588 (716)
..||.|..+.||+. .+..+++|+..... .. ..+.+|.++++.+..-. +++++.+....+..++|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 47899999999984 36678899876532 22 34577888888875322 4567777777778899999998863
Q ss_pred -HHHH--------------Hhh-----cC---CCCCHHHHH-HHHHH----------HHH-HHHHHH--hCCCCeEEcCC
Q 005054 589 -LFRL--------------LQR-----NT---TKLDWRRRI-LMALD----------IAR-GVSYLH--HCNPPIIHRDL 631 (716)
Q Consensus 589 -L~~~--------------l~~-----~~---~~l~~~~v~-~i~~q----------l~~-aL~yLH--~~~~~IvHrDI 631 (716)
+... +.+ +. ......... .+..+ +.. ...+|. .....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 111 00 001111100 01000 111 112222 22234899999
Q ss_pred CCCcEEEccCCcEEEEecCCCcc
Q 005054 632 KSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 632 Kp~NILl~~~~~vkL~DFGla~~ 654 (716)
.|.||+++.++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999887 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.3e-06 Score=96.94 Aligned_cols=151 Identities=21% Similarity=0.234 Sum_probs=96.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccC---------------------------CCH-----HHHH
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQE---------------------------YSD-----EVIH 547 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~---------------------------~~~-----~~~~ 547 (716)
+..+..|.- .-|+.++-|.||+|+.. |+.||||+.++.- ... +..+
T Consensus 122 ee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 122 EELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 334444542 67899999999999986 8999999974421 110 1111
Q ss_pred H------HHHHHHHHHhc-----CCCceeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 005054 548 S------FRQEVSLMKRL-----RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616 (716)
Q Consensus 548 ~------~~~E~~iL~~l-----~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL 616 (716)
. +.+|..-+.++ +.++|.-..-+++-...-.|+|||++|..+.+........++...+.....+++-
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~-- 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL-- 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--
Confidence 1 22233333333 2455444333444456678999999999998885433344664444444333332
Q ss_pred HHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 617 ~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
..+=..| ++|.|.+|.||+++.+|++.+.|||+.....
T Consensus 279 ~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2222347 9999999999999999999999999876443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.1e-06 Score=82.72 Aligned_cols=141 Identities=17% Similarity=0.197 Sum_probs=83.4
Q ss_pred eeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCC--ceeEEecee---ccCCceEEEEeec
Q 005054 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP--NVLLFMGAV---TSPQRLCIVTEFL 584 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hp--nIv~~~~~~---~~~~~~~lVmE~~ 584 (716)
++.|+.|..+.||++...+..+++|+.... .....+.+|..+++.+... .+++++.+. ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999998889999996543 3345667788888877422 345566533 2233478999999
Q ss_pred CCCCHHH----------------HHh---hc---CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 005054 585 PRGSLFR----------------LLQ---RN---TTKLDWRR---------RILM------------ALDIAR-GVSYLH 620 (716)
Q Consensus 585 ~ggsL~~----------------~l~---~~---~~~l~~~~---------v~~i------------~~ql~~-aL~yLH 620 (716)
+|..+.. .+. .. ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 111 11 01111000 0000 011222 233333
Q ss_pred h-----CCCCeEEcCCCCCcEEEc-cCCcEEEEecCCCcc
Q 005054 621 H-----CNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRL 654 (716)
Q Consensus 621 ~-----~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~ 654 (716)
. ....++|+|+.|.|||++ .++.|.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 223499999999999999 667778999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.8e-06 Score=83.90 Aligned_cols=140 Identities=21% Similarity=0.170 Sum_probs=91.5
Q ss_pred eeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHH--------------------H--HHHHHHHHHHHhcC--CCce
Q 005054 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEV--------------------I--HSFRQEVSLMKRLR--HPNV 564 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~--------------------~--~~~~~E~~iL~~l~--hpnI 564 (716)
...|..|--+.||+|.. .+..+|||+++.....-.. + .=..+|+.-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34667788889999886 5778999998654221110 0 01234566666662 3444
Q ss_pred eEEeceeccCCceEEEEeecCCCCH-HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCC
Q 005054 565 LLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 565 v~~~~~~~~~~~~~lVmE~~~ggsL-~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~ 642 (716)
++.+.+.. ..|||||+....+ .-.|+ ...+.......+..++++.+.-|-. .+ +||+||..-|||+. ++
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 45554433 4799999954311 11111 1223333567777788888887766 67 99999999999999 78
Q ss_pred cEEEEecCCCcccccC
Q 005054 643 TVKVGDFGLSRLKHET 658 (716)
Q Consensus 643 ~vkL~DFGla~~~~~~ 658 (716)
.+.|||||-|.....+
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 9999999988765544
|
|
| >COG3290 CitA Signal transduction histidine kinase regulating citrate/malate metabolism [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=8e-06 Score=90.54 Aligned_cols=113 Identities=21% Similarity=0.322 Sum_probs=91.8
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChh--hHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcC
Q 005054 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE--EALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210 (716)
Q Consensus 133 ~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~e--EliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 210 (716)
.++|+++..||+.+|..|.|+.+|.+|++|+|+... +.+|+++.++++++.. +...++.+++...+....
T Consensus 218 ~A~l~si~EGviAvd~~G~It~~N~~A~~ll~~~~~~~~~ig~~i~~v~~p~~~------l~~vl~~~~~~~~~e~~~-- 289 (537)
T COG3290 218 QAMLQSIKEGVIAVDKKGVITLINQAAQKLLGLRQPSGDPIGRSIVEVLPPDSD------LPEVLETGKPQHDEEIRI-- 289 (537)
T ss_pred HHHHHHhhceEEEECCCCeEeehhHHHHHHhcccCcCcccccccceEeeccccC------cHHHHhcCCcccchhhhc--
Confidence 556899999999999999999999999999999765 7999999999987442 455677777655554433
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 211 dG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
+| .++.++..||. .+|+++|.|.++||-||.+++-++|.....
T Consensus 290 ng--~~~i~nr~pI~-~~~~~~GaI~tFRdktei~~L~eqLt~vr~ 332 (537)
T COG3290 290 NG--RLLVANRVPIR-SGGQIVGAIITFRDKTEIKKLTEQLTGVRQ 332 (537)
T ss_pred CC--eEEEEEeccEE-ECCEEeEEEEEEecHHHHHHHHHHHHHHHH
Confidence 34 45666778986 678999999999999999999999876544
|
|
| >PF14598 PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W_A 3F1P_A 3H82_A 3F1N_A 4F3L_B 4DJ3_A 2KDK_A | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.8e-05 Score=71.64 Aligned_cols=96 Identities=22% Similarity=0.285 Sum_probs=78.9
Q ss_pred EEEcCCCcEEEecHH-HHHHhCCChhhHcCCCccccccccccch-hHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEEEEE
Q 005054 144 HIFDLSDRIIYWNRS-AELLYGYSAEEALGQDAIELLTDGRDFD-VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (716)
Q Consensus 144 iv~D~dG~Ii~vN~a-ae~l~Gys~eEliGk~~~~l~~~~~~~~-~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~ 221 (716)
.-.+.||+|+++-.. ...++||.++|++|+++.+++++++... ........+..|+.....++++.++|..+|+....
T Consensus 6 trhs~dgki~~~d~~~v~~~lgy~~~eLvG~s~y~~~H~~D~~~~~~~~~~~~~~~g~~~~~~yR~~~k~g~~vwvqt~~ 85 (111)
T PF14598_consen 6 TRHSLDGKITYVDSRAVSSLLGYLPEELVGRSIYDFVHPDDLQRVLKQHHREVLQKGQSVSPYYRFRTKNGGYVWVQTKA 85 (111)
T ss_dssp EEEETTSBEEEEETTHHHHHHSS-HHHHTTSBGGGGBSCCTHHHHHHHHHHHHHHHSSEEEEEEEEE-TTSSEEEEEEEE
T ss_pred EEECCCcEEEEEcCccChhhcCCCcHHHcCCchHHhCCHhhhhhHHHHHHHHHhhCCCcCcceEEEEecCCcEEEEEEEE
Confidence 347889999999999 5999999999999999999999988664 44567778899998888899999999999999999
Q ss_pred EEEECCC-CCEEEEEEEEE
Q 005054 222 TPFYDDD-GTLVGIVCVST 239 (716)
Q Consensus 222 ~PI~d~~-G~i~g~i~i~~ 239 (716)
..+.+.. +++..++++-+
T Consensus 86 ~~~~n~~~~~~~~Iv~~n~ 104 (111)
T PF14598_consen 86 TLFYNPWTSKPEFIVCTNT 104 (111)
T ss_dssp EEEEETTTTCEEEEEEEEE
T ss_pred EEEECCCCCCccEEEEEEE
Confidence 9998754 56666666543
|
... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-05 Score=82.99 Aligned_cols=138 Identities=19% Similarity=0.183 Sum_probs=84.8
Q ss_pred eeecCCc-EEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEEeecCCCCH
Q 005054 512 QIGQGSC-GTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (716)
Q Consensus 512 ~LG~G~f-g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVmE~~~ggsL 589 (716)
.|-.|.. ..||++...+.++.||+..... ...+.+|+.+++.+. +--+++++.+....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 7899998777788999875542 234556888887773 34456777777766778999999999877
Q ss_pred HHHHh----------------h-cC-----CCCCHH--HHHHHHH--------------------HHHHHHHHHHh----
Q 005054 590 FRLLQ----------------R-NT-----TKLDWR--RRILMAL--------------------DIARGVSYLHH---- 621 (716)
Q Consensus 590 ~~~l~----------------~-~~-----~~l~~~--~v~~i~~--------------------ql~~aL~yLH~---- 621 (716)
..... + +. .++... ....... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64320 0 00 011100 0000000 01111222211
Q ss_pred -CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 622 -CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 622 -~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 112389999999999999887788999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.2e-05 Score=77.55 Aligned_cols=136 Identities=20% Similarity=0.277 Sum_probs=95.4
Q ss_pred cceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeceeccCCceEEEEee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL-LFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv-~~~~~~~~~~~~~lVmE~ 583 (716)
....+.+.|++|.+|.||++.+.+..+|+|+-+.+. ....+..|+++|+.+.--++. ++|.+.++ ++.|||
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 345567889999999999999999999999876543 245677899999988655444 45555433 456999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC-CCcEEEccCCcEEEEecCCCcccccC
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK-SSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK-p~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+.|..|....... +..++. .+++...-|...| |-|..|. |..++|..++.+.|+||.-|+....+
T Consensus 94 i~G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 94 IDGRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hcCcchhhhhhcc----cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 9998887765421 222333 4455545566667 9999886 55455555559999999998854443
|
|
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.5e-05 Score=87.48 Aligned_cols=117 Identities=15% Similarity=0.182 Sum_probs=96.3
Q ss_pred HHHHHHHHHcC--ceeEE-EcC---CCcEEEecHHHHHHhCCChhhHcCCCccc--cccccccchhHHHHHHHHHcCCee
Q 005054 130 RQYLNILQSMG--QSVHI-FDL---SDRIIYWNRSAELLYGYSAEEALGQDAIE--LLTDGRDFDVAYDIVHRIKMGERW 201 (716)
Q Consensus 130 ~~~~~lld~l~--d~Iiv-~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~--l~~~~~~~~~~~~i~~~l~~g~~~ 201 (716)
-+++.++.... +.-++ .+. |-.|+|+|..||++.||.+.|+..+++.- ++....+....+.+.+++.+-+..
T Consensus 14 TFLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~ 93 (971)
T KOG0501|consen 14 TFLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETN 93 (971)
T ss_pred hHHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhc
Confidence 45677766443 44443 333 57899999999999999999999988654 445555566777889999988888
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHH
Q 005054 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (716)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~ 246 (716)
..|+.++.|+..++|+.+.+.||+++...++.++|.++|||..|+
T Consensus 94 qfEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQ 138 (971)
T KOG0501|consen 94 QFEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQ 138 (971)
T ss_pred ceeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcC
Confidence 889999999999999999999999999999999999999998874
|
|
| >PRK15053 dpiB sensor histidine kinase DpiB; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.5e-05 Score=87.53 Aligned_cols=113 Identities=19% Similarity=0.182 Sum_probs=80.7
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCCh--hhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 131 ~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~--eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
.++.+++++.+||+++|.+|+|+++|++|++++|+.. ++++|+++.+++++... ....... .......
T Consensus 223 ~~~~il~~~~egii~~D~~g~I~~~N~~a~~ll~~~~~~~~~~g~~~~~~~~~~~~------~~~~~~~-~~~~~~~--- 292 (545)
T PRK15053 223 QQEALFSSVYEGLIAVDPHGYITAINRNARKMLGLSSPGRQWLGKPIAEVVRPADF------FTEQIDE-KRQDVVA--- 292 (545)
T ss_pred HHHHHHHHhCceEEEECCCCeEEeecHHHHHHhCCCCcchhhcCCcHHHhCCCchh------hhhhcCC-cccceEE---
Confidence 3567899999999999999999999999999999975 57999998888764321 1111111 1111111
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
..+| ..+.++..|+.. +|.+.|++.+++|+|+.++++.++..+..
T Consensus 293 ~~~~--~~~~~~~~~i~~-~~~~~G~v~~~~d~te~~~l~~~l~~~~~ 337 (545)
T PRK15053 293 NFNG--LSVIANREAIRS-GDDLLGAIISFRSKDEISTLNAQLTQIKQ 337 (545)
T ss_pred EECC--EEEEEEeeeEEE-CCeEEEEEEEEEchHHHHHHHHHHHHHHH
Confidence 1234 344467778864 56778999999999999998888766543
|
|
| >PF13188 PAS_8: PAS domain; PDB: 2JHE_D 3VOL_A | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.1e-06 Score=67.47 Aligned_cols=50 Identities=34% Similarity=0.545 Sum_probs=40.6
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~ 183 (716)
++|+.+|+++|++|+++| +++|+++|++|++++||+ +.|+.+..+++...
T Consensus 1 e~~~~l~~~~~~~i~i~d-~~~i~~~N~~~~~l~g~~---~~~~~~~~~~~~~~ 50 (64)
T PF13188_consen 1 ERYRSLFDNSPDGILIID-GGRIIYVNPAFEELFGYS---LEGEDIGQLFPDFS 50 (64)
T ss_dssp HHHHHHHCCSSSEEEEEE-TSBEEEE-HHHHHHHCS----HTCCCHHCTSTT--
T ss_pred CHHHHHHHcCccceEEEE-CCChHHhhHHHHHHhCCC---CCCCCHHHhCcccc
Confidence 478999999999999999 889999999999999999 77877766655433
|
|
| >COG2202 AtoS FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.7e-05 Score=70.10 Aligned_cols=115 Identities=25% Similarity=0.440 Sum_probs=88.8
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHH--HcCCeeEEEEEEEc
Q 005054 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI--KMGERWTGQFPAKT 209 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l--~~g~~~~~e~~~~~ 209 (716)
+..+++.++++++++|.+|.|+++|+++++++|++..+.++.....+................. ........++....
T Consensus 114 ~~~~~~~~~~~~~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (232)
T COG2202 114 LRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEYRVRR 193 (232)
T ss_pred HHHHHhhCCceEEEEeCCCCEEEeCHHHHHHhCCChHHhcCCChhheEecCCCchhhHHHHHHhhccCCCCcceEEEEEe
Confidence 6789999999999999999999999999999999988888888777665544321112223333 33344777888889
Q ss_pred CCCCE-EEEEEEEEEEECCCCCEEEEEEEEEchhHHHHH
Q 005054 210 KTEER-VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (716)
Q Consensus 210 kdG~~-~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~ 247 (716)
++|.. .++.....+... .|.+.+++....|++++++.
T Consensus 194 ~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~ 231 (232)
T COG2202 194 KDGERVRWILSRISPVRD-DGEIVGVVGIARDITERKQA 231 (232)
T ss_pred cCCCEEEEEEeeeeEecC-CCceEEEEEEEechHHHhhc
Confidence 99996 888777777643 68888899999999998764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.2e-06 Score=97.12 Aligned_cols=98 Identities=19% Similarity=0.347 Sum_probs=76.7
Q ss_pred HHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc---------cccCCCCCCccCcccccCCC
Q 005054 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---------TKTGKGTPQWMAPEVLRNEP 681 (716)
Q Consensus 611 ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~---------~~~~~Gt~~Y~aPE~~~~~~ 681 (716)
+.+.||.|+|.. .++||++|.|++|.++.++.+||+.|+++.....+... .....-...|.+||++.+..
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 455899999975 36999999999999999999999999987654431111 11112455899999999988
Q ss_pred CCchhHHHHHHHHHHHHH-cCCCCCCCCC
Q 005054 682 SDEKSDVYSFGVILWELA-TEKIPWDNLN 709 (716)
Q Consensus 682 ~~~~sDIwSlG~ll~ell-tG~~PF~~~~ 709 (716)
.+.++|+|||||++|.++ .|+.-|...+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccC
Confidence 889999999999999998 5666666553
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 716 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-77 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-77 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-41 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-40 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-40 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-39 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-39 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-39 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-39 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-39 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-39 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-39 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-38 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-38 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-38 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-38 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-34 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-29 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-29 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-29 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-29 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-29 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-29 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-29 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-29 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-29 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-29 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-29 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-29 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-29 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-28 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-28 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-28 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-28 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-28 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-28 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-28 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-28 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-28 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-28 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-28 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-28 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-28 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-28 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-28 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-27 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-27 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-27 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-27 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-27 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-27 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-27 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-27 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-27 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-27 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-27 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-27 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-27 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-26 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-26 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-26 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-26 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-26 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-26 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-26 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-26 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-26 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-26 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-26 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-26 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-26 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-26 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-26 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-26 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-25 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-25 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-25 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-25 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-25 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-25 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-25 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-25 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-25 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-25 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-25 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-25 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-25 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-25 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-25 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-25 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-25 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-24 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-24 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-24 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-23 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-23 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-23 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-23 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-23 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-23 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-23 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-23 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-23 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-23 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-23 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-23 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-23 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-22 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-22 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-22 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-22 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-22 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-22 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-22 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-22 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-22 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-22 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-22 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-22 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-21 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-21 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-21 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-21 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-21 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-21 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-21 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-21 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-21 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-21 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-20 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-19 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-18 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3lyx_A | 124 | Crystal Structure Of The Pas Domain Of The Protein | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3LYX|A Chain A, Crystal Structure Of The Pas Domain Of The Protein Cps_1291 From Colwellia Psychrerythraea. Northeast Structural Genomics Consortium Target Id Csr222b Length = 124 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 392 bits (1008), Expect = e-132
Identities = 138/233 (59%), Positives = 176/233 (75%), Gaps = 2/233 (0%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY 541
++ D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF 73
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-- 599
E ++ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ +
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
LD RRR+ MA D+A+G++YLH+ NPPI+HR+LKS NLLVDK +TVKV DFGLSRLK T+
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
L++K+ GTP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN Q
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-119
Identities = 63/218 (28%), Positives = 114/218 (52%), Gaps = 11/218 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I ++ L ++ + G ++ W G+D+ VKV +++S F +E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 561 HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVS 617
HPNVL +GA SP ++T ++P GSL+ +L T +D + + ALD+ARG++
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
+LH P I L S ++++D+ T ++ + P W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEAL 180
Query: 678 RNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ +P D +D++SF V+LWEL T ++P+ +L++M+
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-119
Identities = 87/223 (39%), Positives = 123/223 (55%), Gaps = 15/223 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVF--SRQEYSDEVIHSFRQEVSLMKR 558
EI + +LT+ E IG G G VY A W G +VAVK E + I + RQE L
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
L+HPN++ G LC+V EF G L R+L ++ + A+ IARG++Y
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 619 LHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
LH PIIHRDLKSSN+L+ + + +K+ DFGL+R H T T + G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
WMAPEV+R + SDV+S+GV+LWEL T ++P+ ++ +
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 350 bits (899), Expect = e-116
Identities = 91/219 (41%), Positives = 140/219 (63%), Gaps = 9/219 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV ++++
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
RH N+LLFMG T+PQ L IVT++ SL+ L + TK + ++ I +A ARG+ Y
Sbjct: 77 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEV 676
LH + IIHRDLKS+N+ + + TVK+GDFGL+ K + G+ WMAPEV
Sbjct: 136 LHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 677 LRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+R + P +SDVY+FG++L+EL T ++P+ N+N+
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-114
Identities = 71/228 (31%), Positives = 111/228 (48%), Gaps = 19/228 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-----EVIHSFRQ 551
+ ++ +QIG+G G V+ S VA+K + E F++
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
EV +M L HPN++ G + +P +V EF+P G L+ L + W ++ + LD
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSRLKHETYLTTKTGK 666
IA G+ Y+ + NPPI+HRDL+S N+ + KV DFGLS+ +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 667 GTPQWMAPEVL--RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
G QWMAPE + E EK+D YSF +IL+ + T + P+D + +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-114
Identities = 74/253 (29%), Positives = 128/253 (50%), Gaps = 22/253 (8%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAV 533
S +S+ ++ + L +++I +E L IGE IG+G G VYH W+G +VA+
Sbjct: 6 LSLLSARSFPRKASQTSIFLQ----EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAI 60
Query: 534 KVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 593
++ + +++ + +F++EV ++ RH NV+LFMGA SP L I+T +L+ ++
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 594 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ LD + +A +I +G+ YLH I+H+DLKS N+ D + V + DFGL
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 654 LKHETYLTTKTGK-----GTPQWMAPEVLRN---------EPSDEKSDVYSFGVILWELA 699
+ + K G +APE++R P + SDV++ G I +EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 700 TEKIPWDNLNSMQ 712
+ P+ +
Sbjct: 238 AREWPFKTQPAEA 250
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 342 bits (878), Expect = e-113
Identities = 74/226 (32%), Positives = 111/226 (49%), Gaps = 16/226 (7%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
DL GE +G+G G + + + + +E +F +EV +M+ L
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPNVL F+G + +RL +TE++ G+L +++ ++ W +R+ A DIA G++YLH
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--------------KHETYLTTKTGK 666
N IIHRDL S N LV ++ V V DFGL+RL K T
Sbjct: 126 SMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
G P WMAPE++ DEK DV+SFG++L E+ +
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-112
Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 13/217 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ I ++++ + E +G+G+ G V A W DVA+K + F E+ + R+
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA----FIVELRQLSRV 58
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNTTKLDWRRRILMALDIARGVS 617
HPN++ GA +P +C+V E+ GSL+ +L + L ++GV+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 618 YLHHCNP-PIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
YLH P +IHRDLK NLL+ TV K+ DFG + KG+ WMAPE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPE 173
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
V EK DV+S+G+ILWE+ T + P+D +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-101
Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 42/273 (15%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVA 532
S S S S + L + + + + +QIG+G G V+ W G VA
Sbjct: 12 RDLIEQSQSSGSGSGLPL-------LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA 64
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIVTEFLPRGS 588
VKVF E + E+ +RH N+L F+ A +L ++T++ GS
Sbjct: 65 VKVFFTTEEASWF---RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLH------HCNPPIIHRDLKSSNLLVDKHW 642
L+ L+ T LD + + +A G+ +LH P I HRDLKS N+LV K+
Sbjct: 122 LYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 643 TVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVL------RNEPSDEKSDVYSFG 692
T + D GL+ +E + T GT ++M PEVL + S +D+YSFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
Query: 693 VILWELATE----------KIPWDNLNSMQDSC 715
+ILWE+A ++P+ +L S
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 1e-98
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+ D+T+ E +G+G G V+ W G +VAVK+FS ++ E+ LR
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWF---RETELYNTVMLR 60
Query: 561 HPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
H N+L F+ + S +L ++T + GSL+ LQ T LD + + L IA G+
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGL 118
Query: 617 SYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----LTTKTGK 666
++LH P I HRDLKS N+LV K+ + D GL+ + ++ +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 667 GTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
GT ++MAPEVL S ++ D+++FG++LWE+A + + +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 4e-94
Identities = 75/249 (30%), Positives = 116/249 (46%), Gaps = 35/249 (14%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
L + + + E IG+G G V+ W G +VAVK+FS +E E+
Sbjct: 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF---REAEIYQ 89
Query: 556 MKRLRHPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
LRH N+L F+ A + +L +V+++ GSLF L R T + I +AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALS 147
Query: 612 IARGVSYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--- 662
A G+++LH P I HRDLKS N+LV K+ T + D GL+ T
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 663 -KTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELAT----------EKIPW 705
GT ++MAPEVL + S +++D+Y+ G++ WE+A ++P+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 706 DNLNSMQDS 714
+L S
Sbjct: 268 YDLVPSDPS 276
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 7e-94
Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 26/245 (10%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
G + VDL + L L + E +G G V+ A VAVK+F Q+
Sbjct: 2 GHHHHHHSSGVDLGTENL--YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD 59
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRN 596
EV + ++H N+L F+GA L ++T F +GSL L+ N
Sbjct: 60 KQSWQ---NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
Query: 597 TTKLDWRRRILMALDIARGVSYLHH--------CNPPIIHRDLKSSNLLVDKHWTVKVGD 648
+ W +A +ARG++YLH P I HRD+KS N+L+ + T + D
Sbjct: 117 V--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 649 FGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATE 701
FGL+ ++ T GT ++MAPEVL + + D+Y+ G++LWELA+
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 702 KIPWD 706
D
Sbjct: 235 CTAAD 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 8e-89
Identities = 72/252 (28%), Positives = 110/252 (43%), Gaps = 39/252 (15%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQE 552
++ + + ++L + E IG+G G VY VAVKVFS +F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINE 55
Query: 553 --VSLMKRLRHPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR 605
+ + + H N+ F+ +V E+ P GSL + L +T DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113
Query: 606 ILMALDIARGVSYLH-------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
+A + RG++YLH H P I HRDL S N+LV T + DFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 659 YL--------TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELA---T 700
L + GT ++MAPEVL E + ++ D+Y+ G+I WE+ T
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 701 EKIPWDNLNSMQ 712
+ P +++ Q
Sbjct: 234 DLFPGESVPEYQ 245
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 3e-69
Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 489 NKVDLDNDCLDYEILWEDLT-----IGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY 541
N+ D + L+ + + +IG+GS TVY + +VA ++
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 64
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNT 597
+ F++E ++K L+HPN++ F + V + + +VTE + G+L L+R
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 598 TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKH 656
+ + I +G+ +LH PPIIHRDLK N+ + +VK+GD GL+ LK
Sbjct: 125 -VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ K GTP++MAPE+ + DE DVY+FG+ + E+AT + P+ +
Sbjct: 184 AS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAA 236
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 8/219 (3%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ + EDL +GEQIG+G+ G V+ VAVK R+ ++ F QE ++
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARIL 166
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
K+ HPN++ +G T Q + IV E + G L+ +L + + M D A G+
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAP 674
YL IHRDL + N LV + +K+ DFG+SR + + G P +W AP
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
E L +SDV+SFG++LWE + P+ NL++ Q
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-58
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 8/214 (3%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI +DLT +++G G G V + W G DVA+K+ ++ E F +E +M
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSE--DEFIEEAKVMM 74
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
L H ++ G T + + I+TE++ G L L+ + ++ + M D+ +
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
YL +HRDL + N LV+ VKV DFGLSR + T+ G P +W PEV
Sbjct: 135 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
L KSD+++FGV++WE+ + K+P++
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-57
Identities = 72/213 (33%), Positives = 111/213 (52%), Gaps = 8/213 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ I +LT ++IG G G V+ W VA+K R+ E F +E +M +
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSE--EDFIEEAEVMMK 59
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
L HP ++ G +C+VTEF+ G L L+ + M LD+ G++Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVL 677
L +IHRDL + N LV ++ +KV DFG++R + T+ TG P +W +PEV
Sbjct: 120 LEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 678 RNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
KSDV+SFGV++WE+ +E KIP++N +
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-57
Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 8/215 (3%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
E+ E++T+ +++G G G V W G DVAVK+ ++ E F QE M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSE--DEFFQEAQTMMKL 60
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
HP ++ F G + + IVTE++ G L L+ + L+ + + M D+ G+++L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLR 678
IHRDL + N LVD+ VKV DFG++R + + G P +W APEV
Sbjct: 121 ESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 679 NEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV++FG+++WE+ + K+P+D + +
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 11/221 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
Y I ED+ + +G+G G VY V+ VAVK +++ + + F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEA 64
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+MK L HP+++ +G + + I+ E P G L L+RN L +L +L I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
+ ++YL N +HRD+ N+LV VK+GDFGLSR ++ E Y + +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
+PE + SDV+ F V +WE+ + K P+ L +
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 67/247 (27%), Positives = 101/247 (40%), Gaps = 29/247 (11%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-- 530
S S NK++ D I L +G+ +G+G G+V D
Sbjct: 8 HHHSSGLVPRGSEELQNKLE------DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 531 ---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-----SPQRLCIVTE 582
VAVK S I F E + MK HPNV+ +G + ++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 583 FLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 635
F+ G L L + + + +DIA G+ YL + +HRDL + N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARN 177
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGV 693
++ TV V DFGLS+ + + P +W+A E L + KSDV++FGV
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 694 ILWELAT 700
+WE+AT
Sbjct: 238 TMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-56
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 24/229 (10%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVI 546
+L D I + T+G +G+G G+V A D VAVK+ + I
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVT------SPQRLCIVTEFLPRGSLFRLLQ-----R 595
F +E + MK HP+V +G ++ F+ G L L
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 596 NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
N L + + +DIA G+ YL + IHRDL + N ++ + TV V DFGLSR
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 654 LKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ + P +W+A E L + SDV++FGV +WE+ T
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-56
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 15/228 (6%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS 548
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 667 GTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
P +WMA E + + +SDV+S+GV +WEL T P+D + + +
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-56
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVS 554
L +G+G G V + G VAVK + E I ++E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIE 75
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
+++ L H N++ + G T + ++ EFLP GSL L +N K++ ++++ A+ I
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
+G+ YL +HRDL + N+LV+ VK+GDFGL++ + Y T K + +P
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
W APE L SDV+SFGV L EL T
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-55
Identities = 70/227 (30%), Positives = 106/227 (46%), Gaps = 23/227 (10%)
Query: 492 DLDNDCL----DYEIL--WEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQE 540
DLD+ L D I IG+G G VYH + A+K +
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRI 60
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK 599
+ + +F +E LM+ L HPNVL +G + P+ ++ ++ G L + ++
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 600 LDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657
+ I L +ARG+ YL +HRDL + N ++D+ +TVKV DFGL+R +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 658 T--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
Y + P +W A E L+ KSDV+SFGV+LWEL T
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 15/211 (7%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
+ L +Q+G+G+ G+V + VAVK Q ++E + F +E+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + + I
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
+G+ YL IHRDL + N+LV+ VK+GDFGL+++ + + + K +P
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
W APE L SDV+SFGV+L+EL T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-55
Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 11/218 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 67
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
APE + SDV+ FGV +WE+ P+ +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-55
Identities = 69/212 (32%), Positives = 111/212 (52%), Gaps = 15/212 (7%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEV 553
+ L +Q+G+G+ G+V + VAVK Q ++E + F +E+
Sbjct: 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREI 93
Query: 554 SLMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + +
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP 669
I +G+ YL IHRDL + N+LV+ VK+GDFGL+++ + + Y K +P
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 670 -QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
W APE L SDV+SFGV+L+EL T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 6e-55
Identities = 70/204 (34%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + ++L + + IG+G G V + G+ VAVK + + + + +F E S+M +
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ---AFLAEASVMTQ 70
Query: 559 LRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGV 616
LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
YL N +HRDL + N+LV + KV DFGL++ E T TGK +W APE
Sbjct: 131 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEA 185
Query: 677 LRNEPSDEKSDVYSFGVILWELAT 700
LR + KSDV+SFG++LWE+ +
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYS 209
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-55
Identities = 67/220 (30%), Positives = 111/220 (50%), Gaps = 13/220 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEV 553
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEA 97
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT--P-Q 670
G+ YL + N +HRDL + N+LV+ + KV DFGLSR+ + T T G P +
Sbjct: 158 AGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
W APE + SDV+SFG+++WE+ T + P+ L+
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-55
Identities = 76/222 (34%), Positives = 115/222 (51%), Gaps = 25/222 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
++E+ E +T+ ++GQGS G VY V G VA+K + S F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLN 77
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 602
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 603 RRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
+ I MA +IA G++YL + +HRDL + N +V + +TVK+GDFG++R +ET
Sbjct: 138 SKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 661 TTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
K GKG P +WM+PE L++ SDV+SFGV+LWE+AT
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 18/233 (7%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVI 546
+ VDL + L ++ + E ++IG+GS G G +K + S +
Sbjct: 9 SGVDLGTENLYFQSM-EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK------- 599
R+EV+++ ++HPN++ + + L IV ++ G LF+ +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
LDW +I +AL ++H I+HRD+KS N+ + K TV++GDFG++R+ + T
Sbjct: 128 LDWFVQICLALK------HVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ GTP +++PE+ N+P + KSD+++ G +L+EL T K ++ +
Sbjct: 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 12/221 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSL 555
EI + I + IG G G V + VA+K + Y++ F E S+
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASI 103
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPN++ G VT + IVTE++ GSL L+ + + + + M + G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+ YL +HRDL + N+LVD + KV DFGLSR+ + TT GK +W
Sbjct: 164 MRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
APE + SDV+SFGV++WE+ + P+ N+ +
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
L Q+G+G+ G+V + VAVK Q + F++E+
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQ 76
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
++K L ++ + G P R L +V E+LP G L LQR+ +LD R +L + I
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
+G+ YL +HRDL + N+LV+ VK+ DFGL++L + Y + +P
Sbjct: 137 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
W APE L + +SDV+SFGV+L+EL T
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-54
Identities = 75/206 (36%), Positives = 110/206 (53%), Gaps = 9/206 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+E+ D+T+ ++G G G VY VW VAVK +++ + F +E ++M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV--EEFLKEAAVM 63
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARG 615
K ++HPN++ +G T I+TEF+ G+L L+ N ++ + MA I+
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAP 674
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G P +W AP
Sbjct: 124 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 675 EVLRNEPSDEKSDVYSFGVILWELAT 700
E L KSDV++FGV+LWE+AT
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-54
Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 23/253 (9%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDY------EILWEDLTIGEQIGQGSCG 519
S+S+ + S ++ ++ L+ + + + E IG+G G
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 520 TVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574
VYH +D AVK + + F E +MK HPNVL +G
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 575 QR-LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDL 631
+ +V ++ G L ++ T + I L +A+G+ +L +HRDL
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF----VHRDL 218
Query: 632 KSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSD 687
+ N ++D+ +TVKV DFGL+R ++ P +WMA E L+ + KSD
Sbjct: 219 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 688 VYSFGVILWELAT 700
V+SFGV+LWEL T
Sbjct: 279 VWSFGVLLWELMT 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-54
Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 19/223 (8%)
Query: 492 DLDNDCLDYEIL--WEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDE 544
+L I + E IG+G G VYH +D AVK +
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 68
Query: 545 VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRNTTKLDWR 603
+ F E +MK HPNVL +G + +V ++ G L ++ T +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 128
Query: 604 RRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659
I L +A+G+ YL +HRDL + N ++D+ +TVKV DFGL+R ++ Y
Sbjct: 129 DLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
Query: 660 LTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
P +WMA E L+ + KSDV+SFGV+LWEL T
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-54
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
L +G+G G V + ++ VAVK + + + ++QE+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID 85
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
+++ L H +++ + G L +V E++P GSL L R+ + + +L A I
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQI 143
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
G++YLH + IHRDL + N+L+D VK+GDFGL++ + Y + +P
Sbjct: 144 CEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
W APE L+ SDV+SFGV L+EL T
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-53
Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 12/221 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSL 555
E+ +++I + +G G G V VA+K + Y+++ F E S+
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASI 99
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPN++ G VT + + IVTE++ GSL L+++ + + + M IA G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+ YL +HRDL + N+L++ + KV DFGL R+ E TT+ GK +W
Sbjct: 160 MKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
+PE + SDV+S+G++LWE+ + + P+ +++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-53
Identities = 70/205 (34%), Positives = 113/205 (55%), Gaps = 9/205 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ E L + E++G G G V+ + G VAVK +Q +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP--DAFLAEANLMK 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 616
+L+H ++ VT + + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 675
+++ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 676 VLRNEPSDEKSDVYSFGVILWELAT 700
+ KSDV+SFG++L E+ T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 74/226 (32%), Positives = 107/226 (47%), Gaps = 15/226 (6%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEY--SDEVIH 547
L I +DL + E++G GS G V W VAVK + + E +
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMD 66
Query: 548 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
F +EV+ M L H N++ G V +P + +VTE P GSL L+++
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTG 665
A+ +A G+ YL IHRDL + NLL+ VK+GDFGL R +++ + +
Sbjct: 126 YAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 666 KGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
+ P W APE L+ SD + FGV LWE+ T + PW LN
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-53
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 19/226 (8%)
Query: 501 EILWE----DLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFR 550
+ +L + +G G GTV+ VW V +KV + + +
Sbjct: 5 VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT 63
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+ + L H +++ +G L +VT++LP GSL ++++ L + + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGT 668
IA+G+ YL ++HR+L + N+L+ V+V DFG++ L + L K T
Sbjct: 123 QIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK-T 179
Query: 669 P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
P +WMA E + +SDV+S+GV +WEL T P+ L +
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 5e-53
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
EI + E++G+ G VY +G VA+K + + + FR E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEA 63
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 598
L RL+HPNV+ +G VT Q L ++ + G L L +
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
L+ + + IA G+ YL HH +H+DL + N+LV VK+ D GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 657 ETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
G P +WMAPE + SD++S+GV+LWE+ +
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 6e-53
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 15/225 (6%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS 548
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 667 GTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
P +WMA E + + +SDV+S+GV +WEL T P+D +
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-53
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE+L IG GS G G + K ++ EV+L+
Sbjct: 7 DYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 557 KRLRHPNVLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRR 605
+ L+HPN++ + + + L IV E+ G L ++ + T + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 606 ILMALDIARGVSYLHHCNPP---IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ +AL H + ++HRDLK +N+ +D VK+GDFGL+R+ +
Sbjct: 120 LTLALK------ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
KT GTP +M+PE + +EKSD++S G +L+EL P+ +
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-53
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 13/220 (5%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 61
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 670
G+ YL N +HRDL + N+L+ K+ DFGLS+ ++Y T ++ P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
W APE + +SDV+S+GV +WE + + P+ +
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 9e-53
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 11/221 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 442
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 502 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
APE + SDV+ FGV +WE+ P+ + +
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-52
Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 35/259 (13%)
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVW 526
+ S SS+S S + + + D+ + ++G+G+ G V+ A
Sbjct: 3 MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62
Query: 527 YGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579
+ VAVK +E S+ F++E L+ L+H +++ F G T + L +
Sbjct: 63 HNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 580 VTEFLPRGSLFRLLQRN--------------TTKLDWRRRILMALDIARGVSYL--HHCN 623
V E++ G L R L+ + L + + +A +A G+ YL H
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF- 179
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEP 681
+HRDL + N LV + VK+GDFG+SR + T G+ P +WM PE +
Sbjct: 180 ---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 682 SDEKSDVYSFGVILWELAT 700
+SDV+SFGV+LWE+ T
Sbjct: 237 FTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 71/239 (29%), Positives = 113/239 (47%), Gaps = 33/239 (13%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
I D+ + ++G+G+ G V+ A Y VAVK ++ + F++E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREA 68
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 598
L+ L+H +++ F G L +V E++ G L + L+ +
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
+L + + +A IA G+ YL H +HRDL + N LV + VK+GDFG+SR +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 657 ETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
T G P +WM PE + +SDV+SFGVILWE+ T K PW L++ +
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-52
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
+ I ++IG+G VY A G VA+K + D +E+ L+K+L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRILMALDI 612
PNV+ + + L IV E G L R+++ + + ++ AL+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE- 150
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
++H ++HRD+K +N+ + VK+GD GL R + GTP +M
Sbjct: 151 -----HMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+PE + + KSD++S G +L+E+A + P+
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 9e-52
Identities = 77/231 (33%), Positives = 117/231 (50%), Gaps = 11/231 (4%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DV 531
T+ + + V + D +E+ D+T+ ++G G G VY VW V
Sbjct: 191 TTLHYPAPKRNKPTIYGVSPNYD--KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTV 248
Query: 532 AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
AVK +++ + F +E ++MK ++HPN++ +G T I+TEF+ G+L
Sbjct: 249 AVKTL-KEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 305
Query: 592 LLQ-RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+ N ++ + MA I+ + YL N IHR+L + N LV ++ VKV DFG
Sbjct: 306 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFG 363
Query: 651 LSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
LSRL T G P +W APE L KSDV++FGV+LWE+AT
Sbjct: 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 14/238 (5%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY 541
S + + D ++D L+Y+ +++ +G+G+ G VY +A+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-- 58
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD 601
+E++L K L+H N++ ++G+ + + I E +P GSL LL+ L
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 602 WRRRILM--ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658
+ + I G+ YLH I+HRD+K N+L++ + +K+ DFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 659 YLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFG-VILWELATEKIPWDNL-NSMQ 712
T+T GT Q+MAPE++ P + +D++S G I+ E+AT K P+ L
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQA 233
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-51
Identities = 70/204 (34%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + ++L + + IG+G G V + G+ VAVK + + + + +F E S+M +
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ---AFLAEASVMTQ 242
Query: 559 LRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGV 616
LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
YL N +HRDL + N+LV + KV DFGL++ E T TGK +W APE
Sbjct: 303 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEA 357
Query: 677 LRNEPSDEKSDVYSFGVILWELAT 700
LR + KSDV+SFG++LWE+ +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYS 381
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 84
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 607
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 608 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 662
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 145 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 663 KTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
K G P +WM PE K+D +SFGV+LWE+ +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-51
Identities = 53/234 (22%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
++I EDL E +GQG+ ++ V V +KV + SF
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFF 60
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+ S+M +L H +++L G +V EF+ GSL L++N ++ ++ +A
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 611 DIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSRLKHETYL 660
+A + +L + IH ++ + N+L+ + +K+ D G+S +
Sbjct: 121 QLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 661 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
+ W+ PE + N + + +D +SFG LWE+ + P L+S +
Sbjct: 177 LQERIP----WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 6e-51
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 34/231 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQ 551
+E L+ G+ +G G+ G V A YG VAVK+ + +
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMS 75
Query: 552 EVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------- 596
E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 597 ---TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
LD + + +A+G+++L +C IHRDL + N+L+ K+ DFGL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGL 191
Query: 652 SRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+R G P +WMAPE + N +SDV+S+G+ LWEL +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 8e-51
Identities = 75/217 (34%), Positives = 121/217 (55%), Gaps = 10/217 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 235
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV+SFG++L EL T+ ++P+ + + +
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-51
Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 43/244 (17%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 35 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 93
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR 605
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 606 -----------------------ILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDK 640
+ +A +A G++YL +HRDL + N LV +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGE 209
Query: 641 HWTVKVGDFGLSRLKHET--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILW 696
+ VK+ DFGLSR + Y G P +WM PE + +SDV+++GV+LW
Sbjct: 210 NMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 697 ELAT 700
E+ +
Sbjct: 268 EIFS 271
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 79/215 (36%), Positives = 121/215 (56%), Gaps = 17/215 (7%)
Query: 513 IGQGSCGTVYHAV-WYGSDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G VY G+ VAVK Q + F+ EV ++ H N+L
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ----FQTEVEMISMAVHRNLLRLR 93
Query: 569 G-AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTK--LDWRRRILMALDIARGVSYLH-HCN 623
G +T +RL +V ++ GS+ L +R ++ LDW +R +AL ARG++YLH HC+
Sbjct: 94 GFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEP 681
P IIHRD+K++N+L+D+ + VGDFGL++L +T++TT +GT +APE L
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGK 211
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQDSCR 716
S EK+DV+ +GV+L EL T + +D D
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 125
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 607
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 608 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 662
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 186 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 663 KTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
K G P +WM PE K+D +SFGV+LWE+ +
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 71/243 (29%), Positives = 123/243 (50%), Gaps = 35/243 (14%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFS 537
V++ +L D +E + LT+G+ +G+G+ G V A G D VAVK+
Sbjct: 18 GVSEYELPED-PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML- 75
Query: 538 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 596
+ + +++ + E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 76 KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 597 ---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVD 639
++ ++ + +ARG+ YL C IHRDL + N+LV
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVT 191
Query: 640 KHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWE 697
++ +K+ DFGL+R + KT G P +WMAPE L + +SDV+SFGV++WE
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251
Query: 698 LAT 700
+ T
Sbjct: 252 IFT 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 39/236 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
+E ++L +G+ +G+G G V A + VAVK+ ++ S +
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS 75
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------- 596
E +++K++ HP+V+ GA + L ++ E+ GSL L+ +
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 597 --------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKV 646
L I A I++G+ YL +HRDL + N+LV + +K+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKI 191
Query: 647 GDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
DFGLSR +E K +G P +WMA E L + +SDV+SFGV+LWE+ T
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-50
Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 31/236 (13%)
Query: 489 NKVDLDNDCLDY-EILWEDLTIGEQIGQGSCGTVYHAVWYGSD----VAVKVFSRQEYSD 543
+ + D Y + W D+ + IG+G+ G V A A+K ++ S
Sbjct: 8 HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASK 66
Query: 544 EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------ 596
+ F E+ ++ +L HPN++ +GA L + E+ P G+L L+++
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 597 ---------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVK 645
+ L ++ + A D+ARG+ YL IHRDL + N+LV +++ K
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAK 182
Query: 646 VGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ DFGLSR E Y+ G+ P +WMA E L SDV+S+GV+LWE+ +
Sbjct: 183 IADFGLSR-GQEVYVKKTMGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-50
Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 9/205 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI E L + +++G G G V+ A + VAVK + +F E ++MK
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSV--EAFLAEANVMK 238
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGV 616
L+H ++ VT + + I+TEF+ +GSL L+ + +K + I + IA G+
Sbjct: 239 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 675
+++ N IHRDL+++N+LV K+ DFGL+R+ + T + G P +W APE
Sbjct: 298 AFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 676 VLRNEPSDEKSDVYSFGVILWELAT 700
+ KSDV+SFG++L E+ T
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-50
Identities = 73/256 (28%), Positives = 127/256 (49%), Gaps = 35/256 (13%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--- 530
T S+ + + V++ +L D +E + LT+G+ +G+G G V A G D
Sbjct: 51 TRLSSTADTPMLAGVSEYELPED-PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 531 ------VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEF 583
VAVK+ + + +++ + E+ +MK + +H N++ +GA T L ++ E+
Sbjct: 110 PKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168
Query: 584 LPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPI 626
+G+L L+ ++ ++ + +ARG+ YL C
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---- 224
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDE 684
IHRDL + N+LV ++ +K+ DFGL+R + KT G P +WMAPE L +
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284
Query: 685 KSDVYSFGVILWELAT 700
+SDV+SFGV++WE+ T
Sbjct: 285 QSDVWSFGVLMWEIFT 300
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 13/220 (5%)
Query: 499 DYEILWEDLTIGEQ-IGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ + + LT+ ++ +G G+ GTV + VAVK+ + + E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
++M++L +P ++ +G + + +V E G L + LQ+N + + I + ++
Sbjct: 70 NVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVS 127
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 670
G+ YL N +HRDL + N+L+ K+ DFGLS+ E Y +T P +
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
W APE + KSDV+SFGV++WE + + P+ +
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 31/252 (12%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----- 528
+ S S + ++ L + +E +L G+ +G G+ G V A +G
Sbjct: 16 WKIIESYEGNSYTFIDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED 74
Query: 529 --SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 585
VAVK+ + + + E+ +M L +H N++ +GA T + ++TE+
Sbjct: 75 AVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 586 RGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRD 630
G L L+R + R + + +A+G+++L +C IHRD
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRD 189
Query: 631 LKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDV 688
+ + N+L+ K+GDFGL+R G P +WMAPE + + +SDV
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 689 YSFGVILWELAT 700
+S+G++LWE+ +
Sbjct: 250 WSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-49
Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 42/235 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKV----FSRQEYSDEV 545
+E+ + L +G+ +G+G+ G V A G + VAVK+ + ++ SD
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-- 120
Query: 546 IHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL--------------- 589
E+ +MK + +H N++ +GA T L ++ E+ +G+L
Sbjct: 121 ---LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 590 FRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVG 647
+ +L + + A +ARG+ YL C IHRDL + N+LV + +K+
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIA 233
Query: 648 DFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
DFGL+R H KT G P +WMAPE L + +SDV+SFGV+LWE+ T
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 33/233 (14%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHS 548
D +E + L +G+ +G+G+ G V A +G D VAVK+ ++ + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA 76
Query: 549 FRQEVSLMKRL-RHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRN---------- 596
E+ ++ + H NV+ +GA T P L ++ EF G+L L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 597 -----TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649
L I + +A+G+ +L C IHRDL + N+L+ + VK+ DF
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDF 192
Query: 650 GLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
GL+R ++ + G P +WMAPE + + +SDV+SFGV+LWE+ +
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 4e-49
Identities = 75/217 (34%), Positives = 121/217 (55%), Gaps = 10/217 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 318
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 378 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV+SFG++L EL T+ ++P+ + + +
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 8e-49
Identities = 67/247 (27%), Positives = 110/247 (44%), Gaps = 40/247 (16%)
Query: 488 VNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQE 540
V+ + + D L +E E+L G+ +G G+ G V +A YG VAVK+ +++
Sbjct: 29 VDFREYEYD-LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEK 86
Query: 541 YSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--- 596
+ E+ +M +L H N++ +GA T + ++ E+ G L L+
Sbjct: 87 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 597 -------------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 635
L + + A +A+G+ +L C +HRDL + N
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARN 202
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGV 693
+LV VK+ DFGL+R G P +WMAPE L KSDV+S+G+
Sbjct: 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 694 ILWELAT 700
+LWE+ +
Sbjct: 263 LLWEIFS 269
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 51/269 (18%), Positives = 90/269 (33%), Gaps = 14/269 (5%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H + N + S + + + S + + +
Sbjct: 5 HHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPE------SFFQQS 58
Query: 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPN 563
++G GS G V+ G AVK + + S K +HP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ A L + TE SL + + L + D +++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++H D+K +N+ + K+GDFGL + +G P++MAPE+L
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELL-QGSYG 233
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+DV+S G+ + E+A Q
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQ 262
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 49/244 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
D++ + E IG G G V+ A G +K +EV +
Sbjct: 12 DFKEI-------ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58
Query: 557 KRLRHPNVLLFMGA----------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTK- 599
+L H N++ + G + + L I EF +G+L + +++ +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 600 ------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
L+ +I +D Y+H +I+RDLK SN+ + VK+GDFGL
Sbjct: 119 LDKVLALELFEQITKGVD------YIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 654 -LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
LK++ T G T ++M+PE + ++ ++ D+Y+ G+IL EL +
Sbjct: 171 SLKNDGKRTRSKG--TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228
Query: 713 DSCR 716
R
Sbjct: 229 TDLR 232
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-48
Identities = 64/232 (27%), Positives = 95/232 (40%), Gaps = 47/232 (20%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
D +GQG+ G V A A+K ++E + + EV L+ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQ 62
Query: 563 NVLLFMGA-------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD----WR-- 603
V+ + A V L I E+ G+L+ L+ WR
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 662
R+IL AL Y+H IIHRDLK N+ +D+ VK+GDFGL++ H +
Sbjct: 123 RQILEALS------YIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 663 -------------KTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELAT 700
+ GT ++A EVL +EK D+YS G+I +E+
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-48
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 8/211 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 561
ED IG +G+G G VY A +A+KV + + V H R+EV + LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L G R+ ++ E+ P G+++R LQ+ + + R + +A +SY H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+K NLL+ +K+ DFG S H GT ++ PE++
Sbjct: 128 KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
DEK D++S GV+ +E K P++ +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 50/222 (22%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 563
+I +QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 622
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 91 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 146
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 680
I+H DLK +N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 147 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 681 PS-----------DEKSDVYSFGVILWELATEKIPWDNLNSM 711
S KSDV+S G IL+ + K P+ + +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 50/222 (22%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 563
+I +QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 622
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 72 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 127
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 680
I+H DLK +N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 128 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 681 PS-----------DEKSDVYSFGVILWELATEKIPWDNLNSM 711
S KSDV+S G IL+ + K P+ + +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 56/283 (19%), Positives = 109/283 (38%), Gaps = 34/283 (12%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
S + + A + + SSSA + + Y I
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR--IYSI---- 60
Query: 507 LTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-- 563
+QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 61 ---LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 564 -VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHH 621
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 118 IIRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQ 173
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRN 679
I+H DLK +N L+ +K+ DFG++ T + + G +M PE +++
Sbjct: 174 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 680 EPS-----------DEKSDVYSFGVILWELATEKIPWDNLNSM 711
S KSDV+S G IL+ + K P+ + +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 561
+D IG +G+G G VY A +A+KV + + + V H R+E+ + LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L +R+ ++ EF PRG L++ LQ++ + R M ++A + Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-ELADALHYCHE 132
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+K NLL+ +K+ DFG S H L +T GT ++ PE++ +
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIEGKT 188
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
DEK D++ GV+ +E P+D+ + +
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 68/196 (34%), Positives = 111/196 (56%), Gaps = 14/196 (7%)
Query: 513 IGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571
IG G G VY V G+ VA+K + + S + I F E+ + RHP+++ +G
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 572 TSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ ++ +++ G+L R L T + W +R+ + + ARG+ YLH IIH
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIH 162
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPE-VLRNEPSDE 684
RD+KS N+L+D+++ K+ DFG+S+ E T+L+T KGT ++ PE ++ + E
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV-KGTLGYIDPEYFIKGRLT-E 220
Query: 685 KSDVYSFGVILWELAT 700
KSDVYSFGV+L+E+
Sbjct: 221 KSDVYSFGVVLFEVLC 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-47
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 13/220 (5%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 387
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 670
G+ YL N +HR+L + N+L+ K+ DFGLS+ ++Y T ++ P +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709
W APE + +SDV+S+GV +WE + + P+ +
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-47
Identities = 73/195 (37%), Positives = 113/195 (57%), Gaps = 11/195 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G G VY + VAVK + ++E+ F QE+ +M + +H N++ +G
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 571 VTSPQRLCIVTEFLPRGSL-FRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ LC+V ++P GSL RL + T L W R +A A G+++LH IH
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIH 156
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
RD+KS+N+L+D+ +T K+ DFGL+R + T +T++ GT +MAPE LR E + K
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI-VGTTAYMAPEALRGEIT-PK 214
Query: 686 SDVYSFGVILWELAT 700
SD+YSFGV+L E+ T
Sbjct: 215 SDIYSFGVVLLEIIT 229
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 8/208 (3%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
G +G+G + A K+ + E+S+ + L H +V+
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + +V E R SL L +R + R + I G YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 135
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
+IHRDLK NL +++ VK+GDFGL+ K GTP ++APEVL + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 686 SDVYSFGVILWELATEKIPWD--NLNSM 711
DV+S G I++ L K P++ L
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKET 223
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 23/259 (8%)
Query: 462 WGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTV 521
W S S+ + + + G + + VD + Y +T ++G+GS G V
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE-----YREEVHWMTHQPRVGRGSFGEV 74
Query: 522 YHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579
+ G AVK + + +E+ L P ++ GAV + I
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
E L GSL +L+ + L R + G+ YLH I+H D+K+ N+L+
Sbjct: 128 FMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS 184
Query: 640 KH-WTVKVGDFGLSR-----LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 693
+ DFG + ++ LT GT MAPEV+ +P D K D++S
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244
Query: 694 ILWELATEKIPWDNLNSMQ 712
++ + PW
Sbjct: 245 MMLHMLNGCHPWTQYFRGP 263
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 54/263 (20%), Positives = 107/263 (40%), Gaps = 29/263 (11%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
+ S S+ N + L+ + + D I + QG + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKK 61
Query: 536 FSRQE---------------YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580
+ + F+ E+ ++ +++ L G +T+ + I+
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYLHHCNPPIIHRDLK 632
E++ S+ + + LD + + + + SY+H+ I HRD+K
Sbjct: 122 YEYMENDSILKFDEYFF-VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVK 179
Query: 633 SSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYS 690
SN+L+DK+ VK+ DFG S ++ K +GT ++M PE NE + K D++S
Sbjct: 180 PSNILMDKNGRVKLSDFGES--EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 691 FGVILWELATEKIPWDNLNSMQD 713
G+ L+ + +P+ S+ +
Sbjct: 238 LGICLYVMFYNVVPFSLKISLVE 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 35/226 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 560
D + +G+G G V+ A + A+K +E + E +EV + +L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE---KVMREVKALAKLE 61
Query: 561 HPNVLLFMGA------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
HP ++ + A + L I + + +L + T + R + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 609 --ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT-- 664
L IA V +LH ++HRDLK SN+ VKVGDFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 665 ----------GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
GT +M+PE + K D++S G+IL+EL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 50/231 (21%), Positives = 95/231 (41%), Gaps = 25/231 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ +++G+G V + G A+K E D ++E + + HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHP 86
Query: 563 NVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW--RRRIL-MALDIARG 615
N+L + + ++ F RG+L+ ++R K ++ +IL + L I RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK---------TGK 666
+ +H HRDLK +N+L+ + D G ++ +
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 667 GTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
T + APE+ + DE++DV+S G +L+ + + P+D + DS
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 7e-46
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 14/218 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSL 555
D+++ G +G+GS VY A + G +VA+K+ ++ Y ++ + EV +
Sbjct: 12 DFKV-------GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIAR 614
+L+HP++L + +V E G + R L+ R M I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIIT 123
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
G+ YLH I+HRDL SNLL+ ++ +K+ DFGL+ + T GTP +++P
Sbjct: 124 GMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
E+ +SDV+S G + + L + P+D
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 8/208 (3%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
G +G+G + A K+ + E+S+ + L H +V+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + +V E R SL L +R + R + I G YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 161
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
+IHRDLK NL +++ VK+GDFGL+ K GTP ++APEVL + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 686 SDVYSFGVILWELATEKIPWD--NLNSM 711
DV+S G I++ L K P++ L
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKET 249
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 50/227 (22%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 564
+ + +GQG+ V+ G A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 565 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 619
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 620 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
I+HR++K N++ D K+ DFG +R L+ + + GT +++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHP 184
Query: 675 EVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
++ + D++S GV + AT +P+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-44
Identities = 47/240 (19%), Positives = 89/240 (37%), Gaps = 35/240 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y + E+IG G G+V+ V G A+K + + +EV
Sbjct: 8 RYTTEFH---ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 557 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDI 612
L +H +V+ + A + I E+ GSL + R + + L +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKH-------------------WTVKVGDFGLSR 653
RG+ Y+H + ++H D+K SN+ + + K+GD G
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 654 LKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ +G +++A EVL+ N K+D+++ + + A + N +
Sbjct: 183 RISS----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 18/233 (7%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQ 551
D+ L + I +D + E IG G+ V A VA+K + ++ + +
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLK 62
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E+ M + HPN++ + + L +V + L GS+ +++ K + + +L
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 612 IA-------RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
IA G+ YLH IHRD+K+ N+L+ + +V++ DFG+S T+
Sbjct: 123 IATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 665 GK-----GTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
GTP WMAPEV+ + D K+D++SFG+ ELAT P+ M
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-43
Identities = 50/227 (22%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 564
+ + +GQG+ V+ G A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 565 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 619
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 620 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
I+HR++K N++ D K+ DFG +R L+ + + GT +++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHP 184
Query: 675 EVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
++ + D++S GV + AT +P+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 75/232 (32%), Positives = 119/232 (51%), Gaps = 10/232 (4%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQ 539
+ S + N D E L+ L E+IG+GS G V+ + VA+K+ +
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL---EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
E DE I +QE++++ + P V + G+ +L I+ E+L GS LL+
Sbjct: 59 EAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
IL +I +G+ YLH IHRD+K++N+L+ +H VK+ DFG++ +T
Sbjct: 118 ETQIATILR--EILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
+ T GTP WMAPEV++ D K+D++S G+ ELA + P L+ M
Sbjct: 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-42
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G G G V + G VA+K RQE S + + E+ +MK+L HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 566 -LF-----MGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKL--DWRRRILMALDIARG 615
+ + + E+ G L + L + N L R +L DI+
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS--DISSA 133
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQW 671
+ YLH IIHRDLK N+++ + K+ D G ++ L T GT Q+
Sbjct: 134 LRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQY 189
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
+APE+L + D +SFG + +E T P+
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-41
Identities = 55/246 (22%), Positives = 99/246 (40%), Gaps = 24/246 (9%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA-VWYGSDVAVKVFSRQ 539
GS+ S + D + + + + +G G+ GT+ + ++ DVAVK +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE 59
Query: 540 EYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
+S +EV L++ HPNV+ + Q I E +L +++
Sbjct: 60 CFSFA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF 113
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR 653
I + G+++LH N I+HRDLK N+L+ + DFGL +
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 654 L---KHETYLTTKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATE-KIPWD 706
++ GT W+APE+L + D++S G + + + +E P+
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 707 NLNSMQ 712
Q
Sbjct: 232 KSLQRQ 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 67/269 (24%), Positives = 108/269 (40%), Gaps = 39/269 (14%)
Query: 472 NSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGS 529
S + G S V + E+ L + + +G VY A V G
Sbjct: 3 GPGSLGGASGRDQSDFVGQT--------VELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54
Query: 530 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGA-------VTSPQRLCIVT 581
+ A+K E + QEV MK+L HPN++ F A + Q ++
Sbjct: 55 EYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 582 EFLPRGSLFRLL--QRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638
L +G L L + L +L + R V ++H PPIIHRDLK NLL+
Sbjct: 113 TELCKGQLVEFLKKMESRGPLS-CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171
Query: 639 DKHWTVKVGDFGLSRLKHETYLTTKTGK------------GTPQWMAPEVL---RNEPSD 683
T+K+ DFG + + + + TP + PE++ N P
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
EK D+++ G IL+ L + P+++ ++
Sbjct: 232 EKQDIWALGCILYLLCFRQHPFEDGAKLR 260
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
E +G G+ V+ G A+K + + S E++++K+++H N++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
S +V + + G LF R+L+R T+ D I + V YLH
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ---VLSAVKYLHENG 126
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
I+HRDLK NLL +++ + + DFGLS+++ ++T G TP ++APEVL +
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG--TPGYVAPEVLAQK 182
Query: 681 PSDEKSDVYSFGVIL 695
P + D +S GVI
Sbjct: 183 PYSKAVDCWSIGVIT 197
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-40
Identities = 55/219 (25%), Positives = 107/219 (48%), Gaps = 11/219 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
E+ +D ++G G+ G V+ G +A K+ E + + +E+ ++
Sbjct: 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLH 86
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 615
P ++ F GA S + I E + GSL ++L++ +IL +++ + +G
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKG 143
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YL I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE
Sbjct: 144 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 200
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
L+ +SD++S G+ L E+A + P ++ +
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A K+ + ++ S +E + ++L+HPN++
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 125
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HR+LK NLL+ K VK+ DFGL+ + GTP +++PEVL+
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKK 181
Query: 680 EPSDEKSDVYSFGVIL 695
+P + D+++ GVIL
Sbjct: 182 DPYSKPVDIWACGVIL 197
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 20/224 (8%)
Query: 505 EDLTIGEQIGQG--SCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+ IG+G TV A G V V+ + + S+E++ + E+ + K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVS 617
HPN++ + + L +VT F+ GS L+ + IL + + +
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL--QGVLKALD 142
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-------GTPQ 670
Y+HH +HR +K+S++L+ V + + +
Sbjct: 143 YIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 671 WMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
W++PEVL+ D KSD+YS G+ ELA +P+ ++ + Q
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 66/232 (28%), Positives = 118/232 (50%), Gaps = 11/232 (4%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ 539
+ + K+D D+ E +++ L E++G+GS G+VY A G VA+K +
Sbjct: 9 NPPRRQLKKLDEDSLTKQPEEVFDVL---EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE 65
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
E+I +E+S+M++ P+V+ + G+ L IV E+ GS+ +++
Sbjct: 66 SDLQEII----KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
L + +G+ YLH IHRD+K+ N+L++ K+ DFG++ +T
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
T GTP WMAPEV++ + +D++S G+ E+A K P+ +++ M
Sbjct: 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM 231
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-40
Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 37/237 (15%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ------------------------EY 541
T+ ++IG+GS G V A + A+KV S++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVL-LF--MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
I QE++++K+L HPNV+ L + L +V E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPL 134
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
D R D+ +G+ YLH+ IIHRD+K SNLLV + +K+ DFG+S +
Sbjct: 135 SEDQARFYFQ--DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 659 YLTTKTGKGTPQWMAPEVLRNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
GTP +MAPE L + DV++ GV L+ + P+ + M
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ + +G+G+ G V A VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLRNEP 681
I HRD+K NLL+D+ +K+ DFGL+ + E L GT ++APE+L+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPELLKRRE 183
Query: 682 SD-EKSDVYSFGVILWELATEKIPWD 706
E DV+S G++L + ++PWD
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 11/210 (5%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ + IG+G+ V A + G +VA+K+ + + + + +EV +MK L HPN++
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + + L ++ E+ G +F L+ K R I V Y H
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR--QIVSAVQYCHQKR- 134
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
I+HRDLK+ NLL+D +K+ DFG S L G P + APE+ + + D
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYD 191
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ DV+S GVIL+ L + +P+D N +
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 68/245 (27%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEY 541
S + K+ + + ++ EDL +IG+G+ G+V G +AVK R
Sbjct: 2 SIESSGKLKISPE-QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTV 59
Query: 542 SDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
++ ++ +M+ P ++ F GA+ I E + S + + + L
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVL 118
Query: 601 DWR--RRIL--MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
D IL + L + +++L N IIHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS---- 173
Query: 657 ETYLTTKTGK----GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDNL 708
L K G +MAPE + S D +SDV+S G+ L+ELAT + P+
Sbjct: 174 -GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
Query: 709 NSMQD 713
NS+ D
Sbjct: 233 NSVFD 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 14/221 (6%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
LD +WE + ++G G+ G VY A G+ A KV + S+E + + E+ +
Sbjct: 15 LDPNEVWEIV---GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEI 69
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+ HP ++ +GA +L I+ EF P G++ ++ L + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+++LH IIHRDLK+ N+L+ +++ DFG+S +T + GTP WMAPE
Sbjct: 130 LNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 676 VLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSM 711
V+ E D K+D++S G+ L E+A + P LN M
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 11/216 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
D + + E+IGQG+ GTVY A V G +VA++ + Q+ E+ +M
Sbjct: 17 DPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVM 71
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
+ ++PN++ ++ + L +V E+L GSL ++ + + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--RECLQAL 129
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
+LH +IHRD+KS N+L+ +VK+ DFG T GTP WMAPEV
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 677 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ + K D++S G++ E+ + P+ N N ++
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 16/196 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +G+GS G V + AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR- 196
Query: 680 EPSDEKSDVYSFGVIL 695
DEK DV+S GVIL
Sbjct: 197 GTYDEKCDVWSAGVIL 212
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 3e-38
Identities = 35/231 (15%), Positives = 74/231 (32%), Gaps = 28/231 (12%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFR 550
++++ + + + +G+G+ VY A + +KV + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGT 115
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRI 606
Q + +K + F A +V E G+L + + I
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----------DKHWTVKVGDFGLSRLK 655
A+ + + +H C IIH D+K N ++ D + + D G S
Sbjct: 176 SFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 656 --HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP 704
T + E+L N+P + + D + ++ +
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ + +G+G+ G V A VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLRNEP 681
I HRD+K NLL+D+ +K+ DFGL+ + E L GT ++APE+L+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPELLKRRE 183
Query: 682 SD-EKSDVYSFGVILWELATEKIPWD 706
E DV+S G++L + ++PWD
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 8/210 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
L +IG+GS G V A G VAVK+ ++ EV +M+ +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV+ + + L ++ EFL G+L ++ + + + + + ++YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVC--EAVLQALAYLHAQ 160
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
+IHRD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+
Sbjct: 161 G--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D++S G+++ E+ + P+ + + +Q
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A K+ + ++ S +E + ++L+HPN++
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 148
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HR+LK NLL+ K VK+ DFGL+ + GTP +++PEVL+
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKK 204
Query: 680 EPSDEKSDVYSFGVIL 695
+P + D+++ GVIL
Sbjct: 205 DPYSKPVDIWACGVIL 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 10/210 (4%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNV 564
+G+ +G G+ G V G VAVK+ +RQ+ S +V+ ++E+ +K RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +++P +V E++ G LF + + + RR+ I V Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ--QILSAVDYCHRHM 131
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDLK N+L+D H K+ DFGLS + + +T G+P + APEV+
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRLYA 188
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D++S GVIL+ L +P+D+ +
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 55/240 (22%), Positives = 90/240 (37%), Gaps = 44/240 (18%)
Query: 508 TIGEQIGQGSCGTVYHA-VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVL 565
+ +G GS GTV + G VAVK E+ L+ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVI 72
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR------RILMALDIARGVSY 618
+ + T+ + L I E +L + +N + + + L+ IA GV++
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL-RQIASGVAH 130
Query: 619 LHHCNPPIIHRDLKSSNLLVD-------------KHWTVKVGDFGLSRL----KHETYLT 661
LH IIHRDLK N+LV ++ + + DFGL + +
Sbjct: 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 662 TKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELATEKIP--WDNLNSMQ 712
GT W APE+L D++S G + + + ++ D +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 60/244 (24%), Positives = 104/244 (42%), Gaps = 22/244 (9%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSR 538
GS+ SS L Y+ DL ++G G+CG V+ G +AVK R
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-R 59
Query: 539 QEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRN 596
+ + E ++ ++K P ++ G + + I E + + + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 597 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
++ + I + + YL + +IHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 120 PIPERILGKM--TVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGIS---- 172
Query: 657 ETYLTTKTGK----GTPQWMAPEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDN 707
L K G +MAPE + D ++DV+S G+ L ELAT + P+ N
Sbjct: 173 -GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 708 LNSM 711
+
Sbjct: 232 CKTD 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 72/248 (29%), Positives = 121/248 (48%), Gaps = 28/248 (11%)
Query: 482 STSSSAVNKVDLDNDCL-DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR 538
++ S A + ++D L D ++E + E +G G+ G VY G A+KV
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELV---ELVGNGTYGQVYKGRHVKTGQLAAIKV--- 56
Query: 539 QEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA------VTSPQRLCIVTEFLPRGSLFR 591
+ + + +QE++++K+ H N+ + GA +L +V EF GS+
Sbjct: 57 MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 592 LLQRNTTKL---DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
L++ +W I +I RG+S+LH +IHRD+K N+L+ ++ VK+ D
Sbjct: 117 LIKNTKGNTLKEEWIAYIC--REILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172
Query: 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-----DEKSDVYSFGVILWELATEKI 703
FG+S T T GTP WMAPEV+ + + D KSD++S G+ E+A
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 704 PWDNLNSM 711
P +++ M
Sbjct: 233 PLCDMHPM 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRL 559
+ + +G G+CG V A VA+++ S+++++ + + E+ ++K+L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 618
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 198 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQY 254
Query: 619 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
LH IIHRDLK N+L+ ++ +K+ DFG S+ L + + T GTP ++AP
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLAP 310
Query: 675 EVLRNEPS---DEKSDVYSFGVIL 695
EVL + + + D +S GVIL
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQ------EYSDEVIHSFRQEVSLMKRL 559
+ + +G G+CG V A VA+K+ S++ + + E+ ++K+L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 618
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 73 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQY 129
Query: 619 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
LH IIHRDLK N+L+ ++ +K+ DFG S++ ET L +T GTP ++APE
Sbjct: 130 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPE 186
Query: 676 VLRNEPS---DEKSDVYSFGVIL 695
VL + + + D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV 564
I +++G G TVY A VA+K + E + F +EV +L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + +V E++ +L ++ + L I I G+ + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRNEPS 682
I+HRD+K N+L+D + T+K+ DFG+++ ET LT T GT Q+ +PE + E +
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEAT 189
Query: 683 DEKSDVYSFGVILWELATEKIPWD 706
DE +D+YS G++L+E+ + P++
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
IGE++G G V G + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
NV+ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ +K+ DFGL+ ++ G TP+++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAPE 188
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVS-LM 556
E+ +DL ++G+G+ G V V G +AVK R + + ++ M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LMAL 610
+ + P + F GA+ + I E + SL + ++ K + I +A+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDK---GQTIPEDILGKIAV 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK---- 666
I + + +LH +IHRD+K SN+L++ VK+ DFG+S YL K
Sbjct: 117 SIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISG-----YLVDDVAKDIDA 170
Query: 667 GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDNLNS 710
G +MAPE + E + KSD++S G+ + ELA + P+D+ +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR-------QEYSDEVIHSFRQEVSLMKR 558
E +G+G V + + AVK+ E E+ + +EV ++++
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 559 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARG 615
+ HPN++ + +V + + +G LF L ++ T ++ + R+ + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEV 136
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
+ LH N I+HRDLK N+L+D +K+ DFG S L L GTP ++AP
Sbjct: 137 ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 675 EVLRNEPS------DEKSDVYSFGVIL 695
E++ + ++ D++S GVI+
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 6e-37
Identities = 77/239 (32%), Positives = 116/239 (48%), Gaps = 20/239 (8%)
Query: 482 STSSSAVNKVDLDNDCL--DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFS 537
+ ++ D+ D E L+ DL +IG GS G VY A V VA+K S
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 538 -RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 596
+ S+E +EV +++LRHPN + + G +V E+ GS LL+ +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH 147
Query: 597 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
L + +G++YLH N +IHRD+K+ N+L+ + VK+GDFG +
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA---- 201
Query: 657 ETYLT-TKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATEKIPWDNLNSM 711
+ + + GTP WMAPEV+ D K DV+S G+ ELA K P N+N+M
Sbjct: 202 -SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN- 563
+GE +G G V+ A DVAVKV R + + FR+E L HP
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 564 VLLF-MGAVTSPQRLC--IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
V ++ G +P IV E++ +L ++ + +R I + D + +++ H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH 133
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGK--GTPQWMAPEVL 677
IIHRD+K +N+++ VKV DFG++R ++ + T+T GT Q+++PE
Sbjct: 134 QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWD 706
R + D +SDVYS G +L+E+ T + P+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-37
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A + + ++ S +E + + L+HPN++
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+++ ++ + + G LF ++ R ++ D I V + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQMG 130
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
++HR+LK NLL+ K VK+ DFGL+ GTP +++PEVLR +
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 681 PSDEKSDVYSFGVIL 695
P + D+++ GVIL
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
+GE++G G V G + A K +EV++++ +RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PN++ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH 125
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ + +K+ DFG++ ++ G TP+++APE
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG--TPEFVAPE 181
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 9e-37
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR------QEYSDEVIHSFRQEVSLMKRL 559
+ IG+G V V G + AVK+ E +EV + R+E +++++
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 560 R-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGV 616
HP+++ + + S + +V + + +G LF L ++ ++ + R + + V
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS---IMRSLLEAV 213
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
S+LH N I+HRDLK N+L+D + +++ DFG S L+ L GTP ++APE
Sbjct: 214 SFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 676 VLRNEPS------DEKSDVYSFGVIL 695
+L+ ++ D+++ GVIL
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEV---IHSFRQEVSLMKRLRHP 562
+ E IG+G V + G AVK+ +++ ++E S+ L+HP
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDW--RRRILMALDIARGVSYL 619
+++ + +S L +V EF+ L +++R + I + Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 620 HHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
H N IIHRD+K +L+ + VK+G FG++ E+ L GTP +MAPEV
Sbjct: 147 HDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 677 LRNEPSDEKSDVYSFGVIL 695
++ EP + DV+ GVIL
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV 564
+G+ +G+GS G V AVK+ +++ + ++E+ L++RLRH NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 565 L-LF--MGAVTSPQRLCIVTEFLPRGS--LFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+ L + Q++ +V E+ G + + + + G+ YL
Sbjct: 69 IQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC--QLIDGLEYL 125
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKGTPQWMAPEVL 677
H I+H+D+K NLL+ T+K+ G++ H +T +G+P + PE+
Sbjct: 126 HSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 678 RNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
S K D++S GV L+ + T P++ N +
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 452 EGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGE 511
+ S + +++S ++ ++ G+ S +D N + L + +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSN----RDALSDFFEVES 59
Query: 512 QIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
++G+G+ VY G+ A+KV + R E+ ++ RL HPN++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 570 AVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPII 627
+P + +V E + G LF R++++ ++ D I V+YLH I+
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD---AVKQILEAVAYLHENG--IV 170
Query: 628 HRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
HRDLK NLL +K+ DFGLS+ ++H+ + T G TP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG--TPGYCAPEILRGCAYG 228
Query: 684 EKSDVYSFGVIL 695
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ IG G+ G VAVK R DE + ++E+ + LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIV 79
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVS 617
F + +P L I+ E+ G L+ + R + D AR GVS
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNA------GR---FSEDEARFFFQQLLSGVS 130
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
Y H I HRDLK N L+D +K+ DFG S+ K+ GTP ++APE
Sbjct: 131 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPE 187
Query: 676 VLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
VL + D + +DV+S GV L+ + P+++ +
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
Y + +++G+G V + G + A K ++ + E+++++
Sbjct: 30 YILT------SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 558 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARG 615
+ P V+ + + ++ E+ G +F L + I + I G
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 616 VSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQW 671
V YLH N I+H DLK N+L+ +K+ DFG+SR + H L G TP++
Sbjct: 144 VYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG--TPEY 199
Query: 672 MAPEVLRNEPSDEKSDVYSFGVIL 695
+APE+L +P +D+++ G+I
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 4e-36
Identities = 47/239 (19%), Positives = 86/239 (35%), Gaps = 27/239 (11%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA-----------VWYGSDVAVKV 535
A+ ++ L N L E + ++ ++ ++A + +
Sbjct: 35 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
S + + ++ M N + + + L I + + +L + R
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 596 NTTKLDWRRRILMAL--DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ D + + + IA V +LH ++HRDLK SN+ VKVGDFGL
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 654 LKHETYLTTKT------------GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ GT +M+PE + K D++S G+IL+EL
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
GE++G G V G A K + +EVS++K ++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PNV+ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH 131
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ +K+ DFGL+ + G TP+++APE
Sbjct: 132 SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG--TPEFVAPE 187
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
IGE++G G V G + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PN++ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ +K+ DFGL+ ++ G TP+++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAPE 188
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 2e-35
Identities = 25/247 (10%), Positives = 56/247 (22%), Gaps = 45/247 (18%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP 562
L + E + G V+ D A+KVF+ + + + RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 563 NVLLFMGA--------------------------VTSPQRLCIVTEFLPRGSLFRLLQR- 595
+ + ++ L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 596 -----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
++ + R + L ++H NL + + +GD
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDN 707
+ P AP + + G+ ++ + +P+
Sbjct: 240 ALWKVGTRGPAS----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 708 LNSMQDS 714
+
Sbjct: 296 VTPGIKG 302
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
I E +G+GS G V A VA+K SRQ ++ +E+S +K LRHP+++
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+T+P + +V E+ G LF ++++ D RR I + Y H
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQ--QIICAIEYCHRHK- 128
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
I+HRDLK NLL+D + VK+ DFGLS + +L KT G+P + APEV+ +
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVINGKLYA 185
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ DV+S G++L+ + ++P+D+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 44/194 (22%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E +G+G G V+ V K + ++ ++E+S++ RH N+L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV---KKEISILNIARHRNIL 64
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ S + L ++ EF+ +F R+ +L+ R + + + +LH N
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 681
I H D++ N++ + T+K+ +FG +R LK P++ APEV +++
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDV 179
Query: 682 SDEKSDVYSFGVIL 695
+D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G G+ G V+ V G K + D ++ + E+S+M +L HP ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
A + ++ EFL G LF R+ + K+ I G+ ++H +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 681
I+H D+K N++ K +VK+ DFGL+ L + + T T ++ APE++ EP
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDREP 226
Query: 682 SDEKSDVYSFGVIL 695
+D+++ GV+
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T+ IG+GS G V AV A K + D + F+QE+ +MK L HPN++
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNII 69
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E G LF R++ + + D R + D+ V+Y H N
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCHKLN 126
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
+ HRDLK N L +K+ DFGL+ K + TK GTP +++P+VL
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG 182
Query: 680 EPSDEKSDVYSFGVIL 695
+ D +S GV++
Sbjct: 183 -LYGPECDEWSAGVMM 197
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 17/208 (8%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN 563
+ +G+G G VY A VA+K+ + S ++E RL+ P+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 564 VLLFMGAV----TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
V+ + +L + + L +L+R L R + + I +
Sbjct: 96 VV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA 150
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTPQWMAPEVLR 678
H HRD+K N+LV + DFG++ + LT GT +MAPE
Sbjct: 151 HAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWD 706
+ ++D+Y+ +L+E T P+
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
+G+ +G G+ G V G VAVK+ +RQ+ S +V+ R+E+ +K RHP+++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+++P + +V E++ G LF + + RR+ I GV Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ--QILSGVDYCHRHM- 136
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDLK N+L+D H K+ DFGLS + +L +T G+P + APEV+
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISGRLYA 193
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D++S GVIL+ L +P+D+ +
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPT 223
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 20/197 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 564
+ E IG GS + + AVK+ + + +E+ ++ R +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNI 78
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHC 622
+ + + +VTE + G L ++L++ ++ + + I + V YLH
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVEYLHAQ 135
Query: 623 NPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
++HRDLK SN+L ++++ DFG ++ T T ++APEVL
Sbjct: 136 G--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 679 NEPSDEKSDVYSFGVIL 695
+ D D++S GV+L
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE------YSDEVIHSFRQEVSLMKRL 559
+ +G G+ G V+ A +V VK +++ D + E++++ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGS-LFRLLQRNTTKLDWR--RRILMALDIARGV 616
H N++ + + +V E G LF + R+ +LD I + V
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFR--QLVSAV 143
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPE 675
YL + IIHRD+K N+++ + +T+K+ DFG + + T GT ++ APE
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPE 199
Query: 676 VLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLN 709
VL P + +++S GV L+ L E+ P+ L
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 506 DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
++ E +G G G V+ G +A K+ + D + E+S+M +L H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHAN 147
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ A S + +V E++ G LF R++ + L IL I G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQM 206
Query: 623 NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+H DLK N+L +K+ DFGL+R K L G TP+++APEV+
Sbjct: 207 Y--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG--TPEFLAPEVVNY 262
Query: 680 EPSDEKSDVYSFGVIL 695
+ +D++S GVI
Sbjct: 263 DFVSFPTDMWSVGVIA 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 21/256 (8%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDND-CLDYEILWEDLTIGEQIGQGSCGTVYHA 524
SS + + +S + GS + + + E L +G +G G G+VY
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 525 --VWYGSDVAVKVFSRQEYSDEVIHSF----RQEVSLMKRLRH--PNVLLFMGAVTSPQR 576
V VA+K + SD EV L+K++ V+ + P
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 577 LCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIARGVSYLHHCNPPIIHRDLKS 633
++ E P LF + L R + V + H+C ++HRD+K
Sbjct: 123 FVLILERPEPVQDLFDFITERG-ALQEELARSFFW--QVLEAVRHCHNCG--VLHRDIKD 177
Query: 634 SNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSF 691
N+L+D +K+ DFG L +T T GT + PE +R + V+S
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 692 GVILWELATEKIPWDN 707
G++L+++ IP+++
Sbjct: 236 GILLYDMVCGDIPFEH 251
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSR----QEYSDEVIHSFRQEVSLMKRLR- 560
+G +G+G GTV+ + VA+KV R + EV+L+ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 561 ---HPNVLLFMGAVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIAR 614
HP V+ + + + +V E LP LF + L R +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFG--QVVA 150
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
+ + H ++HRD+K N+L+D + K+ DFG L H+ T GT +
Sbjct: 151 AIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD--GTRVYSP 206
Query: 674 PEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDN 707
PE + + V+S G++L+++ IP++
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y++ + +G+GS V AVK+ S++ ++ ++E++ +
Sbjct: 9 HYDLD----LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-----TQKEITAL 59
Query: 557 KRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIA 613
K HPN++ +V E L G LF R+ ++ ++ + + +
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLV 116
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
VS++H ++HRDLK NLL + + +K+ DFG +RLK KT T
Sbjct: 117 SAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVIL 695
+ APE+L DE D++S GVIL
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 63/243 (25%), Positives = 96/243 (39%), Gaps = 54/243 (22%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR---QEYSDEVIHSFRQEVSLMKRLRHP 562
+ IGQGS G V A+ + A+K+ ++ ++ + + + + EV LMK+L HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL----------- 610
N+ Q +C+V E G L +L ++
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 611 ---------------------------DIARGVSYLHHCNPPIIHRDLKSSNLLV--DKH 641
I + YLH+ I HRD+K N L +K
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206
Query: 642 WTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVIL 695
+ +K+ DFGLS+ + Y T GTP ++APEVL NE K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 696 WEL 698
L
Sbjct: 267 HLL 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-34
Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +G+GS G V + AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR- 196
Query: 680 EPSDEKSDVYSFGVILWEL 698
DEK DV+S GVIL+ L
Sbjct: 197 GTYDEKCDVWSAGVILYIL 215
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 36/241 (14%), Positives = 76/241 (31%), Gaps = 43/241 (17%)
Query: 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR--- 560
L G +GQ A G V V E I ++EV ++ LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 561 -------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ--- 594
P + + + +++ F + +L +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 595 ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 652 SRLKHETYLT-TKTGKGTPQWMAPEVLRNEPSDEK-----SDVYSFGVILWELATEKIPW 705
+ ++ G P+ A +L D ++ G+ ++ + +P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 706 D 706
Sbjct: 318 T 318
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V G A+K+ RQEV
Sbjct: 29 DYQLS------KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHH 75
Query: 557 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 610
+ P+++ + + L I+ E + G LF R+ +R R +
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
DI + +LH N I HRD+K NLL +K +K+ DFG ++ + L T
Sbjct: 136 DIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-- 191
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
TP ++APEVL E D+ D++S GVI+
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 66/276 (23%), Positives = 100/276 (36%), Gaps = 37/276 (13%)
Query: 432 NESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKV 491
+ S Q P P ++ + V S +A+
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSF 549
DY++ + +G G G V A+K+
Sbjct: 62 -------DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KA 101
Query: 550 RQEVSLMKRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWR 603
R+EV L R + P+++ + + L IV E L G LF R+ R R
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETY 659
+ I + YLH N I HRD+K NLL + +K+ DFG ++
Sbjct: 162 EASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
LTT TP ++APEVL E D+ D++S GVI+
Sbjct: 220 LTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G G+ G V + A+K+ + S +EV+++K L HPN++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ +V E G LF ++ R K + ++ + GV+YLH N
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 625 PIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNE 680
I+HRDLK NLL+ +K +K+ DFGLS + +++ + + GT ++APEVLR +
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLR-K 212
Query: 681 PSDEKSDVYSFGVILWEL 698
DEK DV+S GVIL+ L
Sbjct: 213 KYDEKCDVWSIGVILFIL 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 35/253 (13%), Positives = 79/253 (31%), Gaps = 52/253 (20%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-- 560
L G +GQ A G V V E I ++EV ++ LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 561 --------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ-- 594
P + + + +++ F + +L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 595 ----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVL-----------RNEPSDEKSDVYSFGVILWELA 699
+++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLVRDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 700 TEKIPWDNLNSMQ 712
+P ++
Sbjct: 308 CADLPITKDAALG 320
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
++G G+ G V+ G + +K ++ + E+ ++K L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNII 83
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTK--LDWRRRILMALDIARGVSYLHHC 622
+ IV E G L R++ L + + ++Y H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLR 678
+ ++H+DLK N+L H +K+ DFGL+ K + + T GT +MAPEV +
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVFK 199
Query: 679 NEPSDEKSDVYSFGVIL 695
K D++S GV++
Sbjct: 200 -RDVTFKCDIWSAGVVM 215
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G G+ G V+ G++ A K SD + R+E+ M LRHP ++
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLV 217
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
A + ++ EF+ G LF ++ + K+ + + +G+ ++H N
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+H DLK N++ + +K+ DFGL+ L + + TG T ++ APEV +P
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEGKP 332
Query: 682 SDEKSDVYSFGVIL 695
+D++S GV+
Sbjct: 333 VGYYTDMWSVGVLS 346
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNV 564
+G+GS G V G + AVKV S+++ + S +EV L+K+L HPN+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E G LF ++ R + + + G++Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK 146
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK NLL+ K +++ DFGLS + + K GT ++APEVL
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLH- 201
Query: 680 EPSDEKSDVYSFGVILWEL 698
DEK DV+S GVIL+ L
Sbjct: 202 GTYDEKCDVWSTGVILYIL 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED G+ +G+GS TV A + A+K+ ++ ++V + +E +M RL
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLD 88
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
HP + ++L + G L + +++ + + R I+ AL+
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE---- 144
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMA 673
YLH IIHRDLK N+L+++ +++ DFG +++ + GT Q+++
Sbjct: 145 --YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
PE+L + + + SD+++ G I+++L P+ N
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 24/208 (11%)
Query: 509 IGEQIGQGSCGTVYHA---VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-V 564
+ I G G +Y A G V +K E E + + HP+ V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 565 LLF----MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+F IV E++ SL R + KL I L+I +SYLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH 199
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLR 678
+++ DLK N+++ + +K+ D G G GTP + APE++R
Sbjct: 200 SIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSR------INSFGYLYGTPGFQAPEIVR 250
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWD 706
P+ +D+Y+ G L L + +
Sbjct: 251 TGPTV-ATDIYTVGRTLAALTLDLPTRN 277
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 28/239 (11%)
Query: 481 GSTSSSAVNKVDLDNDCL---DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKV 535
+ + ++ + E ++G G+ G V S+ A+KV
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 536 FSRQ-----------EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584
+ + ++ E+SL+K L HPN++ + +VTEF
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 585 PRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 640
G LF +++ R+ K D + I G+ YLH N I+HRD+K N+L+ +
Sbjct: 129 EGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNS 184
Query: 641 HWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+K+ DFGLS + L + GT ++APEVL+ + +EK DV+S GVI++ L
Sbjct: 185 LLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLF 567
+ +G+G+ V + + AVK+ +Q +EV ++ + + H NVL
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLEL 76
Query: 568 MGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPP 625
+ R +V E + GS+ + +R +L+ + D+A + +LH+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG-- 131
Query: 626 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGK-------GTPQWMAPE 675
I HRDLK N+L ++ VK+ DF L + G+ ++MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 676 VLRNEPS-----DEKSDVYSFGVIL 695
V+ D++ D++S GVIL
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 44/216 (20%), Positives = 89/216 (41%), Gaps = 17/216 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+G+ V + A+K+ ++ + EV FR+E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH 127
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A L +V E+ G L LL + ++ +I + +H +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVH 185
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
RD+K N+L+D+ +++ DFG +L+ + + + GTP +++PE+L+ +
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 688 VY-------SFGVILWELATEKIPW--DNLNSMQDS 714
Y + GV +E+ + P+ D+
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 52/217 (23%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
+ + +G GS G V S A+K+ +Q+ ++ H+ E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVN 99
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
P ++ + L +V E++ G +F L+R + R I++ +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---- 155
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
YLH + +I+RDLK NLL+D+ ++V DFG ++ T T GTP+ +APE
Sbjct: 156 --YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPE 208
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ ++ ++ D ++ GV+++E+A P+ +Q
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED + + IG+G+ G V + A+K+ S+ E + F +E +M
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFAN 127
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARGV 616
P V+ A + L +V E++P G L L+ W R +++ALD
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD----- 182
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 675
+H IHRD+K N+L+DK +K+ DFG ++ E + T GTP +++PE
Sbjct: 183 -AIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 676 VLRNEPSDEK----SDVYSFGVILWELATEKIPW--DNLNSMQD 713
VL+++ D D +S GV L+E+ P+ D+L
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 283
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 52/228 (22%), Positives = 102/228 (44%), Gaps = 27/228 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED I + IG+G+ G V +D A+K+ ++ E E FR+E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGD 132
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRR----RILMALDIAR 614
+ A L +V ++ G L LL + +L + R +++A+D
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID--- 189
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
+H + +HRD+K N+L+D + +++ DFG +L + + + GTP +++
Sbjct: 190 ---SVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 674 PEVLRNEPSDEKS-----DVYSFGVILWELATEKIPW--DNLNSMQDS 714
PE+L+ + D +S GV ++E+ + P+ ++L
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 66/275 (24%), Positives = 122/275 (44%), Gaps = 20/275 (7%)
Query: 446 PESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE 505
+ + A S + + S + + ++V ++ ++E L
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN----EFEYL-- 153
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRH 561
+ +G+G+ G V + A+K+ ++ DEV H+ E +++ RH
Sbjct: 154 -----KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRH 207
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P + + + RLC V E+ G LF L R + R R A +I + YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+++RDLK NL++DK +K+ DFGL + + T KT GTP+++APEVL +
Sbjct: 267 EKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 682 SDEKSDVYSFGVILWELATEKIPW--DNLNSMQDS 714
D + GV+++E+ ++P+ + + +
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 79/284 (27%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L D +E + L +G+ +G+G+ G V A +G D VAVK+ ++ +
Sbjct: 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSE 68
Query: 546 IHSFRQEVSL---------------------------MKRLRHPNVLLF----------- 567
+ E+ + ++ + N+ +
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 568 ---------------MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR------- 605
V +RL +T S + +++ + ++
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
Query: 606 -------ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KH 656
I + +A+G+ +L IHRDL + N+L+ + VK+ DFGL+R K
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
Y+ + +WMAPE + + +SDV+SFGV+LWE+ +
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 35/220 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE L E+IG+G+ GTV+ A VA+K R + DE + S R E+
Sbjct: 3 KYEKL-------EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALR-EIC 53
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
L+K L+H N++ + S ++L +V EF + L + LD + + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL-FQLL 111
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ 670
+G+ + H N ++HRDLK NLL++++ +K+ +FGL+R Y + +
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAE 161
Query: 671 ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEKIP 704
W P+VL D++S G I ELA P
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE + +IG+GS G V+ G VA+K F + D VI R E+
Sbjct: 4 KYEKI-------GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALR-EIR 54
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
++K+L+HPN++ + +RL +V E+ ++ L R + + +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT-WQTL 112
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQ 670
+ V++ H N IHRD+K N+L+ KH +K+ DFG +R + Y +
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--------DDE 162
Query: 671 ----WM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
W +PE+L + DV++ G + EL +
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 59/217 (27%), Positives = 114/217 (52%), Gaps = 21/217 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
+D I +G GS G V+ + A+KV ++ +V H+ E ++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVT 64
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
HP ++ G Q++ ++ +++ G LF LL+++ + + + +AL+
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---- 120
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
YLH + II+RDLK N+L+DK+ +K+ DFG ++ + T T GTP ++APE
Sbjct: 121 --YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPE 173
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
V+ +P ++ D +SFG++++E+ P+ + N+M+
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G+ G V + A+K+ ++ DEV H+ E +++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTALK 71
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A + RLC V E+ G LF L R + R R A +I + YLH + +++
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD--VVY 128
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K NL++DK +K+ DFGL + T KT GTP+++APEVL + D
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 689 YSFGVILWELATEKIPW--DNLNSMQDS 714
+ GV+++E+ ++P+ + + +
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFEL 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHS--FRQEVSL 555
Y L E+IG+G+ G VY A YG A+K R E DE I S R E+S+
Sbjct: 3 KYHGL-------EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIR-EISI 53
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 614
+K L+H N++ + + +RL +V E L + L +LL L+ + + L +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-LQLLN 111
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ- 670
G++Y H ++HRDLK NLL+++ +K+ DFGL+R Y T +
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEI 161
Query: 671 ---WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
W AP+VL D++S G I E+
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHS--FRQEVSL 555
Y+ L E++G+G+ G VY A G VA+K R + DE I S R E+SL
Sbjct: 22 KYQKL-------EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIR-EISL 72
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 614
+K L HPN++ + + S + L +V EF+ + L ++L N T L + +I + + R
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL-YQLLR 130
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ- 670
GV++ H I+HRDLK NLL++ +K+ DFGL+R +Y T +
Sbjct: 131 GVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEV 180
Query: 671 ---WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
W AP+VL D++S G I E+ T K
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 513 IGQGSCGTVYHA------VWYGSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNV 564
IG+GS G V Y A+K ++Q+ +EV + F+ E+ +M+ L HP +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMY----AMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFL 77
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + + + +V + L G L LQ+N + ++ + ++ + YL +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR- 135
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
IIHRD+K N+L+D+H V + DF ++ L ET +TT GT +MAPE+ +
Sbjct: 136 -IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGA 192
Query: 684 EKS---DVYSFGVILWELATEKIPWDNLNS 710
S D +S GV +EL + P+ +S
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE L +G+GS G V G VA+K F + D+++ R E+
Sbjct: 26 KYENL-------GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMR-EIK 76
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
L+K+LRH N++ + +R +V EF+ ++ L+ LD++ + + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL-FQII 134
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ--- 670
G+ + H N IIHRD+K N+LV + VK+ DFG +R L +
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYDDEVAT 187
Query: 671 -WM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
W APE+L + K+ DV++ G ++ E+ +
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 53/212 (25%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 513 IGQGSCGTVY---HAVWYGSDV--AVKVFSRQ---EYSDEVIHSFRQEVSLMKRLRHPNV 564
+G+G G V+ + A+KV + + + H+ + E ++++ ++HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + A + +L ++ E+L G LF L+R ++ +A +I+ + +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKG- 141
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
II+RDLK N++++ VK+ DFGL + T T GT ++MAPE+L +
Sbjct: 142 -IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 685 KSDVYSFGVILWELATEKIPW--DNLNSMQDS 714
D +S G +++++ T P+ +N D
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 65/304 (21%), Positives = 129/304 (42%), Gaps = 25/304 (8%)
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
K W ++ E P G++ + + + ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIG-----QGTKAPEEKTA 323
Query: 477 VSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVK 534
+ ++ +++ L D+ L +G+GS G V + G+D AVK
Sbjct: 324 NTISKFDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDELYAVK 372
Query: 535 VFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
+ + D+V + ++ L + P + + RL V E++ G L
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+Q+ + + A +IA G+ +L II+RDLK N+++D +K+ DFG+
Sbjct: 433 IQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNS 710
+ +TTKT GTP ++APE++ +P + D ++FGV+L+E+ + P+ ++ +
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
Query: 711 MQDS 714
+ S
Sbjct: 550 LFQS 553
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 58/241 (24%), Positives = 110/241 (45%), Gaps = 23/241 (9%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVY---HAVWYGSDV--AVKVF 536
K D +E+L + +GQGS G V+ + A+KV
Sbjct: 12 HHVKEGHEKADPS----QFELL-------KVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 537 SRQE-YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
+ + + + + E ++ + HP ++ A + +L ++ +FL G LF L +
Sbjct: 61 KKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
+ + +A ++A + +LH II+RDLK N+L+D+ +K+ DFGLS+
Sbjct: 120 EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 176
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQD 713
+ + GT ++MAPEV+ + +D +SFGV+++E+ T +P+ +
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
Query: 714 S 714
Sbjct: 237 M 237
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/208 (24%), Positives = 75/208 (36%), Gaps = 48/208 (23%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V A+K+ R+EV L
Sbjct: 18 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 64
Query: 557 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 610
R + P+++ + + L IV E L G LF R+ R R +
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
I + YLH N I HRD+K NLL + +K+ DFG
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
A E E D+ D++S GVI+
Sbjct: 167 -----AKETTG-EKYDKSCDMWSLGVIM 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNVLLF 567
+++G+G+ TVY + VA+K R E+ + + R EVSL+K L+H N++
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLHHCNPPI 626
+ + + L +V E+L + L + L ++ ++ + + RG++Y H +
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQK--V 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ----WM-APEVLR 678
+HRDLK NLL+++ +K+ DFGL+R K +TY + W P++L
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVTLWYRPPDILL 173
Query: 679 NEPS-DEKSDVYSFGVILWELATEK 702
+ D++ G I +E+AT +
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVA---VKVFSRQEYSDEV-IHSFRQE 552
YE L + +G+G TVY A VA +K+ R E D + + R E
Sbjct: 11 RYEKL-------DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-E 62
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALD 611
+ L++ L HPN++ + A + +V +F+ L +++ N+ L + M L
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM-LM 120
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK---HETYLTTKTGKGT 668
+G+ YLH I+HRDLK +NLL+D++ +K+ DFGL++ + Y T
Sbjct: 121 TLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------T 170
Query: 669 PQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
Q W APE+L D+++ G IL EL
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEV-IHSFRQEVSL 555
++ L E++G G+ TVY G VA+K + + + + R E+SL
Sbjct: 6 QFKQL-------EKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR-EISL 56
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR------RILMA 609
MK L+H N++ + + +L +V EF+ L + + T R +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ- 114
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGK 666
+ +G+++ H I+HRDLK NLL++K +K+GDFGL+R T+
Sbjct: 115 WQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF------- 165
Query: 667 GTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
+ + W AP+VL + D++S G IL E+ T K
Sbjct: 166 -SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 63/248 (25%), Positives = 120/248 (48%), Gaps = 22/248 (8%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-- 530
+T++VS ++ +++ L D+ L +G+GS G V + G+D
Sbjct: 1 TTNTVSK--FDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDEL 47
Query: 531 VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588
AVK+ + D+V + ++ L + P + + RL V E++ G
Sbjct: 48 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 107
Query: 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
L +Q+ + + A +IA G+ +L II+RDLK N+++D +K+ D
Sbjct: 108 LMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIAD 164
Query: 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--D 706
FG+ + +TTKT GTP ++APE++ +P + D ++FGV+L+E+ + P+ +
Sbjct: 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
Query: 707 NLNSMQDS 714
+ + + S
Sbjct: 225 DEDELFQS 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 64/245 (26%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAV 533
S ++ N++ +D ++E + +G+GS G V A + AV
Sbjct: 5 SSKEGNGIGVNSSNRLGID----NFEFI-------RVLGKGSFGKVMLARVKETGDLYAV 53
Query: 534 KVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
KV + D+V + ++ L HP + +P RL V EF+ G L
Sbjct: 54 KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113
Query: 592 LLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
+Q+ + + D R A +I + +LH II+RDLK N+L+D K+ DFG+
Sbjct: 114 HIQK-SRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLN 709
+ +TT T GTP ++APE+L+ D ++ GV+L+E+ P+ +N +
Sbjct: 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230
Query: 710 SMQDS 714
+ ++
Sbjct: 231 DLFEA 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 20/255 (7%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV 525
+ N + S + S+ D+ L + IG+GS G V A
Sbjct: 10 LMNANPAPPPAPSQQINLGPSSNPHAKPS----DFHFL-------KVIGKGSFGKVLLAR 58
Query: 526 WYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581
+V AVKV ++ E H + L+K ++HP ++ + + +L V
Sbjct: 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641
+++ G LF LQR L+ R R A +IA + YLH N I++RDLK N+L+D
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN--IVYRDLKPENILLDSQ 175
Query: 642 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE 701
+ + DFGL + E TT T GTP+++APEVL +P D D + G +L+E+
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
Query: 702 KIPW--DNLNSMQDS 714
P+ N M D+
Sbjct: 236 LPPFYSRNTAEMYDN 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 9/208 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V+ A + ++ A+K + D+V + ++ L HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L V E+L G L +Q K D R A +I G+ +LH I++
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVY 141
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+DK +K+ DFG+ + T T GTP ++APE+L + + D
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 689 YSFGVILWELATEKIPW--DNLNSMQDS 714
+SFGV+L+E+ + P+ + + S
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHS 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 7/206 (3%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS V +D A+KV ++ +++ ++ + HP ++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR + R A +I+ ++YLH II+
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--IIY 133
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 689 YSFGVILWELATEKIPWDNLNSMQDS 714
++ GV+++E+ + P+D + S +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNP 219
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
Y + ++G+G+ G VY A VA+K R E+ +E + R EVS
Sbjct: 35 RYRRI-------TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIR-EVS 85
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
L+K L+H N++ + RL ++ E+ L + + +N + + +
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFL-YQLIN 143
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRLK---HETYLTTKTGK 666
GV++ H +HRDLK NLL+ +K+GDFGL+R +
Sbjct: 144 GVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF------- 194
Query: 667 GTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + W PE+L D++S I E+ +
Sbjct: 195 -THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 61/272 (22%), Positives = 117/272 (43%), Gaps = 19/272 (6%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H ++ + + + + + S A + + L D+++L
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMN-TRESGKASSSLGLQ----DFDLL--- 57
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHP 562
IG+GS V +D A++V ++ +++ ++ + HP
Sbjct: 58 ----RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ + RL V E++ G L +QR + R A +I+ ++YLH
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER 172
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
II+RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E
Sbjct: 173 G--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQDS 714
D ++ GV+++E+ + P+D + S +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 10/208 (4%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G V+ + A K +++ + E ++ ++ ++
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSLA 251
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPP 625
A + LC+V + G + + R I I G+ +LH N
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
II+RDLK N+L+D V++ D GL+ TK GTP +MAPE+L E D
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 686 SDVYSFGVILWELATEKIPWDNLNSMQD 713
D ++ GV L+E+ + P+ +
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVE 397
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVS 554
+++ +G+G+ G V A G VA+K F + ++ + + R E+
Sbjct: 13 FQLK-------SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA---LRTLR-EIK 61
Query: 555 LMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
++K +H N++ + I+ E + L R++ D + +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-- 118
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
R V LH N +IHRDLK SNLL++ + +KV DFGL+R+ E+ G
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 670 QWM----------APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
M APEV+ DV+S G IL EL +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G V + A K ++ + E +++++ V+
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA 250
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
A + LC+V + G L + R + A +I G+ LH I+
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IV 308
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKS 686
+RDLK N+L+D H +++ D GL+ H T K GT +MAPEV++NE
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 687 DVYSFGVILWELATEKIPWDNLN 709
D ++ G +L+E+ + P+
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRK 389
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFR--QEVSLMKRLRHP 562
+ GQG+ GTV G VA+K V + R Q + + L HP
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI------QDPRFRNRELQIMQDLAVLHHP 79
Query: 563 NVLLFMGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD---- 611
N++ + L +V E++P +L R + +RR++
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-----RNYYRRQVAPPPILIKV 133
Query: 612 ----IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHET-----YLT 661
+ R + LH + + HRD+K N+LV++ T+K+ DFG ++ + Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 662 TKTGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
++ + APE++ D++S G I E+ +
Sbjct: 194 SR-------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 48/226 (21%), Positives = 82/226 (36%), Gaps = 41/226 (18%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQ------- 551
Y + I GS G V V G VA+K ++
Sbjct: 24 YTVQ-------RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 552 --EVSLMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKL-DWR 603
E+ L+ HPN+L + L +VTE + L +++ +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET----- 658
+ M I G+ LH ++HRDL N+L+ + + + DF L+R
Sbjct: 136 IQYFM-YHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 659 YLTTKTGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
Y+T +W APE++ + D++S G ++ E+ K
Sbjct: 193 YVTH-------RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 25/201 (12%), Positives = 50/201 (24%), Gaps = 35/201 (17%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS-FRQEVSLMKRLRHPNVL 565
+ G + A+ VA+ Q + + + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ V + +V E++ GSL + + I +A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
+ S + V V + ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANPQ 182
Query: 686 SDVYSFGVILWELATEKIPWD 706
D+ G L+ L + P
Sbjct: 183 DDIRGIGASLYALLVNRWPLP 203
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 58/283 (20%), Positives = 118/283 (41%), Gaps = 31/283 (10%)
Query: 448 SHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVN------KVDLDNDCLDYE 501
+H + + + G+ +S + N KV ++ ++E
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE----NFE 57
Query: 502 ILWEDLTIGEQIGQGSCGTVY---HAVWYGSDV--AVKVFSRQ---EYSDEVIHSFRQEV 553
+L + +G G+ G V+ + + A+KV + + + H+ +
Sbjct: 58 LL-------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
L + P ++ A + +L ++ +++ G LF L + + +I + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIV 169
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK-HETYLTTKTGKGTPQWM 672
+ +LH II+RD+K N+L+D + V + DFGLS+ + GT ++M
Sbjct: 170 LALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 673 APEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
AP+++R S D+ D +S GV+++EL T P+
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSF--RQEVSLMKRLRHPNVLL 566
IG+G G VY + A+K ++ + R +SL+ P ++
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
A +P +L + + + G L L ++ A +I G+ ++H+ +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF--V 313
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
++RDLK +N+L+D+H V++ D GL+ + GT +MAPEVL+ + + S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 687 -DVYSFGVILWELATEKIPWDNLNS 710
D +S G +L++L P+ +
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKT 396
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--VIHSFRQEVS 554
YE L +IGQG+ G V+ A G VA+K E E I + R E+
Sbjct: 18 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR-EIK 68
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLC--------IVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
+++ L+H NV+ + + +V +F L LL K
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
+ + G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R ++ +
Sbjct: 128 RVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNR 184
Query: 667 GTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + W PE+L E D++ G I+ E+ T
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 66/227 (29%), Positives = 93/227 (40%), Gaps = 43/227 (18%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSF-----RQ 551
YE + +IG G+ GTVY A G VA+K R R
Sbjct: 10 RYEPV-------AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVR- 60
Query: 552 EVSLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDW 602
EV+L++RL HPNV+ M + + ++ +V E + + L L + L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYL 660
+ RG+ +LH I+HRDLK N+LV TVK+ DFGL+R+
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL- 176
Query: 661 TTKTGKGTPQ----WM-APEVLRNEPSDEKSDVYSFGVILWELATEK 702
TP W APEVL D++S G I E+ K
Sbjct: 177 -------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+ IG G+ G V A +VA+K F Q ++ ++R E+ LMK + H
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 83
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
N++ + T + L IV E + +L +++Q R L+ + G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 139
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+ +LH IIHRDLK SN++V T+K+ DFGL+R +++ T T + APE
Sbjct: 140 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPE 196
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEK 702
V+ E D++S G I+ E+
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 47/220 (21%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
T + IG GS G VY A G VA+K V + + R E+ +M++L H N+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKLDHCNI 109
Query: 565 LLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD------- 611
+ S L +V +++P +++R+ + R + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA-----RHYSRAKQTLPVIYVKLYMY 163
Query: 612 -IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHET-----YLTTKT 664
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++ Y+ ++
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 220
Query: 665 GKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
+ APE++ S DV+S G +L EL +
Sbjct: 221 ------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 6e-22
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+Q + ++ + DL II WN+ +E LYGYS E+A+GQ + +L D +
Sbjct: 7 KQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQP-VNMLHVPGDTEHIT 65
Query: 190 -DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ ++ +WTG+ K + + P Y ++ +VG + ++ D
Sbjct: 66 SEVISAVENQGKWTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRD 117
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+G G+ G+V A+ G VA+K F + ++ ++R E+ L+K ++H
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYR-ELLLLKHMQH 82
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
NV+ + T L +V F+ L +++ + + + + L+ + +G
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS--EEKIQYLV-YQMLKG 138
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---YLTTKTGKGTPQW- 671
+ Y+H ++HRDLK NL V++ +K+ DFGL+R Y+ T +W
Sbjct: 139 LKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT-------RWY 189
Query: 672 MAPEVLRNEPS-DEKSDVYSFGVILWELATEK 702
APEV+ + ++ D++S G I+ E+ T K
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 50/221 (22%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD-VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T + IG GS G V+ A SD VA+K V + + R E+ +M+ ++HPNV+
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NR-ELQIMRIVKHPNVV 95
Query: 566 LFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD-------- 611
S L +V E++P +++R + + + M +
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQ 149
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR--LKHET---YLTTKTG 665
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++ + E Y+ ++
Sbjct: 150 LLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-- 205
Query: 666 KGTPQWM-APEVLRNEPSDEKS---DVYSFGVILWELATEK 702
+ APE++ + + D++S G ++ EL +
Sbjct: 206 -----YYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+ IG G+ G V A +VA+K F Q ++ ++R E+ LMK + H
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 120
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
N++ + T + L +V E + +L +++Q R L+ + G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 176
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQ 670
+ +LH IIHRDLK SN++V T+K+ DFGL+R + Y+ T +
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-------R 227
Query: 671 WM-APEVLRNEPSDEKSDVYSFGVILWELATEKI 703
+ APEV+ E D++S G I+ E+ KI
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 499 DYEIL---WE---DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR 550
DYE W D + ++G+G V+ A+ V VK+ + ++
Sbjct: 24 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIK---- 78
Query: 551 QEVSLMKRLR-HPNVLLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+E+ +++ LR PN++ V P +V E + +L Q T D+ R
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDIRFY 135
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET-----YLT 661
M +I + + Y H I+HRD+K N+++D +H +++ D+GL+ H +
Sbjct: 136 M-YEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 662 TKTGKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEKIP 704
++ + PE+L + + S D++S G +L + K P
Sbjct: 193 SR-------YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDE--VIHSFRQEV 553
YE + +IG+G+ G V+ A G VA+K R + +E + + R EV
Sbjct: 12 QYECV-------AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIR-EV 62
Query: 554 SLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDWRR 604
++++ L HPNV+ T + +L +V E + + L L + +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYLTT 662
M + RG+ +LH ++HRDLK N+LV +K+ DFGL+R+
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--- 176
Query: 663 KTGKGTPQ----WM-APEVLRNEPSDEKSDVYSFGVILWELATEK 702
T W APEVL D++S G I E+ K
Sbjct: 177 -----TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+G G+ G+V A G VAVK F ++ ++R E+ L+K ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYR-ELRLLKHMKHENV 90
Query: 565 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ + T + L +VT + L +++ D + ++ I RG+ Y
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIY--QILRGLKY 147
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---YLTTKTGKGTPQW-MAP 674
+H + IIHRDLK SNL V++ +K+ DFGL+R + Y+ T +W AP
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT-------RWYRAP 198
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
E++ N ++ D++S G I+ EL T +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ +G G+ G V AV G+ VA+K F + ++ ++R E+ L+K +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYR-ELRLLKHMRHENV 86
Query: 565 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ + T + L +V F+ L +L++ KL R + + +G+ Y
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRY 143
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---YLTTKTGKGTPQWM-AP 674
+H IIHRDLK NL V++ +K+ DFGL+R Y+ T +W AP
Sbjct: 144 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT-------RWYRAP 194
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
EV+ N + D++S G I+ E+ T K
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 509 IGEQIGQGSCGTVYHA----VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
G ++G+G+ G VY A D A+K S +E++L++ L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNV 80
Query: 565 LLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD--------IAR 614
+ S ++ ++ ++ L+ +++ + ++ + + I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRL--KHETYLTTKTGKGT 668
G+ YLH ++HRDLK +N+LV + VK+ D G +RL L
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 669 PQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
W APE+L K+ D+++ G I EL T +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 49/232 (21%), Positives = 97/232 (41%), Gaps = 53/232 (22%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVF-SRQEYSDEVIHSFRQEVSLM 556
Y ++ ++G G TV+ A + VA+K+ + Y++ E+ L+
Sbjct: 21 YILV-------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLL 69
Query: 557 KRLR--------HPNV-----LL--FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-- 599
+R+ LL F + + +V E L +L L+++ +
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128
Query: 600 -LDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGL 651
L + ++I + + G+ Y+H C IIH D+K N+L++ +K+ D G
Sbjct: 129 PLIYVKQI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 652 SRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ E + T+ ++ +PEVL P +D++S +++EL T
Sbjct: 185 ACWYDEHYTNSIQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK--VFSRQEYSDEVIHSFRQEVSL 555
Y L + +G G G V+ AV VA+K V + + H+ R E+ +
Sbjct: 13 YMDL-------KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALR-EIKI 61
Query: 556 MKRLRHPNVLLFMGAVTSPQRLC--------------IVTEFLPRGSLFRLLQRNTTKLD 601
++RL H N++ + IV E++ L +L++ +
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEE 120
Query: 602 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYL 660
R + + RG+ Y+H N ++HRDLK +NL ++ +K+GDFGL+R+ Y
Sbjct: 121 HARLFMY--QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 661 TTK--TGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
+ +W +P +L + + + D+++ G I E+ T K
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
T IG+G+ G V A VA+K F Q Y + R E+ ++ R RH
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC---QRTLR-EIKILLRFRHE 85
Query: 563 NVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
N++ + +P + IV + + L++LL+ D L I RG+
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLY--QILRGLK 142
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWM-AP 674
Y+H N ++HRDLK SNLL++ +K+ DFGL+R+ + T T +W AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
E++ N + D++S G IL E+ + +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 49/233 (21%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEV 553
Y I IG+GS G VY A +VA+K +F R E+
Sbjct: 28 YIIK-------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILR-EI 76
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
+++ RL+ ++ + L IV E L +L + + + ++
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL 135
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR------------LKH 656
++ G +++H IIHRDLK +N L+++ +VKV DFGL+R
Sbjct: 136 -YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 657 ETYLTTKTGKGTPQWM----------APEVLRNEPS-DEKSDVYSFGVILWEL 698
E K + + APE++ + + + D++S G I EL
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 43/243 (17%)
Query: 483 TSSSAVNKVDLDNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKV 535
+ N D+D Y + + + + IG+GS G V A VA+K+
Sbjct: 70 GMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM 129
Query: 536 F-SRQEYSDEVIHSFRQ---EVSLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLP 585
+ + + RQ E+ +++ LR NV+ + T +C+ E L
Sbjct: 130 VRNEKRF-------HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL- 181
Query: 586 RGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DK 640
+L+ L+++N + L R+ A I + + LH IIH DLK N+L+
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKNR--IIHCDLKPENILLKQQG 237
Query: 641 HWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
+KV DFG S +H+ TY+ ++ + APEV+ D++S G IL E
Sbjct: 238 RSGIKVIDFGSSCYEHQRVYTYIQSR------FYRAPEVILGARYGMPIDMWSLGCILAE 291
Query: 698 LAT 700
L T
Sbjct: 292 LLT 294
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 61/277 (22%), Positives = 100/277 (36%), Gaps = 48/277 (17%)
Query: 461 AWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGT 520
+ + V+ + S+ + D++I + I IG GS G
Sbjct: 10 QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHLIGTGSYGH 68
Query: 521 VYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574
V A VA+K VF R E++++ RL H +V+ + V
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILR-EIAILNRLNHDHVVKVLDIVIPK 124
Query: 575 QRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
+V E +L + + + L+ ++ GV Y+H I+HR
Sbjct: 125 DVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLL-YNLLVGVKYVHSAG--ILHR 180
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM----------------- 672
DLK +N LV++ +VKV DFGL+R +P+
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 673 ----------APEVLRNEPS-DEKSDVYSFGVILWEL 698
APE++ + + E DV+S G I EL
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 53/252 (21%), Positives = 91/252 (36%), Gaps = 79/252 (31%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++G+ +G GS G V G A+K V Y R E+ +MK L H N+
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NR-ELDIMKVLDHVNI 62
Query: 565 ---------------------------------LLFMGAVTSPQR-----LCIVTEFLPR 586
+ L ++ E++P
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP- 121
Query: 587 GSLFRLLQRNTTKLDWRRRILMALD--------IARGVSYLHHCNPPIIHRDLKSSNLLV 638
+L ++L K R + ++ + R V ++H I HRD+K NLLV
Sbjct: 122 DTLHKVL-----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLV 174
Query: 639 D-KHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQWM-APEVLRNEPS-DEKSDVYS 690
+ K T+K+ DFG ++ + Y+ ++ + APE++ D++S
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWS 227
Query: 691 FGVILWELATEK 702
G + EL K
Sbjct: 228 IGCVFGELILGK 239
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 494 DNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVF-SRQEYSDEV 545
D+D DY E + I IG+GS G V A VA+K+ +++ + ++
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 546 IHSFRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
+ EV L++ + ++ LC+V E L +L+ LL+ +
Sbjct: 98 ----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR 152
Query: 600 ---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRL 654
L+ R+ A + + +L IIH DLK N+L+ K +K+ DFG S
Sbjct: 153 GVSLNLTRKF--AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210
Query: 655 KHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ Y+ ++ + +PEVL P D D++S G IL E+ T
Sbjct: 211 LGQRIYQYIQSR------FYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 52/234 (22%), Positives = 103/234 (44%), Gaps = 47/234 (20%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEV 553
YE++ +++G+G+ G V+ ++ G VAVK F + +FR E+
Sbjct: 11 YELV-------KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFR-EI 59
Query: 554 SLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
++ L H N++ + + + + + +V +++ L +++ N + ++ ++
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVV--Y 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-----------LKHETY 659
+ + + YLH ++HRD+K SN+L++ VKV DFGLSR +
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 660 LTTKTGKGTPQWM----------APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T+ + APE+L + D++S G IL E+ K
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 28/98 (28%), Positives = 41/98 (41%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
V I DL RI+Y N + + Y EE +GQD + + D+ I G W
Sbjct: 2 VSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQ 61
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
G+F + K R V +T P D+ G + + D
Sbjct: 62 GEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRD 99
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-15
Identities = 25/122 (20%), Positives = 46/122 (37%), Gaps = 8/122 (6%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + + + + + D + RIIY N + G + E LGQ +L
Sbjct: 107 EAQLARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQS-PSILDSPLAD 165
Query: 186 DVAY-DIVHRIKMGERWTGQFPAKTKTE------ERVLVVATNTPFYDDDGTLVGIVCVS 238
+ ++ G+ W+G+ + +T E + TP + D LVG V +
Sbjct: 166 QETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
Query: 239 TD 240
D
Sbjct: 226 HD 227
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 55/247 (22%), Positives = 106/247 (42%), Gaps = 63/247 (25%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVF-SRQEYSDEVIHSF 549
L+ + ++ ++G G+ G V AVKV + ++Y+ S
Sbjct: 30 GMLLNNAFLVI-------RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR----SA 78
Query: 550 RQEVSLMKRLRH-----PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LD 601
+ E ++K++++ N++ + G +C++ E L SL+ ++ RN ++
Sbjct: 79 KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 602 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT----------------- 643
+ ++I + ++YL + + H DLK N LL D ++
Sbjct: 138 DIKLY--CIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 644 -------VKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 693
+K+ DFG + K + + + T+ Q+ APEV+ N D SD++SFG
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTR------QYRAPEVILNLGWDVSSDMWSFGC 247
Query: 694 ILWELAT 700
+L EL T
Sbjct: 248 VLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 56/243 (23%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV---WYGSDVAVKVF-SRQEYSDEVIHS 548
D L YEI+ +G+G+ G V + S VA+K+ + +Y +
Sbjct: 14 GDWLQERYEIV-------GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--- 63
Query: 549 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 599
R E++++K+++ +L +CI E L + F L+ N +
Sbjct: 64 -RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYP 121
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVD------------------K 640
L R + A + + +LH + H DLK N L V+ K
Sbjct: 122 LPHVRHM--AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 641 HWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
+ +++V DFG + HE T + T+ + PEV+ + DV+S G IL+E
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATR------HYRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 698 LAT 700
Sbjct: 232 YYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVF-SRQEYSDEVIHS 548
D L YEI+ + +G+G+ G V + + G VAVK+ + Y +
Sbjct: 9 GDVLSARYEIV-------DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--- 58
Query: 549 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 599
R E+ +++ L + + +CIV E L S + ++ N
Sbjct: 59 -RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFR 116
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT--------------- 643
LD R++ A I + V++LH + H DLK N L V +T
Sbjct: 117 LDHIRKM--AYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 644 ---VKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
+KV DFG + E T ++T+ + APEV+ + DV+S G IL E
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVSTR------HYRAPEVILALGWSQPCDVWSIGCILIE 226
Query: 698 LAT 700
Sbjct: 227 YYL 229
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* Length = 96 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-13
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG 198
M ++ RI WN+ AE L+G E LG+ +L ++ +
Sbjct: 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENK 57
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E F K ER + +PF + L+ V ++ D
Sbjct: 58 EPVFLNF---YKFGERYFNI-RFSPFRNAKTQLLEGVIITID 95
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 53/274 (19%), Positives = 102/274 (37%), Gaps = 80/274 (29%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVF-SRQEYSDEVIHSFRQEVSLMK 557
++ + ++G G TV+ + + VA+KV S + Y++ + E+ L+K
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLK 88
Query: 558 RLR-----HPN-----VLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTK---LDW 602
+R PN LL ++ +C+V E L L + + ++ + L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147
Query: 603 RRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLV----------------------- 638
++I+ + +G+ YLH C IIH D+K N+L+
Sbjct: 148 VKKIIQ--QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 639 --------------------------DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
+ VK+ D G + H+ + T Q+
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYR 260
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
+ EVL + +D++S + +ELAT ++
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} Length = 349 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 7/112 (6%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
R + +IL+S+ ++ RI WN+ AE L+G E LG+ +L DF+
Sbjct: 7 RNFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLP----DFEEI 62
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + + F K ER + + L G++ D
Sbjct: 63 GSVAESVFENKE--PVFLNFYKFGERYFNIRFSPFRNAKTQLLEGVIITIDD 112
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 5e-12
Identities = 43/264 (16%), Positives = 71/264 (26%), Gaps = 63/264 (23%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV------FSRQEYSDEVIHSFRQEVSLMKR 558
E L E+IG+G G V+ + + VA+K+ + E+ + K
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 559 L---------RHPNVLLFMGA------------------------------VTSPQRLCI 579
L R + +L I
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
V EF G L Q T + + ++ + HRDL N+L+
Sbjct: 140 VLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLK 196
Query: 640 KH-----------WTVKVGDFGLSRLKHETYLTTKTGKGTPQWM---APEVLRNEPSDEK 685
K + + GL + L+ G + E L D +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQ 256
Query: 686 SDVYSF-GVILWELATEKIPWDNL 708
D+Y E P+ N+
Sbjct: 257 FDIYRLMKKENNNRWGEYHPYSNV 280
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 30/220 (13%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G +IG+GS G ++ + VA+K E R E K L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV F G +V + L SL LL K + + A + V +H
Sbjct: 70 NVYYF-G--QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 623 NPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL-------KHETYLTTKTGKGTPQ 670
+ +++RD+K N L+ + + + V DFG+ + +H Y K GT +
Sbjct: 126 S--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 671 WMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
+M+ L E S + D+ + G + +PW L
Sbjct: 184 YMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 56/217 (25%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G +IG GS G +Y + G +VA+K E E + K ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ G +V E L SL L + K + +L+A + + Y+H
Sbjct: 69 TIRWC-G--AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTPQWM 672
N IHRD+K N L+ K V + DFGL++ +H Y K GT ++
Sbjct: 125 N--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 673 APEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708
+ L E S + D+ S G +L +PW L
Sbjct: 183 SINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 50/222 (22%), Positives = 85/222 (38%), Gaps = 34/222 (15%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G++IG G+ G + ++ VA+K+ E E K+L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 563 NVLLFMGAVTSPQRL--CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
V F P +V E L SL L + +++A+ + + Y+H
Sbjct: 69 QVYYF-----GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVG-----DFGLSRL-------KHETYLTTKTGKGT 668
N +I+RD+K N L+ + DF L++ KH Y K+ GT
Sbjct: 123 SKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 669 PQWMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
++M+ L E S + D+ + G + +PW L
Sbjct: 181 ARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-11
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 2/99 (2%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL +M + I D I Y N +AELL+ SA+ + Q +L+ +
Sbjct: 11 AILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL--LTQ 68
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ G+ T +++ T +P ++
Sbjct: 69 PLQSGQSITDSDVTFVVDGRPLMLEVTVSPITWQRQLML 107
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-11
Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
N L+++ + I + R++Y N + GY+ EE + I +T I+
Sbjct: 3 NFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMH-ILTITSAGKMAEGEKILA 61
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPF-YDDDGTLVGIV 235
+ G++ + + K + A + ++ L I+
Sbjct: 62 ELFAGKKESLPLSLEKKEGTSIPAKARIWQGKWHNEPCLFAII 104
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-10
Identities = 17/112 (15%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ +FD R + +R YG + LG ++ + + +
Sbjct: 3 ERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFPEIGEEWKSV 62
Query: 190 DIVHRIKMGERWTG-QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
R GE + + P+Y+ +G + G+V + D
Sbjct: 63 H--RRGLAGEVIRVEEDCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 46/214 (21%), Positives = 81/214 (37%), Gaps = 20/214 (9%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVL 565
+G +IG GS G +Y + +VA+K E E + + L+ +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+V + L SL L + KL + +++A + V ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 626 IIHRDLKSSNLLVDKHWT---VKVGDFGLSRL-------KHETYLTTKTGKGTPQWMAPE 675
+HRD+K N L+ V + DFGL++ +H Y K GT ++ +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
+ D+ S G +L +PW L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 44/229 (19%), Positives = 81/229 (35%), Gaps = 35/229 (15%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G++IG G G +Y A A V + + + S E+ +R+ + +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS---ELKFYQRVAKKDCIK 97
Query: 567 FMGAVTSPQRLCIVT-----EFLPRGSLFR-----LLQRNTTKL-DWRRR-----ILM-A 609
L I +G +R L + K+ +L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------KHETYL 660
+ + + Y+H +H D+K++NLL+ +V D+GLS K
Sbjct: 158 IRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNL 708
K GT ++ + + + S +SDV G + K+PW+
Sbjct: 216 PRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 42/234 (17%), Positives = 82/234 (35%), Gaps = 42/234 (17%)
Query: 509 IGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHS----FRQEVSLMKRLRHPN 563
+G IGQG G +Y A V +V S E+ +R P
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSD----APCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 564 VLLFMGAVTSPQRLCI-------------------VTEFLPRGSLFRLLQRNTTKLDWRR 604
+ + L + + + L ++ + N + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKT 153
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------K 655
+ ++L I + Y+H +H D+K+SNLL++ +V D+GL+ K
Sbjct: 154 VLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 656 HETYLTTKTGKGTPQWMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708
+ GT ++ + + PS + D+ G + + T +PW++
Sbjct: 212 AYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} Length = 152 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 8e-09
Identities = 21/128 (16%), Positives = 41/128 (32%), Gaps = 11/128 (8%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A + +L + ++ I I+ N E + E G++ +EL +
Sbjct: 16 AMAKSRLLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPESA 75
Query: 184 DF------DVAYDIVHRIKMGERWTGQFPAK-----TKTEERVLVVATNTPFYDDDGTLV 232
D+ E+ P K + EE++ P + +DGT+
Sbjct: 76 DYLKRKIDTALVIESSSFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIE 135
Query: 233 GIVCVSTD 240
+ D
Sbjct: 136 HVCLCVYD 143
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 1e-08
Identities = 62/444 (13%), Positives = 128/444 (28%), Gaps = 128/444 (28%)
Query: 312 MDREGGSGDSHHSD--HGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFS--HVDEKS 367
MD E G + D F DA + + D DV P + S +D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNF--DCK---------DVQDMPKSILSKEEIDH-- 53
Query: 368 PGKSVRDSGDESEGKPAIHKIITSK----AEQWMG---KKGLSW---PWKGNEREGSDAK 417
+ S D G + + SK ++++ + + P K E+
Sbjct: 54 ----IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK-TEQRQPSMM 108
Query: 418 TARFAWPWSHGDQDNESVQQKSPSYGTKPESHMY--EGNRSVNNEAWGSWSSSVNVNSTS 475
T + D+ Q + ++ + ++ + + V ++
Sbjct: 109 TRMYI---EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN------VLIDG-- 157
Query: 476 SVSSCGSTS--SSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAV 533
V G T + +D++I W L + + + + Y D
Sbjct: 158 -VLGSGKTWVALDVCLSYKVQ-CKMDFKIFW--LNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 534 KVFSRQEYSDEV-IHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
S + ++ IHS + E+ L+K + N LL +
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL------------V------------ 249
Query: 592 LLQRNTTKLD--WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL---VDKHWTVKV 646
L + A ++ C + R + ++ L H ++
Sbjct: 250 --------LLNVQNAKAWNAFNL--------SCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 647 GDFGLSRLKHET------YLTTKTG-------KGTPQWMA--PEVLRNEPSDEKSDVYSF 691
L+ E YL + P+ ++ E +R+ +
Sbjct: 294 HSMTLT--PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA--------- 342
Query: 692 GVILWELATEKIPWDNLNSMQDSC 715
W+ + + D L ++ +S
Sbjct: 343 ---TWD-NWKHVNCDKLTTIIESS 362
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 3/106 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
Y + + + I D + N + GY+ +E L D +L+ G D A
Sbjct: 11 NAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALD-WGVLSRGVDSGWAA 69
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIV 235
+ RI GE + T+ +++ V + DG ++GI
Sbjct: 70 ASLARIVGGEPLREERTVWTRNGDQLTVELSAHLL--PDGKILGIA 113
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 42/232 (18%), Positives = 85/232 (36%), Gaps = 38/232 (16%)
Query: 509 IGEQIGQGSCGTVYHAV----------WYGSDVAVKVFSRQ-----EYSDEVIHSFRQEV 553
+ + + G +Y A ++K+ ++ E + + +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 554 SLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+ K+L P + F G R +V L R SL L + + R +L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGF-GVHQDKYR-FLVLPSLGR-SLQSALDVSPKHVLSERSVL 162
Query: 608 M-ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-----KHETY 659
A + + +LH +H ++ + N+ VD +V +G + KH Y
Sbjct: 163 QVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 660 LTTKTGK--GTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNL 708
+ G ++++ ++ + PS +SD+ S G + + +PW N
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-08
Identities = 13/91 (14%), Positives = 24/91 (26%), Gaps = 2/91 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKMGERWTGQFPAKT 209
I N ++ + + +G+ L +F+ + I + + K
Sbjct: 23 VIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKR 82
Query: 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E T D L V D
Sbjct: 83 AGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-08
Identities = 13/111 (11%), Positives = 29/111 (26%), Gaps = 6/111 (5%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+++ +++ + + I+ N S G + +GQ ++
Sbjct: 19 KKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLE 78
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + R P D VS D
Sbjct: 79 AGKSAVENGTATRSE----DAVGGRHYHN-QYIPV-DSHRKSDTFQLVSRD 123
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-08
Identities = 16/111 (14%), Positives = 34/111 (30%), Gaps = 3/111 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ + + D I N+ GY E LG+ E D +
Sbjct: 17 SRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLM-FDAEDVQ 75
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + ER + + + + V F + + +S D
Sbjct: 76 TQLSGFSVDERRKFEGLYERRDGSTMSVEVHLLRFNLEGEDR--FLAISRD 124
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 7e-08
Identities = 25/112 (22%), Positives = 50/112 (44%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-DFDVA 188
+ ++ ++ I DL I+Y NR+ + GY +EE LG++ +L++G V
Sbjct: 5 EIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNE-SILSNGTTPRLVY 63
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ R+ + W+G + K + L T P ++ G + + + D
Sbjct: 64 QALWGRLAQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRD 115
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 7e-08
Identities = 15/111 (13%), Positives = 40/111 (36%), Gaps = 7/111 (6%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ ++ + ++ + + +Y N + + YS E+ L + ++ D D A
Sbjct: 13 KFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFAL 67
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
I+ +T + ++++ LV + T D + +
Sbjct: 68 HDWEEIRQKNNYTFKTRYRSQSGRIFLVEMSLTFLEDQERRF--SCVFVRE 116
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} Length = 190 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 21/116 (18%), Positives = 41/116 (35%), Gaps = 22/116 (18%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+L+++ + V D+ ++ N ++ L+G + A +L+ F+
Sbjct: 80 LALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLI---NGFNF-- 134
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVL----VVATNTPFY----DDDGTLVGIVCV 237
RW P + E V+ + TP Y +D L G V +
Sbjct: 135 ---------LRWLESEPQDSHNEHVVINGQNFLMEITPVYLQDENDQHVLTGAVVM 181
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} Length = 129 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 16/119 (13%), Positives = 40/119 (33%), Gaps = 11/119 (9%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + +Q + +++ + + + I N+ + L GQD LT+
Sbjct: 3 HSSLETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQA 62
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVL---------VVATNTPFYDDDGTLVGIV 235
+ H +++G P + +E L V + + + V ++
Sbjct: 63 RYDNLLSHDVQLGTN--CGQPVQHPAQETTLICASGKAKDVELSISYIPGHEPMFVMVM 119
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* Length = 130 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 12/45 (26%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
IL ++ + + I+ +N +A +GY+ EE +GQ+ + +L
Sbjct: 21 ILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQN-LRIL 64
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* Length = 119 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-06
Identities = 12/35 (34%), Positives = 22/35 (62%), Gaps = 1/35 (2%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ D I ++ +AE L+G+S EA+GQ+ + +L
Sbjct: 8 VIDGHGIIQLFSTAAERLFGWSELEAIGQN-VNIL 41
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* Length = 167 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 16/56 (28%), Positives = 31/56 (55%), Gaps = 1/56 (1%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
A N D + L+ + + +D ++++N +AE L+GY EE +G + I++L
Sbjct: 34 ADNAADGIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNN-IDML 88
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 Length = 114 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-06
Identities = 13/103 (12%), Positives = 31/103 (30%), Gaps = 5/103 (4%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGERWT----GQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ +++ E++ V +
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCC 105
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 26/163 (15%), Positives = 56/163 (34%), Gaps = 2/163 (1%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211
+I N++ L GYS EE +G++ L G + + I ++ + + K
Sbjct: 88 LIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPVLVEILNYKKD 147
Query: 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVT 271
P YDDD L+ + + Q + ++ ++ + VT
Sbjct: 148 GTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLKTLSPRQLEVT 207
Query: 272 AKLGLDSQQPLQATI--ASKISNLATKVSNKVKSRIRTGDNFM 312
+ + A S+ + + K ++T + +
Sbjct: 208 TLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSADLV 250
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-05
Identities = 20/90 (22%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I++ N + L GY A+E +G++ L G D I I + K
Sbjct: 21 PIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKK 80
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ E +P ++ +G L V D
Sbjct: 81 SGEAFWNRLHISPVHNANGRLQHFVSSQLD 110
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-05
Identities = 18/62 (29%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDV 187
N+ G D RIIY N S +E LG+ E+L T G FD
Sbjct: 12 SGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDA 71
Query: 188 AY 189
Sbjct: 72 LC 73
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} Length = 233 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 28/180 (15%), Positives = 61/180 (33%), Gaps = 7/180 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD---GRDFDVAY- 189
+ L ++ +V I D IIY NR+ + G + + + + G + DV +
Sbjct: 26 SALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEAD-IRKQLPNFDAGRLMGANIDVFHK 84
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249
+ H+ + TG A+ R + P ++D +G TD
Sbjct: 85 NPAHQRHLLANLTGVHKAELNLGGRRFSL-DVVPVFNDANERLGSAVQWTDRTEEHRAEQ 143
Query: 250 ALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ + + ++ R K G + ++ + +++ + GD
Sbjct: 144 EVSQLVQAAAAGDFSK-RVEEAGKEGFFLRLAKDLNSLVDTADRGLRDVSRMLGALAQGD 202
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A Length = 158 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 17 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 74
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 75 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 131
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 23/90 (25%), Positives = 30/90 (33%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
+IY N + E L GYS +E L QD L D RD I + G K
Sbjct: 49 ILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRK 108
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ TP D + + D
Sbjct: 109 DGSAFWNELSITPVKSDFDQRTYFIGIQKD 138
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} Length = 185 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 37 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 94
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 95 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 151
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 9e-05
Identities = 22/85 (25%), Positives = 31/85 (36%), Gaps = 1/85 (1%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I+Y N+ + GY EE LG++ L D +I ++ E T Q K
Sbjct: 23 PIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKK 82
Query: 211 TEERVLVVATNTPFYDDDGTL-VGI 234
P +D T VGI
Sbjct: 83 DGTMFWNELNIDPMEIEDKTYFVGI 107
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} Length = 151 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 21/128 (16%), Positives = 47/128 (36%), Gaps = 6/128 (4%)
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSA---ELLYGYSAEEALGQDAIELLTDGR 183
+ Q IL + + + D Y+N S E+++ + +G++ +
Sbjct: 16 LSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFKRT-PSQVGRNVELCHPP-K 73
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D + ++ G+R +++ + + V T D G G++ D +P
Sbjct: 74 VLDKVKKVFELLRNGQRDKVNMWFQSERLGKFVYV-TYAAVRDQAGDFQGVLEYVQDIKP 132
Query: 244 FQETRAAL 251
F E +
Sbjct: 133 FFELDSEF 140
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 18/107 (16%), Positives = 30/107 (28%), Gaps = 5/107 (4%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVH 193
LQ+ + + RIIY + +++L GY E +G L + D +
Sbjct: 4 PLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE----DQFLVESY 59
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
F K V V A + +
Sbjct: 60 FYNEHHLMPCTFRFIKKDHTIVWVEAAVEIVTTRAERTEREIILKMK 106
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} Length = 118 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 18/106 (16%), Positives = 39/106 (36%), Gaps = 15/106 (14%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE---EALGQDAIELLTDGRDFDVAYDI 191
+LQS+ + V D + N +A+ L Y E L + +V
Sbjct: 20 MLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVDVSEV---- 75
Query: 192 VHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
++ G + + ++R+L++ P +G ++G +
Sbjct: 76 ---LRDGTPRRDE---EITIKDRLLLI-NTVPVR-SNGVIIGAIST 113
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 26/115 (22%), Positives = 40/115 (34%), Gaps = 3/115 (2%)
Query: 129 DRQYLNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
D + LQ Q+ I D S I+Y +R L GYS ++ LG++ L D
Sbjct: 34 DYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDP 93
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
I + I G + + + D G +V V V +
Sbjct: 94 RAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSK 148
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} Length = 369 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 24/167 (14%), Positives = 58/167 (34%), Gaps = 10/167 (5%)
Query: 80 PDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPSAFNFTDRQYLNILQSM 139
P+ T + + Q + + +G + I +++
Sbjct: 193 PELNVEQLLTLPKEVQQALRGQPLEFDKTQLKREEDIDLGTG----YLNIEELKAIFEAL 248
Query: 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE 199
V D DR+ +++ E ++ + LG+ + V I+ K G
Sbjct: 249 PVDVTFIDKDDRVRFFSP-GERIFTRT-PSVLGRPVQLCHPP-KSVYVVNKILKAFKEGR 305
Query: 200 RWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
+ F + E+ V + P +++ G +G + ++ D P+++
Sbjct: 306 KKEATFWLR-LREKYVYI--KYVPLFNEKGEYIGTLEMTMDIAPYKK 349
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 7e-04
Identities = 23/90 (25%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + S L YS EE LG++ L D I I T Q TK
Sbjct: 26 PIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 85
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ ++ + P D G + + V D
Sbjct: 86 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLD 115
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 33/183 (18%), Positives = 61/183 (33%), Gaps = 38/183 (20%)
Query: 491 VDLDNDCLDYEILWEDL------TIGEQIGQGSCGTVYHAV-WYGSDVAVKVF------- 536
L L + IG+ +G+G V++ + VK
Sbjct: 70 STFTFIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSF 129
Query: 537 ----SRQEYSD-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587
+++Y D I S R E +++L+ V + ++ E +
Sbjct: 130 KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK 185
Query: 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647
L+R+ N ++ I V+ +H I+H DL N+LV + +
Sbjct: 186 ELYRVRVENPDEVLD--------MILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234
Query: 648 DFG 650
DF
Sbjct: 235 DFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 716 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.76 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.73 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.73 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.69 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.68 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.67 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.67 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.65 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.65 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.62 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.62 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.62 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.61 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.61 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.61 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.6 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.6 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.59 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.57 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.57 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.56 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.54 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.53 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.52 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.51 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.49 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.49 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.48 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.46 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.46 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.46 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.42 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.42 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.42 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.42 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.41 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.41 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.38 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.37 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.36 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.34 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.31 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.27 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.19 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.18 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 99.18 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 99.16 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.09 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.08 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 99.02 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 98.99 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 98.98 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.73 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.59 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.0 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.47 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.03 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 97.6 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.33 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.2 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 96.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.64 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.38 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 96.26 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 95.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.67 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.19 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 91.21 | |
| 4dah_A | 217 | Sporulation kinase D; alpha-beta-alpha structure, | 88.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.58 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.74 | |
| 4ew7_A | 127 | Conjugative transfer: regulation; alpha-beta-alpha | 81.01 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=417.09 Aligned_cols=206 Identities=27% Similarity=0.470 Sum_probs=182.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|+++++||+|+||+||+|++ .++.||||++++..........+.+|+.+|+.|+|||||+++++|++++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 37899999999999999999998 4778999999988777777889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+||+|.++|.... ..+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.|||+|||+|+.......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999997543 45799999999999999999999999 99999999999999999999999999987765443
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+..
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 231 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 444568999999999999999999999999999999999999999887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=406.84 Aligned_cols=203 Identities=25% Similarity=0.456 Sum_probs=182.8
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++++.||+|+||+||+|++ .++.||||++.+... .......+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999998 477899999986533 1233567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC--c
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~ 659 (716)
|||+||+|.+++.+.. .+++..++.++.||+.||+|||+++ ||||||||+||||+.++.|||+|||+|+..... .
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999998754 6999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 334567899999999999999999999999999999999999999987664
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=406.95 Aligned_cols=203 Identities=29% Similarity=0.442 Sum_probs=184.4
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+.|+++++||+|+||+||+|++ .++.||||+++...... .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999998 47789999997654332 355788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|||+||+|.+++.+. .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.|||+|||+|+........
T Consensus 151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999999764 5999999999999999999999999 999999999999999999999999999877665555
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
....+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 567799999999999999999999999999999999999999998876544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=395.36 Aligned_cols=211 Identities=41% Similarity=0.708 Sum_probs=184.3
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..|++..++|++.++||+|+||+||+|++.+ .||||+++......+..+.+.+|+.+|++++|||||++++++.. +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 4578888999999999999999999998754 69999998777777778899999999999999999999998764 578
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999986543
Q ss_pred C--ccccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 658 T--YLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 658 ~--~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
. .......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.++.+
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~ 244 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD 244 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH
Confidence 2 223445689999999999964 458999999999999999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=402.37 Aligned_cols=205 Identities=26% Similarity=0.399 Sum_probs=175.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
.++|++++.||+|+||+||+|++ .++.||||++++..........+.+|+.+|+.++|||||+++++|++++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46899999999999999999987 3457999999765433222345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||||+||+|.+++.+.. .+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999998754 6999999999999999999999999 999999999999999999999999999876555
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.......+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+..
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 232 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH
Confidence 44555678999999999999999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=409.63 Aligned_cols=203 Identities=29% Similarity=0.442 Sum_probs=184.6
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+.|+++++||+|+||.||+|++ .++.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 46799999999999999999998 47789999997654332 356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|||+||+|.+++... .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.|||+|||+|+........
T Consensus 228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999999764 4999999999999999999999999 999999999999999999999999999877665555
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+.++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 567789999999999999999999999999999999999999998876554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=388.35 Aligned_cols=201 Identities=33% Similarity=0.573 Sum_probs=178.5
Q ss_pred eeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc----CCceEEE
Q 005054 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIV 580 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----~~~~~lV 580 (716)
|++.++||+|+||+||+|.+. +..||+|++..........+.+.+|+.+|+.++|||||+++++|.. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 478889999999999999984 6679999998877777778889999999999999999999999865 3568999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCCcccccCc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~ 659 (716)
||||+||+|.+++.+. ..+++..++.|+.||+.||+|||+++++||||||||+||||+. ++.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999999875 4699999999999999999999998877999999999999974 789999999999865443
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....+||+.|||||++.+ .|+.++|||||||+||+|+||+.||...++.
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~ 235 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH
Confidence 2345689999999999875 5999999999999999999999999876544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=393.73 Aligned_cols=200 Identities=27% Similarity=0.348 Sum_probs=176.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..+.|++.++||+|+||.||+|++. ++.||||+++.+... .+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4468999999999999999999984 778999999876432 3599999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCcccccCc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETY 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~ 659 (716)
||||+||+|.+++.+.. .+++..++.|+.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999998754 6999999999999999999999999 99999999999999887 69999999998654322
Q ss_pred c-----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 660 L-----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 660 ~-----~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
. .....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+..+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 1 2234579999999999999999999999999999999999999998776543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=382.58 Aligned_cols=201 Identities=31% Similarity=0.554 Sum_probs=165.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
++|++++.||+|+||+||+|++ .++.||||++++.... ......+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999987 4778999999876543 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||| +|+|.+++.++ ..+++..++.++.||+.||+|||++| |+||||||+||||+.++++||+|||+|+...... .
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-F 167 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC-c
Confidence 999 67999999775 46999999999999999999999999 9999999999999999999999999998655433 2
Q ss_pred cccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 217 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 335689999999999999887 5799999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=388.16 Aligned_cols=208 Identities=33% Similarity=0.555 Sum_probs=177.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
++..++|.+.++||+|+||+||+|++. +..||||+++.. .....+.|.+|+.+|++++|||||++++++.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 455678999999999999999999864 456999999753 45667889999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~--------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~ 639 (716)
.+.+|||||||++|+|.+++.+.. .++++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 999999999999999999997642 35899999999999999999999999 99999999999999
Q ss_pred cCCcEEEEecCCCcccccC--ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 640 KHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 640 ~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
.++.+||+|||+++..... .......+||+.|||||++.+..|+.++|||||||+||||+| |+.||...++.+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999865433 222334579999999999999999999999999999999999 999999876544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=385.68 Aligned_cols=208 Identities=33% Similarity=0.559 Sum_probs=181.9
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
++..++|.+.++||+|+||+||+|.+. +..||||+++.. .....+.+.+|+.+|++++|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 455678999999999999999999863 456999998754 45667889999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRN------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~------------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
++.+|||||||++|+|.++|.+. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 99999999999999999999764 246999999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 642 WTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
+.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.++.+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999986543322 2223468999999999999999999999999999999998 999999877543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=381.06 Aligned_cols=209 Identities=29% Similarity=0.513 Sum_probs=182.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
++...++++.++||+|+||+||+|.+. ++.||||+++... .....+.|.+|+.+|++++|||||++++++..
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 455678999999999999999999863 4579999987543 33445788999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl 638 (716)
++.+|||||||++|+|.++|.... ..+++..++.|+.||+.||.|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 999999999999999999996532 35899999999999999999999999 9999999999999
Q ss_pred ccCCcEEEEecCCCcccccC--ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 639 DKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
+.++.+||+|||+++..... .......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999865432 223345689999999999999999999999999999999998 899999877543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=385.19 Aligned_cols=204 Identities=25% Similarity=0.398 Sum_probs=178.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc------CC
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~------~~ 575 (716)
.++|++++.||+|+||+||+|++ .++.||||+++...........+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999998 47789999998776666667788999999999999999999998754 36
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|||||||+ |+|.+++.+. ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+|+..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999995 6899999764 46999999999999999999999999 999999999999999999999999999865
Q ss_pred ccC----ccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 656 HET----YLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~----~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
... .......+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 332 2233456899999999998876 4689999999999999999999999887644
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=369.97 Aligned_cols=197 Identities=27% Similarity=0.430 Sum_probs=162.7
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-------
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------- 575 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~------- 575 (716)
++|++++.||+|+||+||+|++. ++.||||+++... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57999999999999999999984 7789999997654 3455678899999999999999999999987544
Q ss_pred -----ceEEEEeecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEe
Q 005054 576 -----RLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (716)
Q Consensus 576 -----~~~lVmE~~~ggsL~~~l~~~~~--~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~D 648 (716)
.+|||||||++|+|.+++..... ......++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976532 2456678899999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCcc------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 649 FGLSRLKHETYL------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 649 FGla~~~~~~~~------------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
||+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999986543221 1234579999999999999999999999999999999996 8864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=380.80 Aligned_cols=213 Identities=30% Similarity=0.534 Sum_probs=184.5
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC-CceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h-pnIv~~~~ 569 (716)
..||+..++|+++++||+|+||+||+|.+.+ +.||||.++... .....+.+.+|+.+|.++.| ||||++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4578889999999999999999999998754 359999987643 34556788999999999965 89999999
Q ss_pred eeccC-CceEEEEeecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 570 AVTSP-QRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 570 ~~~~~-~~~~lVmE~~~ggsL~~~l~~~---------------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
+|... +.+|||||||++|+|.++|.+. ...+++..++.++.||+.||.|||+++ ||||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 98654 5789999999999999999753 234889999999999999999999999 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccC--ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+||||+.++.+||+|||+|+..... .......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432 223344578999999999999999999999999999999998 9999998775
Q ss_pred ccc
Q 005054 711 MQD 713 (716)
Q Consensus 711 l~~ 713 (716)
.+.
T Consensus 294 ~~~ 296 (353)
T 4ase_A 294 DEE 296 (353)
T ss_dssp SHH
T ss_pred HHH
Confidence 543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=365.76 Aligned_cols=200 Identities=35% Similarity=0.534 Sum_probs=164.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC----ceEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCI 579 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----~~~l 579 (716)
.++|.+.++||+|+||+||+|+++++.||||+++.... .......|+..+..++|||||++++++..++ .+||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 36799999999999999999999999999999975432 1122345666677889999999999998654 5799
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~------~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
|||||++|+|.+++.+. .+++..++.++.|++.||.|||++ .++||||||||+||||+.++.+||+|||+|+
T Consensus 79 V~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999999864 489999999999999999999986 1239999999999999999999999999998
Q ss_pred ccccCcc----ccccCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 654 LKHETYL----TTKTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 654 ~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~------~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
....... .....+||+.|||||++.+. .++.++|||||||+||||+||..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 6544322 12245799999999999765 3567899999999999999998776543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=390.49 Aligned_cols=201 Identities=25% Similarity=0.416 Sum_probs=176.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC----CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY----SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.++|+++++||+|+||+||+|++ .++.||||++++... ..........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 47899999999999999999998 577899999976432 222333344456777888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||+||+|.++|.+.. .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999998754 6999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. ....+||+.|||||++. +..|+.++|||||||+||+|++|++||.+.+
T Consensus 345 ~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 345 KK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp CC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred CC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 34669999999999997 4679999999999999999999999997644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=365.46 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=170.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~ 575 (716)
.+.++|++.++||+|+||+||+|+++ ++.||||++..... ..++.+|+.+|+.+ +|||||+++++|.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 34578999999999999999999863 45699998865432 24567899999988 6999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~ 654 (716)
++|||||||++++|.+++. .+++..++.++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+.
T Consensus 94 ~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999999984 3899999999999999999999999 9999999999999876 7999999999975
Q ss_pred cccCc----------------------------cccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCC
Q 005054 655 KHETY----------------------------LTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPW 705 (716)
Q Consensus 655 ~~~~~----------------------------~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF 705 (716)
..... ......+||+.|||||++.+.. |+.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43321 1123457999999999998864 789999999999999999999999
Q ss_pred CCCC
Q 005054 706 DNLN 709 (716)
Q Consensus 706 ~~~~ 709 (716)
...+
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=385.79 Aligned_cols=205 Identities=25% Similarity=0.431 Sum_probs=183.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|++++.||+|+||.||+|.+ .++.||||++.... ......+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999998 47789999987654 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC--CcEEEEecCCCcccccC
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH--WTVKVGDFGLSRLKHET 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~--~~vkL~DFGla~~~~~~ 658 (716)
||||+||+|.++|.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999776667999999999999999999999999 9999999999999854 89999999999876544
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.. ....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+..+
T Consensus 311 ~~-~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 311 QS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp SE-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred Cc-eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 32 335589999999999999999999999999999999999999998876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.34 Aligned_cols=214 Identities=64% Similarity=1.064 Sum_probs=181.9
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+++...+|++.+.||+|+||.||++.+.++.||||++............+.+|+.+|+.++||||+++++++.....+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45567788999999999999999999999999999999988777777778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~--~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
|+||||+++++|.+++.+... .+++..++.++.||+.||.|||+++.+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999976432 389999999999999999999998767999999999999999999999999999866
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~ 245 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 55544445668999999999999999999999999999999999999999877643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=337.00 Aligned_cols=206 Identities=28% Similarity=0.492 Sum_probs=186.1
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+...++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+|+.++||||+++++++...+.+|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34457899999999999999999997 6778999999887777777788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999999997654 5999999999999999999999999 999999999999999999999999999765543
Q ss_pred ccccccCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.
T Consensus 168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 3 23456899999999999988875 789999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.64 Aligned_cols=205 Identities=28% Similarity=0.468 Sum_probs=182.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|++++.||+|+||+||++.. .++.||||++++... .......+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 347899999999999999999998 477899999976432 12234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+++++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999999765 46899999999999999999999999 9999999999999999999999999998654444
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 445566899999999999999999999999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.15 Aligned_cols=209 Identities=30% Similarity=0.425 Sum_probs=181.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
+.+.++|+++++||+|+||.||+|.+ .++.||||+++...........+.+|+.+|+.++||||+++++++.....+|+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 55668999999999999999999998 56789999997665444456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999965 899988877777999999999999999999999999 9999999999999999999999999998766554
Q ss_pred cccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 660 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 44555689999999999976 568999999999999999999999998766543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.67 Aligned_cols=206 Identities=29% Similarity=0.447 Sum_probs=176.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+..++|++++.||+|+||+||+|++. ++.||||++++... .......+.+|..+|+.+ +||||+++++++...+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999984 67899999986432 223345677899999988 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||++++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999999775 45999999999999999999999999 99999999999999999999999999986554
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 44455567899999999999999999999999999999999999999987664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.10 Aligned_cols=203 Identities=30% Similarity=0.479 Sum_probs=183.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..++|++.+.||+|+||.||+|.+ .++.||||++....... ...+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 457899999999999999999986 57789999997654433 35678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||||++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999865 4899999999999999999999999 99999999999999999999999999987665555
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...++.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 222 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 555668999999999999999999999999999999999999999877653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.55 Aligned_cols=204 Identities=28% Similarity=0.435 Sum_probs=180.6
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+..++|+++++||+|+||+||+|++. ++.||||++++.... ......+..|..+|..+ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34578999999999999999999984 557999999876543 33445677899999887 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||++++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999999875 46999999999999999999999999 99999999999999999999999999986444
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 444555778999999999999999999999999999999999999999743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.21 Aligned_cols=209 Identities=31% Similarity=0.579 Sum_probs=182.7
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC---------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~ 568 (716)
.+++..++|++++.||+|+||.||+|.+.+ ..||||+++... .......+.+|+.+|+.+ +||||++++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 356667899999999999999999998732 259999987653 455567889999999999 899999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
+++...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 99999999999999999999999998653 34789999999999999999999999 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999998654332 22334467889999999999999999999999999999999 9999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.07 Aligned_cols=202 Identities=29% Similarity=0.432 Sum_probs=182.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
..++|++++.||+|+||.||++++. ++.||||++++... .......+.+|+.+|+.+ +||||+++++++.....+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3478999999999999999999984 66799999987654 345567788999999988 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|..++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 87 lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999997653 6999999999999999999999999 999999999999999999999999999865444
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 4445567899999999999999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.55 Aligned_cols=207 Identities=28% Similarity=0.457 Sum_probs=179.7
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
+++.++|++.+.||+|+||.||++.+ .+..||+|++..... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 45678999999999999999999997 467899999866443 456678899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999999998754 6999999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 32 223345799999999999999999999999999999999999999987664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=339.02 Aligned_cols=206 Identities=31% Similarity=0.446 Sum_probs=173.9
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHH-HHhcCCCceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~i-L~~l~hpnIv~~~~~~~~~~~~ 577 (716)
...++|++++.||+|+||+||++++. +..||||++++.... ......+..|..+ ++.++||||+++++++...+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34578999999999999999999984 567999999876543 2334455667666 5678999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+|||||+|++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999997653 5899999999999999999999999 99999999999999999999999999986544
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 44445566899999999999999999999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=349.32 Aligned_cols=209 Identities=22% Similarity=0.363 Sum_probs=181.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.+..++|+++++||+|+||+||++++. ++.||||++++.... ......+.+|+.++..++||||++++++|.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 445689999999999999999999985 567999999753211 11123377899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||++++|.+++.+....+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 9999999999999999876667999999999999999999999999 99999999999999999999999999976544
Q ss_pred Cc-cccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.. ......+||+.|+|||++. +..++.++|||||||+||+|++|+.||...+..
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 32 2333468999999999997 566899999999999999999999999876643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.81 Aligned_cols=206 Identities=29% Similarity=0.477 Sum_probs=180.3
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
...++|++.+.||+|+||.||+|++. ++.||||++++... .......+..|..+|..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44578999999999999999999984 66799999976432 112235567788898877 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+|||||++++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999998653 5999999999999999999999999 99999999999999999999999999986544
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 43445567899999999999999999999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.58 Aligned_cols=209 Identities=21% Similarity=0.351 Sum_probs=182.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.+..++|++.++||+|+||.||+++. .++.||||++++... .......+.+|..+|..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34568999999999999999999998 477899999976432 112234577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||++++|.+++.+....+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||+++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999999999876667999999999999999999999999 99999999999999999999999999986554
Q ss_pred Ccc-ccccCCCCCCccCccccc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 658 TYL-TTKTGKGTPQWMAPEVLR-------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 658 ~~~-~~~~~~Gt~~Y~aPE~~~-------~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
... .....+||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 322 233568999999999997 456889999999999999999999999876643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.72 Aligned_cols=207 Identities=26% Similarity=0.400 Sum_probs=171.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCCC--HHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~--~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
.+..++|++.+.||+|+||.||++.. .++.||+|++++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34457899999999999999999987 4678999999875432 2334567789999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
.+.+|+|||||++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999999997653 5899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 654443344456899999999999999999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=345.97 Aligned_cols=206 Identities=26% Similarity=0.399 Sum_probs=179.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.+..++|+++++||+|+||+||+|.+. ++.||+|++++.... ......+.+|+.+++.++|||||++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 445679999999999999999999984 667999998753211 11123467899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||+|++|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 145 ~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999999999999764 4899999999999999999999999 99999999999999999999999999986554
Q ss_pred Cc-cccccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~~----~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ......+||+.|+|||++.+.. ++.++|||||||+||+|++|+.||...+.
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 32 2334668999999999998766 77899999999999999999999987664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.07 Aligned_cols=206 Identities=26% Similarity=0.429 Sum_probs=181.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+..++|++++.||+|+||.||+|.+. ++.||||++++... .......+..|..+|..+ +||||+++++++...+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 44578999999999999999999985 45799999976432 112345677899999988 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||+|++|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999998654 5999999999999999999999999 99999999999999999999999999986544
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 44445567899999999999999999999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.18 Aligned_cols=202 Identities=28% Similarity=0.514 Sum_probs=180.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|++.+.||+|+||.||++.. .++.||+|++++.... ......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 47899999999999999999998 4778999999764321 12345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 9999999999999764 46999999999999999999999999 999999999999999999999999999865442
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 209 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 23568999999999999999999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=332.38 Aligned_cols=205 Identities=24% Similarity=0.439 Sum_probs=183.8
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
.+.++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999984 6789999998877777777889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC---CcEEEEecCCCcccc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKH 656 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla~~~~ 656 (716)
|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++....
T Consensus 106 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999999764 46899999999999999999999999 9999999999999864 459999999998765
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 183 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp TCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 432 22355899999999999999999999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=321.27 Aligned_cols=200 Identities=28% Similarity=0.378 Sum_probs=179.1
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||+|+||+||+|.+ .++.||||+++...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999998 46789999998776666666788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|+++ +|..++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9965 777777666677999999999999999999999999 9999999999999999999999999998766554455
Q ss_pred ccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 5668999999999998766 79999999999999999998888543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=342.53 Aligned_cols=206 Identities=24% Similarity=0.385 Sum_probs=184.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
.+.++|++.+.||+|+||.||+|.+ .++.||+|++............+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999987 56789999998877666667788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc---cCCcEEEEecCCCcccc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~ 656 (716)
|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 88 v~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999775 46999999999999999999999999 99999999999998 45789999999998766
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 554444566899999999999999999999999999999999999999977653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=332.49 Aligned_cols=205 Identities=26% Similarity=0.428 Sum_probs=181.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
.+.++|++++.||+|+||.||+|.+. +..||+|+++...... .....+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 45578999999999999999999984 7789999998754322 12467889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC----cEEEEecCC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 651 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGl 651 (716)
.+|+|||||++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999999764 46999999999999999999999999 99999999999998776 799999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~ 223 (361)
T 2yab_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (361)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 98765432 23356799999999999999999999999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.38 Aligned_cols=204 Identities=37% Similarity=0.609 Sum_probs=181.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..++|.+.++||+|+||.||++.+. +..||+|++... .......+.+|+.+|+.++||||+++++++...+..|+|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 3578999999999999999999984 678999988543 456678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999999987778999999999999999999999999 99999999999999999999999999976543322
Q ss_pred c--------------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 T--------------TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~--------------~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 1 1145799999999999999999999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=336.19 Aligned_cols=205 Identities=25% Similarity=0.406 Sum_probs=179.7
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
++..++|++++.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+|+.++|||||+++++|.+...+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 455689999999999999999999984 56799999976432 112346778899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+|||||.+++|..++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999999764 46999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 168 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 168 ET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 32 3345689999999999974 458899999999999999999999998544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=326.84 Aligned_cols=202 Identities=22% Similarity=0.363 Sum_probs=180.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|++.+.||+|+||.||+|.+. +..||+|+++... .....+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4578999999999999999999984 6679999987542 3345678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc--CCcEEEEecCCCcccccC
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 658 (716)
||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999876667999999999999999999999999 999999999999987 789999999999876543
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 158 DN-FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp CE-EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred Cc-cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 32 2345789999999999999899999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.56 Aligned_cols=203 Identities=27% Similarity=0.416 Sum_probs=175.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
++|++++.||+|+||.||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999984 77899999976544333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 965 999999877677999999999999999999999999 99999999999999999999999999986654433344
Q ss_pred cCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 664 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 55789999999999764 589999999999999999999999987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.00 Aligned_cols=204 Identities=18% Similarity=0.230 Sum_probs=176.9
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEE-------EcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC---CCceeEE
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAV-------WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLF 567 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~---hpnIv~~ 567 (716)
..+++..++|.+.++||+|+||.||+|. ..++.||||+++... ...+..|+.+++.+. |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3456667899999999999999999993 257789999987543 245667777777776 9999999
Q ss_pred eceeccCCceEEEEeecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---
Q 005054 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--- 640 (716)
Q Consensus 568 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~----~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~--- 640 (716)
++++...+..|||||||++++|.+++.. ....+++..++.++.||+.||.|||+++ ||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999975 3456999999999999999999999999 999999999999998
Q ss_pred --------CCcEEEEecCCCcccc--cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 641 --------HWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 641 --------~~~vkL~DFGla~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
++.+||+|||+++... .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999997543 2223344568999999999999999999999999999999999999999643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=333.42 Aligned_cols=204 Identities=27% Similarity=0.424 Sum_probs=178.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC---CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
+.++|++.+.||+|+||.||+|.+ .++.||||++..... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999988 477899999865321 111246688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc---EEEEecCC
Q 005054 578 CIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGL 651 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFGl 651 (716)
|+|||||++++|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998887543 345899999999999999999999999 999999999999986554 99999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
+.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 987665544445668999999999999999999999999999999999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=332.37 Aligned_cols=202 Identities=25% Similarity=0.401 Sum_probs=180.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|++++.||+|+||.||++.+ .++.||||++++.... ......+.+|+.+|+.++||||+++++++.+...+||
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 457999999999999999999998 4778999999764321 1234667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+++++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999998754 5999999999999999999999999 999999999999999999999999999866543
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 2345799999999999999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.55 Aligned_cols=208 Identities=33% Similarity=0.512 Sum_probs=180.8
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
.++..++|++.+.||+|+||.||++.+. +..||||+++... .......+.+|+.+|+.++||||+++++++...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3566789999999999999999999983 2349999997543 455567889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+.+||||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999999877678999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 655 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 543321 2223356788999999999999999999999999999999 9999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=329.80 Aligned_cols=210 Identities=24% Similarity=0.363 Sum_probs=185.6
Q ss_pred hhcccceeEeeeeecC--CcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 501 EILWEDLTIGEQIGQG--SCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G--~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
....++|+++++||+| +||.||++.+. ++.||||+++...........+.+|+.+|+.++|||||++++++...+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3445789999999999 99999999984 7789999999887777778889999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+|+|||||++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999999764 356999999999999999999999999 999999999999999999999999987643
Q ss_pred ccC-------ccccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 656 HET-------YLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 656 ~~~-------~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 221 112223478999999999988 678999999999999999999999998876554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=343.55 Aligned_cols=207 Identities=28% Similarity=0.467 Sum_probs=173.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.+..++|+++++||+|+||.||++.+ .++.||||+++.... .......+.+|+.+|+.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34567899999999999999999997 467899999986532 233456677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
|||||||++++|..++.+.. .+++..++.++.||+.||.|||+ ++ ||||||||+||||+.++.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999997654 69999999999999999999998 88 9999999999999999999999999998655
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.........+||+.|+|||++.+..++.++|||||||+||+|++|+.||...+.
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 444445567899999999999999999999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.96 Aligned_cols=207 Identities=32% Similarity=0.581 Sum_probs=183.8
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.|.+..++|++.+.||+|+||.||++.+ .+..||+|++....... ..+.+|+.+++.++||||+++++++.+...+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 3566678999999999999999999998 56679999998765544 4578899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999999877777999999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 658 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.. .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 32 22334457888999999999999999999999999999999 9999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=327.95 Aligned_cols=202 Identities=29% Similarity=0.459 Sum_probs=164.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+.+.++|++.+.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+|+.++||||+++++++.....+|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 456688999999999999999999984 5679999997643 2355778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecCCCccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLK 655 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~~ 655 (716)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++...
T Consensus 125 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999999764 45899999999999999999999999 999999999999975 889999999999865
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 4432 22345799999999999999999999999999999999999999986654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.97 Aligned_cols=206 Identities=27% Similarity=0.412 Sum_probs=181.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
+.+.++|++.+.||+|+||.||+|.+. +..||+|+++...... .....+.+|+.+|+.++||||+++++++...
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345578999999999999999999984 7789999997654321 1246788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC----cEEEEecC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFG 650 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFG 650 (716)
..+|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999999764 46999999999999999999999999 99999999999998877 79999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 998765432 22345799999999999999999999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.24 Aligned_cols=202 Identities=19% Similarity=0.321 Sum_probs=178.4
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
++.++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+ +||||+++++++...+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 3457899999999999999999996 5778999998765432 3467899999999 9999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc-----EEEEecCCCc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSR 653 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~-----vkL~DFGla~ 653 (716)
+||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999999 99999999876678999999999999999999999999 999999999999998877 9999999998
Q ss_pred ccccCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 654 LKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 6543321 12456899999999999999999999999999999999999999997653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=344.30 Aligned_cols=205 Identities=25% Similarity=0.359 Sum_probs=182.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|++.+.||+|+||.||+|++ .++.||||++.+..... .....+.+|+.+|+.++||||+++++++.....+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 347899999999999999999998 47789999997643211 224567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 580 VTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
||||++|++|..++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999764 246999999999999999999999999 9999999999999999999999999998766
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 55444445689999999999999999999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.00 Aligned_cols=211 Identities=42% Similarity=0.723 Sum_probs=174.0
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
...+++..++|++.++||+|+||.||++.+.+ .||||+++.........+.+.+|+.+|+.++||||+++++++ ....
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 34567888999999999999999999998655 599999988777777788899999999999999999999965 5567
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccc
Confidence 89999999999999999877778999999999999999999999999 9999999999999999999999999987543
Q ss_pred cC--ccccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 657 ET--YLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 657 ~~--~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.. ........||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 231 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH
Confidence 21 22223457899999999986 667888999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=319.42 Aligned_cols=203 Identities=30% Similarity=0.478 Sum_probs=171.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH------------------------HHHHHHHHHHHHH
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD------------------------EVIHSFRQEVSLM 556 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~------------------------~~~~~~~~E~~iL 556 (716)
..++|++.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999987 46679999997654321 1235688999999
Q ss_pred HhcCCCceeEEeceecc--CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCC
Q 005054 557 KRLRHPNVLLFMGAVTS--PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (716)
Q Consensus 557 ~~l~hpnIv~~~~~~~~--~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~ 634 (716)
+.++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 99999999999999986 5678999999999999876543 46999999999999999999999999 999999999
Q ss_pred cEEEccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 635 NLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~---~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
|||++.++.+||+|||++..............||+.|+|||++.+... +.++|||||||++|+|++|+.||...+
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999876654444445689999999999987663 778999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.60 Aligned_cols=205 Identities=28% Similarity=0.395 Sum_probs=184.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
...++|.+.+.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44578999999999999999999984 56799999976543 4456678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999998764 46899999999999999999999999 999999999999999999999999999876544
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 444455679999999999999999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.70 Aligned_cols=203 Identities=29% Similarity=0.426 Sum_probs=163.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++++.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 36899999999999999999987 477899999976542 222356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 582 EFLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~-----~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
||++ ++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9997 59999986542 45899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 444444456899999999999864 689999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.34 Aligned_cols=208 Identities=28% Similarity=0.423 Sum_probs=174.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc-
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~- 576 (716)
..+.++|++.+.||+|+||.||++.+ .++.||||+++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 34568999999999999999999997 566899999987544 34566788999999999999999999999876654
Q ss_pred ---eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 577 ---LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 577 ---~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
.|+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 399999999999999997654 6999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 654 LKHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 654 ~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 225 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 654322 1223446899999999999999999999999999999999999999876643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=329.66 Aligned_cols=203 Identities=24% Similarity=0.413 Sum_probs=180.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|++.+.||+|+||.||+|.+ .++.||+|++.... ......+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 457899999999999999999998 46779999987653 33345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc--CCcEEEEecCCCcccccC
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 658 (716)
||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999876667999999999999999999999999 999999999999974 477999999999876543
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 205 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 205 EI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp SC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 22 2234799999999999999999999999999999999999999987664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.16 Aligned_cols=205 Identities=26% Similarity=0.380 Sum_probs=175.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|+++++||+|+||.||+|.+. ++.||||++............+.+|+.+++.++||||+++++++...+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 478999999999999999999984 778999999877666666778889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999998998888654 46999999999999999999999999 999999999999999999999999999876654444
Q ss_pred cccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 445689999999999976 66799999999999999999999999876643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=337.36 Aligned_cols=203 Identities=28% Similarity=0.334 Sum_probs=162.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-----CC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQ 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-----~~ 575 (716)
+.++|+++++||+|+||+||+|.+ .++.||||++............+.+|+.+|+.++|||||++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 347899999999999999999987 46789999997765566667889999999999999999999999843 35
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred eEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 789999999 56999999764 46999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCc---------------------------cccccCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHc-------
Q 005054 656 HETY---------------------------LTTKTGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELAT------- 700 (716)
Q Consensus 656 ~~~~---------------------------~~~~~~~Gt~~Y~aPE~~-~~~~~~~~sDIwSlG~ll~ellt------- 700 (716)
.... ......+||+.|+|||++ .+..++.++|||||||+||+|++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 4221 122345789999999986 56678999999999999999999
Q ss_pred ----CCCCCCCCC
Q 005054 701 ----EKIPWDNLN 709 (716)
Q Consensus 701 ----G~~PF~~~~ 709 (716)
|++||.+.+
T Consensus 287 ~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 287 YHADRGPLFPGSS 299 (458)
T ss_dssp SGGGCCCSCC---
T ss_pred ccccccccCCCCc
Confidence 677776544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=310.03 Aligned_cols=206 Identities=33% Similarity=0.615 Sum_probs=182.7
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEcCC-eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+++..++|++.+.||+|+||.||++.+.+. .||+|+++...... ..+.+|+.+++.++||||+++++++.....+|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 456678999999999999999999988654 69999998765544 45788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999887667999999999999999999999999 999999999999999999999999999865443
Q ss_pred c-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 659 Y-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 659 ~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
. .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 2 22334456788999999999899999999999999999999 9999986654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.18 Aligned_cols=206 Identities=24% Similarity=0.377 Sum_probs=169.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCC--c
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--R 576 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~--~ 576 (716)
.+.++|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+|+.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4568999999999999999999987 4778999998766556666778889999999997 999999999997544 6
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+|||||+ ++|..++... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 899999996 5999999764 5899999999999999999999999 9999999999999999999999999997543
Q ss_pred cC---------------------ccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 657 ET---------------------YLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 657 ~~---------------------~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 21 112234579999999999987 678999999999999999999999998876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=323.66 Aligned_cols=205 Identities=33% Similarity=0.485 Sum_probs=175.7
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC---
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--- 575 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~--- 575 (716)
.+.+..++|++.++||+|+||.||+|.+.++.||||+++... .......+|+.+|+.++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred ccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 344556899999999999999999999999999999996543 23345566899999999999999999998754
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEEcCCCCCcEEEccCCcE
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC----------NPPIIHRDLKSSNLLVDKHWTV 644 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~----------~~~IvHrDIKp~NILl~~~~~v 644 (716)
.+|+|||||++++|.+++... .+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCE
T ss_pred ceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeE
Confidence 369999999999999999764 499999999999999999999998 8 9999999999999999999
Q ss_pred EEEecCCCcccccCcc--ccccCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 645 KVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNE-----PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 645 kL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~-----~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999976543322 23345799999999999874 345688999999999999999999986543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=313.38 Aligned_cols=208 Identities=31% Similarity=0.571 Sum_probs=181.1
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcCC-eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..|++..++|++.+.||+|+||.||++.+.+. .||||+++...... ..+.+|+.+++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 45567778999999999999999999988654 69999998765544 457889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+||||+++++|.+++......+++..++.++.||+.+|.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999876667999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 657 ETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 657 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 332 22233457888999999999999999999999999999998 9999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.57 Aligned_cols=205 Identities=22% Similarity=0.413 Sum_probs=176.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC--ce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~--~~ 577 (716)
...++|++.++||+|+||.||+|.+. ++.||||+++...... ....+.+|+.+|+.++||||+++++++.... .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34578999999999999999999985 7789999997644321 2456678999999999999999999987655 78
Q ss_pred EEEEeecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE----ccCCcEEEEecCC
Q 005054 578 CIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGl 651 (716)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999997643 23899999999999999999999999 9999999999999 7778899999999
Q ss_pred CcccccCccccccCCCCCCccCccccc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+........ .....||+.|+|||++. +..++.++|||||||++|+|++|+.||.....
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 163 ARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp CEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred ceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 987654432 23457999999999986 57788999999999999999999999976543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=311.43 Aligned_cols=206 Identities=31% Similarity=0.627 Sum_probs=183.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--CceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~~ 578 (716)
++..++|++.+.||+|+||.||++.+.++.||||+++...........+.+|+.+++.++||||+++++++... ..++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 45568999999999999999999999999999999988777777778899999999999999999999999877 7889
Q ss_pred EEEeecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~-~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+++..|+||||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999999987543 58999999999999999999999877799999999999999999999999998764332
Q ss_pred CccccccCCCCCCccCcccccCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDE---KSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~---~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....||+.|+|||++.+..++. ++|||||||++|+|++|+.||...+..
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 217 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence 2346899999999998876544 799999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=325.00 Aligned_cols=202 Identities=31% Similarity=0.536 Sum_probs=177.2
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|.+.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 357899999999999999999998 57789999987543211 123467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+ +++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 779999887653 5999999999999999999999999 9999999999999999999999999998665443
Q ss_pred cccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 2335689999999999998876 689999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=321.70 Aligned_cols=210 Identities=29% Similarity=0.536 Sum_probs=183.6
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEece
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~ 570 (716)
..+++..++|++.+.||+|+||.||++.+.+ ..||||+++... .......+.+|+.+++.++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456778899999999999999999999864 579999987643 45566788999999999999999999999
Q ss_pred eccCCceEEEEeecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 005054 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPII 627 (716)
Q Consensus 571 ~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~Iv 627 (716)
+...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iv 196 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 196 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 999999999999999999999997642 56899999999999999999999999 99
Q ss_pred EcCCCCCcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 005054 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 704 (716)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~P 704 (716)
||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999987643322 22234568899999999999999999999999999999999 9999
Q ss_pred CCCCCc
Q 005054 705 WDNLNS 710 (716)
Q Consensus 705 F~~~~~ 710 (716)
|...+.
T Consensus 277 ~~~~~~ 282 (343)
T 1luf_A 277 YYGMAH 282 (343)
T ss_dssp TTTSCH
T ss_pred CCCCCh
Confidence 987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=325.91 Aligned_cols=201 Identities=28% Similarity=0.426 Sum_probs=172.3
Q ss_pred cceeE--eeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 505 EDLTI--GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 505 ~~y~i--~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..|.+ .+.||+|+||.||+|.+ .+..||+|+++... ......+.+|+.+|+.++||||+++++++...+.+|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 34554 67899999999999987 47789999998654 34456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE--ccCCcEEEEecCCCcccccC
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl--~~~~~vkL~DFGla~~~~~~ 658 (716)
||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9999999999999776667999999999999999999999999 9999999999999 56678999999999876543
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 243 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 243 EK-LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp CB-CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cc-cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 2345799999999999999999999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.49 Aligned_cols=214 Identities=29% Similarity=0.520 Sum_probs=182.9
Q ss_pred CccccchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeE
Q 005054 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLL 566 (716)
Q Consensus 495 ~~~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~ 566 (716)
.....|++..++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|+.+|+.+ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 334567888899999999999999999999853 2569999997643 345567789999999999 7999999
Q ss_pred EeceeccCCc-eEEEEeecCCCCHHHHHhhcCC-----------------------------------------------
Q 005054 567 FMGAVTSPQR-LCIVTEFLPRGSLFRLLQRNTT----------------------------------------------- 598 (716)
Q Consensus 567 ~~~~~~~~~~-~~lVmE~~~ggsL~~~l~~~~~----------------------------------------------- 598 (716)
+++++...+. +++|||||++++|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 8999999999999999976432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC--
Q 005054 599 ------------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (716)
Q Consensus 599 ------------------~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 658 (716)
.+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1889999999999999999999999 999999999999999999999999999865332
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 223334568899999999999999999999999999999998 99999876643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.38 Aligned_cols=204 Identities=25% Similarity=0.441 Sum_probs=183.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|++.+.||+|+||.||+|.+. +..||+|++............+.+|+.+++.++||||+++++++...+..|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999884 67899999988777777778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc---EEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFGla~~~~~ 657 (716)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999988765 45899999999999999999999999 999999999999986655 99999999976654
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 161 SEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp SCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Ccc-ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 432 2345799999999999999999999999999999999999999976653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=312.88 Aligned_cols=205 Identities=28% Similarity=0.483 Sum_probs=160.4
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|++.+.||+|+||.||++.+ .++.||||++...... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999997 5778999998754321 12246788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999999887678999999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 34456789999999999999999999999999999999999999986553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=337.71 Aligned_cols=202 Identities=29% Similarity=0.420 Sum_probs=172.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------ 574 (716)
+.++|+++++||+|+||+||+|.+ .++.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999988 467899999987665666778889999999999999999999998655
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+||||||+++ +|.+.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 356999999965 67777743 3899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..... .....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+..
T Consensus 214 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~ 269 (464)
T 3ttj_A 214 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 269 (464)
T ss_dssp ---CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65432 233568999999999999999999999999999999999999999987644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.56 Aligned_cols=210 Identities=33% Similarity=0.575 Sum_probs=184.4
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC---------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEE
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~ 567 (716)
..+++..++|.+.++||+|+||.||+|.+.+ ..||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3457778899999999999999999998743 359999987653 455667889999999999 89999999
Q ss_pred eceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC
Q 005054 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (716)
Q Consensus 568 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK 632 (716)
++++...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 999999999999999999999999998754 35899999999999999999999999 9999999
Q ss_pred CCcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 633 SSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654332 22334467889999999999999999999999999999999 999998765
Q ss_pred c
Q 005054 710 S 710 (716)
Q Consensus 710 ~ 710 (716)
.
T Consensus 299 ~ 299 (382)
T 3tt0_A 299 V 299 (382)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.02 Aligned_cols=204 Identities=27% Similarity=0.423 Sum_probs=179.8
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-----CCceeEEecee
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----HPNVLLFMGAV 571 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-----hpnIv~~~~~~ 571 (716)
....+.++|++.++||+|+||.||+|.+ .++.||||+++.. ......+..|+.+++.+. ||||+++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3356678999999999999999999998 5678999998642 344566778999999986 99999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc----------
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---------- 640 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---------- 640 (716)
...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccch
Confidence 9999999999999 889999998654 45899999999999999999999999 999999999999975
Q ss_pred ---------------CCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005054 641 ---------------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705 (716)
Q Consensus 641 ---------------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF 705 (716)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 788999999999865443 23457899999999999999999999999999999999999999
Q ss_pred CCCCcc
Q 005054 706 DNLNSM 711 (716)
Q Consensus 706 ~~~~~l 711 (716)
...+..
T Consensus 260 ~~~~~~ 265 (360)
T 3llt_A 260 RTHEHM 265 (360)
T ss_dssp CCSSHH
T ss_pred CCCcHH
Confidence 876643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.67 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=175.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++++.||+|+||.||++.+ .++.||||++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999988 477899999876543 223356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC--c
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~ 659 (716)
|||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999998754 45999999999999999999999999 999999999999999999999999999764322 2
Q ss_pred cccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 22335689999999999988776 6789999999999999999999986654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.36 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=179.1
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
.|...+.||+|+||.||+|.+ .++.||||++....... ...+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 488888999999999999998 47889999997654322 45678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 9999999998753 5999999999999999999999999 99999999999999999999999999987655444445
Q ss_pred cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 668999999999999999999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=317.19 Aligned_cols=203 Identities=23% Similarity=0.243 Sum_probs=173.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
+.+.++|++.++||+|+||+||+|.+. ++.||||++...............|+..+..+ +||||+++++++...+.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 445578999999999999999999984 77899999876655555555555666666555 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999999 67999999887778999999999999999999999999 99999999999999999999999999876654
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 210 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 210 AGA-GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred CCC-CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 332 334579999999999887 6899999999999999999997666543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=311.38 Aligned_cols=209 Identities=33% Similarity=0.570 Sum_probs=171.3
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
.++++..++|++.+.||+|+||.||+|.+.. ..||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3467778899999999999999999998742 348999876543 4556678899999999999999999999985
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC----
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccc
Confidence 56789999999999999999877767999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 653 RLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 653 ~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 8654432 12234457889999999999999999999999999999997 9999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.74 Aligned_cols=210 Identities=32% Similarity=0.551 Sum_probs=184.4
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..|++..++|++.+.||+|+||.||+|.+. ++.||||+++.. ........+.+|+.+|+.++||||+++++++...+
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 356677789999999999999999999984 778999998754 34555667889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+||||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999999999877667999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCccccc--cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 656 HETYLTTK--TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~~~~--~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
........ ...+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 44322211 1234678999999999899999999999999999998 9999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.40 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=170.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~------ 575 (716)
.++|++.+.||+|+||.||+|.+ .++.||||+++... .....+.+.+|+.+|+.++||||++++++|....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 47899999999999999999998 47789999997654 2334577889999999999999999999885433
Q ss_pred ---------------------------------------------------ceEEEEeecCCCCHHHHHhhcC--CCCCH
Q 005054 576 ---------------------------------------------------RLCIVTEFLPRGSLFRLLQRNT--TKLDW 602 (716)
Q Consensus 576 ---------------------------------------------------~~~lVmE~~~ggsL~~~l~~~~--~~l~~ 602 (716)
.+|+|||||++++|.+++.... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3799999999999999998654 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc------------cccccCCCCCC
Q 005054 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY------------LTTKTGKGTPQ 670 (716)
Q Consensus 603 ~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~------------~~~~~~~Gt~~ 670 (716)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 678999999999999999999 9999999999999999999999999998655432 22234579999
Q ss_pred ccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 671 Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999988764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=313.27 Aligned_cols=203 Identities=33% Similarity=0.549 Sum_probs=174.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS- 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~- 573 (716)
++..++|+++++||+|+||.||++.+ .++.||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 44568999999999999999999985 4567999998754 35556788999999999999999999998854
Q ss_pred -CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 574 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 574 -~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
...+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999999887667999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 653 RLKHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 653 ~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
....... .......+++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 8654332 122234577789999999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.80 Aligned_cols=198 Identities=27% Similarity=0.467 Sum_probs=155.5
Q ss_pred ccceeEe---eeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCce
Q 005054 504 WEDLTIG---EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~---~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~ 577 (716)
.++|++. +.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 4567775 78999999999999984 6789999987542 355678999999996 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---cEEEEecCCCcc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRL 654 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~---~vkL~DFGla~~ 654 (716)
|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999999875 46999999999999999999999999 99999999999998765 899999999987
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 6655444556688999999999999999999999999999999999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=342.14 Aligned_cols=205 Identities=24% Similarity=0.357 Sum_probs=181.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+..++|++.+.||+|+||.||+|.+ .++.||||++.+.... ......+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4457899999999999999999998 4778999999764321 122356778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
||||||+|++|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999997643 34999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 339 ~~~-~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 339 GQT-IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TCC-EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred Ccc-ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 332 234589999999999999999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.43 Aligned_cols=205 Identities=24% Similarity=0.358 Sum_probs=168.2
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..++|++.++||+|+||.||++.+ .++.||||+++...........+.+|+.+|+.++||||+++++++.....+|||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 347899999999999999999987 466899999987665555566778999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-----cCCcEEEEecCCCccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-----KHWTVKVGDFGLSRLK 655 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-----~~~~vkL~DFGla~~~ 655 (716)
|||+++ +|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+ ..+.+||+|||++...
T Consensus 112 ~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999965 9999997754 5999999999999999999999999 99999999999994 4556999999999876
Q ss_pred ccCccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 244 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 54444444567899999999998754 799999999999999999999999876643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=326.10 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=164.6
Q ss_pred cccceeEe-eeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHH-hcCCCceeEEeceecc----C
Q 005054 503 LWEDLTIG-EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMK-RLRHPNVLLFMGAVTS----P 574 (716)
Q Consensus 503 ~~~~y~i~-~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~-~l~hpnIv~~~~~~~~----~ 574 (716)
..++|.+. +.||+|+||+||++.+. ++.||||+++.. ..+.+|+.++. ..+||||++++++|.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 45678776 78999999999999984 677999998642 34567888774 4589999999998875 5
Q ss_pred CceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFG 650 (716)
..+|||||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence 67899999999999999998653 46999999999999999999999999 999999999999987 7889999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 210 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred cccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 998654332 233568999999999999999999999999999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.44 Aligned_cols=201 Identities=30% Similarity=0.453 Sum_probs=166.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..++|++.+.||+|+||.||++.+ .++.||||++....... ..+.+|+.+++.++||||+++++++.....+|+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 347899999999999999999998 46789999997654333 4567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc--EEEEecCCCcccccC
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHET 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~--vkL~DFGla~~~~~~ 658 (716)
||||++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||+++.....
T Consensus 95 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 95 MEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999997644 5999999999999999999999999 999999999999987665 999999998754332
Q ss_pred ccccccCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEK-SDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.
T Consensus 172 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 172 S-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred C-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 2 2234579999999999998888665 8999999999999999999987554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.36 Aligned_cols=202 Identities=26% Similarity=0.412 Sum_probs=168.9
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++++.||+|+||.||+|.+. ++.||||+++.... ......+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 68999999999999999999984 67899999865432 1112234568999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
|++ ++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 996 5999999887778999999999999999999999999 9999999999999999999999999998665544444
Q ss_pred ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 45678999999999877 5679999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.96 Aligned_cols=209 Identities=32% Similarity=0.555 Sum_probs=183.1
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~ 571 (716)
.+++..++|.+.+.||+|+||.||++.+. +..||||+++... .......+.+|+.+|+.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 45667789999999999999999999872 2569999987543 455667889999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEE
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~-----------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvH 628 (716)
...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 99999999999999999999997643 23889999999999999999999999 999
Q ss_pred cCCCCCcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 005054 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPW 705 (716)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF 705 (716)
|||||+|||++.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998654332 22334467889999999999999999999999999999999 99999
Q ss_pred CCCCc
Q 005054 706 DNLNS 710 (716)
Q Consensus 706 ~~~~~ 710 (716)
...+.
T Consensus 254 ~~~~~ 258 (314)
T 2ivs_A 254 PGIPP 258 (314)
T ss_dssp TTCCG
T ss_pred CCCCH
Confidence 87654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.14 Aligned_cols=210 Identities=30% Similarity=0.517 Sum_probs=179.7
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~ 569 (716)
..+++..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+|+.+ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 456778899999999999999999999872 3369999997543 233456788999999999 8999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTT----------------------KLDWRRRILMALDIARGVSYLHHCNPPII 627 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~~----------------------~l~~~~v~~i~~ql~~aL~yLH~~~~~Iv 627 (716)
++...+.+|+||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 99999999999999999999999976543 3789999999999999999999999 99
Q ss_pred EcCCCCCcEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 005054 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 704 (716)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~P 704 (716)
||||||+||||+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999976543321 2223457889999999999999999999999999999998 9999
Q ss_pred CCCCCc
Q 005054 705 WDNLNS 710 (716)
Q Consensus 705 F~~~~~ 710 (716)
|.....
T Consensus 275 ~~~~~~ 280 (344)
T 1rjb_A 275 YPGIPV 280 (344)
T ss_dssp STTCCC
T ss_pred cccCCc
Confidence 987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=324.91 Aligned_cols=206 Identities=19% Similarity=0.286 Sum_probs=171.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHH----HH-----HHHHHHHHHHHhcCCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDE----VI-----HSFRQEVSLMKRLRHPNV 564 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~----~~-----~~~~~E~~iL~~l~hpnI 564 (716)
+...++|++.++||+|+||.||+|.+. ++.||||++........ .. ..+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456679999999999999999999884 35799999876532110 00 123345566777889999
Q ss_pred eEEeceeccC----CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-
Q 005054 565 LLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD- 639 (716)
Q Consensus 565 v~~~~~~~~~----~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~- 639 (716)
+++++++... ...||||||| +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998765 4589999999 99999999887678999999999999999999999999 99999999999999
Q ss_pred -cCCcEEEEecCCCcccccCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 640 -KHWTVKVGDFGLSRLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 640 -~~~~vkL~DFGla~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 889999999999976543221 1123459999999999999999999999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.18 Aligned_cols=201 Identities=29% Similarity=0.433 Sum_probs=173.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----- 575 (716)
+.++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999998 4778999999776556666788899999999999999999999997653
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 8899999976 35999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 178 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 232 (367)
T 1cm8_A 178 ADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232 (367)
T ss_dssp CCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5443 234578999999999987 67899999999999999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=350.15 Aligned_cols=207 Identities=26% Similarity=0.428 Sum_probs=181.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~ 576 (716)
.+..++|++++.||+|+||.||++.+. ++.||||++++... .......+..|..+|..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 445679999999999999999999984 55799999986422 122345677889999987 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+||||||+++++|..++.+.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999998754 6999999999999999999999999 9999999999999999999999999998655
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.........+||+.|+|||++.+..|+.++|||||||+||+|++|+.||...+.
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 444455577899999999999999999999999999999999999999987664
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=306.90 Aligned_cols=205 Identities=28% Similarity=0.395 Sum_probs=183.9
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
...++|.+.+.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45578999999999999999999985 66799999977643 3456678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999998764 36899999999999999999999999 999999999999999999999999999876544
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 444445679999999999999999999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=317.53 Aligned_cols=211 Identities=30% Similarity=0.481 Sum_probs=166.4
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcCC-----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
.+.+..++|++.+.||+|+||.||+|.+... .||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 4456678999999999999999999986432 69999998765555667889999999999999999999999987
Q ss_pred CCce------EEEEeecCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC
Q 005054 574 PQRL------CIVTEFLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 574 ~~~~------~lVmE~~~ggsL~~~l~~~~-----~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~ 642 (716)
.... ++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTS
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCC
Confidence 7655 99999999999999996532 25899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 643 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 643 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 99999999997654332 12223457889999999999999999999999999999999 99999876654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.96 Aligned_cols=205 Identities=34% Similarity=0.608 Sum_probs=179.8
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-ce
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RL 577 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~-~~ 577 (716)
.|++..++|++.+.||+|+||.||++.+.++.||||+++... ..+.+.+|+.+|+.++||||+++++++.... .+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 456778899999999999999999999999999999997654 2356788999999999999999999976654 79
Q ss_pred EEEEeecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~-~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
|||||||++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999999987654 3799999999999999999999999 9999999999999999999999999998543
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
... ....+++.|+|||++.+..++.++|||||||+||+|++ |..||...+..+
T Consensus 341 ~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 341 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred ccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 321 23367899999999999999999999999999999998 999998776543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.89 Aligned_cols=206 Identities=27% Similarity=0.356 Sum_probs=177.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..++|++.+.||+|+||.||+|.+. ++.||||++............+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4579999999999999999999985 77899999987776677777888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999888887654 346999999999999999999999999 99999999999999999999999999987655444
Q ss_pred ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 44556899999999999876 6789999999999999999999999877643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.13 Aligned_cols=208 Identities=30% Similarity=0.528 Sum_probs=171.6
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
.++...+|.+.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+|+.++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 3556679999999999999999999864 5569999987643 455667899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+.+||||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999999887778999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 655 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 543321 1222345778999999999999999999999999999998 9999987653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=318.08 Aligned_cols=208 Identities=31% Similarity=0.521 Sum_probs=181.1
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
+.+...++|++.+.||+|+||.||++.+. +..||||++..... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34556689999999999999999999974 67899998876543 3356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 578 CIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~---~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999986543 35899999999999999999999999 99999999999999999999999999976
Q ss_pred cccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 43321 122334589999999999999999999999999999999999999986554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.71 Aligned_cols=206 Identities=33% Similarity=0.590 Sum_probs=182.7
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|.+..++|++.+.||+|+||.||++.+ .+..||+|++....... +.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 455668999999999999999999998 45679999998765443 56788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999887777999999999999999999999999 999999999999999999999999998865432
Q ss_pred c-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 659 Y-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 659 ~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
. .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 2 22234467889999999999999999999999999999999 9999987553
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.99 Aligned_cols=203 Identities=21% Similarity=0.336 Sum_probs=178.7
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
.++.++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+ +|+||+++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45568899999999999999999996 5778999998754432 3466789999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc-----EEEEecCCC
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLS 652 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~-----vkL~DFGla 652 (716)
|+||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 99999999887777999999999999999999999999 999999999999987765 999999999
Q ss_pred cccccCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 653 RLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 653 ~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 86544321 23455799999999999999999999999999999999999999988653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.67 Aligned_cols=203 Identities=24% Similarity=0.385 Sum_probs=173.9
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC--CceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h--pnIv~~~~~~~~~~~~ 577 (716)
.+..++|++.+.||+|+||.||++.+ .+..||||++............+.+|+.+|+.+.| |||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45568899999999999999999987 45679999998877777777889999999999976 9999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||++ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||++.....
T Consensus 85 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECG-NIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCC-SEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeCC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999954 78999999874 46999999999999999999999999 99999999999997 67899999999986543
Q ss_pred Ccc--ccccCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TYL--TTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~~--~~~~~~Gt~~Y~aPE~~~~-----------~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 322 2234579999999999865 67888999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.01 Aligned_cols=197 Identities=26% Similarity=0.448 Sum_probs=173.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~l 579 (716)
+.++|++.+.||+|+||.||+|.+. ++.||||+++..... ..+|+.+|.++ +||||+++++++.+...+|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4578999999999999999999984 667999999875432 23577888877 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC----CcEEEEecCCCccc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLK 655 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~----~~vkL~DFGla~~~ 655 (716)
|||||++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||+... +.+||+|||++...
T Consensus 94 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999764 46999999999999999999999999 9999999999998543 35999999999876
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 55544455678999999999999888899999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.04 Aligned_cols=210 Identities=29% Similarity=0.489 Sum_probs=183.8
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~ 569 (716)
..+++..++|++.+.||+|+||.||++.+. +..||||+++... .......+.+|+.+|+.+ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 456777899999999999999999999862 3569999997653 344567889999999999 9999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTT-----------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~~-----------------~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK 632 (716)
++...+..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 99999999999999999999999986543 4899999999999999999999999 9999999
Q ss_pred CCcEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 633 SSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999986554322 2223457889999999999999999999999999999999 999998765
Q ss_pred c
Q 005054 710 S 710 (716)
Q Consensus 710 ~ 710 (716)
.
T Consensus 253 ~ 253 (313)
T 1t46_A 253 V 253 (313)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.56 Aligned_cols=206 Identities=41% Similarity=0.697 Sum_probs=169.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCC--HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
++..++|++.+.||+|+||.||++.+.+..||||+++..... ....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 345679999999999999999999999999999998764332 233567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEEcCCCCCcEEEcc--------CCcEEEEec
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGDF 649 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~-~IvHrDIKp~NILl~~--------~~~vkL~DF 649 (716)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++. +|+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999964 469999999999999999999999873 3889999999999985 678999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|++........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 161 g~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 161 GLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred Ccccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99976554322 245789999999999999999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=324.70 Aligned_cols=207 Identities=28% Similarity=0.458 Sum_probs=178.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
++..++|++++.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 455689999999999999999999853 3469999986533 44555678889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---cE
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TV 644 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~---~v 644 (716)
....|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999998653 35899999999999999999999999 99999999999998554 59
Q ss_pred EEEecCCCcccccC--ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 645 KVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 645 kL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999754221 122234467999999999999999999999999999999998 9999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.43 Aligned_cols=200 Identities=36% Similarity=0.614 Sum_probs=168.6
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHh--cCCCceeEEeceecc----C
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTS----P 574 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~--l~hpnIv~~~~~~~~----~ 574 (716)
..+.++|++.+.||+|+||.||++.+.++.||||++.... ...+.+|.+++.. ++||||+++++++.. .
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 3456899999999999999999999999999999986542 2344556666666 799999999998643 3
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEEcCCCCCcEEEccCCcEEE
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVKV 646 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH--------~~~~~IvHrDIKp~NILl~~~~~vkL 646 (716)
..+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +++ |+||||||+|||++.++.+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred ceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence 568999999999999999964 35999999999999999999999 888 999999999999999999999
Q ss_pred EecCCCcccccCccc----cccCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcC----------CCCCC
Q 005054 647 GDFGLSRLKHETYLT----TKTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELATE----------KIPWD 706 (716)
Q Consensus 647 ~DFGla~~~~~~~~~----~~~~~Gt~~Y~aPE~~~~~------~~~~~sDIwSlG~ll~elltG----------~~PF~ 706 (716)
+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999764433221 2234799999999999877 345689999999999999999 88987
Q ss_pred CCC
Q 005054 707 NLN 709 (716)
Q Consensus 707 ~~~ 709 (716)
...
T Consensus 235 ~~~ 237 (301)
T 3q4u_A 235 DVV 237 (301)
T ss_dssp TTS
T ss_pred ccC
Confidence 643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=305.88 Aligned_cols=208 Identities=32% Similarity=0.541 Sum_probs=180.9
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc---
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--- 573 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--- 573 (716)
........|++.+.||+|+||.||+|.+. +..||+|++............+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred hcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 33445567999999999999999999984 5579999998877777778889999999999999999999998864
Q ss_pred -CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-cCCcEEEEecCC
Q 005054 574 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGL 651 (716)
Q Consensus 574 -~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGl 651 (716)
...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++.+|+|+||||+|||++ .++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 35689999999999999999764 458999999999999999999999876799999999999997 788999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+........ ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....
T Consensus 179 ~~~~~~~~~--~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 179 ATLKRASFA--KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp GGGCCTTSB--EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred ccccccccc--ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 976544322 24578999999998875 488999999999999999999999987554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.49 Aligned_cols=205 Identities=26% Similarity=0.413 Sum_probs=180.7
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
.+.++|++.+.||+|+||.||++.+. +..||||+++...... .....+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 44578999999999999999999984 6789999997654322 12467889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC----cEEEEecCC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 651 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGl 651 (716)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999999764 46899999999999999999999999 99999999999999887 799999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 98665432 22345799999999999999999999999999999999999999987553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=325.54 Aligned_cols=201 Identities=26% Similarity=0.335 Sum_probs=171.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-----
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----- 574 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~----- 574 (716)
.+.++|++.+.||+|+||.||+|.+. ++.||||+++...........+.+|+.+|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 34589999999999999999999984 56799999987655666678899999999999999999999999766
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 56899999995 5999999764 46999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCcc----------------------ccccCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 655 KHETYL----------------------TTKTGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 655 ~~~~~~----------------------~~~~~~Gt~~Y~aPE~~-~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
...... .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543321 12456899999999986 56668999999999999999998555543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.83 Aligned_cols=206 Identities=30% Similarity=0.362 Sum_probs=170.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC---HHHHHHHHHHHHHHHhc---CCCceeEEeceecc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS 573 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~E~~iL~~l---~hpnIv~~~~~~~~ 573 (716)
+..++|++.++||+|+||.||+|.+ .++.||||+++..... ......+.+|+.+++.+ .||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999996 5778999998754321 11113445566666655 59999999999876
Q ss_pred CC-----ceEEEEeecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEE
Q 005054 574 PQ-----RLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (716)
Q Consensus 574 ~~-----~~~lVmE~~~ggsL~~~l~~~~~-~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~ 647 (716)
.. .+++||||+. ++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 54 4799999996 599999987543 3899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 648 DFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 648 DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 163 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 163 DFGLARIYSYQMA-LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp SCSCTTTSTTCCC-SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred eCccccccCCCcc-cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999986554332 23457899999999999999999999999999999999999999876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=309.32 Aligned_cols=202 Identities=31% Similarity=0.488 Sum_probs=174.4
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP- 574 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~- 574 (716)
...++|++.+.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3356799999999999999999984 466799999876532 23346788999999999999999999999876
Q ss_pred -CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 575 -~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
..+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence 6689999999999999999877778999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 654 LKHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 654 ~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 655432 22334568889999999999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=332.82 Aligned_cols=206 Identities=31% Similarity=0.586 Sum_probs=181.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
....++|.+++.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+|+.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34457899999999999999999998 47889999997643211 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+|||||++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999999764 46999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp TC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred cc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 32 2335689999999999998876 6899999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.91 Aligned_cols=204 Identities=35% Similarity=0.622 Sum_probs=175.7
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH--HHH---HHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD--EVI---HSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~---~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
+..++|++.+.||+|+||.||++.+ .++.||||++....... ... +.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3457899999999999999999998 57789999987654322 111 6788999999999999999999999765
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc-----EEEEec
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDF 649 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~-----vkL~DF 649 (716)
. ++||||+++++|.+++......+++..++.++.||+.||.|||+++.+|+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 799999999999999987777899999999999999999999998766999999999999987776 999999
Q ss_pred CCCcccccCccccccCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|++...... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.
T Consensus 174 g~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 174 GLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp TTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred Ccccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 999754442 33457999999999984 55578899999999999999999999987653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=317.63 Aligned_cols=202 Identities=34% Similarity=0.495 Sum_probs=178.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..+.|++.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.+|+.++||||+++++++...+..|+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 346799999999999999999997 5678999999866443 3455778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
||||+. |+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 999996 5898888776678999999999999999999999999 999999999999999999999999999765432
Q ss_pred cccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 660 LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 259 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 2457999999999985 567889999999999999999999999876643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.90 Aligned_cols=202 Identities=28% Similarity=0.408 Sum_probs=169.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----- 575 (716)
+.++|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 457999999999999999999987 4667999999876666666788889999999999999999999987665
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|+|||||++ +|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 68999999965 78888853 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 177 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 232 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 55432 223457999999999999999999999999999999999999999887643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.66 Aligned_cols=204 Identities=32% Similarity=0.540 Sum_probs=176.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+..++|++.+.||+|+||.||++.+. +..||||++....... .....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 44579999999999999999999984 4569999987643221 22456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999999765 45899999999999999999999999 999999999999999999999999988655443
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 163 R--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred c--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 2 2345789999999999999999999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=321.36 Aligned_cols=203 Identities=23% Similarity=0.382 Sum_probs=174.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC--CCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~--hpnIv~~~~~~~~~~~~~ 578 (716)
+...+|++++.||+|+||.||++.+. +..||||++............+.+|+.+|+.+. ||||+++++++...+.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34567999999999999999999874 667999999887767777888999999999996 599999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
|||| +.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 45889999998754 6899999999999999999999999 99999999999995 579999999999865433
Q ss_pred c--cccccCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 659 Y--LTTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 659 ~--~~~~~~~Gt~~Y~aPE~~~~-----------~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
. ......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 2 12335579999999999876 368889999999999999999999998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.14 Aligned_cols=210 Identities=35% Similarity=0.562 Sum_probs=182.5
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEece
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~ 570 (716)
..+++..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 355777889999999999999999999864 4579999987543 34455678899999999999999999999
Q ss_pred eccCCceEEEEeecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 571 ~~~~~~~~lVmE~~~ggsL~~~l~~~~---------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
+...+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 999999999999999999999997532 45789999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 642 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 999999999997654332 22234457889999999999999999999999999999999 8999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=312.05 Aligned_cols=209 Identities=31% Similarity=0.568 Sum_probs=182.3
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEE
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~ 567 (716)
..|++..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 345677789999999999999999999863 4569999987543 455567888999999999 89999999
Q ss_pred eceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC
Q 005054 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (716)
Q Consensus 568 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK 632 (716)
++++...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 999999999999999999999999997643 24889999999999999999999999 9999999
Q ss_pred CCcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 633 SSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999998654432 22334467889999999999999999999999999999999 999998765
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=319.22 Aligned_cols=207 Identities=26% Similarity=0.320 Sum_probs=173.7
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH---HHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~---~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
...++|++.+.||+|+||.||+|.+. ++.||||+++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999884 6789999987543221 223467789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+||||+++ +|..++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 9999999976 899999877777999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 554444566899999999999764 4789999999999999999999999876643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.31 Aligned_cols=204 Identities=29% Similarity=0.489 Sum_probs=177.0
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+...++|++.+.||+|+||.||++.+. ++.||||++..... ...+.+|+.+++.++||||+++++++...+.+|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345678999999999999999999985 77899999986543 245778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999999866678999999999999999999999999 999999999999999999999999999876655
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 230 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4444566799999999999999999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.81 Aligned_cols=201 Identities=28% Similarity=0.421 Sum_probs=176.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|++.+.||+|+||.||++.+. +..||+|++....... ...+.+|+.+++.++||||+++++++.....+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 3478999999999999999999985 4579999987654332 46788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE---ccCCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~ 657 (716)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 85 MELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999998765 35899999999999999999999999 9999999999999 7788999999999976554
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+.
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 162 GK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp TS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 33 23355799999999998765 88999999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.13 Aligned_cols=204 Identities=23% Similarity=0.315 Sum_probs=175.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-------- 573 (716)
.++|+++++||+|+||.||+|.+ .++.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47899999999999999999998 46789999987665444334567789999999999999999999876
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
.+.+|+||||+++ +|...+......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 3468999999965 888888776677999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccC----ccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 654 LKHET----YLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~----~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 65421 122234578999999999976 4579999999999999999999999987653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.39 Aligned_cols=205 Identities=27% Similarity=0.373 Sum_probs=164.6
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
+++..++|++.+.||+|+||.||++.+ .++.||||+++...........+.++..+++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356678999999999999999999998 677899999977654444455556666678888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 578 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
|+||||+++ +|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999964 88877754 456799999999999999999999997 8 9999999999999999999999999998
Q ss_pred ccccCccccccCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVL----RNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 159 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 159 YLVDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccccccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 6654432 2244799999999996 5667889999999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.25 Aligned_cols=205 Identities=28% Similarity=0.537 Sum_probs=170.7
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCe----EEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~----vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
+..++|++.++||+|+||.||+|.+. +.. ||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 34578999999999999999999873 333 5777765432 233456788999999999999999999999875
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
..++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 478999999999999999887778999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 656 HETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 4332 22233457889999999999999999999999999999999 9999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.36 Aligned_cols=210 Identities=30% Similarity=0.438 Sum_probs=174.3
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC---CHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
...+.++|++.+.||+|+||.||++.+ .+..||+|++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345668999999999999999999988 456799999876432 234567889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhc---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRN---------------------------------------TTKLDWRRRILMALDIARG 615 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~---------------------------------------~~~l~~~~v~~i~~ql~~a 615 (716)
+.+|+|||||++++|.+++... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521 1123577888999999999
Q ss_pred HHHHHhCCCCeEEcCCCCCcEEEccCC--cEEEEecCCCcccccC----ccccccCCCCCCccCcccccC--CCCCchhH
Q 005054 616 VSYLHHCNPPIIHRDLKSSNLLVDKHW--TVKVGDFGLSRLKHET----YLTTKTGKGTPQWMAPEVLRN--EPSDEKSD 687 (716)
Q Consensus 616 L~yLH~~~~~IvHrDIKp~NILl~~~~--~vkL~DFGla~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~sD 687 (716)
|.|||+++ |+||||||+|||++.++ .+||+|||++...... ........||+.|+|||++.+ ..++.++|
T Consensus 181 l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 181 LHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 99999999 99999999999998766 8999999999754321 112335579999999999975 67889999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 688 VYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 688 IwSlG~ll~elltG~~PF~~~~~l 711 (716)
||||||++|+|++|+.||...+..
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~ 282 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDA 282 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChH
Confidence 999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.14 Aligned_cols=204 Identities=26% Similarity=0.446 Sum_probs=177.0
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
+.++|++.+.||+|+||.||++.+. ++.||+|+++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4578999999999999999999984 7789999998754322 124678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC----cEEEEecCCC
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLS 652 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGla 652 (716)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++ .+||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999999764 46899999999999999999999999 99999999999998776 8999999999
Q ss_pred cccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
........ .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 160 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 160 HKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp EECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eeccCCCc-ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 86554322 2345789999999999999999999999999999999999999987653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=303.61 Aligned_cols=207 Identities=32% Similarity=0.554 Sum_probs=177.3
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEcCC-----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
+.+..++|++.+.||+|+||.||+|.+.+. .||+|+++... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 455668999999999999999999987432 39999987653 34556788999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4679999999999999999887777999999999999999999999999 99999999999999999999999999886
Q ss_pred cccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 655 KHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
..... .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 54432 22234467889999999999999999999999999999998 9999976543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.52 Aligned_cols=207 Identities=28% Similarity=0.455 Sum_probs=178.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec--cCCceEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRLCI 579 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~--~~~~~~l 579 (716)
.++|++.+.||+|+||.||++.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++. ....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 47899999999999999999998 4678999999887777777788999999999999999999999874 4678999
Q ss_pred EEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 580 VTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~---~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ .+|+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 345899999999999999999999876 339999999999999999999999999987
Q ss_pred ccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.............|++.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 655433223344689999999999999999999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=308.57 Aligned_cols=216 Identities=30% Similarity=0.473 Sum_probs=174.9
Q ss_pred CCccccchhcccceeEeeeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEe
Q 005054 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568 (716)
Q Consensus 494 ~~~~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~ 568 (716)
......+.+..++|.+.+.||+|+||.||+|.+.. ..||||+++...........+.+|+.+++.++||||++++
T Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp -CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 33345566677899999999999999999998743 2699999987766677778899999999999999999999
Q ss_pred ceeccCC-----ceEEEEeecCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE
Q 005054 569 GAVTSPQ-----RLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (716)
Q Consensus 569 ~~~~~~~-----~~~lVmE~~~ggsL~~~l~~-----~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl 638 (716)
+++.... ..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli 180 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCML 180 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEE
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE
Confidence 9988655 35999999999999999853 2356999999999999999999999999 9999999999999
Q ss_pred ccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 639 DKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
+.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 999999999999997654332 22233457889999999999999999999999999999999 99999876643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.76 Aligned_cols=201 Identities=26% Similarity=0.447 Sum_probs=174.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC---------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~ 571 (716)
++..++|++.+.||+|+||.||++.+.. ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4556899999999999999999998743 459999986543 23346788999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc--------
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------- 643 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~-------- 643 (716)
...+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999887666999999999999999999999999 999999999999998877
Q ss_pred EEEEecCCCcccccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcC-CCCCCCCC
Q 005054 644 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATE-KIPWDNLN 709 (716)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG-~~PF~~~~ 709 (716)
+||+|||++....... ...||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+
T Consensus 160 ~kl~Dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp EEECCCCSCTTTSCHH----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred eeeccCcccccccCcc----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 9999999987654332 2346889999999987 7789999999999999999995 56665543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.32 Aligned_cols=204 Identities=27% Similarity=0.463 Sum_probs=168.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|++.+.||+|+||.||++.+ .+..||||+++.... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999997 577899999986443 45667788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 580 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999864 3456899999999999999999999999 9999999999999999999999999988665
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
..........|++.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 5443444557899999999999999999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.68 Aligned_cols=203 Identities=34% Similarity=0.551 Sum_probs=181.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.+.|++++.||+|+||.||+|.+ .++.||||++...... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 36799999999999999999987 4678999999765433 23567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999975 35999999999999999999999999 999999999999999999999999999876655444
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 225 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 225 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH
Confidence 45668999999999999999999999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.67 Aligned_cols=209 Identities=35% Similarity=0.595 Sum_probs=184.1
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
...|++..++|++.+.||+|+||.||++.+. +..||+|++..... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3567788899999999999999999999985 66799999875432 346788899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
..+|+||||+++++|.+++.... ..+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999999998643 45899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 654 LKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 655432 22223356889999999999999999999999999999999 9999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.97 Aligned_cols=209 Identities=32% Similarity=0.518 Sum_probs=176.8
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcCC------eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~------~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
..++..++|.+.+.||+|+||.||+|.+... .||||+++... .......+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3466778999999999999999999987432 49999987543 4555667889999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
..+.++|||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999999999887778999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 653 RLKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 653 ~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 86543321 1223356889999999999999999999999999999999 9999976553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.95 Aligned_cols=204 Identities=26% Similarity=0.434 Sum_probs=177.7
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHH------HHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~------~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
...++|++.+.||+|+||.||++.+ .++.||||+++....... ....+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457999999999999999999987 566799999987643221 23456679999999999999999999999
Q ss_pred CCceEEEEeecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 574 PQRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 574 ~~~~~lVmE~~~gg-sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
.+.+++||||+.++ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 99999999999666 999999764 46999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 178 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 178 AYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp EECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred eECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 87654432 234579999999999998887 789999999999999999999997644
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=332.95 Aligned_cols=203 Identities=33% Similarity=0.517 Sum_probs=176.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|+++++||+|+||.||+|.+. ++.||||++............+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999984 77899999975433222346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc---cCCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~ 657 (716)
||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999998765 36999999999999999999999999 99999999999995 456799999999986554
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.
T Consensus 177 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 177 NT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp C-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 33 2335579999999999986 488999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=330.16 Aligned_cols=209 Identities=34% Similarity=0.592 Sum_probs=184.3
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..|++...+|++.++||+|+||.||+|.+. +..||||+++..... ...+.+|+.+|+.++||||+++++++....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 456777889999999999999999999985 668999999765443 367889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|||||||++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999999864 346899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 655 KHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
..... .......+++.|+|||++.+..++.++|||||||+||+|++ |..||...+..
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 54332 22233456789999999999999999999999999999999 99999887643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.56 Aligned_cols=206 Identities=26% Similarity=0.495 Sum_probs=179.2
Q ss_pred hhcccceeEee-eeecCCcEEEEEEEE----cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 501 EILWEDLTIGE-QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 501 e~~~~~y~i~~-~LG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
.+..++|.+.+ .||+|+||.||+|.+ .+..||||+++... .......+.+|+.+++.++||||+++++++ ..+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 34557888887 999999999999986 35569999997653 455667889999999999999999999999 456
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 799999999999999999877777999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 656 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
..... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 43321 1223457899999999998889999999999999999998 9999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.79 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=180.5
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
++..++|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 455689999999999999999999985 7789999997653 4556678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+||||+++++|.+++.... .+++..++.++.||+.+|.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999997754 589999999999999999999985 8 99999999999999999999999999875533
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 185 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 185 SM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HC------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred cc--ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 234579999999999999999999999999999999999999998755
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.07 Aligned_cols=205 Identities=34% Similarity=0.565 Sum_probs=178.0
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..+...++|++.+.||+|+||.||++.. .++.||||++....... ....+.+|+.+++.++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 4566778999999999999999999986 47789999987653221 123578899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 578 CIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHC---NPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~---~~l~~~~v~~i~~ql~~aL~yLH~~---~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCcc
Confidence 99999999999999997643 3489999999999999999999998 8 99999999999999999999999999
Q ss_pred CcccccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 652 SRLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 652 a~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 98654332 22334569999999999999999999999999999999999999996
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.50 Aligned_cols=205 Identities=24% Similarity=0.387 Sum_probs=174.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCC--CHHHHHHHHHHHHHHHhc-CCCceeEEeceecc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~ 573 (716)
+..++|++.+.||+|+||.||++.. .++.||||+++.... .......+.+|+.+|+.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 3457999999999999999999988 567899999865321 111224456789999999 69999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
...+|||||||++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999997654 6999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccC-ccccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 654 LKHET-YLTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 654 ~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 64332 2223345799999999999863 46889999999999999999999997544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.48 Aligned_cols=193 Identities=22% Similarity=0.400 Sum_probs=170.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceecc--CCceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS--PQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~--~~~~~ 578 (716)
.++|+++++||+|+||.||+|.+ .++.||||+++... ...+.+|+.+|+.+. ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999987 57789999987543 356788999999997 9999999999987 56789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 657 (716)
+||||+++++|.+++.. +++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999999853 889999999999999999999999 99999999999999776 899999999986554
Q ss_pred CccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 184 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 184 GQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 332 335578999999999987 66899999999999999999999999543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=330.31 Aligned_cols=203 Identities=32% Similarity=0.473 Sum_probs=172.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|+++++||+|+||.||+|.+ .+..||||+++...........+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456899999999999999999998 466899999987654443456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~ 657 (716)
||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999988765 45999999999999999999999999 999999999999976 44599999999987654
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.
T Consensus 192 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 192 QK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp TB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 43 2335679999999999864 688999999999999999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=303.15 Aligned_cols=201 Identities=22% Similarity=0.324 Sum_probs=175.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|++.+.||+|+||.||+|.+ .++.||||+++...........+.+|+.++..+ +||||+++++++...+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 347899999999999999999998 478899999987665555567788899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC---------------
Q 005054 580 VTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH--------------- 641 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~--------------- 641 (716)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999764 256899999999999999999999999 9999999999999844
Q ss_pred ----CcEEEEecCCCcccccCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 642 ----WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 642 ----~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..||...+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred cCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 479999999998765432 34689999999999876 55679999999999999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=305.41 Aligned_cols=202 Identities=24% Similarity=0.412 Sum_probs=171.2
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|.+.++||+|+||.||++.+ .+..||+|++...... .....+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 347899999999999999999998 4678999998775432 2246778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE---ccCCcEEEEecCCCcc
Q 005054 581 TEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL 654 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~---~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~ 654 (716)
|||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999988542 467999999999999999999999999 9999999999999 4567899999999976
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||...+
T Consensus 177 ~~~~~~-~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 177 FKSDEH-STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCccc-CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 544322 23557999999999986 467899999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.12 Aligned_cols=204 Identities=31% Similarity=0.522 Sum_probs=175.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH-----------HHHHHHHHHHHHHHhcCCCceeEEe
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-----------EVIHSFRQEVSLMKRLRHPNVLLFM 568 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~-----------~~~~~~~~E~~iL~~l~hpnIv~~~ 568 (716)
.+.++|.++++||+|+||.||+|.+. +..||||+++...... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35688999999999999999999984 5679999997654321 2346788999999999999999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---cEE
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVK 645 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~---~vk 645 (716)
+++.....+|||||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999999765 45999999999999999999999999 99999999999998775 699
Q ss_pred EEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 646 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.
T Consensus 190 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK-LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp ECCCTTCEECCTTSC-BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCEEcCCCCc-cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987654432 335579999999999874 588999999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=328.31 Aligned_cols=208 Identities=32% Similarity=0.571 Sum_probs=181.2
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..+++..++|++.+.||+|+||.||+|.+. +..||||+++..... .+.+.+|+.+|+.++||||+++++++. .+.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 356778899999999999999999999985 567999999865433 467889999999999999999999986 667
Q ss_pred eEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+|||||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999999997542 35889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 656 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
.... .......+++.|+|||++.+..++.++|||||||+||+|++ |+.||...+..
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 4332 12223456789999999999999999999999999999999 99999876643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.85 Aligned_cols=206 Identities=34% Similarity=0.604 Sum_probs=179.4
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.|++..++|++.+.||+|+||.||++.+.+ ..||||+++...... ..+.+|+.+|+.++||||+++++++. .+..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH---HHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 567788999999999999999999999865 479999997655433 56788999999999999999999986 4568
Q ss_pred EEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999997532 25899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 657 ETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 657 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 432 22234457889999999998889999999999999999999 9999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.08 Aligned_cols=210 Identities=30% Similarity=0.472 Sum_probs=161.0
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEecee----
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAV---- 571 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~---- 571 (716)
.+++...+|++.++||+|+||.||++.+ .++.||||++.... ......+.+|+.+++.+. ||||+++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 4455667999999999999999999998 67789999986543 445567889999999995 99999999998
Q ss_pred ----ccCCceEEEEeecCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEE
Q 005054 572 ----TSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (716)
Q Consensus 572 ----~~~~~~~lVmE~~~ggsL~~~l~~--~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vk 645 (716)
.....+++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+++.+|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 34455899999995 699998865 34569999999999999999999999876799999999999999999999
Q ss_pred EEecCCCcccccCccc------------cccCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 646 VGDFGLSRLKHETYLT------------TKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 646 L~DFGla~~~~~~~~~------------~~~~~Gt~~Y~aPE~~---~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|+|||++......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999865432211 1134689999999998 567788999999999999999999999986554
Q ss_pred c
Q 005054 711 M 711 (716)
Q Consensus 711 l 711 (716)
.
T Consensus 259 ~ 259 (337)
T 3ll6_A 259 L 259 (337)
T ss_dssp -
T ss_pred H
Confidence 3
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=311.63 Aligned_cols=209 Identities=28% Similarity=0.522 Sum_probs=181.6
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEece
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~ 570 (716)
.+++..++|++.+.||+|+||.||+|.+.+ ..||+|+++... .......+.+|+.+|+.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 466777899999999999999999999743 369999987643 345567889999999999 89999999999
Q ss_pred eccCCceEEEEeecCCCCHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEE
Q 005054 571 VTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL 637 (716)
Q Consensus 571 ~~~~~~~~lVmE~~~ggsL~~~l~~~-------------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NIL 637 (716)
+...+.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999999753 245899999999999999999999999 999999999999
Q ss_pred EccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 638 VDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 638 l~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 99999999999999986543221 2233456889999999999999999999999999999998 9999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=310.20 Aligned_cols=206 Identities=32% Similarity=0.490 Sum_probs=170.6
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceecc----
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS---- 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~---- 573 (716)
....++|++.+.||+|+||.||+|.+ .++.||||++....... ..+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT---HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH---HHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34568999999999999999999998 67789999997654332 5677899999998 79999999999976
Q ss_pred --CCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecC
Q 005054 574 --PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (716)
Q Consensus 574 --~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 650 (716)
...+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 467899999999999999997643 46899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCccccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
++..............||+.|+|||++. +..++.++|||||||++|+|++|..||...+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 9987654433344557999999999987 566889999999999999999999999876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=313.59 Aligned_cols=209 Identities=23% Similarity=0.424 Sum_probs=179.2
Q ss_pred cchhcccceeEe-eeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccC
Q 005054 499 DYEILWEDLTIG-EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP 574 (716)
Q Consensus 499 ~~e~~~~~y~i~-~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~ 574 (716)
..+.+.++|.+. +.||+|+||.||+|.+. ++.||||+++...........+.+|+.+++.+ .||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 446677889988 89999999999999984 77899999987655444456788899999999 569999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFG 650 (716)
..+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999999998643 356899999999999999999999999 999999999999987 7899999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 180 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 180 MSRKIGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp GCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9987654332 2345799999999999999999999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.57 Aligned_cols=204 Identities=28% Similarity=0.478 Sum_probs=171.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCe----EEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~----vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..++|++.+.||+|+||.||+|.+. +.. |++|++..... ......+.+|+.+++.++||||+++++++. ...
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 3578999999999999999999874 333 77777654321 122245667899999999999999999886 567
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 89999999999999999876667999999999999999999999999 9999999999999999999999999998754
Q ss_pred cCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 657 ETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.... ......|++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 3321 2234467889999999999999999999999999999999 9999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.11 Aligned_cols=210 Identities=29% Similarity=0.519 Sum_probs=180.7
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~ 569 (716)
..+++..++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|+.+++.+ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 456677899999999999999999999853 3569999997653 345567788999999999 7999999999
Q ss_pred eeccCC-ceEEEEeecCCCCHHHHHhhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 570 AVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK---------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 570 ~~~~~~-~~~lVmE~~~ggsL~~~l~~~~~~---------------l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
++...+ .+|+||||+++++|.+++...... +++..++.++.||+.||.|||+++ |+||||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 987654 589999999999999999865432 789999999999999999999999 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999999999997654322 22233457889999999999999999999999999999998 9999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=312.17 Aligned_cols=205 Identities=28% Similarity=0.534 Sum_probs=169.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCe----EEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~----vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
+..++|++.++||+|+||.||+|.+ .+.. |++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3457899999999999999999997 3444 4666664432 2233467888999999999999999999998654
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.++||+|+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999887778999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 656 HETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 4322 22233457889999999999999999999999999999999 9999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.13 Aligned_cols=201 Identities=30% Similarity=0.422 Sum_probs=160.4
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC------
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~------ 574 (716)
+.++|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 348999999999999999999987 467899999977655566677888999999999999999999998654
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC------
T ss_pred CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 5689999999 7899998875 45999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 236 (367)
T 2fst_X 182 TADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5433 234578999999999987 67899999999999999999999999887653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.22 Aligned_cols=204 Identities=31% Similarity=0.544 Sum_probs=179.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH-HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~-~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
...++|++.+.||+|+||.||++.+. +..||||++....... .....+.+|+.+++.++||||+++++++...+.+|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999984 5579999987543211 12356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999997754 5899999999999999999999999 999999999999999999999999998765443
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 168 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 217 (284)
T 2vgo_A 168 R--RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217 (284)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred c--cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH
Confidence 2 2345799999999999999999999999999999999999999986553
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.44 Aligned_cols=205 Identities=34% Similarity=0.543 Sum_probs=173.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCC-----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee-ccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~-~~~~~~ 577 (716)
..+|++.+.||+|+||.||+|.+... .||+|.+.... .......+.+|+.+++.++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 45799999999999999999986322 38888886533 445567888999999999999999999985 456688
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999877777999999999999999999999999 99999999999999999999999999976543
Q ss_pred Cc----cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 658 TY----LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 658 ~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
.. .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 22 12233457889999999999999999999999999999999 67777766543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.24 Aligned_cols=196 Identities=34% Similarity=0.642 Sum_probs=166.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
..++|++.+.||+|+||.||++.+.++.||||++... .....+.+|+.+|+.++||||+++++++. +..|+|||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence 4578999999999999999999999999999998643 23467889999999999999999999887 45899999
Q ss_pred ecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCCeEEcCCCCCcEEEccCCc-EEEEecCCCcccc
Q 005054 583 FLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHH---CNPPIIHRDLKSSNLLVDKHWT-VKVGDFGLSRLKH 656 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~--~l~~~~v~~i~~ql~~aL~yLH~---~~~~IvHrDIKp~NILl~~~~~-vkL~DFGla~~~~ 656 (716)
|+++++|.+++..... .++...++.++.||+.||.|||+ ++ |+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999999976542 47899999999999999999999 67 999999999999998876 7999999997654
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 158 THM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccc---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 322 23468999999999999999999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=323.23 Aligned_cols=198 Identities=26% Similarity=0.349 Sum_probs=166.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc------CC
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~------~~ 575 (716)
..+|++.+.||+|+||.||+|.+ .++.||||++..... ...+|+.+|+.++|||||+++++|.. ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 45799999999999999999998 477899999875432 23469999999999999999998843 22
Q ss_pred ceEEEEeecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-CcEEEEecCC
Q 005054 576 RLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGL 651 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~---~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGl 651 (716)
.+++||||+++ +|.+++. .....+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 46899999965 6766654 33567999999999999999999999999 9999999999999955 6789999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
++....... ....+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.+.+..
T Consensus 204 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~ 263 (420)
T 1j1b_A 204 AKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263 (420)
T ss_dssp CEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 986543322 2345789999999999765 6899999999999999999999999887643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=307.97 Aligned_cols=205 Identities=31% Similarity=0.504 Sum_probs=174.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
..++|++.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4578999999999999999999985 67899999875432 2346778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999999876777999999999999999999999999 99999999999999999999999998764433322
Q ss_pred ccccCCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVL-----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~-----~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||...+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 228 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 33345789999999998 4677889999999999999999999999876643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=323.44 Aligned_cols=204 Identities=23% Similarity=0.414 Sum_probs=175.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC--ce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~--~~ 577 (716)
...++|++.++||+|+||.||+|.+. ++.||||+++..... .....+.+|+.+|+.++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44578999999999999999999985 778999999764332 22456678999999999999999999988655 78
Q ss_pred EEEEeecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE----ccCCcEEEEecCC
Q 005054 578 CIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGl 651 (716)
|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999997643 23899999999999999999999999 9999999999999 7777899999999
Q ss_pred CcccccCccccccCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN--------EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 163 ARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CEECCCGGG-SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ceEccCCCc-cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 987654432 234579999999999875 456789999999999999999999997544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.59 Aligned_cols=201 Identities=23% Similarity=0.335 Sum_probs=172.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC--------CCceeEEece
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--------HPNVLLFMGA 570 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~--------hpnIv~~~~~ 570 (716)
+.+.++|++.++||+|+||.||+|.+ .++.||||+++.. ......+.+|+.+|+.+. |+||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34568999999999999999999987 4667999998743 445567888999999885 7889999999
Q ss_pred ec----cCCceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCC--
Q 005054 571 VT----SPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHW-- 642 (716)
Q Consensus 571 ~~----~~~~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~-- 642 (716)
+. ....+||||||+ +++|.+++... ...+++..++.++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchh
Confidence 87 566899999999 55666666543 36699999999999999999999998 8 99999999999998765
Q ss_pred -----------------------------------------------cEEEEecCCCcccccCccccccCCCCCCccCcc
Q 005054 643 -----------------------------------------------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675 (716)
Q Consensus 643 -----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE 675 (716)
.+||+|||++...... ....+||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876543 23457899999999
Q ss_pred cccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 676 ~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++.+..++.++|||||||+||+|++|+.||...+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999999999999999999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=330.43 Aligned_cols=205 Identities=32% Similarity=0.477 Sum_probs=179.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
.+.++|++.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4557899999999999999999998 4778999999765432 233567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE---ccCCcEEEEecCCCccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~ 655 (716)
+|||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999764 46999999999999999999999999 9999999999999 46789999999999765
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..
T Consensus 180 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 180 EASKK-MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp CCCCS-HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccc-cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 54332 224479999999999977 6889999999999999999999999876643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.68 Aligned_cols=203 Identities=28% Similarity=0.426 Sum_probs=175.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-----Cc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~-----~~ 576 (716)
.++|++++.||+|+||.||++.+ .+..||||++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46899999999999999999988 46679999987533 345567888999999999999999999998755 36
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999996 5999999764 4999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCccc---cccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 657 ETYLT---TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 657 ~~~~~---~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 33221 234579999999998754 458999999999999999999999998876544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.84 Aligned_cols=203 Identities=22% Similarity=0.315 Sum_probs=169.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999997 466799999976543 345567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY- 659 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 659 (716)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999999865 36999999999999999999999999 9999999999999999999999999987654432
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 22234578999999999999999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.85 Aligned_cols=201 Identities=16% Similarity=0.217 Sum_probs=163.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHH---HHHhcCCCceeEEe-------c
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVS---LMKRLRHPNVLLFM-------G 569 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~---iL~~l~hpnIv~~~-------~ 569 (716)
..++|++.+.||+|+||.||+|.+ .++.||||++..... .....+.+.+|+. +|+.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999986 478899999986532 3345677889994 55555899999998 5
Q ss_pred eeccCC-----------------ceEEEEeecCCCCHHHHHhhcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCC
Q 005054 570 AVTSPQ-----------------RLCIVTEFLPRGSLFRLLQRNTTKLD-------WRRRILMALDIARGVSYLHHCNPP 625 (716)
Q Consensus 570 ~~~~~~-----------------~~~lVmE~~~ggsL~~~l~~~~~~l~-------~~~v~~i~~ql~~aL~yLH~~~~~ 625 (716)
++...+ ..||||||+ +|+|.+++.... .++ +..++.++.||+.||.|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 554443 379999999 679999997643 233 4788889999999999999999
Q ss_pred eEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCC-----------CCCchhHHHHHHHH
Q 005054 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-----------PSDEKSDVYSFGVI 694 (716)
Q Consensus 626 IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----------~~~~~sDIwSlG~l 694 (716)
|+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999999999986443 2335577 999999999888 89999999999999
Q ss_pred HHHHHcCCCCCCCCCcc
Q 005054 695 LWELATEKIPWDNLNSM 711 (716)
Q Consensus 695 l~elltG~~PF~~~~~l 711 (716)
||+|++|+.||...+..
T Consensus 303 l~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 303 IYWIWCADLPITKDAAL 319 (377)
T ss_dssp HHHHHHSSCCC------
T ss_pred HHHHHHCCCCCcccccc
Confidence 99999999999876643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.27 Aligned_cols=201 Identities=35% Similarity=0.581 Sum_probs=168.2
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc--CCCceeEEeceeccC---
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSP--- 574 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l--~hpnIv~~~~~~~~~--- 574 (716)
...+.++|++.+.||+|+||.||++.+.++.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 35566899999999999999999999999999999986543 12334455555554 899999999998876
Q ss_pred -CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEEcCCCCCcEEEccCCcEE
Q 005054 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC--------NPPIIHRDLKSSNLLVDKHWTVK 645 (716)
Q Consensus 575 -~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~--------~~~IvHrDIKp~NILl~~~~~vk 645 (716)
..+|+||||+++++|.+++... .+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEE
Confidence 6789999999999999999764 599999999999999999999998 7 99999999999999999999
Q ss_pred EEecCCCcccccCccc----cccCCCCCCccCcccccCCCCCch------hHHHHHHHHHHHHHcC----------CCCC
Q 005054 646 VGDFGLSRLKHETYLT----TKTGKGTPQWMAPEVLRNEPSDEK------SDVYSFGVILWELATE----------KIPW 705 (716)
Q Consensus 646 L~DFGla~~~~~~~~~----~~~~~Gt~~Y~aPE~~~~~~~~~~------sDIwSlG~ll~elltG----------~~PF 705 (716)
|+|||++......... .....||+.|+|||++.+..+... +|||||||++|+|++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999999765433221 224579999999999988776554 9999999999999999 7777
Q ss_pred CCCC
Q 005054 706 DNLN 709 (716)
Q Consensus 706 ~~~~ 709 (716)
....
T Consensus 263 ~~~~ 266 (337)
T 3mdy_A 263 HDLV 266 (337)
T ss_dssp TTTS
T ss_pred hhhc
Confidence 6543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.90 Aligned_cols=197 Identities=32% Similarity=0.525 Sum_probs=172.8
Q ss_pred ceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC--Cce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~--~~~ 577 (716)
.|+++++||+|+||.||++.+ .++.||||+++.. ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 349999999999999999865 4667999999765 3455667889999999999999999999999874 578
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++||||+++++|.+++.... +++..++.++.||+.+|.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999997654 999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 658 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 32 123344688899999999999999999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=303.08 Aligned_cols=203 Identities=34% Similarity=0.611 Sum_probs=171.2
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-Cce
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-QRL 577 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~-~~~ 577 (716)
.+.+..++|++.+.||+|+||.||++.+.++.||||+++... ..+.+.+|+.+++.++||||+++++++... +.+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 345667899999999999999999999999999999987543 245678899999999999999999986544 578
Q ss_pred EEEEeecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~-~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
|+||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999999976432 3789999999999999999999999 9999999999999999999999999987654
Q ss_pred cCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 169 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred ccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 432 23367899999999999999999999999999999998 9999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.23 Aligned_cols=206 Identities=27% Similarity=0.486 Sum_probs=179.5
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC--C----HHHHHHHHHHHHHHHhc-CCCceeEEecee
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY--S----DEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~----~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~ 571 (716)
..+.++|++.+.||+|+||.||+|.+. ++.||||++..... . ......+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445678999999999999999999984 77899999976542 1 23356778899999999 799999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
......|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+|||++.++.+||+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCc
Confidence 9999999999999999999999764 45999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 247 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 310 (365)
T 2y7j_A 247 SCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310 (365)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence 98665432 2335689999999999864 3578899999999999999999999986543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=315.00 Aligned_cols=204 Identities=21% Similarity=0.283 Sum_probs=167.6
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEc-----CCeEEEEEeeccCCCH----H-----HHHHHHHHHHHHHhcCCCcee
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSD----E-----VIHSFRQEVSLMKRLRHPNVL 565 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~----~-----~~~~~~~E~~iL~~l~hpnIv 565 (716)
.+...++|++.+.||+|+||.||+|.+. +..||||++....... . ....+.+|+.+++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3455689999999999999999999984 4679999987653211 0 012355788889999999999
Q ss_pred EEeceecc----CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 566 LFMGAVTS----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 566 ~~~~~~~~----~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
++++++.. ...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK 187 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence 99999887 67899999999 999999997655 7999999999999999999999999 9999999999999987
Q ss_pred C--cEEEEecCCCcccccCc-------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 642 W--TVKVGDFGLSRLKHETY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 642 ~--~vkL~DFGla~~~~~~~-------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
+ .+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 99999999997653321 112345799999999999999999999999999999999999999964
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.02 Aligned_cols=201 Identities=33% Similarity=0.501 Sum_probs=176.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec--cC
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SP 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~--~~ 574 (716)
..++|++.+.||+|+||.||++.+ .+..||||++... .....+.+.+|+.+++.++||||+++++++. ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 347999999999999999999985 4567999998764 3455677899999999999999999999876 45
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccccee
Confidence 6689999999999999999876667999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 655 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 655 ~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 543321 22344688899999999999999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.94 Aligned_cols=200 Identities=33% Similarity=0.501 Sum_probs=162.9
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHH--HHhcCCCceeEEeceec-----c
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL--MKRLRHPNVLLFMGAVT-----S 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~i--L~~l~hpnIv~~~~~~~-----~ 573 (716)
.+..++|++.+.||+|+||.||++...++.||||+++.... ..+..|..+ +..++||||+++++.+. .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 34557999999999999999999999999999999975431 223334444 45589999999987442 3
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEEcCCCCCcEEEccCCcE
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC---------NPPIIHRDLKSSNLLVDKHWTV 644 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~---------~~~IvHrDIKp~NILl~~~~~v 644 (716)
...+|+|||||++++|.+++.... +++..++.++.||+.||.|||++ + |+||||||+||||+.++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCcE
Confidence 346799999999999999997654 58899999999999999999998 8 9999999999999999999
Q ss_pred EEEecCCCcccccC--------ccccccCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 645 KVGDFGLSRLKHET--------YLTTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 645 kL~DFGla~~~~~~--------~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
||+|||++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 99999999765432 112224479999999999987 345678999999999999999977765443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.37 Aligned_cols=202 Identities=24% Similarity=0.377 Sum_probs=168.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-----
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----- 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----- 573 (716)
+...++|++++.||+|+||.||+|.+ .++.||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34567899999999999999999988 577899999875432 12369999999999999999999843
Q ss_pred ---------------------------------CCceEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHH
Q 005054 574 ---------------------------------PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVS 617 (716)
Q Consensus 574 ---------------------------------~~~~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~ 617 (716)
...+++||||++ ++|.+.+.. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 334899999997 488777753 3567999999999999999999
Q ss_pred HHHhCCCCeEEcCCCCCcEEEc-cCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHH
Q 005054 618 YLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVIL 695 (716)
Q Consensus 618 yLH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll 695 (716)
|||++| |+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999999 99999999999998 68899999999998654433 233557899999999988754 89999999999999
Q ss_pred HHHHcCCCCCCCCCccc
Q 005054 696 WELATEKIPWDNLNSMQ 712 (716)
Q Consensus 696 ~elltG~~PF~~~~~l~ 712 (716)
|+|++|+.||.+.+..+
T Consensus 233 ~ell~g~~pf~~~~~~~ 249 (383)
T 3eb0_A 233 GELILGKPLFSGETSID 249 (383)
T ss_dssp HHHHHSSCSSCCSSHHH
T ss_pred HHHHhCCCCCCCCChHH
Confidence 99999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.97 Aligned_cols=203 Identities=33% Similarity=0.573 Sum_probs=173.8
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CC---eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce-E
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL-C 578 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~-~ 578 (716)
-.|.+.++||+|+||.||+|.+. +. .||+|+++... .......+.+|+.+++.++||||+++++++...+.. +
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 36778899999999999999863 22 59999986533 445567888999999999999999999999877665 9
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999999887778999999999999999999999999 999999999999999999999999999754332
Q ss_pred c----cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCc
Q 005054 659 Y----LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNS 710 (716)
Q Consensus 659 ~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG-~~PF~~~~~ 710 (716)
. .......+++.|+|||++.+..++.++|||||||++|+|++| .+||...+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 1 222344678999999999999999999999999999999995 555555443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.42 Aligned_cols=206 Identities=28% Similarity=0.492 Sum_probs=174.7
Q ss_pred hhcccceeEee-eeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 501 EILWEDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 501 e~~~~~y~i~~-~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
.+..++|.+.+ .||+|+||.||++.+. +..||||+++...........+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34457899998 9999999999999652 45699999987655555677899999999999999999999999 567
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 789999999999999999874 46999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 656 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 43321 1223356789999999999889999999999999999999 9999987653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.54 Aligned_cols=209 Identities=29% Similarity=0.483 Sum_probs=175.7
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
...+....++|.....||+|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 344455556677777999999999999998 46679999987654 23456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 651 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGl 651 (716)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999999999998753 34678999999999999999999999 999999999999987 89999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+..............|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 987654433344567999999999997654 7889999999999999999999997543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=303.07 Aligned_cols=202 Identities=36% Similarity=0.598 Sum_probs=175.4
Q ss_pred eeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccC--CCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeec
Q 005054 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
|..++.||+|+||.||+|.+.+..||||++.... ......+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4445899999999999999999999999987543 23345678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--c
Q 005054 585 PRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--L 660 (716)
Q Consensus 585 ~ggsL~~~l~~~--~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~ 660 (716)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999743 346899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 23345799999999998764 788999999999999999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=318.86 Aligned_cols=202 Identities=26% Similarity=0.332 Sum_probs=176.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc------CCCceeEEeceec
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL------RHPNVLLFMGAVT 572 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l------~hpnIv~~~~~~~ 572 (716)
+.+..+|+++++||+|+||.||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 456678999999999999999999884 567999998753 34445677788888877 5779999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc--EEEEec
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDF 649 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~--vkL~DF 649 (716)
....+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++. +||+||
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999999995 69999987654 45899999999999999999999999 999999999999999887 999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
|++...... ....+||+.|+|||++.+..++.++|||||||+||+|++|..||...+..
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999765443 23457899999999999999999999999999999999999999887643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=318.47 Aligned_cols=200 Identities=13% Similarity=0.136 Sum_probs=155.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhc--CCCceeEEecee-------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL--RHPNVLLFMGAV------- 571 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l--~hpnIv~~~~~~------- 571 (716)
..+|++.+.||+|+||.||+|.+ .++.||||+++..... ......+.+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 35699999999999999999997 4667999999886653 34556777785544444 699988865333
Q ss_pred ccC-----------------CceEEEEeecCCCCHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCeEE
Q 005054 572 TSP-----------------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR------ILMALDIARGVSYLHHCNPPIIH 628 (716)
Q Consensus 572 ~~~-----------------~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v------~~i~~ql~~aL~yLH~~~~~IvH 628 (716)
... ..+|||||||+ ++|.+++......+....+ +.++.||+.||.|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 222 34899999997 7999999875444555555 677799999999999999 999
Q ss_pred cCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
|||||+||||+.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986654321 3356799999999987 778999999999999999999999998
Q ss_pred CCC
Q 005054 707 NLN 709 (716)
Q Consensus 707 ~~~ 709 (716)
...
T Consensus 295 ~~~ 297 (371)
T 3q60_A 295 LVT 297 (371)
T ss_dssp BCC
T ss_pred CcC
Confidence 774
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=324.10 Aligned_cols=207 Identities=35% Similarity=0.598 Sum_probs=176.1
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..|++..++|++.++||+|+||.||+|.+.+ ..||||+++...... +.+.+|+.+|+.++||||+++++++.. +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 4567788999999999999999999999865 469999998755443 567899999999999999999999876 77
Q ss_pred eEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+||||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999999999753 345899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 656 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.... .......+++.|+|||++.+..++.++|||||||+||+|++ |..||...+.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 4332 22233457889999999999999999999999999999999 9999987654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.68 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=173.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce---
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL--- 577 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~--- 577 (716)
+.++|.+.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457999999999999999999988 467899999987766677778889999999999999999999999877655
Q ss_pred ---EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 578 ---CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 578 ---~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
|+||||+. ++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 588888743 4999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 248 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 248 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 5443 234578999999999987 67899999999999999999999999877643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=303.62 Aligned_cols=200 Identities=27% Similarity=0.450 Sum_probs=174.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|.+.+.||+|+||.||++.+ .++.||+|+++.... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 457899999999999999999998 477899999986532 2235678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE---ccCCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~ 657 (716)
|||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999997654 5899999999999999999999999 9999999999999 7788999999999876543
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 162 GI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp BT--THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred Cc--cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 223368999999999999999999999999999999999999997654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=298.38 Aligned_cols=201 Identities=24% Similarity=0.357 Sum_probs=172.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEece-eccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~-~~~~~~~~l 579 (716)
+.++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+.|++++..+.+ +......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999996 5778999998765443 246789999999988776655544 456677899
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE---ccCCcEEEEecCCCcccc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~ 656 (716)
||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 89999999876778999999999999999999999999 9999999999999 478899999999998655
Q ss_pred cCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 4322 22455799999999999999999999999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.99 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=169.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEece-eccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~-~~~~~~~~l 579 (716)
+.++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+.|++++..+.. +......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 347899999999999999999996 5678999987654332 346779999999988776655554 466778899
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE---ccCCcEEEEecCCCcccc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~ 656 (716)
||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99999 99999999876777999999999999999999999999 9999999999999 788999999999998654
Q ss_pred cCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 657 ETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 657 ~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 4321 223557999999999999999999999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=333.24 Aligned_cols=208 Identities=25% Similarity=0.483 Sum_probs=174.6
Q ss_pred hhcccceeEee-eeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 501 EILWEDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 501 e~~~~~y~i~~-~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
.+..+++.+.+ .||+|+||.||+|.+. +..||||+++.... ......+.+|+.+|+.++|||||++++++.. +
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 44456677777 8999999999999873 34599999976532 2335678899999999999999999999976 5
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|||||||++++|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 699999999999999999877777999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 656 HETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 656 ~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
.... .......+++.|+|||++.+..++.++|||||||+||+|++ |+.||...+..+
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 547 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 4322 11223346789999999999999999999999999999998 999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.84 Aligned_cols=202 Identities=25% Similarity=0.380 Sum_probs=169.1
Q ss_pred ccceeEe-eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEE
Q 005054 504 WEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 504 ~~~y~i~-~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~l 579 (716)
.++|++. +.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+|.++ +||||+++++++...+.+|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3678885 7899999999999987 5778999999765432 245678899999885 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc---EEEEecCCCcccc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKH 656 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFGla~~~~ 656 (716)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999775 36899999999999999999999999 999999999999987765 9999999987543
Q ss_pred cCc-------cccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETY-------LTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~-------~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 211 11223469999999999975 4578899999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.92 Aligned_cols=204 Identities=33% Similarity=0.547 Sum_probs=166.9
Q ss_pred cceeEeeeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec-cCCceE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLC 578 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~-~~~~~~ 578 (716)
..|++.+.||+|+||.||+|.+.. ..||+|.++... .......+.+|+.+|+.++||||+++++++. ..+..|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 468899999999999999998632 248999886533 3445678899999999999999999999865 456789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999877777999999999999999999999999 999999999999999999999999999755332
Q ss_pred cc----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 659 YL----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 659 ~~----~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 11 1223457889999999999999999999999999999999 78899876644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.92 Aligned_cols=205 Identities=29% Similarity=0.500 Sum_probs=166.5
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC------HHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
..+.++|.+.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.+|+.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 44568999999999999999999998 4568999999865421 122335788999999999999999999986
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC---cEEEEec
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDF 649 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~---~vkL~DF 649 (716)
. +.+|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred c-CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeec
Confidence 4 5589999999999999988654 46999999999999999999999999 99999999999997544 5999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 287 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 287 GHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp STTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ccceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 9998765433 2235579999999999864 5678899999999999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.01 Aligned_cols=205 Identities=29% Similarity=0.562 Sum_probs=171.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.+..++|.+.+.||+|+||.||++.+. ++.||||++...... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 445689999999999999999999984 778999998764321 12345788899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999997654 5899999999999999999999999 99999999999999999999999999876554
Q ss_pred CccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
... .....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+
T Consensus 164 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 164 GEF-LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc-eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 322 234578999999999988776 579999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.83 Aligned_cols=211 Identities=30% Similarity=0.503 Sum_probs=161.2
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..+.+..++|++.+.||+|+||.||++.+ .+..||||++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 44567778999999999999999999986 577899998865432 233466788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEe
Q 005054 576 RLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~-------~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~D 648 (716)
..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEe
Confidence 99999999999999999974 2455899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCc-----cccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 649 FGLSRLKHETY-----LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 649 FGla~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 233 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh
Confidence 99987543221 11234478999999999876 56889999999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.32 Aligned_cols=203 Identities=29% Similarity=0.452 Sum_probs=177.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++.+.||+|+||.||++.+. ++.||||++...... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 478999999999999999999984 778999999765432 33567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc--
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (716)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999998653 46899999999999999999999999 9999999999999999999999999997643221
Q ss_pred cccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 22335578999999999988775 6789999999999999999999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.92 Aligned_cols=208 Identities=27% Similarity=0.426 Sum_probs=163.8
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..+....++|++.+.||+|+||.||+|.+ .++.||||++............+.++..+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 45666778999999999999999999998 4778999999876554444555556667788889999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|+||||+ ++.+..++......+++..++.++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 6677777766567799999999999999999999985 8 99999999999999999999999999976
Q ss_pred cccCccccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
...... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||....
T Consensus 175 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 175 LVDDKA-KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCCcc-ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 544322 22447899999999994 5567889999999999999999999998643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.74 Aligned_cols=197 Identities=29% Similarity=0.425 Sum_probs=173.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-----
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----- 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----- 573 (716)
..+..+|++.+.||+|+||.||++.+. ++.||+|+++... ..+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 345678999999999999999999984 7889999997653 245679999999999999999998854
Q ss_pred -----------CCceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 574 -----------PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 574 -----------~~~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT 158 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC
Confidence 34589999999999999999754 356899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 642 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
+.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp TEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCEEECcchhheecccccc-ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999999987654332 234579999999999999999999999999999999999998874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.09 Aligned_cols=204 Identities=32% Similarity=0.599 Sum_probs=172.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCe--EEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCce
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~--vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~ 577 (716)
..++|++.+.||+|+||.||++.+. +.. |++|.++... .......+.+|+.+|+.+ +||||+++++++...+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 3479999999999999999999874 443 4889887532 234456788999999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC
Q 005054 578 CIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~ 642 (716)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCC
Confidence 99999999999999997643 46899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 643 TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 643 ~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 99999999987443221 2234467889999999999989999999999999999998 9999987653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=309.76 Aligned_cols=207 Identities=21% Similarity=0.315 Sum_probs=170.7
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCC---------CHHHHHHHHHHHHHHHhcCCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY---------SDEVIHSFRQEVSLMKRLRHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~~~E~~iL~~l~hpnIv~~~ 568 (716)
....+.++|++.+.||+|+||.||++.+ .+..||||++..... .......+.+|+.+|+.++||||++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 3456678999999999999999999987 567899999865322 234457889999999999999999999
Q ss_pred ceec-----cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc
Q 005054 569 GAVT-----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (716)
Q Consensus 569 ~~~~-----~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~ 643 (716)
+++. ....+|+||||+. ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCC
Confidence 9984 3346899999996 5899988877677999999999999999999999999 999999999999999999
Q ss_pred EEEEecCCCcccccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 644 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 173 ~kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 173 ITICDFNLAREDTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp EEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEEEecCcccccccccc-cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999975444322 234578999999999987 678999999999999999999999998765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.60 Aligned_cols=204 Identities=30% Similarity=0.510 Sum_probs=170.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC------HHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~------~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
.+.++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45578999999999999999999984 567999998765321 1233457889999999999999999999876
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc---EEEEecC
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFG 650 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFG 650 (716)
.. +|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 54 89999999999999999754 46999999999999999999999999 999999999999987654 9999999
Q ss_pred CCcccccCccccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 163 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 163 HSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp TCEECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cceecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9987654322 22346899999999974 56678999999999999999999999986554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.84 Aligned_cols=205 Identities=25% Similarity=0.434 Sum_probs=178.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC---C----HHHHHHHHHHHHHHHhcC-CCceeEEecee
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---S----DEVIHSFRQEVSLMKRLR-HPNVLLFMGAV 571 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~----~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~ 571 (716)
.+.++|++.+.||+|+||.||+|.+ .++.||||+++.... . ......+.+|+.+|+.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3457899999999999999999998 456899999976531 1 234567788999999995 99999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
.....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccc
Confidence 9999999999999999999999765 46899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLR------NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+....... ......|++.|+|||++. ...++.++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 171 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 98655432 233457899999999985 45678899999999999999999999976553
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=302.85 Aligned_cols=201 Identities=27% Similarity=0.391 Sum_probs=176.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE---cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCC------ceeEEecee
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW---YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP------NVLLFMGAV 571 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hp------nIv~~~~~~ 571 (716)
+.+.++|++.+.||+|+||.||++.+ .++.||||+++.. ......+.+|+.+++.++|+ +|+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 55678999999999999999999987 4667999998643 34456788899999988654 599999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc----------
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---------- 640 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---------- 640 (716)
...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999999 889999997654 36899999999999999999999999 999999999999987
Q ss_pred ---------CCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 641 ---------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 641 ---------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999865443 2345789999999999999999999999999999999999999987664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=302.48 Aligned_cols=203 Identities=22% Similarity=0.321 Sum_probs=172.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec----cC
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT----SP 574 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~----~~ 574 (716)
.+..++|++.+.||+|+||.||++.+ .++.||||++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34567999999999999999999997 5778999998664 3455678889999999999999999999986 34
Q ss_pred CceEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
...|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCc
Confidence 578999999999999999976 3567999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCcc---------ccccCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 652 SRLKHETYL---------TTKTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 652 a~~~~~~~~---------~~~~~~Gt~~Y~aPE~~~~~~---~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
+........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 875432111 011235799999999997665 58899999999999999999999963
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=329.65 Aligned_cols=206 Identities=35% Similarity=0.608 Sum_probs=180.5
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.|++..++|++.++||+|+||.||++.+.+ ..||||+++...... +.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 467778899999999999999999999865 469999998765443 567899999999999999999999876 779
Q ss_pred EEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
|||||||++++|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999999753 345899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 657 ETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 657 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
... .......++..|+|||++.+..++.++|||||||+||+|++ |+.||...+.
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 332 12233457889999999999999999999999999999999 9999987654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.01 Aligned_cols=207 Identities=36% Similarity=0.559 Sum_probs=168.8
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc---CC--eEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
.+..++|++.+.||+|+||.||++.+. +. .||||+++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 344579999999999999999999863 22 489999876543 235567889999999999999999999999876
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
. .++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 5 89999999999999999876667999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 655 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 543321 2223467889999999999889999999999999999999 9999987653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.71 Aligned_cols=207 Identities=27% Similarity=0.447 Sum_probs=174.5
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE-------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
++..++|++.+.||+|+||.||++.+ .+..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 45568999999999999999999984 34579999986433 44556678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcE
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTV 644 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~v 644 (716)
....|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999998754 34899999999999999999999999 999999999999984 4469
Q ss_pred EEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 645 KVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 645 kL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 999999987543221 12223467899999999999999999999999999999998 9999987653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.55 Aligned_cols=201 Identities=27% Similarity=0.401 Sum_probs=172.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-----C
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----Q 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~-----~ 575 (716)
+.++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4579999999999999999999985 7789999986533 345566788999999999999999999987654 6
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
..|+||||+. ++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999996 5999999763 5999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCcc----------ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 656 HETYL----------TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 656 ~~~~~----------~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43211 1223478999999998765 678999999999999999999999998765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=304.18 Aligned_cols=203 Identities=28% Similarity=0.380 Sum_probs=172.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc---CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeceec-----
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT----- 572 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l---~hpnIv~~~~~~~----- 572 (716)
.++|++.+.||+|+||.||++.+. ++.||||+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999983 56799999876543222223345666666665 8999999999987
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCC
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 651 (716)
....+++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5667899999997 59999997754 34899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 98655432 23356789999999999999999999999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.54 Aligned_cols=206 Identities=25% Similarity=0.419 Sum_probs=180.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCH---------------HHHHHHHHHHHHHHhcCCCcee
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD---------------EVIHSFRQEVSLMKRLRHPNVL 565 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~---------------~~~~~~~~E~~iL~~l~hpnIv 565 (716)
+...++|++.+.||+|+||.||+|.+.++.||||++....... .....+.+|+.+++.++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456899999999999999999999988899999987543211 1126788999999999999999
Q ss_pred EEeceeccCCceEEEEeecCCCCHHHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEE
Q 005054 566 LFMGAVTSPQRLCIVTEFLPRGSLFRL------LQRN-TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLL 637 (716)
Q Consensus 566 ~~~~~~~~~~~~~lVmE~~~ggsL~~~------l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NIL 637 (716)
++++++...+.+|+||||+++++|.++ +... ...+++..++.++.||+.||.|||+ ++ |+|+||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 5542 4679999999999999999999999 88 999999999999
Q ss_pred EccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 638 VDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDE-KSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 638 l~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~-~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||...+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999875443 23355799999999999887 5666 99999999999999999999987665
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.06 Aligned_cols=202 Identities=22% Similarity=0.343 Sum_probs=175.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h-pnIv~~~~~~~~~~~~~ 578 (716)
.+.++|+++++||+|+||.||+|.+ .++.||||++....... .+.+|+.+++.+.| ++|+.+..++...+..|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 3568999999999999999999997 47789999987654432 36679999999976 56666777777788899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE---ccCCcEEEEecCCCccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~ 655 (716)
|||||+ +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+|||+++..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999999 89999999877778999999999999999999999999 9999999999999 58899999999999865
Q ss_pred ccCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 656 HETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 44321 22356799999999999999999999999999999999999999987654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=314.69 Aligned_cols=201 Identities=24% Similarity=0.346 Sum_probs=166.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC----
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~---- 575 (716)
+....+|++.++||+|+||.||+|.+. +..||+|.+..... ...+|+.+|+.++||||+++++++....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 445578999999999999999999984 44588887765432 1236899999999999999999985433
Q ss_pred --ceEEEEeecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-cCCcEEEEec
Q 005054 576 --RLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDF 649 (716)
Q Consensus 576 --~~~lVmE~~~ggsL~~~l~---~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-~~~~vkL~DF 649 (716)
.+|+|||||++ +|...+. .....+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+||
T Consensus 110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 38899999976 4444332 23456999999999999999999999999 99999999999999 7899999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..
T Consensus 187 G~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 248 (394)
T 4e7w_A 187 GSAKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI 248 (394)
T ss_dssp TTCEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCcccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99986544322 2345789999999999765 4899999999999999999999999987643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.53 Aligned_cols=202 Identities=33% Similarity=0.546 Sum_probs=176.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE------cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
...++|++++.||+|+||.||++.+ .++.||||++... .......+.+|+.+|+.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 3457899999999999999999985 4667999998764 3445678899999999999999999999887654
Q ss_pred --ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 576 --RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 576 --~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 789999999999999999887777999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCcc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 654 LKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 654 ~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 7654322 12234578889999999998899999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=314.54 Aligned_cols=200 Identities=26% Similarity=0.402 Sum_probs=156.9
Q ss_pred cccceeE-eeeeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee--ccCC
Q 005054 503 LWEDLTI-GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV--TSPQ 575 (716)
Q Consensus 503 ~~~~y~i-~~~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~--~~~~ 575 (716)
+.+.|++ +++||+|+||.||+|.+. +..||||++....... .+.+|+.+|+.++||||+++++++ ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3456877 558999999999999964 5679999997655443 466899999999999999999999 4567
Q ss_pred ceEEEEeecCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE----ccCCc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWT 643 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~--------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl----~~~~~ 643 (716)
.+||||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence 8999999995 5888887532 124899999999999999999999999 9999999999999 67789
Q ss_pred EEEEecCCCcccccCc---cccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 644 VKVGDFGLSRLKHETY---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 644 vkL~DFGla~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999998654321 223345799999999999875 48999999999999999999999997654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.90 Aligned_cols=198 Identities=17% Similarity=0.229 Sum_probs=170.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc----------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeE-----
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY----------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL----- 566 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~----- 566 (716)
...++|++.+.||+|+||.||+|.+. +..||||++... ..+.+|+.+++.++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence 34579999999999999999999874 568999998754 35678999999999999987
Q ss_pred ----------Eeceecc-CCceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCC
Q 005054 567 ----------FMGAVTS-PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (716)
Q Consensus 567 ----------~~~~~~~-~~~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~ 634 (716)
+++++.. ...+||||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 188 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE 188 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence 4555554 67789999999 99999999875 356999999999999999999999999 999999999
Q ss_pred cEEEccCC--cEEEEecCCCcccccCcc-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 005054 635 NLLVDKHW--TVKVGDFGLSRLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705 (716)
Q Consensus 635 NILl~~~~--~vkL~DFGla~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF 705 (716)
|||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999988 899999999976543221 113347999999999999999999999999999999999999999
Q ss_pred CCCC
Q 005054 706 DNLN 709 (716)
Q Consensus 706 ~~~~ 709 (716)
....
T Consensus 269 ~~~~ 272 (352)
T 2jii_A 269 TNCL 272 (352)
T ss_dssp GGGT
T ss_pred ccCC
Confidence 8764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.26 Aligned_cols=207 Identities=27% Similarity=0.415 Sum_probs=156.6
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHH-HHHhcCCCceeEEeceeccC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~-iL~~l~hpnIv~~~~~~~~~ 574 (716)
..+++..++|++.+.||+|+||.||++.+. ++.||||+++.... ......+..|+. +++.++||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 455677789999999999999999999985 77899999986543 333344555555 77778999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 575 QRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~----~~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
+..|+||||+++ +|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999975 88887753 245689999999999999999999998 8 999999999999999999999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVL----RNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
|++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...+
T Consensus 171 g~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 171 GISGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred CCceecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 99986654322 2234789999999998 56678899999999999999999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=303.88 Aligned_cols=201 Identities=35% Similarity=0.609 Sum_probs=173.8
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHh--cCCCceeEEeceeccCC--
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSPQ-- 575 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~--l~hpnIv~~~~~~~~~~-- 575 (716)
.+.+.++|++.+.||+|+||.||++.+.++.||||++.... ...+.+|+.++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 35567899999999999999999999999999999986542 2456678888887 68999999999998776
Q ss_pred --ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEEcCCCCCcEEEccCCcEE
Q 005054 576 --RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVK 645 (716)
Q Consensus 576 --~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH--------~~~~~IvHrDIKp~NILl~~~~~vk 645 (716)
.+|+||||+++++|.+++.+. .+++..++.++.||+.||.||| +++ |+||||||+||||+.++.+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999764 5899999999999999999999 778 99999999999999999999
Q ss_pred EEecCCCcccccCcc----ccccCCCCCCccCcccccCCCC------CchhHHHHHHHHHHHHHcC----------CCCC
Q 005054 646 VGDFGLSRLKHETYL----TTKTGKGTPQWMAPEVLRNEPS------DEKSDVYSFGVILWELATE----------KIPW 705 (716)
Q Consensus 646 L~DFGla~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~~~------~~~sDIwSlG~ll~elltG----------~~PF 705 (716)
|+|||++........ ......||+.|+|||++.+... +.++|||||||++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 999999976544321 2234579999999999987633 3689999999999999999 8899
Q ss_pred CCCC
Q 005054 706 DNLN 709 (716)
Q Consensus 706 ~~~~ 709 (716)
....
T Consensus 268 ~~~~ 271 (342)
T 1b6c_B 268 YDLV 271 (342)
T ss_dssp TTTS
T ss_pred cccC
Confidence 7654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=310.02 Aligned_cols=210 Identities=33% Similarity=0.613 Sum_probs=177.2
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
...+++..++|++.+.||+|+||.||++.+.+ .|++|+++...........+.+|+.+++.++||||+++++++.....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35667778999999999999999999999865 59999987654433334556779999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999877667999999999999999999999999 99999999999998 6799999999986542
Q ss_pred cC-----ccccccCCCCCCccCcccccC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ET-----YLTTKTGKGTPQWMAPEVLRN---------EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~-----~~~~~~~~Gt~~Y~aPE~~~~---------~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11 122234468999999999875 4578899999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=307.44 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=172.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR---- 576 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~---- 576 (716)
+.++|.+.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 357899999999999999999998 46789999998766666667888999999999999999999999987654
Q ss_pred --eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 577 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 577 --~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999996 588777643 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5433 224578999999999987 6788999999999999999999999987664
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.94 Aligned_cols=203 Identities=26% Similarity=0.424 Sum_probs=167.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec-------
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT------- 572 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~------- 572 (716)
.+.++|++.+.||+|+||.||++.+. ++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 34589999999999999999999985 678999998754 3455678889999999999999999998874
Q ss_pred -------cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-cCCcE
Q 005054 573 -------SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 644 (716)
Q Consensus 573 -------~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-~~~~v 644 (716)
....+|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 599999975 45899999999999999999999999 99999999999997 56799
Q ss_pred EEEecCCCcccccCc---cccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 645 KVGDFGLSRLKHETY---LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 645 kL~DFGla~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999998654321 11223457999999998865 67899999999999999999999999877643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.82 Aligned_cols=206 Identities=23% Similarity=0.378 Sum_probs=174.1
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC--CCceeEEeceeccCC
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQ 575 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~--hpnIv~~~~~~~~~~ 575 (716)
...+..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.+. ||||+++++++....
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 3456678899999999999999999987 4667999999887777777888999999999997 599999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. +.+||+|||++...
T Consensus 102 ~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 102 YIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEECC-CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEEec-CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 99999995 488999999875 46899999999999999999999999 999999999999964 89999999999865
Q ss_pred ccCcc--ccccCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 656 HETYL--TTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 656 ~~~~~--~~~~~~Gt~~Y~aPE~~~~-----------~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 43321 2234578999999999876 467889999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.59 Aligned_cols=204 Identities=26% Similarity=0.449 Sum_probs=170.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC--HHHHHHHHHHHHHHHhcCCCceeEEecee--ccCCc
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAV--TSPQR 576 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~~~~~~E~~iL~~l~hpnIv~~~~~~--~~~~~ 576 (716)
+.++|++.+.||+|+||.||++.+ .+..||+|+++..... ......+.+|+.+++.++||||+++++++ .....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999998 4668999999764321 23456788999999999999999999998 44568
Q ss_pred eEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+|+||||++++ |.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 89999999775 77777653 456899999999999999999999999 999999999999999999999999999765
Q ss_pred ccC--ccccccCCCCCCccCcccccCCCC--CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 656 HET--YLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 656 ~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~--~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
... ........||+.|+|||++.+... +.++|||||||++|+|++|..||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 422 222335579999999999987554 779999999999999999999998755
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.48 Aligned_cols=205 Identities=32% Similarity=0.501 Sum_probs=177.5
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
..+.++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++.....+|
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 44568999999999999999999998 4778999999776544444567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC---CcEEEEecCCCccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLK 655 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla~~~ 655 (716)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||++...
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999999887653 5899999999999999999999999 9999999999999754 46999999998765
Q ss_pred ccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 656 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... .....|++.|+|||++.+. ++.++|||||||++|+|++|..||...+.
T Consensus 175 ~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 175 QQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp CCCSS-CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCc-cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 44322 1233578999999998765 88999999999999999999999987653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=302.48 Aligned_cols=202 Identities=26% Similarity=0.414 Sum_probs=174.2
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--C-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc------eeEEecee
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--G-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN------VLLFMGAV 571 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn------Iv~~~~~~ 571 (716)
+.+.++|++.+.||+|+||.||+|.+. + ..||||+++.. ......+.+|+.+++.+.|++ ++.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 456789999999999999999999983 3 57999998643 344567788999999887655 89999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE------------
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV------------ 638 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl------------ 638 (716)
...+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence 9999999999999 667777776543 56999999999999999999999999 9999999999999
Q ss_pred -------ccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 639 -------DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 639 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865443 23457999999999999999999999999999999999999999876643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.95 Aligned_cols=192 Identities=30% Similarity=0.462 Sum_probs=163.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-------- 573 (716)
.++|++.+.||+|+||.||+|.+ .++.||||+++.. ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 46899999999999999999997 5778999998653 3456778899999999999999999998754
Q ss_pred -----CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEe
Q 005054 574 -----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (716)
Q Consensus 574 -----~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~D 648 (716)
...+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEee
Confidence 45689999999999999999877667889999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccC--------------ccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHc
Q 005054 649 FGLSRLKHET--------------YLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELAT 700 (716)
Q Consensus 649 FGla~~~~~~--------------~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~ellt 700 (716)
||++...... ........||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9998765422 1122345689999999999865 68899999999999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=328.12 Aligned_cols=204 Identities=28% Similarity=0.501 Sum_probs=171.6
Q ss_pred ccceeEe-eeeecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 504 WEDLTIG-EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 504 ~~~y~i~-~~LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
...+.+. ++||+|+||.||+|.+. ++.||||+++...........+.+|+.+|+.++|||||++++++.. +.++
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 3445543 48999999999999762 3569999998766555566789999999999999999999999864 5689
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||||++++|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 446 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 999999999999999764 46999999999999999999999999 999999999999999999999999999765432
Q ss_pred c---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 659 Y---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 659 ~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
. .......+|+.|+|||++.+..++.++|||||||+||+|++ |+.||...+..
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 2 12223457889999999999999999999999999999998 99999887643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=305.41 Aligned_cols=204 Identities=26% Similarity=0.353 Sum_probs=174.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CC-----ceeEEeceec
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HP-----NVLLFMGAVT 572 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hp-----nIv~~~~~~~ 572 (716)
+.+.++|++.+.||+|+||.||+|.+. ++.||||+++.. ......+..|+.+++.+. |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 445689999999999999999999884 667999998743 344566778888888874 44 4999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc--cCCcEEEEec
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDF 649 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~--~~~~vkL~DF 649 (716)
..+.+||||||++ ++|.+++.... ..+++..++.++.||+.||.|||.+..+||||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999995 59999998754 568999999999999999999995323399999999999995 4778999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999876543 23457899999999999999999999999999999999999999977643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.25 Aligned_cols=203 Identities=23% Similarity=0.295 Sum_probs=158.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc--
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-- 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~-- 576 (716)
....++|++.+.||+|+||.||+|.+. +..||||++....... ....+++..+..++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 445579999999999999999999984 6789999886543222 344567788888999999999999865433
Q ss_pred -----eEEEEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEEcCCCCCcEEEcc-CCcEE
Q 005054 577 -----LCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLH--HCNPPIIHRDLKSSNLLVDK-HWTVK 645 (716)
Q Consensus 577 -----~~lVmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH--~~~~~IvHrDIKp~NILl~~-~~~vk 645 (716)
+|+||||+++ +|...+.. ....+++..++.++.||+.||.||| +++ |+||||||+||||+. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence 7899999976 66554432 3456899999999999999999999 888 999999999999996 89999
Q ss_pred EEecCCCcccccCccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 646 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus 173 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp ECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999999986654432 23457899999999987655 79999999999999999999999987664
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.74 Aligned_cols=205 Identities=24% Similarity=0.399 Sum_probs=165.8
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhc----CCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRL----RHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l----~hpnIv~~~ 568 (716)
..+.+.++|++.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.++..+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3456678999999999999999999987 56789999997654322 1233455688999888 899999999
Q ss_pred ceeccCCceEEEEee-cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-cCCcEEE
Q 005054 569 GAVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKV 646 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~-~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-~~~~vkL 646 (716)
+++...+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 78999999998754 5999999999999999999999999 99999999999999 7899999
Q ss_pred EecCCCcccccCccccccCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 647 GDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 647 ~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
+|||++....... .....|++.|+|||++.+..+. .++|||||||++|+|++|+.||...
T Consensus 182 ~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 182 IDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp CCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9999998765432 2345789999999999877764 5899999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=323.81 Aligned_cols=209 Identities=33% Similarity=0.568 Sum_probs=178.4
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~ 572 (716)
..+++..++|++.+.||+|+||.||+|.+.. ..||||.++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3556777899999999999999999998842 34888887653 24556678899999999999999999999985
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 573 ~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
.+.+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCC
Confidence 46789999999999999999877667999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 653 RLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 653 ~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 8654432 22233467889999999999999999999999999999997 9999987654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=300.26 Aligned_cols=204 Identities=25% Similarity=0.417 Sum_probs=174.4
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhcC--CCceeEEecee
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAV 571 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l~--hpnIv~~~~~~ 571 (716)
.+.+.++|++.+.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.+++.+. |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 355678999999999999999999987 56789999997654321 11234567899999996 59999999999
Q ss_pred ccCCceEEEEeecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-cCCcEEEEec
Q 005054 572 TSPQRLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDF 649 (716)
Q Consensus 572 ~~~~~~~lVmE~~~g-gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-~~~~vkL~DF 649 (716)
...+.+++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999976 8999999764 46899999999999999999999999 99999999999999 7889999999
Q ss_pred CCCcccccCccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
|++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 195 g~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 9998765432 234579999999999987776 67899999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.82 Aligned_cols=197 Identities=26% Similarity=0.407 Sum_probs=146.7
Q ss_pred cccceeEee-eeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc----CC
Q 005054 503 LWEDLTIGE-QIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQ 575 (716)
Q Consensus 503 ~~~~y~i~~-~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----~~ 575 (716)
+.++|.+.+ .||+|+||.||+|.+. ++.||||++... .... .+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457899965 6999999999999985 778999998653 2222 223344666799999999999876 45
Q ss_pred ceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecCC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGL 651 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGl 651 (716)
.+|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 5899999999999999998654 46999999999999999999999999 999999999999976 45599999999
Q ss_pred CcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 178 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 178 AKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 98655432 234578999999999998889999999999999999999999997654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=301.35 Aligned_cols=198 Identities=21% Similarity=0.339 Sum_probs=168.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-----------CCceeEEec
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLFMG 569 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-----------hpnIv~~~~ 569 (716)
..++|++.+.||+|+||.||+|.+ .++.||||++... ......+.+|+.+++.+. ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 457899999999999999999997 5678999998753 334466778999988875 899999999
Q ss_pred eeccCC----ceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEcCCCCCcEEEcc---
Q 005054 570 AVTSPQ----RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDK--- 640 (716)
Q Consensus 570 ~~~~~~----~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~-~~~IvHrDIKp~NILl~~--- 640 (716)
++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ + |+||||||+||||+.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCC
Confidence 988654 789999999 88999999764 34599999999999999999999998 8 999999999999953
Q ss_pred ---CCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 641 ---HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 641 ---~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 347999999999866543 234578999999999999999999999999999999999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.12 Aligned_cols=196 Identities=22% Similarity=0.251 Sum_probs=163.5
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCC------CHHHHHHHHHHHHHHHhcC---------C-----
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY------SDEVIHSFRQEVSLMKRLR---------H----- 561 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~iL~~l~---------h----- 561 (716)
+..++|++.++||+|+||.||+|+++++.||||+++.... .......+.+|+.+|+.++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4457899999999999999999999999999999987542 1223466778999888885 4
Q ss_pred ------------CceeEEeceecc-------------CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 005054 562 ------------PNVLLFMGAVTS-------------PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616 (716)
Q Consensus 562 ------------pnIv~~~~~~~~-------------~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL 616 (716)
|||++++++|.. ...+|||||||++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 555555555554 6789999999999976666643 4589999999999999999
Q ss_pred HHHH-hCCCCeEEcCCCCCcEEEccCC--------------------cEEEEecCCCcccccCccccccCCCCCCccCcc
Q 005054 617 SYLH-HCNPPIIHRDLKSSNLLVDKHW--------------------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675 (716)
Q Consensus 617 ~yLH-~~~~~IvHrDIKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE 675 (716)
.||| +++ |+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 899 99999999999999887 8999999999876543 337899999999
Q ss_pred cccCCCCCchhHHHHHHHH-HHHHHcCCCCCCC
Q 005054 676 VLRNEPSDEKSDVYSFGVI-LWELATEKIPWDN 707 (716)
Q Consensus 676 ~~~~~~~~~~sDIwSlG~l-l~elltG~~PF~~ 707 (716)
++.+.. +.++|||||+++ .++++.|..||..
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999877 889999998777 7778889999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=310.78 Aligned_cols=201 Identities=25% Similarity=0.389 Sum_probs=163.2
Q ss_pred hhcccceeEeeeeecCCcEEE-EEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTV-YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~V-y~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~ 578 (716)
.+...+|.+.++||+|+||+| |++...++.||||++...... .+.+|+.+|+.+ +|||||++++++.+...+|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 344467999999999999984 555668899999998754332 245799999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-----CCcEEEEecCCCc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 653 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-----~~~vkL~DFGla~ 653 (716)
||||||. ++|.+++......+....++.++.||+.||.|||+++ |+||||||+||||+. ...+||+|||+++
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9999995 5999999877666666677899999999999999999 999999999999953 2358899999998
Q ss_pred ccccCc---cccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 654 LKHETY---LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 654 ~~~~~~---~~~~~~~Gt~~Y~aPE~~~---~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
...... ......+||+.|+|||++. +..++.++|||||||++|+|++ |..||....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 654321 2233457999999999997 4566789999999999999999 999997543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=285.65 Aligned_cols=179 Identities=16% Similarity=0.135 Sum_probs=158.2
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
++.++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45678999999999999999999985 678999999876543 566678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
+||||++|++|.+++... .....+..++.||+.||.|||++| |+||||||+||||+.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999999642 456678899999999999999999 9999999999999999999997443
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
|++ +++.++|||||||++|+|++|+.||...+..+
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 333 36889999999999999999999999877643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=323.85 Aligned_cols=195 Identities=26% Similarity=0.365 Sum_probs=169.4
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc---CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc-
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~- 576 (716)
+++.++|++.++||+|+||.||++.+. ++.||||++.... .......+.+|+.+|+.++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 456689999999999999999999984 5789999986543 34556778899999999999999999999987665
Q ss_pred ----eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCC
Q 005054 577 ----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (716)
Q Consensus 577 ----~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 652 (716)
.||||||++|++|.+++.. .+++..++.++.||+.+|.|||+++ ||||||||+||||+.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999988754 5999999999999999999999999 9999999999999875 8999999999
Q ss_pred cccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~ 707 (716)
+..... ....||+.|+|||++.+.. +.++|||||||+||+|++|..||..
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 876543 3457999999999998765 8899999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-32 Score=301.41 Aligned_cols=199 Identities=29% Similarity=0.405 Sum_probs=157.9
Q ss_pred cccceeEeeeeecCCcEEEEEEE-EcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.+.|.+.+.||+|+||+||.+. ..++.||||++.... ...+.+|+.+|+.+ +||||+++++++.....+|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34567778999999999997553 478899999987542 24567899999876 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC-------------
Q 005054 581 TEFLPRGSLFRLLQRNTTK------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH------------- 641 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~------l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~------------- 641 (716)
||||. ++|.+++...... .++..++.++.||+.||.|||+++ |+||||||+||||+.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCc
Confidence 99995 5999999764321 123345779999999999999999 9999999999999754
Q ss_pred CcEEEEecCCCcccccCcc----ccccCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 642 WTVKVGDFGLSRLKHETYL----TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 4899999999987654321 1224579999999999976 668899999999999999999 999997543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=315.46 Aligned_cols=201 Identities=27% Similarity=0.366 Sum_probs=174.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc------CC
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~------~~ 575 (716)
.++|++.++||+|+||.||++.+ .++.||||+++.. ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999987 5778999998764 345667788999999999999999999998765 67
Q ss_pred ceEEEEeecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCc---EEEEecC
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFG 650 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~--~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFG 650 (716)
..|+|||||++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999998643 25899999999999999999999999 999999999999997665 9999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 170 ~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 170 YAKELDQGEL-CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCBTTSCCC-CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccc-cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 9987654432 23557999999999999999999999999999999999999999653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=298.07 Aligned_cols=201 Identities=17% Similarity=0.203 Sum_probs=157.8
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCC-Ccee--------------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRH-PNVL-------------- 565 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~h-pnIv-------------- 565 (716)
...|.+.+.||+|+||.||+|.+. ++.||||+++.... .....+.+.+|+.+++.+.| +|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 456899999999999999999985 88999999874332 22335678899999999876 2211
Q ss_pred -------EEeceecc-----CCceEEEEeecCCCCHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 005054 566 -------LFMGAVTS-----PQRLCIVTEFLPRGSLFRLLQR------NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627 (716)
Q Consensus 566 -------~~~~~~~~-----~~~~~lVmE~~~ggsL~~~l~~------~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~Iv 627 (716)
.++.++.. ...++++|+++ +++|.+++.. ....+++..++.++.||+.||.|||+++ ||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 11111111 22467888877 6799999852 2344778889999999999999999999 99
Q ss_pred EcCCCCCcEEEccCCcEEEEecCCCcccccCccccccCCCCCCccCcccc----------cCCCCCchhHHHHHHHHHHH
Q 005054 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL----------RNEPSDEKSDVYSFGVILWE 697 (716)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~----------~~~~~~~~sDIwSlG~ll~e 697 (716)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998865543 335578 999999999 55567889999999999999
Q ss_pred HHcCCCCCCCCCcc
Q 005054 698 LATEKIPWDNLNSM 711 (716)
Q Consensus 698 lltG~~PF~~~~~l 711 (716)
|++|+.||...+..
T Consensus 310 lltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 310 IWCADLPNTDDAAL 323 (413)
T ss_dssp HHHSSCCCCTTGGG
T ss_pred HHHCCCCCCCcchh
Confidence 99999999876653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=273.70 Aligned_cols=177 Identities=27% Similarity=0.424 Sum_probs=150.8
Q ss_pred cccceeEe-eeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHH-HhcCCCceeEEeceecc----C
Q 005054 503 LWEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTS----P 574 (716)
Q Consensus 503 ~~~~y~i~-~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL-~~l~hpnIv~~~~~~~~----~ 574 (716)
+.++|.+. +.||+|+||.||++.+ .++.||||+++.. ..+.+|+.++ +.++||||+++++++.. .
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 44678777 7899999999999998 5678999998643 3456788877 55689999999999876 6
Q ss_pred CceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFG 650 (716)
..+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 77899999999999999998754 46999999999999999999999999 999999999999997 7889999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
++.... +..++.++|||||||++|+|++|..||...+.
T Consensus 166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 886432 23467799999999999999999999976543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=295.63 Aligned_cols=187 Identities=16% Similarity=0.109 Sum_probs=133.6
Q ss_pred eeeecCCcEEEEEEEE--cCCeEEEEEeeccCC----C----HHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCceEE
Q 005054 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY----S----DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~----~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~~~l 579 (716)
..++.|++|.+..++. -+..|+||++.+... . ....+++.+|+.+|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3567778877776643 688999999976532 1 23456799999999999 69999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
|||||+|++|.++|.+. .+++.. .|+.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999875 456654 47889999999999999 9999999999999999999999999998766554
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP 704 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~P 704 (716)
......+||+.|||||++.+. +..++|+|++|+++++|+++..|
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 445566899999999999875 55789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=264.86 Aligned_cols=186 Identities=18% Similarity=0.189 Sum_probs=148.8
Q ss_pred eEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCH------HHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
...+.||+|+||.||++...+..+++|......... ...+++.+|+.+|++++||||+++..++...+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 446789999999999998889999999876544321 12456789999999999999996555555677789999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|||++++|.+++.. ++.++.||+.+|.|||+++ |+||||||+|||++. .+||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999975 5688999999999999999 999999999999998 9999999999876543221
Q ss_pred -------cccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 662 -------TKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 662 -------~~~~~Gt~~Y~aPE~~~~--~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
....+||+.|||||++.+ ..|+...|+|+..+-.++.+.++-+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 134579999999999987 567778899999999999888888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=211.85 Aligned_cols=146 Identities=22% Similarity=0.204 Sum_probs=116.3
Q ss_pred cceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCH----------------HHHHHHHHHHHHHHhcCCCceeEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD----------------EVIHSFRQEVSLMKRLRHPNVLLF 567 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~----------------~~~~~~~~E~~iL~~l~hpnIv~~ 567 (716)
..|.+++.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.+|+.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 4566779999999999999998 46789999986532211 23567889999999998 4 566
Q ss_pred eceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEE
Q 005054 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (716)
Q Consensus 568 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~ 647 (716)
++++. .+..|+|||||+|++|.+ +.. .....++.||+.||.|||++| |+||||||+|||++ ++.+||+
T Consensus 167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEE
Confidence 66554 356799999999999987 421 234578999999999999999 99999999999999 9999999
Q ss_pred ecCCCcccccCccccccCCCCCCccCccccc
Q 005054 648 DFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678 (716)
Q Consensus 648 DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 678 (716)
|||+++. +..|+|||++.
T Consensus 235 DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE-------------TTSTTHHHHHH
T ss_pred ECCCCeE-------------CCCCCHHHHHH
Confidence 9999863 34478888874
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.3e-20 Score=177.26 Aligned_cols=160 Identities=15% Similarity=0.144 Sum_probs=140.6
Q ss_pred HHHHHHHHHcCceeEEEcCC---CcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLS---DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~d---G~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (716)
+.|+.++++++++|+++|.+ |+|+|+|++|++++||+.++++|+++..++++.........+...+..+..+..++.
T Consensus 7 ~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 86 (176)
T 4hia_A 7 EKIRAVFDRSGVALTLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVVLR 86 (176)
T ss_dssp HHHHHHHHHCSSCCEEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEE
T ss_pred HHHHHHHhcCCCcEEEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEEEE
Confidence 56889999999999999999 999999999999999999999999999888877766666678888889998999999
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHHH
Q 005054 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (716)
Q Consensus 207 ~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~i 286 (716)
..++||..+|+.+++.|+.+.+|.+.+++++++|||++|++|++ .+++.+|.++++.++.......+..+.+..+..+.
T Consensus 87 ~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e~~-~~~a~~d~LtgL~NR~~~~~~~~~~~~~~~~~~~~ 165 (176)
T 4hia_A 87 NYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSEEA-AAAGHAGALTGELARIGTVAARLEMDSRRHLAQAA 165 (176)
T ss_dssp EECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGHHH-HHHHHHHHHHHHHHHTTSSCGGGHHHHHHHHHHHH
T ss_pred EEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHHHH-HHHhhhhHHhhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999 88999999998888777666666666666665554
Q ss_pred HHHH
Q 005054 287 ASKI 290 (716)
Q Consensus 287 ~~~I 290 (716)
+..+
T Consensus 166 ~~~~ 169 (176)
T 4hia_A 166 AALV 169 (176)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.3e-19 Score=182.34 Aligned_cols=139 Identities=20% Similarity=0.214 Sum_probs=107.9
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCe--EEEEEeeccCCC----------------------HHHHHHHHHHHHHHHhc
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSD--VAVKVFSRQEYS----------------------DEVIHSFRQEVSLMKRL 559 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~~----------------------~~~~~~~~~E~~iL~~l 559 (716)
-|.+.+.||+|+||.||+|.+ .++. ||||+++..... ......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999988 7888 999997653211 01123678899999999
Q ss_pred CCCce--eEEeceeccCCceEEEEeecCC-C----CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEEcCC
Q 005054 560 RHPNV--LLFMGAVTSPQRLCIVTEFLPR-G----SLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDL 631 (716)
Q Consensus 560 ~hpnI--v~~~~~~~~~~~~~lVmE~~~g-g----sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH-~~~~~IvHrDI 631 (716)
.|++| +.++.+ ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++| ||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 87754 334332 367999999942 3 77776543 234567889999999999999 998 999999
Q ss_pred CCCcEEEccCCcEEEEecCCCcccc
Q 005054 632 KSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 632 Kp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
||+|||++. .++|+|||+|....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETT
T ss_pred CHHHEEEcC--cEEEEECcccccCC
Confidence 999999988 99999999997543
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.76 E-value=8.5e-18 Score=151.10 Aligned_cols=118 Identities=20% Similarity=0.320 Sum_probs=106.6
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEE
Q 005054 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (716)
.++.|+.++++++++|+++|.+|+|+|+|++|++++||+.+|++|+++..+.++.........++..+..+..+..++..
T Consensus 3 ~~~~~~~~~~~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (120)
T 2gj3_A 3 LPEIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVN 82 (120)
T ss_dssp CHHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred hHHHHHHHHHhCCCeEEEECCCCCEEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEEEEEE
Confidence 35789999999999999999999999999999999999999999999988877665444455677888888889999999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHH
Q 005054 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245 (716)
Q Consensus 208 ~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk 245 (716)
+++||+.+|+.+++.|+++.+|.+.+++++++|||++|
T Consensus 83 ~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 83 RRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp ECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 99999999999999999999999999999999999864
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.1e-17 Score=148.53 Aligned_cols=122 Identities=22% Similarity=0.167 Sum_probs=104.1
Q ss_pred HHHHHHcCceeEEEcCCC---cEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 133 LNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 133 ~~lld~l~d~Iiv~D~dG---~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
+.++++++++|+++|.+| +|+|+|++|++++||+.+|++|+++..+.++.........+...+..+..+..++.+++
T Consensus 2 ~~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 81 (132)
T 2pr5_A 2 SHMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYK 81 (132)
T ss_dssp ----CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEEC
T ss_pred hhHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEe
Confidence 357899999999999976 99999999999999999999999988777665544445567778888888888999999
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
+||+.+|+.+++.|+.+.+ +.+++++++|||++|++|++|+++..
T Consensus 82 kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~e~~l~~~~~ 126 (132)
T 2pr5_A 82 KDGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEYEKLLEDSLT 126 (132)
T ss_dssp TTSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHHHHHHHHHHH
T ss_pred cCCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHHHHHHHHHHH
Confidence 9999999999999998765 88899999999999999999987654
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.5e-17 Score=169.21 Aligned_cols=174 Identities=15% Similarity=0.131 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEE
Q 005054 127 FTDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (716)
Q Consensus 127 ~~~~~~~~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (716)
-.++.|+.+|++++++|+++|. +|+|+|+|++|++++||+.+|++|+++.+++++.........+...+..+..+..
T Consensus 60 ~~~~~~~~i~~~~~~~i~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (258)
T 3p7n_A 60 PPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPVLV 139 (258)
T ss_dssp -CCHHHHHHHHTCSSEEEEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEE
T ss_pred hHHHHHHHHHhcCCccEEEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHHHHHHHcCCCeEE
Confidence 3457899999999999999999 9999999999999999999999999999888887766666778888989999999
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHH
Q 005054 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQ 283 (716)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~ 283 (716)
++..+++||..+|+.+++.|++|++|.+.+++++++|||++|+.+.+.+..+.++.+..+.++...++..+... ..+
T Consensus 140 e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~~~~e~~~~~~~~~l~~L~~r~~~i~~~~~~g---~~~ 216 (258)
T 3p7n_A 140 EILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLKTLSPRQLEVTTLVASG---LRN 216 (258)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC-------CHHHHHHHHHHHTTSCHHHHHHHHHHHTT---CCH
T ss_pred EEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhhhhhHHHHHHHHHHHhhcCHHHHHHHHHHHcC---CCH
Confidence 99999999999999999999999999999999999999999666666666666666777776655565554432 244
Q ss_pred HHHHHHHHhhHHHHHhhhhc
Q 005054 284 ATIASKISNLATKVSNKVKS 303 (716)
Q Consensus 284 ~~i~~~I~~La~~v~n~~~s 303 (716)
..|+..+..-...|.+.++.
T Consensus 217 ~eia~~l~~s~~tv~~~l~~ 236 (258)
T 3p7n_A 217 KEVAARLGLSEKTVKMHRGL 236 (258)
T ss_dssp HHHHHHHTCCHHHHHHHHHH
T ss_pred HHHHHHHCcCHHHHHHHHHH
Confidence 55566655444445544443
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.9e-16 Score=139.21 Aligned_cols=105 Identities=23% Similarity=0.287 Sum_probs=95.3
Q ss_pred cCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEE
Q 005054 139 MGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (716)
Q Consensus 139 l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 215 (716)
++++|+++|. +|+|+|+|++|++++||+.+|++|+++..+.++.........++.++..++.+..++..+++||+.+
T Consensus 2 ~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (109)
T 1n9l_A 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCEE
Confidence 5789999994 7999999999999999999999999987777666555556678889999999999999999999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEchhH
Q 005054 216 LVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (716)
Q Consensus 216 ~v~~~~~PI~d~~G~i~g~i~i~~DITe 243 (716)
|+.+++.|++|++|.+.+++++++|||+
T Consensus 82 ~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 9999999999999999999999999984
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=7.5e-16 Score=145.02 Aligned_cols=125 Identities=20% Similarity=0.149 Sum_probs=113.2
Q ss_pred HHHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (716)
.+.+..++++++++|+++|. +|+|+++|++|++++||+.++++|+++..++++.........+...+..+..+..++
T Consensus 34 ~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~ 113 (166)
T 3ue6_A 34 DYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCL 113 (166)
T ss_dssp CCHHHHHHHHTTSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHHhcCCceEEEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHHHHHHhcCCceEEEE
Confidence 35789999999999999999 799999999999999999999999999888877766666667788888898899999
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHH
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~ 253 (716)
...+++|..+|+.+++.|+.+.+|.+.+++++++|||++|+.+...+.
T Consensus 114 ~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~~~~~e~ 161 (166)
T 3ue6_A 114 LNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLLVNEQ 161 (166)
T ss_dssp EEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHHHHHHHHH
T ss_pred EEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHHHHHHHhh
Confidence 999999999999999999999999999999999999999998776543
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.67 E-value=4e-16 Score=140.25 Aligned_cols=119 Identities=19% Similarity=0.143 Sum_probs=103.0
Q ss_pred HHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCC
Q 005054 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (716)
Q Consensus 135 lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (716)
+|++++++|+++|. +|+|+++|++|++++||+.++++|+++.+++++.........+...+..+..+..++.+.+++
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 81 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKKS 81 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCcccEEEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEEcCC
Confidence 46788999999999 999999999999999999999999999988877766666667788888888888899999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHH
Q 005054 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (716)
Q Consensus 212 G~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~ 253 (716)
|..+|+.+++.|+.+.+|.+.+++++++|||++|+++++...
T Consensus 82 g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~~~~~ 123 (128)
T 3t50_A 82 GEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRGSLEH 123 (128)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC-------
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhhhhhh
Confidence 999999999999999999999999999999999999987654
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-15 Score=142.38 Aligned_cols=132 Identities=19% Similarity=0.157 Sum_probs=120.0
Q ss_pred CCCCHHHHHHHHHHcCceeEEEcCCC---cEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCee
Q 005054 125 FNFTDRQYLNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (716)
Q Consensus 125 ~~~~~~~~~~lld~l~d~Iiv~D~dG---~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 201 (716)
....++.++.+++.++++|+++|.+| +|+++|+++++++||+.++++|+++..++++.........+...+..+..+
T Consensus 20 ~~~~~~~~~~i~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (162)
T 3sw1_A 20 HMINAQLLQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPC 99 (162)
T ss_dssp -CCCHHHHHHHHHTCSSEEEEEEEETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCCE
T ss_pred ccchHHHHHHHHhhccCcEEEEeCCCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCCC
Confidence 34567889999999999999999999 999999999999999999999999998887776666666778888889888
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
..++.+..++|..+|+.+++.|+.+.+|.+.+++++++|||++++++++|+++..
T Consensus 100 ~~~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~e~~l~~~~~ 154 (162)
T 3sw1_A 100 REVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVELERELAELRA 154 (162)
T ss_dssp EEEEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHHHHHHHHHTC
T ss_pred cceEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHHHHHHHHHHH
Confidence 8899999999999999999999999999999999999999999999999987754
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-15 Score=142.28 Aligned_cols=127 Identities=15% Similarity=0.132 Sum_probs=107.9
Q ss_pred CHHHHHHHHHHcCceeEEEc-CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEE-E
Q 005054 128 TDRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ-F 205 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D-~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e-~ 205 (716)
+++.|+.+|++++++|+++| .+|+|+++|+++++++|++ +++|+++.+++++.........+.+++..|++...+ .
T Consensus 15 ~~~~~~~~~~~~~~~i~~~d~~~~~i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 92 (158)
T 3k3c_A 15 AAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEW 92 (158)
T ss_dssp CHHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCEEEEEE
T ss_pred HHHHHHHHHhcCCceEEEEECCCcEeHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCcccccce
Confidence 35789999999999999999 9999999999999999999 999999999998766555556677788888875443 3
Q ss_pred EE--EcC-C-CCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 206 PA--KTK-T-EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 206 ~~--~~k-d-G~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
.+ .+. + |..+|+.++..|+++.+|.+.|++++++|||++|+++++|+.++.
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~~e~~l~~~~~ 147 (158)
T 3k3c_A 93 RLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEARVE 147 (158)
T ss_dssp EEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHHH
T ss_pred eEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHHHHHHHHHHHH
Confidence 22 222 2 778999999999999999999999999999999999999987655
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=141.71 Aligned_cols=117 Identities=13% Similarity=0.192 Sum_probs=97.6
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHH-cCCeeEEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK-MGERWTGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~-~g~~~~~e~~~~ 208 (716)
+++..+++++++.|+++|.+|+|+|+|+++++++||+++|++|+++.+++++++.......+...+. .+..+..+++++
T Consensus 2 ~~~~ll~e~~~d~i~~~d~~g~i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~ 81 (121)
T 3f1p_B 2 EFKGLNVCQPTRFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFR 81 (121)
T ss_dssp ------CCCCCEEEEEECTTSBEEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEEEE
T ss_pred CcccceecCCCceEEEECCCceEEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEEEE
Confidence 3456788999999999999999999999999999999999999999999988776555555566664 455688899999
Q ss_pred cCCCCEEEEEEEEEEEECC-CCCEEEEEEEEEchhHHHH
Q 005054 209 TKTEERVLVVATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~-~G~i~g~i~i~~DITerk~ 246 (716)
++||+.+|+.++..|++|. +|.+.+++++.+|||++|+
T Consensus 82 ~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 82 SKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp CTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred ecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 9999999999999999987 7889999999999999875
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-15 Score=136.43 Aligned_cols=114 Identities=17% Similarity=0.131 Sum_probs=80.5
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe----eEEEEEEEcCCCCE
Q 005054 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEER 214 (716)
Q Consensus 139 l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~~ 214 (716)
++++|+++|.+|+|+++|++|++++||+++|++|+++..++++.........+...+..+.. ...++..+++||+.
T Consensus 2 ~~d~i~~~d~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG~~ 81 (119)
T 2vv6_A 2 IPDAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTT 81 (119)
T ss_dssp CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCE
T ss_pred CcceEEEECCCCeEEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeCCCCE
Confidence 68999999999999999999999999999999999998887765432222233333444432 34567788999999
Q ss_pred EEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHH
Q 005054 215 VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (716)
Q Consensus 215 ~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~l 254 (716)
+|+.+++.|+.+. ...+++++++|||++|++|++|+++
T Consensus 82 ~~~~~~~~~~~~~--~~~~~~~~~~DITerk~~e~~l~~l 119 (119)
T 2vv6_A 82 FPMHLSIGEMQSG--GEPYFTGFVRDLTEHQQTQARLQEL 119 (119)
T ss_dssp EEEEEEEEEEEET--TEEEEEEEEEECC------------
T ss_pred EEEEEEEEEEEEC--CeEEEEEEEEEcHHHHHHHHHHHhC
Confidence 9999999999753 3456899999999999999988754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4e-16 Score=169.27 Aligned_cols=136 Identities=17% Similarity=0.148 Sum_probs=98.2
Q ss_pred ceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCC---------------CH-HH----HHHHHHHHHHHHhcCCCce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY---------------SD-EV----IHSFRQEVSLMKRLRHPNV 564 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~---------------~~-~~----~~~~~~E~~iL~~l~hpnI 564 (716)
-|.++++||.|+||.||+|.+ .|+.||||+++.... .. .. .....+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 399999999999999999987 678899999754211 00 00 0112346667776644433
Q ss_pred e--EEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC
Q 005054 565 L--LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 565 v--~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~ 642 (716)
. ..+++ ...+|||||++|.+|..+.. ......++.||+.+|.+||++| ||||||||.|||++.++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCC
Confidence 2 22222 23489999999988754432 1234567889999999999999 99999999999998776
Q ss_pred ----------cEEEEecCCCcc
Q 005054 643 ----------TVKVGDFGLSRL 654 (716)
Q Consensus 643 ----------~vkL~DFGla~~ 654 (716)
.+.|+||+-+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999997754
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.8e-15 Score=130.06 Aligned_cols=110 Identities=24% Similarity=0.197 Sum_probs=98.5
Q ss_pred HHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCC
Q 005054 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (716)
Q Consensus 135 lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (716)
.+++++++|+++|. +|+|+|+|++|++++||+.++++|+++..++++.........+...+..+..+..++...+++
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINYTKS 81 (115)
T ss_dssp ---CCCCSEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCCCcEEEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEecCC
Confidence 46889999999999 999999999999999999999999998888877766556667788888888888899999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchhHH
Q 005054 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (716)
Q Consensus 212 G~~~~v~~~~~PI~d~~G~i~g~i~i~~DITer 244 (716)
|..+|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 82 g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer 114 (115)
T 4eet_B 82 GKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114 (115)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECSCC
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEeeccc
Confidence 999999999999999999999999999999975
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=136.78 Aligned_cols=115 Identities=11% Similarity=0.076 Sum_probs=93.9
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-chhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 131 ~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
.|+.+|++++++|+ +|.+|+|+++|++|++++||+.++++|+++..++++... ......+...+..+..+..++.+++
T Consensus 4 ~~~~~~~~~~~~i~-~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 82 (120)
T 3mqq_A 4 DYKTAFHLAPIGLV-LSRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKR 82 (120)
T ss_dssp CHHHHHHHCSSEEE-EEETTEEEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEEEEEC
T ss_pred hHHHHHhcCCceEE-EecCCEEHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEEEEEe
Confidence 38899999999996 578999999999999999999999999999888765433 2233345566777777888999999
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHH
Q 005054 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~ 247 (716)
+||..+|+.++..|+ +.+|...+++++++|||++|++
T Consensus 83 ~dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk~~ 119 (120)
T 3mqq_A 83 AGGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATRRV 119 (120)
T ss_dssp TTSCEEEEEEEEEES-STTSTTSSEEEEEEESCC----
T ss_pred CCCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhhcc
Confidence 999999999999998 5566667889999999999986
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.62 E-value=9.4e-15 Score=135.53 Aligned_cols=130 Identities=9% Similarity=0.166 Sum_probs=111.9
Q ss_pred CCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcC--CCccccccccccchhHHHHHHHHHcCCeeEEE
Q 005054 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (716)
Q Consensus 127 ~~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliG--k~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 204 (716)
.++++|+.+++..+++++.+|.++.++++|+++++++||+.+++.+ ..+..+++|++.......+...+..+..+..+
T Consensus 6 ~se~rl~~~~~~~~~g~w~~d~~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~e 85 (142)
T 3mr0_A 6 ASEERFQLAVSGASAGLWDWNPKTGAMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEHRDTYDVE 85 (142)
T ss_dssp ---CCHHHHHHHTTCEEEEECTTTCCEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHHCCCEEEE
T ss_pred HHHHHHHHHHHhCCcEEEEEEcCCCeEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhCCCceEEE
Confidence 3456799999999999999999999999999999999999999877 34566777777666666677778888888999
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
++++++||..+|+.....|++|.+|.+.+++++++|||++|++|++|+....
T Consensus 86 ~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~~E~~L~~~~~ 137 (142)
T 3mr0_A 86 YRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKRDEDALRVSRE 137 (142)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHHH
T ss_pred EEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999987643
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.61 E-value=9.1e-15 Score=147.24 Aligned_cols=115 Identities=28% Similarity=0.347 Sum_probs=104.3
Q ss_pred eeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEEEEE
Q 005054 142 SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (716)
Q Consensus 142 ~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~ 221 (716)
.|+++|.+|+|+|+|++|++++||+++|++|+++..+.++.........+++.+..|..+..++.++++||..+|+.++.
T Consensus 1 ~i~i~D~~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~ 80 (227)
T 3ewk_A 1 LVSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVDSTI 80 (227)
T ss_dssp CEEEEETTCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSCSCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEEEEE
T ss_pred CEEEECCCCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeeeeEE
Confidence 37889999999999999999999999999999988887665555566678888889999999999999999999999999
Q ss_pred EEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHh
Q 005054 222 TPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (716)
Q Consensus 222 ~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~ 256 (716)
.|++|.+|.+.+++++.+|||++|+++++|+.+..
T Consensus 81 ~p~~d~~g~~~~~~~~~~DIT~~k~~e~~l~~~~~ 115 (227)
T 3ewk_A 81 VPLMDNAGKPRQYISIRRDITAQKEAEAQLARLKQ 115 (227)
T ss_dssp EEEECSSSCEEEEEEEEEECTTTTHHHHHHHHHHH
T ss_pred EEEEcCCCCEEEEEEEEEehhhHHHHHHHHHHHHH
Confidence 99999999999999999999999999999876643
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.61 E-value=7e-15 Score=128.65 Aligned_cols=119 Identities=24% Similarity=0.415 Sum_probs=104.2
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
.+.++.++++++++|+++|.+|+|+++|+++++++|++.++++|+++..+.++.........+...+..+..+..++...
T Consensus 6 ~~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (124)
T 3lyx_A 6 LKQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRML 85 (124)
T ss_dssp HHHHHHGGGTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEEEEEEEE
T ss_pred HHHHHHHHhhcCceEEEECCCCcEeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCcccceEEEE
Confidence 46789999999999999999999999999999999999999999999866665554444556777888888888899999
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~ 247 (716)
.++|..+|+.++..|+.+.+|.+.|++++++|||++|++
T Consensus 86 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~l 124 (124)
T 3lyx_A 86 HKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKKE 124 (124)
T ss_dssp CTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC---
T ss_pred ccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhcC
Confidence 999999999999999999999999999999999998763
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-15 Score=135.31 Aligned_cols=108 Identities=19% Similarity=0.228 Sum_probs=97.2
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEE
Q 005054 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (716)
Q Consensus 139 l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (716)
.++.|+++|.+|+|+|+|+++++++||+++|++|+++.+++++++.......+...+..+..+..+++++++||..+|+.
T Consensus 8 ~~~~i~~~d~~g~i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~ 87 (117)
T 3f1p_A 8 SKTFLSEHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLE 87 (117)
T ss_dssp GGEEEEEECTTCBEEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSEEEEE
T ss_pred CccEEEEECCCceEEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEEEEE
Confidence 36788999999999999999999999999999999999999988766666667777888888878999999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEchhHHHH
Q 005054 219 ATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (716)
Q Consensus 219 ~~~~PI~d~-~G~i~g~i~i~~DITerk~ 246 (716)
++..|+.|+ +|.+.+++++.+|||++|+
T Consensus 88 ~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 88 TQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EeeEEEECCCCCCceEEEEEeeecccccc
Confidence 999999987 7899999999999998864
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-14 Score=128.36 Aligned_cols=122 Identities=20% Similarity=0.278 Sum_probs=105.3
Q ss_pred HHHHHHHHHHcCceeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D---~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (716)
++.++.++++++++|+++| .+|+|+++|+++++++|++.++++|+++..++++.........+...+..+.....++
T Consensus 5 ~~~~~~~~~~~~~~i~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (130)
T 2z6d_A 5 SQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRL 84 (130)
T ss_dssp --CHHHHHHHTTCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEE
T ss_pred HHHHHHHHHhcccceeeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCcceeEE
Confidence 3568999999999999999 9999999999999999999999999999988877665555666777888888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHH
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~ 250 (716)
....++|..+|+.+...|+.+.+|.+.+++++++|||++++++++
T Consensus 85 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~e~e 129 (130)
T 2z6d_A 85 LNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGVND 129 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC-----
T ss_pred EEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHhhcc
Confidence 888999999999999999999999999999999999999988764
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.60 E-value=8.9e-15 Score=131.12 Aligned_cols=113 Identities=19% Similarity=0.199 Sum_probs=91.3
Q ss_pred CCCCCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEE
Q 005054 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (716)
Q Consensus 124 ~~~~~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (716)
.+..+++.|+.+|++++++|+++|.+|+|+++|+++++++||+++|++|+++..+.++.. ..........+..+..+..
T Consensus 5 ~l~~se~~~~~l~e~~~d~i~~~d~~g~i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 83 (117)
T 2r78_A 5 NLYFQSNAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALDWGVLSRGVD-SGWAAASLARIVGGEPLRE 83 (117)
T ss_dssp SHHHHHHHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBTTTTTTCST-TSHHHHHHHHHHTTCCEEE
T ss_pred HHHHhHHHHHHHHhcCCceEEEECCCCCEEEecHHHHHHHCcCHHHHcCCCHHHhCCccc-hhHHHHHHHHHHcCCcEEE
Confidence 344557889999999999999999999999999999999999999999998776644322 2223345666777777888
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
+..++++||+.+|+.+++.|+. +|. ++++++|||
T Consensus 84 e~~~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 84 ERTVWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp EEEEECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred EEEEEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 8999999999999999999984 565 678899997
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.59 E-value=7e-15 Score=130.35 Aligned_cols=120 Identities=6% Similarity=0.101 Sum_probs=93.0
Q ss_pred CCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcC--CCccccccccccchhHHHHHHHHHcCCeeEEE
Q 005054 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (716)
Q Consensus 127 ~~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliG--k~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 204 (716)
..++.|+.+++.++++|+++|.+|.++++|+++++++||+.++++| ..+..++++++.......+...+..+.....+
T Consensus 4 ~~~~~l~~~~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~e 83 (125)
T 3nja_A 4 MAEKLLHTAESDAGIGSWVLHMESGRLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGDRPFDVE 83 (125)
T ss_dssp -------------CCEEEEEETTTTEEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSCCCEEEE
T ss_pred HHHHHHHHHHHhCCeeEEEEEcCCCcEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcCCCceEE
Confidence 3457789999999999999999999999999999999999999999 55666677766555555667777888888889
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHH
Q 005054 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (716)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~ 246 (716)
+++.+++|..+|+.+...|+.+.+|.+.+++++++|||++|+
T Consensus 84 ~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 84 YRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred EEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 999999999999999999999999999999999999999874
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-14 Score=125.32 Aligned_cols=112 Identities=16% Similarity=0.188 Sum_probs=91.9
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEE-EEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ-FPA 207 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e-~~~ 207 (716)
++.++.++++++++|+++|.+|+|+++|+++++++|++.++++|+++.++++. .... .......+..+.....+ ..+
T Consensus 2 e~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 79 (114)
T 3luq_A 2 DERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFPE-IGEE-WKSVHRRGLAGEVIRVEEDCF 79 (114)
T ss_dssp CHHHHHHHHTCSSEEEEEETTCBEEEECHHHHHHTTCCSSCCTTCBHHHHCTT-CCHH-HHHHHHHHHTTCCEEEEEEEE
T ss_pred hHHHHHHHhcCCceEEEEcCCcEEEEECHHHHHHHCCCHHHHcCCcHHHHCCc-cHHH-HHHHHHHHhcCCcceeeeeEE
Confidence 46789999999999999999999999999999999999999999999998843 3222 33333444445554444 477
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 208 ~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
..++|..+|+.++..|+++.+|.+.|++++++|||
T Consensus 80 ~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 80 VRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 88999999999999999999999999999999997
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.7e-15 Score=140.17 Aligned_cols=117 Identities=15% Similarity=0.131 Sum_probs=93.6
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEE----
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF---- 205 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~---- 205 (716)
..++.+|+++++||+++|.+|+|++||+++++++|++.++++|+++.++++. ........+..++..|.+....+
T Consensus 22 ~~l~~il~~~~~gi~v~D~~g~I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~~~~~~~~~~~ 100 (152)
T 3mxq_A 22 LLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIESSSFSSWEQKP 100 (152)
T ss_dssp HHHHHHHHHHCCEEEEEETTSBEEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTSCEEEECCSSS
T ss_pred HHHHHHHhcCCCCEEEEcCCCEEEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCCceeeeccccc
Confidence 3568899999999999999999999999999999999999999999999988 43444456788888887643321
Q ss_pred -----EE---EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHH
Q 005054 206 -----PA---KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (716)
Q Consensus 206 -----~~---~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~ 247 (716)
.. ...+|..+|..+++.|++|++|++.|++.+++|||+++.+
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~a 150 (152)
T 3mxq_A 101 HLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQASQ 150 (152)
T ss_dssp CSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC---
T ss_pred ccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHhc
Confidence 11 1246778889999999999999999999999999998764
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-14 Score=140.26 Aligned_cols=122 Identities=16% Similarity=0.135 Sum_probs=101.0
Q ss_pred HHHHHHHHHHcCceeEEEc-CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEE-EE
Q 005054 129 DRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ-FP 206 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D-~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e-~~ 206 (716)
++.|+.++++++++|+++| .+|+|+++|++|++++|++ +++|+++.+++++.........+..++..|.....+ ..
T Consensus 36 ~~~l~~l~~~~~~~i~~~d~~~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~ 113 (185)
T 3kx0_X 36 AEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEWR 113 (185)
T ss_dssp HHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCEEEEEEE
T ss_pred HHHHHHHHhcCCceEEEEECCCcEEEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCccccccee
Confidence 4789999999999999999 9999999999999999999 999999999998766555556677788888875544 33
Q ss_pred EE--cCC--CCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHH
Q 005054 207 AK--TKT--EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (716)
Q Consensus 207 ~~--~kd--G~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~ 252 (716)
+. +++ |..+|+.++..|+++.+|.+.|++++++|||++|+++++++
T Consensus 114 ~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~~~ 163 (185)
T 3kx0_X 114 LQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAE 163 (185)
T ss_dssp EC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC---
T ss_pred EEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHHHH
Confidence 32 222 77899999999999999999999999999999999998833
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.8e-14 Score=151.90 Aligned_cols=121 Identities=23% Similarity=0.192 Sum_probs=109.9
Q ss_pred HHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcC
Q 005054 134 NILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210 (716)
Q Consensus 134 ~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 210 (716)
.+++.++++|+++|. +|+|+|+|++|++++||+++|++|+++.+++++.........+...+..+..+..++..+++
T Consensus 15 ~~~~~~~~~i~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 94 (332)
T 2wkq_A 15 TTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 94 (332)
T ss_dssp CCGGGCCSEEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECT
T ss_pred hHhhcCCCcEEEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEEEcC
Confidence 467899999999999 99999999999999999999999999999888776666667788889999989999999999
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHH
Q 005054 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (716)
Q Consensus 211 dG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~l 254 (716)
||..+|+.+++.|++|.+|.+.|++++++|||++++.+++++..
T Consensus 95 dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~e~~~~~~ 138 (332)
T 2wkq_A 95 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAEREGV 138 (332)
T ss_dssp TCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHHHHHHH
T ss_pred CCCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhhhhhccch
Confidence 99999999999999999999999999999999998888766433
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=7.8e-14 Score=126.82 Aligned_cols=110 Identities=15% Similarity=0.158 Sum_probs=88.0
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe----eEEEEE
Q 005054 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFP 206 (716)
Q Consensus 131 ~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~ 206 (716)
.|+.++++++++|+++|.+|+|+++|++|++++||+.+|++|+++..++++.........+...+..+.. ...++.
T Consensus 17 ~~~~l~~~~~d~i~~~d~~g~i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 96 (130)
T 1d06_A 17 HLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVS 96 (130)
T ss_dssp CHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTSCEEEE
T ss_pred HHHHHHhhCcCeEEEECCCCeEEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHHHHHhcCCccccCCeeEEE
Confidence 3889999999999999999999999999999999999999999999888765433222233334444432 234677
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 207 ~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
.+++||+.+|+.+++.|+.+. ...+++++++|||
T Consensus 97 ~~~kdG~~~~~~~~~~~~~~~--~~~~~~~~~~DIT 130 (130)
T 1d06_A 97 GQRKDGSTFPMKLAVGEMRSG--GERFFTGFIRDLT 130 (130)
T ss_dssp EECTTSCEEEEEEEEEEEEET--TEEEEEEEEEECC
T ss_pred EEeCCCCEEEEEEEEEEEEEC--CeEEEEEEEEECc
Confidence 889999999999999999753 3446899999997
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=6.4e-14 Score=126.43 Aligned_cols=118 Identities=23% Similarity=0.206 Sum_probs=105.9
Q ss_pred HHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
++.+++.++++|+++|. +|+|+++|+++++++||+.++++|+++..++++.........+...+..+..+..++...
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINY 83 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEEEEE
Confidence 45678999999999999 999999999999999999999999999888877665555667778888888888899999
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHH
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~ 249 (716)
.++|..+|+.++..|+.+.+|.+.+++++++|||++++.++
T Consensus 84 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~~~ 124 (146)
T 2v0u_A 84 TKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAA 124 (146)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHH
T ss_pred ecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHHHHH
Confidence 99999999999999999999999999999999999988443
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.6e-14 Score=126.32 Aligned_cols=123 Identities=11% Similarity=0.095 Sum_probs=87.9
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCC
Q 005054 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (716)
Q Consensus 133 ~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 212 (716)
+.++++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+...+..+. ...++.+.+++|
T Consensus 2 ~~l~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~g 80 (126)
T 3mjq_A 2 KNFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGEKILAELFAGKK-ESLPLSLEKKEG 80 (126)
T ss_dssp CTTGGGCSSEEEEEETTSBEEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHHHHHHHHHHTCC-SEEEEEEECTTS
T ss_pred hhHHhhCCceEEEEeCCCcEEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHHHHHHHHHhCCC-ceeEEEEEccCC
Confidence 4578999999999999999999999999999999999999999999876654433334444444444 477788889999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhhc
Q 005054 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSD 258 (716)
Q Consensus 213 ~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~D 258 (716)
..+|+.++..|+.. +...+++++++|||+++++++++.....++
T Consensus 81 ~~~~~~~~~~~~~~--~~~~~~~~~~~DITe~k~a~~~~~~~~~~~ 124 (126)
T 3mjq_A 81 TSIPAKARIWQGKW--HNEPCLFAIIKDLSKEERASSPPFLEHHHH 124 (126)
T ss_dssp CEEEEEEEEEEEES--SSSEEEEEEEEECC----------------
T ss_pred CEEEEEEEEEeeeE--CCceEEEEEEEechHHHHhhcccchhhccc
Confidence 99999999988754 335678999999999999999887766543
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.2e-13 Score=137.05 Aligned_cols=111 Identities=23% Similarity=0.336 Sum_probs=102.5
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
+.++.++++++++|+++|.+|+|+|+|++|++++||+.+|++|+++..+.++.........+++.+..|..+..++..++
T Consensus 111 ~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 190 (227)
T 3ewk_A 111 ARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRLLNRR 190 (227)
T ss_dssp HHHHHHHHTCCSEEEEECTTSCEEEECHHHHHHHTCCTHHHHSSCGGGGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEE
T ss_pred HHHHHHHhcCcCeEEEEcCCCcEEEEchHHHHHhCCCHHHHcCCChhhccCCCCCHHHHHHHHHHHHcCCceeEEEEEEC
Confidence 34677899999999999999999999999999999999999999999888877766777788999999999999999999
Q ss_pred CCCC------EEEEEEEEEEEECCCCCEEEEEEEEEc
Q 005054 210 KTEE------RVLVVATNTPFYDDDGTLVGIVCVSTD 240 (716)
Q Consensus 210 kdG~------~~~v~~~~~PI~d~~G~i~g~i~i~~D 240 (716)
++|. .+|+.+++.||+|.+|.+.+++++++|
T Consensus 191 k~G~~~~dg~~~~~~~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 191 RTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp ECCSSSSCEEEEEEEEEEEEEECSSSCEEEEEEEEEC
T ss_pred CCCCcCcccceEEEEEEEEEEECCCCCEEEEEEEecC
Confidence 9987 899999999999999999999999987
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.4e-13 Score=139.98 Aligned_cols=125 Identities=13% Similarity=0.134 Sum_probs=97.3
Q ss_pred CCCCCCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHh------------CCChhhHcCCCccccccccccchhHHH
Q 005054 123 SAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLY------------GYSAEEALGQDAIELLTDGRDFDVAYD 190 (716)
Q Consensus 123 ~~~~~~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~------------Gys~eEliGk~~~~l~~~~~~~~~~~~ 190 (716)
.+.....+++..+|++++++|+++|.+|+|+|+|++|++++ ||+.++++|+++.++++... ....
T Consensus 15 ~~~~~e~~~l~~iLd~~~~~vii~D~~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~~~---~~~~ 91 (233)
T 3vol_A 15 VPRGSHMARIKSALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQRH 91 (233)
T ss_dssp ---CTHHHHHHHHHTTSSSEEEEEETTSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSSHH---HHHH
T ss_pred CchHHHHHHHHHHHhcCCCcEEEECCCCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCCHH---HHHH
Confidence 34445567789999999999999999999999999999999 89999999999988876422 2223
Q ss_pred HHHHHHcCCeeEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHHhh
Q 005054 191 IVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS 257 (716)
Q Consensus 191 i~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la~~ 257 (716)
++..+. ..+..++. .+| .|+.+++.||+|++|.+.|++++++|||++++++++++.++..
T Consensus 92 ~~~~~~--~~~~~~~~---~~g--~~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~e~ei~~l~~a 151 (233)
T 3vol_A 92 LLANLT--GVHKAELN---LGG--RRFSLDVVPVFNDANERLGSAVQWTDRTEEHRAEQEVSQLVQA 151 (233)
T ss_dssp HHHTCC--SCEEEEEE---ETT--EEEEEEEEEEECTTCCEEEEEEEEEECHHHHHHHHHHHHHHHH
T ss_pred HHHhcc--cceeEEEE---ECC--EEEEEEEEEEECCCCCEEEEEEEEehhhHHHHHHHHHHHHHHH
Confidence 333322 22443433 245 3678899999999999999999999999999999998876663
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=122.71 Aligned_cols=111 Identities=12% Similarity=0.048 Sum_probs=94.2
Q ss_pred cCceeEEEc-CCCcEEEecHHHHHHhCCChhhHcCCC-ccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEE
Q 005054 139 MGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQD-AIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (716)
Q Consensus 139 l~d~Iiv~D-~dG~Ii~vN~aae~l~Gys~eEliGk~-~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (716)
++++++.+| .+|+++|+|+++++++||+.++++|.. +..++++++.......+...+..+..+..+++++++||..+|
T Consensus 2 a~~giw~~d~~~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w 81 (115)
T 3h9w_A 2 TKAIPWKINWQTMAFEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGHYVW 81 (115)
T ss_dssp -CCEEEEEETTTTEEEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred cceEEEEEEcCCCcEEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCCEEE
Confidence 468899999 679999999999999999999999842 345677766555566677778888888899999999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEchhHHHHHHH
Q 005054 217 VVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (716)
Q Consensus 217 v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~ 249 (716)
+...+.|++|++|.+++++++..|||++|+.|+
T Consensus 82 ~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~~ 114 (115)
T 3h9w_A 82 IRDVVHVVRDDSGEVEALIGFMFDISLEHHHHH 114 (115)
T ss_dssp EEEEEEEEECTTSCEEEEEEEEEECGGGGC---
T ss_pred EEEEEEEEECCCCCEEEEEEEEeccCccccccc
Confidence 999999999999999999999999999998875
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.9e-13 Score=116.26 Aligned_cols=106 Identities=13% Similarity=0.083 Sum_probs=88.5
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
+.++.++++++++|+++|.+|+|+++|+++++++||++++++|+++.++++...... +..+..+.....+..+.+
T Consensus 13 ~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~~~ 87 (118)
T 3olo_A 13 KFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQKNNYTFKTRYRS 87 (118)
T ss_dssp HHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHHSEEEEEEEEEC
T ss_pred HHHHHHHhcCCceEEEECCCCcEEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhcCcEEEEEEEEc
Confidence 557889999999999999999999999999999999999999999999886544322 344555666788889999
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
++|..+|+.++..|+.+.+ ..+++++++|||
T Consensus 88 ~~g~~~~~~~~~~~~~~~~--~~~~~~~~~DIT 118 (118)
T 3olo_A 88 QSGRIFLVEMSLTFLEDQE--RRFSCVFVREKS 118 (118)
T ss_dssp TTCCEEEEEEEEEEEEETT--EEEEEEEEEEC-
T ss_pred cCCCEEEEEEEEEEEEECC--ccEEEEEEEeCC
Confidence 9999999999999996543 346789999997
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-13 Score=127.32 Aligned_cols=124 Identities=15% Similarity=0.220 Sum_probs=86.0
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe----eEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQF 205 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~ 205 (716)
+.+..+++.++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++.........+...+..+.. +..++
T Consensus 40 ~~~~~~l~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (167)
T 1v9y_A 40 GIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSREL 119 (167)
T ss_dssp CCHHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CEE
T ss_pred HHHHHHHHhCCCCEEEECCCCcEEEECHHHHHHhCCCHHHHcCCChhhccCccccchHHHHHHHHhhcCCCcccccceEE
Confidence 44899999999999999999999999999999999999999999999988776544333334444433332 34477
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHHHH
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~la 255 (716)
.+..++|..+|+.++..|+ +.+|.+ +++++++|||++++++++|++++
T Consensus 120 ~~~~~~g~~~~~~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~e~~l~~la 167 (167)
T 1v9y_A 120 QLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQTRQLI 167 (167)
T ss_dssp EEECTTSCEEEEEEEEEEE-EETTEE-EEEEEEEC---------------
T ss_pred EEEcCCCcEEEEEEEEEEE-ecCCCE-EEEEEEecCcHHHHHHHHHHhhC
Confidence 7788999999999999999 456665 48999999999999999988764
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=121.91 Aligned_cols=115 Identities=11% Similarity=0.119 Sum_probs=102.1
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCc--cccccccccchhHHHHHHHHHcCCeeEEEE
Q 005054 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDA--IELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~--~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (716)
++++|+.++++++++|+++|.+|.++++|+++++++||+.++++++.. .+++++++.......+...+..+..+..++
T Consensus 2 s~~~~~~l~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~e~ 81 (118)
T 3icy_A 2 NAEELQALVDNIPAAIYHLDVSGQATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLTLVY 81 (118)
T ss_dssp HHHHHHHHHTTCCCCCEEECTTSCEEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEEEEE
T ss_pred cHHHHHHHHhcCCceEEEEEcCCCceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCceEEE
Confidence 357899999999999999999999999999999999999999988754 567777765555556677778888888999
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
++.+++|+.+|+.....|+++++|.+.+++++++|||
T Consensus 82 r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 82 RIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999999999999999999997
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.7e-13 Score=128.50 Aligned_cols=123 Identities=18% Similarity=0.246 Sum_probs=100.1
Q ss_pred CCHHHHHHHHHHcCceeEEEcCCCcEEEecHH---HHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEE
Q 005054 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRS---AELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (716)
Q Consensus 127 ~~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~a---ae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (716)
++.+.+.++|++++++|+++|.+|+|+|+|++ +++++| ..++++|+++.++.++.. ....+.+...++.|+....
T Consensus 16 l~~~~l~~IL~~~~~gI~~vD~~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~~-~~~v~~i~~~l~~g~~~~~ 93 (151)
T 2qkp_A 16 LSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPKV-LDKVKKVFELLRNGQRDKV 93 (151)
T ss_dssp ECHHHHHHHHHHSSSEEEEEETTSBEEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHHH-HHHHHHHHHHHHTTSBSEE
T ss_pred ecHHHHHHHHHhCCCceEEEcCCCeEEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHHH-HHHHHHHHHHHHcCCccEE
Confidence 56688999999999999999999999999999 999999 567899999999876432 3344567788888987766
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHH
Q 005054 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (716)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~ 252 (716)
++.....+ ...++.++..||+|++|+++|++.+++|||+.++++++.+
T Consensus 94 ~~~~~~~~-~~~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~~r~ 141 (151)
T 2qkp_A 94 NMWFQSER-LGKFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDSEFN 141 (151)
T ss_dssp EEEEEETT-TTEEEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGGC--
T ss_pred EEEEecCC-CCeEEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhhhhh
Confidence 66654332 1256778899999999999999999999999988877644
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.42 E-value=6.6e-13 Score=116.52 Aligned_cols=114 Identities=14% Similarity=0.170 Sum_probs=96.6
Q ss_pred CHHHHHHHHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCC--ccccccccccchhHHHHHHHHHcCCeeEEE
Q 005054 128 TDRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D~d-G~Ii~vN~aae~l~Gys~eEliGk~--~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 204 (716)
.++.|+.++++++++|+++|.+ |+|+++|+++++++|++.++++|+. +..++++++.... ......+..+.....+
T Consensus 9 ~~~~~~~~~~~~~~~i~~~d~~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~e 87 (125)
T 3eeh_A 9 SERRVRELTEATNDILWEFTADLSEVLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDRELM-KDTMQSLMDGESADVE 87 (125)
T ss_dssp -CHHHHHHHSCCCCEEEEEETTSSCEEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHHH-HHHHHHHHTTCCEEEE
T ss_pred HHHHHHHHHhcCCceEEEEEcCCCcEEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHHH-HHHHHHHHcCCCccEE
Confidence 4478999999999999999999 9999999999999999999999987 4555655543332 2333446677778888
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
+.+..++|..+|+.++..|+.+.+|.+.+++++++|||
T Consensus 88 ~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 88 CRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp EEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 88899999999999999999999999999999999997
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.2e-13 Score=120.28 Aligned_cols=111 Identities=18% Similarity=0.215 Sum_probs=92.3
Q ss_pred HHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHc-CCeeEEEEEEEcCCC
Q 005054 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERWTGQFPAKTKTE 212 (716)
Q Consensus 134 ~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~-g~~~~~e~~~~~kdG 212 (716)
.++++.+++|+++|.+|+|+|+|+++++++||+.+|++|+++.+++++++.......+...+.. +.....+++++++||
T Consensus 7 ~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~~dG 86 (121)
T 2kdk_A 7 EINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDG 86 (121)
T ss_dssp CCCCCSSEEEEEECTTSBEEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEECSSS
T ss_pred ccccCCccEEEEECCCeeEEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Confidence 3567789999999999999999999999999999999999999988877654444445555654 344677888999999
Q ss_pred CEEEEEEEEEEEECCC-CCEEEEEEEEEchhHH
Q 005054 213 ERVLVVATNTPFYDDD-GTLVGIVCVSTDSRPF 244 (716)
Q Consensus 213 ~~~~v~~~~~PI~d~~-G~i~g~i~i~~DITer 244 (716)
+.+|+.++..|++|.. +.+.+++++.+||++.
T Consensus 87 ~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~ 119 (121)
T 2kdk_A 87 SFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGH 119 (121)
T ss_dssp CEEEEEEEEEEEECCSSSCEEEEEEEEECCSSC
T ss_pred CEEEEEEEEEEEECCCCCeeeEEEEEEEecccc
Confidence 9999999999999876 5677788999999864
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.42 E-value=7.4e-13 Score=121.86 Aligned_cols=111 Identities=14% Similarity=0.063 Sum_probs=84.4
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCC-------eeE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-------RWT 202 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~-------~~~ 202 (716)
+.+..++++++++|+++|.+|+|+++|++|++++||++++++|+++.+++++.........+......+. ...
T Consensus 7 ~~l~~i~~~~~d~i~~~D~~g~I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (129)
T 3mfx_A 7 ETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPVQHPA 86 (129)
T ss_dssp HHHHHHHTTCSSEEEEEETTSBEEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCSCEEE
T ss_pred HHHHHHHhcCCceEEEECCCCEEEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCcccccccCCCc
Confidence 5678899999999999999999999999999999999999999999999987654321111111111221 245
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhH
Q 005054 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (716)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITe 243 (716)
.++.++++||+.+|+.++++|+. ++.. .++++++|+..
T Consensus 87 ~E~~~~rkdG~~~~velsis~i~--~~~~-~~v~~~~~~~~ 124 (129)
T 3mfx_A 87 QETTLICASGKAKDVELSISYIP--GHEP-MFVMVMHDLEH 124 (129)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEC--SSSC-EEEEEEEEC--
T ss_pred eEEEEEcCCCCEEEEEEEEEEec--CCCc-EEEEEEechhh
Confidence 78889999999999999999996 3333 37888999754
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.3e-12 Score=115.13 Aligned_cols=113 Identities=16% Similarity=0.135 Sum_probs=94.1
Q ss_pred HHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCC--ccccccccccchhHHHHHHHHHcCCeeEEEEE
Q 005054 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~--~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (716)
+...++.++++|+++|. +|+|+++|+++++++||+.++++|++ +..+.++.........+...+..+..+..++.
T Consensus 21 ~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (138)
T 2l0w_A 21 IIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIA 100 (138)
T ss_dssp HHHHHTTTTSEEEEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEEEEE
T ss_pred HHHHHhcCCCCEEEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCceeEEE
Confidence 34445559999999999 99999999999999999999999998 44454444433334556677777777888888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHH
Q 005054 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (716)
Q Consensus 207 ~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITer 244 (716)
...++|..+|+.++..|+.+.+|.+.+++++++|||++
T Consensus 101 ~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 101 FYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred EECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 88999999999999999999999999999999999863
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.41 E-value=3.1e-12 Score=109.00 Aligned_cols=104 Identities=17% Similarity=0.161 Sum_probs=87.6
Q ss_pred ceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCc-cc-cccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEE
Q 005054 141 QSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDA-IE-LLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (716)
Q Consensus 141 d~Iiv~D~---dG~Ii~vN~aae~l~Gys~eEliGk~~-~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 215 (716)
.+|+++|. +|+|+++|+++++++||+.++++|+++ .. +.++.........+...+..+..+..++....++|..+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 58899997 599999999999999999999999982 44 44443333344566777888888888888889999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEchhHH
Q 005054 216 LVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (716)
Q Consensus 216 ~v~~~~~PI~d~~G~i~g~i~i~~DITer 244 (716)
|+.++..|+.+.+|.+.+++++++|||++
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 99999999999999999999999999863
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.38 E-value=6e-12 Score=116.29 Aligned_cols=105 Identities=17% Similarity=0.205 Sum_probs=91.8
Q ss_pred HHHHcCceeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccc-----------cchhHHHHHHHHHcCCe
Q 005054 135 ILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-----------DFDVAYDIVHRIKMGER 200 (716)
Q Consensus 135 lld~l~d~Iiv~D---~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~-----------~~~~~~~i~~~l~~g~~ 200 (716)
+++. +++|+++| .+|+|+|+|+++++++||+.+|++|+++..++++.. .......+...+..+..
T Consensus 31 ~~~~-~~~i~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (149)
T 3d72_A 31 PVDT-SVALILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAE 109 (149)
T ss_dssp SCCT-TSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSCCCTTCCCSSSCHHHHHHHHHHHHHTCC
T ss_pred hhcC-CccEEEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhHhCCccccccccccccccChHHHHHHHHHHHCCCc
Confidence 4455 48999999 799999999999999999999999999988887653 44445567778888888
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEc
Q 005054 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (716)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~D 240 (716)
+..++..+++||..+|+.+++.|+++.+|.+.+++++++|
T Consensus 110 ~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 110 VQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp EEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred eEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 8889999999999999999999999999999999999876
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.37 E-value=5e-12 Score=113.29 Aligned_cols=109 Identities=13% Similarity=0.109 Sum_probs=81.3
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhH--cCCCccccccccccchhHHHHHHHHHcCCeeEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA--LGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEl--iGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (716)
++.|+.++++++++|+++|.+|+|+++|+++++++||+.+|+ +|+++.++++ +. ......+.....+.....+..
T Consensus 16 ~~~~~~l~e~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~e~~ 92 (126)
T 3bwl_A 16 SSRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DA-EDVQTQLSGFSVDERRKFEGL 92 (126)
T ss_dssp HHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CH-HHHHHHHHTCCTTCEEEEEEE
T ss_pred HHHHHHHHhhCCcEEEEEcCCCCEEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CH-HHHHHHHHHHhcCCCcceEEE
Confidence 467899999999999999999999999999999999999999 5677777765 21 111111111123344555667
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 207 ~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
+.++||..+|+.++..++. .+|.. +++++++|||
T Consensus 93 ~~~~dG~~~~~~~~~~~~~-~~~~~-~~~~~~~DIT 126 (126)
T 3bwl_A 93 YERRDGSTMSVEVHLLRFN-LEGED-RFLAISRDIT 126 (126)
T ss_dssp EECTTSCEEEEEEEEEEEE-ETTEE-EEEEEEEEC-
T ss_pred EEeCCCCEEEEEEEeEEEe-cCCcE-EEEEEEEeCC
Confidence 7899999999999888874 34443 5788999997
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.9e-12 Score=112.22 Aligned_cols=108 Identities=18% Similarity=0.146 Sum_probs=87.7
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCee-EEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAK 208 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~-~~e~~~~ 208 (716)
.....++++++++|+++|.+|+|+++|++|++++|++.++++|+++.++++.... ....+..++..+... ..+..+.
T Consensus 7 ~l~~~il~~~~~~i~~~D~~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 84 (115)
T 3b33_A 7 SLPSAILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVTFV 84 (115)
T ss_dssp CHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEEEE
T ss_pred ccHHHHHhhcCceEEEECCCCcEEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceEEe
Confidence 3457799999999999999999999999999999999999999999998765432 123455566666653 3455555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 209 ~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
++|..+|+.+++.|+.+ +|. .+++.+++||+
T Consensus 85 -~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 85 -VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp -ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred -cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 78999999999999988 776 68999999985
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.34 E-value=5.5e-12 Score=113.53 Aligned_cols=106 Identities=16% Similarity=0.211 Sum_probs=80.8
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhC------------CChhhHcCCCccccccccccchhHHHHHHHHH
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYG------------YSAEEALGQDAIELLTDGRDFDVAYDIVHRIK 196 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~G------------ys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~ 196 (716)
..+++.+|++++++|+++|.+|+|+|+|++|++++| |+.++++|+++.++++... ....+...+.
T Consensus 4 ~~rl~~il~~~~~gviv~D~~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~~~---~~~~~~~~~~ 80 (121)
T 4hi4_A 4 MARIASALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQRHLLANLT 80 (121)
T ss_dssp HHHHHHHHTTSSSEEEEEETTCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSSHH---HHHHHHHHCS
T ss_pred HHHHHHHHhcCCccEEEEcCCCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCCHH---HHHHHHhCcC
Confidence 367899999999999999999999999999999996 8999999999988875421 1122222222
Q ss_pred cCCeeEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHH
Q 005054 197 MGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (716)
Q Consensus 197 ~g~~~~~e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITer 244 (716)
..+..++.. +|. ++.+++.||++.+|.+.|++++++|||+.
T Consensus 81 --~~~~~~~~~---~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 81 --GVHKAELNL---GGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp --SCEEEEEEE---TTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred --CCcEEEEEE---CCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 223333332 443 45778999999999999999999999974
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.4e-12 Score=116.02 Aligned_cols=107 Identities=10% Similarity=0.057 Sum_probs=76.6
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEE
Q 005054 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (716)
++.|+.++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++.............+..+... .
T Consensus 18 ~~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 91 (125)
T 3fc7_A 18 RKKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTAT------R 91 (125)
T ss_dssp --------CCSCCEEEEEETTSBEEEECHHHHHHHTSCHHHHTTSBGGGSSCHHHHHHHHHHHHHHHHHTSCE------E
T ss_pred HHHHHHHHhcCCCeEEEEcCCCeEEEECHHHHHHhCCCHHHHcCccHHHhCCHHHHHHHHHHHHHHhcCCCeE------E
Confidence 4678999999999999999999999999999999999999999999999884332222222224455666643 2
Q ss_pred cCCCC-EEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 209 TKTEE-RVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 209 ~kdG~-~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
..+|. .+|+.++..|+.+. |...|++++++|||
T Consensus 92 ~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 92 SEDAVGGRHYHNQYIPVDSH-RKSDTFQLVSRDIT 125 (125)
T ss_dssp EEEEETTEEEEEEEEESSTT-TTTTEEEEEEEECC
T ss_pred eEcCCCcEEEEEEEEeEecC-CCeEEEEEEEecCC
Confidence 23444 68999999998654 66678999999997
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.7e-12 Score=114.93 Aligned_cols=107 Identities=17% Similarity=0.079 Sum_probs=86.0
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
..++.+|++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+..++..|+....++....
T Consensus 12 ~~~~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (118)
T 3fg8_A 12 SGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQQTRVDSLY 91 (118)
T ss_dssp -CCCCSSSCTTCEEEEECTTCBEEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCEEEEEECSS
T ss_pred chHHHHHhhCCceEEEECCCCeEEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCceEEEEEEEc
Confidence 34577899999999999999999999999999999999999999999999876555555567788888887766433333
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHH
Q 005054 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITer 244 (716)
.+| .|+.+++.|+. + |++++++|||++
T Consensus 92 ~~g--~~~~~~~~p~~--~----g~v~~~~DITer 118 (118)
T 3fg8_A 92 SPG--MTIEVTAAADS--G----ALVVHFRDVTAE 118 (118)
T ss_dssp STT--CEEEEEEEEET--T----EEEEEEEECSCC
T ss_pred CCC--eEEEEEEEEcC--C----cEEEEEEeccCC
Confidence 356 57778888884 3 378899999974
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=127.00 Aligned_cols=143 Identities=15% Similarity=0.033 Sum_probs=111.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEEe
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVmE 582 (716)
...|++...++.|+++.||++...+..+++|+........ ...+.+|+.+|+.+. +..++++++++...+..|+|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3568999999999999999998888899999987532111 134678899998884 6678889988888888999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN--------------------------------------- 623 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~--------------------------------------- 623 (716)
|++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999999987632 11223467789999999999810
Q ss_pred ------------------CCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 624 ------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 624 ------------------~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..++|+|++|.|||++.+..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 2289999999999998765567999998754
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.1e-11 Score=107.13 Aligned_cols=92 Identities=21% Similarity=0.160 Sum_probs=68.5
Q ss_pred HHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHc-CCeeEEEEEEEcCCC
Q 005054 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERWTGQFPAKTKTE 212 (716)
Q Consensus 134 ~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~-g~~~~~e~~~~~kdG 212 (716)
.+++++++.|+++|.+|+|+|+|+++++++||+.+|++|+++.+++++++.... ...+.. +.....+++++++||
T Consensus 3 ~lle~~~d~i~v~d~~G~i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~----~~~~~~~~~~~~~e~r~~~kdG 78 (111)
T 2vlg_A 3 FPLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLV----ESYFYNEHHLMPCTFRFIKKDH 78 (111)
T ss_dssp ------CCEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHH----HHHHHCSCCSSCEEEEEECTTS
T ss_pred chhhcCCCEEEEEcCCCeEEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHH----HHHHhccCCCccEEEEEEcCCC
Confidence 478999999999999999999999999999999999999999999988774332 233332 333456788889999
Q ss_pred CEEEEEEEEEEEECCCC
Q 005054 213 ERVLVVATNTPFYDDDG 229 (716)
Q Consensus 213 ~~~~v~~~~~PI~d~~G 229 (716)
+.+|+.+++.++.+..+
T Consensus 79 ~~~wve~~~~~v~~~~~ 95 (111)
T 2vlg_A 79 TIVWVEAAVEIVTTRAE 95 (111)
T ss_dssp CEEEEEEEEEEC-----
T ss_pred CEEEEEEEEEEEecccC
Confidence 99999999999987654
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=5.2e-11 Score=129.03 Aligned_cols=109 Identities=16% Similarity=0.138 Sum_probs=97.7
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEEE
Q 005054 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (716)
Q Consensus 140 ~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (716)
.+.++..|.+|+|+|+|++++.++||+++|++|+++.+++++++.......+...+..|+....+++++++||..+|+..
T Consensus 251 ~~f~~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv~~ 330 (361)
T 4f3l_A 251 EEFTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQT 330 (361)
T ss_dssp CEEEEEECTTSBEEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEEEE
T ss_pred ceeEEEEcCCceEEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEEEE
Confidence 35566789999999999999999999999999999999999888766666677788888877778999999999999999
Q ss_pred EEEEEECC-CCCEEEEEEEEEchhHHHHHH
Q 005054 220 TNTPFYDD-DGTLVGIVCVSTDSRPFQETR 248 (716)
Q Consensus 220 ~~~PI~d~-~G~i~g~i~i~~DITerk~~e 248 (716)
+..|++|. +|++.++|++.+|||+++..+
T Consensus 331 ~~~~v~~~~~g~~~~iv~~~~dITe~~~~~ 360 (361)
T 4f3l_A 331 HYYITYHQWNSRPEFIVCTHTVVSYAEVRA 360 (361)
T ss_dssp EEEEEECTTTCCEEEEEEEEEECCHHHHHH
T ss_pred EEEEEEcCCCCCeeEEEEEEEECChhHhhc
Confidence 99999997 799999999999999998765
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=99.18 E-value=5.6e-12 Score=134.66 Aligned_cols=142 Identities=17% Similarity=0.197 Sum_probs=102.9
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEc
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (716)
++++.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.++.... .....+...+..+...... .
T Consensus 8 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~ 80 (349)
T 3a0r_A 8 NFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENKEPVFLN----F 80 (349)
T ss_dssp -CCCSSGGGSSSEEEEEESSSBCSCBCHHHHHHHSCCSTTTTTCBSTTSTTTT---HHHHHHHHHHHHCCCCEEE----C
T ss_pred HHHHHHHhhhcCeEEEECCCCCEEeeHHHHHHHhCCCHHHHcCcCHHHCcChh---HHHHHHHHHHhcCCceeec----c
Confidence 45678999999999999999999999999999999999999999998883322 2233345556666543322 2
Q ss_pred CCCCEEEEEEEEEEEECCCCCE-EEEEEEEEchhHHHHHHHHHHHHHhhcCcCCcCCchhHHHHHhCCCchhHHHHH
Q 005054 210 KTEERVLVVATNTPFYDDDGTL-VGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (716)
Q Consensus 210 kdG~~~~v~~~~~PI~d~~G~i-~g~i~i~~DITerk~~e~~L~~la~~D~~~~l~~~~~~l~~~~~~d~~q~l~~~ 285 (716)
..+...|+.++..|+.+.+|.. .|++++++|||+++++++++++..... ....+.+.+.|+..+||..+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~~~~~~~-------~~~~~~~~i~Helr~pL~~i 150 (349)
T 3a0r_A 81 YKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERKRRERLS-------ILGEMTARVAHEIRNPITII 150 (349)
T ss_dssp CCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTTHHHHHH-------HHHHHHHHHHHHHHHHHHHH
T ss_pred cccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHHHHHHHH-------HHHHHHHHHHHHhcchHHHH
Confidence 2223457888999998877764 589999999999998887765443211 11236666777777777654
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=99.16 E-value=5.3e-11 Score=129.28 Aligned_cols=119 Identities=17% Similarity=0.324 Sum_probs=99.0
Q ss_pred CCCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEE
Q 005054 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (716)
Q Consensus 126 ~~~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (716)
.+..+.+.++|++++++|+++|.+|+|+|+|++ +++| ++.++++|+++.+++++.. ......+..++..|.....++
T Consensus 235 ~~~~~~l~~IL~~l~dgIivvD~~g~I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~~-~~~~~~l~~~l~~g~~~~~~~ 311 (369)
T 3cax_A 235 YLNIEELKAIFEALPVDVTFIDKDDRVRFFSPG-ERIF-TRTPSVLGRPVQLCHPPKS-VYVVNKILKAFKEGRKKEATF 311 (369)
T ss_dssp EECHHHHHHHHHHSSSEEEEECTTSBEEEECCS-SCSS-CCCGGGTTCBTTTSSCGGG-HHHHHHHHHHHHHTSCSCEEE
T ss_pred hhhHHHHHHHHHhCCCcEEEECCCCcEEEEcCH-HHcc-CChHHHcCCcHHHHCChhh-HHHHHHHHHHHHcCCceEEEE
Confidence 356788999999999999999999999999999 9999 9999999999999887543 233456777888888755555
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHH
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~ 250 (716)
... .+| .++.++..||+|.+|.++|++.+++|||++++++++
T Consensus 312 ~~~-~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~~ 353 (369)
T 3cax_A 312 WLR-LRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEGE 353 (369)
T ss_dssp EEE-ETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCSC
T ss_pred EEe-eCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHHH
Confidence 544 345 578889999999999999999999999999877544
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.09 E-value=2.8e-11 Score=106.88 Aligned_cols=101 Identities=16% Similarity=0.187 Sum_probs=75.6
Q ss_pred cCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHH-HH-cCCee---EEEEEEEcCCC
Q 005054 139 MGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR-IK-MGERW---TGQFPAKTKTE 212 (716)
Q Consensus 139 l~d~Iiv~D~d-G~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~-l~-~g~~~---~~e~~~~~kdG 212 (716)
.+++|+++|.+ |+|+++|++|+++|||+++|++|+++.+++++.... ....+... +. .+... ..++.++++||
T Consensus 7 ~~~~i~~~d~~~g~I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG 85 (114)
T 1ll8_A 7 FNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSD-VVEALSEEHMEADGHAAVVFGTVVDIISRSG 85 (114)
T ss_dssp TTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTH-HHHHTTSSTTSSSSCSSCCCSSSEEECCTTC
T ss_pred CCceEEEEECCCCeEEEehHHHHHHhCCCHHHHcCCCHHHhcCcchhH-HHHHHHHHhhccCCcceeccCcEEEEEecCC
Confidence 45799999999 999999999999999999999999999998875431 11122211 11 12211 23466789999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 213 ~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
+.+|+.+++.|+.+.++. +++++++|++
T Consensus 86 ~~~~v~~~~~~~~~~~~~--~~v~~~~~~~ 113 (114)
T 1ll8_A 86 EKIPVSVWMKRMRQERRL--CCVVVLEPVE 113 (114)
T ss_dssp CCEEEECCEECCBSSSSB--EEEEEEEECC
T ss_pred CEEEEEEEEEeeccCCcc--EEEEEEeecC
Confidence 999999999999765543 5788888875
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.5e-10 Score=124.78 Aligned_cols=108 Identities=15% Similarity=0.112 Sum_probs=89.3
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe-eEEEEEEEcCCCCEEEE
Q 005054 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAKTKTEERVLV 217 (716)
Q Consensus 139 l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~~kdG~~~~v 217 (716)
..+.++..|.+|+|+|+|++++.++||+++|++|+++.+++++++.......+...+..+.. ...+++++++||..+|+
T Consensus 277 ~~~fi~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~vWv 356 (387)
T 4f3l_B 277 SMEYVSRHAIDGKFVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSFITL 356 (387)
T ss_dssp CCEEEEEECTTSBEEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCEEEE
T ss_pred CceEEEEECCCCEEEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCEEEE
Confidence 34567779999999999999999999999999999999999988765554455555655443 55689999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEchhHHHH
Q 005054 218 VATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (716)
Q Consensus 218 ~~~~~PI~d~-~G~i~g~i~i~~DITerk~ 246 (716)
..+..++++. +|.+.++|++.+|||+||+
T Consensus 357 ~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 357 RSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 9999999987 7899999999999999874
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.2e-09 Score=90.62 Aligned_cols=95 Identities=21% Similarity=0.280 Sum_probs=72.5
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEE
Q 005054 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (716)
Q Consensus 139 l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (716)
++++|+++|.+|+|+++|+++++++|++.++++|+++.++ +. . ......+...+..+.... +... +|..+|+.
T Consensus 1 ~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~-~~-~-~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~ 73 (96)
T 3a0s_A 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDL-PD-F-EEIGSVAESVFENKEPVF--LNFY--KFGERYFN 73 (96)
T ss_dssp CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGS-TT-C-HHHHHHHHHHHHHTCCEE--EEEE--EETTEEEE
T ss_pred CCceEEEEcCCCCEeehhHHHHHHhCCCHHHhcCCCHHHC-cc-h-HHHHHHHHHHhccCCeEE--EEEE--cCCcEEEE
Confidence 4789999999999999999999999999999999999888 32 2 223334555666666543 2222 34457899
Q ss_pred EEEEEEECCCCC-EEEEEEEEEc
Q 005054 219 ATNTPFYDDDGT-LVGIVCVSTD 240 (716)
Q Consensus 219 ~~~~PI~d~~G~-i~g~i~i~~D 240 (716)
++..|+.+.+|. +.|++++++|
T Consensus 74 ~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 74 IRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEeEcCCCCeeeEEEEEecC
Confidence 999999987654 6799999887
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=4.7e-10 Score=120.95 Aligned_cols=144 Identities=19% Similarity=0.237 Sum_probs=106.9
Q ss_pred eEeeeeecCCcEEEEEEEEcCCeEEEEEee--ccCCCHHHHHHHHHHHHHHHhcC--CCceeEEeceeccC---CceEEE
Q 005054 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFS--RQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSP---QRLCIV 580 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~E~~iL~~l~--hpnIv~~~~~~~~~---~~~~lV 580 (716)
..++.|+.|.++.||++...+..+++|+.. ..... .....+.+|+.+|+.+. +..+++++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999999888889999875 32211 12346778999999886 44577888887766 458999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-------------------------------------- 622 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~-------------------------------------- 622 (716)
|||++|..+.+.. ...++......++.+++..|..||..
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999987764311 12367888888999999999999973
Q ss_pred ------------------CCCeEEcCCCCCcEEEccCCc--EEEEecCCCccc
Q 005054 623 ------------------NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLK 655 (716)
Q Consensus 623 ------------------~~~IvHrDIKp~NILl~~~~~--vkL~DFGla~~~ 655 (716)
...+||+|++|.|||++.++. +.|+||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 134999999999999987653 699999988643
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=99.02 E-value=3.4e-09 Score=96.08 Aligned_cols=100 Identities=10% Similarity=0.035 Sum_probs=79.8
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccc-ccccccchhHHHHHHHHHcCCeeEEEEEEE-cC
Q 005054 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIEL-LTDGRDFDVAYDIVHRIKMGERWTGQFPAK-TK 210 (716)
Q Consensus 133 ~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l-~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~-~k 210 (716)
..++++++.||+++|.+|+|++||.+++++.||++++++|+++.+. .+..........+.+.+..|. ....+.+. ++
T Consensus 20 ~~~ld~l~~Gii~lD~~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~-l~~~~~~v~~~ 98 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGN-LNTMFEYTFDY 98 (125)
T ss_dssp HHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTC-CEEEEEEEECT
T ss_pred HHHHhccCceEEEECCCCEEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEEcC
Confidence 4479999999999999999999999999999999999999999874 444444566667888888888 66666555 89
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEE
Q 005054 211 TEERVLVVATNTPFYDDDGTLVGIV 235 (716)
Q Consensus 211 dG~~~~v~~~~~PI~d~~G~i~g~i 235 (716)
+|.++++ .++...+++|...+++
T Consensus 99 ~~~p~~v--~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 99 QMTPTKV--KVHMKKALSGDSYWVF 121 (125)
T ss_dssp TSCCEEE--EEEEEECSSSSEEEEE
T ss_pred CCCEEEE--EEEEEEcCCCCEEEEE
Confidence 9986665 5555666888776554
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.99 E-value=8.8e-11 Score=102.77 Aligned_cols=104 Identities=18% Similarity=0.218 Sum_probs=82.0
Q ss_pred CCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCC---ChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEE
Q 005054 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGY---SAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (716)
Q Consensus 127 ~~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gy---s~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (716)
...+.++.++++++++|+++|.+|+|+++|++|++++|| +.++++|+++.+++++.. +...+..+.....
T Consensus 12 ~~~~~~~~il~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~~ 84 (118)
T 2w0n_A 12 TLFEQRQAMLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVLRDGTPRRD 84 (118)
T ss_dssp TTHHHHHHHHHCCCCCCEEEBTTTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHHHTTCCCCC
T ss_pred HHHHHHHHHHhhccccEEEECCCCcEeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHhccCceecc
Confidence 345778999999999999999999999999999999997 889999999988876532 4455565554322
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
.. . ..+| .|+.++..|+.+ +|.+.|++++++|||
T Consensus 85 ~~-~-~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 85 EE-I-TIKD--RLLLINTVPVRS-NGVIIGAISTFRDKT 118 (118)
T ss_dssp CC-E-ESSS--CEECCCEECCCC-SSCCCCEEECCCCCC
T ss_pred EE-E-EECC--EEEEEeeceeee-CCEEEEEEEEEEeCC
Confidence 21 1 2355 467778889986 788889999999997
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=98.98 E-value=4.6e-09 Score=95.49 Aligned_cols=98 Identities=14% Similarity=0.028 Sum_probs=78.4
Q ss_pred HHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccc-ccccccchhHHHHHHHHHcCCeeEEEEEEE-cCCC
Q 005054 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIEL-LTDGRDFDVAYDIVHRIKMGERWTGQFPAK-TKTE 212 (716)
Q Consensus 135 lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l-~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~-~kdG 212 (716)
+|++++.||+++|.+|+|++||.+++++.||++++++|+++.+. .+..........+.+.+..|. ....+.+. +++|
T Consensus 27 ~ld~l~~GiivlD~dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~-l~~~~~yv~~~~~ 105 (129)
T 1mzu_A 27 EFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT-LDARFDFVFDFQM 105 (129)
T ss_dssp TGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSC-CEEEEEEEEECSS
T ss_pred HHhccCceEEEECCCCeEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEEcCCC
Confidence 59999999999999999999999999999999999999999874 444444566667888888777 66565555 8899
Q ss_pred CEEEEEEEEEEEECCCCCEEEEE
Q 005054 213 ERVLVVATNTPFYDDDGTLVGIV 235 (716)
Q Consensus 213 ~~~~v~~~~~PI~d~~G~i~g~i 235 (716)
..+++ .++...+.+|...+++
T Consensus 106 ~p~~v--~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 106 APVRV--QIRMQNAGVPDRYWIF 126 (129)
T ss_dssp CEEEE--EEEEEECSSTTEEEEE
T ss_pred CEEEE--EEEEEEcCCCCEEEEE
Confidence 86665 5555666888776553
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=5.9e-10 Score=113.58 Aligned_cols=137 Identities=16% Similarity=0.093 Sum_probs=98.0
Q ss_pred cceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn--Iv~~~~~~~~~~~~~lVm 581 (716)
..|.+....+.|..+.||++... +..+++|+..... ...+.+|+.+++.+.+.+ +++++.++...+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 45666544456667999999764 5679999976541 134667888888885434 556888888878899999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-------------------------------------- 623 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~-------------------------------------- 623 (716)
||++|.+|. ... ... ..++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998873 211 121 245667777777777643
Q ss_pred ------------------CCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 624 ------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 624 ------------------~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
..++|+|++|.|||++.++.+.|+||+.+...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 12999999999999987766679999987643
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.95 E-value=6.2e-10 Score=108.07 Aligned_cols=104 Identities=14% Similarity=0.203 Sum_probs=80.2
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCC-e-eEEEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-R-WTGQFPA 207 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~-~-~~~e~~~ 207 (716)
+.++.+|+++++||+++|.+|+|+++|++|+++||++.++++|+++.++++... +...+..+. . ...++..
T Consensus 80 ~~l~~il~~~~~gvi~~D~~g~I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 152 (190)
T 2jhe_A 80 LALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLINGFN-------FLRWLESEPQDSHNEHVVI 152 (190)
T ss_dssp HHHHHHHHHCSSCEEEECTTCBEEEECHHHHHHHTSCHHHHTTSBGGGTSTTCC-------HHHHHHTCCCSCEEEEEEE
T ss_pred HHHHHHHHhCCCcEEEEcCCCCEEEEcHHHHHHhCCCHHHhcCccHHHHhCCCC-------HHHHHhcCCCCCcceEEEE
Confidence 568999999999999999999999999999999999999999999999887542 223444443 2 3333332
Q ss_pred EcCCCCEEEEEEEEEEEECCCCC----EEEEEEEEEchhHHH
Q 005054 208 KTKTEERVLVVATNTPFYDDDGT----LVGIVCVSTDSRPFQ 245 (716)
Q Consensus 208 ~~kdG~~~~v~~~~~PI~d~~G~----i~g~i~i~~DITerk 245 (716)
+|. ++.+.+.|+.+.+|. +.|++++++|||+++
T Consensus 153 ---~g~--~~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~ 189 (190)
T 2jhe_A 153 ---NGQ--NFLMEITPVYLQDENDQHVLTGAVVMLRSTIRMG 189 (190)
T ss_dssp ---TTE--EEEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTC
T ss_pred ---CCe--EEEEEEEEEEecCCCCcceEEeEEEEEeccchhc
Confidence 664 455678899775665 788899999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.4e-09 Score=114.48 Aligned_cols=186 Identities=21% Similarity=0.200 Sum_probs=123.1
Q ss_pred eeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCc--eeEEeceeccCC---ceEEEEee
Q 005054 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPN--VLLFMGAVTSPQ---RLCIVTEF 583 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpn--Iv~~~~~~~~~~---~~~lVmE~ 583 (716)
++.++.|.+..||++. ..+++|+.... .....+.+|..+|+.+ .+.. +++++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999873 67999986432 3456788899999887 3322 344554443333 34899999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN---------------------------------------- 623 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~---------------------------------------- 623 (716)
++|.+|...... .++......++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999888654322 3677777788888888888888621
Q ss_pred ----------------CCeEEcCCCCCcEEEcc--CCcEEEEecCCCcccccCccccccCCCCCCccCccccc----CCC
Q 005054 624 ----------------PPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR----NEP 681 (716)
Q Consensus 624 ----------------~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~ 681 (716)
..++|+|++|.|||++. ...+.|+||+.+............ .....-..|+... ...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~-~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISL-MEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTT-CCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHH-HhhccccCHHHHHHHHHHcC
Confidence 13799999999999998 456889999988754332111111 1000002333211 111
Q ss_pred C-C---------chhHHHHHHHHHHHHHcCCCCCC
Q 005054 682 S-D---------EKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 682 ~-~---------~~sDIwSlG~ll~elltG~~PF~ 706 (716)
. + ...++|+++.++|.+.+|..||-
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 1 12689999999999999998873
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.73 E-value=4.9e-08 Score=104.31 Aligned_cols=103 Identities=13% Similarity=0.051 Sum_probs=87.1
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe-----eEEEEEEEcCCCCE
Q 005054 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-----WTGQFPAKTKTEER 214 (716)
Q Consensus 140 ~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~-----~~~e~~~~~kdG~~ 214 (716)
.+.|+..|.+|+|+|+|+++..++||+++|++|+++.+++++++.......+...+..|+. ...+++++++||..
T Consensus 154 ~~fi~r~~~dG~~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kdG~~ 233 (339)
T 3rty_A 154 PKFAIRHTATGIISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQNGCY 233 (339)
T ss_dssp CEEEEEEETTCBEEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTTSCE
T ss_pred ceEEEEECCCCeEEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccCCCE
Confidence 5677889999999999999999999999999999999999998866555566777777774 35688999999999
Q ss_pred EEEEEEEEEEECCC-CCEEEEEEEEEchh
Q 005054 215 VLVVATNTPFYDDD-GTLVGIVCVSTDSR 242 (716)
Q Consensus 215 ~~v~~~~~PI~d~~-G~i~g~i~i~~DIT 242 (716)
+|++.+..+++|.. +.+..+|++-+.|+
T Consensus 234 vWlet~~~~~~np~s~~~~~II~~h~vi~ 262 (339)
T 3rty_A 234 VLLETEWTSFVNPWSRKLEFVVGHHRVFQ 262 (339)
T ss_dssp EEEEEEEEEEECTTTCSEEEEEEEEEEEE
T ss_pred EEEEEEEEEEECCCCCCeeEEEEEEEECC
Confidence 99999999999875 56777777766553
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.59 E-value=4.5e-07 Score=95.94 Aligned_cols=99 Identities=12% Similarity=0.054 Sum_probs=82.2
Q ss_pred ceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe---eEEEEEEEcCCCCEEEE
Q 005054 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTKTEERVLV 217 (716)
Q Consensus 141 d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~kdG~~~~v 217 (716)
.-+...|.+|+|+|+|+++..++||.++|++|+++.+++++++.......+.+.+..+.. ...+++++++||..+|+
T Consensus 175 ~Fitrh~~dG~~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vwv 254 (317)
T 4dj3_A 175 IFTTTHTPGCVFLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVIL 254 (317)
T ss_dssp EEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEEE
T ss_pred ceEEEecCCCeEEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEEE
Confidence 456668889999999999999999999999999999999998876655566666776553 35678999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEE
Q 005054 218 VATNTPFYDD-DGTLVGIVCVST 239 (716)
Q Consensus 218 ~~~~~PI~d~-~G~i~g~i~i~~ 239 (716)
+....++++. .+++..+|+.-+
T Consensus 255 et~~~~~~np~s~~~e~II~~h~ 277 (317)
T 4dj3_A 255 DSSWSSFVNPWSRKVSFIIGRHK 277 (317)
T ss_dssp EEEEEEEECSSSCCEEEEEEEEE
T ss_pred EEEEEEEECCCCCcccEEEEEEE
Confidence 9999999986 456666777665
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.00 E-value=6e-09 Score=110.06 Aligned_cols=112 Identities=16% Similarity=0.126 Sum_probs=80.3
Q ss_pred HHHHcCceeEEEcCCCcEEEecHHHHHHhC---CChhhHcCCCcccccccc---ccc--hhHHHHHHHHHc-CCeeEEEE
Q 005054 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYG---YSAEEALGQDAIELLTDG---RDF--DVAYDIVHRIKM-GERWTGQF 205 (716)
Q Consensus 135 lld~l~d~Iiv~D~dG~Ii~vN~aae~l~G---ys~eEliGk~~~~l~~~~---~~~--~~~~~i~~~l~~-g~~~~~e~ 205 (716)
+++.+++||+++|.+|+|+|+|++|+++|+ +. ++++|+++.++++.. ... .....+...+.. +.....++
T Consensus 175 ~~~~~~dGIivvD~~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~~~~l~~vl~~~~~~~~~ei 253 (305)
T 2ykf_A 175 SSPRAGDGFIRLDVDGVVSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKGMRMEV 253 (305)
Confidence 456899999999999999999999999985 44 789999999988653 100 111112223333 33222222
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchhHHHHHHHHHHH
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DITerk~~e~~L~~ 253 (716)
. .+ ..++.++..|+.+ +|.+.|++.+++|||++++++++|+.
T Consensus 254 ~---~~--~~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~~lE~eL~~ 295 (305)
T 2ykf_A 254 D---AG--GATVLLRTLPLVV-AGRNVGAAILIRDVTEVKRRDRALIS 295 (305)
Confidence 1 12 3567778889975 57888999999999999999999864
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.47 E-value=1e-06 Score=92.95 Aligned_cols=102 Identities=10% Similarity=0.032 Sum_probs=83.6
Q ss_pred ceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCC-eeE-EEEEEEcCCCCEEEEE
Q 005054 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-RWT-GQFPAKTKTEERVLVV 218 (716)
Q Consensus 141 d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~-~e~~~~~kdG~~~~v~ 218 (716)
.-+...+.+|+|+|+|+++..++||.++|++|+++.+++++++...........+..+. ... .+++++++||..+|++
T Consensus 166 ~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwve 245 (309)
T 3gdi_A 166 IFTTTHTPNCLFQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLD 245 (309)
T ss_dssp EEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEE
T ss_pred eEEEEecCCCeEEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEE
Confidence 45666889999999999999999999999999999999998886555455566666544 344 5899999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEchh
Q 005054 219 ATNTPFYDD-DGTLVGIVCVSTDSR 242 (716)
Q Consensus 219 ~~~~PI~d~-~G~i~g~i~i~~DIT 242 (716)
....++.+. .+++..+|++-+-++
T Consensus 246 t~~~~~~np~s~~~e~ii~~h~v~~ 270 (309)
T 3gdi_A 246 TSWSSFINPWSRKISFIIGRHKVRV 270 (309)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEEEE
T ss_pred EEEEEEECCCCCcccEEEEEEEEcc
Confidence 999999886 567778888776654
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.42 E-value=7.7e-07 Score=94.22 Aligned_cols=103 Identities=12% Similarity=0.041 Sum_probs=83.2
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHc-CCee-EEEEEEEcCCCCEEEE
Q 005054 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERW-TGQFPAKTKTEERVLV 217 (716)
Q Consensus 140 ~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~-g~~~-~~e~~~~~kdG~~~~v 217 (716)
..-+...|.+|+|+|+|+++..++||.++|++|+++.+++++++.......+...+.. |... ..+++++++||..+|+
T Consensus 176 ~~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwv 255 (320)
T 4dj2_A 176 RIFTTRHTPSCLFQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVTM 255 (320)
T ss_dssp CEEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEEE
T ss_pred ceEEEEecCCceEEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEEE
Confidence 4456678899999999999999999999999999999999988865444444555553 4444 3588999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEchh
Q 005054 218 VATNTPFYDD-DGTLVGIVCVSTDSR 242 (716)
Q Consensus 218 ~~~~~PI~d~-~G~i~g~i~i~~DIT 242 (716)
+....++.+. .+++..+|+.-+-|+
T Consensus 256 et~~~~~~np~s~~~e~II~~h~v~~ 281 (320)
T 4dj2_A 256 DTSWAGFVHPWSRKVAFVLGRHKVRT 281 (320)
T ss_dssp ECEEEEEECTTTCSEEEEEEEEEESS
T ss_pred EEEEEEEECCCCCCccEEEEEEEEcc
Confidence 9999999886 567878888766554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.9e-06 Score=89.31 Aligned_cols=137 Identities=18% Similarity=0.140 Sum_probs=93.3
Q ss_pred eeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCC---ceeEEeceec-cCCceEEEEeecC
Q 005054 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP---NVLLFMGAVT-SPQRLCIVTEFLP 585 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hp---nIv~~~~~~~-~~~~~~lVmE~~~ 585 (716)
++.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .+++++.+.. ..+..|+||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888999999988 78899998532 34456788999999998642 3456665553 4556789999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 005054 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN------------------------------------------ 623 (716)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~------------------------------------------ 623 (716)
|..|....-. .++......++.++...|..||+..
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9887653211 1334444444444444444444321
Q ss_pred ----------------CCeEEcCCCCCcEEEcc---CCc-EEEEecCCCcccc
Q 005054 624 ----------------PPIIHRDLKSSNLLVDK---HWT-VKVGDFGLSRLKH 656 (716)
Q Consensus 624 ----------------~~IvHrDIKp~NILl~~---~~~-vkL~DFGla~~~~ 656 (716)
..++|+|++|.|||++. ++. +.|+||+.+....
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 23699999999999987 455 4899999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=7.1e-06 Score=84.06 Aligned_cols=134 Identities=17% Similarity=0.212 Sum_probs=93.8
Q ss_pred eeecCCcE-EEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEEeecCCC
Q 005054 512 QIGQGSCG-TVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 512 ~LG~G~fg-~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
.+..|..+ .||+... .+..++||+.... ....+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34455554 6898765 3457999986532 2456778899888773 333667888888888999999999998
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 005054 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-------------------------------------------- 623 (716)
Q Consensus 588 sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~-------------------------------------------- 623 (716)
++.+...... .....+..++...|..||...
T Consensus 106 ~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8877654321 122334556666666666421
Q ss_pred ------------CCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 624 ------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 624 ------------~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
..++|+|+++.|||++.++.+-|+||+.+...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 01799999999999998766779999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=4e-06 Score=89.80 Aligned_cols=81 Identities=7% Similarity=0.022 Sum_probs=53.8
Q ss_pred eeEeeee-ecCCcEEEEEEEEc--------CCeEEEEEeeccC---CCHHHHHHHHHHHHHHHhcC-C--CceeEEecee
Q 005054 507 LTIGEQI-GQGSCGTVYHAVWY--------GSDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAV 571 (716)
Q Consensus 507 y~i~~~L-G~G~fg~Vy~~~~~--------~~~vAvK~~~~~~---~~~~~~~~~~~E~~iL~~l~-h--pnIv~~~~~~ 571 (716)
....+.| +.|....+|++... +..+++|+..... ... ...+.+|+.+|+.+. + -.+++++.++
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 3345678 88889999998765 6789999865432 100 123556777777763 2 3466777766
Q ss_pred ccC---CceEEEEeecCCCCH
Q 005054 572 TSP---QRLCIVTEFLPRGSL 589 (716)
Q Consensus 572 ~~~---~~~~lVmE~~~ggsL 589 (716)
.+. +..|+||||++|..+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 554 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.2e-05 Score=83.01 Aligned_cols=139 Identities=16% Similarity=0.091 Sum_probs=78.7
Q ss_pred eeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC--CCceeEEece------eccCCceEEEE
Q 005054 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGA------VTSPQRLCIVT 581 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~--hpnIv~~~~~------~~~~~~~~lVm 581 (716)
.+.|+.|....||++...+..+++|+.... . ..+..|..+++.|. .-.+++++.. ....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778899999887777999998752 2 22334455554442 1123344431 12356789999
Q ss_pred eecCCCCHH-----------HHH---hh--cCC--C---------CCHHH------------------------------
Q 005054 582 EFLPRGSLF-----------RLL---QR--NTT--K---------LDWRR------------------------------ 604 (716)
Q Consensus 582 E~~~ggsL~-----------~~l---~~--~~~--~---------l~~~~------------------------------ 604 (716)
+|++|..+. ..+ .. ... + ..+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999886431 111 11 000 0 01111
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 605 -RILMALDIARGVSYLHH-----------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 605 -v~~i~~ql~~aL~yLH~-----------~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+..+..++..++.+|+. ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223345666652 223499999999999998778899999998754
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.98 E-value=5e-05 Score=81.78 Aligned_cols=64 Identities=14% Similarity=0.169 Sum_probs=55.3
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHH
Q 005054 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI 191 (716)
Q Consensus 128 ~~~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i 191 (716)
.+++...+++++++.|+++|.+|+|+|+|++++.++||+.+|++|+++.+++++++.......+
T Consensus 84 ~~~~~~~~l~a~~~~i~v~~~~G~i~yvs~~~~~~lGy~~~el~g~~~~~~ihp~D~~~~~~~l 147 (361)
T 4f3l_A 84 NEEFTQLMLEALDGFFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEGEHSEVYKIL 147 (361)
T ss_dssp HHHHHHHHHHHTTEEEEEEETTSBEEEECTTHHHHHCCCHHHHTTSBGGGGSCGGGHHHHHHHH
T ss_pred HHHHHHHHHHhcCceEEEEcCCccEEEEechhhhhcCCCHHHhcCCcHHHhcCHHHHHHHHHHh
Confidence 3456677789999999999999999999999999999999999999999999988754444333
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.8e-05 Score=84.56 Aligned_cols=76 Identities=21% Similarity=0.157 Sum_probs=48.4
Q ss_pred eeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC--CH---HHHHHHHHHHHHHHhcCC--C-ceeEEeceeccCCceEE
Q 005054 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY--SD---EVIHSFRQEVSLMKRLRH--P-NVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~---~~~~~~~~E~~iL~~l~h--p-nIv~~~~~~~~~~~~~l 579 (716)
.+.||.|.++.||++.. .++.|+||....... .. ....++..|..+|+.+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 56899999999999954 467899998653211 00 012345678888887632 3 34456544 3445689
Q ss_pred EEeecCCC
Q 005054 580 VTEFLPRG 587 (716)
Q Consensus 580 VmE~~~gg 587 (716)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.80 E-value=8.3e-05 Score=80.90 Aligned_cols=60 Identities=18% Similarity=0.257 Sum_probs=52.3
Q ss_pred HHHHHHHHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccchhH
Q 005054 129 DRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188 (716)
Q Consensus 129 ~~~~~~lld~l~d~Iiv~D~d-G~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~ 188 (716)
+++...+++++...|++++.+ |+|+|+|++++.++||+.+|++|+++.+++++++.....
T Consensus 85 ~~~~~~ll~~~~gfi~v~~~~~G~i~yvs~~~~~~lG~~~~el~g~~~~~~ihp~D~~~~~ 145 (387)
T 4f3l_B 85 DELKHLILRAADGFLFVVGCDRGKILFVSESVFKILNYSQNDLIGQSLFDYLHPKDIAKVK 145 (387)
T ss_dssp HHHHHHHHHTCCSEEEEEETTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHH
T ss_pred HHHHHHHHhcCCCEEEEEecCCeEEEEEchhhHHHcCCCHHHHCCCcHHHhcCCCCHHHHH
Confidence 445566788999999999987 999999999999999999999999999999988754443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00014 Score=76.72 Aligned_cols=77 Identities=22% Similarity=0.166 Sum_probs=60.7
Q ss_pred eEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC---CCceeEEeceeccCCceEEEEeec
Q 005054 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIVTEFL 584 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~---hpnIv~~~~~~~~~~~~~lVmE~~ 584 (716)
.-.+.|+.|.+..+|+....+..++||+..... ...+..|...|+.|. ...+++++.+....+..++||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 345678999999999998888889999876431 356778888888773 356778888887778899999999
Q ss_pred CCCCH
Q 005054 585 PRGSL 589 (716)
Q Consensus 585 ~ggsL 589 (716)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 88753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00012 Score=80.29 Aligned_cols=76 Identities=16% Similarity=0.120 Sum_probs=45.0
Q ss_pred CeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccC-CCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHc
Q 005054 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELAT 700 (716)
Q Consensus 625 ~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~---~~~~sDIwSlG~ll~ellt 700 (716)
.++|+|++|.|||++.++ ++|+||+.+............. .-...|++|+...... .....++..+...+|.+++
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 499999999999998776 9999999887544221111000 0012355555443111 1123455566777776665
Q ss_pred C
Q 005054 701 E 701 (716)
Q Consensus 701 G 701 (716)
+
T Consensus 312 ~ 312 (420)
T 2pyw_A 312 K 312 (420)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00012 Score=77.97 Aligned_cols=97 Identities=15% Similarity=0.141 Sum_probs=66.3
Q ss_pred eEEEc-CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCee------------EEEEEEE-
Q 005054 143 VHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW------------TGQFPAK- 208 (716)
Q Consensus 143 Iiv~D-~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~------------~~e~~~~- 208 (716)
++|++ .+|+|+|+|+++..++||+.+|++|+++.+++++++.. .++..+..|.++ ..-.+.+
T Consensus 6 ~~vv~~~~G~i~yvS~~~~~~LGy~~~el~G~s~~d~ihp~D~~----~f~~~L~~gl~~~~~~~~~~~~~rsffcR~~r 81 (339)
T 3rty_A 6 CCVISMHDGIVLYTTPSITDVLGYPRDMWLGRSFIDFVHLKDRA----TFASQITTGIPIAESRGSVPKDAKSTFCVMLR 81 (339)
T ss_dssp EEEEETTTCBEEEECTTHHHHHCCCTTSSTTSBGGGGBCHHHHH----HHHHHHHTTSCCC----------CCEEEEEEE
T ss_pred EEEEECCCcEEEEEChHHHHHcCCCHHHHCCCcHHHhcCHHHHH----HHHHHHhcCCCCCccccCCCCCCceEEEEEEe
Confidence 56778 69999999999999999999999999999999987743 355556555432 1111111
Q ss_pred ---------------cCCCCEEEEEEEEEEEECC---------CCCEEEEEEEEEchhH
Q 005054 209 ---------------TKTEERVLVVATNTPFYDD---------DGTLVGIVCVSTDSRP 243 (716)
Q Consensus 209 ---------------~kdG~~~~v~~~~~PI~d~---------~G~i~g~i~i~~DITe 243 (716)
.+....+|+..+..++.++ +|...+++++.++++.
T Consensus 82 r~~~l~s~gy~v~~~~~~~~p~~l~~~~~~~~~e~~~~~~~~~~g~~~~lv~~a~~i~s 140 (339)
T 3rty_A 82 RYRGLKSGGFGVIGRPVSYEPFRLGLTFREAPEEARPDNYMVSNGTNMLLVICATPIKS 140 (339)
T ss_dssp CCC-------------CCEEEEEEEEEEEECCCC----------CCCEEEEEEEEECCC
T ss_pred ccCCCCcCCcceecccccceeEEEEEEEeccccccccccccccCCceEEEEEEcccCCc
Confidence 1123345555555666544 5666778888888873
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00028 Score=63.70 Aligned_cols=93 Identities=9% Similarity=-0.031 Sum_probs=73.9
Q ss_pred EEEcCCCcEEEecHHHHHHhCCCh--hhHcCCCccccccccccc--hhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEEE
Q 005054 144 HIFDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDF--DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (716)
Q Consensus 144 iv~D~dG~Ii~vN~aae~l~Gys~--eEliGk~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (716)
.=.|.+|+|+++.+...+ .+|.. +|++|+.+.+++++.+.. ...+...+++..|+......+++.++|..+|+..
T Consensus 11 sRh~~dGKf~~vDq~~~r-~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~~qT 89 (132)
T 1oj5_A 11 TKQDTTGKIISIDTSSLR-AAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHT 89 (132)
T ss_dssp EEECTTCCEEEEECHHHH-TTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEE
T ss_pred EeecCCCcEEEEeccccc-ccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCcEEEEEE
Confidence 347889999999999874 67777 999999999999998854 5556677788889888888999999999999999
Q ss_pred EEEEEECCC-CCEEEEEEE
Q 005054 220 TNTPFYDDD-GTLVGIVCV 237 (716)
Q Consensus 220 ~~~PI~d~~-G~i~g~i~i 237 (716)
....+++.. .++-.+|++
T Consensus 90 ~sk~f~np~t~e~e~Ivs~ 108 (132)
T 1oj5_A 90 RCKLCYPQSPDMQPFIMGI 108 (132)
T ss_dssp EEEEECC----CCCEEEEE
T ss_pred EEEEecCCCCCCCCEEEEE
Confidence 998887752 344445554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0007 Score=70.49 Aligned_cols=136 Identities=13% Similarity=0.098 Sum_probs=74.1
Q ss_pred eeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCce-eEEeceeccCCceEEEEeec-CCC
Q 005054 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFL-PRG 587 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnI-v~~~~~~~~~~~~~lVmE~~-~gg 587 (716)
++.|+.|....+|++ ..+++|+...... ......+|+.+++.+...++ ++++.+. .+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 678999999999999 6799998764311 01112346766666531111 4555443 33457899999 665
Q ss_pred CHHH---------------HHh---hcCCCC----C-HHHHHHHHHH--------------HHHHHH----HHHh--CCC
Q 005054 588 SLFR---------------LLQ---RNTTKL----D-WRRRILMALD--------------IARGVS----YLHH--CNP 624 (716)
Q Consensus 588 sL~~---------------~l~---~~~~~l----~-~~~v~~i~~q--------------l~~aL~----yLH~--~~~ 624 (716)
+|.. .+. .....+ . ...+..+... +...+. .|.. ...
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4321 010 111111 1 1111111110 111111 1111 112
Q ss_pred CeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 625 ~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.++|+|+.+.||| ..++.+.|+||..+...
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 3899999999999 55678999999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00081 Score=71.01 Aligned_cols=33 Identities=36% Similarity=0.443 Sum_probs=27.8
Q ss_pred CeEEcCCCCCcEEEccC----CcEEEEecCCCccccc
Q 005054 625 PIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLKHE 657 (716)
Q Consensus 625 ~IvHrDIKp~NILl~~~----~~vkL~DFGla~~~~~ 657 (716)
.++|+|+.+.|||++.+ +.+.|+||+.+.....
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 49999999999999874 6799999998875443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0024 Score=66.74 Aligned_cols=143 Identities=17% Similarity=0.153 Sum_probs=79.2
Q ss_pred eEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEece------eccCCceEE
Q 005054 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGA------VTSPQRLCI 579 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn--Iv~~~~~------~~~~~~~~l 579 (716)
.-.+.|+.|....+|++...+..+++|+...... ...+..|+.+++.+...+ +++++.. ....+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 3456778888899999988777899999875311 123445677766653111 3333322 122356789
Q ss_pred EEeecCCCCHH-----------HHH---hhc--C--CC----CC---HHHHHH------------HHHHHHHHHHHHHhC
Q 005054 580 VTEFLPRGSLF-----------RLL---QRN--T--TK----LD---WRRRIL------------MALDIARGVSYLHHC 622 (716)
Q Consensus 580 VmE~~~ggsL~-----------~~l---~~~--~--~~----l~---~~~v~~------------i~~ql~~aL~yLH~~ 622 (716)
+|+|++|..+. ..+ ... . .+ .. +..... +...+...+++|...
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 99999886421 111 111 0 00 11 111000 001134445555532
Q ss_pred -----CCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 623 -----NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 623 -----~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
...+||+|+++.|||++.++.+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 12399999999999998775568999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0022 Score=66.27 Aligned_cols=81 Identities=15% Similarity=0.113 Sum_probs=56.1
Q ss_pred hcccceeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-C--CceeEEeceeccCCce
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVTSPQRL 577 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-h--pnIv~~~~~~~~~~~~ 577 (716)
.......-++.+|.|..+.||++.. .|++|+||+........ ...+..|...|+.|. . --+++++.+. .-
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~ 85 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR 85 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred hcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence 3455677788999999999999987 57889999865443221 234667888888773 2 1244555442 34
Q ss_pred EEEEeecCCCC
Q 005054 578 CIVTEFLPRGS 588 (716)
Q Consensus 578 ~lVmE~~~ggs 588 (716)
++||||+++..
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 88999997664
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00043 Score=73.08 Aligned_cols=67 Identities=18% Similarity=0.129 Sum_probs=54.4
Q ss_pred CCCCCCCCHHHHHHH-----HHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccchh
Q 005054 121 GPSAFNFTDRQYLNI-----LQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDV 187 (716)
Q Consensus 121 g~~~~~~~~~~~~~l-----ld~l~d~Iiv~D~d-G~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~ 187 (716)
+-....++.+.+..+ |+++..-++++..+ |+|+|+++.+..++||+.+|++|+++.+++++++....
T Consensus 12 ~~~~~~~s~eel~~l~~e~lLqaldGF~~vvs~~~G~i~yvS~sv~~~Lg~~~~~l~g~s~~d~iHp~D~~~f 84 (320)
T 4dj2_A 12 AMDMSTYTLEELEHITSEYTLRNQDTFSVAVSFLTGRIVYISEQAGVLLRCKRDVFRGARFSELLAPQDVGVF 84 (320)
T ss_dssp --CCSEECHHHHHHHHHHHTTSCSSEEEEEEETTTCBEEEECTHHHHHHTSCSTTTTTSBGGGGBCHHHHHHH
T ss_pred ccCccccCHHHHHHHHHHHHHhccCCEEEEEECCCceEEEECcHHHHHhCcCHHHHcCCcHHHhcCHHHHHHH
Confidence 334455778888877 66677777788875 99999999999999999999999999999998875433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0048 Score=65.47 Aligned_cols=32 Identities=22% Similarity=0.347 Sum_probs=27.9
Q ss_pred CeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 625 ~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.++|+|+.+.|||++.++.+.|+||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 49999999999999988889999999876543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0045 Score=68.07 Aligned_cols=71 Identities=14% Similarity=0.200 Sum_probs=47.1
Q ss_pred EeeeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc-eeEEeceeccCCceE
Q 005054 509 IGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLC 578 (716)
Q Consensus 509 i~~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn-Iv~~~~~~~~~~~~~ 578 (716)
-++.|+.|....||++... +..|++|+..... . ...+.+|..+++.+...+ .+++++.+.. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3567888889999999874 4679999884321 1 123346888888774222 3566665542 3
Q ss_pred EEEeecCCC
Q 005054 579 IVTEFLPRG 587 (716)
Q Consensus 579 lVmE~~~gg 587 (716)
+||||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0054 Score=67.97 Aligned_cols=73 Identities=14% Similarity=0.115 Sum_probs=46.5
Q ss_pred EeeeeecCCcEEEEEEEEcC--CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCce-eEEeceeccCCceEEEEeecC
Q 005054 509 IGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFLP 585 (716)
Q Consensus 509 i~~~LG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnI-v~~~~~~~~~~~~~lVmE~~~ 585 (716)
-++.|+.|-...+|++...+ ..|++|+...... ... ...+|..+|+.|...++ +++++++.. .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence 34678888889999998876 7899998754211 001 11468888888854334 467766632 35999998
Q ss_pred CCC
Q 005054 586 RGS 588 (716)
Q Consensus 586 ggs 588 (716)
|..
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0082 Score=62.86 Aligned_cols=140 Identities=11% Similarity=0.059 Sum_probs=77.7
Q ss_pred eeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC--CceeEEece-----eccCCceEEEEe
Q 005054 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGA-----VTSPQRLCIVTE 582 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h--pnIv~~~~~-----~~~~~~~~lVmE 582 (716)
..|+ |....||++... ++.+++|+........ ..+..|..+++.+.. -.+++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 888899988764 5579999987543333 344557777776631 123444443 112345688999
Q ss_pred ecCCCCHH-----------HHH---hh--cC------CCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 005054 583 FLPRGSLF-----------RLL---QR--NT------TKLDWRRR----ILM---------------ALDIARGVSYLHH 621 (716)
Q Consensus 583 ~~~ggsL~-----------~~l---~~--~~------~~l~~~~v----~~i---------------~~ql~~aL~yLH~ 621 (716)
|++|..+. ..+ .. .. ..++.... ..+ ...+-..+..+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99874321 111 10 00 01121110 000 0011112223321
Q ss_pred -----CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 622 -----CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 622 -----~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
....++|+|+++.|||++ + .+.|+||+.+....
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP 225 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence 222389999999999998 4 89999999876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0066 Score=65.59 Aligned_cols=141 Identities=13% Similarity=0.159 Sum_probs=81.0
Q ss_pred ceeEeeeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCC
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ 575 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~ 575 (716)
.+. ++.|..|-...+|++... +..|++|+...... ....+.+|..+++.|. +.-.+++++++..
T Consensus 52 ~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-- 125 (379)
T 3feg_A 52 ELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE-- 125 (379)
T ss_dssp GCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred ceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence 344 356777888899999863 36799998633211 1234457888887773 3223566666654
Q ss_pred ceEEEEeecCCCCHH--------------HHHhh---cC----CCCC--HHHHHHHHHHHHH------------------
Q 005054 576 RLCIVTEFLPRGSLF--------------RLLQR---NT----TKLD--WRRRILMALDIAR------------------ 614 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~--------------~~l~~---~~----~~l~--~~~v~~i~~ql~~------------------ 614 (716)
.+||||++|..|. ..|.+ .. .... +.++..+..++-.
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 3999999875432 11111 11 1122 3455555544322
Q ss_pred -HHHHH----HhCC--CCeEEcCCCCCcEEEccC----CcEEEEecCCCcc
Q 005054 615 -GVSYL----HHCN--PPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRL 654 (716)
Q Consensus 615 -aL~yL----H~~~--~~IvHrDIKp~NILl~~~----~~vkL~DFGla~~ 654 (716)
.+..| ...+ ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22333 2221 238999999999999876 7899999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0031 Score=67.63 Aligned_cols=72 Identities=13% Similarity=0.168 Sum_probs=42.2
Q ss_pred eeeeecCCcEEEEEEEEcC----------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc-eeEEeceeccCCceE
Q 005054 510 GEQIGQGSCGTVYHAVWYG----------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLC 578 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn-Iv~~~~~~~~~~~~~ 578 (716)
.+.|+.|....+|++...+ ..|++|+..... . .......|..+++.+...+ ++++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--D-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--G-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--c-ceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4677888888999998754 679999875421 1 1111245777777663222 345655442 37
Q ss_pred EEEeecCCCC
Q 005054 579 IVTEFLPRGS 588 (716)
Q Consensus 579 lVmE~~~ggs 588 (716)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998753
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0013 Score=69.25 Aligned_cols=53 Identities=11% Similarity=0.107 Sum_probs=47.2
Q ss_pred HHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccchh
Q 005054 135 ILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDV 187 (716)
Q Consensus 135 lld~l~d~Iiv~D~d-G~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~ 187 (716)
+++++..-++|++.+ |+|+|+++++..++||+.+|++|+++.+++++.+....
T Consensus 31 ~L~aldgF~~vvs~~~G~i~yvS~~~~~~Lg~~~~el~g~s~~d~ihp~D~~~f 84 (317)
T 4dj3_A 31 TSKNTDTFAAVFSFLSGRLVHISEQAALILNSKRGFLKSVHFVDLLAPQDVRAF 84 (317)
T ss_dssp HTSCTTEEEEEEETTTCBEEEECTTHHHHTTCCHHHHHTSBGGGGBCGGGHHHH
T ss_pred HHhccCCEEEEEEcCCcEEEEECCHHHHHcCCCHHHHcCCchhhhcChhhHHHH
Confidence 478877778889986 99999999999999999999999999999999885443
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.0027 Score=66.58 Aligned_cols=55 Identities=11% Similarity=0.123 Sum_probs=38.9
Q ss_pred HHHHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccchh
Q 005054 133 LNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDV 187 (716)
Q Consensus 133 ~~lld~l~d~Iiv~D~d-G~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~ 187 (716)
+-+|+++..-+++++.+ |+|+|+++++..++||+.+|++|+++.+++++++....
T Consensus 18 ~lll~a~dgF~~vvs~~~G~i~yvS~s~~~~Lg~~~~el~g~s~~d~iHp~D~~~~ 73 (309)
T 3gdi_A 18 EYIVKNADMFAVAVSLVSGKILYISNQVASIFHCKKDAFSDAKFVEFLAPHDVSVF 73 (309)
T ss_dssp C----CTTEEEEEECTTTCBEEEECTTTTTTC-------CCSBGGGGBCTTTHHHH
T ss_pred HHHHHhcCCEEEEEECCCceEEEECCHHHHHcCCCHHHHcCCchhhccCHhHHHHH
Confidence 34678888888899986 99999999999999999999999999999999885443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.68 E-value=0.12 Score=50.98 Aligned_cols=99 Identities=14% Similarity=0.117 Sum_probs=67.3
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccccC
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (716)
.+|.++|...+.+++++++|.++.|.+..|.-+-. .. -..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 47999999999999999999999999998877622 11 12333457899999999998763 2111
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC
Q 005054 666 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE 701 (716)
Q Consensus 666 ~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG 701 (716)
.....+.+||... ...+.+.=|||||+++|.-+--
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123466787763 3345788999999999998763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.30 E-value=0.13 Score=56.15 Aligned_cols=73 Identities=10% Similarity=0.136 Sum_probs=46.2
Q ss_pred EeeeeecCCcEEEEEEEEc---------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceE
Q 005054 509 IGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 509 i~~~LG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~ 578 (716)
-++.|..|-...+|++... +..|++|+..... .. .-...+|..+++.+. +.-.+++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GK-FYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3466777888899999876 5789999864421 11 111245777777763 222345555432 27
Q ss_pred EEEeecCCCC
Q 005054 579 IVTEFLPRGS 588 (716)
Q Consensus 579 lVmE~~~ggs 588 (716)
+||+|++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999998865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.19 E-value=0.67 Score=49.96 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=24.9
Q ss_pred eEEcCCCCCcEEE------ccCCcEEEEecCCCcc
Q 005054 626 IIHRDLKSSNLLV------DKHWTVKVGDFGLSRL 654 (716)
Q Consensus 626 IvHrDIKp~NILl------~~~~~vkL~DFGla~~ 654 (716)
++|+|+.+.|||+ +.+..++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456799999999864
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=91.21 E-value=0.31 Score=51.41 Aligned_cols=78 Identities=15% Similarity=0.074 Sum_probs=50.5
Q ss_pred CceeE-EEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe---eEEEEEEEcC-CCC
Q 005054 140 GQSVH-IFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTK-TEE 213 (716)
Q Consensus 140 ~d~Ii-v~D~-dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~k-dG~ 213 (716)
|.|++ ++|. +++|+.+|..+++++|++.++++|+++.+++++.. ...+...+..+.. ....+..... +|.
T Consensus 41 p~G~Ll~~~~~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~~----~~~l~~~l~~~~~~~~~p~~~~~~~~~~~~ 116 (337)
T 2ool_A 41 PHGYLFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGGDPAAINPIRLDVVTPDGER 116 (337)
T ss_dssp TTSEEEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC----CCCSEEEEEEETTEEE
T ss_pred CCEEEEEEECCCCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHHH----HHHHHHHHhcCCccccCcEEEEEeccCCCe
Confidence 44444 5676 48999999999999999999999999999998643 2345555543321 2223343333 355
Q ss_pred EEEEEEEE
Q 005054 214 RVLVVATN 221 (716)
Q Consensus 214 ~~~v~~~~ 221 (716)
.+|+.+..
T Consensus 117 ~f~~~~Hr 124 (337)
T 2ool_A 117 AFNGILHR 124 (337)
T ss_dssp EEEEEEEE
T ss_pred EEEEEEEE
Confidence 66665443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.58 E-value=0.9 Score=44.55 Aligned_cols=115 Identities=12% Similarity=0.086 Sum_probs=77.2
Q ss_pred CCCceeEEeceeccCCceEEEEeecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEE
Q 005054 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (716)
Q Consensus 560 ~hpnIv~~~~~~~~~~~~~lVmE~~~gg-sL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl 638 (716)
.||+++.. .+-...+.+.+.++.-+.+ ++.. ++ .++....+.++.+|+....+++. -+|--|+|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 68888865 4555566666666654322 2222 32 26788899999999988866553 4788999999999
Q ss_pred ccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 005054 639 DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (716)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~ 706 (716)
+.++.++|.-.|+-... +|. ..+...=+-.+=|++..+++++..|+
T Consensus 113 ~~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999877653221 121 12222233467788889999988886
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.74 E-value=2.5 Score=41.57 Aligned_cols=114 Identities=14% Similarity=0.142 Sum_probs=74.8
Q ss_pred CCCceeEEeceeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCeEEcCCCCCcEEE
Q 005054 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS-YLHHCNPPIIHRDLKSSNLLV 638 (716)
Q Consensus 560 ~hpnIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~-yLH~~~~~IvHrDIKp~NILl 638 (716)
.||++. -.+-.+.+.+.+.++.-+++.=+..++ .++....++++.+|+.... +++. -+|--|+|+||++
T Consensus 48 ~~~~f~--~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCIV--RDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSSE--EEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEE
T ss_pred cCCCCC--eEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEE
Confidence 688883 333356677777776653433233443 2678888888888887766 5543 6888999999999
Q ss_pred ccCCcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHH-HHHHHHHHHHcCCCCCC
Q 005054 639 DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVY-SFGVILWELATEKIPWD 706 (716)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIw-SlG~ll~elltG~~PF~ 706 (716)
+.++.++|.-.|+-.. ++|.. .+ ..|.| .+=|++..++.++..|+
T Consensus 118 ~~~~~p~i~hRGi~~~-----------------lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKES-----------------LPPDE-----WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETTT-----------------BSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCccc-----------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999987775322 22221 11 22333 66778888888877775
|
| >4ew7_A Conjugative transfer: regulation; alpha-beta-alpha structure, structural genomics, midwest CEN structural genomics (MCSG), PSI-biology; 1.67A {Salmonella enterica subsp} | Back alignment and structure |
|---|
Probab=81.01 E-value=10 Score=32.13 Aligned_cols=89 Identities=15% Similarity=0.064 Sum_probs=51.0
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCC
Q 005054 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (716)
.+.+..+.|.+|+|-+....|+|+|.+|++||--...-+-|.+.. .+.-+--....+.-...+-.|...... ..-.
T Consensus 22 iq~iY~nSPVpVCVRNq~RkilYaN~aF~elF~Ked~~~sg~S~~-~~~vE~~LS~LELeCqsLGhG~af~r~---Fn~~ 97 (127)
T 4ew7_A 22 IQDIYKNSPVPVCVRNQSRKIIYANGAFIELFSKEDQPLSGDSYN-RYGVEVFLSSLELECQSLGHGAAFCRR---FNFH 97 (127)
T ss_dssp HHHHHTTCSSCEEEECTTSCEEEECHHHHHHTTSCCCGGGCTTSS-HHHHHHHHHHHHHHHHHHCTTCEEEEE---EEET
T ss_pred HHhhhcCCCccEEEecccceEEEecchHHHHhhcccCcccCcccc-eeeehhhHHHHHHHHHhhcCCceEEEE---eecC
Confidence 366677899999999999999999999999975433323332211 111000000111123344445543333 3446
Q ss_pred CCEEEEEEEEEEE
Q 005054 212 EERVLVVATNTPF 224 (716)
Q Consensus 212 G~~~~v~~~~~PI 224 (716)
|+.+.+.+-...+
T Consensus 98 ~e~yQIRmE~iSf 110 (127)
T 4ew7_A 98 GEIYQIRMENISF 110 (127)
T ss_dssp TEEEEEEEEEEEC
T ss_pred CceEEEEEEEeee
Confidence 7777777666554
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 716 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-14 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 3e-12 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 6e-07 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 3e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 3e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 8e-05 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 1e-04 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 2e-04 | |
| d1v9ya_ | 113 | d.110.3.2 (A:) Direct oxygen sensor protein, DOS { | 5e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 2e-75
Identities = 90/219 (41%), Positives = 138/219 (63%), Gaps = 9/219 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV ++++
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
RH N+LLFMG T+PQ L IVT++ SL+ L TK + + I +A A+G+ Y
Sbjct: 61 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYLTTKTGKGTPQWMAPEV 676
LH IIHRDLKS+N+ + + TVK+GDFGL+ +K + G+ WMAPEV
Sbjct: 120 LHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 677 LRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+R + P +SDVY+FG++L+EL T ++P+ N+N+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 6e-67
Identities = 53/215 (24%), Positives = 108/215 (50%), Gaps = 7/215 (3%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
E+ +D ++G G+ G V+ G +A K+ E + + +E+ ++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHE 60
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
P ++ F GA S + I E + GSL ++L++ ++ + +++ + +G++Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
L + I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 176
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
+SD++S G+ L E+A + P ++ +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-64
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 10/218 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + IG GS G G + K ++ EV+L++ L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 563 NVLLFMGAVT--SPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVS 617
N++ + + + L IV E+ G L ++ + T + LD + + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 618 YLH---HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
H ++HRDLK +N+ +D VK+GDFGL+R+ + K GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
E + +EKSD++S G +L+EL P+ + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 5e-63
Identities = 71/216 (32%), Positives = 112/216 (51%), Gaps = 12/216 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ + ++L + + IG+G G V + G+ VAVK + F E S+M +L
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQL 57
Query: 560 RHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVS 617
RH N++ +G V L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
YL N +HRDL + N+LV + KV DFGL++ T TGK +W APE L
Sbjct: 118 YLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEAL 172
Query: 678 RNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
R + KSDV+SFG++LWE+ + ++P+ +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 7e-62
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 11/215 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ I ++G G+ G VY A A KV + S+E + + E+ ++ HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHP 69
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + A L I+ EF G++ ++ L + ++ ++YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL----- 677
IIHRDLK+ N+L +K+ DFG+S T + GTP WMAPEV+
Sbjct: 130 K--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ P D K+DV+S G+ L E+A + P LN M+
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 8/214 (3%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I +DLT +++G G G V + W DVA+K+ S++ F +E +M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
H ++ G T + + I+TE++ G L L+ + ++ + M D+ + YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAPEVLRN 679
+HRDL + N LV+ VKV DFGLSR + T+ G K +W PEVL
Sbjct: 118 S--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 680 EPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSD+++FGV++WE+ + K+P++ + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-61
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 11/214 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
L +IG+GS TVY + +VA ++ + F++E ++K L+HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 565 LLFMGAVTSPQR----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ F + S + + +VTE + G+L L+R + + I +G+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 129
Query: 621 HCNPPIIHRDLKSSN-LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
PPIIHRDLK N + +VK+GD GL+ LK ++ K GTP++MAPE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEE 187
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
DE DVY+FG+ + E+AT + P+ +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 8e-61
Identities = 68/218 (31%), Positives = 114/218 (52%), Gaps = 9/218 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ E L + E++G G G V+ + + VAVK + S + +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMK 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 616
+L+H ++ VT + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAPE 675
+++ N IHRDL+++N+LV + K+ DFGL+RL + Y + K +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
+ KSDV+SFG++L E+ T + +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-60
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
ED IG +G+G G VY A +A+KV + + V H R+EV + LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L G R+ ++ E+ P G+++R LQ+ + K D +R ++A +SY H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 124
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+K NLL+ +K+ DFG S + T GT ++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
DEK D++S GV+ +E K P++ +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 9e-60
Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 8/214 (3%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I +LT ++IG G G V+ W VA+K S+E F +E +M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP ++ G +C+V EF+ G L L+ + M LD+ G++YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
+IHRDL + N LV ++ +KV DFG++R + + Y ++ K +W +PEV
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 680 EPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
KSDV+SFGV++WE+ +E KIP++N ++ +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 7e-59
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 11/221 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 59
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 60 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
APE + SDV+ FGV +WE+ P+ + +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-58
Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ + E IG+G G V+ W G +VAVK+FS +E E+ LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENI 59
Query: 565 LLFMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
L F+ A +L +V+++ GSLF L R + I +AL A G+++LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 621 H------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQ 670
P I HRDLKS N+LV K+ T + D GL+ + GT +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 671 WMAPEVLRNE------PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+MAPEVL + S +++D+Y+ G++ WE+A Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-58
Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 40/269 (14%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD------- 530
T SS +D +Y++ WE +L G+ +G G+ G V +A YG
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
VAVK+ + S E E+ +M +L H N++ +GA T + ++ E+ G L
Sbjct: 70 VAVKMLKEKADSSEREA-LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 590 FRLLQRNTTK----------------------LDWRRRILMALDIARGVSYLHHCNPPII 627
L+ K L + + A +A+G+ +L + +
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
HRDL + N+LV VK+ DFGL+R Y+ + +WMAPE L K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 686 SDVYSFGVILWELATE-KIPWDNLNSMQD 713
SDV+S+G++LWE+ + P+ + +
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 7e-58
Identities = 76/218 (34%), Positives = 116/218 (53%), Gaps = 9/218 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 67
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIARGV 616
+LRH ++ V S + + IVTE++ +GSL L+ T K + + MA IA G+
Sbjct: 68 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAPE 675
+Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G K +W APE
Sbjct: 127 AYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
KSDV+SFG++L EL T+ ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 3e-57
Identities = 72/220 (32%), Positives = 105/220 (47%), Gaps = 16/220 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A VA+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+++LRHPN + + G +V E+ + L L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQG 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YLH N +IHRD+K+ N+L+ + VK+GDFG + + + GTP WMAPE
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPE 181
Query: 676 VLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
V+ D K DV+S G+ ELA K P N+N+M
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 5e-57
Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 14/223 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSL 555
EI + I + IG G G V VA+K + Y+++ F E S+
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 80
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPNV+ G VT + I+TEF+ GSL L++N + + + M IA G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTPQ 670
+ YL N +HRDL + N+LV+ + KV DFGLSR TY + GK +
Sbjct: 141 MKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
W APE ++ SDV+S+G+++WE+ + + P+ ++ +
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 6e-57
Identities = 76/221 (34%), Positives = 104/221 (47%), Gaps = 13/221 (5%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSD-EVIHSFRQEVSL 555
I +DL + E++G GS G V W VAVK S E + F +EV+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M L H N++ G V +P + +VTE P GSL L+++ A+ +A G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+ YL IHRDL + NLL+ VK+GDFGL R + Y+ + K W
Sbjct: 124 MGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
APE L+ SD + FGV LWE+ T + PW LN Q
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 8e-57
Identities = 77/219 (35%), Positives = 110/219 (50%), Gaps = 9/219 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+E+ D+T+ ++G G G VY VW Y VAVK E F +E ++M
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVM 67
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARG 615
K ++HPN++ +G T I+TEF+ G+L L + N ++ + MA I+
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAP 674
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G K +W AP
Sbjct: 128 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
E L KSDV++FGV+LWE+AT + +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-56
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 13/217 (5%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ LT+ + ++G G+ GTV + VAVK+ + + E ++M++L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+P ++ +G + + +V E G L + LQ+N + + I + ++ G+ YL
Sbjct: 66 DNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL 123
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEV 676
N +HRDL + N+L+ K+ DFGLS+ Y GK +W APE
Sbjct: 124 EESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
+ KSDV+SFGV++WE + + P+ + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 13/217 (5%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
++L I + ++G G+ G+V V+ DVA+KV +Q +E +M +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 66
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+P ++ +G V + L +V E G L + L ++ + ++ G+ YL
Sbjct: 67 DNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEV 676
N +HRDL + N+L+ K+ DFGLS+ Y GK +W APE
Sbjct: 126 EEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
+ +SDV+S+GV +WE + + P+ + +
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ T E+IGQG+ GTVY A+ G +VA++ + Q+ + E+ +M+ ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ ++ + L +V E+L GSL ++ + + + + +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV--CRECLQALEFLHSN 135
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
+IHRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ +
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
K D++S G++ E+ + P+ N N ++
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-56
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 9/213 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + + +G+G+ G V AV VAVK+ + + + + ++E+ + K L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV+ F G + E+ G LF ++ + + + GV YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 680
I HRD+K NLL+D+ +K+ DFGL+ + + GT ++APE+L+
Sbjct: 123 G--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 681 P-SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
E DV+S G++L + ++PWD +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 9e-56
Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 25/233 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ W D+ + IG+G+ G V A D A+K ++ S + F E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVL 64
Query: 557 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKL 600
+L HPN++ +GA L + E+ P G+L L+++ + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 125 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
G+ +WMA E L SDV+S+GV+LWE+ + P+ + +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 1e-55
Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 36/253 (14%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 59
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-------- 597
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 598 ---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642
L ++ +A +A G++YL +HRDL + N LV ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM 177
Query: 643 TVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
VK+ DFGLSR + + Y +WM PE + +SDV+++GV+LWE+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 701 -EKIPWDNLNSMQ 712
P+ + +
Sbjct: 238 YGLQPYYGMAHEE 250
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-55
Identities = 69/256 (26%), Positives = 111/256 (43%), Gaps = 34/256 (13%)
Query: 489 NKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFS 537
N V +D L Y+ WE L+ G+ +G G+ G V A YG VAVK+
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 538 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR- 595
+ E + E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 63 PSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 596 ----------------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
+ LD + + +A+G+++L N IHRDL + N+L+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179
Query: 640 KHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
K+ DFGL+R Y+ + +WMAPE + N +SDV+S+G+ LWE
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 698 LATEKIPWDNLNSMQD 713
L + +
Sbjct: 240 LFSLGSSPYPGMPVDS 255
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 190 bits (483), Expect = 5e-55
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 9/212 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ I E++G G+ G V+ G++ A K SD+ + R+E+ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHP 83
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ A + ++ EF+ G LF + K+ + + +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 623 NPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
N +H DLK N++ + +K+ DFGL+ + K GT ++ APEV +
Sbjct: 144 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAEGK 200
Query: 681 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
P +D++S GV+ + L + P+ N +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 189 bits (481), Expect = 1e-54
Identities = 51/214 (23%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+++ I E++G G+ G V+ V G K + D+ ++ + E+S+M +L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLH 84
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP ++ A + ++ EFL G LF + K+ I G+ ++H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 621 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
+ I+H D+K N++ + K +VK+ DFGL+ + + T T ++ APE++
Sbjct: 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVD 201
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
EP +D+++ GV+ + L + P+ + ++
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 3e-54
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 8/213 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
ED G+ +G+GS TV A + A+K+ ++ E + +E +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P + ++L + G L + +++ D +I + YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG 126
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRN 679
IIHRDLK N+L+++ +++ DFG +++ + GT Q+++PE+L
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ + + SD+++ G I+++L P+ N
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-54
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 12/222 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 61
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQW 671
G + N +HRDL + N+LV+ + KV DFGLSR+ E TT GK +W
Sbjct: 122 G--MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
APE + SDV+SFG+++WE+ T S +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 47/214 (21%), Positives = 96/214 (44%), Gaps = 10/214 (4%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L+E I E +G+G G V+ V S K + ++E+S++ R
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIAR 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
H N+L + S + L ++ EF+ +F + + +L+ R + + + +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 621 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
N I H D++ N++ + T+K+ +FG +R + P++ APEV +
Sbjct: 120 SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQ 176
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ +D++S G +++ L + P+ + Q
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-53
Identities = 73/234 (31%), Positives = 107/234 (45%), Gaps = 15/234 (6%)
Query: 492 DLDNDCLDYEILWEDLTI--GEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDE 544
+L I L + E IG+G G VYH +D AVK +R E
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 545 VIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
V F E +MK HPNVL +G + S +V ++ G L ++ T +
Sbjct: 72 VSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TY 659
I L +A+G+ + +HRDL + N ++D+ +TVKV DFGL+R ++ +
Sbjct: 131 DLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
K +WMA E L+ + KSDV+SFGV+LWEL T P + D
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 9e-53
Identities = 76/233 (32%), Positives = 119/233 (51%), Gaps = 22/233 (9%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
++E+ E +T+ ++GQGS G VY V G VA+K + E I F
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 72
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 602
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYL 660
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +E Y
Sbjct: 133 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
G +WM+PE L++ SDV+SFGV+LWE+AT + P+ L++ Q
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 13/217 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + +G G+ GTVY +W VA+K R+ S + E +M
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 67
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ +P+V +G + + ++T+ +P G L ++ + + + + + IA+G++Y
Sbjct: 68 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEV 676
L ++HRDL + N+LV VK+ DFGL++L E + GK +WMA E
Sbjct: 127 LEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
+ + +SDV+S+GV +WEL T P+D + + +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 2e-51
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 10/213 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ + +G G+ V A VA+K +++ + S E++++ +++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHP 67
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ S L ++ + + G LF + R + + V YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 126
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK NLL D+ + + DFGLS+++ + + T GTP ++APEVL
Sbjct: 127 G--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQ 183
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+P + D +S GVI + L P+ + N +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 216
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 7/212 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR 560
ED + + +G+GS G V+ A + A+K + D+V + ++ L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP + + + L V E+L G L +Q K D R A +I G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
I++RDLK N+L+DK +K+ DFG+ + T T GTP ++APE+L +
Sbjct: 121 SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 681 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D +SFGV+L+E+ + P+ + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 68/244 (27%), Positives = 111/244 (45%), Gaps = 28/244 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
+E + L +G+ +G+G+ G V A +G D VAVK+ E +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 552 EVSLMKRLRHPNVLLFMGAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTK----------- 599
L+ H NV+ +GA T P L ++ EF G+L L+ +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 600 ----LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL- 654
L I + +A+G+ +L IHRDL + N+L+ + VK+ DFGL+R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 655 -KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
K Y+ + +WMAPE + + +SDV+SFGV+LWE+ + P+ + +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 713 DSCR 716
+ CR
Sbjct: 245 EFCR 248
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 71/242 (29%), Positives = 119/242 (49%), Gaps = 31/242 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSF 549
+E+ + L +G+ +G+G+ G V A G D VAVK+ + + +++ +
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 65
Query: 550 RQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------ 596
E+ +MK + +H N++ +GA T L ++ E+ +G+L LQ
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 597 ---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+L + + A +ARG+ YL IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 654 LKHE--TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNS 710
H Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T P+ +
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 711 MQ 712
+
Sbjct: 244 EE 245
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (441), Expect = 6e-50
Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 20/225 (8%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-------EYSDEVIHSFRQEVS 554
+E+ E +G+G V + + AVK+ E E+ + +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 555 LMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+++++ HPN++ + +V + + +G LF L L + + +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALL 120
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
+ LH N I+HRDLK N+L+D +K+ DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLA 177
Query: 674 PEVLRNEPSD------EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
PE++ +D ++ D++S GVI++ L P+ + M
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (432), Expect = 8e-49
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 13/220 (5%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRL 559
L + +GE +G G V+ A DVAVKV D FR+E L
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 560 RHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
HP ++ + IV E++ +L ++ + +R I + D +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQA 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+++ H IIHRD+K +N+++ VKV DFG++R + T GT Q++
Sbjct: 124 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+PE R + D +SDVYS G +L+E+ T + P+ + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (435), Expect = 1e-48
Identities = 56/211 (26%), Positives = 109/211 (51%), Gaps = 9/211 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 561
+D I +G GS G V+ G A+KV ++ + + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P ++ G Q++ ++ +++ G LF LL+++ + + A ++ + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHS 122
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
II+RDLK N+L+DK+ +K+ DFG ++ + T GTP ++APEV+ +P
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ D +SFG++++E+ P+ + N+M+
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 5/211 (2%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E+ E+IG+G+ G VY A G VA+K ++ V + +E+SL+K L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + + + +L +V EFL + + T + + +G+++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP- 681
++HRDLK NLL++ +K+ DFGL+R T T + APE+L
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
D++S G I E+ T + + + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (427), Expect = 5e-47
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE----VIHSFRQEVSLMKR 558
D ++ IG+G G VY G A+K ++ + + + R +SL+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
P ++ A +P +L + + + G L L ++ + R A +I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 122
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL- 677
+H+ +++RDLK +N+L+D+H V++ D GL+ + GT +MAPEVL
Sbjct: 123 MHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D +D +S G +L++L P+ +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 27/225 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V A+K+ R+EV L
Sbjct: 12 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 58
Query: 557 KRL-RHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMAL 610
R + P+++ ++ + L IV E L G LF +Q R R +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTTKTGKG 667
I + YLH N I HRD+K NLL +K+ DFG ++ + T
Sbjct: 119 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCY 175
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
TP ++APEVL E D+ D++S GVI++ L P+ + + +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVI 546
KV ++ D++ L + +G+G+ G V G A+K+ ++ + + +
Sbjct: 1 KVTMN----DFDYL-------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV 49
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
E +++ RHP + A + RLC V E+ G LF L R + R R
Sbjct: 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
A +I + + + +++RD+K NL++DK +K+ DFGL + T KT
Sbjct: 110 YGA-EIVSALE--YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
GTP+++APEVL + D + GV+++E+ ++P+ N + +
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (404), Expect = 7e-45
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 5/210 (2%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E E+IG+G+ G VY A YG A+K ++ + + + +E+S++K L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ + + +RL +V E L L +LL L+ L + G++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS- 682
++HRDLK NLL+++ +K+ DFGL+R T + AP+VL
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
D++S G I E+ + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-45
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFS---RQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ +G+G TVY A VA+K R E D + + +E+ L++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ A + +V +F+ L +++ N+ L L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DE 684
I+HRDLK +NLL+D++ +K+ DFGL++ T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQ 712
D+++ G IL EL + +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLD 208
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 14/214 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR- 560
+G +G G G+VY + VA+K + SD EV L+K++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 561 -HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
V+ + P ++ E L + V +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 620 HHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
H+C ++HRD+K N+L+D + +K+ DFG L +T T G T + PE +R
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG--TRVYSPPEWIR 182
Query: 679 NEP-SDEKSDVYSFGVILWELATEKIPWDNLNSM 711
+ V+S G++L+++ IP+++ +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 14/219 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-- 559
+ +IG+G+ G V+ A G VA+K Q + + S +EV++++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 560 -RHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
HPNV+ T + +L +V E + + L + + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
RG+ +LH ++HRDLK N+LV +K+ DFGL+R+ + + + T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
PEVL D++S G I E+ K + + +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-44
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 14/215 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE----VIHSFRQEVSLMKRLRH 561
GE++G G V G A K ++ +EVS++K ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PNV+ + + ++ E + G LF L L I GV +
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY--YL 129
Query: 622 CNPPIIHRDLKSSNLLVDKHWT----VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
+ I H DLK N+++ +K+ DFGL+ GTP+++APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIV 188
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
EP ++D++S GVI + L + P+ +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 4e-43
Identities = 48/218 (22%), Positives = 85/218 (38%), Gaps = 18/218 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+G +IG GS G +Y G +VA+K+ + + E + K ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGI 65
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ + ++ L SL L + K + +L+A + + Y+H N
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 626 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTPQWMAPE 675
IHRD+K N L+ K V + DFGL++ +H Y K GT ++ +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
+ D+ S G +L +PW L +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 9e-43
Identities = 51/211 (24%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 561
+ + +G GS G V G+ A+K+ +Q+ + I E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P ++ + L +V E++ G +F L+R + A I YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS 159
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+ +I+RDLK NLL+D+ ++V DFG ++ T GTP+ +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEALAPEIILSKG 214
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ D ++ GV+++E+A P+ +Q
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 1e-42
Identities = 43/220 (19%), Positives = 82/220 (37%), Gaps = 20/220 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+G +IG+GS G ++ VA+K R+ + + R E K L +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGI 63
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ ++ L SL LL K + + A + V +H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 626 IIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL-------KHETYLTTKTGKGTPQWMA 673
+++RD+K N L+ + + + V DFG+ + +H Y K GT ++M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
+ D+ + G + +PW L + +
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T IG+G+ G V A VA+K S E +E+ ++ R RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENII 69
Query: 566 LFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+ +P + + L L++LL+ L I RG+ Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS 127
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLR 678
N ++HRDLK SNLL++ +K+ DFGL+R+ H+ T + APE++
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 679 NE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
N + D++S G IL E+ + + + + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 25/229 (10%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
YE L +IGQG+ G V+ A G VA+K + + + +E+ ++
Sbjct: 11 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 63
Query: 557 KRLRHPNVLLFMGAVTSPQ--------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
+ L+H NV+ + + + +V +F L K +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRV 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKT 664
+ G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R K+
Sbjct: 123 MQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 665 GKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
T + PE+L E D++ G I+ E+ T
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 6/212 (2%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ E+IG+G+ GTV+ A VA+K + + V S +E+ L+K L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + S ++L +V EF + N + + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLKGLGFCHSR 120
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
N ++HRDLK NLL++++ +K+ +FGL+R T + P+VL
Sbjct: 121 N--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 683 -DEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
D++S G I ELA P N + D
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-39
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ +G G+ G V AV G+ VA+K R S+ +E+ L+K +RH NV+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 566 LFMGAVTSPQRLCIVTEF-----LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ T + L T+F L +L++ KL R + + +G+ Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 138
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN- 679
HRDLK NL V++ +K+ DFGL+R T + APEV+ N
Sbjct: 139 AAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNW 193
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D++S G I+ E+ T K + + +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 19/218 (8%)
Query: 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
T + IG GS G VY A G VA+K + + +E+ +M++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 564 VLLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARG 615
++ S L +V +++P R L L + R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
++Y+H I HRD+K NLL+D +K+ DFG ++
Sbjct: 135 LAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ DV+S G +L EL + + + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 16/222 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ +L + + IG G+ G V A +VA+K SR + +E+ LM
Sbjct: 12 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 557 KRLRHPNVLLFMGAVTSP------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
K + H N++ + T Q + +V E + + D R +
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLY 126
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+ G+ +LH IHRDLK SN++V T+K+ DFGL+R +++ T T
Sbjct: 127 QMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRY 183
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ APEV+ E D++S G I+ E+ KI + + +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 14/219 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV-----WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMK 557
E+ + + +G G+ G V+ G A+KV + + R E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 558 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
+R P ++ A + +L ++ +++ G LF L + + + +I +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL 142
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 675
+LH II+RD+K N+L+D + V + DFGLS + GT ++MAP+
Sbjct: 143 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 676 VLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++R S D+ D +S GV+++EL T P+
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 136 bits (344), Expect = 4e-36
Identities = 48/228 (21%), Positives = 96/228 (42%), Gaps = 22/228 (9%)
Query: 496 DCLDYEILW---EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFR 550
D + + W +D + ++G+G V+ A+ V VK+ + +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IK 77
Query: 551 QEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+E+ +++ LR PN++ V P + +V E + +L Q L
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGK 666
+I + + Y H I+HRD+K N+++D +H +++ D+GL+ H
Sbjct: 134 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV- 190
Query: 667 GTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQD 713
+ + PE+L + D D++S G +L + K P+ + + D
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-35
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 18/223 (8%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
+ +WE +G G+ G+V A G VAVK SR S +E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 556 MKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+K ++H NV+ + T + L + L L +++ KL +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIY 128
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
I RG+ Y+H + IIHRDLK SNL V++ +K+ DFGL+ T T
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 183
Query: 671 WMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ APE+ L ++ D++S G I+ EL T + + + +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 1e-28
Identities = 43/222 (19%), Positives = 87/222 (39%), Gaps = 30/222 (13%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ ++G G TV+ A + VA+K+ + E + E+ L++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72
Query: 566 L---------------FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
F + + +V E L L + + + ++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGLSRLKHETYLTTKT 664
+ G+ Y+H IIH D+K N+L++ +K+ D G + E Y +
Sbjct: 133 QLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI- 190
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
T ++ +PEVL P +D++S +++EL T ++
Sbjct: 191 --QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 1e-19
Identities = 29/162 (17%), Positives = 55/162 (33%), Gaps = 32/162 (19%)
Query: 509 IGEQIGQGSCGTVYHAVWY-GSDVAVKVF----------------SRQEYSDEVIHSFRQ 551
IG+ +G+G V++ + VK +S I S R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E +++L+ V ++ E + + +++ +L
Sbjct: 64 EFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK------ELYRVRVENPDEVL--DM 111
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I V+ +H I+H DL N+LV + + + DF S
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 68.3 bits (166), Expect = 1e-14
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 139 MGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI 195
+ + + D + ++Y + + GY +E LG + L +G D I I
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 196 KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K GE + + K + T TP DG + V V D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 61.1 bits (147), Expect = 3e-12
Identities = 20/90 (22%), Positives = 31/90 (34%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + L Y+ EE LG + L G D I +K T Q TK
Sbjct: 14 PIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTK 73
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ D++G + + V +
Sbjct: 74 GGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 46.2 bits (109), Expect = 6e-07
Identities = 13/99 (13%), Positives = 24/99 (24%), Gaps = 1/99 (1%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR 194
++ D S I +NR+ L G E +G++ + +
Sbjct: 8 EFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMD 67
Query: 195 IKMGERWTGQFP-AKTKTEERVLVVATNTPFYDDDGTLV 232
+F V V D +
Sbjct: 68 GVTSGTLDARFDFVFDFQMAPVRVQIRMQNAGVPDRYWI 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 41.3 bits (95), Expect = 3e-05
Identities = 15/102 (14%), Positives = 29/102 (28%), Gaps = 6/102 (5%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK----MG 198
+ + D I ++ +AE L+G+S EA+GQ+ L+ + I
Sbjct: 3 MIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHI 62
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K + + + D
Sbjct: 63 IGIGRIVTGKRRDGTTFPMHLSIGEMQSGGEP--YFTGFVRD 102
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 3e-05
Identities = 14/107 (13%), Positives = 35/107 (32%), Gaps = 6/107 (5%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGT-LVGIV 235
++ + +++ E++ V + V ++
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCCVVVL 109
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (93), Expect = 8e-05
Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
+ + + Y + L GY EE LG+ A E ++ + G+ +
Sbjct: 9 LSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVS 68
Query: 203 GQFPAKTKTEERVLVVATNTPFYDD-DGTLVGIVCVSTD 240
GQ+ K V + T Y+ + I+CV+
Sbjct: 69 GQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYV 107
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 1e-04
Identities = 17/92 (18%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD--FDVAYDIVHRIKMGERWTGQFPAK 208
+IY N L GYS E + + G A I + E +
Sbjct: 15 AVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFY 74
Query: 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K L + P ++DG ++ +
Sbjct: 75 RKDGSCFLCLVDVVPVKNEDGAVIMFILNFEV 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 39.6 bits (91), Expect = 2e-04
Identities = 17/116 (14%), Positives = 37/116 (31%), Gaps = 6/116 (5%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
D +IL ++ + + I+ +N +A +GY+ EE +GQ+ L+ + +
Sbjct: 15 DAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHD 74
Query: 189 YDIVHRIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + GE+ + K + D
Sbjct: 75 GYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGER--FFTGFIRD 128
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} Length = 113 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Score = 38.3 bits (87), Expect = 5e-04
Identities = 18/113 (15%), Positives = 42/113 (37%), Gaps = 6/113 (5%)
Query: 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI 191
+ L+ + + +D ++++N +AE L+GY EE +G + L+ I
Sbjct: 3 FFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYI 62
Query: 192 VHRIKMG----ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
H + G E + + + K ++ + + + + D
Sbjct: 63 RHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKVSAEGKVYY--LALVRD 113
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 716 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.77 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.66 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.66 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.59 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.55 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.55 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.54 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.35 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.34 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.14 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.34 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.56 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 93.87 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 90.88 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=382.11 Aligned_cols=202 Identities=30% Similarity=0.493 Sum_probs=183.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|++.++||+|+||+||+|.+ .++.||||+++...... .+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999997 47889999998654432 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||+|++|.+++.++ .+++..++.++.||+.||.|||++| ||||||||+||||+.++++||+|||+++.........
T Consensus 98 y~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 99999999998764 5999999999999999999999999 9999999999999999999999999998776555555
Q ss_pred ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 56789999999999999999999999999999999999999998876544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=377.69 Aligned_cols=208 Identities=27% Similarity=0.448 Sum_probs=172.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--CCceEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCI 579 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~--~~~~~l 579 (716)
.++|++++.||+|+||+||+|++. ++.||||++......+...+.+.+|+.+|++++|||||++++++.+ .+.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999984 6789999998887777778889999999999999999999998864 466899
Q ss_pred EEeecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 580 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~---~~~~l~~~~v~~i~~ql~~aL~yLH~~~---~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
|||||++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ .+||||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 3457999999999999999999999854 249999999999999999999999999998
Q ss_pred ccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
............+||+.|||||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~ 220 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH
Confidence 7665544455678999999999999999999999999999999999999999876643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=375.92 Aligned_cols=203 Identities=33% Similarity=0.548 Sum_probs=181.4
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|++++.||+|+||+||+|++. ++.||+|++.+.... ......+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999984 668999998764322 12346678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||||++|+|.+++.+.. .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||++.......
T Consensus 85 mEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 99999999999998654 5999999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....+||+.|||||++.+..++.++|||||||+||+|++|+.||...+..
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 210 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH
Confidence 23558999999999999999999999999999999999999999876643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=379.23 Aligned_cols=205 Identities=31% Similarity=0.475 Sum_probs=183.1
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
+.|+++++||+|+||.||+|++ .+..||||+++.... ...+.+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4699999999999999999998 466799999976532 334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||++|+|.+++.+....+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998877777999999999999999999999999 9999999999999999999999999998765544445
Q ss_pred ccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005054 663 KTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQD 713 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~~ 713 (716)
...+||+.|+|||++. +..|+.++|||||||+||+|++|+.||.+.++.+.
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~ 223 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 223 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH
Confidence 5678999999999984 55678999999999999999999999998776553
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=377.25 Aligned_cols=210 Identities=42% Similarity=0.721 Sum_probs=181.9
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
+|++..++|+++++||+|+||.||+|++.+ .||||+++.........+.+.+|+.+|++++|||||++++++. .+.+|
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 567888999999999999999999998654 6999999877666667788999999999999999999999875 45789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
||||||++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999877778999999999999999999999999 999999999999999999999999999865432
Q ss_pred --ccccccCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 659 --YLTTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 659 --~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
........||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.++.+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~ 216 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH
Confidence 2233456799999999999643 47889999999999999999999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=375.35 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=176.5
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|+++++||+|+||+||+|++. ++.||||+++.... .+..+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 368999999999999999999984 77899999976543 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC--c
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~ 659 (716)
|||++|+|.+++.+. ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+|+..... .
T Consensus 83 Ey~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999654 46999999999999999999999999 999999999999999999999999999865433 2
Q ss_pred cccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+||+.|||||++.+..+ +.++|||||||+||+|++|+.||...+.
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 23345689999999999998876 5689999999999999999999976543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=385.17 Aligned_cols=204 Identities=25% Similarity=0.421 Sum_probs=181.7
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
|+..++|+++++||+|+||+||+|++. +..||+|+++... .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456789999999999999999999984 6789999997653 3444577889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
||||||++++|.+++.+.. .+++..++.++.||+.||.|||+ ++ |+||||||+||||+.++++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999999998754 59999999999999999999997 58 99999999999999999999999999986544
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 SM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HT--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred Cc--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32 2356899999999999999999999999999999999999999987653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=376.69 Aligned_cols=205 Identities=24% Similarity=0.446 Sum_probs=179.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|++++.||+|+||+||+|.+. ++.||||++++... .......+.+|+.+|++++|||||++++++.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 368999999999999999999984 67899999976432 122346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC--
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 658 (716)
||||++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999987654 6999999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.......+||+.|+|||++.+..++.++|||||||+||+|++|+.||...+..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 216 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH
Confidence 22334568999999999999999999999999999999999999999876643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=381.21 Aligned_cols=205 Identities=28% Similarity=0.468 Sum_probs=184.9
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~l 579 (716)
..++|++++.||+|+||.||+|++ .++.||||++++... .......+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 347899999999999999999997 477899999986532 12235677889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (716)
|||||+||+|..++.+.. .+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+......
T Consensus 83 v~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999998754 6899999999999999999999999 9999999999999999999999999998766555
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 555567899999999999999999999999999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=366.63 Aligned_cols=203 Identities=33% Similarity=0.572 Sum_probs=178.1
Q ss_pred ceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc----CCceEE
Q 005054 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCI 579 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~----~~~~~l 579 (716)
.|++.++||+|+||+||+|++. +..||+|++..........+.+.+|+++|++++|||||+++++|.. ...+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 3577889999999999999984 5679999998877777777889999999999999999999999864 356899
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc-cCCcEEEEecCCCcccccC
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~ 658 (716)
|||||++++|.+++.+. ..+++..++.++.||+.||+|||+++.+||||||||+||||+ .++.+||+|||+++.....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999775 469999999999999999999999887799999999999996 5789999999999865443
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
. ....+||+.|||||++.+ .++.++|||||||++|+|++|+.||....+.+
T Consensus 169 ~--~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~ 219 (270)
T d1t4ha_ 169 F--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219 (270)
T ss_dssp S--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred c--cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH
Confidence 2 235689999999999876 58999999999999999999999998765443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-43 Score=377.13 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=182.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.++|++++.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999984 7789999987653 34457788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc--CCcEEEEecCCCcccccC
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 658 (716)
||||+||+|.+++.+....+++..++.++.||+.||.|||++| ||||||||+||||+. ++.+||+|||+++.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999999766667999999999999999999999999 999999999999964 578999999999876544
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.. .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 180 ~~-~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 180 QS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp SC-EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cc-cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 32 23458999999999999999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6e-43 Score=376.76 Aligned_cols=203 Identities=25% Similarity=0.420 Sum_probs=182.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
.++|++++.||+|+||.||+|++ .++.||||+++... ......+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999998 47789999987654 333467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc--cCCcEEEEecCCCcccccCc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETY 659 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~--~~~~vkL~DFGla~~~~~~~ 659 (716)
|||+|++|.+++.....++++..++.++.||+.||.|||++| ||||||||+||||+ .++.|||+|||+|.......
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999999999998877778999999999999999999999999 99999999999997 57899999999998766543
Q ss_pred cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 660 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
. .....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..
T Consensus 184 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 184 I-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp C-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred c-eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 2 33457999999999999999999999999999999999999999876644
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-43 Score=372.78 Aligned_cols=203 Identities=27% Similarity=0.445 Sum_probs=164.1
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
+.+.|++.+.||+|+||+||+|.+. ++.||||++....... ....+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4577999999999999999999984 6789999998765432 235678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEc---cCCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~ 657 (716)
||||+|++|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+|||+. .++.+||+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp ECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999764 46999999999999999999999999 99999999999995 478999999999986654
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
... ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+.
T Consensus 163 ~~~-~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 163 GSV-LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCe-eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 332 3356899999999999999999999999999999999999999987653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-43 Score=371.50 Aligned_cols=202 Identities=28% Similarity=0.506 Sum_probs=181.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|++++.||+|+||+||+|++. ++.||||++++.... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 368999999999999999999984 778999999764321 22356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||||+|++|..++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 9999999999998764 46899999999999999999999999 9999999999999999999999999998765532
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 159 --~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 207 (316)
T d1fota_ 159 --YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207 (316)
T ss_dssp --CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred --ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH
Confidence 3568999999999999999999999999999999999999999887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=362.95 Aligned_cols=205 Identities=27% Similarity=0.407 Sum_probs=182.2
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
+.++|++++.||+|+||+||+|++. ++.||||++++..... ...+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999984 7789999997654322 235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC----cEEEEecCCC
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLS 652 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGla 652 (716)
+|||||||++|+|.+++.+.. .+++..++.++.||+.||.|||+++ ||||||||+|||++.++ .+||+|||++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999997754 6999999999999999999999999 99999999999998766 5999999999
Q ss_pred cccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 165 ~~~~~~~~-~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 222 (293)
T d1jksa_ 165 HKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222 (293)
T ss_dssp EECTTSCB-CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhcCCCcc-ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH
Confidence 87654432 33568999999999999999999999999999999999999999877643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-42 Score=367.82 Aligned_cols=201 Identities=33% Similarity=0.471 Sum_probs=178.5
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVm 581 (716)
+.|+++++||+|+||+||+|++ .++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4699999999999999999997 4667999999876554 355677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccc
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (716)
|||.+++|..++.. ...+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999988776654 456999999999999999999999999 999999999999999999999999999865443
Q ss_pred cccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 662 TKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~---~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
...+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..+
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 34589999999999864 457889999999999999999999998876544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-42 Score=363.58 Aligned_cols=207 Identities=35% Similarity=0.566 Sum_probs=181.9
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
..|++..++|++.++||+|+||+||+|++. ++.||||+++..... .+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 357888899999999999999999999984 667999998765543 356889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+|||||||++|+|.+++.+. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999999754 456899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCccc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 655 KHETYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 655 ~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....... .....|++.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 6544322 233358999999999999999999999999999999999766655433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-42 Score=373.06 Aligned_cols=202 Identities=25% Similarity=0.408 Sum_probs=181.7
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
.++|+++++||+|+||.||+|++. ++.||||++++.... ......+.+|+.+|+.++|||||++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 368999999999999999999984 778999999764321 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
|||+.+++|..++.+.. .+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999997754 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....+||+.|||||++.+..++.++|||||||+||+|++|+.||.+.+..
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 244 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH
Confidence 23457999999999999999999999999999999999999999877643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=356.28 Aligned_cols=202 Identities=32% Similarity=0.593 Sum_probs=169.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.++|+++++||+|+||+||+|.+. +..||||+++...... +.+.+|+.+++.++|||||++++++..++.+|||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 368999999999999999999985 5579999998755444 468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc-cc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LT 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 661 (716)
||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999999999887778999999999999999999999999 9999999999999999999999999998655432 22
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
.....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~ 208 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH
Confidence 334578999999999999999999999999999999999 5666665543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-42 Score=362.90 Aligned_cols=208 Identities=33% Similarity=0.539 Sum_probs=172.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEc--CC---eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~ 575 (716)
++..++|++.++||+|+||+||+|.+. ++ .||||.+.... .....+.+.+|+.+|++++|||||++++++..++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 455678999999999999999999874 22 37788775433 4556678999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999887778999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCcc-----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 656 HETYL-----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 656 ~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
..... ......||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 43221 1222457999999999999999999999999999999998 89999877654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=367.07 Aligned_cols=212 Identities=30% Similarity=0.518 Sum_probs=180.2
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcCC-------eEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-------~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~ 569 (716)
..|++..++|+++++||+|+||+||+|++.+. .||+|.+.... .......+.+|+.+|.++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 35677789999999999999999999987432 48899886543 233456788899999998 8999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------TKLDWRRRILMALDIARGVSYLHHCNPPII 627 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~----------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~Iv 627 (716)
++.+.+.+|||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--Ii 186 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999999999999999999999997643 24789999999999999999999999 99
Q ss_pred EcCCCCCcEEEccCCcEEEEecCCCcccccCcc--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 005054 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 704 (716)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~P 704 (716)
||||||+|||++.++.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||+||||++ |..|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999986544322 2234468999999999999999999999999999999998 8999
Q ss_pred CCCCCccc
Q 005054 705 WDNLNSMQ 712 (716)
Q Consensus 705 F~~~~~l~ 712 (716)
|.+.+..+
T Consensus 267 f~~~~~~~ 274 (325)
T d1rjba_ 267 YPGIPVDA 274 (325)
T ss_dssp STTCCCSH
T ss_pred CCCCCHHH
Confidence 99876544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=364.92 Aligned_cols=204 Identities=29% Similarity=0.484 Sum_probs=179.4
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHH-hcCCCceeEEeceeccCCceEEE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMK-RLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~-~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
++|+++++||+|+||+||+|++ .++.||||++++... .......+..|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 567899999976432 1122345556666655 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (716)
||||++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999997654 6899999999999999999999999 99999999999999999999999999987665555
Q ss_pred ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 661 ~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~ 209 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 555678999999999999999999999999999999999999999876643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=364.69 Aligned_cols=203 Identities=22% Similarity=0.357 Sum_probs=180.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lV 580 (716)
++++|++++.||+|+||+||+|.+. ++.||||+++.... ....+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999999999999984 66799999976532 235678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc--CCcEEEEecCCCcccccC
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 658 (716)
||||+|++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ...+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999877667999999999999999999999999 999999999999985 457999999999876543
Q ss_pred ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 659 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 158 ~~-~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 158 DN-FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp CE-EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred Cc-ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 32 23457899999999999999999999999999999999999999877643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-41 Score=355.21 Aligned_cols=207 Identities=29% Similarity=0.436 Sum_probs=175.3
Q ss_pred cccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~---- 575 (716)
+.++|++.+.||+|+||.||+|++ .++.||||+++.... .......+.+|+.+|+.++|||||++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 457899999999999999999997 477899999987655 3556678999999999999999999999987654
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+|||||||+|++|..++.... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.++|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhh
Confidence 3799999999999999987654 6999999999999999999999999 999999999999999999999999988754
Q ss_pred ccC---ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 656 HET---YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 656 ~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
... .......+||+.|+|||++.+..++.++|||||||++|+|+||++||...++.+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence 322 223345579999999999999999999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=355.44 Aligned_cols=206 Identities=34% Similarity=0.595 Sum_probs=178.3
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
.+|++..++|++.++||+|+||.||+|.+.+ +.||||+++...... +.+.+|+.+|++++|||||++++++.. +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 4677888999999999999999999999864 579999997655443 568899999999999999999998754 56
Q ss_pred eEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+|||||||++|+|.+++... ..++++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 89999999999999987543 235899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCC
Q 005054 656 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709 (716)
Q Consensus 656 ~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG-~~PF~~~~ 709 (716)
.... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 5432 233455789999999999999999999999999999999995 45555443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-41 Score=366.19 Aligned_cols=202 Identities=25% Similarity=0.420 Sum_probs=175.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC----HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.++|+++++||+|+||.||+|++ .++.||||++.+.... ........+++.+++.++|||||+++++|.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999998 4778999999754321 22223334457778888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||+|++|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999999775 46899999999999999999999999 99999999999999999999999999986654
Q ss_pred CccccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
. .....+||+.|+|||++. +..|+.++|||||||+||+|++|+.||...+.
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 3 233568999999999997 45689999999999999999999999987553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=354.57 Aligned_cols=205 Identities=26% Similarity=0.492 Sum_probs=178.6
Q ss_pred cccceeEeee-eecCCcEEEEEEEEc----CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 503 LWEDLTIGEQ-IGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 503 ~~~~y~i~~~-LG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
..++|.+... ||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+|++++|||||++++++.. +.+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 3467888884 999999999999763 3359999997643 45566789999999999999999999999875 568
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999999999777778999999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 658 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 32 22234468999999999999999999999999999999998 99999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-41 Score=349.74 Aligned_cols=204 Identities=25% Similarity=0.436 Sum_probs=180.6
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC-------HHHHHHHHHHHHHHHhcC-CCceeEEeceecc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS 573 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~ 573 (716)
.++|++.+.||+|+||+||+|++ .++.||||++++.... ......+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57899999999999999999998 5678999999875432 234456889999999996 9999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
++.+|||||||++++|.+++..+. .+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999997654 6999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCccccccCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....... ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~~-~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 159 QLDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp ECCTTCC-BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EccCCCc-eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 7665433 335689999999999863 34678999999999999999999999987643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-42 Score=359.29 Aligned_cols=205 Identities=27% Similarity=0.401 Sum_probs=176.1
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|+++++||+|+||+||+|.+. ++.||||+++...........+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999984 7789999997665444445778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
||.++.+..........+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99654444444445567999999999999999999999999 9999999999999999999999999998776665566
Q ss_pred ccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 663 KTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
....||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~ 209 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence 66689999999999877664 78999999999999999999999876543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=350.63 Aligned_cols=210 Identities=33% Similarity=0.582 Sum_probs=173.4
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC-----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~ 573 (716)
+|++..++|++++.||+|+||.||+|++.. ..||||.++.. ........+.+|+.+|++++|||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 477888999999999999999999998743 23777776543 24556678999999999999999999999986
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
.+.+|+|||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence 56789999999999999998887778999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccC-ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 654 LKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 654 ~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
..... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence 65432 223345578999999999999999999999999999999998 899999877654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=348.03 Aligned_cols=203 Identities=31% Similarity=0.575 Sum_probs=182.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
.++|+++++||+|+||+||+|++.+ ..||||+++...... +.+.+|+.++++++|||||++++++.+++.+++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 3688999999999999999999854 479999998766554 467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-c
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (716)
|+++|+|..++......+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999998877778999999999999999999999999 99999999999999999999999999986544322 3
Q ss_pred cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 662 ~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 334578999999999999999999999999999999998 89999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=351.43 Aligned_cols=197 Identities=28% Similarity=0.511 Sum_probs=168.1
Q ss_pred eeeecCCcEEEEEEEEcC----CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEeecCC
Q 005054 511 EQIGQGSCGTVYHAVWYG----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (716)
Q Consensus 511 ~~LG~G~fg~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~~~g 586 (716)
++||+|+||+||+|.+.. +.||||+++.........+.+.+|+.+|++++|||||++++++.. +..|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998642 359999998765555667889999999999999999999999865 467899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCc---cccc
Q 005054 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---LTTK 663 (716)
Q Consensus 587 gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~ 663 (716)
|+|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...... ....
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999999764 46999999999999999999999999 9999999999999999999999999998654322 1223
Q ss_pred cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
...||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 4578999999999999999999999999999999998 99999987643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-41 Score=350.43 Aligned_cols=205 Identities=31% Similarity=0.506 Sum_probs=172.3
Q ss_pred hhcccceeEeeeeecCCcEEEEEEEEcC------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC
Q 005054 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (716)
Q Consensus 501 e~~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~ 574 (716)
|+...+|++.++||+|+||.||+|.+.. ..||||+++... .......+.+|+.+|++++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4555789999999999999999998743 259999986543 445566788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
+.+++|||||.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999999887778999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCc---cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCC
Q 005054 655 KHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNL 708 (716)
Q Consensus 655 ~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~P-F~~~ 708 (716)
..... .......||+.|||||++.+..++.++|||||||++|||++|..| |...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 54332 122334689999999999999999999999999999999996555 4443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=359.64 Aligned_cols=199 Identities=29% Similarity=0.423 Sum_probs=172.2
Q ss_pred cccceeEee-eeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceecc----C
Q 005054 503 LWEDLTIGE-QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS----P 574 (716)
Q Consensus 503 ~~~~y~i~~-~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~----~ 574 (716)
+.++|++.+ .||+|+||+||+|++ .++.||||+++.. ..+.+|+.++.++ +|||||+++++|++ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 457899875 599999999999998 4678999998753 3466789886654 89999999999865 4
Q ss_pred CceEEEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecC
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFG 650 (716)
..+|||||||+||+|.+++.++. ..+++..++.++.||+.||+|||++| |+||||||+|||++. .+.+||+|||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 67899999999999999997653 56999999999999999999999999 999999999999985 5679999999
Q ss_pred CCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
+++...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.+..
T Consensus 160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 998765443 234568999999999999999999999999999999999999999876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-41 Score=352.55 Aligned_cols=200 Identities=27% Similarity=0.326 Sum_probs=170.0
Q ss_pred EeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCC---HHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 509 IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 509 i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
.+++||+|+||+||+|++ .++.||||+++..... ......+.+|+.+|+.++|||||++++++..++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999997 4678999998765432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
|.++++..++ .....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9876655554 44567999999999999999999999999 99999999999999999999999999987766555555
Q ss_pred cCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 664 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
..+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 207 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH
Confidence 67899999999998754 5799999999999999999999999876543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=345.89 Aligned_cols=205 Identities=35% Similarity=0.546 Sum_probs=171.4
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCc
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~ 576 (716)
..|++..++|++.+.||+|+||.||+|++.+ ..||||+++...... +.+.+|+.+|++++|||||++++++. .+.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEP 85 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEe-cCC
Confidence 3566777899999999999999999999855 469999997665443 56889999999999999999999985 456
Q ss_pred eEEEEeecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~-~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
+++|||||++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhc
Confidence 89999999999999888643 356999999999999999999999999 999999999999999999999999999866
Q ss_pred ccCc-cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 005054 656 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708 (716)
Q Consensus 656 ~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~ 708 (716)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 4332 2233457899999999999999999999999999999999965555443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-40 Score=347.74 Aligned_cols=204 Identities=26% Similarity=0.376 Sum_probs=174.1
Q ss_pred cceeEeeeeecCCcEEEEEEEEc-CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE~ 583 (716)
++|+++++||+|+||+||+|++. ++.||||+++...........+.+|+.+|+.++|||||++++++..++..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999984 67899999977654444457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCccccc
Q 005054 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (716)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (716)
+.++.+..+. .....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 9765555554 44567999999999999999999999999 99999999999999999999999999987665555555
Q ss_pred cCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 664 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 664 ~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...|++.|++||++.+. .++.++|||||||++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 66799999999998765 5689999999999999999999999876543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=349.45 Aligned_cols=204 Identities=27% Similarity=0.367 Sum_probs=172.6
Q ss_pred cceeEeeeeecCCcEEEEEEEEc---CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeceec-----c
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT-----S 573 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l---~hpnIv~~~~~~~-----~ 573 (716)
++|+++++||+|+||+||+|++. ++.||||+++...........+.+|+.+|+.| +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999983 34589999976544332223445677776655 7999999999985 3
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
...+|++||||+++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35689999999887776666666677999999999999999999999999 9999999999999999999999999988
Q ss_pred ccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 165 ~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~ 221 (305)
T d1blxa_ 165 IYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221 (305)
T ss_dssp CCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH
Confidence 655443 334668999999999999999999999999999999999999999877643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=341.45 Aligned_cols=204 Identities=34% Similarity=0.609 Sum_probs=172.8
Q ss_pred chhcccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-CCceE
Q 005054 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLC 578 (716)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-~~~~~ 578 (716)
|++..++|+++++||+|+||.||+|.++++.||||+++.+.. .+.+.+|+.+|++++|||||++++++.+ ++.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 667788999999999999999999999999999999976542 3567899999999999999999998854 56789
Q ss_pred EEEeecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~-~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
|||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999996543 35899999999999999999999998 99999999999999999999999999986544
Q ss_pred CccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
. .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..+
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 3 224468999999999999999999999999999999998 789998766543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=346.15 Aligned_cols=213 Identities=29% Similarity=0.513 Sum_probs=171.2
Q ss_pred cccchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe
Q 005054 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (716)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~ 568 (716)
...|++..++|+++++||+|+||.||+|.+.+ +.||||+++... .....+.+.+|+.++.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 45677888999999999999999999998742 369999987543 334456677787777776 689999999
Q ss_pred ceeccC-CceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC
Q 005054 569 GAVTSP-QRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (716)
Q Consensus 569 ~~~~~~-~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK 632 (716)
+++... ..+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlK 161 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA 161 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCC
Confidence 987654 56899999999999999996532 34889999999999999999999999 9999999
Q ss_pred CCcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCC
Q 005054 633 SSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLN 709 (716)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG-~~PF~~~~ 709 (716)
|+||||+.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++| ..||...+
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654332 233355799999999999999999999999999999999986 57898776
Q ss_pred ccc
Q 005054 710 SMQ 712 (716)
Q Consensus 710 ~l~ 712 (716)
..+
T Consensus 242 ~~~ 244 (299)
T d1ywna1 242 IDE 244 (299)
T ss_dssp CSH
T ss_pred HHH
Confidence 544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=344.55 Aligned_cols=201 Identities=24% Similarity=0.415 Sum_probs=172.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCH----HHHHHHHHHHHHHHhcC--CCceeEEeceeccCC
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~iL~~l~--hpnIv~~~~~~~~~~ 575 (716)
.++|++.+.||+|+||+||+|++ .++.||||++++..... ....++.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999998 47789999997654321 11234567999999986 899999999999999
Q ss_pred ceEEEEeecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-CCcEEEEecCCCc
Q 005054 576 RLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSR 653 (716)
Q Consensus 576 ~~~lVmE~~~g-gsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~ 653 (716)
.+|+||||+.+ +++.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccce
Confidence 99999999975 5788888764 46999999999999999999999999 999999999999985 4799999999998
Q ss_pred ccccCccccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+
T Consensus 160 ~~~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 160 LLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp ECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred eccccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 755443 335689999999999988776 567899999999999999999998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-40 Score=347.31 Aligned_cols=203 Identities=29% Similarity=0.544 Sum_probs=171.5
Q ss_pred cceeEeeeeecCCcEEEEEEEEc--CC----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceE
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWY--GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~ 578 (716)
.+|+++++||+|+||+||+|.+. ++ +||+|.++... ..+..+.+.+|+.+|++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999874 33 48888876432 233456789999999999999999999999864 577
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccC
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (716)
++|||+.+++|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 888999999999999888888999999999999999999999999 999999999999999999999999999865433
Q ss_pred c--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005054 659 Y--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (716)
Q Consensus 659 ~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l 711 (716)
. .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 2 22334468999999999999999999999999999999998 89999877644
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=343.08 Aligned_cols=206 Identities=35% Similarity=0.546 Sum_probs=169.3
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCC-----eEEEEEeeccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~vAvK~~~~~~~-~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~ 577 (716)
.++|++.+.||+|+||.||+|++... .||||++++... ..+..+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 47899999999999999999987322 589999876544 33556789999999999999999999999975 578
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
++|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999999998877777999999999999999999999999 99999999999999999999999999987544
Q ss_pred Ccc---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005054 658 TYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (716)
Q Consensus 658 ~~~---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~l~ 712 (716)
... ......|+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~ 222 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH
Confidence 322 2223457889999999999999999999999999999998 899998776543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-39 Score=343.90 Aligned_cols=211 Identities=28% Similarity=0.542 Sum_probs=182.3
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~ 571 (716)
.+|+..++|++++.||+|+||+||+|++.+ +.||||+++... ..+....+.+|+.+|+.++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 467777899999999999999999998754 469999987543 455667899999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEE
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~~-----------------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvH 628 (716)
...+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999996532 24889999999999999999999999 999
Q ss_pred cCCCCCcEEEccCCcEEEEecCCCcccccC--ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC-CCC
Q 005054 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK-IPW 705 (716)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~-~PF 705 (716)
|||||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||+||||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999754332 22233457899999999999999999999999999999999985 688
Q ss_pred CCCCccc
Q 005054 706 DNLNSMQ 712 (716)
Q Consensus 706 ~~~~~l~ 712 (716)
...+..+
T Consensus 244 ~~~~~~e 250 (301)
T d1lufa_ 244 YGMAHEE 250 (301)
T ss_dssp TTSCHHH
T ss_pred CCCCHHH
Confidence 8776543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-39 Score=337.78 Aligned_cols=209 Identities=33% Similarity=0.581 Sum_probs=177.8
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEcC---------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~ 568 (716)
.|++..++|++++.||+|+||.||+|++.+ ..||||+++... .......+.+|+..+.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 477888999999999999999999998633 259999987644 445567788899999888 799999999
Q ss_pred ceeccCCceEEEEeecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCC
Q 005054 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (716)
Q Consensus 569 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp 633 (716)
+++.+++.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 99999999999999999999999997543 35899999999999999999999999 99999999
Q ss_pred CcEEEccCCcEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005054 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (716)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~~ 710 (716)
+|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|++ |.+||...+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999999998654432 22334578999999999999999999999999999999998 7999987654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=345.32 Aligned_cols=202 Identities=29% Similarity=0.427 Sum_probs=173.6
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC-----
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----- 575 (716)
+.++|+++++||+|+||+||+|.+. ++.||||+++.........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3589999999999999999999984 778999999877667777788999999999999999999999997654
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 576 -~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
.+||||||| +.+|..+++.. .+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceec
Confidence 579999999 67888887653 5999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCccccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
..... ....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+
T Consensus 171 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~ 226 (346)
T d1cm8a_ 171 ADSEM---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226 (346)
T ss_dssp CCSSC---CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCCcc---ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH
Confidence 65432 355799999999999865 56889999999999999999999998876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-38 Score=333.96 Aligned_cols=202 Identities=21% Similarity=0.349 Sum_probs=176.0
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeceeccCCceE
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLC 578 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~h-pnIv~~~~~~~~~~~~~ 578 (716)
++.++|+++++||+|+||+||+|++. ++.||||+++..... ..+.+|+++++.+.| +||+.+++++......|
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 45689999999999999999999974 678999998765432 235678888988865 89999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc-----CCcEEEEecCCCc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 653 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~-----~~~vkL~DFGla~ 653 (716)
+||||+ +++|.+++......++...+..++.|++.||+|||++| ||||||||+||||+. .+.+||+|||+|+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999 78999999887778999999999999999999999999 999999999999974 5789999999998
Q ss_pred ccccC-------ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 654 LKHET-------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... .......+||+.|||||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 65432 1223355799999999999999999999999999999999999999986654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=336.01 Aligned_cols=211 Identities=30% Similarity=0.512 Sum_probs=183.6
Q ss_pred ccchhcccceeEeeeeecCCcEEEEEEEEcC-------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEec
Q 005054 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (716)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~ 569 (716)
..|++..++|+++++||+|+||.||+|++.+ +.||||+++... .......+.+|+.+++.+ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3677888999999999999999999998632 369999997654 344566788999999999 6999999999
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCC
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT-----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------------~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIK 632 (716)
++.....+|||||||++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |||||||
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLK 172 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccc
Confidence 9999999999999999999999997543 25889999999999999999999999 9999999
Q ss_pred CCcEEEccCCcEEEEecCCCcccccC--ccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005054 633 SSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (716)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~ellt-G~~PF~~~~ 709 (716)
|+|||++.++.+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|+| |.+||...+
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865543 223334578999999999999999999999999999999999 677777666
Q ss_pred cc
Q 005054 710 SM 711 (716)
Q Consensus 710 ~l 711 (716)
..
T Consensus 253 ~~ 254 (311)
T d1t46a_ 253 VD 254 (311)
T ss_dssp SS
T ss_pred HH
Confidence 54
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=337.31 Aligned_cols=211 Identities=35% Similarity=0.561 Sum_probs=183.9
Q ss_pred cchhcccceeEeeeeecCCcEEEEEEEEc-------CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEecee
Q 005054 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (716)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~ 571 (716)
.|++..++|+++++||+|+||.||+|.+. +..||||+++... .......+.+|+.++++++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 47888899999999999999999999874 3579999997543 445566789999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC
Q 005054 572 TSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (716)
Q Consensus 572 ~~~~~~~lVmE~~~ggsL~~~l~~~---------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~ 642 (716)
...+..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 9999999999999999999998642 134789999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCcccccCc--cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCccc
Q 005054 643 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712 (716)
Q Consensus 643 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG-~~PF~~~~~l~ 712 (716)
++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+..+
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~ 243 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999998654332 223344689999999999999999999999999999999997 58888776543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=338.42 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=169.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC----ce
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RL 577 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----~~ 577 (716)
..+|+++++||+|+||+||+|++ .++.||||+++... .......+.+|+.+|+.++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 36799999999999999999998 47789999997644 3555678889999999999999999999987653 23
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccccc
Q 005054 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (716)
+++|+|+.+++|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4445556689999999764 5999999999999999999999999 99999999999999999999999999976543
Q ss_pred Cc---cccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 658 TY---LTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 658 ~~---~~~~~~~Gt~~Y~aPE~~~-~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 22 1234557999999999984 45678899999999999999999999987653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=331.08 Aligned_cols=202 Identities=27% Similarity=0.344 Sum_probs=181.1
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCCceEEEEe
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~~~~lVmE 582 (716)
++|+++++||+|+||+||+|++ .++.||||+++...........+.+|+.+|+.++||||+++++++.....+++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999998 46679999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcccc
Q 005054 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (716)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (716)
++.+++|..++.. ...+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.+..........
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9998888887754 457899999999999999999999999 9999999999999999999999999998876655555
Q ss_pred ccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 663 ~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 206 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC
Confidence 5667889999999988765 5899999999999999999999975443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=337.20 Aligned_cols=206 Identities=32% Similarity=0.587 Sum_probs=172.8
Q ss_pred hcccceeEeeeeecCCcEEEEEEEEcC--C--eEEEEEeeccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeceeccCCc
Q 005054 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG--S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (716)
Q Consensus 502 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~--~--~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l-~hpnIv~~~~~~~~~~~ 576 (716)
+.+++|++.++||+|+||.||+|++.+ . .||||.++... ..+..+.+.+|+.+|+++ +|||||++++++...+.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 345799999999999999999998843 3 36777765433 234456789999999998 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccC
Q 005054 577 LCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~---------------~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~ 641 (716)
+|||||||++|+|.+++.+. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.+
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC
Confidence 99999999999999999653 356899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC-CCCCCCCcc
Q 005054 642 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK-IPWDNLNSM 711 (716)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~-~PF~~~~~l 711 (716)
+.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|. +||...+..
T Consensus 164 ~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~ 233 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233 (309)
T ss_dssp GCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999976554332 23457899999999999999999999999999999999965 678776543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=336.15 Aligned_cols=204 Identities=24% Similarity=0.321 Sum_probs=169.9
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc--------
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-------- 573 (716)
.++|+++++||+|+||+||+|++ .++.||||++...........++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37999999999999999999998 46789999987665545455678899999999999999999998754
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 574 ~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
.+.+|+|||||.++ +...+......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~-~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEE-HHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCC-ccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 35689999999665 44555555667999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCc----cccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 654 LKHETY----LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 654 ~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~-~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 544221 222345799999999999765 688999999999999999999999987654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=332.82 Aligned_cols=201 Identities=34% Similarity=0.530 Sum_probs=165.1
Q ss_pred ccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccCC----ceEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCI 579 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~~----~~~l 579 (716)
.++|.+.++||+|+||.||+|++.++.||||+++.... .......|+..+..++|||||++++++...+ .+||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 46899999999999999999999999999999865431 1122234555666789999999999987654 5799
Q ss_pred EEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEEcCCCCCcEEEccCCcEEEEecCCCc
Q 005054 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (716)
Q Consensus 580 VmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~------~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 653 (716)
|||||++|+|.+++.+. .+++..++.++.|++.||.|||.. ..+||||||||+||||+.++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999875 489999999999999999999973 1139999999999999999999999999998
Q ss_pred ccccCcc----ccccCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 654 LKHETYL----TTKTGKGTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 654 ~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~~------~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
....... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 6543321 233457999999999987653 4668999999999999999998886443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-38 Score=339.27 Aligned_cols=196 Identities=26% Similarity=0.318 Sum_probs=164.4
Q ss_pred ceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc------CCce
Q 005054 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQRL 577 (716)
Q Consensus 506 ~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~------~~~~ 577 (716)
+|+.+++||+|+||+||+|++ .++.||||+++.... ...+|+.+|+.++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999998 467899999976542 22469999999999999999999853 2357
Q ss_pred EEEEeecCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCcc
Q 005054 578 CIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRL 654 (716)
Q Consensus 578 ~lVmE~~~ggsL~~~l~--~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~ 654 (716)
|||||||+++.+..+.. .....+++..++.++.||+.||+|||++| |+||||||+||||+.++ .+||+|||++..
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999997654333322 34557999999999999999999999999 99999999999999765 899999999986
Q ss_pred cccCccccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 173 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 173 LVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred ccCCcc-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 654332 235589999999999875 4689999999999999999999999987654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-37 Score=327.68 Aligned_cols=202 Identities=23% Similarity=0.346 Sum_probs=170.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCc-eeEEeceeccCCceEEE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIV 580 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpn-Iv~~~~~~~~~~~~~lV 580 (716)
.++|+++++||+|+||.||+|++. ++.||||++...... ..+..|+.+++.+.|+| |+.+..++...+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 468999999999999999999984 678999998765432 24667999999997665 55666667788889999
Q ss_pred EeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEcc---CCcEEEEecCCCccccc
Q 005054 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLKHE 657 (716)
Q Consensus 581 mE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~ 657 (716)
|||+ +++|...+......+++..++.++.||+.||+|||++| ||||||||+|||++. +..+||+|||+|+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999 66888888777778999999999999999999999999 999999999999863 55799999999986543
Q ss_pred Cc-------cccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005054 658 TY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (716)
Q Consensus 658 ~~-------~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~l~ 712 (716)
.. .......||+.|||||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 21 22345579999999999999999999999999999999999999998766543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=329.43 Aligned_cols=199 Identities=33% Similarity=0.521 Sum_probs=170.7
Q ss_pred eEeeeeecCCcEEEEEEEEcCC-----eEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc-CCceEEEE
Q 005054 508 TIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCIVT 581 (716)
Q Consensus 508 ~i~~~LG~G~fg~Vy~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~-~~~~~lVm 581 (716)
.+.++||+|+||+||+|++... .||||.++.. .......++.+|+.+|++++|||||++++++.. +..+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3468899999999999987332 4899988643 356667889999999999999999999999765 56789999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccccCcc-
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (716)
|||++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999999887777889999999999999999999999 99999999999999999999999999986543321
Q ss_pred ---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 661 ---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 661 ---~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
......||+.|+|||++.+..++.++|||||||+||||++|..||....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 2223468999999999999999999999999999999999877776543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=336.85 Aligned_cols=205 Identities=25% Similarity=0.395 Sum_probs=175.2
Q ss_pred ccceeEeeeeecCCcEEEEEEEE-----cCCeEEEEEeeccCC--CHHHHHHHHHHHHHHHhcCC-CceeEEeceeccCC
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQ 575 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~iL~~l~h-pnIv~~~~~~~~~~ 575 (716)
.++|+++++||+|+||+||+|.+ .++.||||++++... .....+.+.+|+.+|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999987 356799999865432 11223567789999999976 89999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 576 ~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999997754 5789999999999999999999999 999999999999999999999999999765
Q ss_pred cc-CccccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005054 656 HE-TYLTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (716)
Q Consensus 656 ~~-~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~sDIwSlG~ll~elltG~~PF~~~~~l 711 (716)
.. .........|++.|++||.+.+. .++.++|||||||+||+|++|+.||...+..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 43 22334455799999999999765 4578999999999999999999999877544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=334.03 Aligned_cols=201 Identities=29% Similarity=0.410 Sum_probs=166.8
Q ss_pred cccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceecc------C
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------P 574 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~------~ 574 (716)
+.++|+++++||+|+||+||+|.+. ++.||||+++..........++.+|+.+|+.++|||||+++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3478999999999999999999984 7789999998877777777889999999999999999999999864 3
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 575 ~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
..+|+|||||.+ ++...+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred ceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhc
Confidence 678999999965 5555553 35899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 655 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
..... .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 55443 23355799999999999999999999999999999999999999987653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-37 Score=328.99 Aligned_cols=194 Identities=22% Similarity=0.398 Sum_probs=168.0
Q ss_pred ccceeEeeeeecCCcEEEEEEEEc--CCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceecc--CCceE
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS--PQRLC 578 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~--~~~~~ 578 (716)
.++|+++++||+|+||+||+|++. ++.||||+++... ..++.+|+.+|+.+. ||||++++++|.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 468999999999999999999984 6789999987543 356788999999995 9999999999874 45689
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCC-cEEEEecCCCccccc
Q 005054 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 657 (716)
Q Consensus 579 lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 657 (716)
+|||||.+++|..+. ..+++..++.++.||+.||.|||++| ||||||||+||||+.++ .+||+|||+++....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999987653 35999999999999999999999999 99999999999998654 699999999986654
Q ss_pred CccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 658 TYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 658 ~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 33 234567999999999987754 7899999999999999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=333.01 Aligned_cols=200 Identities=30% Similarity=0.382 Sum_probs=171.6
Q ss_pred ccceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCceeEEeceeccC-----Cc
Q 005054 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (716)
Q Consensus 504 ~~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnIv~~~~~~~~~-----~~ 576 (716)
.++|+++++||+|+||+||+|++ .++.||||++++..........+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999997 477899999987766666677889999999999999999999998643 33
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEecCCCcccc
Q 005054 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (716)
Q Consensus 577 ~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (716)
.+++|+|+.+++|.+++..+ .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccC
Confidence 46667777799999999653 5999999999999999999999999 9999999999999999999999999987654
Q ss_pred cCccccccCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005054 657 ETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS 710 (716)
Q Consensus 657 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~sDIwSlG~ll~elltG~~PF~~~~~ 710 (716)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 43 23457899999999987765 58899999999999999999999987654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4e-32 Score=292.38 Aligned_cols=197 Identities=21% Similarity=0.358 Sum_probs=158.6
Q ss_pred cceeEeeeeecCCcEEEEEEEE--cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-----------CCceeEEecee
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLFMGAV 571 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-----------hpnIv~~~~~~ 571 (716)
.+|+++++||+|+||+||+|++ .++.||||+++... ...+.+.+|+.+|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999998 46789999997643 33456778888888774 57899999887
Q ss_pred ccC--CceEEEEeecCCCCH-H-HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEcCCCCCcEEEccCC----
Q 005054 572 TSP--QRLCIVTEFLPRGSL-F-RLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW---- 642 (716)
Q Consensus 572 ~~~--~~~~lVmE~~~ggsL-~-~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~-~~~~IvHrDIKp~NILl~~~~---- 642 (716)
... ...+++|+++..... . .........+++..++.++.||+.||.|||+ +| |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 643 456667766644432 2 2233344678999999999999999999997 77 99999999999998654
Q ss_pred --cEEEEecCCCcccccCccccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 005054 643 --TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (716)
Q Consensus 643 --~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~sDIwSlG~ll~elltG~~PF~~~~ 709 (716)
.++|+|||.+....... ...+||+.|+|||++.+..++.++|||||||++++|++|+.||...+
T Consensus 168 ~~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cceeeEeeccccccccccc---ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 49999999998655432 35579999999999999999999999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=9e-23 Score=199.19 Aligned_cols=166 Identities=19% Similarity=0.171 Sum_probs=120.9
Q ss_pred eeEeeeeecCCcEEEEEEEE-cCCeEEEEEeeccCCC----------------HHHHHHHHHHHHHHHhcCCCceeEEec
Q 005054 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS----------------DEVIHSFRQEVSLMKRLRHPNVLLFMG 569 (716)
Q Consensus 507 y~i~~~LG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~----------------~~~~~~~~~E~~iL~~l~hpnIv~~~~ 569 (716)
+.++++||+|+||.||+|.+ +++.||||+++..... ........+|...+..+.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999987 5778999987532110 111234456888999999999998876
Q ss_pred eeccCCceEEEEeecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcCCCCCcEEEccCCcEEEEec
Q 005054 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (716)
Q Consensus 570 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 649 (716)
+.. .+++|||+++..+. .++...+..++.||+.+|.|||++| |+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 543 38999999875432 2445566788999999999999999 9999999999999865 5999999
Q ss_pred CCCcccccCccccccCCCCCCccCcc-----cccCCCCCchhHHHHHHHHH
Q 005054 650 GLSRLKHETYLTTKTGKGTPQWMAPE-----VLRNEPSDEKSDVYSFGVIL 695 (716)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~Y~aPE-----~~~~~~~~~~sDIwSlG~ll 695 (716)
|.|.....+... .|.... .+....|..++|+||+.--+
T Consensus 147 G~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999765433211 111110 01235567889999986544
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.77 E-value=2.2e-18 Score=151.91 Aligned_cols=104 Identities=23% Similarity=0.285 Sum_probs=97.2
Q ss_pred cCceeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEE
Q 005054 139 MGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (716)
Q Consensus 139 l~d~Iiv~D---~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 215 (716)
+.++++++| +||+|+|||++|++++||+++|++|+++..+..+.........+.+++..|+.+..++.++++||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 578999999 58999999999999999999999999998888777666777788999999999999999999999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 216 LVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 216 ~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
|+.+++.||+|++|++.+++++++|||
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DIT 108 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVT 108 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECC
Confidence 999999999999999999999999998
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=3e-16 Score=137.90 Aligned_cols=103 Identities=17% Similarity=0.123 Sum_probs=90.7
Q ss_pred eeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccc--cccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEE
Q 005054 142 SVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (716)
Q Consensus 142 ~Iiv~D---~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~--~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (716)
.++|+| +|+.|+|||++|++++||+.+|++|+++..++ +++........+..++..+.++..++..++++|+.+|
T Consensus 3 ~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w 82 (110)
T d1bywa_ 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFL 82 (110)
T ss_dssp EEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeecccceee
Confidence 357788 46789999999999999999999999987644 3444455667888899999999999999999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEchhHH
Q 005054 217 VVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (716)
Q Consensus 217 v~~~~~PI~d~~G~i~g~i~i~~DITer 244 (716)
+.+++.||+|++|++.++|++++|||||
T Consensus 83 ~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 83 CLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 9999999999999999999999999974
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.66 E-value=3.5e-16 Score=135.93 Aligned_cols=100 Identities=23% Similarity=0.174 Sum_probs=93.8
Q ss_pred eeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEE
Q 005054 142 SVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (716)
Q Consensus 142 ~Iiv~D---~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (716)
.++|+| +||+|+|+|++|++++||+.+|++|+++.+++.+.........+...+..+..+..++.++++||+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 367898 68999999999999999999999999999898888877777888999999999999999999999999999
Q ss_pred EEEEEEECCCCCEEEEEEEEEch
Q 005054 219 ATNTPFYDDDGTLVGIVCVSTDS 241 (716)
Q Consensus 219 ~~~~PI~d~~G~i~g~i~i~~DI 241 (716)
+++.||+|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 99999999999999999999997
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.59 E-value=2.2e-15 Score=135.76 Aligned_cols=111 Identities=14% Similarity=0.164 Sum_probs=94.3
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe----eEEEE
Q 005054 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQF 205 (716)
Q Consensus 130 ~~~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~ 205 (716)
++|+.+|++++++|+++|.+|+|++||+++++++||++++++|+++..++++.........+...+..+.. ...++
T Consensus 16 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 95 (130)
T d1ew0a_ 16 AHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVV 95 (130)
T ss_dssp SCHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHHHHHHCCCSSTTSCEEE
T ss_pred HHHHHHHHcCCCeEEEEeCCccEEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHHHHHHhCCCccccceeeE
Confidence 45899999999999999999999999999999999999999999998888877765555555556665543 56788
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 206 ~~~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
...++||..+|+.+++.|+.+.++ ..++++++|||
T Consensus 96 ~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 96 SGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred EEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEECC
Confidence 889999999999999999976543 35889999997
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.55 E-value=1.4e-14 Score=124.83 Aligned_cols=102 Identities=15% Similarity=0.112 Sum_probs=83.4
Q ss_pred ceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe----eEEEEEEEcCCCCEEE
Q 005054 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEERVL 216 (716)
Q Consensus 141 d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~~~~ 216 (716)
|||+++|.+|+|+++|++|++++||+.+|++|+++..++++.........+...+..+.. ...++..+++||..+|
T Consensus 1 dgi~~~D~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~ 80 (106)
T d1xj3a1 1 DAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTTFP 80 (106)
T ss_dssp CCEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCEEE
T ss_pred CEEEEECCCCcEEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccceEEE
Confidence 689999999999999999999999999999999999988876654444444444443332 5568888999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEchhHH
Q 005054 217 VVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (716)
Q Consensus 217 v~~~~~PI~d~~G~i~g~i~i~~DITer 244 (716)
+.+++.|+.+.++ .+++++++||||.
T Consensus 81 v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 81 MHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 9999999987544 4688999999974
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.55 E-value=1.7e-14 Score=125.95 Aligned_cols=107 Identities=16% Similarity=0.252 Sum_probs=85.8
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCC----eeEEEEEE
Q 005054 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE----RWTGQFPA 207 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~----~~~~e~~~ 207 (716)
|.++|++.+++|+++|.+|+|+++|++|++++||+++|++|+++..+++..........+...+..+. ....++..
T Consensus 3 ~~~~~e~~~d~i~~~d~~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRELQL 82 (113)
T ss_dssp HHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CEEEE
T ss_pred HHHHHHcCcCcEEEEeCCCCEEEEchhHhhhhccchhhhcCcceecccccccccccccccccccccccccccccceeeee
Confidence 78899999999999999999999999999999999999999999998877665444444444443332 25567888
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEc
Q 005054 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (716)
Q Consensus 208 ~~kdG~~~~v~~~~~PI~d~~G~i~g~i~i~~D 240 (716)
+++||+.+|+.+++.||.++++. .++++++|
T Consensus 83 ~~~dG~~~~v~~~~~~i~~~~~~--~~~~v~rD 113 (113)
T d1v9ya_ 83 EKKDGSKIWTRFALSKVSAEGKV--YYLALVRD 113 (113)
T ss_dssp ECTTSCEEEEEEEEEEEEETTEE--EEEEEEEC
T ss_pred ccccceeEEEEEEEEEEEECCeE--EEEEEEEC
Confidence 99999999999999999876543 47888887
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.6e-15 Score=131.59 Aligned_cols=108 Identities=19% Similarity=0.270 Sum_probs=92.6
Q ss_pred cCceeEE--EcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCeeEEEEEEEcCCCCEEE
Q 005054 139 MGQSVHI--FDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (716)
Q Consensus 139 l~d~Iiv--~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (716)
+...++| .|.+|+|+|+|+++++++||+.+|++|+++.+++++++.....+.+...+..+.....++.++++||+.+|
T Consensus 3 ~d~~~fi~r~~~dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~w 82 (114)
T d1p97a_ 3 MDSKTFLSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVW 82 (114)
T ss_dssp CCCEEEEEEECTTTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEE
T ss_pred cCcCEEEEEECCCCcEEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcceE
Confidence 3444555 69999999999999999999999999999999988877655555555566666668889999999999999
Q ss_pred EEEEEEEEECC-CCCEEEEEEEEEchhHHHH
Q 005054 217 VVATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (716)
Q Consensus 217 v~~~~~PI~d~-~G~i~g~i~i~~DITerk~ 246 (716)
+.++..|++|+ +|.+.+++++.+||||+|+
T Consensus 83 v~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 83 LETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 99999999986 6899999999999999874
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.35 E-value=3.1e-12 Score=114.81 Aligned_cols=106 Identities=10% Similarity=0.000 Sum_probs=86.1
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-chhHHHHHHHHHcCCeeEEEEEEEcC
Q 005054 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKTK 210 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~~~~k 210 (716)
+..+||++|+||+++|.+|+|+++|+++++++||++++++|+++.+++.+... ......+.+.+..|.....+....++
T Consensus 19 ~d~~ld~~p~gi~~lD~~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 98 (125)
T d1nwza_ 19 DDGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYTFDY 98 (125)
T ss_dssp CHHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEEECT
T ss_pred HHHHHhCCCccEEEEeCCCCEEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEEEEecc
Confidence 47789999999999999999999999999999999999999999887755433 44555677888888877776677889
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEch
Q 005054 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (716)
Q Consensus 211 dG~~~~v~~~~~PI~d~~G~i~g~i~i~~DI 241 (716)
+|..+|+.+...++. +|.- +..+++||
T Consensus 99 ~G~~~~v~v~l~~~~--~g~~--~~v~V~di 125 (125)
T d1nwza_ 99 QMTPTKVKVHMKKAL--SGDS--YWVFVKRV 125 (125)
T ss_dssp TSCCEEEEEEEEECS--SSSE--EEEEEEEC
T ss_pred CCcEEEEEEEEEEec--CCCE--EEEEEEEC
Confidence 999999999988774 4443 34456665
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.34 E-value=3.1e-12 Score=112.18 Aligned_cols=95 Identities=13% Similarity=-0.053 Sum_probs=77.3
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccc-ccchhHHHHHHHHHcCCeeEEEEEEEcC
Q 005054 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDG-RDFDVAYDIVHRIKMGERWTGQFPAKTK 210 (716)
Q Consensus 132 ~~~lld~l~d~Iiv~D~dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~-~~~~~~~~i~~~l~~g~~~~~e~~~~~k 210 (716)
+.++||++|++|+++|.+|+|++||+++++|+||+++|++|+++.+++.+. ........+.+.+..|+.........++
T Consensus 5 ~~A~ld~~p~gvi~~D~~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~l~~ 84 (110)
T d1mzua_ 5 GTAEFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVFDF 84 (110)
T ss_dssp -CTTGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEEEC
T ss_pred HHHHHhCCCcEEEEEcCCCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEEEEec
Confidence 567899999999999999999999999999999999999999987766543 3344556778888888864443334578
Q ss_pred CCCEEEEEEEEEEEEC
Q 005054 211 TEERVLVVATNTPFYD 226 (716)
Q Consensus 211 dG~~~~v~~~~~PI~d 226 (716)
+|..+++.++..++.+
T Consensus 85 ~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 85 QMAPVRVQIRMQNAGV 100 (110)
T ss_dssp SSCEEEEEEEEEECSS
T ss_pred CCceEEEEEEEEEecC
Confidence 9999999999888743
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=5.3e-12 Score=111.04 Aligned_cols=104 Identities=15% Similarity=0.176 Sum_probs=80.5
Q ss_pred HHcCceeEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe----eEEEEEEEcCC
Q 005054 137 QSMGQSVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKT 211 (716)
Q Consensus 137 d~l~d~Iiv~D~-dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kd 211 (716)
+.+.++|+++|. +|+|+++|++++++|||+++|++|+++.+++++.........+...+..+.. ...++...+++
T Consensus 5 ~~~n~AI~~id~~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 84 (114)
T d1ll8a_ 5 PEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISRS 84 (114)
T ss_dssp TTTTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECCTT
T ss_pred hhcCcEEEEEECCCCEEEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEEccC
Confidence 456889999995 6999999999999999999999999999999877653332222233443322 33367888999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchh
Q 005054 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (716)
Q Consensus 212 G~~~~v~~~~~PI~d~~G~i~g~i~i~~DIT 242 (716)
|+.+|+++++.++..+ |+. .++++++||+
T Consensus 85 G~~~pvevs~~~i~~~-~~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 85 GEKIPVSVWMKRMRQE-RRL-CCVVVLEPVE 113 (114)
T ss_dssp CCCEEEECCEECCBSS-SSB-EEEEEEEECC
T ss_pred CcEEEEEEEEEEEEEC-CeE-EEEEEEEECc
Confidence 9999999999999654 444 3789999994
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.81 E-value=2.4e-09 Score=93.13 Aligned_cols=94 Identities=11% Similarity=-0.012 Sum_probs=74.8
Q ss_pred eEEEcCCCcEEEecHHHHHHhCCC-hhhHcCCCccccccccccchh-HH-HHHHHHHcCCeeEEEEEEEcCCCCEEEEEE
Q 005054 143 VHIFDLSDRIIYWNRSAELLYGYS-AEEALGQDAIELLTDGRDFDV-AY-DIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (716)
Q Consensus 143 Iiv~D~dG~Ii~vN~aae~l~Gys-~eEliGk~~~~l~~~~~~~~~-~~-~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (716)
+.-.|.+|+|+++|+++.+++||. .+|++|+++.+++++++.... .. .....+..|+....++++++|||..+|++.
T Consensus 5 ~trh~~~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t 84 (109)
T d1oj5a_ 5 MTKQDTTGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHT 84 (109)
T ss_dssp EEEECTTCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEE
T ss_pred EEEECCCceEEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEEE
Confidence 334699999999999999999998 589999999999999885432 22 345667889888889999999999999999
Q ss_pred EEEEEECCCC-CEEEEEE
Q 005054 220 TNTPFYDDDG-TLVGIVC 236 (716)
Q Consensus 220 ~~~PI~d~~G-~i~g~i~ 236 (716)
++.+++++.| .+..+|+
T Consensus 85 ~~~~~~~~~~~~~~~Ii~ 102 (109)
T d1oj5a_ 85 RCKLCYPQSPDMQPFIMG 102 (109)
T ss_dssp EEEEECC----CCCEEEE
T ss_pred EEEEEECCCCCcccEEEE
Confidence 9999998754 3333334
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=8.6e-07 Score=88.05 Aligned_cols=145 Identities=15% Similarity=0.036 Sum_probs=96.7
Q ss_pred cccceeEeeeeecCCcEEEEEEEEcCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccCCceEEEE
Q 005054 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (716)
Q Consensus 503 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~~~~~lVm 581 (716)
..+.|++.+..+-++.+.||+....+..++||......... ...+.+|..++..+. +--+.+++.+...++..++||
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 34677877776556667999998888889999876543221 123556777777663 333567777777788899999
Q ss_pred eecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005054 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-------------------------------------- 623 (716)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~v~~i~~ql~~aL~yLH~~~-------------------------------------- 623 (716)
++++|.++....... .. ...++.++...+..||+..
T Consensus 90 ~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 90 SEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred Eeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999998876543211 11 1122334444444444311
Q ss_pred -------------------CCeEEcCCCCCcEEEccCCcEEEEecCCCccc
Q 005054 624 -------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (716)
Q Consensus 624 -------------------~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (716)
..++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 11799999999999987665679999988643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=4.8e-05 Score=74.54 Aligned_cols=73 Identities=18% Similarity=0.159 Sum_probs=49.2
Q ss_pred eeecCCc-EEEEEEEEcCC-eEEEEEeeccCCCHHHHHHHHHHHHHHHhcC--CCceeEEeceeccCCceEEEEeecCCC
Q 005054 512 QIGQGSC-GTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 512 ~LG~G~f-g~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~--hpnIv~~~~~~~~~~~~~lVmE~~~gg 587 (716)
.+..|.. ..||+....+. .+++|....... ..+..|...|+.+. .-.+++++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445553 67899887544 588898665432 23556777776663 223567787778888899999999876
Q ss_pred CH
Q 005054 588 SL 589 (716)
Q Consensus 588 sL 589 (716)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.34 E-value=0.00018 Score=75.73 Aligned_cols=77 Identities=21% Similarity=0.116 Sum_probs=47.5
Q ss_pred eeeeecCCcEEEEEEEE--cCCeEEEEEeeccC-C----CHHHHHHHHHHHHHHHhcC-C--CceeEEeceeccCCceEE
Q 005054 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE-Y----SDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVTSPQRLCI 579 (716)
Q Consensus 510 ~~~LG~G~fg~Vy~~~~--~~~~vAvK~~~~~~-~----~~~~~~~~~~E~~iL~~l~-h--pnIv~~~~~~~~~~~~~l 579 (716)
.+.||.|....||++.. .++.|+||.-.... . .+....+...|...|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999975 35678999653210 0 0111233456777777662 2 345566654 3456689
Q ss_pred EEeecCCCC
Q 005054 580 VTEFLPRGS 588 (716)
Q Consensus 580 VmE~~~ggs 588 (716)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.79 E-value=0.00085 Score=57.35 Aligned_cols=51 Identities=18% Similarity=0.132 Sum_probs=41.5
Q ss_pred eEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHc
Q 005054 143 VHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM 197 (716)
Q Consensus 143 Iiv~D~-dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~ 197 (716)
++++|. +|+|+|+.+....++|++.++++|+++.+++++.+ ...+.+.+..
T Consensus 20 Llvld~~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~----~~~i~~~l~~ 71 (114)
T d2oola2 20 LFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHG 71 (114)
T ss_dssp EEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC
T ss_pred EEEEECCCCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCHHH----HHHHHHHHhc
Confidence 456775 79999999999999999999999999999998754 3345555543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.42 E-value=0.005 Score=62.35 Aligned_cols=67 Identities=12% Similarity=0.054 Sum_probs=41.8
Q ss_pred cEEEEEEEE-cCCeEEEEEeeccCCCHHHHHHHHHHHHHHHhcCCCce--eEEe-----ceeccCCceEEEEeecCCC
Q 005054 518 CGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV--LLFM-----GAVTSPQRLCIVTEFLPRG 587 (716)
Q Consensus 518 fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~hpnI--v~~~-----~~~~~~~~~~lVmE~~~gg 587 (716)
--.||++.. .|.+|++|+.+...... ..+..|..++..|...+| +..+ ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999986 57789999987665444 345567777776632111 1111 1123445678899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.92 E-value=0.014 Score=60.48 Aligned_cols=75 Identities=17% Similarity=0.283 Sum_probs=49.4
Q ss_pred cceeEeeeeecCCcEEEEEEEEcC---------CeEEEEEeeccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeceeccC
Q 005054 505 EDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP 574 (716)
Q Consensus 505 ~~y~i~~~LG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~iL~~l~-hpnIv~~~~~~~~~ 574 (716)
+.+++ +.|+.|-.-.+|++.... ..|.+++.-... .. ....+|..+++.+. +.-.+++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34444 678888889999998632 357788765321 11 23456888888774 4334577777753
Q ss_pred CceEEEEeecCCCC
Q 005054 575 QRLCIVTEFLPRGS 588 (716)
Q Consensus 575 ~~~~lVmE~~~ggs 588 (716)
.+||||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 68999997653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.56 E-value=0.032 Score=55.51 Aligned_cols=30 Identities=23% Similarity=0.171 Sum_probs=26.5
Q ss_pred CeEEcCCCCCcEEEccCCcEEEEecCCCcc
Q 005054 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (716)
Q Consensus 625 ~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (716)
++||+|+.++||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 399999999999999887678999998863
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=93.87 E-value=0.05 Score=46.91 Aligned_cols=77 Identities=12% Similarity=0.039 Sum_probs=52.3
Q ss_pred Ccee-EEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHcCCe--eEEEEEEEcCCCCEE
Q 005054 140 GQSV-HIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER--WTGQFPAKTKTEERV 215 (716)
Q Consensus 140 ~d~I-iv~D~-dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~~~~~~~~i~~~l~~g~~--~~~e~~~~~kdG~~~ 215 (716)
+.|+ +++|. +++|++++..+..++|++.++++|+++.++++.. ...+...+..... ....+.....++..+
T Consensus 34 phG~LLald~~~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f 108 (127)
T d2o9ca2 34 PHGALLTADGHSGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-----WPALQAALPPGCPDALQYRATLDWPAAGHL 108 (127)
T ss_dssp TTSEEEEEETTTCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-----HHHHHHHSCTTCCTTCCEEEEECCSSSSEE
T ss_pred CCeEEEEEECCCCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHH-----HHHHHHHhhhcCcccccceeeeecCCCceE
Confidence 3444 45675 7999999999999999999999999999998642 2233444433322 333444445567777
Q ss_pred EEEEEE
Q 005054 216 LVVATN 221 (716)
Q Consensus 216 ~v~~~~ 221 (716)
++.+..
T Consensus 109 ~~~~Hr 114 (127)
T d2o9ca2 109 SLTVHR 114 (127)
T ss_dssp EEEEEE
T ss_pred EEEEEE
Confidence 775543
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=90.88 E-value=0.064 Score=46.18 Aligned_cols=41 Identities=20% Similarity=0.186 Sum_probs=35.5
Q ss_pred eEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccc
Q 005054 143 VHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183 (716)
Q Consensus 143 Iiv~D~-dG~Ii~vN~aae~l~Gys~eEliGk~~~~l~~~~~ 183 (716)
++++|. +++|+++...+..++|++.++++|+++.+++.+..
T Consensus 29 LLald~~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~ 70 (127)
T d2veaa3 29 VVVLQEPDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQ 70 (127)
T ss_dssp EEEEETTTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC-
T ss_pred EEEEECCCCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHH
Confidence 445774 78999999999999999999999999999997654
|